{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Como manipular XML com XPath"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gensim.models import KeyedVectors\n",
    "import unicodedata\n",
    "\n",
    "import gzip\n",
    "import xml.etree.ElementTree as ET\n",
    "\n",
    "with gzip.open('pordesc2018-small.xml.gz') as pordesc2018:\n",
    "    tree = ET.parse(pordesc2018)\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Monta Dicionario"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from unicodedata import normalize\n",
    "def remover_acentos(txt):\n",
    "    return normalize('NFKD', txt).encode('ASCII', 'ignore').decode('ASCII')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1859"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "wordModel = KeyedVectors.load_word2vec_format('health_w2v_unigram_50.bin', binary=True)\n",
    "\n",
    "dictMesh = {}\n",
    "for d in tree.findall(\"./DescriptorRecord\"):\n",
    "    terms = []\n",
    "    \n",
    "    qualifier = '#'\n",
    "    \n",
    "    for aql in d.findall('.AllowableQualifiersList/AllowableQualifier/QualifierReferredTo/QualifierName'):\n",
    "        teste_qualifier = aql.find('./String').text\n",
    "        if(teste_qualifier == 'anatomy & histology' or teste_qualifier == 'pharmacology' or teste_qualifier == 'methods' or teste_qualifier == 'diagnosis'):\n",
    "            qualifier = teste_qualifier\n",
    "            break\n",
    "    \n",
    "    for c in d.findall('.ConceptList/'):\n",
    "        if c.find('./ScopeNote') != None:\n",
    "            scope = c.find('./ScopeNote').text.replace('\\n','').strip()\n",
    "        for t in c.findall('./TermList/'):\n",
    "            terms.append(t.find('./String').text)\n",
    "            \n",
    "            palavra_similar = []\n",
    "            \n",
    "            if t.find('./String').text.lower() in wordModel.vocab:\n",
    "                sem_assento = remover_acentos(t.find('./String').text)\n",
    "                palavra_similar = wordModel.most_similar_cosmul(sem_assento.lower(),topn=10)\n",
    "                for similar, porcentagem in palavra_similar:\n",
    "                    if(porcentagem > 0.9 and qualifier != 'pharmacology'):\n",
    "                        ID = d.find('.DescriptorUI').text\n",
    "                        terms.append(\"<i>\"+similar+\"</i>\" + \" <input type='radio' name='\"+similar+\"' value='1'/> Certo <input type='radio' name='\"+similar+\"'' value='0'/> Errado\")\n",
    "                    elif(porcentagem > 0.95 and qualifier == 'pharmacology'):\n",
    "                        ID = d.find('.DescriptorUI').text\n",
    "                        terms.append(\"<i>\"+similar+\"</i>\"  + \" <input type='radio' name='\"+similar+\"' value='1'/> Certo <input type='radio' name='\"+similar+\"'' value='0'/> Errado\")\n",
    "    \n",
    "    terms.append(\" <input type='hidden' name='ID' value='\"+ID+\"'/> \")                         \n",
    "    dictMesh[d.find('.DescriptorUI').text] = {\n",
    "        'ID': d.find('.DescriptorUI').text,\n",
    "        'name': d.find('.DescriptorName/String').text,\n",
    "        'scope': scope,\n",
    "        'terms': sorted(set(terms), reverse=True),\n",
    "        'qualifier': qualifier\n",
    "    }\n",
    "                \n",
    "    #break\n",
    "len(dictMesh)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Imprime Exemplo"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\" <input type='hidden' name='ID' value='D000339'/> \",\n",
       " 'Afibrinogenemia',\n",
       " 'Afibrinogenemia',\n",
       " 'Afibrinogenemias',\n",
       " 'Deficiency, Fibrinogen',\n",
       " 'Deficiência de Fibrinogênio',\n",
       " 'Fibrinogen Deficiencies',\n",
       " 'Fibrinogen Deficiency']"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(terms)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Salva Dicionario"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "import gzip, pickle\n",
    "\n",
    "with gzip.open('dictMesh.dict.gz','wb') as fp:\n",
    "    pickle.dump(dictMesh,fp)\n",
    "    fp.close()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Carrega Dicionario"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "import gzip, pickle\n",
    "\n",
    "with gzip.open('dictMesh.dict.gz','rb') as fp:\n",
    "    dictMesh = pickle.load(fp)\n",
    "    fp.close()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9-((2-Hydroxyethoxy)methyl)guanine<br/>- Aci Sanorania<br/>- Aci-Sanorania<br/>- Acic<br/>- Aciclobeta<br/>- Acicloguanosina<br/>- Aciclostad<br/>- Aciclovir<br/>- Aciclovir<br/>- Aciclovir Alonga<br/>- Aciclovir Sanorania<br/>- Aciclovir-Sanorania<br/>- Acifur<br/>- Acipen Solutab<br/>- Acivir<br/>- Activir<br/>- Acyclo V<br/>- Acyclo-V<br/>- Acycloguanosine<br/>- Acyclovir<br/>- Acyclovir Sodium<br/>- Alonga, Aciclovir<br/>- Antiherpes Creme<br/>- Avirax<br/>- Cicloferon<br/>- Clonorax<br/>- Cusiviral<br/>- Genvir<br/>- Herpetad<br/>- Herpofug<br/>- Herpotern<br/>- Herpoviric<br/>- Isavir<br/>- Laciken<br/>- Mapox<br/>- Maynar<br/>- Milavir<br/>- Opthavir<br/>- Sodium, Acyclovir<br/>- Solutab, Acipen<br/>- Supraviran<br/>- Viclovir<br/>- Vipral<br/>- Virax Puren<br/>- Virax-Puren<br/>- ViraxPuren<br/>- Virherpes<br/>- Virmen<br/>- Virolex<br/>- Virupos<br/>- Virzin<br/>- Wellcome 248U<br/>- Wellcome-248U<br/>- Wellcome248U<br/>- Zoliparin<br/>- Zovirax<br/>- Zyclir<br/>- aciclovir von ct\n"
     ]
    }
   ],
   "source": [
    "evolucao = 'Wellcome 248U'\n",
    "evolucao = evolucao.split(' ')\n",
    "for i, palavra in enumerate(evolucao):\n",
    "\n",
    "    ## Busca palavra no Mesh\n",
    "    for dui in dictMesh:\n",
    "        d = dictMesh[dui]\n",
    "        for t in d['terms']:\n",
    "            new_t = t.replace('<i>', '')\n",
    "            new_t = new_t.replace('</i>', '')\n",
    "\n",
    "            if i+1 < (len(evolucao)) and palavra.lower()+\" \"+evolucao[i+1].lower() == new_t.lower():\n",
    "                    teste = dictMesh[dui]['terms']\n",
    "                    termos = '<br/>- '.join(teste)\n",
    "                    print(termos)\n",
    "                    break\n",
    "            elif new_t.lower() == palavra.lower():\n",
    "                teste = dictMesh[dui]['terms']\n",
    "                termos = '<br/>- '.join(teste)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Fibrinogen Deficiency Deficiência de Fibrinogênio Fibrinogen Deficiencies Afibrinogenemia Afibrinogenemias Deficiency, Fibrinogen'"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "termos=\" \"\n",
    "confirma = False\n",
    "evolucao = \"abd\"\n",
    "strr = \"\"\n",
    "\n",
    "#Verifica a lista para ver se a palavra esta no dicionario\n",
    "cont = 0\n",
    "for palavra in evolucao:\n",
    "    for dui in dictMesh:\n",
    "        d = dictMesh[dui]\n",
    "        for t in d['terms']:\n",
    "            if t.lower() == palavra.lower():\n",
    "                evolucao[cont] = '<a href=\"#\" data-ui=\"das\" data-term=\"\" data-scope=\"'+d['scope']+'\">'+palavra+'</a>'\n",
    "                cont +=1\n",
    "\n",
    "    teste = dictMesh[dui]['terms']\n",
    "    termos = ' '.join(teste)\n",
    "evolucao = evolucao.replace('data-terms=\"\"', 'data-terms=\"'+termos+'\"')#pegar os termos da lista e por aqui\n",
    "strr += ' '+evolucao\n",
    "\n",
    "#print(termos)\n",
    "termos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'D000001': {'ID': 'D000001',\n",
       "  'name': 'Calcimicina[Calcimycin]',\n",
       "  'scope': 'An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.',\n",
       "  'terms': ['A 23187',\n",
       "   'A-23187',\n",
       "   'A23187',\n",
       "   'A23187, Antibiotic',\n",
       "   'Antibiotic A23187',\n",
       "   'Calcimicina',\n",
       "   'Calcimycin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000002': {'ID': 'D000002',\n",
       "  'name': 'Temefós[Temefos]',\n",
       "  'scope': 'An organothiophosphate insecticide.',\n",
       "  'terms': ['Abate', 'Difos', 'Temefos', 'Temefós', 'Temephos'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000003': {'ID': 'D000003',\n",
       "  'name': 'Matadouros[Abattoirs]',\n",
       "  'scope': 'Places where animals are slaughtered and dressed for market.',\n",
       "  'terms': ['Abatedouros',\n",
       "   'Abattoir',\n",
       "   'Abattoirs',\n",
       "   'House, Slaughter',\n",
       "   'Houses, Slaughter',\n",
       "   'Matadouro',\n",
       "   'Matadouros',\n",
       "   'Slaughter House',\n",
       "   'Slaughter Houses',\n",
       "   'Slaughterhouse',\n",
       "   'Slaughterhouses'],\n",
       "  'qualifier': '#'},\n",
       " 'D000004': {'ID': 'D000004',\n",
       "  'name': 'Abreviaturas como Assunto[Abbreviations as Topic]',\n",
       "  'scope': 'Works about shortened forms of written words or phrases used for brevity.',\n",
       "  'terms': ['Abbreviations as Topic',\n",
       "   'Abreviatura dos Medicamentos',\n",
       "   'Abreviaturas como Assunto',\n",
       "   'Acronyms as Topic',\n",
       "   'Acrônimos como Assunto'],\n",
       "  'qualifier': '#'},\n",
       " 'D000005': {'ID': 'D000005',\n",
       "  'name': 'Abdome[Abdomen]',\n",
       "  'scope': 'That portion of the body that lies between the THORAX and the PELVIS.',\n",
       "  'terms': ['<i>abd</i>',\n",
       "   '<i>abd</i>',\n",
       "   '<i>abdome</i>',\n",
       "   '<i>abdomem</i>',\n",
       "   '<i>abdomem</i>',\n",
       "   '<i>abdomen</i>',\n",
       "   '<i>abdomne</i>',\n",
       "   '<i>abdomne</i>',\n",
       "   '<i>abm</i>',\n",
       "   '<i>abm</i>',\n",
       "   '<i>abome</i>',\n",
       "   '<i>abome</i>',\n",
       "   '<i>abomen</i>',\n",
       "   '<i>abomen</i>',\n",
       "   '<i>adbome</i>',\n",
       "   '<i>adbome</i>',\n",
       "   '<i>adome</i>',\n",
       "   '<i>adome</i>',\n",
       "   '<i>adomen</i>',\n",
       "   '<i>adomen</i>',\n",
       "   'Abdome',\n",
       "   'Abdomen',\n",
       "   'Abdomens',\n",
       "   'Abdômen'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000006': {'ID': 'D000006',\n",
       "  'name': 'Abdome Agudo[Abdomen, Acute]',\n",
       "  'scope': 'A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.',\n",
       "  'terms': ['Abdome Agudo',\n",
       "   'Abdomen, Acute',\n",
       "   'Abdomens, Acute',\n",
       "   'Acute Abdomen',\n",
       "   'Acute Abdomens'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000007': {'ID': 'D000007',\n",
       "  'name': 'Traumatismos Abdominais[Abdominal Injuries]',\n",
       "  'scope': 'General or unspecified injuries involving organs in the abdominal cavity.',\n",
       "  'terms': ['Abdominal Injuries',\n",
       "   'Abdominal Injury',\n",
       "   'Injuries, Abdominal',\n",
       "   'Injury, Abdominal',\n",
       "   'Lesões Abdominais',\n",
       "   'Traumatismos Abdominais'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000008': {'ID': 'D000008',\n",
       "  'name': 'Neoplasias Abdominais[Abdominal Neoplasms]',\n",
       "  'scope': 'New abnormal growth of tissue in the ABDOMEN.',\n",
       "  'terms': ['Abdominal Neoplasm',\n",
       "   'Abdominal Neoplasms',\n",
       "   'Neoplasias Abdominais',\n",
       "   'Neoplasm, Abdominal',\n",
       "   'Neoplasms, Abdominal',\n",
       "   'Tumores Abdominais',\n",
       "   'Tumores do Abdome'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000009': {'ID': 'D000009',\n",
       "  'name': 'Músculos Abdominais[Abdominal Muscles]',\n",
       "  'scope': 'Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS; ABDOMINAL OBLIQUE MUSCLES, transversus abdominis, pyramidalis muscles and quadratus abdominis.',\n",
       "  'terms': ['Abdominal Muscle',\n",
       "   'Abdominal Muscles',\n",
       "   'Abdominal, Transverse',\n",
       "   'Abdominals, Transverse',\n",
       "   'Abdomini, Quadratus',\n",
       "   'Abdominis, Quadratus',\n",
       "   'Cremaster Muscle',\n",
       "   'Cremaster Muscles',\n",
       "   'Muscle, Abdominal',\n",
       "   'Muscle, Cremaster',\n",
       "   'Muscle, Pyramidalis',\n",
       "   'Muscles, Abdominal',\n",
       "   'Muscles, Cremaster',\n",
       "   'Muscles, Pyramidalis',\n",
       "   'Músculo Cremaster',\n",
       "   'Músculo Piramidal',\n",
       "   'Músculo Quadrado do Abdome',\n",
       "   'Músculo Transverso Abdominal',\n",
       "   'Músculo Transverso do Abdome',\n",
       "   'Músculos Abdominais',\n",
       "   'Pyramidalis Muscle',\n",
       "   'Pyramidalis Muscles',\n",
       "   'Quadratus Abdomini',\n",
       "   'Quadratus Abdominis',\n",
       "   'Transverse Abdominal',\n",
       "   'Transverse Abdominals',\n",
       "   'Transversus Abdominis'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000010': {'ID': 'D000010',\n",
       "  'name': 'Nervo Abducente[Abducens Nerve]',\n",
       "  'scope': 'The 6th cranial nerve which originates in the ABDUCENS NUCLEUS of the PONS and sends motor fibers to the lateral rectus muscles of the EYE. Damage to the nerve or its nucleus disrupts horizontal eye movement control.',\n",
       "  'terms': ['Abducen, Nervus',\n",
       "   'Abducens Nerve',\n",
       "   'Abducens, Nervus',\n",
       "   'Abducent Nerve',\n",
       "   'Abducent Nerves',\n",
       "   'Cranial Nerve VI',\n",
       "   'Cranial Nerve VIs',\n",
       "   'Cranial Nerve, Sixth',\n",
       "   'Nerve VI',\n",
       "   'Nerve VI, Cranial',\n",
       "   'Nerve VIs',\n",
       "   'Nerve VIs, Cranial',\n",
       "   'Nerve, Abducens',\n",
       "   'Nerve, Abducent',\n",
       "   'Nerve, Sixth Cranial',\n",
       "   'Nerves, Sixth Cranial',\n",
       "   'Nervo Abducente',\n",
       "   'Nervo Craniano VI',\n",
       "   'Nervo Motor Ocular Externo',\n",
       "   'Nervus Abducen',\n",
       "   'Nervus Abducens',\n",
       "   'Sexto Nervo Craniano',\n",
       "   'Sixth Cranial Nerve',\n",
       "   'Sixth Cranial Nerves',\n",
       "   'VI Nervo Craniano',\n",
       "   'VI Par Craniano'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000011': {'ID': 'D000011',\n",
       "  'name': 'Vírus da Leucemia Murina de Abelson[Abelson murine leukemia virus]',\n",
       "  'scope': 'A replication-defective strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.',\n",
       "  'terms': ['Abelson Leukemia Virus',\n",
       "   'Abelson murine leukemia virus',\n",
       "   'Leukemia Virus, Abelson',\n",
       "   'Virus, Abelson Leukemia',\n",
       "   'Vírus da Leucemia Murina de Abelson',\n",
       "   'Vírus da Leucemia de Abelson'],\n",
       "  'qualifier': '#'},\n",
       " 'D000012': {'ID': 'D000012',\n",
       "  'name': 'Abetalipoproteinemia[Abetalipoproteinemia]',\n",
       "  'scope': 'An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.',\n",
       "  'terms': ['Abetalipoproteinemia',\n",
       "   'Abetalipoproteinemia',\n",
       "   'Acanthocytoses',\n",
       "   'Acanthocytosis',\n",
       "   'Bassen Kornzweig Disease',\n",
       "   'Bassen Kornzweig Syndrome',\n",
       "   'Bassen-Kornzweig Disease',\n",
       "   'Bassen-Kornzweig Syndrome',\n",
       "   'Betalipoprotein Deficiency Disease',\n",
       "   'Betalipoprotein Deficiency Diseases',\n",
       "   'Deficiency Disease, Betalipoprotein',\n",
       "   'Deficiency Diseases, Betalipoprotein',\n",
       "   'Deficiência de Proteína de Transferência de Triglicerídeo Microssômico',\n",
       "   'Deficiência de Proteína de Transferência de Triglicerídeos Microssômicos',\n",
       "   'Disease, Betalipoprotein Deficiency',\n",
       "   'Diseases, Betalipoprotein Deficiency',\n",
       "   'Doença por Deficiência da Proteína de Transferência de Triglicerídeos Microssômicos',\n",
       "   'Microsomal Triglyceride Transfer Protein Deficiency',\n",
       "   'Microsomal Triglyceride Transfer Protein Deficiency Disease',\n",
       "   'Síndrome de Bassen-Kornzweig'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000013': {'ID': 'D000013',\n",
       "  'name': 'Anormalidades Congênitas[Congenital Abnormalities]',\n",
       "  'scope': 'Malformations of organs or body parts during development in utero.',\n",
       "  'terms': ['Abnormalities, Congenital',\n",
       "   'Abnormality, Congenital',\n",
       "   'Anomalia Congênita',\n",
       "   'Anomalias Congênitas',\n",
       "   'Anormalidade Congênita',\n",
       "   'Anormalidades Congênitas',\n",
       "   'Birth Defect',\n",
       "   'Birth Defects',\n",
       "   'Congenital Abnormalities',\n",
       "   'Congenital Abnormality',\n",
       "   'Congenital Defect',\n",
       "   'Congenital Defects',\n",
       "   'Defect, Birth',\n",
       "   'Defect, Congenital',\n",
       "   'Defects, Birth',\n",
       "   'Defects, Congenital',\n",
       "   'Defeitos Congênitos',\n",
       "   'Deformidades',\n",
       "   'Deformities',\n",
       "   'Deformity',\n",
       "   'Malformações',\n",
       "   'Malformações Congênitas'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000014': {'ID': 'D000014',\n",
       "  'name': 'Anormalidades Induzidas por Medicamentos[Abnormalities, Drug-Induced]',\n",
       "  'scope': 'Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.',\n",
       "  'terms': ['Abnormalities, Drug Induced',\n",
       "   'Abnormalities, Drug-Induced',\n",
       "   'Abnormality, Drug-Induced',\n",
       "   'Anomalias Induzidas por Drogas',\n",
       "   'Anomalias Induzidas por Medicamentos',\n",
       "   'Anomalias Induzidas por Substâncias Medicamentosas',\n",
       "   'Anormalidades Induzidas por Drogas',\n",
       "   'Anormalidades Induzidas por Medicamentos',\n",
       "   'Anormalidades Induzidas por Substâncias Medicamentosas',\n",
       "   'Drug Induced Abnormalities',\n",
       "   'Drug-Induced Abnormalities',\n",
       "   'Drug-Induced Abnormality',\n",
       "   'Malformações Induzidas por Drogas',\n",
       "   'Malformações Induzidas por Medicamentos',\n",
       "   'Malformações Induzidas por Substâncias Medicamentosas'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000015': {'ID': 'D000015',\n",
       "  'name': 'Anormalidades Múltiplas[Abnormalities, Multiple]',\n",
       "  'scope': 'Congenital abnormalities that affect more than one organ or body structure.',\n",
       "  'terms': ['Abnormalities, Multiple',\n",
       "   'Anomalias Múltiplas',\n",
       "   'Anormalidades Múltiplas',\n",
       "   'Malformações Múltiplas',\n",
       "   'Multiple Abnormalities'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000016': {'ID': 'D000016',\n",
       "  'name': 'Anormalidades Induzidas por Radiação[Abnormalities, Radiation-Induced]',\n",
       "  'scope': 'Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.',\n",
       "  'terms': ['Abnormalities, Radiation Induced',\n",
       "   'Abnormalities, Radiation-Induced',\n",
       "   'Abnormality, Radiation-Induced',\n",
       "   'Anomalia Induzida por Radiação',\n",
       "   'Anomalias Induzidas por Radiação',\n",
       "   'Anormalidade Induzida por Radiação',\n",
       "   'Anormalidades Induzidas por Radiação',\n",
       "   'Malformação Induzida por Radiação',\n",
       "   'Malformações Induzidas por Radiação',\n",
       "   'Radiation Induced Abnormalities',\n",
       "   'Radiation-Induced Abnormalities',\n",
       "   'Radiation-Induced Abnormality'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000017': {'ID': 'D000017',\n",
       "  'name': 'Sistema do Grupo Sanguíneo ABO[ABO Blood-Group System]',\n",
       "  'scope': 'The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.',\n",
       "  'terms': ['ABH Blood Group',\n",
       "   'ABH Blood Groups',\n",
       "   'ABO Blood Group System',\n",
       "   'ABO Blood-Group System',\n",
       "   'ABO Blood-Group Systems',\n",
       "   'ABO Factor',\n",
       "   'ABO Factors',\n",
       "   'Blood Group H Type 1 Antigen',\n",
       "   'Blood Group, ABH',\n",
       "   'Blood Group, H',\n",
       "   'Blood Groups, ABH',\n",
       "   'Blood Groups, H',\n",
       "   'Blood-Group System, ABO',\n",
       "   'Blood-Group Systems, ABO',\n",
       "   'Factor, ABO',\n",
       "   'Factors, ABO',\n",
       "   'Fatores ABO',\n",
       "   'Grupo Sanguíneo ABH',\n",
       "   'H Blood Group',\n",
       "   'H Blood Group System',\n",
       "   'H Blood Groups',\n",
       "   'Sistema do Grupo Sanguíneo ABO',\n",
       "   'System, ABO Blood-Group',\n",
       "   'Systems, ABO Blood-Group'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000018': {'ID': 'D000018',\n",
       "  'name': 'Abomaso[Abomasum]',\n",
       "  'scope': 'The fourth stomach of ruminating animals. It is also called the \"true\" stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. (From Black\\'s Veterinary Dictionary, 17th ed)',\n",
       "  'terms': ['Abomaso', 'Abomasum', 'Abomasums'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000019': {'ID': 'D000019',\n",
       "  'name': 'Abortivos[Abortifacient Agents]',\n",
       "  'scope': 'Chemical substances that interrupt pregnancy after implantation.',\n",
       "  'terms': ['Abortifacient Agents',\n",
       "   'Abortifacient Effect',\n",
       "   'Abortifacient Effects',\n",
       "   'Abortifacients',\n",
       "   'Abortivos',\n",
       "   'Agents, Abortifacient',\n",
       "   'Agents, Postconception Contraceptive',\n",
       "   'Contraceptive Agents, Postconception',\n",
       "   'Efeito Abortivo',\n",
       "   'Effect, Abortifacient',\n",
       "   'Effects, Abortifacient',\n",
       "   'Postconception Contraceptive Agents',\n",
       "   'Substâncias Abortivas'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000020': {'ID': 'D000020',\n",
       "  'name': 'Abortivos não Esteroides[Abortifacient Agents, Nonsteroidal]',\n",
       "  'scope': 'Non-steroidal chemical compounds with abortifacient activity.',\n",
       "  'terms': ['Abortifacient Agents, Non Steroidal',\n",
       "   'Abortifacient Agents, Non-Steroidal',\n",
       "   'Abortifacient Agents, Nonsteroidal',\n",
       "   'Abortivos não Esteroides',\n",
       "   'Agents, Non-Steroidal Abortifacient',\n",
       "   'Agents, Nonsteroidal Abortifacient',\n",
       "   'Non-Steroidal Abortifacient Agents',\n",
       "   'Nonsteroidal Abortifacient Agents'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000021': {'ID': 'D000021',\n",
       "  'name': 'Abortivos Esteroides[Abortifacient Agents, Steroidal]',\n",
       "  'scope': 'Steroidal compounds with abortifacient activity.',\n",
       "  'terms': ['Abortifacient Agents, Steroidal',\n",
       "   'Abortifacients, Steroid',\n",
       "   'Abortivos Esteroides',\n",
       "   'Agents, Steroidal Abortifacient',\n",
       "   'Steroid Abortifacients',\n",
       "   'Steroidal Abortifacient Agents'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000022': {'ID': 'D000022',\n",
       "  'name': 'Aborto Espontâneo[Abortion, Spontaneous]',\n",
       "  'scope': 'Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.',\n",
       "  'terms': ['Abortion, Spontaneous',\n",
       "   'Abortion, Tubal',\n",
       "   'Abortions, Spontaneous',\n",
       "   'Abortions, Tubal',\n",
       "   'Aborto Espontâneo',\n",
       "   'Early Pregnancy Loss',\n",
       "   'Early Pregnancy Losses',\n",
       "   'Miscarriage',\n",
       "   'Miscarriages',\n",
       "   'Pregnancy Loss, Early',\n",
       "   'Pregnancy Losses, Early',\n",
       "   'Spontaneous Abortion',\n",
       "   'Spontaneous Abortions',\n",
       "   'Tubal Abortion',\n",
       "   'Tubal Abortions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000023': {'ID': 'D000023',\n",
       "  'name': 'Aspirantes a Aborto[Abortion Applicants]',\n",
       "  'scope': 'Individuals requesting induced abortions.',\n",
       "  'terms': ['Abortion Applicant',\n",
       "   'Abortion Applicants',\n",
       "   'Abortion Seeker',\n",
       "   'Abortion Seeker, Refused',\n",
       "   'Abortion Seeker, Repeated',\n",
       "   'Abortion Seekers',\n",
       "   'Abortion Seekers, Refused',\n",
       "   'Abortion Seekers, Repeated',\n",
       "   'Applicant, Abortion',\n",
       "   'Applicants, Abortion',\n",
       "   'Aspirantes a Aborto',\n",
       "   'Interessados em Aborto',\n",
       "   'Refused Abortion Seeker',\n",
       "   'Refused Abortion Seekers',\n",
       "   'Repeated Abortion Seeker',\n",
       "   'Repeated Abortion Seekers',\n",
       "   'Requerentes de Aborto',\n",
       "   'Seeker, Abortion',\n",
       "   'Seeker, Refused Abortion',\n",
       "   'Seeker, Repeated Abortion',\n",
       "   'Seekers, Abortion',\n",
       "   'Seekers, Refused Abortion',\n",
       "   'Seekers, Repeated Abortion'],\n",
       "  'qualifier': '#'},\n",
       " 'D000024': {'ID': 'D000024',\n",
       "  'name': 'Aborto Criminoso[Abortion, Criminal]',\n",
       "  'scope': 'Illegal termination of pregnancy.',\n",
       "  'terms': ['Abortion, Criminal',\n",
       "   'Abortion, Illegal',\n",
       "   'Abortions, Criminal',\n",
       "   'Abortions, Illegal',\n",
       "   'Aborto Criminoso',\n",
       "   'Aborto Ilegal',\n",
       "   'Criminal Abortion',\n",
       "   'Criminal Abortions',\n",
       "   'Illegal Abortion',\n",
       "   'Illegal Abortions'],\n",
       "  'qualifier': '#'},\n",
       " 'D000025': {'ID': 'D000025',\n",
       "  'name': 'Aborto Eugênico[Abortion, Eugenic]',\n",
       "  'scope': 'Abortion performed because of possible fetal defects.',\n",
       "  'terms': ['Abortion, Eugenic',\n",
       "   'Abortion, Selective',\n",
       "   'Abortions, Eugenic',\n",
       "   'Abortions, Selective',\n",
       "   'Aborto Eugênico',\n",
       "   'Eugenic Abortion',\n",
       "   'Eugenic Abortions',\n",
       "   'Selective Abortion',\n",
       "   'Selective Abortions'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000026': {'ID': 'D000026',\n",
       "  'name': 'Aborto Habitual[Abortion, Habitual]',\n",
       "  'scope': 'Three or more consecutive spontaneous abortions.',\n",
       "  'terms': ['Abortamento Habitual',\n",
       "   'Abortion, Habitual',\n",
       "   'Abortion, Recurrent',\n",
       "   'Aborto Habitual',\n",
       "   'Aborto Recidivante',\n",
       "   'Habitual Abortion',\n",
       "   'Habitual Abortions',\n",
       "   'Miscarriage, Recurrent',\n",
       "   'Perda Recidivante do Feto',\n",
       "   'Recurrent Abortion',\n",
       "   'Recurrent Abortions',\n",
       "   'Recurrent Early Pregnancy Loss',\n",
       "   'Recurrent Miscarriage',\n",
       "   'Recurrent Miscarriages'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000027': {'ID': 'D000027',\n",
       "  'name': 'Aborto Incompleto[Abortion, Incomplete]',\n",
       "  'scope': 'Premature loss of PREGNANCY in which not all the products of CONCEPTION have been expelled.',\n",
       "  'terms': ['Abortion, Incomplete',\n",
       "   'Abortions, Incomplete',\n",
       "   'Aborto Incompleto',\n",
       "   'Incomplete Abortion',\n",
       "   'Incomplete Abortions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000028': {'ID': 'D000028',\n",
       "  'name': 'Aborto Induzido[Abortion, Induced]',\n",
       "  'scope': 'Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)',\n",
       "  'terms': ['Abortion (Induced)',\n",
       "   'Abortion Failure',\n",
       "   'Abortion Failures',\n",
       "   'Abortion Histories',\n",
       "   'Abortion History',\n",
       "   'Abortion Rate',\n",
       "   'Abortion Rates',\n",
       "   'Abortion Technic',\n",
       "   'Abortion Technics',\n",
       "   'Abortion Technique',\n",
       "   'Abortion Techniques',\n",
       "   'Abortion, Drug Induced',\n",
       "   'Abortion, Drug-Induced',\n",
       "   'Abortion, Induced',\n",
       "   'Abortion, Previous',\n",
       "   'Abortion, Rivanol',\n",
       "   'Abortion, Saline Solution',\n",
       "   'Abortion, Saline-Solution',\n",
       "   'Abortion, Soap Solution',\n",
       "   'Abortion, Soap-Solution',\n",
       "   'Abortions (Induced)',\n",
       "   'Abortions, Drug-Induced',\n",
       "   'Abortions, Induced',\n",
       "   'Abortions, Previous',\n",
       "   'Abortions, Rivanol',\n",
       "   'Abortions, Saline-Solution',\n",
       "   'Abortions, Soap-Solution',\n",
       "   'Aborto Induzido',\n",
       "   'Aborto Provocado',\n",
       "   'Anti Abortion Groups',\n",
       "   'Anti-Abortion Group',\n",
       "   'Anti-Abortion Groups',\n",
       "   'Drug-Induced Abortion',\n",
       "   'Drug-Induced Abortions',\n",
       "   'Embriotomia',\n",
       "   'Embryotomies',\n",
       "   'Embryotomy',\n",
       "   'Failure, Abortion',\n",
       "   'Failures, Abortion',\n",
       "   'Fertility Control, Postconception',\n",
       "   'Group, Anti-Abortion',\n",
       "   'Groups, Anti-Abortion',\n",
       "   'Histories, Abortion',\n",
       "   'History, Abortion',\n",
       "   'Induced Abortion',\n",
       "   'Induced Abortions',\n",
       "   'Postconception Fertility Control',\n",
       "   'Previous Abortion',\n",
       "   'Previous Abortions',\n",
       "   'Rate, Abortion',\n",
       "   'Rates, Abortion',\n",
       "   'Rivanol Abortion',\n",
       "   'Rivanol Abortions',\n",
       "   'Saline-Solution Abortion',\n",
       "   'Saline-Solution Abortions',\n",
       "   'Soap-Solution Abortion',\n",
       "   'Soap-Solution Abortions',\n",
       "   'Tasa de Aborto',\n",
       "   'Tasa de Abortos',\n",
       "   'Technic, Abortion',\n",
       "   'Technics, Abortion',\n",
       "   'Technique, Abortion',\n",
       "   'Techniques, Abortion',\n",
       "   'Índice de Aborto',\n",
       "   'Índice de Abortos'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000029': {'ID': 'D000029',\n",
       "  'name': 'Aborto Legal[Abortion, Legal]',\n",
       "  'scope': 'Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)',\n",
       "  'terms': ['Abortion on Demand',\n",
       "   'Abortion, Legal',\n",
       "   'Abortions, Legal',\n",
       "   'Aborto Legal',\n",
       "   'Aborto por Demanda',\n",
       "   'Aborto sob Demanda',\n",
       "   'Legal Abortion',\n",
       "   'Legal Abortions'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000030': {'ID': 'D000030',\n",
       "  'name': 'Aborto Retido[Abortion, Missed]',\n",
       "  'scope': 'The retention in the UTERUS of a dead FETUS two months or more after its DEATH.',\n",
       "  'terms': ['Abortion, Missed',\n",
       "   'Abortions, Missed',\n",
       "   'Aborto Retido',\n",
       "   'Missed Abortion',\n",
       "   'Missed Abortions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000031': {'ID': 'D000031',\n",
       "  'name': 'Aborto Séptico[Abortion, Septic]',\n",
       "  'scope': 'Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.',\n",
       "  'terms': ['Abortion, Septic',\n",
       "   'Abortions, Septic',\n",
       "   'Aborto Séptico',\n",
       "   'Septic Abortion',\n",
       "   'Septic Abortions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000032': {'ID': 'D000032',\n",
       "  'name': 'Aborto Terapêutico[Abortion, Therapeutic]',\n",
       "  'scope': 'Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)',\n",
       "  'terms': ['Abortion, Therapeutic',\n",
       "   'Abortions, Therapeutic',\n",
       "   'Aborto Terapêutico',\n",
       "   'Therapeutic Abortion',\n",
       "   'Therapeutic Abortions'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000033': {'ID': 'D000033',\n",
       "  'name': 'Ameaça de Aborto[Abortion, Threatened]',\n",
       "  'scope': 'UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.',\n",
       "  'terms': ['Abortion, Threatened',\n",
       "   'Ameaça de Aborto',\n",
       "   'Ameaço de Aborto',\n",
       "   'Miscarriage, Threatened',\n",
       "   'Threatened Abortion',\n",
       "   'Threatened Abortions',\n",
       "   'Threatened Miscarriage',\n",
       "   'Threatened Miscarriages'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000034': {'ID': 'D000034',\n",
       "  'name': 'Aborto Animal[Abortion, Veterinary]',\n",
       "  'scope': 'Premature expulsion of the FETUS in animals.',\n",
       "  'terms': ['Abortion, Veterinary',\n",
       "   'Abortions, Veterinary',\n",
       "   'Aborto Animal',\n",
       "   'Veterinary Abortion',\n",
       "   'Veterinary Abortions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000035': {'ID': 'D000035',\n",
       "  'name': 'Ab-Reação[Abreaction]',\n",
       "  'scope': 'A process in psychotherapy in which the patient is \"desensitized\" to emotionally painful, often forgotten (repressed) memories by recalling and reacting to them in the \"safety\" of the treatment setting.',\n",
       "  'terms': ['Ab-Reação', 'Abreaction', 'Abreactions'],\n",
       "  'qualifier': '#'},\n",
       " 'D000036': {'ID': 'D000036',\n",
       "  'name': 'Abrina[Abrin]',\n",
       "  'scope': 'A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, & abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.',\n",
       "  'terms': ['Abrin', 'Abrin A', 'Abrin C', 'Abrina'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000037': {'ID': 'D000037',\n",
       "  'name': 'Descolamento Prematuro da Placenta[Abruptio Placentae]',\n",
       "  'scope': 'Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.',\n",
       "  'terms': ['Abruptio Placentae',\n",
       "   'Abruptio Placentae',\n",
       "   'Abruption, Placental',\n",
       "   'Abruptions, Placental',\n",
       "   'Descolamento Prematuro da Placenta',\n",
       "   'Placental Abruption',\n",
       "   'Placental Abruptions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000038': {'ID': 'D000038',\n",
       "  'name': 'Abscesso[Abscess]',\n",
       "  'scope': 'Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.',\n",
       "  'terms': ['<i>abcesso</i>',\n",
       "   '<i>absceso</i>',\n",
       "   'Abscess',\n",
       "   'Abscesses',\n",
       "   'Abscesso'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000039': {'ID': 'D000039',\n",
       "  'name': 'Abscesso Peritonsilar[Peritonsillar Abscess]',\n",
       "  'scope': 'An accumulation of purulent material in the area between the PALATINE TONSIL and its capsule.',\n",
       "  'terms': ['Abscess, Peritonsillar',\n",
       "   'Abscesses, Peritonsillar',\n",
       "   'Abscesso Periamigdaliano',\n",
       "   'Abscesso Peritonsilar',\n",
       "   'Peritonsillar Abscess',\n",
       "   'Peritonsillar Abscesses'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000040': {'ID': 'D000040',\n",
       "  'name': 'Ácido Abscísico[Abscisic Acid]',\n",
       "  'scope': 'Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.',\n",
       "  'terms': ['Abscisic Acid',\n",
       "   'Abscisic Acid Monoammonium Salt, (R)-Isomer',\n",
       "   'Abscisic Acid, (+,-)-Isomer',\n",
       "   'Abscisic Acid, (E,E)-(+-)-Isomer',\n",
       "   'Abscisic Acid, (E,Z)-(+,-)-Isomer',\n",
       "   'Abscisic Acid, (R)-Isomer',\n",
       "   'Abscisic Acid, (Z,E)-Isomer',\n",
       "   'Abscissic Acid',\n",
       "   'Abscissins',\n",
       "   'Ácido Abscísico'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000041': {'ID': 'D000041',\n",
       "  'name': 'Absenteísmo[Absenteeism]',\n",
       "  'scope': 'Chronic absence from work or other duty.',\n",
       "  'terms': ['Absenteeism',\n",
       "   'Absenteísmo',\n",
       "   'Absentismo',\n",
       "   'Abstencionismo',\n",
       "   'Ausentismo',\n",
       "   'Ausência'],\n",
       "  'qualifier': '#'},\n",
       " 'D000042': {'ID': 'D000042',\n",
       "  'name': 'Absorção[Absorption]',\n",
       "  'scope': 'The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.',\n",
       "  'terms': ['Absorption', 'Absorção'],\n",
       "  'qualifier': '#'},\n",
       " 'D000043': {'ID': 'D000043',\n",
       "  'name': 'Resumos e Indexação como Assunto[Abstracting and Indexing as Topic]',\n",
       "  'scope': 'Works about activities performed to identify concepts and aspects of published information and research reports.',\n",
       "  'terms': ['Abstracting',\n",
       "   'Abstracting and Indexing',\n",
       "   'Abstracting and Indexing as Topic',\n",
       "   'Abstracting as Topic',\n",
       "   'Indexação como Assunto',\n",
       "   'Indexes as Topic',\n",
       "   'Indexing',\n",
       "   'Indexing and Abstracting',\n",
       "   'Indexing and Abstracting as Topic',\n",
       "   'Indexing as Topic',\n",
       "   'Resumos como Assunto',\n",
       "   'Resumos e Indexação como Assunto',\n",
       "   'Índices como Assunto'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000044': {'ID': 'D000044',\n",
       "  'name': 'Dente Suporte[Dental Abutments]',\n",
       "  'scope': 'Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis (such as an implant) serving the same purpose.',\n",
       "  'terms': ['Abutment, Dental',\n",
       "   'Abutments, Dental',\n",
       "   'Dental Abutment',\n",
       "   'Dental Abutments',\n",
       "   'Dente Suporte',\n",
       "   'Dente-Suporte',\n",
       "   'Pivô'],\n",
       "  'qualifier': '#'},\n",
       " 'D000045': {'ID': 'D000045',\n",
       "  'name': 'Acacia[Acacia]',\n",
       "  'scope': 'A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name catechu is more often used for Areca catechu (ARECA).',\n",
       "  'terms': ['Acacia',\n",
       "   'Acacia',\n",
       "   'Acacia arabica',\n",
       "   'Acacia catechu',\n",
       "   'Acacia catechus',\n",
       "   'Acacia decurrens',\n",
       "   'Acacia mearnsii',\n",
       "   'Acacias',\n",
       "   'Acácia da Austrália',\n",
       "   'Acácia-Negra',\n",
       "   'Acácia-do-Nilo',\n",
       "   'Locust Tree',\n",
       "   'Locust Trees',\n",
       "   'Tree, Locust',\n",
       "   'Tree, Wattle',\n",
       "   'Trees, Locust',\n",
       "   'Trees, Wattle',\n",
       "   'Wattle Tree',\n",
       "   'Wattle Trees',\n",
       "   'catechus, Acacia',\n",
       "   'Árvore-da-Goma-Arábica'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000046': {'ID': 'D000046',\n",
       "  'name': 'Centros Médicos Acadêmicos[Academic Medical Centers]',\n",
       "  'scope': 'Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.',\n",
       "  'terms': ['Academic Medical Center',\n",
       "   'Academic Medical Centers',\n",
       "   'Center, Academic Medical',\n",
       "   'Center, University Medical',\n",
       "   'Centers, Academic Medical',\n",
       "   'Centers, University Medical',\n",
       "   'Centros Médicos Acadêmicos',\n",
       "   'Centros Médicos Universitários',\n",
       "   'Medical Center, Academic',\n",
       "   'Medical Center, University',\n",
       "   'Medical Centers, Academic',\n",
       "   'Medical Centers, University',\n",
       "   'University Medical Center',\n",
       "   'University Medical Centers'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000047': {'ID': 'D000047',\n",
       "  'name': 'Academias e Institutos[Academies and Institutes]',\n",
       "  'scope': 'Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.',\n",
       "  'terms': ['Academias e Institutos',\n",
       "   'Academies',\n",
       "   'Academies and Institutes',\n",
       "   'Academy',\n",
       "   'Academy and Institute',\n",
       "   'Centro de Pesquisa',\n",
       "   'Instituição de Pesquisa',\n",
       "   'Institute and Academy',\n",
       "   'Institute, Research',\n",
       "   'Institutes',\n",
       "   'Institutes and Academies',\n",
       "   'Institutes, Research',\n",
       "   'Institutos',\n",
       "   'Institutos de Pesquisa',\n",
       "   'Research Institute',\n",
       "   'Research Institutes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000048': {'ID': 'D000048',\n",
       "  'name': 'Acanthamoeba[Acanthamoeba]',\n",
       "  'scope': 'A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.',\n",
       "  'terms': ['Acanthamoeba', 'Acanthamoeba', 'Acanthamoebas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000049': {'ID': 'D000049',\n",
       "  'name': 'Acantocéfalos[Acanthocephala]',\n",
       "  'scope': 'A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.',\n",
       "  'terms': ['Acanthocephala',\n",
       "   'Acanthocephala',\n",
       "   'Acanthocephalas',\n",
       "   'Acantocéfalos',\n",
       "   'Thorny Headed Worms',\n",
       "   'Thorny-Headed Worm',\n",
       "   'Thorny-Headed Worms',\n",
       "   'Vermes de Cabeça Espinhosa',\n",
       "   'Worm, Thorny-Headed',\n",
       "   'Worms, Thorny-Headed'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000050': {'ID': 'D000050',\n",
       "  'name': 'Acantócitos[Acanthocytes]',\n",
       "  'scope': 'Erythrocytes with protoplasmic projections giving the cell a thorny appearance.',\n",
       "  'terms': ['Acanthocyte', 'Acanthocytes', 'Acantócitos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000051': {'ID': 'D000051',\n",
       "  'name': 'Acantólise[Acantholysis]',\n",
       "  'scope': 'Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.',\n",
       "  'terms': ['Acantholyses', 'Acantholysis', 'Acantólise'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000052': {'ID': 'D000052',\n",
       "  'name': 'Acantose Nigricans[Acanthosis Nigricans]',\n",
       "  'scope': 'A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.',\n",
       "  'terms': ['Acanthosis Nigrican',\n",
       "   'Acanthosis Nigricans',\n",
       "   'Acantose Nigricans',\n",
       "   'Nigrican, Acanthosis',\n",
       "   'Nigricans, Acanthosis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000053': {'ID': 'D000053',\n",
       "  'name': 'Ácaros e Carrapatos[Acari]',\n",
       "  'scope': 'A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.',\n",
       "  'terms': ['Acari', 'Acari', 'Acarina', 'Acarinos', 'Ácaros e Carrapatos'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000054': {'ID': 'D000054',\n",
       "  'name': 'Aceleração[Acceleration]',\n",
       "  'scope': 'An increase in the rate of speed.',\n",
       "  'terms': ['Acceleration', 'Accelerations', 'Aceleração'],\n",
       "  'qualifier': '#'},\n",
       " 'D000055': {'ID': 'D000055',\n",
       "  'name': 'Nervo Acessório[Accessory Nerve]',\n",
       "  'scope': 'The 11th cranial nerve which originates from NEURONS in the MEDULLA and in the CERVICAL SPINAL CORD. It has a cranial root, which joins the VAGUS NERVE (10th cranial) and sends motor fibers to the muscles of the LARYNX, and a spinal root, which sends motor fibers to the TRAPEZIUS and the sternocleidomastoid muscles.',\n",
       "  'terms': ['Accessorius, Nervus',\n",
       "   'Accessory Nerve',\n",
       "   'Accessory Nerve, Spinal',\n",
       "   'Accessory Nerves',\n",
       "   'Accessory Nerves, Spinal',\n",
       "   'Cranial Nerve XI',\n",
       "   'Cranial Nerve, Eleventh',\n",
       "   'Cranial Nerves, Eleventh',\n",
       "   'Décimo Primeiro Nervo Craniano',\n",
       "   'Eleventh Cranial Nerve',\n",
       "   'Eleventh Cranial Nerves',\n",
       "   'Nerve XI',\n",
       "   'Nerve XIs',\n",
       "   'Nerve, Accessory',\n",
       "   'Nerve, Eleventh Cranial',\n",
       "   'Nerve, Spinal Accessory',\n",
       "   'Nerves, Accessory',\n",
       "   'Nerves, Eleventh Cranial',\n",
       "   'Nerves, Spinal Accessory',\n",
       "   'Nervo Acessório',\n",
       "   'Nervo Acessório Espinal',\n",
       "   'Nervo Acessório Espinhal',\n",
       "   'Nervo Craniano XI',\n",
       "   'Nervus Accessorius',\n",
       "   'Spinal Accessory Nerve',\n",
       "   'Spinal Accessory Nerves',\n",
       "   'XI Nervo Craniano',\n",
       "   'XI Par Craniano'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000056': {'ID': 'D000056',\n",
       "  'name': 'Prevenção de Acidentes[Accident Prevention]',\n",
       "  'scope': 'Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.',\n",
       "  'terms': ['Accident Prevention',\n",
       "   'Accident Preventions',\n",
       "   'Prevention, Accident',\n",
       "   'Preventions, Accident',\n",
       "   'Prevenção de Acidentes'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000057': {'ID': 'D000057',\n",
       "  'name': 'Propensão a Acidentes[Accident Proneness]',\n",
       "  'scope': 'Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.',\n",
       "  'terms': ['Accident Proneness',\n",
       "   'Accident Pronenesses',\n",
       "   'Proneness, Accident',\n",
       "   'Pronenesses, Accident',\n",
       "   'Propensão a Acidentes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000058': {'ID': 'D000058',\n",
       "  'name': 'Acidentes por Quedas[Accidental Falls]',\n",
       "  'scope': 'Falls due to slipping or tripping which may result in injury.',\n",
       "  'terms': ['Accidental Fall',\n",
       "   'Accidental Falls',\n",
       "   'Acidentes por Quedas',\n",
       "   'Fall and Slip',\n",
       "   'Fall, Accidental',\n",
       "   'Falling',\n",
       "   'Falls',\n",
       "   'Falls, Accidental',\n",
       "   'Slip and Fall'],\n",
       "  'qualifier': '#'},\n",
       " 'D000059': {'ID': 'D000059',\n",
       "  'name': 'Acidentes[Accidents]',\n",
       "  'scope': 'Unexpected and unintentional events, typically resulting in damage or injury.',\n",
       "  'terms': ['Accident', 'Accidents', 'Acidentes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000060': {'ID': 'D000060',\n",
       "  'name': 'Acidentes Aeronáuticos[Accidents, Aviation]',\n",
       "  'scope': 'Unanticipated events associated with AIRCRAFT.',\n",
       "  'terms': ['Accident, Aviation',\n",
       "   'Accidents, Aviation',\n",
       "   'Acidentes Aeronáuticos',\n",
       "   'Aviation Accident',\n",
       "   'Aviation Accidents'],\n",
       "  'qualifier': '#'},\n",
       " 'D000061': {'ID': 'D000061',\n",
       "  'name': 'Acidentes Domésticos[Accidents, Home]',\n",
       "  'scope': 'ACCIDENTS which occur within the home.',\n",
       "  'terms': ['Accident, Home',\n",
       "   'Accidents, Home',\n",
       "   'Acidentes Domésticos',\n",
       "   'Home Accident',\n",
       "   'Home Accidents'],\n",
       "  'qualifier': '#'},\n",
       " 'D000062': {'ID': 'D000062',\n",
       "  'name': 'Acidentes de Trabalho[Accidents, Occupational]',\n",
       "  'scope': 'Unforeseen occurrences, especially injuries in the course of work-related activities.',\n",
       "  'terms': ['Accident, Industrial',\n",
       "   'Accident, Occupational',\n",
       "   'Accidents, Industrial',\n",
       "   'Accidents, Occupational',\n",
       "   'Acidente de Trabalho',\n",
       "   'Acidentes Ocupacionais',\n",
       "   'Acidentes de Trabalho',\n",
       "   'Acidentes de Trabalho Fatais',\n",
       "   'Acidentes de Trabalho Graves',\n",
       "   'Acidentes na Indústria',\n",
       "   'Industrial Accident',\n",
       "   'Industrial Accidents',\n",
       "   'Occupational Accident',\n",
       "   'Occupational Accidents'],\n",
       "  'qualifier': '#'},\n",
       " 'D000063': {'ID': 'D000063',\n",
       "  'name': 'Acidentes de Trânsito[Accidents, Traffic]',\n",
       "  'scope': 'Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES (passenger cars, buses, and trucks), BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.',\n",
       "  'terms': ['Accident, Traffic',\n",
       "   'Accidents, Traffic',\n",
       "   'Acidente de Tráfego',\n",
       "   'Acidente de Trânsito',\n",
       "   'Acidentes de Transporte',\n",
       "   'Acidentes de Tráfego',\n",
       "   'Acidentes de Trânsito',\n",
       "   'Traffic Accident',\n",
       "   'Traffic Accidents'],\n",
       "  'qualifier': '#'},\n",
       " 'D000064': {'ID': 'D000064',\n",
       "  'name': 'Aclimatação[Acclimatization]',\n",
       "  'scope': 'Adaptation to a new environment or to a change in the old.',\n",
       "  'terms': ['Acclimation', 'Acclimatization', 'Aclimatação', 'Aclimação'],\n",
       "  'qualifier': '#'},\n",
       " 'D000065': {'ID': 'D000065',\n",
       "  'name': 'Acomodação Ocular[Accommodation, Ocular]',\n",
       "  'scope': 'Adjustment of lens to distance.',\n",
       "  'terms': ['Accommodation, Lens',\n",
       "   'Accommodation, Ocular',\n",
       "   'Accommodation, Ocular Distance',\n",
       "   'Acomodação Ocular',\n",
       "   'Distance Accommodation, Ocular',\n",
       "   'Lens Accommodation',\n",
       "   'Ocular Accommodation',\n",
       "   'Ocular Distance Accommodation',\n",
       "   'Ocular Distance Accommodations'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066': {'ID': 'D000066',\n",
       "  'name': 'Contabilidade[Accounting]',\n",
       "  'scope': 'System of recording financial transactions.',\n",
       "  'terms': ['<i>balconista</i>',\n",
       "   '<i>escritorio</i>',\n",
       "   '<i>obras</i>',\n",
       "   '<i>telemarketing</i>',\n",
       "   '<i>vendas</i>',\n",
       "   'Accounting',\n",
       "   'Accountings',\n",
       "   'Contabilidade',\n",
       "   'Contabilidade de Custos'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066388': {'ID': 'D000066388',\n",
       "  'name': 'Indústria de Petróleo e Gás[Oil and Gas Industry]',\n",
       "  'scope': 'INDUSTRY concerned with the extraction, processing, distribution, marketing and storage of PETROLEUM and NATURAL GAS.',\n",
       "  'terms': ['Crude Oil Industries',\n",
       "   'Crude Oil Industry',\n",
       "   'Derivados de Petróleo',\n",
       "   'Gas Industries, Natural',\n",
       "   'Gas Industry, Natural',\n",
       "   'Gas and Oil Industry',\n",
       "   'Industries, Crude Oil',\n",
       "   'Industries, Natural Gas',\n",
       "   'Industries, Petroleum',\n",
       "   'Industry, Crude Oil',\n",
       "   'Industry, Natural Gas',\n",
       "   'Industry, Petroleum',\n",
       "   'Indústria Petroleira',\n",
       "   'Indústria Petrolífera',\n",
       "   'Indústria Petroquímica',\n",
       "   'Indústria de Petróleo e Gás',\n",
       "   'Indústria do Petróleo',\n",
       "   'Natural Gas Industries',\n",
       "   'Natural Gas Industry',\n",
       "   'Oil Industries, Crude',\n",
       "   'Oil Industry, Crude',\n",
       "   'Oil and Gas Industry',\n",
       "   'Petroleum Industries',\n",
       "   'Petroleum Industry',\n",
       "   'Refinarias de Petróleo'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066428': {'ID': 'D000066428',\n",
       "  'name': 'Indústria do Carvão Mineral[Coal Industry]',\n",
       "  'scope': 'Enterprise associated with the mining, processing, marketing and distribution of COAL.',\n",
       "  'terms': ['Coal Industries',\n",
       "   'Coal Industry',\n",
       "   'Industries, Coal',\n",
       "   'Industry, Coal',\n",
       "   'Indústria da Mineração do Carvão',\n",
       "   'Indústria do Carvão Mineral'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066448': {'ID': 'D000066448',\n",
       "  'name': 'Dirigir sob a Influência[Driving Under the Influence]',\n",
       "  'scope': 'Operating a motor vehicle while impaired by alcohol or other drugs including those prescribed by physicians.',\n",
       "  'terms': ['Dirigir sob Influência',\n",
       "   'Dirigir sob a Influência',\n",
       "   'Drinking and Driving',\n",
       "   'Driving Under the Influence',\n",
       "   'Driving While Intoxicated',\n",
       "   'Driving and Drinking',\n",
       "   'Driving, Drunk',\n",
       "   'Driving, Drunken',\n",
       "   'Drunk Driving',\n",
       "   'Drunken Driving',\n",
       "   'While Intoxicated, Driving'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066449': {'ID': 'D000066449',\n",
       "  'name': 'Células-Tronco Embrionárias Humanas[Human Embryonic Stem Cells]',\n",
       "  'scope': 'A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.',\n",
       "  'terms': ['Cells, Human Embryonic Stem',\n",
       "   'Células Estaminais Embrionárias Humanas',\n",
       "   'Células Tronco Embrionárias Humanas',\n",
       "   'Células Tronco Humanas Embrionárias',\n",
       "   'Células-Tronco Embrionárias Humanas',\n",
       "   'Células-Tronco Humanas Embrionárias',\n",
       "   'Human Embryonic Stem Cell',\n",
       "   'Human Embryonic Stem Cells',\n",
       "   'Stem Cells, Human Embryonic',\n",
       "   'hESCs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066450': {'ID': 'D000066450',\n",
       "  'name': 'Células-Tronco Embrionárias Murinas[Mouse Embryonic Stem Cells]',\n",
       "  'scope': 'PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos.',\n",
       "  'terms': ['Cells, Mouse Embryonic Stem',\n",
       "   'Células Estaminais Embrionárias Murinas',\n",
       "   'Células Estaminais Embrionárias de Camundongos',\n",
       "   'Células Tronco Embrionárias Murinas',\n",
       "   'Células Tronco Embrionárias de Camundongos',\n",
       "   'Células-Tronco Embrionárias Murinas',\n",
       "   'Células-Tronco Embrionárias de Camundongos',\n",
       "   'Mouse Embryonic Stem Cell',\n",
       "   'Mouse Embryonic Stem Cells',\n",
       "   'Stem Cells, Mouse Embryonic',\n",
       "   'mESCs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066473': {'ID': 'D000066473',\n",
       "  'name': 'Células Germinativas Embrionárias[Embryonic Germ Cells]',\n",
       "  'scope': 'PLURIPOTENT STEM CELLS that are derived from early GERM CELLS.',\n",
       "  'terms': ['Cell, EG',\n",
       "   'Cell, Embryonic Germ',\n",
       "   'Cells, EG',\n",
       "   'Cells, Embryonic Germ',\n",
       "   'Célula Germinativa Embrionária',\n",
       "   'Células Embrionárias Germinativas',\n",
       "   'Células Germinativas Embrionárias',\n",
       "   'Células Germinativas de Embriões',\n",
       "   'Células Germinativas do Embrião',\n",
       "   'Células Germinativas dos Embriões',\n",
       "   'EG Cell',\n",
       "   'EG Cells',\n",
       "   'Embryonic Germ Cell',\n",
       "   'Embryonic Germ Cells',\n",
       "   'Germ Cell, Embryonic',\n",
       "   'Germ Cells, Embryonic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066477': {'ID': 'D000066477',\n",
       "  'name': 'Desempenho Profissional[Work Performance]',\n",
       "  'scope': 'Measure of how well an individual performs tasks in a work-related environment.',\n",
       "  'terms': ['Desempenho Laboral',\n",
       "   'Desempenho Ocupacional',\n",
       "   'Desempenho Profissional',\n",
       "   'Desempenho no Trabalho',\n",
       "   'Job Performance',\n",
       "   'Job Performances',\n",
       "   'Performance at Work',\n",
       "   'Performance, Job',\n",
       "   'Performance, Work',\n",
       "   'Performances, Job',\n",
       "   'Performances, Work',\n",
       "   'Work Performance',\n",
       "   'Work Performances'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066479': {'ID': 'D000066479',\n",
       "  'name': 'Comportamento Criminoso[Criminal Behavior]',\n",
       "  'scope': 'Conduct leading to commission of unlawful acts.',\n",
       "  'terms': ['Behavior, Criminal',\n",
       "   'Behavior, Illegal',\n",
       "   'Behavior, Illicit',\n",
       "   'Behavior, Unlawful',\n",
       "   'Behaviors, Criminal',\n",
       "   'Behaviors, Illegal',\n",
       "   'Behaviors, Illicit',\n",
       "   'Behaviors, Unlawful',\n",
       "   'Comportamento Criminoso',\n",
       "   'Conduct, Criminal',\n",
       "   'Criminal Behavior',\n",
       "   'Criminal Behaviors',\n",
       "   'Criminal Conduct',\n",
       "   'Criminal Intent',\n",
       "   'Criminal Intents',\n",
       "   'Illegal Behavior',\n",
       "   'Illegal Behaviors',\n",
       "   'Illicit Behavior',\n",
       "   'Illicit Behaviors',\n",
       "   'Intent, Criminal',\n",
       "   'Intents, Criminal',\n",
       "   'Unlawful Behavior',\n",
       "   'Unlawful Behaviors'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066491': {'ID': 'D000066491',\n",
       "  'name': 'Tomada de Decisão Clínica[Clinical Decision-Making]',\n",
       "  'scope': 'Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention.',\n",
       "  'terms': ['Clinical Decision Making',\n",
       "   'Clinical Decision-Making',\n",
       "   'Decision-Making, Clinical',\n",
       "   'Decision-Making, Medical',\n",
       "   'Medical Decision Making',\n",
       "   'Medical Decision-Making',\n",
       "   'Tomada de Decisão Clínica',\n",
       "   'Tomada de Decisões Clínicas',\n",
       "   'Tomadas de Decisão Clínica'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066492': {'ID': 'D000066492',\n",
       "  'name': 'Envelhecimento Cognitivo[Cognitive Aging]',\n",
       "  'scope': 'Phenomenon that occurs when learning and memory abilities decrease naturally due to age.',\n",
       "  'terms': ['Aging, Cognitive', 'Cognitive Aging', 'Envelhecimento Cognitivo'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066494': {'ID': 'D000066494',\n",
       "  'name': 'Neurociência Cognitiva[Cognitive Neuroscience]',\n",
       "  'scope': 'Field of study concerning MENTAL PROCESSES; LEARNING; and the brain regions associated with them.',\n",
       "  'terms': ['Cognitive Neuroscience',\n",
       "   'Neurociência Cognitiva',\n",
       "   'Neuroscience, Cognitive'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066498': {'ID': 'D000066498',\n",
       "  'name': 'Ajustamento Emocional[Emotional Adjustment]',\n",
       "  'scope': 'Psychological process that occurs when an individual adapts to a significant emotional event or stimulus.',\n",
       "  'terms': ['Adaptation, Emotional',\n",
       "   'Adaptations, Emotional',\n",
       "   'Adjustment, Emotional',\n",
       "   'Adjustment, Psychological',\n",
       "   'Adjustments, Emotional',\n",
       "   'Adjustments, Psychological',\n",
       "   'Ajustamento Emocional',\n",
       "   'Ajustamento Psicológico',\n",
       "   'Ajuste Emocional',\n",
       "   'Emotional Adaptation',\n",
       "   'Emotional Adaptations',\n",
       "   'Emotional Adjustment',\n",
       "   'Emotional Adjustments',\n",
       "   'Psychological Adjustment',\n",
       "   'Psychological Adjustments'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066499': {'ID': 'D000066499',\n",
       "  'name': 'Reconhecimento Facial[Facial Recognition]',\n",
       "  'scope': 'Identification of another individual by their facial and other bodily features.',\n",
       "  'terms': ['Face Perception',\n",
       "   'Facial Recognition',\n",
       "   'Identity Recognition',\n",
       "   'Perception, Face',\n",
       "   'Recognition, Facial',\n",
       "   'Recognition, Identity',\n",
       "   'Reconhecimento Facial'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066502': {'ID': 'D000066502',\n",
       "  'name': 'Avós[Grandparents]',\n",
       "  'scope': 'Member of a family who has children and grandchildren.',\n",
       "  'terms': ['Avó',\n",
       "   'Avós',\n",
       "   'Avô',\n",
       "   'Grandfather',\n",
       "   'Grandfathers',\n",
       "   'Grandmother',\n",
       "   'Grandmothers',\n",
       "   'Grandparent',\n",
       "   'Grandparents'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066505': {'ID': 'D000066505',\n",
       "  'name': 'Comportamento de Busca de Ajuda[Help-Seeking Behavior]',\n",
       "  'scope': 'Form of social behavior in which assistance is sought from others.',\n",
       "  'terms': ['Behavior, Help-Seeking',\n",
       "   'Behaviors, Help-Seeking',\n",
       "   'Comportamento de Busca de Ajuda',\n",
       "   'Help Seeking Behavior',\n",
       "   'Help-Seeking Behavior',\n",
       "   'Help-Seeking Behaviors'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066506': {'ID': 'D000066506',\n",
       "  'name': 'Heurística[Heuristics]',\n",
       "  'scope': 'Experience-based techniques for problem-solving, learning, and discovery that find a solution which is not guaranteed to be optimal, but sufficient for a given set of goals.',\n",
       "  'terms': ['Heuristic', 'Heuristics', 'Heurística', 'Rule of Thumb'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066511': {'ID': 'D000066511',\n",
       "  'name': 'Violência por Parceiro Íntimo[Intimate Partner Violence]',\n",
       "  'scope': 'A pattern of assaultive and coercive behavior by an individual against their partner or spouse that may include physical injury, psychological abuse, sexual assault, progressive isolation, stalking, deprivation, intimidation, and reproductive coercion.',\n",
       "  'terms': ['Abuse, Intimate Partner',\n",
       "   'Dating Violence',\n",
       "   'Intimate Partner Abuse',\n",
       "   'Intimate Partner Violence',\n",
       "   'Partner Abuse, Intimate',\n",
       "   'Partner Violence, Intimate',\n",
       "   'Violence, Dating',\n",
       "   'Violence, Intimate Partner',\n",
       "   'Violência contra Parceiro Íntimo',\n",
       "   'Violência contra a Parceira Íntima',\n",
       "   'Violência entre Parceiros Íntimos',\n",
       "   'Violência por Parceiro Íntimo'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066530': {'ID': 'D000066530',\n",
       "  'name': 'Reabilitação Neurológica[Neurological Rehabilitation]',\n",
       "  'scope': 'Physician-supervised programs designed to rehabilitate people with diseases, trauma, or disorders of the NERVOUS SYSTEM.',\n",
       "  'terms': ['Neurologic Rehabilitation',\n",
       "   'Neurological Rehabilitation',\n",
       "   'Neurorehabilitation',\n",
       "   'Reabilitação Neurológica',\n",
       "   'Rehabilitation, Neurologic',\n",
       "   'Rehabilitation, Neurological'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066550': {'ID': 'D000066550',\n",
       "  'name': 'Abuso Físico[Physical Abuse]',\n",
       "  'scope': 'Violence inflicted on an individual through physical contact.',\n",
       "  'terms': ['Abuse, Physical',\n",
       "   'Abuso Físico',\n",
       "   'Maltreatment, Physical',\n",
       "   'Physical Abuse',\n",
       "   'Physical Maltreatment',\n",
       "   'Physical Violence',\n",
       "   'Violence, Physical'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066553': {'ID': 'D000066553',\n",
       "  'name': 'Comportamento Problema[Problem Behavior]',\n",
       "  'scope': 'Troublesome or disruptive behavioral displays.',\n",
       "  'terms': ['Behavior, Disruptive',\n",
       "   'Behavior, Problem',\n",
       "   'Behavior, Psychology Dysfunctional',\n",
       "   'Behavioral Problem',\n",
       "   'Behavioral Problems',\n",
       "   'Behaviors, Disruptive',\n",
       "   'Behaviors, Problem',\n",
       "   'Behaviors, Psychology Dysfunctional',\n",
       "   'Comportamento Disruptivo',\n",
       "   'Comportamento Problema',\n",
       "   'Comportamento Problemático',\n",
       "   'Comportamento-Problema',\n",
       "   'Disruptive Behavior',\n",
       "   'Disruptive Behaviors',\n",
       "   'Dysfunctional Behavior, Psychology',\n",
       "   'Dysfunctional Behaviors, Psychology',\n",
       "   'Problem Behavior',\n",
       "   'Problem Behaviors',\n",
       "   'Problem, Behavioral',\n",
       "   'Problems, Behavioral',\n",
       "   'Psicologia do Comportamento Disfuncional',\n",
       "   'Psychology Dysfunctional Behavior',\n",
       "   'Psychology Dysfunctional Behaviors'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066608': {'ID': 'D000066608',\n",
       "  'name': 'Consumo de Álcool por Menores[Underage Drinking]',\n",
       "  'scope': 'The age at which an individual can lawfully consume alcohol',\n",
       "  'terms': ['Adolescent Alcohol Consumption',\n",
       "   'Adolescent Alcohol Use',\n",
       "   'Adolescent Drinking',\n",
       "   'Alcohol Consumption, Adolescent',\n",
       "   'Alcohol Consumption, Underage',\n",
       "   'Alcohol Consumption, Youth',\n",
       "   'Alcohol Use, Adolescent',\n",
       "   'Alcohol Use, Underage',\n",
       "   'Consumo Alcoólico por Menores',\n",
       "   'Consumo Alcoólico por Menores de Idade',\n",
       "   'Consumo de Álcool por Menores',\n",
       "   'Consumo de Álcool por Menores de Idade',\n",
       "   'Drinking Age, Legal',\n",
       "   'Drinking Age, Minimum',\n",
       "   'Drinking Ages, Legal',\n",
       "   'Drinking Ages, Minimum',\n",
       "   'Drinking, Adolescent',\n",
       "   'Drinking, Teen',\n",
       "   'Drinking, Teenage',\n",
       "   'Drinking, Underage',\n",
       "   'Drinking, Youth',\n",
       "   'Legal Drinking Age',\n",
       "   'Legal Drinking Ages',\n",
       "   'Minimum Drinking Age',\n",
       "   'Minimum Drinking Ages',\n",
       "   'Minimum Legal Drinking Age',\n",
       "   'Teen Drinking',\n",
       "   'Teenage Drinking',\n",
       "   'Underage Alcohol Consumption',\n",
       "   'Underage Alcohol Use',\n",
       "   'Underage Drinking',\n",
       "   'Youth Alcohol Consumption',\n",
       "   'Youth Drinking'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066630': {'ID': 'D000066630',\n",
       "  'name': 'Expressão Ectópica do Gene[Ectopic Gene Expression]',\n",
       "  'scope': 'The expression of a gene in an abnormal place,  or at an abnormal  time in an organism. Ectopic Gene  Expression is often induced artificially by genetic techniques.',\n",
       "  'terms': ['Ectopic Expression',\n",
       "   'Ectopic Expressions',\n",
       "   'Ectopic Gene Expression',\n",
       "   'Ectopic Gene Expressions',\n",
       "   'Expression, Ectopic',\n",
       "   'Expression, Ectopic Gene',\n",
       "   'Expressions, Ectopic',\n",
       "   'Expressions, Ectopic Gene',\n",
       "   'Expressão Ectópica do Gene',\n",
       "   'Expressão Gênica Ectópica',\n",
       "   'Gene Expression, Ectopic',\n",
       "   'Gene Expressions, Ectopic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066670': {'ID': 'D000066670',\n",
       "  'name': 'Plasticidade Celular[Cell Plasticity]',\n",
       "  'scope': 'The ability of a cell to change its PHENOTYPE in response to changes in the environment.',\n",
       "  'terms': ['Cell Plasticities',\n",
       "   'Cell Plasticity',\n",
       "   'Cellular Plasticities',\n",
       "   'Cellular Plasticity',\n",
       "   'Plasticidade Celular',\n",
       "   'Plasticities, Cell',\n",
       "   'Plasticities, Cellular',\n",
       "   'Plasticity, Cell',\n",
       "   'Plasticity, Cellular'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066673': {'ID': 'D000066673',\n",
       "  'name': 'Autorrenovação Celular[Cell Self Renewal]',\n",
       "  'scope': 'The ability of STEM CELLS to divide while maintaining an undifferentiated state. This process perpetuates the stem cell pool throughout the life of an organism.',\n",
       "  'terms': ['Auto-Renovação das Células',\n",
       "   'Auto-Renovação de Células',\n",
       "   'Autorrenovação Celular',\n",
       "   'Autorrenovação da Célula-Tronco',\n",
       "   'Autorrenovação das Células',\n",
       "   'Autorrenovação de Células',\n",
       "   'Autorrenovação de Células-Tronco',\n",
       "   'Cell Renewal, Stem',\n",
       "   'Cell Renewals, Stem',\n",
       "   'Cell Self Renewal',\n",
       "   'Cell Self Renewals',\n",
       "   'Cell Self-Renewal, Stem',\n",
       "   'Cell Self-Renewals, Stem',\n",
       "   'Renewal, Cell Self',\n",
       "   'Renewal, Stem Cell',\n",
       "   'Renewals, Cell Self',\n",
       "   'Renewals, Stem Cell',\n",
       "   'Self Renewal, Cell',\n",
       "   'Self Renewals, Cell',\n",
       "   'Self-Renewal, Stem Cell',\n",
       "   'Self-Renewals, Stem Cell',\n",
       "   'Stem Cell Renewal',\n",
       "   'Stem Cell Renewals',\n",
       "   'Stem Cell Self Renewal',\n",
       "   'Stem Cell Self-Renewal',\n",
       "   'Stem Cell Self-Renewals'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066768': {'ID': 'D000066768',\n",
       "  'name': 'Pesquisa de Reabilitação[Rehabilitation Research]',\n",
       "  'scope': 'Studies and research concerning the psychological, educational, social, vocational, industrial, and economic aspects of REHABILITATION.',\n",
       "  'terms': ['Pesquisa de Reabilitação',\n",
       "   'Rehabilitation Research',\n",
       "   'Research, Rehabilitation'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066792': {'ID': 'D000066792',\n",
       "  'name': 'Ortodontistas[Orthodontists]',\n",
       "  'scope': 'Dentists who specialize in the diagnosis and treatment of neuromuscular and skeletal abnormalities of the developing or mature orofacial structures.',\n",
       "  'terms': ['Dentofacial Orthopedist',\n",
       "   'Dentofacial Orthopedists',\n",
       "   'Orthodontist',\n",
       "   'Orthodontists',\n",
       "   'Orthopedist, Dentofacial',\n",
       "   'Orthopedists, Dentofacial',\n",
       "   'Ortodontista',\n",
       "   'Ortodontistas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066794': {'ID': 'D000066794',\n",
       "  'name': 'Cirurgiões Bucomaxilofaciais[Oral and Maxillofacial Surgeons]',\n",
       "  'scope': 'Dentists specializing in TOOTH EXTRACTION.',\n",
       "  'terms': ['Cirurgiões Bucais e Maxilofaciais',\n",
       "   'Cirurgiões Buco-Maxilo-Faciais',\n",
       "   'Cirurgiões Bucomaxilofaciais',\n",
       "   'Cirurgiões Orais e Maxilofaciais',\n",
       "   'Cirurgiões da Boca, Maxilares e da Face',\n",
       "   'Exodontist',\n",
       "   'Exodontists',\n",
       "   'Maxillofacial Surgeon',\n",
       "   'Maxillofacial Surgeons',\n",
       "   'Oral Surgeon',\n",
       "   'Oral Surgeons',\n",
       "   'Oral and Maxillofacial Surgeons',\n",
       "   'Surgeon, Maxillofacial',\n",
       "   'Surgeon, Oral',\n",
       "   'Surgeons, Maxillofacial',\n",
       "   'Surgeons, Oral'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066829': {'ID': 'D000066829',\n",
       "  'name': 'Neuroproteção[Neuroprotection]',\n",
       "  'scope': 'The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases.',\n",
       "  'terms': ['Neural Protection',\n",
       "   'Neuron Protection',\n",
       "   'Neuronal Protection',\n",
       "   'Neuroprotection',\n",
       "   'Neuroproteção',\n",
       "   'Protection, Neural',\n",
       "   'Protection, Neuron',\n",
       "   'Protection, Neuronal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066888': {'ID': 'D000066888',\n",
       "  'name': 'Alimentos, Dieta e Nutrição[Diet, Food, and Nutrition]',\n",
       "  'scope': 'Concepts involved with nutritional physiology, including categories of substances eaten for sustenance, nutritional phenomena and processes, eating patterns and habits, and measurable nutritional parameters.',\n",
       "  'terms': ['Alimento, Dieta e Nutrição',\n",
       "   'Alimentos, Alimentação e Nutrição',\n",
       "   'Alimentos, Dieta e Nutrição',\n",
       "   'Alimentos, Regimes Alimentares e Nutrição',\n",
       "   'Diet, Food, and Nutrition',\n",
       "   'Dieta, Alimento e Nutrição',\n",
       "   'Dieta, Alimentos e Nutrição',\n",
       "   'Nutrição, Dieta e Alimentação',\n",
       "   'Nutrição, Dieta e Alimento',\n",
       "   'Nutrição, Dieta e Alimentos',\n",
       "   'Nutrição, Regime Alimentar e Alimentos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066889': {'ID': 'D000066889',\n",
       "  'name': 'Triticale[Triticale]',\n",
       "  'scope': 'A CEREAL GRAIN plant resulting from a cross between TRITICUM and SECALE CEREALE.',\n",
       "  'terms': ['Triticale', 'Triticale', 'Triticosecale', 'Triticum x Secale'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000066891': {'ID': 'D000066891',\n",
       "  'name': 'Resultados de Cuidados Críticos[Critical Care Outcomes]',\n",
       "  'scope': 'A measure of the mortality and morbidity rates among patients who receive CRITICAL CARE and INTENSIVE CARE as determined from the date of hospital discharge or release.',\n",
       "  'terms': ['Care Outcome, Critical',\n",
       "   'Care Outcomes, Critical',\n",
       "   'Critical Care Outcome',\n",
       "   'Critical Care Outcomes',\n",
       "   'Evolução do Cuidado Crítico',\n",
       "   'Evolução dos Cuidados Críticos',\n",
       "   'Outcome, Critical Care',\n",
       "   'Outcomes, Critical Care',\n",
       "   'Resultado do Cuidado Crítico',\n",
       "   'Resultados da Terapia Intensiva',\n",
       "   'Resultados de Cuidados Críticos',\n",
       "   'Resultados de Terapia Intensiva',\n",
       "   'Resultados dos Cuidados Críticos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066908': {'ID': 'D000066908',\n",
       "  'name': 'Treinamento por Simulação[Simulation Training]',\n",
       "  'scope': 'A highly customized interactive medium or program that allows individuals to learn and practice real world activities in an accurate, realistic, safe and secure environment.',\n",
       "  'terms': ['Interactive Learning',\n",
       "   'Learning, Interactive',\n",
       "   'Simulation Training',\n",
       "   'Training, Simulation',\n",
       "   'Treinamento Simulado',\n",
       "   'Treinamento por Simulação'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066928': {'ID': 'D000066928',\n",
       "  'name': 'Milhetes[Millets]',\n",
       "  'scope': 'An agronomic group especially of small-seeded grasses, mainly grown for human and animal consumption.',\n",
       "  'terms': ['Milhete',\n",
       "   'Milhetes',\n",
       "   'Milheto',\n",
       "   'Milhetos',\n",
       "   'Milho-Miúdo',\n",
       "   'Millet',\n",
       "   'Millets',\n",
       "   'Painço',\n",
       "   'Painços'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000066949': {'ID': 'D000066949',\n",
       "  'name': 'Ciências Biocomportamentais[Biobehavioral Sciences]',\n",
       "  'scope': 'An interdisciplinary scientific approach to the study of complex interactions among biological, social, behavioral, environmental factors, and their effects on health outcomes.',\n",
       "  'terms': ['Approach, Biobehavioral',\n",
       "   'Biobehavioral Approach',\n",
       "   'Biobehavioral Model',\n",
       "   'Biobehavioral Models',\n",
       "   'Biobehavioral Science',\n",
       "   'Biobehavioral Sciences',\n",
       "   'Ciências Biocomportamentais',\n",
       "   'Model, Biobehavioral',\n",
       "   'Models, Biobehavioral',\n",
       "   'Science, Biobehavioral',\n",
       "   'Sciences, Biobehavioral'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066970': {'ID': 'D000066970',\n",
       "  'name': 'Coroa de Proteína[Protein Corona]',\n",
       "  'scope': 'A layer of protein coating adsorbed by NANOPARTICLES upon entry into PLASMA or other protein-containing biological fluids, which affects how nanoparticles are internalized by cells and cleared from the body.',\n",
       "  'terms': ['Coroa Proteica',\n",
       "   'Coroa de Proteína',\n",
       "   'Corona Proteica',\n",
       "   'Corona de Proteína',\n",
       "   'Corona, Protein',\n",
       "   'Protein Corona'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000066988': {'ID': 'D000066988',\n",
       "  'name': 'Vegetarianos[Vegetarians]',\n",
       "  'scope': 'Persons who adopt a VEGETARIAN DIET that includes both EGGS and DAIRY PRODUCTS, but no MEAT.',\n",
       "  'terms': ['Lacto Ovo Vegetarians',\n",
       "   'Lacto-Ovo Vegetarian',\n",
       "   'Lacto-Ovo Vegetarians',\n",
       "   'Ovo Lacto Vegetarians',\n",
       "   'Ovo-Lacto Vegetarian',\n",
       "   'Ovo-Lacto Vegetarians',\n",
       "   'Vegetarian',\n",
       "   'Vegetarian, Lacto-Ovo',\n",
       "   'Vegetarian, Ovo-Lacto',\n",
       "   'Vegetarianos',\n",
       "   'Vegetarians',\n",
       "   'Vegetarians, Lacto-Ovo',\n",
       "   'Vegetarians, Ovo-Lacto'],\n",
       "  'qualifier': '#'},\n",
       " 'D000066989': {'ID': 'D000066989',\n",
       "  'name': 'Veganos[Vegans]',\n",
       "  'scope': 'Persons who avoid consuming animal products or animal-derived substances, such as MEAT; EGGS; or HONEY.  Some vegans also refrain from using animals or animal products in any form or for any purpose, such as in CLOTHING or household goods.',\n",
       "  'terms': ['Vegan', 'Veganos', 'Vegans'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067': {'ID': 'D000067',\n",
       "  'name': 'Contas a Pagar e a Receber[Accounts Payable and Receivable]',\n",
       "  'scope': 'Short-term debt obligations and assets occurring in the regular course of operational transactions.',\n",
       "  'terms': ['Accounts Payable',\n",
       "   'Accounts Payable and Receivable',\n",
       "   'Contas a Pagar e a Receber'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067009': {'ID': 'D000067009',\n",
       "  'name': 'Esportes Juvenis[Youth Sports]',\n",
       "  'scope': 'SPORTS activities designed and/or organized for CHILDREN or YOUTH.',\n",
       "  'terms': ['Adolescent Sport',\n",
       "   'Adolescent Sports',\n",
       "   'Children Sports',\n",
       "   \"Children's Sport\",\n",
       "   \"Children's Sports\",\n",
       "   'Childrens Sports',\n",
       "   'Esportes Juvenis',\n",
       "   'Esportes para Jovens',\n",
       "   'Organized Youth Sport',\n",
       "   'Organized Youth Sports',\n",
       "   'Sport, Adolescent',\n",
       "   \"Sport, Children's\",\n",
       "   'Sport, Organized Youth',\n",
       "   'Sport, Youth',\n",
       "   'Sports, Adolescent',\n",
       "   \"Sports, Children's\",\n",
       "   'Sports, Organized Youth',\n",
       "   'Sports, Youth',\n",
       "   'Youth Sport',\n",
       "   'Youth Sport, Organized',\n",
       "   'Youth Sports',\n",
       "   'Youth Sports, Organized'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067010': {'ID': 'D000067010',\n",
       "  'name': 'Alfabetização[Literacy]',\n",
       "  'scope': 'Ability to read and write.',\n",
       "  'terms': ['Alfabetismo',\n",
       "   'Alfabetização',\n",
       "   'Analfabetismo',\n",
       "   'Illiteracy',\n",
       "   'Literacy'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067011': {'ID': 'D000067011',\n",
       "  'name': 'Desnutrição Aguda Grave[Severe Acute Malnutrition]',\n",
       "  'scope': 'Acute form of MALNUTRITION which usually affects children, characterized by a very low weight for height (below -3z scores of the median World Health Organization standards), visible severe wasting, or occurrence of nutritional EDEMA.  It can be a direct or indirect cause of fatality in children suffering from DIARRHEA and PNEUMONIA. Do not confuse with starvation, a condition in which the body is not getting enough food, usually for extended periods of time.',\n",
       "  'terms': ['Acute Malnutrition, Severe',\n",
       "   'Desnutrição Aguda Grave',\n",
       "   'Malnutrition, Severe Acute',\n",
       "   'Severe Acute Malnutrition'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067012': {'ID': 'D000067012',\n",
       "  'name': 'Conta Bancária[Banking, Personal]',\n",
       "  'scope': 'A financial account set up between a financial institution (such as a commercial bank) and a customer (individual, group, or business), whereby the latter may deposit and withdraw money, and where applicable, be paid interest.',\n",
       "  'terms': ['Account, Bank',\n",
       "   'Account, Checking',\n",
       "   'Account, Savings',\n",
       "   'Accounts, Bank',\n",
       "   'Accounts, Checking',\n",
       "   'Accounts, Savings',\n",
       "   'Bank Account',\n",
       "   'Bank Accounts',\n",
       "   'Banking, Commercial',\n",
       "   'Banking, Financial',\n",
       "   'Banking, Personal',\n",
       "   'Caderneta de Poupança',\n",
       "   'Checking Account',\n",
       "   'Checking Accounts',\n",
       "   'Commercial Banking',\n",
       "   'Conta Bancária',\n",
       "   'Conta Corrente',\n",
       "   'Conta Corrente Comercial',\n",
       "   'Conta Corrente Individual',\n",
       "   'Conta Poupança',\n",
       "   'Conta de Poupança',\n",
       "   'Financial Banking',\n",
       "   'Personal Banking',\n",
       "   'Savings Account',\n",
       "   'Savings Accounts',\n",
       "   'Serviços Bancários Pessoais'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067013': {'ID': 'D000067013',\n",
       "  'name': 'Projeto Arquitetônico Baseado em Evidências[Evidence-Based Facility Design]',\n",
       "  'scope': 'An approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.',\n",
       "  'terms': ['Arquitetura Hospitalar Baseada em Evidências',\n",
       "   'Design Arquitetônico Baseado em Evidências',\n",
       "   'Design Baseado em Evidências',\n",
       "   'Design, Evidence-Based Facility',\n",
       "   'Designs, Evidence-Based Facility',\n",
       "   'Evidence Based Facility Design',\n",
       "   'Evidence-Based Facility Design',\n",
       "   'Evidence-Based Facility Designs',\n",
       "   'Facility Design, Evidence-Based',\n",
       "   'Facility Designs, Evidence-Based',\n",
       "   'Projeto Arquitetônico Baseado em Evidências',\n",
       "   'Projeto de Instalação Baseado em Evidências'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067029': {'ID': 'D000067029',\n",
       "  'name': 'Aparência Física[Physical Appearance, Body]',\n",
       "  'scope': 'The superficial physical looks, characteristics or qualities of an individual as distinguished from the underlying unseen nature or attributes.',\n",
       "  'terms': ['Aparência Corporal',\n",
       "   'Aparência Corporal Física',\n",
       "   'Aparência Física',\n",
       "   'Aparência Física Corporal',\n",
       "   'Aparência Física do Corpo',\n",
       "   'Aparência do Corpo',\n",
       "   'Aparência do Corpo Físico',\n",
       "   'Appearance, Body Physical',\n",
       "   'Appearance, Outward',\n",
       "   'Appearance, Physical',\n",
       "   'Body Physical Appearance',\n",
       "   'Body, Physical Appearance',\n",
       "   'Outward Appearance',\n",
       "   'Physical Appearance',\n",
       "   'Physical Appearance, Body'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067030': {'ID': 'D000067030',\n",
       "  'name': 'Sucos de Frutas e Vegetais[Fruit and Vegetable Juices]',\n",
       "  'scope': 'The liquids extracted from plants.',\n",
       "  'terms': ['Bebida Vegetal',\n",
       "   'Bebida de Fruta',\n",
       "   'Bebida de Frutas',\n",
       "   'Bebida de Hortaliça',\n",
       "   'Bebida de Legume',\n",
       "   'Bebida de Planta',\n",
       "   'Bebida de Vegetal',\n",
       "   'Bebida de Verdura',\n",
       "   'Bebidas Vegetais',\n",
       "   'Bebidas de Frutas',\n",
       "   'Bebidas de Hortaliças',\n",
       "   'Bebidas de Legumes',\n",
       "   'Bebidas de Plantas',\n",
       "   'Bebidas de Vegetais',\n",
       "   'Bebidas de Verduras',\n",
       "   'Fruit Juice',\n",
       "   'Fruit Juices',\n",
       "   'Fruit and Vegetable Juices',\n",
       "   'Juice, Fruit',\n",
       "   'Juice, Vegetable',\n",
       "   'Juices, Fruit',\n",
       "   'Juices, Vegetable',\n",
       "   'Suco Vegetal',\n",
       "   'Suco de Fruta',\n",
       "   'Suco de Fruta e Hortaliça',\n",
       "   'Suco de Fruta e Legume',\n",
       "   'Suco de Fruta e Vegetal',\n",
       "   'Suco de Fruta e Verdura',\n",
       "   'Suco de Frutas',\n",
       "   'Suco de Frutas e Hortaliças',\n",
       "   'Suco de Frutas e Legumes',\n",
       "   'Suco de Frutas e Vegetais',\n",
       "   'Suco de Frutas e Verduras',\n",
       "   'Suco de Hortaliça',\n",
       "   'Suco de Hortaliças',\n",
       "   'Suco de Legume',\n",
       "   'Suco de Legumes',\n",
       "   'Suco de Planta',\n",
       "   'Suco de Vegetais',\n",
       "   'Suco de Vegetal',\n",
       "   'Suco de Verdura',\n",
       "   'Suco de Verduras',\n",
       "   'Sucos de Frutas',\n",
       "   'Sucos de Frutas e Hortaliças',\n",
       "   'Sucos de Frutas e Legumes',\n",
       "   'Sucos de Frutas e Vegetais',\n",
       "   'Sucos de Frutas e Verduras',\n",
       "   'Sucos de Hortaliças',\n",
       "   'Sucos de Vegetais',\n",
       "   'Sucos de Verduras',\n",
       "   'Sumo Vegetal',\n",
       "   'Sumo de Fruta',\n",
       "   'Sumo de Frutas',\n",
       "   'Sumo de Legume',\n",
       "   'Sumo de Planta',\n",
       "   'Sumo de Vegetal',\n",
       "   'Sumo de Verdura',\n",
       "   'Sumos Vegetais',\n",
       "   'Sumos de Frutas',\n",
       "   'Sumos de Legumes',\n",
       "   'Sumos de Plantas',\n",
       "   'Sumos de Vegetais',\n",
       "   'Vegetable Juice',\n",
       "   'Vegetable Juices'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067048': {'ID': 'D000067048',\n",
       "  'name': 'Ghee[Ghee]',\n",
       "  'scope': 'The clarified portion of milk, cream, or butter obtained by the removal of the nonfat constituents. (from Dictionary of Food Ingredients, 4th ed., 2001)',\n",
       "  'terms': ['Anhydrous Butterfat',\n",
       "   'Anhydrous Butterfats',\n",
       "   'Butter Oil',\n",
       "   'Butter Oils',\n",
       "   'Butter, Clarified',\n",
       "   'Butterfat, Anhydrous',\n",
       "   'Butterfats, Anhydrous',\n",
       "   'Butters, Clarified',\n",
       "   'Clarified Butter',\n",
       "   'Clarified Butters',\n",
       "   'Ghee',\n",
       "   'Ghee',\n",
       "   'Ghees',\n",
       "   'Ghi',\n",
       "   'Oil, Butter',\n",
       "   'Oils, Butter'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067071': {'ID': 'D000067071',\n",
       "  'name': 'Fraturamento Hidráulico[Hydraulic Fracking]',\n",
       "  'scope': 'A drilling technology in which NATURAL GAS is extracted from large deposits of impermeable rock formations known as shale, deep within the earth’s crust. This drilling technique involves injecting large volumes of high-pressure fracturing fluid (a mixture of water, sand, and chemicals) several thousand feet underground, thereby creating cracks or fissures in the shale formation, and releasing trapped gas.',\n",
       "  'terms': ['Fraccing',\n",
       "   'Fracking',\n",
       "   'Fracking, Hydraulic',\n",
       "   'Fracturing, Hydraulic',\n",
       "   'Fraturamento Hidráulico',\n",
       "   'Hydraulic Fracking',\n",
       "   'Hydraulic Fracturing',\n",
       "   'Hydrofracking',\n",
       "   'Hydrofracturing',\n",
       "   'Hydrofracturings'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067073': {'ID': 'D000067073',\n",
       "  'name': 'Trauma Psicológico[Psychological Trauma]',\n",
       "  'scope': 'Overwhelming emotional damage caused by a distressful event or series of events.',\n",
       "  'terms': ['Psychological Trauma',\n",
       "   'Trauma Psicológico',\n",
       "   'Trauma, Psychological'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067074': {'ID': 'D000067074',\n",
       "  'name': 'Infuência dos Pares[Peer Influence]',\n",
       "  'scope': 'The effect or sway that a PEER GROUP exerts on the beliefs, value systems and behavior of each member of a group. The social expectations for individuals to conform to peer group influence is known as peer pressure.',\n",
       "  'terms': ['Influence, Peer',\n",
       "   'Influência do Grupo',\n",
       "   'Influência dos Colegas',\n",
       "   'Influência dos Companheiros',\n",
       "   'Infuência dos Pares',\n",
       "   'Peer Influence',\n",
       "   'Peer Pressure',\n",
       "   'Pressure, Peer'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067075': {'ID': 'D000067075',\n",
       "  'name': 'Produtos Vegetais[Vegetable Products]',\n",
       "  'scope': 'Food that is manufactured from various parts of vegetables.',\n",
       "  'terms': ['Product, Vegetable',\n",
       "   'Products, Vegetable',\n",
       "   'Produtos Vegetais',\n",
       "   'Vegetable Product',\n",
       "   'Vegetable Products'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067088': {'ID': 'D000067088',\n",
       "  'name': 'Publicidade Direta ao Consumidor[Direct-to-Consumer Advertising]',\n",
       "  'scope': 'Advertising that directly targets consumers of certain products such as pharmaceuticals.',\n",
       "  'terms': ['Advertising, Direct-to-Consumer',\n",
       "   'Direct to Consumer Advertising',\n",
       "   'Direct to Consumer Marketing',\n",
       "   'Direct-to-Consumer Advertising',\n",
       "   'Direct-to-Consumer Marketing',\n",
       "   'Marketing, Direct-to-Consumer',\n",
       "   'Propaganda Direta ao Consumidor',\n",
       "   'Publicidade Direta ao Consumidor'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067108': {'ID': 'D000067108',\n",
       "  'name': 'Triagem e Testes Direto ao Consumidor[Direct-To-Consumer Screening and Testing]',\n",
       "  'scope': 'Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.',\n",
       "  'terms': ['Direct To Consumer Screening',\n",
       "   'Direct To Consumer Screening and Testing',\n",
       "   'Direct To Consumer Testing',\n",
       "   'Direct-To-Consumer Screening',\n",
       "   'Direct-To-Consumer Screening and Testing',\n",
       "   'Direct-To-Consumer Screenings',\n",
       "   'Direct-To-Consumer Testing',\n",
       "   'Direct-To-Consumer Testings',\n",
       "   'Screening, Direct-To-Consumer',\n",
       "   'Screenings, Direct-To-Consumer',\n",
       "   'Testing, Direct-To-Consumer',\n",
       "   'Testings, Direct-To-Consumer',\n",
       "   'Triagem e Teste Diagnóstico Direto ao Consumidor',\n",
       "   'Triagem e Teste Direto ao Consumidor',\n",
       "   'Triagem e Testes Diagnósticos Direto ao Consumidor',\n",
       "   'Triagem e Testes Direto ao Consumidor'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067128': {'ID': 'D000067128',\n",
       "  'name': 'Vesículas Extracelulares[Extracellular Vesicles]',\n",
       "  'scope': 'Extracellular vesicles released from fragmenting apoptotic cells.',\n",
       "  'terms': ['Apoptotic Bodies',\n",
       "   'Apoptotic Body',\n",
       "   'Bodies, Apoptotic',\n",
       "   'Body, Apoptotic',\n",
       "   'Exovesicle',\n",
       "   'Exovesicles',\n",
       "   'Extracellular Vesicle',\n",
       "   'Extracellular Vesicles',\n",
       "   'Vesicle, Extracellular',\n",
       "   'Vesicles, Extracellular',\n",
       "   'Vesículas Extracelulares'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067148': {'ID': 'D000067148',\n",
       "  'name': 'Micovírus[Fungal Viruses]',\n",
       "  'scope': 'Viruses infecting species of FUNGI.',\n",
       "  'terms': ['Fungal Virus',\n",
       "   'Fungal Viruses',\n",
       "   'Micovírus',\n",
       "   'Mycovirus',\n",
       "   'Mycoviruses',\n",
       "   'Virus, Fungal',\n",
       "   'Viruses, Fungal',\n",
       "   'Vírus Fúngicos',\n",
       "   'Vírus de Fungos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067170': {'ID': 'D000067170',\n",
       "  'name': 'Telócitos[Telocytes]',\n",
       "  'scope': 'A type of interstitial cells that have very long and thin CELL SURFACE EXTENSIONS called TELOPODES.',\n",
       "  'terms': ['Cajal-Like Cells, Interstitial',\n",
       "   'Cells, Interstitial Cajal-Like',\n",
       "   'Interstitial Cajal Like Cells',\n",
       "   'Interstitial Cajal-Like Cells',\n",
       "   'Interstitial Cell of Cajal Like Cells',\n",
       "   'Interstitial Cell of Cajal-Like Cells',\n",
       "   'Telocyte',\n",
       "   'Telocytes',\n",
       "   'Telócitos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067190': {'ID': 'D000067190',\n",
       "  'name': 'Exoesqueleto Energizado[Exoskeleton Device]',\n",
       "  'scope': 'Robotic Exoskeleton',\n",
       "  'terms': ['Armadura Elétrica',\n",
       "   'Device, Exoskeleton',\n",
       "   'Devices, Exoskeleton',\n",
       "   'Dispositivo Exoesqueleto',\n",
       "   'Dispositivo Robótico Exoesqueleto',\n",
       "   'Dispositivo de Exoesqueleto',\n",
       "   'Exoesqueleto Energizado',\n",
       "   'Exoesqueleto Robótico',\n",
       "   'Exoskeleton Device',\n",
       "   'Exoskeleton Devices',\n",
       "   'Exoskeleton, Robotic',\n",
       "   'Exoskeletons, Robotic',\n",
       "   'Exoterno',\n",
       "   'Robotic Exoskeleton',\n",
       "   'Robotic Exoskeletons'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067208': {'ID': 'D000067208',\n",
       "  'name': 'Hipersensibilidade a Frutos do Mar[Shellfish Hypersensitivity]',\n",
       "  'scope': 'Allergic reaction to SHELLFISH or shellfish products.',\n",
       "  'terms': ['Allergies, Shellfish',\n",
       "   'Allergy, Shellfish',\n",
       "   'Hipersensibilidade a Camarão',\n",
       "   'Hipersensibilidade a Camarões',\n",
       "   'Hipersensibilidade a Crustáceos e Moluscos',\n",
       "   'Hipersensibilidade a Frutos do Mar',\n",
       "   'Hipersensibilidade a Mariscos',\n",
       "   'Hipersensibilidade a Mexilhões',\n",
       "   'Hipersensibilidade a Moluscos',\n",
       "   'Hipersensibilidade a Moluscos e Crustáceos',\n",
       "   'Hypersensitivities, Shellfish',\n",
       "   'Hypersensitivity, Shellfish',\n",
       "   'Shellfish Allergies',\n",
       "   'Shellfish Allergy',\n",
       "   'Shellfish Hypersensitivities',\n",
       "   'Shellfish Hypersensitivity'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067248': {'ID': 'D000067248',\n",
       "  'name': 'Falha da Terapia de Resgate[Failure to Rescue, Health Care]',\n",
       "  'scope': 'Inability to prevent a clinical deterioration resulting from a complication of an underlying medical condition or a complication of medical care. It implies that common risk factors for such a complication were not recognized in a timely manner or treated appropriately.',\n",
       "  'terms': ['Failure to Rescue (Health Care)',\n",
       "   'Failure to Rescue, Health Care',\n",
       "   'Failure to Rescues (Health Care)',\n",
       "   'Falha da Terapia de Resgate',\n",
       "   'Falha do Resgate Terapêutico',\n",
       "   'Falha do Tratamento de Resgate',\n",
       "   'Falha no Resgate em Cuidados de Saúde',\n",
       "   'Health Care, Failure to Rescue',\n",
       "   'Health Care, Failures to Rescue',\n",
       "   'Incapacidade de Inversão do Quadro pelo Cuidado de Saúde',\n",
       "   'Incapacidade de Recuperação pelo Cuidado de Saúde',\n",
       "   'Incapacidade de Reversão do Quadro pelo Cuidado de Saúde',\n",
       "   'Rescue, Failure to (Health Care)',\n",
       "   'Rescues, Failure to (Health Care)'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067250': {'ID': 'D000067250',\n",
       "  'name': 'Reabilitação Psiquiátrica[Psychiatric Rehabilitation]',\n",
       "  'scope': 'Specialty field that promotes recovery, community functioning, and increased well-being of individuals diagnosed with mental disorders that impair their ability to live meaningful lives.',\n",
       "  'terms': ['Health Rehabilitation, Mental',\n",
       "   'Mental Health Rehabilitation',\n",
       "   'Psychiatric Rehabilitation',\n",
       "   'Psychosocial Rehabilitation',\n",
       "   'Reabilitação Psiquiátrica',\n",
       "   'Rehabilitation, Mental Health',\n",
       "   'Rehabilitation, Psychiatric',\n",
       "   'Rehabilitation, Psychosocial'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067251': {'ID': 'D000067251',\n",
       "  'name': 'Exacerbação dos Sintomas[Symptom Flare Up]',\n",
       "  'scope': 'A transient exacerbation of symptoms of an existing disease or condition.',\n",
       "  'terms': ['Acute Symptom Flare',\n",
       "   'Acute Symptom Flares',\n",
       "   'Exacerbação Súbita dos Sintomas',\n",
       "   'Exacerbação Transitória dos Sintomas',\n",
       "   'Exacerbação dos Sintomas',\n",
       "   'Flare Up de Sintomas',\n",
       "   'Flare Up, Symptom',\n",
       "   'Flare Ups, Symptom',\n",
       "   'Flare, Acute Symptom',\n",
       "   'Flare-up, Symptom',\n",
       "   'Flare-ups, Symptom',\n",
       "   'Flares, Acute Symptom',\n",
       "   'Flareup, Symptom',\n",
       "   'Flareups, Symptom',\n",
       "   'Flaring Up, Symptom',\n",
       "   'Flaring Ups, Symptom',\n",
       "   'Surgimento de Sintomas',\n",
       "   'Symptom Flare Up',\n",
       "   'Symptom Flare Ups',\n",
       "   'Symptom Flare, Acute',\n",
       "   'Symptom Flare-up',\n",
       "   'Symptom Flare-ups',\n",
       "   'Symptom Flares, Acute',\n",
       "   'Symptom Flareup',\n",
       "   'Symptom Flareups',\n",
       "   'Symptom Flaring Up',\n",
       "   'Symptom Flaring Ups'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067268': {'ID': 'D000067268',\n",
       "  'name': 'Preparação de Coração Isolado[Isolated Heart Preparation]',\n",
       "  'scope': 'Method of isolation and maintenance of\\xa0a working heart for\\xa0various cardiac measurements. The model allows for the separation of cardiac and systemic variables in the denervated heart.',\n",
       "  'terms': ['Heart, Langendorff Perfused',\n",
       "   'Isolated Heart Preparation',\n",
       "   'Isolated Heart Preparation Technique',\n",
       "   'Isolated Heart Preparations',\n",
       "   'Isolated Perfused Heart Model',\n",
       "   'Langendorff Perfused Heart',\n",
       "   'Langendorff Perfused Isolated Heart Preparation',\n",
       "   'Perfused Heart, Langendorff',\n",
       "   'Preparation, Isolated Heart',\n",
       "   'Preparation, Working Heart',\n",
       "   'Preparations, Isolated Heart',\n",
       "   'Preparations, Working Heart',\n",
       "   'Preparação de Coração Isolado',\n",
       "   'Preparação do Coração Isolado',\n",
       "   'Technique, Working Heart',\n",
       "   'Techniques, Working Heart',\n",
       "   'Working Heart Preparation',\n",
       "   'Working Heart Preparation Technique',\n",
       "   'Working Heart Preparations',\n",
       "   'Working Heart Technique',\n",
       "   'Working Heart Techniques'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067269': {'ID': 'D000067269',\n",
       "  'name': 'Dieta Vegana[Diet, Vegan]',\n",
       "  'scope': 'Dietary practice of avoiding animal products in any form.',\n",
       "  'terms': ['Diet, Vegan',\n",
       "   'Dieta Vegan',\n",
       "   'Dieta Vegana',\n",
       "   'Dieta Vegã',\n",
       "   'Dieta Végan',\n",
       "   'Diets, Vegan',\n",
       "   'Vegan Diet',\n",
       "   'Vegan Diets',\n",
       "   'Veganism'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067289': {'ID': 'D000067289',\n",
       "  'name': 'Técnicas de Observação do Comportamento[Behavior Observation Techniques]',\n",
       "  'scope': 'A wide range of formal and informal techniques used to document behavior.',\n",
       "  'terms': ['Behavior Observation',\n",
       "   'Behavior Observation Technique',\n",
       "   'Behavior Observation Techniques',\n",
       "   'Behavior Observations',\n",
       "   'Behavioral Observation',\n",
       "   'Behavioral Observation Technique',\n",
       "   'Behavioral Observation Techniques',\n",
       "   'Behavioral Observations',\n",
       "   'Observation Technique, Behavior',\n",
       "   'Observation Technique, Behavioral',\n",
       "   'Observation Techniques, Behavior',\n",
       "   'Observation Techniques, Behavioral',\n",
       "   'Observation, Behavior',\n",
       "   'Observation, Behavioral',\n",
       "   'Observations, Behavior',\n",
       "   'Observations, Behavioral',\n",
       "   'Técnicas de Observação Comportamental',\n",
       "   'Técnicas de Observação do Comportamento'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067290': {'ID': 'D000067290',\n",
       "  'name': 'Escala de Avaliação Comportamental[Behavior Rating Scale]',\n",
       "  'scope': 'Written, visual, or verbal evaluation administered to assess the cognitive and emotional functioning of both humans and animals.',\n",
       "  'terms': ['Behavior Rating Scale',\n",
       "   'Behavior Rating Scales',\n",
       "   'Behavior Test',\n",
       "   'Behavior Tests',\n",
       "   'Behavioral Rating Scale',\n",
       "   'Behavioral Rating Scales',\n",
       "   'Behavioral Test',\n",
       "   'Behavioral Tests',\n",
       "   'Escala de Avaliação Comportamental',\n",
       "   'Escala de Avaliação de Comportamentos',\n",
       "   'Escala de Classificação Comportamental',\n",
       "   'Escala de Classificação do Comportamento',\n",
       "   'Escala de Graus de Comportamento',\n",
       "   'Rating Scale, Behavior',\n",
       "   'Rating Scale, Behavioral',\n",
       "   'Rating Scales, Behavior',\n",
       "   'Rating Scales, Behavioral',\n",
       "   'Scale, Behavioral Rating',\n",
       "   'Test, Behavior',\n",
       "   'Test, Behavioral',\n",
       "   'Tests, Behavior',\n",
       "   'Tests, Behavioral'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067292': {'ID': 'D000067292',\n",
       "  'name': 'Consumo de Álcool na Faculdade[Alcohol Drinking in College]',\n",
       "  'scope': 'Alcohol consumption among college students.',\n",
       "  'terms': ['Alcohol Drinking in College',\n",
       "   'Alcohol Drinking, College Students',\n",
       "   'Alcoolismo na Faculdade',\n",
       "   'Alcoolismo na Universidade',\n",
       "   'College Drinking',\n",
       "   'College Student Drinking',\n",
       "   'Consumo de Álcool em Escolas',\n",
       "   'Consumo de Álcool em Faculdades',\n",
       "   'Consumo de Álcool em Universidades',\n",
       "   'Consumo de Álcool na Faculdade',\n",
       "   'Consumo de Álcool na Universidade',\n",
       "   'Drinking, College',\n",
       "   'Student Drinking, College',\n",
       "   'Student Drinking, University',\n",
       "   'University Student Drinking'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067329': {'ID': 'D000067329',\n",
       "  'name': 'Obesidade Metabolicamente Benigna[Obesity, Metabolically Benign]',\n",
       "  'scope': 'A sub-PHENOTYPE of obese individuals who have a risk for CARDIOVASCULAR DISEASES between that of healthy individuals with normal weight and unhealthy individuals with obesity.',\n",
       "  'terms': ['Benign Obesity, Metabolically',\n",
       "   'Healthy Obesity, Metabolically',\n",
       "   'Metabolically Benign Obesity',\n",
       "   'Metabolically Healthy Obesity',\n",
       "   'Obesidade Metabolicamente Benigna',\n",
       "   'Obesity, Metabolically Benign',\n",
       "   'Obesity, Metabolically Healthy'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067348': {'ID': 'D000067348',\n",
       "  'name': 'Grãos Integrais[Whole Grains]',\n",
       "  'scope': 'Edible seeds which contain all components of the seed - germ, bran, and ENDOSPERM.',\n",
       "  'terms': ['Cariopse Integral',\n",
       "   'Cariopses Integrais',\n",
       "   'Cereais Integrais',\n",
       "   'Cereal Integral',\n",
       "   'Cereal, Whole Grain',\n",
       "   'Cereals, Whole Grain',\n",
       "   'Grain Cereal, Whole',\n",
       "   'Grain Cereals, Whole',\n",
       "   'Grain, Whole',\n",
       "   'Grains, Whole',\n",
       "   'Grão Integral',\n",
       "   'Grãos Integrais',\n",
       "   'Whole Grain',\n",
       "   'Whole Grain Cereal',\n",
       "   'Whole Grain Cereals',\n",
       "   'Whole Grains'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000067368': {'ID': 'D000067368',\n",
       "  'name': 'Cirurgia Endoscópica Transanal[Transanal Endoscopic Surgery]',\n",
       "  'scope': 'Surgical procedures performed through the anus using a PROCTOSCOPE.',\n",
       "  'terms': ['Cirurgia Endoscópica Transanal',\n",
       "   'Endoscopic Surgeries, Transanal',\n",
       "   'Endoscopic Surgery, Transanal',\n",
       "   'Surgeries, Transanal Endoscopic',\n",
       "   'Surgery, Transanal Endoscopic',\n",
       "   'TAMIS',\n",
       "   'Transanal Endoscopic Surgeries',\n",
       "   'Transanal Endoscopic Surgery',\n",
       "   'Transanal Endoscopic Surgical Procedures',\n",
       "   'Transanal Minimally Invasive Surgery'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067369': {'ID': 'D000067369',\n",
       "  'name': 'Microcirurgia Endoscópica Transanal[Transanal Endoscopic Microsurgery]',\n",
       "  'scope': 'A specialized form of transanal endoscopic surgery for microscopically controlled operations in the RECTUM.',\n",
       "  'terms': ['Endoscopic Microsurgeries, Transanal',\n",
       "   'Endoscopic Microsurgery, Transanal',\n",
       "   'Microcirurgia Endoscópica Transanal',\n",
       "   'Microsurgeries, Transanal Endoscopic',\n",
       "   'Microsurgery, Transanal Endoscopic',\n",
       "   'Transanal Endoscopic Microsurgeries',\n",
       "   'Transanal Endoscopic Microsurgery'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067390': {'ID': 'D000067390',\n",
       "  'name': 'Lesão por Frio[Cold Injury]',\n",
       "  'scope': 'A physical injury caused by exposure of the body to extremely low ambient temperatures that may lead to loss of body parts, or in extreme cases, death. Examples of cold injury are FROSTBITE and CHILBLAINS.',\n",
       "  'terms': ['Cold Injuries',\n",
       "   'Cold Injury',\n",
       "   'Injuries, Cold',\n",
       "   'Injury, Cold',\n",
       "   'Lesão Causada pelo Frio',\n",
       "   'Lesão Provocada pelo Frio',\n",
       "   'Lesão pelo Frio',\n",
       "   'Lesão por Congelamento',\n",
       "   'Lesão por Frio',\n",
       "   'Lesões Causadas pelo Frio',\n",
       "   'Lesões Provocadas pelo Frio',\n",
       "   'Lesões pelo Frio',\n",
       "   'Lesões por Congelamento',\n",
       "   'Lesões por Frio'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067393': {'ID': 'D000067393',\n",
       "  'name': 'Equipamento de Proteção Individual[Personal Protective Equipment]',\n",
       "  'scope': 'Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear.',\n",
       "  'terms': ['Equipamento de Proteção Individual',\n",
       "   'Equipamento de Proteção Pessoal',\n",
       "   'Equipamentos de Proteção Individual',\n",
       "   'Equipamentos de Proteção Pessoal',\n",
       "   'Equipment, Personal Protective',\n",
       "   'Personal Protective Equipment',\n",
       "   'Protective Equipment, Personal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067397': {'ID': 'D000067397',\n",
       "  'name': 'Agentes Neurotóxicos[Nerve Agents]',\n",
       "  'scope': 'A class of compounds that adversely affect the transmission of impulses through the NERVOUS SYSTEM.',\n",
       "  'terms': ['Agentes Afetadores dos Nervos',\n",
       "   'Agentes Afetantes dos Nervos',\n",
       "   'Agentes Nervosos',\n",
       "   'Agentes Neurais',\n",
       "   'Agentes Neurotóxicos',\n",
       "   'Agentes que Afetam a Sinapse',\n",
       "   'Agentes que Afetam a Transmissão Sináptica',\n",
       "   'Agentes que Afetam os Nervos',\n",
       "   'Agents, Nerve',\n",
       "   'Compostos Afetadores da Transmissão Neural',\n",
       "   'Compostos Afetantes da Transmissão Neural',\n",
       "   'Compostos Neurais',\n",
       "   'Compostos Neurotóxicos',\n",
       "   'Compostos que Afetam a Transmissão Neural',\n",
       "   'Gas, Nerve',\n",
       "   'Nerve Agents',\n",
       "   'Nerve Gas',\n",
       "   'Substâncias Afetadoras dos Nervos',\n",
       "   'Substâncias Afetantes dos Nervos',\n",
       "   'Substâncias Neurais',\n",
       "   'Substâncias Neurotóxicas',\n",
       "   'Substâncias Prejudiciais à Transmissão Neural',\n",
       "   'Substâncias que Afetam a Sinapse',\n",
       "   'Substâncias que Afetam a Transmissão Agentes que Afetam a Transmissão Neural',\n",
       "   'Substâncias que Afetam a Transmissão Neural',\n",
       "   'Substâncias que Afetam a Transmissão Sinâptica',\n",
       "   'Substâncias que Afetam os Nervos'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067398': {'ID': 'D000067398',\n",
       "  'name': 'Lesões Relacionadas à Guerra[War-Related Injuries]',\n",
       "  'scope': 'Distress resulting from severe injuries.',\n",
       "  'terms': ['Injuries, War-Related',\n",
       "   'Injury, War-Related',\n",
       "   'Lesões Relacionadas à Guerra',\n",
       "   'Trauma, War-Related',\n",
       "   'War Related Injuries',\n",
       "   'War Related Trauma',\n",
       "   'War-Related Injuries',\n",
       "   'War-Related Injury',\n",
       "   'War-Related Trauma'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067399': {'ID': 'D000067399',\n",
       "  'name': 'Escala de Movimento Involuntário Anormal[Abnormal Involuntary Movement Scale]',\n",
       "  'scope': 'A rating scale that measures INVOLUNTARY MOVEMENTS known as TARDIVE DYSKINESIA.',\n",
       "  'terms': ['Abnormal Involuntary Movement Scale',\n",
       "   'Escala de Movimento Involuntário Anormal',\n",
       "   'Escala de Movimentos Involuntários Anormais'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067401': {'ID': 'D000067401',\n",
       "  'name': 'Concentração Alcoólica no Sangue[Blood Alcohol Content]',\n",
       "  'scope': 'Mass of alcohol per unit of BLOOD volume.',\n",
       "  'terms': ['Alcohol Concentration, Blood',\n",
       "   'Alcohol Content, Blood',\n",
       "   'Alcohol Level, Blood',\n",
       "   'Blood Alcohol Concentration',\n",
       "   'Blood Alcohol Content',\n",
       "   'Blood Alcohol Level',\n",
       "   'Concentration, Blood Alcohol',\n",
       "   'Concentração Alcoólica no Sangue',\n",
       "   'Content, Blood Alcohol',\n",
       "   'Conteúdo Alcóolico Plasmático',\n",
       "   'Conteúdo Alcóolico no Sangue',\n",
       "   'Level, Blood Alcohol',\n",
       "   'Teor Alcoólico no Sangue'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067404': {'ID': 'D000067404',\n",
       "  'name': 'Transtorno de Comunicação Social[Social Communication Disorder]',\n",
       "  'scope': 'Persistent difficulties in the social uses of verbal and nonverbal communications. (DSM-V)',\n",
       "  'terms': ['Communication Disorder, Pragmatic',\n",
       "   'Communication Disorder, Social',\n",
       "   'Communication Disorders, Pragmatic',\n",
       "   'Communication Disorders, Social',\n",
       "   'Disorders, Pragmatic Communication',\n",
       "   'Distúrbio Social de Comunicação',\n",
       "   'Distúrbio de Comunicação Social',\n",
       "   'Pragmatic Communication Disorder',\n",
       "   'Pragmatic Communication Disorders',\n",
       "   'Social Communication Disorder',\n",
       "   'Social Communication Disorders',\n",
       "   'Transtorno Social de Comunicação',\n",
       "   'Transtorno de Comunicação Social'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067408': {'ID': 'D000067408',\n",
       "  'name': 'Serviços Jurídicos[Legal Services]',\n",
       "  'scope': 'Services provided by ATTORNEYS and paralegal staff.',\n",
       "  'terms': ['Legal Service',\n",
       "   'Legal Services',\n",
       "   'Service, Legal',\n",
       "   'Services, Legal',\n",
       "   'Serviços Jurídicos',\n",
       "   'Serviços Legais'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067448': {'ID': 'D000067448',\n",
       "  'name': 'Difamação[Defamation]',\n",
       "  'scope': 'Written statements intended to harm',\n",
       "  'terms': ['Calumnies',\n",
       "   'Calumny',\n",
       "   'Defamation',\n",
       "   'Defamations',\n",
       "   'Difamação',\n",
       "   'Libel',\n",
       "   'Libels',\n",
       "   'Slander',\n",
       "   'Vilification',\n",
       "   'Vilifications'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067449': {'ID': 'D000067449',\n",
       "  'name': 'Terapia de Controle da Ira[Anger Management Therapy]',\n",
       "  'scope': 'System of psychological and/or therapeutic techniques used to control and or reduce the triggers, degrees, and effects of ANGER.',\n",
       "  'terms': ['Anger Management',\n",
       "   'Anger Management Therapy',\n",
       "   'Anger Management Training',\n",
       "   'Management Training, Anger',\n",
       "   'Management, Anger',\n",
       "   'Terapia de Controle da Fúria',\n",
       "   'Terapia de Controle da Ira',\n",
       "   'Therapy, Anger Management',\n",
       "   'Training, Anger Management'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067450': {'ID': 'D000067450',\n",
       "  'name': 'Psicologia do Esporte[Psychology, Sports]',\n",
       "  'scope': 'Field of research that studies mental factors influencing the attainment of athletic skills and athletic performance.',\n",
       "  'terms': ['Psicologia do Esporte',\n",
       "   'Psychology, Sport',\n",
       "   'Psychology, Sports',\n",
       "   'Sport Psychology',\n",
       "   'Sports Psychology'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067453': {'ID': 'D000067453',\n",
       "  'name': 'Exposição à Guerra[War Exposure]',\n",
       "  'scope': 'The health and other ramifications of military and civilian exposure to WAR .',\n",
       "  'terms': ['Exposição à Guerra',\n",
       "   'Exposure, War',\n",
       "   'Exposures, War',\n",
       "   'War Exposure',\n",
       "   'War Exposures'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067454': {'ID': 'D000067454',\n",
       "  'name': 'Transtorno da Fluência com Início na Infância[Childhood-Onset Fluency Disorder]',\n",
       "  'scope': \"Disturbances in the normal fluency and time patterning of speech that are inappropriate for the individual's age and language skills. (DSM-V)\",\n",
       "  'terms': ['Childhood Onset Fluency Disorder',\n",
       "   'Childhood-Onset Fluency Disorder',\n",
       "   'Childhood-Onset Fluency Disorders',\n",
       "   'Disorder, Childhood-Onset Fluency',\n",
       "   'Disorders, Childhood-Onset Fluency',\n",
       "   'Distúrbio da Fluência com Início na Infância',\n",
       "   'Fluency Disorder, Childhood-Onset',\n",
       "   'Fluency Disorders, Childhood-Onset',\n",
       "   'Transtorno da Fluência com Início na Infância'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067455': {'ID': 'D000067455',\n",
       "  'name': 'Pacientes não Comparecentes[No-Show Patients]',\n",
       "  'scope': 'PATIENTS who do not turn up for scheduled healthcare appointments. Do not confuse with PATIENT DROPOUTS.',\n",
       "  'terms': ['No Show Patients',\n",
       "   'No-Show Patient',\n",
       "   'No-Show Patients',\n",
       "   'No-Show, Patient',\n",
       "   'No-Shows, Patient',\n",
       "   'Non-Attendance, Patient',\n",
       "   'Pacientes Ausentes',\n",
       "   'Pacientes Faltantes',\n",
       "   'Pacientes não Comparecentes',\n",
       "   'Pacientes que não Comparecem',\n",
       "   'Patient No Show',\n",
       "   'Patient No-Show',\n",
       "   'Patient Non Attendance',\n",
       "   'Patient Non-Attendance',\n",
       "   'Patient, No-Show',\n",
       "   'Patients, No-Show'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067470': {'ID': 'D000067470',\n",
       "  'name': 'Técnicas de Reprogramação Celular[Cellular Reprogramming Techniques]',\n",
       "  'scope': 'The creation of a pluripotent stem cell or other cell type from an adult somatic cell by the forced expression of specific genes or other methods.',\n",
       "  'terms': ['Cell Programming Technique',\n",
       "   'Cell Programming Techniques',\n",
       "   'Cell Reprogramming Technique',\n",
       "   'Cell Reprogramming Techniques',\n",
       "   'Cellular Reprogramming Technique',\n",
       "   'Cellular Reprogramming Techniques',\n",
       "   'Differentiation Technique, Directed',\n",
       "   'Differentiation Techniques, Directed',\n",
       "   'Direct Cell Reprogramming Techniques',\n",
       "   'Directed Differentiation Technique',\n",
       "   'Directed Differentiation Techniques',\n",
       "   'Programming Technique, Cell',\n",
       "   'Programming Techniques, Cell',\n",
       "   'Reprogramming Technique, Cell',\n",
       "   'Reprogramming Technique, Cellular',\n",
       "   'Reprogramming Techniques, Cell',\n",
       "   'Reprogramming Techniques, Cellular',\n",
       "   'Technique, Cell Programming',\n",
       "   'Technique, Cell Reprogramming',\n",
       "   'Technique, Cellular Reprogramming',\n",
       "   'Technique, Directed Differentiation',\n",
       "   'Techniques, Cell Programming',\n",
       "   'Techniques, Cell Reprogramming',\n",
       "   'Techniques, Cellular Reprogramming',\n",
       "   'Techniques, Directed Differentiation',\n",
       "   'Técnicas de Reprogramação Celular'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067489': {'ID': 'D000067489',\n",
       "  'name': 'Metacognição[Metacognition]',\n",
       "  'scope': \"Awareness and understanding of one's own thought processes.\",\n",
       "  'terms': ['Awareness, Meta-cognitive',\n",
       "   'Awareness, Metacognitive',\n",
       "   'Knowledge, Metacognitive',\n",
       "   'Meta cognition',\n",
       "   'Meta cognitive Awareness',\n",
       "   'Meta cognitive Control',\n",
       "   'Meta cognitive Monitoring',\n",
       "   'Meta emotion',\n",
       "   'Meta memory',\n",
       "   'Meta-cognition',\n",
       "   'Meta-cognitive Awareness',\n",
       "   'Meta-cognitive Awarenesses',\n",
       "   'Meta-cognitive Control',\n",
       "   'Meta-cognitive Controls',\n",
       "   'Meta-cognitive Monitoring',\n",
       "   'Meta-cognitive Monitorings',\n",
       "   'Meta-emotion',\n",
       "   'Meta-memories',\n",
       "   'Meta-memory',\n",
       "   'Metacognition',\n",
       "   'Metacognitive Awareness',\n",
       "   'Metacognitive Awarenesses',\n",
       "   'Metacognitive Control',\n",
       "   'Metacognitive Controls',\n",
       "   'Metacognitive Knowledge',\n",
       "   'Metacognitive Knowledges',\n",
       "   'Metacognitive Monitoring',\n",
       "   'Metacognição',\n",
       "   'Metaemotion',\n",
       "   'Metaemotions',\n",
       "   'Metamemories',\n",
       "   'Metamemory',\n",
       "   'Monitoring, Metacognitive'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067490': {'ID': 'D000067490',\n",
       "  'name': 'Uso Excessivo de Medicamentos Prescritos[Prescription Drug Overuse]',\n",
       "  'scope': 'The use of a medication in an amount more than as prescribed.',\n",
       "  'terms': ['Consumo Excessivo de Medicamentos',\n",
       "   'Consumo Excessivo de Medicamentos Prescritos',\n",
       "   'Consumo Excessivo de Remédios Controlados',\n",
       "   'Drug Overuse, Prescription',\n",
       "   'Drug Overuses, Prescription',\n",
       "   'Drug Overutilization, Prescription',\n",
       "   'Drug Overutilizations, Prescription',\n",
       "   'Medication Overuse',\n",
       "   'Medication Overuses',\n",
       "   'Medication Overutilization',\n",
       "   'Medication Overutilizations',\n",
       "   'Overuse, Medication',\n",
       "   'Overuse, Prescription Drug',\n",
       "   'Overuses, Medication',\n",
       "   'Overuses, Prescription Drug',\n",
       "   'Overutilization, Medication',\n",
       "   'Overutilization, Prescription Drug',\n",
       "   'Overutilizations, Medication',\n",
       "   'Overutilizations, Prescription Drug',\n",
       "   'Prescription Drug Overuse',\n",
       "   'Prescription Drug Overuses',\n",
       "   'Prescription Drug Overutilization',\n",
       "   'Prescription Drug Overutilizations',\n",
       "   'Sobrecarga de Fármacos',\n",
       "   'Sobrecarga de Medicamentos',\n",
       "   'Sobrecarga do Medicamento',\n",
       "   'Sobremedicação',\n",
       "   'Sobreuso de Antibacterianos',\n",
       "   'Sobreuso de Antibióticos',\n",
       "   'Sobreuso de Fármacos',\n",
       "   'Sobreuso de Medicamentos',\n",
       "   'Sobreuso do Medicamento',\n",
       "   'Sobreutilização de Medicamentos',\n",
       "   'Sobreutilização do Medicamento',\n",
       "   'Uso Excessivo de Antibacterianos',\n",
       "   'Uso Excessivo de Antibióticos',\n",
       "   'Uso Excessivo de Medicamento',\n",
       "   'Uso Excessivo de Medicamentos',\n",
       "   'Uso Excessivo de Medicamentos Controlados',\n",
       "   'Uso Excessivo de Medicamentos Prescritos',\n",
       "   'Uso Excessivo do Medicamento',\n",
       "   'Utilização Excessiva de Medicamentos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067491': {'ID': 'D000067491',\n",
       "  'name': 'Near Miss[Near Miss, Healthcare]',\n",
       "  'scope': 'Event that presented a risk but did not result in a patient harm.',\n",
       "  'terms': ['Close Call, Healthcare',\n",
       "   'Close Calls, Healthcare',\n",
       "   'Healthcare Close Call',\n",
       "   'Healthcare Close Calls',\n",
       "   'Healthcare Near Miss',\n",
       "   'Healthcare Near Misses',\n",
       "   'Near Miss',\n",
       "   'Near Miss em Cuidados de Saúde',\n",
       "   'Near Miss em Saúde',\n",
       "   'Near Miss na Assistência à Saude',\n",
       "   'Near Miss, Healthcare',\n",
       "   'Near Misses, Healthcare',\n",
       "   'Potencial Evento Adverso em Cuidados de Saúde',\n",
       "   'Potencial Evento Adverso na Assistência à Saúde',\n",
       "   'Quase Erro em Saúde',\n",
       "   'Resultado por Pouco não Adverso',\n",
       "   'Resultado por Pouco não Errado',\n",
       "   'Resultado por Pouco não Falho',\n",
       "   'Resultado por Pouco não Negativo'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067492': {'ID': 'D000067492',\n",
       "  'name': 'Terapêutica com RNAi[RNAi Therapeutics]',\n",
       "  'scope': 'A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE.',\n",
       "  'terms': ['RNAi Based Therapy',\n",
       "   'RNAi Therapeutics',\n",
       "   'RNAi Therapies',\n",
       "   'RNAi Therapy',\n",
       "   'RNAi-Based Therapeutics',\n",
       "   'RNAi-Based Therapies',\n",
       "   'RNAi-Based Therapy',\n",
       "   'Terapia Baseada em RNAi',\n",
       "   'Terapia de RNA de Interferência',\n",
       "   'Terapia de RNAi',\n",
       "   'Terapias Baseadas em RNAi',\n",
       "   'Terapias de RNA de Interferência',\n",
       "   'Terapias de RNAi',\n",
       "   'Terapêutica Baseada em RNAi',\n",
       "   'Terapêutica com RNAi',\n",
       "   'Terapêutica de RNA de Interferência',\n",
       "   'Therapies, RNAi',\n",
       "   'Therapies, RNAi-Based',\n",
       "   'Therapy, RNAi',\n",
       "   'Therapy, RNAi-Based'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067493': {'ID': 'D000067493',\n",
       "  'name': 'Difusão Dinâmica da Luz[Dynamic Light Scattering]',\n",
       "  'scope': 'An analytical technique for measuring particle size of molecules that are less than a micron in diameter dispersed or dissolved in a liquid.',\n",
       "  'terms': ['Difusão Dinâmica da Luz',\n",
       "   'Difusão Quase Elástica da Luz',\n",
       "   'Dispersão Dinâmica da Luz',\n",
       "   'Dynamic Light Scattering',\n",
       "   'Espectroscopia de Correlação de Fótons',\n",
       "   'Light Scattering, Dynamic',\n",
       "   'Light Scattering, Quasi-Elastic (QELS)',\n",
       "   'Quasi Elastic Light Scattering (QELS)',\n",
       "   'Quasi-Elastic Light Scattering (QELS)',\n",
       "   'Quasi-Elastic Light Scatterings (QELS)',\n",
       "   'Scattering, Dynamic Light',\n",
       "   'Scattering, Quasi-Elastic Light (QELS)',\n",
       "   'Scatterings, Quasi-Elastic Light (QELS)'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067494': {'ID': 'D000067494',\n",
       "  'name': 'Time Out na Assistência à Saúde[Time Out, Healthcare]',\n",
       "  'scope': 'A period of time away from normal workflow taken to ensure key procedural details have been reviewed for better PATIENT SAFETY and help prevent MEDICAL ERRORS.',\n",
       "  'terms': ['Check List de Segurança do Paciente',\n",
       "   'Healthcare Time Out',\n",
       "   'Healthcare Time Outs',\n",
       "   'Healthcare Timeout',\n",
       "   'Healthcare Timeouts',\n",
       "   'Pausa Cirúrgica',\n",
       "   'Pausa de Segurança em Procedimentos Médicos',\n",
       "   'Pausa de Segurança em Práticas Assistenciais e Procedimentos Cirúrgicos',\n",
       "   'Pausa de Segurança em Serviços de Saúde',\n",
       "   'Surgical Time Out',\n",
       "   'Surgical Time Outs',\n",
       "   'Surgical Timeout',\n",
       "   'Surgical Timeouts',\n",
       "   'Time Out em Procedimentos Médicos',\n",
       "   'Time Out na Assistência à Saúde',\n",
       "   'Time Out, Healthcare',\n",
       "   'Time Out, Surgical',\n",
       "   'Time Outs, Healthcare',\n",
       "   'Time Outs, Surgical',\n",
       "   'Timeout, Healthcare',\n",
       "   'Timeout, Surgical',\n",
       "   'Timeouts, Healthcare',\n",
       "   'Timeouts, Surgical'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067495': {'ID': 'D000067495',\n",
       "  'name': 'Análise do Modo e do Efeito de Falhas na Assistência à Saúde[Healthcare Failure Mode and Effect Analysis]',\n",
       "  'scope': 'Prospective risk assessment tool aimed at identifying potential risks and their impact in healthcare settings.',\n",
       "  'terms': ['Análise Modal de Falhas e Efeitos na Assistência à Saúde',\n",
       "   'Análise do Modo e do Efeito de Falhas na Assistência à Saúde',\n",
       "   'FMEA-HC',\n",
       "   'Failure Mode and Effect Analysis',\n",
       "   'Failure Mode and Effect Analysis, Healthcare',\n",
       "   'HFMEA',\n",
       "   'Healthcare Failure Mode and Effect Analysis'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067496': {'ID': 'D000067496',\n",
       "  'name': 'Possessão Espiritual[Spirit Possession]',\n",
       "  'scope': 'The idea that abnormal behavior or a medical condition is evidence that a person is under the control of a supernatural power or spirit. This belief was most commonly held in religion and medicine of the medieval period and is also held in many tribal cultures today.',\n",
       "  'terms': ['Demon Possession',\n",
       "   'Demon Possessions',\n",
       "   'Demonic Possession',\n",
       "   'Demonic Possessions',\n",
       "   'Possession, Demon',\n",
       "   'Possession, Demonic',\n",
       "   'Possession, Spirit',\n",
       "   'Possessions, Demon',\n",
       "   'Possessions, Demonic',\n",
       "   'Possessions, Spirit',\n",
       "   'Possessão Espiritual',\n",
       "   'Spirit Possession',\n",
       "   'Spirit Possessions'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067498': {'ID': 'D000067498',\n",
       "  'name': 'Gestão de Recursos da Equipe de Assistência à Saúde[Crew Resource Management, Healthcare]',\n",
       "  'scope': 'A range of healthcare related training designed to reduce MEDICAL ERRORS and improve PATIENT SAFETY by emphasizing TEAMWORK and human factors (see HUMAN ENGINEERING).',\n",
       "  'terms': ['CRM, Healthcare',\n",
       "   'CRMs, Healthcare',\n",
       "   'Crew Resource Management, Healthcare',\n",
       "   'Crisis Resource Management, Healthcare',\n",
       "   'Gestão de Recursos da Assistência à Saúde',\n",
       "   'Gestão de Recursos da Equipe de Assistência à Saúde',\n",
       "   'Healthcare CRM',\n",
       "   'Healthcare CRMs',\n",
       "   'Healthcare Crew Resource Management',\n",
       "   'Healthcare Crisis Resource Management'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067508': {'ID': 'D000067508',\n",
       "  'name': 'Heurística Computacional[Computer Heuristics]',\n",
       "  'scope': 'Trial-and-error methods of problem-solving used when an algorithmic approach is impractical',\n",
       "  'terms': ['Computer Heuristic',\n",
       "   'Computer Heuristics',\n",
       "   'Heuristic, Computer',\n",
       "   'Heuristics, Computer',\n",
       "   'Heurística Computacional'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067528': {'ID': 'D000067528',\n",
       "  'name': 'Ataxinas[Ataxins]',\n",
       "  'scope': 'A family of predominantly nuclear proteins that regulate gene transcription and protein degradation. The expansion of CAG trinucleotide repeats in genes that encode Ataxins is associated with SPINOCEREBELLAR ATAXIAS (SCA). In SCA patients, the number of CAG repeats correlates with the severity of disease and inversely correlates with the age of disease onset.',\n",
       "  'terms': ['Ataxia Proteins, Spinocerebellar',\n",
       "   'Ataxin Proteins',\n",
       "   'Ataxinas',\n",
       "   'Ataxins',\n",
       "   'Proteins, Ataxin',\n",
       "   'Proteins, Spinocerebellar Ataxia',\n",
       "   'Proteínas Ataxinas',\n",
       "   'Spinocerebellar Ataxia Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067531': {'ID': 'D000067531',\n",
       "  'name': 'Alarminas[Alarmins]',\n",
       "  'scope': 'A structurally diverse group of endogenous molecules that are multifunctional, having physiological functions inside the cell, but when released from dying cells or from cells under stress or certain immune cells, they function to activate INNATE IMMUNITY. Uncontrolled and excessive release of alarmins may contribute to INFLAMMATION; CARCINOGENESIS, and NEOPLASM METASTASIS. Alarmins are also critical for heart and nerve tissue homeostasis.',\n",
       "  'terms': ['Alarmin',\n",
       "   'Alarmin Proteins',\n",
       "   'Alarminas',\n",
       "   'Alarmins',\n",
       "   'Damage Associated Molecular Pattern Molecules',\n",
       "   'Damage-Associated Molecular Pattern Molecules',\n",
       "   'Danger Associated Molecular Pattern Molecules',\n",
       "   'Danger-Associated Molecular Pattern Molecules',\n",
       "   'Moléculas de Padrões Moleculares Associados a Perigo',\n",
       "   'Padrões Moleculares Associados a Perigo'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067548': {'ID': 'D000067548',\n",
       "  'name': 'Preenchedores Dérmicos[Dermal Fillers]',\n",
       "  'scope': 'Materials such as COLLAGEN or HYALURONIC ACID that are injected or deposited into the DERMIS for the purpose of skin augmentation.',\n",
       "  'terms': ['Agentes de Preenchimento Dérmico',\n",
       "   'Dermal Filler',\n",
       "   'Dermal Fillers',\n",
       "   'Filler, Dermal',\n",
       "   'Filler, Skin',\n",
       "   'Fillers, Dermal',\n",
       "   'Fillers, Skin',\n",
       "   'Materiais de Preenchimento Dérmico',\n",
       "   'Preenchedores Dérmicos',\n",
       "   'Produtos de Preenchimento Dérmico',\n",
       "   'Skin Filler',\n",
       "   'Skin Fillers',\n",
       "   'Substâncias de Preenchimento Dérmico'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067549': {'ID': 'D000067549',\n",
       "  'name': 'Espectro de Ação[Action Spectrum]',\n",
       "  'scope': 'A technique used to measure the rate of physiological activity plotted against wavelength of light. An action spectrum depicts the most effective wavelength of light (also known as spectral sensitivity) that is required for each specific process.',\n",
       "  'terms': ['Action Spectrum', 'Espectro de Ação', 'Spectrum, Action'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067551': {'ID': 'D000067551',\n",
       "  'name': 'Diplomacia[Diplomacy]',\n",
       "  'scope': 'The art and practice of conducting negotiations between people, nations or other parties such as organizations.',\n",
       "  'terms': ['Diplomacia', 'Diplomacy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067552': {'ID': 'D000067552',\n",
       "  'name': 'Acúmulo de Mutações[Mutation Accumulation]',\n",
       "  'scope': 'Concept which describes the incremental effects of MUTATION in living organisms.',\n",
       "  'terms': ['Accumulation, Mutation',\n",
       "   'Accumulation, Spontaneous Mutation',\n",
       "   'Accumulations, Mutation',\n",
       "   'Accumulations, Spontaneous Mutation',\n",
       "   'Acumulação de Mutações',\n",
       "   'Acúmulo Espontâneo de Mutações',\n",
       "   'Acúmulo de Mutações',\n",
       "   'Mutation Accumulation',\n",
       "   'Mutation Accumulation, Spontaneous',\n",
       "   'Mutation Accumulations',\n",
       "   'Mutation Accumulations, Spontaneous',\n",
       "   'Spontaneous Mutation Accumulation',\n",
       "   'Spontaneous Mutation Accumulations'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067556': {'ID': 'D000067556',\n",
       "  'name': 'Sítios Internos de Entrada Ribossomal[Internal Ribosome Entry Sites]',\n",
       "  'scope': \"Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA.\",\n",
       "  'terms': ['Internal Ribosome Entry Site',\n",
       "   'Internal Ribosome Entry Sites',\n",
       "   'Sitio Interno de Entrada de Ribossomo',\n",
       "   'Sítio Interno de Entrada Ribossomal',\n",
       "   'Sítio Interno de Entrada do Ribossomo',\n",
       "   'Sítio de Entrada Interno do Ribossomo',\n",
       "   'Sítio de Entrada Ribossomal',\n",
       "   'Sítio de Entrada Ribossomal Interno',\n",
       "   'Sítio de Entrada de Ribossomo',\n",
       "   'Sítio de Entrada do Ribossomo',\n",
       "   'Sítios Internos de Entrada Ribossomal',\n",
       "   'Sítios Internos de Entrada no Ribossomo',\n",
       "   'Sítios de Entrada Ribossomais',\n",
       "   'Sítios de Entrada Ribossomais Internos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067558': {'ID': 'D000067558',\n",
       "  'name': 'Mimetismo Biológico[Biological Mimicry]',\n",
       "  'scope': 'The blending in of an organism with the colors and patterns of its physical environment or surroundings, such that it becomes indistinguishable from the latter.',\n",
       "  'terms': ['Aposematism',\n",
       "   'Aposematisms',\n",
       "   'Batesian Mimicries',\n",
       "   'Batesian Mimicry',\n",
       "   'Biological Camouflage',\n",
       "   'Biological Camouflages',\n",
       "   'Biological Mimicry',\n",
       "   'Biomimetismo',\n",
       "   'Camouflage, Biological',\n",
       "   'Camouflages, Biological',\n",
       "   'Crypses',\n",
       "   'Mimetismo Biológico',\n",
       "   'Mimicries, Batesian',\n",
       "   'Mimicries, Mullerian',\n",
       "   'Mimicry, Batesian',\n",
       "   'Mimicry, Biological',\n",
       "   'Mimicry, Mullerian',\n",
       "   'Mullerian Mimicries',\n",
       "   'Mullerian Mimicry'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067559': {'ID': 'D000067559',\n",
       "  'name': 'Transtorno de Aprendizagem Específico[Specific Learning Disorder]',\n",
       "  'scope': 'Diagnosed when there are specific deficits in an individual’s ability to perceive or process information efficiently and accurately. This  disorder first manifests during the years of formal schooling and is characterized by persistent and impairing difficulties with learning foundational academic skills in reading, writing, and/or math. The individual’s performance of the affected academic skills is well below average for age, or acceptable performance levels are achieved only with extraordinary effort. Specific learning disorder may occur in individuals identified as intellectually gifted and manifest only when the learning demands or assessment procedures (e.g., timed tests) pose barriers that cannot be overcome by their innate intelligence and compensatory strategies. For all individuals, specific learning disorder can produce lifelong impairments in activities dependent on the skills, including occupational performance. (from DSM-V)',\n",
       "  'terms': ['Disorder, Specific Learning',\n",
       "   'Distúrbio Específico de Aprendizado',\n",
       "   'Distúrbio Específico de Aprendizagem',\n",
       "   'Distúrbio de Aprendizado Específico',\n",
       "   'Distúrbio de Aprendizagem Específico',\n",
       "   'Learning Disorder, Specific',\n",
       "   'Learning Disorders, Specific',\n",
       "   'Specific Learning Disorder',\n",
       "   'Specific Learning Disorders',\n",
       "   'Transtorno Específico de Aprendizado',\n",
       "   'Transtorno Específico de Aprendizagem',\n",
       "   'Transtorno de Aprendizado Específico',\n",
       "   'Transtorno de Aprendizagem Específico'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067561': {'ID': 'D000067561',\n",
       "  'name': 'Lista de Medicamentos Potencialmente Inapropriados[Potentially Inappropriate Medication List]',\n",
       "  'scope': \"A list, criteria, or screening tool designed to improve PATIENT SAFETY by determining an individual's exposure to potentially inappropriate drugs. They are designed to prevent MEDICATION ERRORS by INAPPROPRIATE PRESCRIBING. Analysis for a list includes factors such as DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; AGE FACTORS; GENDER; and existing medical conditions.\",\n",
       "  'terms': ['Appropriateness Index, Medication',\n",
       "   'Appropriateness Indices, Medication',\n",
       "   'Beers Criteria',\n",
       "   'Beers Criteria, de',\n",
       "   'Beers Potentially Inappropriate Medications',\n",
       "   'Criteria, STOPP START',\n",
       "   'Criterias, STOPP START',\n",
       "   'Inappropriate Medication, Potentially',\n",
       "   'Inappropriate Medications, Potentially',\n",
       "   'Index, Medication Appropriateness',\n",
       "   'Indices, Medication Appropriateness',\n",
       "   'Lista de Medicamentos Potencialmente Impróprios',\n",
       "   'Lista de Medicamentos Potencialmente Inapropriados',\n",
       "   'Lista de Medicamentos Potencialmente Perigosos',\n",
       "   'Medicamentos Potencialmente Inapropriados',\n",
       "   'Medicamentos Potencialmente Perigosos',\n",
       "   'Medication Appropriateness Index',\n",
       "   'Medication Appropriateness Indices',\n",
       "   'Medication, Potentially Inappropriate',\n",
       "   'Medications, Potentially Inappropriate',\n",
       "   'PIM List',\n",
       "   'PIM Lists',\n",
       "   'Potentially Inappropriate Medication',\n",
       "   'Potentially Inappropriate Medication List',\n",
       "   'Potentially Inappropriate Medications',\n",
       "   'START Criteria, STOPP',\n",
       "   'START Criterias, STOPP',\n",
       "   'STOPP',\n",
       "   \"STOPP (Screening Tool of Older Person's Potentially Inappropriate Prescriptions)\",\n",
       "   'STOPP START Criteria',\n",
       "   'STOPP START Criterias',\n",
       "   \"STOPPs (Screening Tool of Older Person's Potentially Inappropriate Prescriptions)\",\n",
       "   \"Screening Tool of Older Person's Potentially Inappropriate Prescriptions\",\n",
       "   'de Beers Criteria'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067562': {'ID': 'D000067562',\n",
       "  'name': 'Transtornos de Início Tardio[Late Onset Disorders]',\n",
       "  'scope': 'Pathological conditions (Disorder, SYNDROME, or DISEASE) whose SIGNS AND SYMPTOMS manifest late in the life of an individual.',\n",
       "  'terms': ['Disease, Late Onset',\n",
       "   'Diseases, Late Onset',\n",
       "   'Disorder, Late Onset',\n",
       "   'Disorder, Late-Onset',\n",
       "   'Disorder, Later Onset',\n",
       "   'Disorders, Late Onset',\n",
       "   'Disorders, Late-Onset',\n",
       "   'Disorders, Later Onset',\n",
       "   'Distúrbios de Acometimento Tardio',\n",
       "   'Distúrbios de Início Tardio',\n",
       "   'Late Onset Disease',\n",
       "   'Late Onset Diseases',\n",
       "   'Late Onset Disorder',\n",
       "   'Late Onset Disorders',\n",
       "   'Late-Onset Disorder',\n",
       "   'Late-Onset Disorders',\n",
       "   'Later Onset Disorder',\n",
       "   'Later Onset Disorders',\n",
       "   'Onset Disease, Late',\n",
       "   'Onset Diseases, Late',\n",
       "   'Onset Disorder, Late',\n",
       "   'Onset Disorder, Later',\n",
       "   'Onset Disorders, Late',\n",
       "   'Onset Disorders, Later',\n",
       "   'Transtornos de Acometimento Tardio',\n",
       "   'Transtornos de Início Tardio'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067563': {'ID': 'D000067563',\n",
       "  'name': 'Phakopsora pachyrhizi[Phakopsora pachyrhizi]',\n",
       "  'scope': 'Fungal pathogen which causes Soybean Rust disease in Soybeans (Glycine max).',\n",
       "  'terms': ['Asian Soybean Rust',\n",
       "   'Phakopsora pachyrhizi',\n",
       "   'Phakopsora pachyrhizi',\n",
       "   'Phakopsora pachyrhizus',\n",
       "   'Rust, Asian Soybean',\n",
       "   'Soybean Rust, Asian',\n",
       "   'Soybean Rusts, Asian',\n",
       "   'pachyrhizi, Phakopsora',\n",
       "   'pachyrhizus, Phakopsora'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067565': {'ID': 'D000067565',\n",
       "  'name': 'Fazendeiros[Farmers]',\n",
       "  'scope': 'Persons who cultivate land or crops, or raise LIVESTOCK.',\n",
       "  'terms': ['<i>agricultora</i>',\n",
       "   '<i>caminhoneiro</i>',\n",
       "   '<i>comerciante</i>',\n",
       "   '<i>cozinheira</i>',\n",
       "   '<i>faxineira</i>',\n",
       "   '<i>metalurgico</i>',\n",
       "   '<i>pedreiro</i>',\n",
       "   '<i>servente</i>',\n",
       "   '<i>taxista</i>',\n",
       "   '<i>vendedora</i>',\n",
       "   'Agricultor',\n",
       "   'Agricultores',\n",
       "   'Agricultural Worker',\n",
       "   'Agricultural Workers',\n",
       "   'Chacareiro',\n",
       "   'Chacareiros',\n",
       "   'Farm Worker',\n",
       "   'Farm Workers',\n",
       "   'Farmer',\n",
       "   'Farmers',\n",
       "   'Farmworker',\n",
       "   'Farmworkers',\n",
       "   'Fazendeiro',\n",
       "   'Fazendeiros',\n",
       "   'Granjeiro',\n",
       "   'Granjeiros',\n",
       "   'Rancheiros',\n",
       "   'Rancher',\n",
       "   'Ranchers',\n",
       "   'Sitiante',\n",
       "   'Sitiantes',\n",
       "   'Worker, Agricultural',\n",
       "   'Worker, Farm',\n",
       "   'Workers, Agricultural',\n",
       "   'Workers, Farm'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067568': {'ID': 'D000067568',\n",
       "  'name': 'Tecnologia Culturalmente Apropriada[Culturally Appropriate Technology]',\n",
       "  'scope': 'A SCIENCE or TECHNOLOGY that promotes self-sufficiency and is suitable to the cultural, environmental, economic and social conditions of the geographic area in which it is applied.',\n",
       "  'terms': ['Appropriate Technologies, Culturally',\n",
       "   'Appropriate Technology, Culturally',\n",
       "   'Culturally Appropriate Technologies',\n",
       "   'Culturally Appropriate Technology',\n",
       "   'Intermediate Technologies',\n",
       "   'Intermediate Technology',\n",
       "   'Soft Technologies',\n",
       "   'Soft Technology',\n",
       "   'Technologies, Culturally Appropriate',\n",
       "   'Technologies, Intermediate',\n",
       "   'Technologies, Soft',\n",
       "   'Technology, Culturally Appropriate',\n",
       "   'Technology, Intermediate',\n",
       "   'Technology, Soft',\n",
       "   'Tecnologia Alternativa',\n",
       "   'Tecnologia Apropriada',\n",
       "   'Tecnologia Básica',\n",
       "   'Tecnologia Culturalmente Apropriada',\n",
       "   'Tecnologia Intermediária',\n",
       "   'Tecnologia Leve',\n",
       "   'Tecnologia de Custo Intermediário',\n",
       "   'Tecnologias Leves'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067570': {'ID': 'D000067570',\n",
       "  'name': 'Aprendizado Social[Social Learning]',\n",
       "  'scope': 'The concept of new knowledge acquisition through observation and interaction with others.',\n",
       "  'terms': ['Aprendizado Social',\n",
       "   'Aprendizagem Social',\n",
       "   'Learning, Social',\n",
       "   'Social Learning'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067571': {'ID': 'D000067571',\n",
       "  'name': 'Declarações Financeiras[Financial Statements]',\n",
       "  'scope': 'Formal and structured record of financial activities of a business, person, or other entity.',\n",
       "  'terms': ['Asset, Financial',\n",
       "   'Assets, Financial',\n",
       "   'Balance Sheet',\n",
       "   'Balance Sheets',\n",
       "   'Cash Flow Statement',\n",
       "   'Cash Flow Statements',\n",
       "   'Declarações Financeiras',\n",
       "   'Equities, Financial',\n",
       "   'Equity, Financial',\n",
       "   'Expense Statement',\n",
       "   'Expense Statements',\n",
       "   'Financial Asset',\n",
       "   'Financial Assets',\n",
       "   'Financial Equities',\n",
       "   'Financial Equity',\n",
       "   'Financial Liabilities',\n",
       "   'Financial Liability',\n",
       "   'Financial Statement',\n",
       "   'Financial Statements',\n",
       "   'Flow Statement, Cash',\n",
       "   'Flow Statements, Cash',\n",
       "   'Income Statement',\n",
       "   'Income Statements',\n",
       "   'Liabilities, Financial',\n",
       "   'Liability, Financial',\n",
       "   'Net Worth',\n",
       "   'Sheet, Balance',\n",
       "   'Sheets, Balance',\n",
       "   'Statement, Cash Flow',\n",
       "   'Statement, Expense',\n",
       "   'Statement, Financial',\n",
       "   'Statement, Income',\n",
       "   'Statements, Cash Flow',\n",
       "   'Statements, Expense',\n",
       "   'Statements, Financial',\n",
       "   'Statements, Income',\n",
       "   'Worth, Net'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000067572': {'ID': 'D000067572',\n",
       "  'name': 'Mineradores[Miners]',\n",
       "  'scope': 'Persons who work in a mine to extract ore or MINERALS from the earth.',\n",
       "  'terms': ['Mine Worker',\n",
       "   'Mine Workers',\n",
       "   'Mineiros',\n",
       "   'Miner',\n",
       "   'Minerador',\n",
       "   'Mineradores',\n",
       "   'Miners',\n",
       "   'Mineworker',\n",
       "   'Mineworkers',\n",
       "   'Worker, Mine',\n",
       "   'Workers, Mine'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067573': {'ID': 'D000067573',\n",
       "  'name': 'Cronofarmacocinética[Chronopharmacokinetics]',\n",
       "  'scope': 'Absorption, metabolism and elimination of drugs in relation to time of day at which they are administered, and the mechanisms responsible for time-dependent variations.',\n",
       "  'terms': ['Chronopharmacokinetic',\n",
       "   'Chronopharmacokinetics',\n",
       "   'Cronofarmacocinética'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067575': {'ID': 'D000067575',\n",
       "  'name': 'Demandas Administrativas em Assistência à Saúde[Administrative Claims, Healthcare]',\n",
       "  'scope': 'Information relating to itemized coding of procedures and costs associated with healthcare delivery, used as a means for tracking healthcare utilization, patterns of care, and treatment outcomes.',\n",
       "  'terms': ['Administrative Claim, Healthcare',\n",
       "   'Administrative Claims, Healthcare',\n",
       "   'Claim, Healthcare Administrative',\n",
       "   'Claims, Healthcare Administrative',\n",
       "   'Demandas Administrativas em Assistência à Saúde',\n",
       "   'Healthcare Administrative Claim',\n",
       "   'Healthcare Administrative Claims',\n",
       "   'Processos Administrativos dos Serviços de Saúde'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067576': {'ID': 'D000067576',\n",
       "  'name': 'Saúde da Criança[Child Health]',\n",
       "  'scope': 'The concept covering the physical and mental conditions of CHILDREN.',\n",
       "  'terms': ['Child Health',\n",
       "   \"Children's Health\",\n",
       "   'Childrens Health',\n",
       "   'Health, Child',\n",
       "   \"Health, Children's\",\n",
       "   'Health, Childrens',\n",
       "   'Saúde Infantil',\n",
       "   'Saúde Pediátrica',\n",
       "   'Saúde da Criança',\n",
       "   'Saúde das Crianças'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067596': {'ID': 'D000067596',\n",
       "  'name': 'Interleucina-33[Interleukin-33]',\n",
       "  'scope': 'A member of the INTERLEUKIN-1 protein  family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage.',\n",
       "  'terms': ['IL-33',\n",
       "   'IL33',\n",
       "   'Interleucina-33',\n",
       "   'Interleukin 33',\n",
       "   'Interleukin-33'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067616': {'ID': 'D000067616',\n",
       "  'name': 'Proteína S100A12[S100A12 Protein]',\n",
       "  'scope': 'A member of the S100 PROTEIN FAMILY that regulates INFLAMMATION and the immune response. It recruits LEUKOCYTES, promotes cytokine and chemokine production, and regulates leukocyte adhesion and migration. S100A12 can also function via binding to ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTORS, to stimulate innate immune cells.',\n",
       "  'terms': ['A12 Protein, S100',\n",
       "   'C Protein, Calgranulin',\n",
       "   'CAAF1 Protein',\n",
       "   'Calgranulin C Protein',\n",
       "   'EN RAGE Protein',\n",
       "   'EN-RAGE Protein',\n",
       "   'ENRAGE Protein',\n",
       "   'MRP 6 Protein',\n",
       "   'MRP-6 Protein',\n",
       "   'Protein, CAAF1',\n",
       "   'Protein, Calgranulin C',\n",
       "   'Protein, EN-RAGE',\n",
       "   'Protein, ENRAGE',\n",
       "   'Protein, MRP-6',\n",
       "   'Protein, S100 A12',\n",
       "   'Protein, S100A12',\n",
       "   'Proteína S100A12',\n",
       "   'S100 A12 Protein',\n",
       "   'S100A12',\n",
       "   'S100A12 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067617': {'ID': 'D000067617',\n",
       "  'name': 'Telopódios[Telopodes]',\n",
       "  'scope': 'The thicker sections of telopodes.',\n",
       "  'terms': ['Podom',\n",
       "   'Podomer',\n",
       "   'Podomers',\n",
       "   'Podoms',\n",
       "   'Podômeros',\n",
       "   'Telopode',\n",
       "   'Telopodes',\n",
       "   'Telopódios'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067636': {'ID': 'D000067636',\n",
       "  'name': 'Drosophila simulans[Drosophila simulans]',\n",
       "  'scope': 'A species of fruit fly.',\n",
       "  'terms': ['D. simulans',\n",
       "   'Drosophila simulans',\n",
       "   'Drosophila simulans',\n",
       "   'simulans, Drosophila'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000067656': {'ID': 'D000067656',\n",
       "  'name': 'Otimismo[Optimism]',\n",
       "  'scope': 'Mental attitude that interprets life events as generally being positive.',\n",
       "  'terms': ['Optimism',\n",
       "   'Otimismo',\n",
       "   'Pensamento Positivo',\n",
       "   'Positive Thinking'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067657': {'ID': 'D000067657',\n",
       "  'name': 'Pessimismo[Pessimism]',\n",
       "  'scope': 'Mental attitude that interprets life events as generally being negative.',\n",
       "  'terms': ['Negative Thinking',\n",
       "   'Pensamento Negativo',\n",
       "   'Pessimism',\n",
       "   'Pessimismo',\n",
       "   'Thinking, Negative'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067696': {'ID': 'D000067696',\n",
       "  'name': 'Ataxina-1[Ataxin-1]',\n",
       "  'scope': 'A chromatin-binding factor that represses Notch signaling and associates with RNA. Expansion of the polyglutamine tract by expanded CAG repeats in the ATXN1 gene coding region is associated with SPINOCEREBELLAR ATAXIA 1.',\n",
       "  'terms': ['Ataxin 1',\n",
       "   'Ataxin 1 Protein',\n",
       "   'Ataxin-1',\n",
       "   'Ataxin-1 Protein',\n",
       "   'Ataxina-1',\n",
       "   'Atxn 1 Protein',\n",
       "   'Atxn-1 Protein',\n",
       "   'Atxn1 Protein',\n",
       "   'Protein, Ataxin-1',\n",
       "   'Protein, Atxn-1',\n",
       "   'Protein, Atxn1',\n",
       "   'Protein, SCA1',\n",
       "   'Proteína SCA1',\n",
       "   'SCA1 Protein',\n",
       "   'Spinocerebellar Ataxia Type 1 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067697': {'ID': 'D000067697',\n",
       "  'name': 'Saúde do Adolescente[Adolescent Health]',\n",
       "  'scope': 'The concept covering the physical and mental conditions of ADOLESCENTS.',\n",
       "  'terms': ['Adolescent Health',\n",
       "   'Caderneta de Saúde do Adolescente',\n",
       "   'Health, Adolescent',\n",
       "   'Health, Teen',\n",
       "   'Saúde Integral do Adolescente',\n",
       "   'Saúde do Adolescente',\n",
       "   'Saúde do Jovem',\n",
       "   'Saúde dos Adolescentes',\n",
       "   'Teen Health'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067698': {'ID': 'D000067698',\n",
       "  'name': 'Ataxina-2[Ataxin-2]',\n",
       "  'scope': 'A Poly(A) RNA-binding protein that negatively regulates EGFR ENDOCYTOSIS. An increased risk for developing AMYOTROPHIC LATERAL SCLEROSIS 13 is observed in patients who have more than 23 CAG repeats in the ATXN2 gene coding sequence. Larger CAG expansions in the ATXN2 gene occur in SPINOCEREBELLAR ATAXIA 2 patients.',\n",
       "  'terms': ['ATXN2 Protein',\n",
       "   'Ataxin 2',\n",
       "   'Ataxin 2 Protein',\n",
       "   'Ataxin-2',\n",
       "   'Ataxin-2 Protein',\n",
       "   'Ataxina-2',\n",
       "   'Atx 2 Protein',\n",
       "   'Atx-2 Protein',\n",
       "   'Protein, ATXN2',\n",
       "   'Protein, Ataxin-2',\n",
       "   'Protein, Atx-2',\n",
       "   'Protein, SCA2',\n",
       "   'Proteína SCA2',\n",
       "   'SCA2 Protein',\n",
       "   'Spinocerebellar Ataxia Type 2 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067699': {'ID': 'D000067699',\n",
       "  'name': 'Ataxina-3[Ataxin-3]',\n",
       "  'scope': 'A deubiquitinating enzyme of the ATAXINS family. It functions in protein homeostasis, GENETIC TRANSCRIPTION; CYTOSKELETON regulation, and MYOGENESIS. CAG TRINUCLEOTIDE REPEAT EXPANSION in the Ataxin-3 gene coding region is associated with spinocerebellar ataxia-3 (MACHADO-JOSEPH DISEASE).',\n",
       "  'terms': ['ATXN3 Protein',\n",
       "   'Ataxin 3',\n",
       "   'Ataxin 3 Protein',\n",
       "   'Ataxin-3',\n",
       "   'Ataxin-3 Protein',\n",
       "   'Ataxina-3',\n",
       "   'Machado Joseph Disease Protein',\n",
       "   'Machado-Joseph Disease Protein',\n",
       "   'Proteína SCA3',\n",
       "   'SCA3 Protein',\n",
       "   'Spinocerebellar Ataxia 3 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067716': {'ID': 'D000067716',\n",
       "  'name': 'Testes Imediatos[Point-of-Care Testing]',\n",
       "  'scope': 'Allows patient diagnoses in the physician’s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)',\n",
       "  'terms': ['Análises Clínicas Ambulatoriais',\n",
       "   'Análises Clínicas no Ambulatório',\n",
       "   'Análises Diagnósticas no Consultório',\n",
       "   'Análises do Paciente no Consultório',\n",
       "   'Bedside Testing',\n",
       "   'Bedside Testings',\n",
       "   'Diagnóstico Junto ao Leito',\n",
       "   'Diagnóstico no Local de Atendimento',\n",
       "   'Diagnóstico à Beira do Leito',\n",
       "   'Diagnósticos Ambulatoriais',\n",
       "   'Diagnósticos Junto ao Leito',\n",
       "   'Diagnósticos de Cabeceira',\n",
       "   'Diagnósticos no Ambulatório',\n",
       "   'Diagnósticos no Local de Atendimento',\n",
       "   'Diagnósticos à Beira do Leito',\n",
       "   'Exames Imediatos',\n",
       "   'Exames de Cabeceira',\n",
       "   'Point of Care Testing',\n",
       "   'Point-of-Care Testing',\n",
       "   'Point-of-Care Testings',\n",
       "   'Teste Junto ao Leito',\n",
       "   'Teste Point-of-Care',\n",
       "   'Teste no Consultório',\n",
       "   'Teste no Local de Atendimento',\n",
       "   'Teste à Beira do Leito',\n",
       "   'Testes Diagnósticos no Consultório',\n",
       "   'Testes Imediatos',\n",
       "   'Testes Junto ao Leito',\n",
       "   'Testes de Cabeceira',\n",
       "   'Testes no Consultório',\n",
       "   'Testes no Local da Intervenção',\n",
       "   'Testes no Local de Atendimento',\n",
       "   'Testes à Beira do Leito',\n",
       "   'Testing, Bedside',\n",
       "   'Testing, Point-of-Care',\n",
       "   'Testings, Point-of-Care'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067719': {'ID': 'D000067719',\n",
       "  'name': 'Ataxina-7[Ataxin-7]',\n",
       "  'scope': 'A component of the STAGA transcription coactivator-HAT complex that functions in Cone Rod Homeobox Protein (CRX)-dependent gene activation. It also stabilizes MICROTUBULES. CAG repeat expansion in the ATXN-7 coding region is associated with the development of SPINOCEREBELLAR ATAXIA 7.',\n",
       "  'terms': ['ATXN7 Protein',\n",
       "   'Ataxin 7',\n",
       "   'Ataxin-7',\n",
       "   'Ataxina-7',\n",
       "   'Atxn 7 Protein',\n",
       "   'Atxn-7 Protein',\n",
       "   'Protein, ATXN7',\n",
       "   'Protein, Atxn-7',\n",
       "   'Protein, SCA7',\n",
       "   'Proteína SCA7',\n",
       "   'SCA7 Protein',\n",
       "   'Spinocerebellar Ataxia 7 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067736': {'ID': 'D000067736',\n",
       "  'name': 'Ataxina-10[Ataxin-10]',\n",
       "  'scope': 'An ataxin that is associated with the survival of cerebellar neurons. Expansion of the ATTCT pentanucleotide in the ATXN10 coding region is associated with SPINOCEREBELLAR ATAXIA 10.',\n",
       "  'terms': ['ATXN10 Protein',\n",
       "   'Ataxin 10',\n",
       "   'Ataxin-10',\n",
       "   'Ataxina-10',\n",
       "   'Atxn 10 Protein',\n",
       "   'Atxn-10 Protein',\n",
       "   'Protein, ATXN10',\n",
       "   'Protein, Atxn-10',\n",
       "   'Protein, SCA10',\n",
       "   'Proteína SCA10',\n",
       "   'SCA10 Protein',\n",
       "   'Spinocerebellar Ataxia 10 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067756': {'ID': 'D000067756',\n",
       "  'name': 'Receptores de Peptídeos Semelhantes ao Glucagon[Glucagon-Like Peptide Receptors]',\n",
       "  'scope': 'G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues. These receptors regulate cellular responses to BLOOD GLUCOSE, INSULIN, and INFLAMMATION signals.',\n",
       "  'terms': ['GLPR Proteins',\n",
       "   'Glucagon Like Peptide Receptors',\n",
       "   'Glucagon Like Receptors',\n",
       "   'Glucagon-Like Peptide Receptors',\n",
       "   'Glucagon-Like Receptors',\n",
       "   'Peptide Receptors, Glucagon-Like',\n",
       "   'Proteins, GLPR',\n",
       "   'Receptor de Peptídeo Semelhante a Glucagon',\n",
       "   'Receptor de Peptídeo Semelhante ao Glucagon',\n",
       "   'Receptores de Peptídeo Semelhante a Glucagon',\n",
       "   'Receptores de Peptídeo Semelhante ao Glucagon',\n",
       "   'Receptores de Peptídeos Semelhantes a Glucagon',\n",
       "   'Receptores de Peptídeos Semelhantes ao Glucagon',\n",
       "   'Receptors, Glucagon-Like',\n",
       "   'Receptors, Glucagon-Like Peptide'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067757': {'ID': 'D000067757',\n",
       "  'name': 'Receptor do Peptídeo Semelhante ao Glucagon 1[Glucagon-Like Peptide-1 Receptor]',\n",
       "  'scope': 'A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS).',\n",
       "  'terms': ['GLP 1 Receptor',\n",
       "   'GLP 1R Receptor',\n",
       "   'GLP-1 Receptor',\n",
       "   'GLP-1R Receptor',\n",
       "   'GLP1R Protein',\n",
       "   'GLP1R Receptor',\n",
       "   'Glucagon Like Peptide 1 Receptor',\n",
       "   'Glucagon-Like Peptide-1 Receptor',\n",
       "   'Peptide-1 Receptor, Glucagon-Like',\n",
       "   'Protein, GLP1R',\n",
       "   'Receptor de GLP-1',\n",
       "   'Receptor de Peptídeo Glucacon-Like 1',\n",
       "   'Receptor de Peptídeo Glucagon-Símile 1',\n",
       "   'Receptor de Peptídeo Glucagon-Símile Tipo 1',\n",
       "   'Receptor de Peptídeo Semelhante a Glucagon 1',\n",
       "   'Receptor de Peptídeo Semelhante ao Glucagon 1',\n",
       "   'Receptor de Peptídeo-1 Semelhante ao Glucagon',\n",
       "   'Receptor do GLP-1',\n",
       "   'Receptor do Peptídeo Glucacon-Like 1',\n",
       "   'Receptor do Peptídeo Glucagon-Símile Tipo 1',\n",
       "   'Receptor do Peptídeo Semelhante a Glucagon 1',\n",
       "   'Receptor do Peptídeo Semelhante ao Glucagon 1',\n",
       "   'Receptor, GLP-1',\n",
       "   'Receptor, GLP-1R',\n",
       "   'Receptor, GLP1R',\n",
       "   'Receptor, Glucagon-Like Peptide-1'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067758': {'ID': 'D000067758',\n",
       "  'name': 'Receptor do Peptídeo Semelhante ao Glucagon 2[Glucagon-Like Peptide-2 Receptor]',\n",
       "  'scope': 'A receptor for GLUCAGON-LIKE PEPTIDE 2 (GLP-2) that is expressed on the surface of intestinal cells as well as neural cells. GLP-2 and other peptides act through GLP-2R to regulate cellular responses to BLOOD GLUCOSE, INFLAMMATION, and FOOD INTAKE.',\n",
       "  'terms': ['GLP 2 Receptor',\n",
       "   'GLP 2R Receptor',\n",
       "   'GLP-2 Receptor',\n",
       "   'GLP-2R Receptor',\n",
       "   'GLP2R Protein',\n",
       "   'Glucagon Like Peptide 2 Receptor',\n",
       "   'Glucagon-Like Peptide 2 Receptor',\n",
       "   'Glucagon-Like Peptide-2 Receptor',\n",
       "   'Peptide-2 Receptor, Glucagon-Like',\n",
       "   'Protein, GLP2R',\n",
       "   'Receptor de GLP-2',\n",
       "   'Receptor de Peptídeo Glucacon-Like 2',\n",
       "   'Receptor de Peptídeo Glucagon-Símile 2',\n",
       "   'Receptor de Peptídeo Glucagon-Símile Tipo 2',\n",
       "   'Receptor de Peptídeo Semelhante ao Glucagon 2',\n",
       "   'Receptor de Peptídeo-2 Semelhante ao Glucagon',\n",
       "   'Receptor do Peptídeo Glucacon-Like 2',\n",
       "   'Receptor do Peptídeo Glucagon-Símile 2',\n",
       "   'Receptor do Peptídeo Glucagon-Símile Tipo 2',\n",
       "   'Receptor do Peptídeo Semelhante a Glucagon 2',\n",
       "   'Receptor do Peptídeo Semelhante ao Glucagon 2',\n",
       "   'Receptor, GLP-2',\n",
       "   'Receptor, GLP-2R',\n",
       "   'Receptor, Glucagon-Like Peptide-2'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067759': {'ID': 'D000067759',\n",
       "  'name': 'Receptor para Produtos Finais de Glicação Avançada[Receptor for Advanced Glycation End Products]',\n",
       "  'scope': 'A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES and the ALARMINS - S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.',\n",
       "  'terms': ['AGE Receptor',\n",
       "   'AGER Protein',\n",
       "   'Advanced Glycosylation End Product Receptor',\n",
       "   'Advanced Glycosylation End Product Receptors',\n",
       "   'Advanced Glycosylation End Product Specific Receptor',\n",
       "   'Advanced Glycosylation End Product-Specific Receptor',\n",
       "   'Advanced Glycosylation End-Product Receptor',\n",
       "   'Advanced Glycosylation End-Product Receptors',\n",
       "   'Advanced Glycosylation Endproduct Receptors',\n",
       "   'Amphoterin Receptor',\n",
       "   'Protein, AGER',\n",
       "   'Proteína AGER',\n",
       "   'RAGE (Receptor for Advanced Glycation End Products)',\n",
       "   'Receptor AGE',\n",
       "   'Receptor Específico para Produtos Finais de Glicação Avançada',\n",
       "   'Receptor Específico para Produtos Finais de Glicosilação Avançada',\n",
       "   'Receptor RAGE para Produtos Finais de Glicação Avançada',\n",
       "   'Receptor for Advanced Glycation End Products',\n",
       "   'Receptor for Advanced Glycation End Products (RAGE)',\n",
       "   'Receptor for Advanced Glycation Endproducts',\n",
       "   'Receptor para Anfoterina',\n",
       "   'Receptor para Produtos Finais de Glicação Avançada',\n",
       "   'Receptor, AGE',\n",
       "   'Receptor, Advanced Glycosylation End Product',\n",
       "   'Receptor, Advanced Glycosylation End Products',\n",
       "   'Receptor, Advanced Glycosylation End-Product',\n",
       "   'Receptor, Advanced Glycosylation End-Products',\n",
       "   'Receptor, Amphoterin',\n",
       "   'Receptores para Produto Final de Glicação Avançada',\n",
       "   'Receptores para Produtos Finais de Glicosilação Avançada'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067776': {'ID': 'D000067776',\n",
       "  'name': 'Proteínas com Motivo de Reconhecimento de RNA[RNA Recognition Motif Proteins]',\n",
       "  'scope': 'A family of RNA-BINDING PROTEINS that contain an RNA RECOGNITION MOTIF and two ribonucleoprotein (RNP) domains which bind RNA, in addition to other domains that allow for high affinity binding, sequence specificity, and protein interactions. Examples of RNA recognition motif proteins include HETEROGENEOUS NUCLEAR RIBONUCLEARPROTEINS (hnRNP) and EMBRYONIC LETHAL ABNORMAL-VISION (ELAV) proteins.',\n",
       "  'terms': ['Proteínas RRM',\n",
       "   'Proteínas com Domínio de Ligação a RNA',\n",
       "   'Proteínas com Domínios de Ribonucleoproteínas',\n",
       "   'Proteínas com Motivo de Reconhecimento de RNA',\n",
       "   'Proteínas com Motivos de Reconhecimento de RNA',\n",
       "   'Proteínas com RRM',\n",
       "   'RNA Binding Domain Proteins',\n",
       "   'RNA Recognition Motif Proteins',\n",
       "   'RNA-Binding Domain Proteins',\n",
       "   'RRM Proteins',\n",
       "   'Ribonucleoprotein Domain Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067777': {'ID': 'D000067777',\n",
       "  'name': 'Proteína Semelhante a ELAV 2[ELAV-Like Protein 2]',\n",
       "  'scope': \"A neural-specific RRM protein that binds to several 3'UTRs, including its own as well as that of PROTO-ONCOGENE PROTEINS C-FOS  and ID DNA BINDING PROTEIN INHIBITOR. It binds through the recognition of a GAAA motif in the RNAs.\",\n",
       "  'terms': ['2, ELAV-Like Protein',\n",
       "   'Antigen, HuB',\n",
       "   'ELAV (Embryonic Lethal, Abnormal Vision, Drosophila)-Like 2 (Hu Antigen B)',\n",
       "   'ELAV Like Protein 2',\n",
       "   'ELAV-Like Protein 2',\n",
       "   'ELAVL2 protein',\n",
       "   'HuB Antigen',\n",
       "   'HuB Paraneoplastic Encephalomyelitis Antigen',\n",
       "   'HuB Protein',\n",
       "   'Protein 2, ELAV-Like',\n",
       "   'Protein, HuB',\n",
       "   'Proteína 2 ELAV-Like',\n",
       "   'Proteína 2 Semelhante a ELAV 2',\n",
       "   'Proteína 2 Similar a ELAV',\n",
       "   'Proteína ELAV-Like 2',\n",
       "   'Proteína Semelhante a ELAV 2',\n",
       "   'Proteína Similar a ELAV 2',\n",
       "   'protein, ELAVL2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067778': {'ID': 'D000067778',\n",
       "  'name': 'Proteína Semelhante a ELAV 3[ELAV-Like Protein 3]',\n",
       "  'scope': 'A neural-specific RRM protein which contains three RNP-type RNA recognition motifs (RRMs). Human ELAVL3 is recognized by the anti-Hu serum antibody from patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN). It also functions in neurogenesis.',\n",
       "  'terms': ['3, ELAV-Like Protein',\n",
       "   'Antigen, HuC',\n",
       "   'ELAV Like Protein 3',\n",
       "   'ELAV-Like Protein 3',\n",
       "   'ELAVL3 Protein',\n",
       "   'HuC Antigen',\n",
       "   'HuC Paraneoplastic Encephalomyelitis Antigen',\n",
       "   'HuC Protein',\n",
       "   'Protein 3, ELAV-Like',\n",
       "   'Protein, ELAVL3',\n",
       "   'Protein, HuC',\n",
       "   'Proteína 3 ELAV-Like',\n",
       "   'Proteína 3 Semelhante a ELAV',\n",
       "   'Proteína 3 Similar a ELAV',\n",
       "   'Proteína ELAV-Like 3',\n",
       "   'Proteína Semelhante a ELAV 3',\n",
       "   'Proteína Similar a ELAV 3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067779': {'ID': 'D000067779',\n",
       "  'name': 'Proteína Semelhante a ELAV 4[ELAV-Like Protein 4]',\n",
       "  'scope': \"An RRM protein which binds AU-rich sequences in the 3' UNTRANSLATED REGIONS of mRNAs for PROTO-ONCOGENE PROTEINS C-FOS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; and GAP-43 PROTEIN. It functions in neuron-specific RNA processing.\",\n",
       "  'terms': ['Antigen, HuD',\n",
       "   'ELAV Like Protein 4',\n",
       "   'ELAV-Like Protein 4',\n",
       "   'ELAVL4 Protein',\n",
       "   'HuD Antigen',\n",
       "   'HuD Paraneoplastic Encephalomyelitis Antigen',\n",
       "   'HuD Protein',\n",
       "   'Protein, ELAVL4',\n",
       "   'Protein, HuD',\n",
       "   'Proteína 4 ELAV-Like',\n",
       "   'Proteína 4 Semelhante a ELAV',\n",
       "   'Proteína 4 Similar a ELAV',\n",
       "   'Proteína ELAV-Like 4',\n",
       "   'Proteína Semelhante a ELAV 4',\n",
       "   'Proteína Similar a ELAV 4'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067780': {'ID': 'D000067780',\n",
       "  'name': 'Proteína Semelhante a ELAV 1[ELAV-Like Protein 1]',\n",
       "  'scope': \"An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation.\",\n",
       "  'terms': ['Antigen, HuR',\n",
       "   'ELAV Like Protein 1',\n",
       "   'ELAV-Like Protein 1',\n",
       "   'ELAVL1 protein',\n",
       "   'HuR Antigen',\n",
       "   'HuR Paraneoplastic Encephalomyelitis Antigen',\n",
       "   'HuR Protein',\n",
       "   'Protein, HuR',\n",
       "   'Proteína 1 ELAV-Like',\n",
       "   'Proteína 1 Semelhante a ELAV',\n",
       "   'Proteína 1 Similar a ELAV',\n",
       "   'Proteína ELAV-Like 1',\n",
       "   'Proteína Semelhante a ELAV 1',\n",
       "   'Proteína Similar a ELAV 1',\n",
       "   'protein, ELAVL1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067796': {'ID': 'D000067796',\n",
       "  'name': 'Soro do Leite[Whey]',\n",
       "  'scope': 'The liquid components of milk that remain after the CASEIN, fat, and fat soluble components have been removed. It is also a byproduct of cheese production.',\n",
       "  'terms': ['Soro Lácteo', 'Soro de Leite', 'Soro do Leite', 'Whey'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067816': {'ID': 'D000067816',\n",
       "  'name': 'Proteínas do Soro do Leite[Whey Proteins]',\n",
       "  'scope': 'The protein components of milk obtained from the whey.',\n",
       "  'terms': ['Protein, Whey',\n",
       "   'Proteins, Whey',\n",
       "   'Proteínas do Soro do Leite',\n",
       "   'Whey Protein',\n",
       "   'Whey Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067836': {'ID': 'D000067836',\n",
       "  'name': 'Transtorno de Acumulação[Hoarding Disorder]',\n",
       "  'scope': 'Disordered behavior associated with clinically significant distress or impairment in social, occupational or other important areas of functioning and persistent difficulty parting with possessions due to a perceived need to save the items and distress associated with discarding them. (from DSM-V) The quantity of collected items sets the behavior apart from normal collecting behaviors.',\n",
       "  'terms': ['Colecionismo Obsessivo',\n",
       "   'Disorders, Hoarding',\n",
       "   'Hoarding Disorder',\n",
       "   'Hoarding Disorders',\n",
       "   'Hoarding, Obsessive',\n",
       "   'Obsessive Hoarding',\n",
       "   'Transtorno da Acumulação',\n",
       "   'Transtorno de Acumulação',\n",
       "   'Transtorno de Colecionismo'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067856': {'ID': 'D000067856',\n",
       "  'name': 'Inibidores de Poli(ADP-Ribose) Polimerases[Poly(ADP-ribose) Polymerase Inhibitors]',\n",
       "  'scope': 'Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.',\n",
       "  'terms': ['Inhibitors of Poly(ADP-ribose) Polymerases',\n",
       "   'Inhibitors, PARP',\n",
       "   'Inibidores de Poli(ADP-Ribose) Polimerases',\n",
       "   'PARP Inhibitors',\n",
       "   'Poly(ADP-ribose) Polymerase Inhibitors',\n",
       "   'Poly(ADP-ribosylation) Inhibitors'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067877': {'ID': 'D000067877',\n",
       "  'name': 'Transtorno do Espectro Autista[Autism Spectrum Disorder]',\n",
       "  'scope': 'Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)',\n",
       "  'terms': ['Autism Spectrum Disorder',\n",
       "   'Autism Spectrum Disorders',\n",
       "   'Spectrum Disorders, Autism',\n",
       "   'Transtorno de Espectro Autista',\n",
       "   'Transtorno do Espectro Autista',\n",
       "   'Transtorno do Espectro do Autismo'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000067878': {'ID': 'D000067878',\n",
       "  'name': 'Proteínas CELF[CELF Proteins]',\n",
       "  'scope': 'A family of RRM proteins which contain two N-terminal RNA RECOGNITION MOTIF (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 amino acids between the second and third RRM domains. They regulate pre-mRNA ALTERNATIVE SPLICING and also function in RNA EDITING and PROTEIN BIOSYNTHESIS.',\n",
       "  'terms': ['BRUNOL Proteins',\n",
       "   'Bruno Like Family Member Proteins',\n",
       "   'Bruno-Like Family Member Proteins',\n",
       "   'CELF Proteins',\n",
       "   'CUG BP Proteins',\n",
       "   'CUG Triplet Repeat, RNA Binding Proteins',\n",
       "   'CUG Triplet Repeat, RNA-Binding Proteins',\n",
       "   'CUG-BP Proteins',\n",
       "   'CUGBP Proteins',\n",
       "   'CUGBP, Elav Like Family Member Proteins',\n",
       "   'CUGBP, Elav-Like Family Member Proteins',\n",
       "   'Proteins, BRUNOL',\n",
       "   'Proteins, CELF',\n",
       "   'Proteins, CUG-BP',\n",
       "   'Proteins, CUGBP',\n",
       "   'Proteínas CELF'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067879': {'ID': 'D000067879',\n",
       "  'name': 'Proteínas CELF1[CELF1 Protein]',\n",
       "  'scope': \"A member of the CELF PROTEINS family which binds GU rich elements (GREs) and CUG-triplet repeats in the 3'UTR of mammalian mRNA transcripts that undergo rapid turnover. It also binds AU-rich elements (AREs or EDEN-like) in the 3'UTR of JUN and FOS mRNAs. Mutations in the human CELF1 gene are associated with MYOTONIC DYSTROPHY type 1.\",\n",
       "  'terms': ['2 Protein, Bruno-Like',\n",
       "   'BRUNOL2 Protein',\n",
       "   'Bruno Like 2 Protein',\n",
       "   'Bruno-Like 2 Protein',\n",
       "   'CELF1 Protein',\n",
       "   'CUG Triplet Repeat, RNA Binding Protein 1',\n",
       "   'CUG Triplet Repeat, RNA-Binding Protein 1',\n",
       "   'CUGBP, Elav Like Family Member 1 Protein',\n",
       "   'CUGBP, Elav-Like Family Member 1 Protein',\n",
       "   'CUGBP1 Protein',\n",
       "   'Protein, BRUNOL2',\n",
       "   'Protein, Bruno-Like 2',\n",
       "   'Protein, CELF1',\n",
       "   'Protein, CUGBP1',\n",
       "   'Proteínas CELF1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067896': {'ID': 'D000067896',\n",
       "  'name': 'Desenvolvimento Industrial[Industrial Development]',\n",
       "  'scope': 'Activity concerned with the planning and building of industries through manufacturing, provision of specialized services, and COMMERCE.',\n",
       "  'terms': ['Crescimento Industrial',\n",
       "   'Desenvolvimento Industrial',\n",
       "   'Development, Industrial',\n",
       "   'Development, Technology',\n",
       "   'Developments, Industrial',\n",
       "   'Expansão Industrial',\n",
       "   'Industrial Development',\n",
       "   'Industrial Developments',\n",
       "   'Industrialization',\n",
       "   'Industrialização',\n",
       "   'Industrialização (Saúde Ambiental)',\n",
       "   'Progresso Industrial',\n",
       "   'Technology Development',\n",
       "   'Technology Developments'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067917': {'ID': 'D000067917',\n",
       "  'name': 'Computação em Nuvem[Cloud Computing]',\n",
       "  'scope': 'Storing and processing data on multiple servers that can be accessed through the Internet.',\n",
       "  'terms': ['Cloud Computing',\n",
       "   'Cloud Processing',\n",
       "   'Cloud Service',\n",
       "   'Cloud Storage',\n",
       "   'Cloud Storages',\n",
       "   'Computação em Nuvem',\n",
       "   'Computing, Cloud',\n",
       "   'Processing, Cloud',\n",
       "   'Service, Cloud',\n",
       "   'Storage, Cloud',\n",
       "   'Storages, Cloud'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067936': {'ID': 'D000067936',\n",
       "  'name': 'Recursos Naturais[Natural Resources]',\n",
       "  'scope': 'The amount of land available for use or development.',\n",
       "  'terms': ['Land Supplies',\n",
       "   'Land Supply',\n",
       "   'Natural Resource',\n",
       "   'Natural Resources',\n",
       "   'Recursos Naturais',\n",
       "   'Resource, Natural',\n",
       "   'Resources, Natural',\n",
       "   'Supplies, Land',\n",
       "   'Supply, Land'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067940': {'ID': 'D000067940',\n",
       "  'name': 'Carga Glicêmica[Glycemic Load]',\n",
       "  'scope': 'A quantitative value of a measured amount of a specific food that is equal to the GLYCEMIC INDEX of that food multiplied by the carbohydrate content of that food.',\n",
       "  'terms': ['Carga Glicêmica', 'Glycemic Load', 'Load, Glycemic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000067956': {'ID': 'D000067956',\n",
       "  'name': 'Inibidores de Adenilil Ciclases[Adenylyl Cyclase Inhibitors]',\n",
       "  'scope': 'Compounds that bind to and inhibit the action of ADENYLYL CYCLASES.',\n",
       "  'terms': ['Adenylate Cyclase Inhibitors',\n",
       "   'Adenylyl Cyclase Inhibitors',\n",
       "   'Cyclase Inhibitors, Adenylate',\n",
       "   'Cyclase Inhibitors, Adenylyl',\n",
       "   'Inhibitors, Adenylate Cyclase',\n",
       "   'Inhibitors, Adenylyl Cyclase',\n",
       "   'Inibidores de Adenilato Ciclase',\n",
       "   'Inibidores de Adenilil Ciclase',\n",
       "   'Inibidores de Adenilil Ciclases',\n",
       "   'Inibidores de Adenililciclase',\n",
       "   'Inibidores de Adenililciclases'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000067996': {'ID': 'D000067996',\n",
       "  'name': 'Células RAW 264.7[RAW 264.7 Cells]',\n",
       "  'scope': 'A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS.',\n",
       "  'terms': ['264.7 Cell, RAW',\n",
       "   '264.7 Cells, RAW',\n",
       "   'Cell, RAW 264.7',\n",
       "   'Cells, RAW 264.7',\n",
       "   'Células RAW 264.7',\n",
       "   'RAW 264.7 Cell',\n",
       "   'RAW 264.7 Cell Line',\n",
       "   'RAW 264.7 Cells'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068': {'ID': 'D000068',\n",
       "  'name': 'Acreditação[Accreditation]',\n",
       "  'scope': 'Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.',\n",
       "  'terms': ['Accreditation', 'Accreditations', 'Acreditação'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068016': {'ID': 'D000068016',\n",
       "  'name': 'Clostridiales[Clostridiales]',\n",
       "  'scope': 'An order of anaerobic bacteria that are predominantly GRAM POSITIVE within the phylum Firmicutes. It includes the Clostridium and Eubacterium genera.',\n",
       "  'terms': ['Clostridiales', 'Clostridiales'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068036': {'ID': 'D000068036',\n",
       "  'name': 'Histórias em Quadrinhos[Graphic Novels]',\n",
       "  'scope': 'Book-length narratives told using a combination of words and sequential art, often presented in comic book style. from (Fletcher-Spear et al., ALA Review, Winter 2005)',\n",
       "  'terms': ['Banda Desenhada',\n",
       "   'Comic Books',\n",
       "   'Gibis',\n",
       "   'Graphic Novels',\n",
       "   'História em Quadrinhos',\n",
       "   'Histórias em Quadrinhos',\n",
       "   'Revista em Quadrinhos',\n",
       "   'Revistas em Quadrinhos',\n",
       "   'Revistinha em Quadrinhos',\n",
       "   'Revistinhas em Quadrinhos',\n",
       "   'Romance Gráfico',\n",
       "   'Romances Gráficos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068037': {'ID': 'D000068037',\n",
       "  'name': 'Sudão do Sul[South Sudan]',\n",
       "  'scope': 'A nation located in East-Central Africa; south of Sudan, north of Uganda and Kenya, west of Ethiopia. Independence from SUDAN was attained on 9 July 2011. The capital is Juba. (from CIA. World Factbook, 2014.)',\n",
       "  'terms': ['República do Sudão do Sul',\n",
       "   'South Sudan',\n",
       "   'Sudão Meridional',\n",
       "   'Sudão do Sul'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068079': {'ID': 'D000068079',\n",
       "  'name': 'Transtornos Motores[Motor Disorders]',\n",
       "  'scope': 'Motor skills deficits that significantly and persistently interfere with ACTIVITIES OF DAILY LIVING appropriate to chronological age.  (from DSM-V)',\n",
       "  'terms': ['Distúrbio Motor',\n",
       "   'Distúrbios Motores',\n",
       "   'Motor Disorders',\n",
       "   'Transtorno Motor',\n",
       "   'Transtornos Motores'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000068097': {'ID': 'D000068097',\n",
       "  'name': 'Saúde Materna[Maternal Health]',\n",
       "  'scope': 'The health of women during PREGNANCY; childbirth and the POSTPARTUM PERIOD.',\n",
       "  'terms': ['Health, Maternal', 'Maternal Health', 'Saúde Materna'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068098': {'ID': 'D000068098',\n",
       "  'name': 'Banco de Sementes[Seed Bank]',\n",
       "  'scope': 'A repository of seeds maintained under optimal conditions that ensure long term storage, intended for use as a source of replenishment of seed stock or plant genetic material.',\n",
       "  'terms': ['Banco de Germoplasma',\n",
       "   'Banco de Sementes',\n",
       "   'Bank, Germplasm',\n",
       "   'Bank, Seed',\n",
       "   'Bank, Seeds',\n",
       "   'Banks, Germplasm',\n",
       "   'Banks, Seed',\n",
       "   'Germplasm Bank',\n",
       "   'Germplasm Banks',\n",
       "   'Seed Bank',\n",
       "   'Seed Banks',\n",
       "   'Seedbank',\n",
       "   'Seedbanks',\n",
       "   'Seeds Bank'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068099': {'ID': 'D000068099',\n",
       "  'name': 'Transtornos Relacionados a Trauma e Fatores de Estresse[Trauma and Stressor Related Disorders]',\n",
       "  'scope': 'Disorders in which exposure to a traumatic or stressful event is explicitly a diagnostic criterion.',\n",
       "  'terms': ['Transtornos Relacionados a Trauma e Estresse',\n",
       "   'Transtornos Relacionados a Trauma e Fatores de Estresse',\n",
       "   'Transtornos Relacionados a Trauma e Fatores de Stress',\n",
       "   'Transtornos Relacionados a Trauma e a Estressores',\n",
       "   'Trauma and Stressor Related Disorders'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000068101': {'ID': 'D000068101',\n",
       "  'name': 'Serviços de Saúde Materno-Infantil[Maternal-Child Health Services]',\n",
       "  'scope': 'Programs organized for the purpose of providing medical and social services for mothers and children.',\n",
       "  'terms': ['Assistência Materno-Infantil',\n",
       "   'Assistência à Saúde Materno-Infantil',\n",
       "   'Assistência à Saúde da Mulher e da Criança',\n",
       "   'Health Service, Maternal-Child',\n",
       "   'Health Services, Maternal Child',\n",
       "   'Health Services, Maternal-Child',\n",
       "   'Maternal Child Health Services',\n",
       "   'Maternal-Child Health Service',\n",
       "   'Maternal-Child Health Services',\n",
       "   'Rede Cegonha',\n",
       "   'Service, Maternal-Child Health',\n",
       "   'Services, Maternal-Child Health',\n",
       "   'Serviços de Saúde Materno-Infantil'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068103': {'ID': 'D000068103',\n",
       "  'name': 'Fatores de Processamento de Serina-Arginina[Serine-Arginine Splicing Factors]',\n",
       "  'scope': 'A family of regulatory factors essential for constitutive and alternative splicing in RNA metabolism.',\n",
       "  'terms': ['Factors, Serine-Arginine Splicing',\n",
       "   'Fatores de Processamento de Serina-Arginina',\n",
       "   'Proteins, SR-Rich Splicing',\n",
       "   'Proteins, Serine-Arginine-Rich Splicing',\n",
       "   'SR Rich Splicing Proteins',\n",
       "   'SR-Rich Splicing Proteins',\n",
       "   'Serine Arginine Rich Splicing Proteins',\n",
       "   'Serine Arginine Splicing Factors',\n",
       "   'Serine-Arginine Splicing Factors',\n",
       "   'Serine-Arginine-Rich Splicing Proteins',\n",
       "   'Splicing Factors, Serine-Arginine',\n",
       "   'Splicing Proteins, SR-Rich',\n",
       "   'Splicing Proteins, Serine-Arginine-Rich'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068104': {'ID': 'D000068104',\n",
       "  'name': 'Saúde do Lactente[Infant Health]',\n",
       "  'scope': 'The concept covering the physical and mental conditions of INFANTS.',\n",
       "  'terms': ['Baby Health',\n",
       "   'Health of Newborn Infants',\n",
       "   'Health of the Newborn Infant',\n",
       "   'Health, Baby',\n",
       "   'Health, Infant',\n",
       "   'Health, Neonatal',\n",
       "   'Health, Newborn',\n",
       "   'Health, Newborn Infant',\n",
       "   'Infant Health',\n",
       "   'Infant Health, Newborn',\n",
       "   'Neonatal Health',\n",
       "   'Newborn Health',\n",
       "   'Newborn Infant Health',\n",
       "   'Saúde do Lactente'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068105': {'ID': 'D000068105',\n",
       "  'name': 'Transtornos Bipolares e Relacionados[Bipolar and Related Disorders]',\n",
       "  'scope': 'These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) .',\n",
       "  'terms': ['Bipolar and Related Disorders',\n",
       "   'Transtornos Bipolares e Relacionados',\n",
       "   'Transtornos Bipolares e Transtornos Relacionados'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000068116': {'ID': 'D000068116',\n",
       "  'name': 'Disforia de Gênero[Gender Dysphoria]',\n",
       "  'scope': 'A marked difference between the individual’s expressed/experienced gender and the gender others would assign him or her, and it must continue for at least six months. (from DSM-5)',\n",
       "  'terms': ['Disforia da Identidade de Gênero',\n",
       "   'Disforia de Gênero',\n",
       "   'Distúrbio de Identidade de Gênero',\n",
       "   'Gender Dysphoria',\n",
       "   'Transtorno da Identidade de Gênero',\n",
       "   'Transtorno de Identidade de Gênero'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000068156': {'ID': 'D000068156',\n",
       "  'name': 'Feedback Formativo[Formative Feedback]',\n",
       "  'scope': 'Information communicated to the learner that is intended to modify the learner’s thinking or behavior for the purpose of improving learning.',\n",
       "  'terms': ['Constructive Feedback',\n",
       "   'Feedback (Learning)',\n",
       "   'Feedback Formal',\n",
       "   'Feedback Formativo',\n",
       "   'Feedback, Constructive',\n",
       "   'Feedback, Formative',\n",
       "   'Formative Feedback',\n",
       "   'Retroalimentação Formal',\n",
       "   'Retroalimentação Formativa'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068180': {'ID': 'D000068180',\n",
       "  'name': 'Aripiprazol[Aripiprazole]',\n",
       "  'scope': 'An antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A.',\n",
       "  'terms': ['14597, OPC',\n",
       "   '7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone',\n",
       "   'Abilify',\n",
       "   'Abilify',\n",
       "   'Aripiprazol',\n",
       "   'Aripiprazol',\n",
       "   'Aripiprazole',\n",
       "   'OPC 14597',\n",
       "   'OPC-14597'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068181': {'ID': 'D000068181',\n",
       "  'name': 'Prunus dulcis[Prunus dulcis]',\n",
       "  'scope': 'Nuts from almond tree and from which almond oil is pressed.',\n",
       "  'terms': ['Almond',\n",
       "   'Almond Tree',\n",
       "   'Almond Trees',\n",
       "   'Almond, Sweet',\n",
       "   'Almonds',\n",
       "   'Almonds, Sweet',\n",
       "   'Amendoeira',\n",
       "   'Amygdalus communis',\n",
       "   'Amygdalus communis',\n",
       "   'Amêndoa',\n",
       "   'Amêndoa Doce',\n",
       "   'Amêndoas',\n",
       "   'Prunis communis',\n",
       "   'Prunus amygdalus',\n",
       "   'Prunus amygdalus',\n",
       "   'Prunus communis',\n",
       "   'Prunus dulcis',\n",
       "   'Prunus dulcis',\n",
       "   'Sweet Almond',\n",
       "   'Sweet Almonds',\n",
       "   'Tree, Almond',\n",
       "   'Trees, Almond'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068196': {'ID': 'D000068196',\n",
       "  'name': 'Paclitaxel Ligado a Albumina[Albumin-Bound Paclitaxel]',\n",
       "  'scope': 'An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.',\n",
       "  'terms': ['ABI 007',\n",
       "   'ABI-007',\n",
       "   'ABI007',\n",
       "   'Abraxane',\n",
       "   'Abraxane',\n",
       "   'Albumin Bound Paclitaxel',\n",
       "   'Albumin-Bound Paclitaxel',\n",
       "   'Paclitaxel Ligado a Albumina',\n",
       "   'Paclitaxel, Albumin-Bound',\n",
       "   'Paclitaxel, Protein-Bound',\n",
       "   'Protein Bound Paclitaxel',\n",
       "   'Protein-Bound Paclitaxel'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068216': {'ID': 'D000068216',\n",
       "  'name': 'Serviços de Proteção Infantil[Child Protective Services]',\n",
       "  'scope': 'Local governmental offices which investigate reports of abuse and neglect of children, and act to assure a safe environment for minors.',\n",
       "  'terms': ['Child Protective Service',\n",
       "   'Child Protective Services',\n",
       "   'Child Welfare Agencies',\n",
       "   'Child Welfare Agency',\n",
       "   'Serviços de Proteção Infantil',\n",
       "   'Serviços de Proteção à Criança',\n",
       "   'Serviços de Proteção às Crianças',\n",
       "   'Welfare Agency, Child'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068217': {'ID': 'D000068217',\n",
       "  'name': 'Assistentes Sociais[Social Workers]',\n",
       "  'scope': 'Professionals who work with persons affected by social disadvantages such as POVERTY; mental and physical illness or disability, and social injustice.  Their focus is on both the individual and his or her environment, including violations of their civil liberties and human rights.',\n",
       "  'terms': ['Asistente Social',\n",
       "   'Assistentes Sociais',\n",
       "   'Social Worker',\n",
       "   'Social Workers',\n",
       "   'Worker, Social',\n",
       "   'Workers, Social'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068218': {'ID': 'D000068218',\n",
       "  'name': 'Prunus africana[Prunus africana]',\n",
       "  'scope': 'A plant species in the family ROSACEAE. The bark extract known as pygeum is an ingredient in FOLK REMEDIES.',\n",
       "  'terms': ['African Prune',\n",
       "   'African Prunes',\n",
       "   'Ameixa-Africana',\n",
       "   'Prune, African',\n",
       "   'Prunes, African',\n",
       "   'Prunus africana',\n",
       "   'Prunus africana',\n",
       "   'Pygeum',\n",
       "   'Pygeum africanum',\n",
       "   'Pygeum africanum'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068219': {'ID': 'D000068219',\n",
       "  'name': 'Prunus armeniaca[Prunus armeniaca]',\n",
       "  'scope': 'A plant species in the family ROSACEAE. It is the source of apricot fruit.',\n",
       "  'terms': ['Abricoqueiro',\n",
       "   'Abricoteiro',\n",
       "   'Abricô',\n",
       "   'Apricot',\n",
       "   'Apricot Tree',\n",
       "   'Apricot Trees',\n",
       "   'Apricots',\n",
       "   'Damasco',\n",
       "   'Damascos',\n",
       "   'Damasqueiro',\n",
       "   'Prunus armeniaca',\n",
       "   'Prunus armeniaca',\n",
       "   'Tree, Apricot',\n",
       "   'Trees, Apricot'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068220': {'ID': 'D000068220',\n",
       "  'name': 'Prunus avium[Prunus avium]',\n",
       "  'scope': 'A plant species in the family ROSACEAE. It is the source of the sweet cherry fruit.',\n",
       "  'terms': ['Black Cherries',\n",
       "   'Black Cherry',\n",
       "   'Cerejeira-Negra',\n",
       "   'Cherries, Black',\n",
       "   'Cherries, Pie',\n",
       "   'Cherries, Sour',\n",
       "   'Cherries, Sweet',\n",
       "   'Cherry Tree, Sweet',\n",
       "   'Cherry Trees, Sweet',\n",
       "   'Cherry, Black',\n",
       "   'Cherry, Pie',\n",
       "   'Cherry, Sour',\n",
       "   'Cherry, Sweet',\n",
       "   'Pie Cherries',\n",
       "   'Pie Cherry',\n",
       "   'Prunus avium',\n",
       "   'Prunus avium',\n",
       "   'Prunus cerasus',\n",
       "   'Prunus serotina',\n",
       "   'Prunus serotina',\n",
       "   'Sour Cherries',\n",
       "   'Sour Cherry',\n",
       "   'Sweet Cherries',\n",
       "   'Sweet Cherry',\n",
       "   'Sweet Cherry Tree',\n",
       "   'Sweet Cherry Trees',\n",
       "   'Tree, Sweet Cherry',\n",
       "   'Trees, Sweet Cherry'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068236': {'ID': 'D000068236',\n",
       "  'name': 'Refúgio[Refugium]',\n",
       "  'scope': 'Area in an environment in which a population of organisms can survive through a period of unfavorable conditions.',\n",
       "  'terms': ['Refugia', 'Refugium', 'Refúgio'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068237': {'ID': 'D000068237',\n",
       "  'name': 'Aconselhamento à Distância[Distance Counseling]',\n",
       "  'scope': 'Counseling conducted via electronic or other non-face-to-face interactions.',\n",
       "  'terms': ['Aconselhamento à Distância',\n",
       "   'Counseling, Distance',\n",
       "   'Distance Counseling',\n",
       "   'E Counseling',\n",
       "   'E Therapy',\n",
       "   'E-Counseling',\n",
       "   'E-Therapies',\n",
       "   'E-Therapy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068238': {'ID': 'D000068238',\n",
       "  'name': 'Lubiprostona[Lubiprostone]',\n",
       "  'scope': 'Member of a bicyclic fatty acid class of compounds derived from PROSTAGLANDIN E1 involved in chloride channel gating.',\n",
       "  'terms': ['0211, RU',\n",
       "   '0211, SPI',\n",
       "   'Amitiza',\n",
       "   'Lubiprostona',\n",
       "   'Lubiprostone',\n",
       "   'Lubiprostone',\n",
       "   'Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11alpha)-',\n",
       "   'RU 0211',\n",
       "   'RU-0211',\n",
       "   'RU0211',\n",
       "   'SPI 0211',\n",
       "   'SPI-0211',\n",
       "   'SPI0211'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068239': {'ID': 'D000068239',\n",
       "  'name': 'Prunus persica[Prunus persica]',\n",
       "  'scope': 'Prunus persica (L.) Batsch is the source of peaches.',\n",
       "  'terms': ['Peach',\n",
       "   'Peach Tree',\n",
       "   'Peach Trees',\n",
       "   'Peaches',\n",
       "   'Pessegueiro',\n",
       "   'Prunus persica',\n",
       "   'Prunus persica',\n",
       "   'Pêssego',\n",
       "   'Pêssegos',\n",
       "   'Tree, Peach',\n",
       "   'Trees, Peach'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068240': {'ID': 'D000068240',\n",
       "  'name': 'Anonimização de Dados[Data Anonymization]',\n",
       "  'scope': 'Removal of personally identifiable information via encryption or other methods.',\n",
       "  'terms': ['Anonimização de Dados',\n",
       "   'Anonimização dos Dados',\n",
       "   'Anonymization, Data',\n",
       "   'Data Anonymization',\n",
       "   'Data Masking',\n",
       "   'De Identification',\n",
       "   'De-Identification',\n",
       "   'Deidentification',\n",
       "   'Deidentifications',\n",
       "   'Mascaramento de Dados',\n",
       "   'Masking, Data'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068241': {'ID': 'D000068241',\n",
       "  'name': 'Informações Pessoalmente Identificáveis[Personally Identifiable Information]',\n",
       "  'scope': 'Information that can be used to distinguish or trace an individual’s identity, either alone or when combined with other personal or identifying information that is linked or linkable to a specific individual.',\n",
       "  'terms': ['Informação Identificável Pessoalmente',\n",
       "   'Informação Pessoalmente Identificável',\n",
       "   'Informação de Identidade Pessoal',\n",
       "   'Informações Pessoalmente Identificáveis',\n",
       "   'Informações de Identidade Pessoal',\n",
       "   'Personally Identifiable Information'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068242': {'ID': 'D000068242',\n",
       "  'name': 'Prunus domestica[Prunus domestica]',\n",
       "  'scope': 'A plant species of the family ROSACEAE. It produces the drupes called cherry plums.',\n",
       "  'terms': ['<i>aveia</i>',\n",
       "   '<i>caldo</i>',\n",
       "   '<i>farinha</i>',\n",
       "   '<i>limao</i>',\n",
       "   '<i>mamao</i>',\n",
       "   '<i>milho</i>',\n",
       "   '<i>mortadela</i>',\n",
       "   '<i>queijo</i>',\n",
       "   '<i>salgadas</i>',\n",
       "   '<i>trigo</i>',\n",
       "   'Ameixa',\n",
       "   'Ameixas',\n",
       "   'Ameixeira',\n",
       "   'Ameixeiras',\n",
       "   'Cherry Plum Tree',\n",
       "   'Cherry Plum Trees',\n",
       "   'Japanese Plum',\n",
       "   'Japanese Plums',\n",
       "   'Plum',\n",
       "   'Plum Tree',\n",
       "   'Plum Tree, Cherry',\n",
       "   'Plum Trees',\n",
       "   'Plum Trees, Cherry',\n",
       "   'Plum, Japanese',\n",
       "   'Plums',\n",
       "   'Plums, Japanese',\n",
       "   'Prunus cerasifera',\n",
       "   'Prunus domestica',\n",
       "   'Prunus domestica',\n",
       "   'Prunus salicina',\n",
       "   'Prunus salicinas',\n",
       "   'Tree, Cherry Plum',\n",
       "   'Tree, Plum',\n",
       "   'Trees, Cherry Plum',\n",
       "   'Trees, Plum',\n",
       "   'salicina, Prunus',\n",
       "   'salicinas, Prunus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068256': {'ID': 'D000068256',\n",
       "  'name': 'Darbepoetina alfa[Darbepoetin alfa]',\n",
       "  'scope': 'A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.',\n",
       "  'terms': ['Aranesp',\n",
       "   'Aranest',\n",
       "   'Darbepoetin alfa',\n",
       "   'Darbepoetina alfa',\n",
       "   'Darbepoietin alfa',\n",
       "   'KRN 321',\n",
       "   'KRN-321',\n",
       "   'KRN321',\n",
       "   'NESP',\n",
       "   'Novel Erythropoiesis Stimulating Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068257': {'ID': 'D000068257',\n",
       "  'name': 'Combinação Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila[Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination]',\n",
       "  'scope': 'Inhibitor or Reverse Transcriptases or of RNA-dIrected DNA polymerase.',\n",
       "  'terms': ['Atripla',\n",
       "   'Combinação Efavirenz, Emtricitabina, Disoproxil Fumarato de Tenofovir',\n",
       "   'Combinação Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação Efavirenz, Emtricitabina, Fumarato de Tenofovir Disoproxil',\n",
       "   'Combinação de Drogas Efavirenz, Emtricitabina, Disoproxil Fumarato de Tenofovir',\n",
       "   'Combinação de Drogas Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação de Drogas Efavirenz, Emtricitabina, Fumarato de Tenofovir Disoproxil',\n",
       "   'Combinação de Medicamentos Efavirenz, Emtricitabina, Disoproxil Fumarato de Tenofovir',\n",
       "   'Combinação de Medicamentos Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação de Medicamentos Efavirenz, Emtricitabina, Fumarato de Tenofovir Disoproxil',\n",
       "   'Efavirenz, Emtricitabina, Disoproxil Fumarato de Tenofovir, Combinação de Medicamentos',\n",
       "   'Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxil',\n",
       "   'Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Efavirenz, Emtricitabina, Fumarato de Tenofovir Desoproxila, Combinação de Medicamentos',\n",
       "   'Efavirenz, Emtricitabina, Fumarato de Tenofovir Disoproxil, Combinação de Medicamentos',\n",
       "   'Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068258': {'ID': 'D000068258',\n",
       "  'name': 'Bevacizumab[Bevacizumab]',\n",
       "  'scope': 'An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF RECEPTORS and helps prevent the proliferation of blood vessels.',\n",
       "  'terms': ['Avastin',\n",
       "   'Avastin',\n",
       "   'Bevacizumab',\n",
       "   'Bevacizumab',\n",
       "   'Bevacizumabe'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068276': {'ID': 'D000068276',\n",
       "  'name': 'Girafas[Giraffes]',\n",
       "  'scope': 'Four-legged hoofed mammals that are closely related to giraffes, although they bear stripes similar to zebras.',\n",
       "  'terms': ['Girafas',\n",
       "   'Giraffa',\n",
       "   'Giraffa camelopardalis',\n",
       "   'Giraffe',\n",
       "   'Giraffes',\n",
       "   'Ocapi',\n",
       "   'Ocapis',\n",
       "   'Okapi',\n",
       "   'Okapi',\n",
       "   'Okapia johnstoni',\n",
       "   'Okapis',\n",
       "   'Okapis'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068296': {'ID': 'D000068296',\n",
       "  'name': 'Risedronato Sódico[Risedronate Sodium]',\n",
       "  'scope': 'An aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS.',\n",
       "  'terms': ['1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate',\n",
       "   '2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate',\n",
       "   '2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate',\n",
       "   'Acid, Risedronic',\n",
       "   'Actonel',\n",
       "   'Actonel',\n",
       "   'Atelvia',\n",
       "   'Bisphosphate Risedronate Sodium',\n",
       "   'Risedronate',\n",
       "   'Risedronate Sodium',\n",
       "   'Risedronate Sodium, Bisphosphate',\n",
       "   'Risedronato Sódico',\n",
       "   'Risedronato de Sódio',\n",
       "   'Risedronic Acid',\n",
       "   'Risedronic Acid, Monosodium Salt',\n",
       "   'Sodium, Bisphosphate Risedronate',\n",
       "   'Sodium, Risedronate'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068297': {'ID': 'D000068297',\n",
       "  'name': 'Combinação Fluticasona-Salmeterol[Fluticasone-Salmeterol Drug Combination]',\n",
       "  'scope': 'A metered dose inhaler formulation of fluticasone-salmeterol drug combination.',\n",
       "  'terms': ['<i>clenil</i>',\n",
       "   '<i>clenil</i>',\n",
       "   'Advair',\n",
       "   'Advair',\n",
       "   'Advair Diskus',\n",
       "   'Advair Diskus',\n",
       "   'Advair HFA',\n",
       "   'Advair HFA',\n",
       "   'Combination, Fluticasone-Salmeterol',\n",
       "   'Combinação Fluticasona-Salmeterol',\n",
       "   'Combinação Propionato de Fluticasona e Xinafoato de Salmeterol',\n",
       "   'Combinação das Drogas Propionato de Fluticasona e Xinafoato de Salmeterol',\n",
       "   'Combinação de Medicamentos Propionato de Fluticasona e Xinafoato de Salmeterol',\n",
       "   'Drug Combination, Fluticasone-Salmeterol',\n",
       "   'Fluticasone - Salmeterol',\n",
       "   'Fluticasone Propionate - Salmeterol',\n",
       "   'Fluticasone Propionate - Salmeterol Combination',\n",
       "   'Fluticasone Propionate - Salmeterol Xinafoate',\n",
       "   'Fluticasone Propionate Salmeterol',\n",
       "   'Fluticasone Propionate Salmeterol Combination',\n",
       "   'Fluticasone Propionate Salmeterol Drug Combination',\n",
       "   'Fluticasone Propionate Salmeterol Xinafoate',\n",
       "   'Fluticasone Propionate Salmeterol Xinafoate Combination',\n",
       "   'Fluticasone Propionate Salmeterol Xinafoate Drug Combination',\n",
       "   'Fluticasone Propionate, Salmeterol Xinafoate Drug Combination',\n",
       "   'Fluticasone Propionate-Salmeterol Drug Combination',\n",
       "   'Fluticasone Propionate-Salmeterol Xinafoate Combination',\n",
       "   'Fluticasone Propionate-Salmeterol Xinafoate Drug Combination',\n",
       "   'Fluticasone Salmeterol',\n",
       "   'Fluticasone Salmeterol Combination',\n",
       "   'Fluticasone Salmeterol Drug Combination',\n",
       "   'Fluticasone-Salmeterol Combination',\n",
       "   'Fluticasone-Salmeterol Drug Combination',\n",
       "   'Propionato de Fluticasona e Xinafoato de Salmeterol',\n",
       "   'Propionato de Fluticasona e Xinafoato de Salmeterol, Combinação de Medicamentos',\n",
       "   'Seretide',\n",
       "   'Seretide'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068298': {'ID': 'D000068298',\n",
       "  'name': 'Fluticasona[Fluticasone]',\n",
       "  'scope': 'A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.',\n",
       "  'terms': ['<i>salmeterol</i>',\n",
       "   'Cutivate',\n",
       "   'Flixonase',\n",
       "   'Flixotide',\n",
       "   'Flixotide',\n",
       "   'Flonase',\n",
       "   'Flovent',\n",
       "   'Flovent HFA',\n",
       "   'Fluticasona',\n",
       "   'Fluticasone',\n",
       "   'Fluticasone Propionate',\n",
       "   'HFA, Flovent',\n",
       "   'Propionate, Fluticasone',\n",
       "   'Propionato de Fluticasona'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068299': {'ID': 'D000068299',\n",
       "  'name': 'Xinafoato de Salmeterol[Salmeterol Xinafoate]',\n",
       "  'scope': 'A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.',\n",
       "  'terms': ['<i>fluticasona</i>',\n",
       "   'Salmeterol',\n",
       "   'Salmeterol Xinafoate',\n",
       "   'Serevent',\n",
       "   'Xinafoate, Salmeterol',\n",
       "   'Xinafoato de Salmeterol'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068316': {'ID': 'D000068316',\n",
       "  'name': 'Parques Recreativos[Parks, Recreational]',\n",
       "  'scope': 'An area of land open to the public for enjoyment.',\n",
       "  'terms': ['Community Park',\n",
       "   'Community Parks',\n",
       "   'National Park',\n",
       "   'National Parks',\n",
       "   'Park, Community',\n",
       "   'Park, National',\n",
       "   'Park, Recreational',\n",
       "   'Park, Urban',\n",
       "   'Parks, Community',\n",
       "   'Parks, National',\n",
       "   'Parks, Recreational',\n",
       "   'Parks, Urban',\n",
       "   'Parques Recreacionais',\n",
       "   'Parques Recreativos',\n",
       "   'Recreational Park',\n",
       "   'Recreational Parks',\n",
       "   'Urban Park',\n",
       "   'Urban Parks'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068336': {'ID': 'D000068336',\n",
       "  'name': 'Guerras e Conflitos Armados[Warfare and Armed Conflicts]',\n",
       "  'scope': 'Engaging in any type of conflict including war or military conflict against another nation or organized group..',\n",
       "  'terms': ['Armed Conflicts and Warfare',\n",
       "   'Conflitos Bélicos e Conflitos Armados',\n",
       "   'Guerras e Conflitos Armados',\n",
       "   'Warfare and Armed Conflicts'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068337': {'ID': 'D000068337',\n",
       "  'name': 'Conflitos Armados[Armed Conflicts]',\n",
       "  'scope': 'Any differences arising between two nations or groups and leading to the intervention of armed forces.',\n",
       "  'terms': ['Armed Conflict',\n",
       "   'Armed Conflicts',\n",
       "   'Conflict, Armed',\n",
       "   'Conflicts, Armed',\n",
       "   'Conflito Armado',\n",
       "   'Conflitos Armados'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068338': {'ID': 'D000068338',\n",
       "  'name': 'Everolimo[Everolimus]',\n",
       "  'scope': 'A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.',\n",
       "  'terms': ['001, RAD',\n",
       "   '40-O-(2-hydroxyethyl)-rapamycin',\n",
       "   'Afinitor',\n",
       "   'Afinitor',\n",
       "   'Certican',\n",
       "   'Everolimo',\n",
       "   'Everolimus',\n",
       "   'Everolimus',\n",
       "   'RAD 001',\n",
       "   'RAD, SDZ',\n",
       "   'RAD001',\n",
       "   'SDZ RAD',\n",
       "   'SDZ-RAD'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068342': {'ID': 'D000068342',\n",
       "  'name': 'Combinação Aspirina e Dipiridamol[Aspirin, Dipyridamole Drug Combination]',\n",
       "  'scope': 'A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.',\n",
       "  'terms': ['3301, TX',\n",
       "   'Aggrenox',\n",
       "   'Asasantin',\n",
       "   'Asasantin Retard',\n",
       "   'Aspirin Dipyridamole Drug Combination',\n",
       "   'Aspirin, Dipyridamole Drug Combination',\n",
       "   'Aspirin-Dipyridamole Drug Combination',\n",
       "   'Aspirina e Dipiridamol',\n",
       "   'Aspirina e Dipiridamol, Combinação de Medicamentos',\n",
       "   'Combination, Aspirin-Dipyridamole Drug',\n",
       "   'Combinação Aspirina e Dipiridamol',\n",
       "   'Combinação de Medicamentos Aspirina e Dipiridamol',\n",
       "   'Dipyridamole-Aspirin, Extended-Release',\n",
       "   'Drug Combination, Aspirin-Dipyridamole',\n",
       "   'Extended Release Dipyridamole Aspirin',\n",
       "   'Extended-Release Dipyridamole-Aspirin',\n",
       "   'Retard, Asasantin',\n",
       "   'TX 3301',\n",
       "   'TX-3301'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068356': {'ID': 'D000068356',\n",
       "  'name': 'Autocontrole[Self-Control]',\n",
       "  'scope': \"An individual's ability to manage and monitor their emotions, behaviors, and desires in the face of external demands in order to function in society.\",\n",
       "  'terms': ['Autocontrole',\n",
       "   'Control, Self',\n",
       "   'Regulation, Self',\n",
       "   'Self Control',\n",
       "   'Self Regulation',\n",
       "   'Self-Control',\n",
       "   'Self-Regulation'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068357': {'ID': 'D000068357',\n",
       "  'name': 'Águas Salinas[Saline Waters]',\n",
       "  'scope': 'Water from natural sources which contain significant concentrations of dissolved salts such as sodium chloride.',\n",
       "  'terms': ['Brackish Water',\n",
       "   'Brackish Waters',\n",
       "   'Saline Water',\n",
       "   'Saline Waters',\n",
       "   'Water, Brackish',\n",
       "   'Water, Saline',\n",
       "   'Waters, Brackish',\n",
       "   'Waters, Saline',\n",
       "   'Água Salgada',\n",
       "   'Água Salina',\n",
       "   'Água Salobra',\n",
       "   'Águas Salinas',\n",
       "   'Águas Salobras'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068376': {'ID': 'D000068376',\n",
       "  'name': 'Fadiga por Compaixão[Compassion Fatigue]',\n",
       "  'scope': 'Emotional distress caused by repeated or prolonged expression of compassion or empathy. It may occur in individuals working in care giving professions.',\n",
       "  'terms': ['Compassion Fatigue',\n",
       "   'Distúrbio Secundário a Estresse Traumático',\n",
       "   'Fadiga por Compaixão',\n",
       "   'Fatigue, Compassion',\n",
       "   'Secondary Trauma',\n",
       "   'Secondary Traumas',\n",
       "   'Secondary Traumatic Stress',\n",
       "   'Secondary Traumatization',\n",
       "   'Secondary Traumatizations',\n",
       "   'Stress, Secondary Traumatic',\n",
       "   'Stresses, Secondary Traumatic',\n",
       "   'Trauma, Secondary',\n",
       "   'Trauma, Vicarious',\n",
       "   'Traumas, Secondary',\n",
       "   'Traumas, Vicarious',\n",
       "   'Traumatic Stress, Secondary',\n",
       "   'Traumatization, Secondary',\n",
       "   'Traumatization, Vicarious',\n",
       "   'Traumatizations, Secondary',\n",
       "   'Vicarious Trauma',\n",
       "   'Vicarious Traumas',\n",
       "   'Vicarious Traumatization'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000068377': {'ID': 'D000068377',\n",
       "  'name': 'Plantaginaceae[Plantaginaceae]',\n",
       "  'scope': 'A plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.',\n",
       "  'terms': ['Families, Speedwell',\n",
       "   'Family, Speedwell',\n",
       "   'Globularia',\n",
       "   'Globularia',\n",
       "   'Plantaginaceae',\n",
       "   'Plantaginaceae',\n",
       "   'Speedwell Families',\n",
       "   'Speedwell Family',\n",
       "   'Stemodia',\n",
       "   'Stemodia'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068378': {'ID': 'D000068378',\n",
       "  'name': 'Lamiales[Lamiales]',\n",
       "  'scope': 'A plant genus of the family Martyniaceae, order Lamiales. Common name devilsclaw is also a common name of the genus HARPAGOPHYTUM PROCUMBENS.',\n",
       "  'terms': ['Lamiales',\n",
       "   'Lamiales',\n",
       "   'Plant, Proboscidea',\n",
       "   'Plants, Proboscidea',\n",
       "   'Proboscidea',\n",
       "   'Proboscidea (Planta)',\n",
       "   'Proboscidea Plant',\n",
       "   'Proboscidea Plants'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068397': {'ID': 'D000068397',\n",
       "  'name': 'Estudo Clínico[Clinical Study]',\n",
       "  'scope': 'A work that reports on the results of a research study to evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies. While most clinical studies concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans.',\n",
       "  'terms': ['Clinical Study', 'Estudo Clínico'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068436': {'ID': 'D000068436',\n",
       "  'name': 'Liberação de Cirurgia[Surgical Clearance]',\n",
       "  'scope': 'Process of evaluating the health of a patient and determining if they are healthy enough for surgery.',\n",
       "  'terms': ['Clearance, Medical',\n",
       "   'Clearance, Surgical',\n",
       "   'Clearances, Medical',\n",
       "   'Clearances, Surgical',\n",
       "   'Liberação de Cirurgia',\n",
       "   'Liberação para Cirurgia',\n",
       "   'Liberação para a Cirurgia',\n",
       "   'Medical Clearance',\n",
       "   'Medical Clearances',\n",
       "   'Surgical Clearance',\n",
       "   'Surgical Clearances'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068437': {'ID': 'D000068437',\n",
       "  'name': 'Pemetrexede[Pemetrexed]',\n",
       "  'scope': 'A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.',\n",
       "  'terms': ['231,514, LY',\n",
       "   '231514, LY',\n",
       "   'Alimta',\n",
       "   'Alimta',\n",
       "   'Disodium, Pemetrexed',\n",
       "   'LY 231,514',\n",
       "   'LY 231514',\n",
       "   'LY-231,514',\n",
       "   'LY-231514',\n",
       "   'LY231514',\n",
       "   'MTA',\n",
       "   'N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid',\n",
       "   'Pemetrexed',\n",
       "   'Pemetrexed Disodium',\n",
       "   'Pemetrexede',\n",
       "   'Pemetrexede Dissódico'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068438': {'ID': 'D000068438',\n",
       "  'name': 'Tartarato de Brimonidina[Brimonidine Tartrate]',\n",
       "  'scope': 'A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.',\n",
       "  'terms': ['190342, AGN',\n",
       "   '5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate',\n",
       "   '5-bromo-6-(imidazolidinylideneamino)quinoxaline',\n",
       "   '5-bromo-6-(imidazolin-2-ylamino)quinoxaline',\n",
       "   'AGN 190342',\n",
       "   'AGN-190342',\n",
       "   'AGN190342',\n",
       "   'Alphagan',\n",
       "   'Alphagan',\n",
       "   'Alphagan P',\n",
       "   'Brimonidine',\n",
       "   'Brimonidine Purite',\n",
       "   'Brimonidine Tartrate',\n",
       "   'Brimonidine Tartrate (1:1)',\n",
       "   'Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer',\n",
       "   'Brimonidine Tartrate, (R-(R*,R*))-Isomer',\n",
       "   'Bromoxidine',\n",
       "   'Mirvaso',\n",
       "   'Purite, Brimonidine',\n",
       "   'Ratio Brimonidine',\n",
       "   'Ratio-Brimonidine',\n",
       "   'Sanrosa',\n",
       "   'Tartarato de Brimonidina',\n",
       "   'Tartrate, Brimonidine',\n",
       "   'UK 14,304',\n",
       "   'UK 14,304 18',\n",
       "   'UK 14,304-18',\n",
       "   'UK 14,30418',\n",
       "   'UK 14,308',\n",
       "   'UK 14304',\n",
       "   'UK 14308',\n",
       "   'UK-14,304-18',\n",
       "   'UK-14,308',\n",
       "   'UK-14304',\n",
       "   'UK14,30418',\n",
       "   'UK14,308',\n",
       "   'UK14304'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068456': {'ID': 'D000068456',\n",
       "  'name': 'Estudos Clínicos como Assunto[Clinical Studies as Topic]',\n",
       "  'scope': 'Works about research studies that evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies.',\n",
       "  'terms': ['Clinical Studies as Topic',\n",
       "   'Estudos Clínicos como Assunto',\n",
       "   'Estudos Clínicos como Tema'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068476': {'ID': 'D000068476',\n",
       "  'name': 'Pequim[Beijing]',\n",
       "  'scope': 'Capital of CHINA.',\n",
       "  'terms': ['Beijing', 'Beijing', 'Peking', 'Pequim'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068516': {'ID': 'D000068516',\n",
       "  'name': 'União Africana[African Union]',\n",
       "  'scope': 'A geopolitical organization of African nations with a mission to integrate vital interests, promote international relations, political stability, and economic development among member states.',\n",
       "  'terms': ['African Union', 'Union, African', 'União Africana'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068536': {'ID': 'D000068536',\n",
       "  'name': 'Firmicutes[Firmicutes]',\n",
       "  'scope': 'A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.',\n",
       "  'terms': ['Firmicutes', 'Firmicutes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068538': {'ID': 'D000068538',\n",
       "  'name': 'Dutasterida[Dutasteride]',\n",
       "  'scope': 'A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA.',\n",
       "  'terms': ['17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one',\n",
       "   '745, GG',\n",
       "   'Avodart',\n",
       "   'Avodart',\n",
       "   'Dutasterida',\n",
       "   'Dutasteride',\n",
       "   'GG 745',\n",
       "   'GG-745',\n",
       "   'GG745',\n",
       "   'GI198745'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068543': {'ID': 'D000068543',\n",
       "  'name': 'Calceolariaceae[Calceolariaceae]',\n",
       "  'scope': 'A family in the order Lamiales with several species that are used in TRADITIONAL MEDICINE.',\n",
       "  'terms': ['Calceolaria',\n",
       "   'Calceolaria',\n",
       "   'Calceolariaceae',\n",
       "   'Calceolariaceae',\n",
       "   'Jovellana',\n",
       "   'Porodittia'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068556': {'ID': 'D000068556',\n",
       "  'name': 'Interferon beta-1a[Interferon beta-1a]',\n",
       "  'scope': 'An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.',\n",
       "  'terms': ['1a, Interferon beta',\n",
       "   '<i>copaxone</i>',\n",
       "   'Avonex',\n",
       "   'Avonex Pen',\n",
       "   'Interferon beta 1a',\n",
       "   'Interferon beta-1a',\n",
       "   'Interferon beta-1a',\n",
       "   'Pen, Avonex',\n",
       "   'Rebif',\n",
       "   'beta 1a, Interferon',\n",
       "   'beta-1a, Interferon'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068557': {'ID': 'D000068557',\n",
       "  'name': 'Olmesartana Medoxomila[Olmesartan Medoxomil]',\n",
       "  'scope': 'An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.',\n",
       "  'terms': ['5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346',\n",
       "   '866, CS',\n",
       "   'Benicar',\n",
       "   'Benicar',\n",
       "   'CS 866',\n",
       "   'CS-866',\n",
       "   'Medoxomil, Olmesartan',\n",
       "   'Olmesartan Medoxomil',\n",
       "   'Olmesartana Medoxomila',\n",
       "   'Olmetec',\n",
       "   'Olmetec',\n",
       "   'Votum'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068558': {'ID': 'D000068558',\n",
       "  'name': 'Combinação Besilato de Anlodipino e Olmesartana Medoxomila[Amlodipine Besylate, Olmesartan Medoxomil Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil  that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.',\n",
       "  'terms': ['Amlodipine Besylate Olmesartan Medoxomil',\n",
       "   'Amlodipine Besylate Olmesartan Medoxomil Drug Combination',\n",
       "   'Amlodipine Besylate, Olmesartan Medoxomil',\n",
       "   'Amlodipine Besylate, Olmesartan Medoxomil Drug Combination',\n",
       "   'Amlodipine Besylate-Olmesartan Medoxomil',\n",
       "   'Amlodipine Besylate-Olmesartan Medoxomil Drug Combination',\n",
       "   'Associação Medicamentosa Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Associação de Medicamentos Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Associação dos Medicamentos Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Azor',\n",
       "   'Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Besilato de Anlodipino e Olmesartana Medoxomila, Associação Medicamentosa',\n",
       "   'Besilato de Anlodipino e Olmesartana Medoxomila, Combinação de Medicamentos',\n",
       "   'Besylate-Olmesartan Medoxomil, Amlodipine',\n",
       "   'Combinação Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Combinação das Drogas Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Combinação de Medicamentos Besilato de Anlodipino e Olmesartana Medoxomila',\n",
       "   'Medoxomil, Amlodipine Besylate-Olmesartan'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068576': {'ID': 'D000068576',\n",
       "  'name': 'Interferon beta-1b[Interferon beta-1b]',\n",
       "  'scope': 'A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.',\n",
       "  'terms': ['1b, Interferon beta',\n",
       "   'Beta Seron',\n",
       "   'Beta-IFN-1b',\n",
       "   'Beta-Seron',\n",
       "   'Betaferon',\n",
       "   'Betaseron',\n",
       "   'Extavia',\n",
       "   'IFN-Beta Ser',\n",
       "   'Interferon Beta, Ser(17)',\n",
       "   'Interferon Beta, Serine(17)',\n",
       "   'Interferon beta 1b',\n",
       "   'Interferon beta-1b',\n",
       "   'Interferon beta-1b',\n",
       "   'Ser(17) IFN-beta',\n",
       "   'Serine(17) Interferon Beta',\n",
       "   'beta 1b, Interferon',\n",
       "   'beta-1b, Interferon'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068577': {'ID': 'D000068577',\n",
       "  'name': 'Nebivolol[Nebivolol]',\n",
       "  'scope': 'A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.',\n",
       "  'terms': ['67555, R',\n",
       "   '<i>ramipril</i>',\n",
       "   '<i>ramipril</i>',\n",
       "   \"Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol\",\n",
       "   'Bystolic',\n",
       "   'Cloridrato de Nebivolol',\n",
       "   'Hydrochloride, Nebivolol',\n",
       "   'Lobivon',\n",
       "   'Nebilet',\n",
       "   'Nebilet',\n",
       "   'Nebivolol',\n",
       "   'Nebivolol',\n",
       "   'Nebivolol Hydrochloride',\n",
       "   'R 67555',\n",
       "   'R-67555',\n",
       "   'R67555',\n",
       "   'Silostar'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068579': {'ID': 'D000068579',\n",
       "  'name': 'Celecoxib[Celecoxib]',\n",
       "  'scope': 'A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.',\n",
       "  'terms': ['4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide',\n",
       "   '58635, SC',\n",
       "   'Celebrex',\n",
       "   'Celecoxib',\n",
       "   'Celecoxib',\n",
       "   'Celecoxibe',\n",
       "   'SC 58635',\n",
       "   'SC-58635',\n",
       "   'SC58635'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068580': {'ID': 'D000068580',\n",
       "  'name': 'Vareniclina[Varenicline]',\n",
       "  'scope': 'A benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.',\n",
       "  'terms': ['6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine',\n",
       "   'Champix',\n",
       "   'Chantix',\n",
       "   'Tartrate, Varenicline',\n",
       "   'Vareniclina',\n",
       "   'Varenicline',\n",
       "   'Varenicline Tartrate'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068581': {'ID': 'D000068581',\n",
       "  'name': 'Tadalafila[Tadalafil]',\n",
       "  'scope': 'A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION.',\n",
       "  'terms': ['351, IC',\n",
       "   'Cialis',\n",
       "   'Cialis',\n",
       "   'IC 351',\n",
       "   'IC-351',\n",
       "   'IC351',\n",
       "   'Tadalafil',\n",
       "   'Tadalafil',\n",
       "   'Tadalafila'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068582': {'ID': 'D000068582',\n",
       "  'name': 'Certolizumab Pegol[Certolizumab Pegol]',\n",
       "  'scope': \"A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.\",\n",
       "  'terms': ['CDP 870',\n",
       "   'CDP870',\n",
       "   'Certolizumab Pegol',\n",
       "   'Certolizumab Pegol',\n",
       "   'Cetolizumabe Pegol',\n",
       "   'Cimzia',\n",
       "   'Cimzia'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068597': {'ID': 'D000068597',\n",
       "  'name': 'Censura Científica[Censorship, Research]',\n",
       "  'scope': 'The act or practice of scrutinizing the practice of scientific research for the purpose of preventing or suppressing the unethical applications as well knowledge derived from it.',\n",
       "  'terms': ['Censorship, Research',\n",
       "   'Censura Científica',\n",
       "   'Censura de Pesquisa',\n",
       "   'Censura na Pesquisa Científica',\n",
       "   'Censura à Pesquisa Científica',\n",
       "   'Research Censorship'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068598': {'ID': 'D000068598',\n",
       "  'name': 'Confiabilidade dos Dados[Data Accuracy]',\n",
       "  'scope': 'A measure of scientific precision, exactness, or correctness of quantitative or qualitative values, relative to the actual or true measurements.',\n",
       "  'terms': ['Accuracies, Data',\n",
       "   'Accuracy, Data',\n",
       "   'Acurácia dos Dados',\n",
       "   'Confiabilidade dos Dados',\n",
       "   'Data Accuracies',\n",
       "   'Data Accuracy',\n",
       "   'Data Qualities',\n",
       "   'Data Quality',\n",
       "   'Exatidão dos Dados',\n",
       "   'Precisão dos Dados',\n",
       "   'Qualidade dos Dados',\n",
       "   'Qualities, Data',\n",
       "   'Quality, Data'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068599': {'ID': 'D000068599',\n",
       "  'name': 'Combinação Tartarato de Brimonidina e Maleato de Timolol[Brimonidine Tartrate, Timolol Maleate Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.',\n",
       "  'terms': ['<i>azorga</i>',\n",
       "   '<i>azorga</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brinzolamida</i>',\n",
       "   '<i>brinzolamida</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>dorzolamida</i>',\n",
       "   '<i>dorzolamida</i>',\n",
       "   '<i>drusolol</i>',\n",
       "   '<i>drusolol</i>',\n",
       "   '<i>glaub</i>',\n",
       "   '<i>glaub</i>',\n",
       "   '<i>timolol</i>',\n",
       "   '<i>timolol</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   'Brimonidine Tartrate Timolol Maleate',\n",
       "   'Brimonidine Tartrate Timolol Maleate Drug Combination',\n",
       "   'Brimonidine Tartrate, Timolol Maleate Drug Combination',\n",
       "   'Brimonidine Tartrate-Timolol Maleate',\n",
       "   'Brimonidine Tartrate-Timolol Maleate Drug Combination',\n",
       "   'Combigan',\n",
       "   'Combigan',\n",
       "   'Combinação Tartarato de Brimonidina e Maleato de Timolol',\n",
       "   'Combinação das Drogas Maleato de Timolol e Tartarato de Brimonidina',\n",
       "   'Combinação das Drogas Tartarato de Brimonidina e Maleato de Timolol',\n",
       "   'Combinação de Medicamentos Tartarato de Brimonidina e Maleato de Timolol',\n",
       "   'Maleate, Brimonidine Tartrate-Timolol',\n",
       "   'Tartarato de Brimonidina e Maleato de Timolol',\n",
       "   'Tartarato de Brimonidina e Maleato de Timolol, Combinação de Medicamentos',\n",
       "   'Tartrate-Timolol Maleate, Brimonidine'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068600': {'ID': 'D000068600',\n",
       "  'name': 'Combinação Albuterol e Ipratrópio[Albuterol, Ipratropium Drug Combination]',\n",
       "  'scope': 'A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.',\n",
       "  'terms': ['<i>1jato</i>',\n",
       "   '<i>1jato</i>',\n",
       "   '<i>sabutamol</i>',\n",
       "   '<i>sabutamol</i>',\n",
       "   'Albuterol Ipratropium',\n",
       "   'Albuterol Ipratropium Drug Combination',\n",
       "   'Albuterol e Ipratrópio',\n",
       "   'Albuterol e Ipratrópio, Combinação de Medicamentos',\n",
       "   'Albuterol, Ipratropium Drug Combination',\n",
       "   'Albuterol-Ipratropium',\n",
       "   'Albuterol-Ipratropium Drug Combination',\n",
       "   'Combination, Albuterol-Ipratropium Drug',\n",
       "   'Combination, Dey',\n",
       "   'Combinação Albuterol e Ipratrópio',\n",
       "   'Combinação de Medicamentos Albuterol e Ipratrópio',\n",
       "   'Combivent',\n",
       "   'Combivent',\n",
       "   'Combivent Respimat',\n",
       "   'Dey Combination',\n",
       "   'Drug Combination, Albuterol-Ipratropium',\n",
       "   'Respimat, Combivent'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068601': {'ID': 'D000068601',\n",
       "  'name': 'Pesquisa de Uso Dual[Dual Use Research]',\n",
       "  'scope': 'Concept relating to technologies and/or information emanating from research that holds the potential for both benevolent and malevolent applications to humanity and the environment.',\n",
       "  'terms': ['Dual Use Research',\n",
       "   'Pesquisa de Uso Dual',\n",
       "   'Pesquisas Sensíveis',\n",
       "   'Research, Dual Use',\n",
       "   'Tecnologias Sensíveis',\n",
       "   'Tecnologias de Uso Dual',\n",
       "   'Use Research, Dual',\n",
       "   'Áreas Sensíveis de Pesquisa'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068616': {'ID': 'D000068616',\n",
       "  'name': 'Profissionalismo[Professionalism]',\n",
       "  'scope': 'The level of skill, good judgment, and polite behavior expected from people trained to do their jobs well.',\n",
       "  'terms': ['Education, Professionalism',\n",
       "   'Medical Professionalism',\n",
       "   'Professionalism',\n",
       "   'Professionalism Education',\n",
       "   'Professionalism, Medical',\n",
       "   'Professionalism, Surgical',\n",
       "   'Profissionalismo',\n",
       "   'Surgical Professionalism'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068617': {'ID': 'D000068617',\n",
       "  'name': 'Patrimônio Genético[Genetic Background]',\n",
       "  'scope': 'The entire genetic composition of a strain or individual that interacts with a gene of interest.',\n",
       "  'terms': ['Arcabouço Genético',\n",
       "   'Background Genético',\n",
       "   'Background, Genetic',\n",
       "   'Backgrounds, Genetic',\n",
       "   'Bagagem Genética',\n",
       "   'Conjunto Genético',\n",
       "   'Genetic Background',\n",
       "   'Genetic Backgrounds',\n",
       "   'Patrimônio Genético'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068618': {'ID': 'D000068618',\n",
       "  'name': 'Seleção Artificial[Selective Breeding]',\n",
       "  'scope': 'A process in which offspring possessing desired genetic traits are produced.',\n",
       "  'terms': ['Breeding, Selective',\n",
       "   'Breedings, Selective',\n",
       "   'Cruzamento Seletivo',\n",
       "   'Reprodução Seletiva',\n",
       "   'Selective Breeding',\n",
       "   'Selective Breedings',\n",
       "   'Seleção Artificial'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068636': {'ID': 'D000068636',\n",
       "  'name': 'Criaturas Lendárias[Legendary Creatures]',\n",
       "  'scope': 'Half-human sea creatures with the head and torso of a woman and the tail of a fish. Commonly believed in FOLKLORE, these creatures have relevance to the disorder known as SIRENOMELIA in which the legs or other bones and limbs are fused together.',\n",
       "  'terms': ['Animal, Mythical',\n",
       "   'Animals, Mythical',\n",
       "   'Bigfoot',\n",
       "   'Bigfoots',\n",
       "   'Creature, Legendary',\n",
       "   'Creature, Mythical',\n",
       "   'Creatures, Legendary',\n",
       "   'Creatures, Mythical',\n",
       "   'Criaturas Lendárias',\n",
       "   'Himalayan Yeti',\n",
       "   'Legendary Creature',\n",
       "   'Legendary Creatures',\n",
       "   'Mermaid',\n",
       "   'Mermaids',\n",
       "   'Mythical Animal',\n",
       "   'Mythical Animals',\n",
       "   'Mythical Creature',\n",
       "   'Mythical Creatures',\n",
       "   'Sasquatch',\n",
       "   'Seres Lendários',\n",
       "   'Unicorn',\n",
       "   'Unicorns',\n",
       "   'Vampire',\n",
       "   'Vampires',\n",
       "   'Werewolves',\n",
       "   'Yeti, Himalayan'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068656': {'ID': 'D000068656',\n",
       "  'name': 'Furoato de Mometasona[Mometasone Furoate]',\n",
       "  'scope': 'A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.',\n",
       "  'terms': ['Asmanex',\n",
       "   'Asmanex Twisthaler',\n",
       "   'Elocon',\n",
       "   'Furoate Monohydrate, Mometasone',\n",
       "   'Furoate, Mometasone',\n",
       "   'Furoato de Mometasona',\n",
       "   'Mometasona',\n",
       "   'Mometasone',\n",
       "   'Mometasone Furoate',\n",
       "   'Mometasone Furoate Monohydrate',\n",
       "   'Monohydrate, Mometasone Furoate',\n",
       "   'Nasonex',\n",
       "   'Rinelon',\n",
       "   'Sch 32088',\n",
       "   'Sch-32088',\n",
       "   'Sch32088',\n",
       "   'Twisthaler, Asmanex'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068676': {'ID': 'D000068676',\n",
       "  'name': 'Fallopia multiflora[Fallopia multiflora]',\n",
       "  'scope': 'A species of Fallopia in the buckwheat family (Polygonaceae). Its roots are used in TRADITIONAL CHINESE MEDICINE.',\n",
       "  'terms': ['Fallopia multiflora',\n",
       "   'Fallopia multiflora',\n",
       "   'Fo Ti',\n",
       "   'Fo-Ti',\n",
       "   'Polygonum multiflorum'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068677': {'ID': 'D000068677',\n",
       "  'name': 'Citrato de Sildenafila[Sildenafil Citrate]',\n",
       "  'scope': 'A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT  that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.',\n",
       "  'terms': ['1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate',\n",
       "   'Acetildenafil',\n",
       "   'Citrate, Sildenafil',\n",
       "   'Citrato de Sildenafila',\n",
       "   'Desmethyl Sildenafil',\n",
       "   'Desmethylsildenafil',\n",
       "   'Homosildenafil',\n",
       "   'Hydroxyhomosildenafil',\n",
       "   'Lactate, Sildenafil',\n",
       "   'NCX 911',\n",
       "   'NCX-911',\n",
       "   'NCX911',\n",
       "   'Nitrate, Sildenafil',\n",
       "   'Revatio',\n",
       "   'Sildenafil',\n",
       "   'Sildenafil Citrate',\n",
       "   'Sildenafil Lactate',\n",
       "   'Sildenafil Nitrate',\n",
       "   'Sildenafil, Desmethyl',\n",
       "   'UK 92,480 10',\n",
       "   'UK 92480 10',\n",
       "   'UK 92480-10',\n",
       "   'UK 9248010',\n",
       "   'UK-92,480-10',\n",
       "   'Viagra',\n",
       "   'Viagra'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068678': {'ID': 'D000068678',\n",
       "  'name': 'Combinação Emtricitabina, Rilpivirina e Tenofovir[Emtricitabine, Rilpivirine, Tenofovir Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.',\n",
       "  'terms': ['Combination, Emtricitabine-Rilpivirine-Tenofovir Drug',\n",
       "   'Combinação Emtricitabina, Rilpivirina e Tenofovir',\n",
       "   'Combinação das Drogas Emtricitabina, Rilpivirina e Tenofovir',\n",
       "   'Combinação de Medicamentos Emtricitabina, Rilpivirina e Tenofovir',\n",
       "   'Complera',\n",
       "   'Complera',\n",
       "   'Drug Combination, Emtricitabine-Rilpivirine-Tenofovir',\n",
       "   'Emtricitabina, Rilpivirina e Tenofovir',\n",
       "   'Emtricitabina, Rilpivirina e Tenofovir, Combinação de Medicamentos',\n",
       "   'Emtricitabine Rilpivirine Tenofovir Drug Combination',\n",
       "   'Emtricitabine, Rilpivirine, Tenofovir Drug Combination',\n",
       "   'Emtricitabine-Rilpivirine-Tenofovir Drug Combination'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068679': {'ID': 'D000068679',\n",
       "  'name': 'Emtricitabina[Emtricitabine]',\n",
       "  'scope': 'A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.',\n",
       "  'terms': [\"Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine\",\n",
       "   \"Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine\",\n",
       "   'Coviracil',\n",
       "   'Emtricitabina',\n",
       "   'Emtricitabine',\n",
       "   'Emtriva',\n",
       "   'Emtriva'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068696': {'ID': 'D000068696',\n",
       "  'name': 'Rilpivirina[Rilpivirine]',\n",
       "  'scope': 'A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.',\n",
       "  'terms': ['278, TMC',\n",
       "   'Cloridrato de Rilpivirina',\n",
       "   'Edurant',\n",
       "   'HCl, Rilpivirine',\n",
       "   'Hydrochloride, Rilpivirine',\n",
       "   'R278474',\n",
       "   'Rilpivirina',\n",
       "   'Rilpivirine',\n",
       "   'Rilpivirine HCl',\n",
       "   'Rilpivirine Hydrochloride',\n",
       "   'TMC 278',\n",
       "   'TMC-278',\n",
       "   'TMC278'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068698': {'ID': 'D000068698',\n",
       "  'name': 'Tenofovir[Tenofovir]',\n",
       "  'scope': 'An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.',\n",
       "  'terms': ['(R)-9-(2-phosphonylmethoxypropyl)adenine',\n",
       "   '9-(2-Phosphonomethoxypropyl)adenine',\n",
       "   '9-(2-Phosphonylmethoxypropyl)adenine',\n",
       "   '9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer',\n",
       "   '9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098',\n",
       "   '9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer',\n",
       "   '9-PMPA (tenofovir)',\n",
       "   '<i>atazanavir</i>',\n",
       "   '<i>atazanavir</i>',\n",
       "   '<i>efavirenz</i>',\n",
       "   '<i>efavirenz</i>',\n",
       "   '<i>lamivudina</i>',\n",
       "   '<i>lamivudina</i>',\n",
       "   '<i>ritonavir</i>',\n",
       "   '<i>ritonavir</i>',\n",
       "   'Disoproxil Fumarate, Tenofovir',\n",
       "   'Disoproxil, Tenofovir',\n",
       "   'Fumarate, Tenofovir Disoproxil',\n",
       "   'Tenofovir',\n",
       "   'Tenofovir',\n",
       "   'Tenofovir Disoproxil',\n",
       "   'Tenofovir Disoproxil Fumarate',\n",
       "   'Viread',\n",
       "   'Viread'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068717': {'ID': 'D000068717',\n",
       "  'name': 'Acetato de Glatiramer[Glatiramer Acetate]',\n",
       "  'scope': 'A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.',\n",
       "  'terms': ['5010, TV',\n",
       "   '<i>avonex</i>',\n",
       "   '<i>avonex</i>',\n",
       "   'Acetate, Glatiramer',\n",
       "   'Acetato de Glatiramer',\n",
       "   'Acetato de Glatirâmer',\n",
       "   'Copaxone',\n",
       "   'Copaxone',\n",
       "   'Glatiramer',\n",
       "   'Glatiramer Acetate',\n",
       "   'TV 5010',\n",
       "   'TV-5010',\n",
       "   'TV5010'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068718': {'ID': 'D000068718',\n",
       "  'name': 'Rosuvastatina Cálcica[Rosuvastatin Calcium]',\n",
       "  'scope': 'A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.',\n",
       "  'terms': ['Calcium, Rosuvastatin',\n",
       "   'Crestor',\n",
       "   'Crestor',\n",
       "   'Rosuvastatin',\n",
       "   'Rosuvastatin Calcium',\n",
       "   'Rosuvastatina',\n",
       "   'Rosuvastatina Cálcica',\n",
       "   'ZD 4522',\n",
       "   'ZD4522'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068736': {'ID': 'D000068736',\n",
       "  'name': 'Cloridrato de Duloxetina[Duloxetine Hydrochloride]',\n",
       "  'scope': 'A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.',\n",
       "  'terms': ['Cloridrato de Duloxetina',\n",
       "   'Cymbalta',\n",
       "   'Cymbalta',\n",
       "   'Duloxetine',\n",
       "   'Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987',\n",
       "   'Duloxetine HCl',\n",
       "   'Duloxetine Hydrochloride',\n",
       "   'Duloxetine, (+)-isomer',\n",
       "   'HCl, Duloxetine',\n",
       "   'Hidrocloreto de Duloxetina',\n",
       "   'Hydrochloride, Duloxetine',\n",
       "   'LY 227942',\n",
       "   'LY 248686',\n",
       "   'LY-227942',\n",
       "   'LY-248686',\n",
       "   'LY227942',\n",
       "   'LY248686',\n",
       "   'N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine',\n",
       "   'N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068737': {'ID': 'D000068737',\n",
       "  'name': 'Tartarato de Tolterodina[Tolterodine Tartrate]',\n",
       "  'scope': 'An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.',\n",
       "  'terms': ['Detrol',\n",
       "   'Detrol LA',\n",
       "   'Detrusitol',\n",
       "   'PHA 686464B',\n",
       "   'PHA-686464B',\n",
       "   'PHA686464B',\n",
       "   'Tartarato de Tolterodina',\n",
       "   'Tartrate, Tolterodine',\n",
       "   'Tolterodine',\n",
       "   'Tolterodine Tartrate',\n",
       "   'Unidet',\n",
       "   'Urotrol'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068756': {'ID': 'D000068756',\n",
       "  'name': 'Valsartana[Valsartan]',\n",
       "  'scope': 'A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION.',\n",
       "  'terms': ['48933, CGP',\n",
       "   '<i>valsartan</i>',\n",
       "   '<i>valsartana</i>',\n",
       "   'CGP 48933',\n",
       "   'Diovan',\n",
       "   'Kalpress',\n",
       "   'Miten',\n",
       "   \"N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine\",\n",
       "   'Nisis',\n",
       "   'Provas',\n",
       "   'Tareg',\n",
       "   'Vals',\n",
       "   'Valsartan',\n",
       "   'Valsartana'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068757': {'ID': 'D000068757',\n",
       "  'name': 'Ononis[Ononis]',\n",
       "  'scope': 'A genus of the pea family (Fabaceae), native from Europe to Central Asia and used in TRADITIONAL MEDICINE.',\n",
       "  'terms': ['Ononis',\n",
       "   'Ononis',\n",
       "   'Rest Harrow',\n",
       "   'Rest-Harrow',\n",
       "   'Rest-Harrows',\n",
       "   'Restharrow',\n",
       "   'Restharrows'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068758': {'ID': 'D000068758',\n",
       "  'name': 'Combinação Furoato de Mometasona e Fumarato de Formoterol[Mometasone Furoate, Formoterol Fumarate Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA.',\n",
       "  'terms': ['Combinação Furoato de Mometasona e Fumarato de Formoterol',\n",
       "   'Combinação das Drogas Furoato de Mometasona e Furamato de Formoterol',\n",
       "   'Combinação de Medicamentos Furoato de Mometasona e Fumarato de Formoterol',\n",
       "   'Dulera',\n",
       "   'Furoato de Mometasona e Fumarato de Formoterol',\n",
       "   'Furoato de Mometasona e Fumarato de Formoterol, Combinação de Medicamentos',\n",
       "   'Mometasone Furoate Formoterol Fumarate Drug Combination',\n",
       "   'Mometasone Furoate, Formoterol Fumarate Drug Combination',\n",
       "   'Mometasone Furoate-Formoterol Fumarate Drug Combination',\n",
       "   'Zenhale',\n",
       "   'Zenhale'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068759': {'ID': 'D000068759',\n",
       "  'name': 'Fumarato de Formoterol[Formoterol Fumarate]',\n",
       "  'scope': 'An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.',\n",
       "  'terms': ['3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate',\n",
       "   'Arformoterol',\n",
       "   'BD 40A',\n",
       "   'Eformoterol',\n",
       "   'Foradil',\n",
       "   'Formoterol',\n",
       "   'Formoterol',\n",
       "   'Formoterol Fumarate',\n",
       "   'Formoterol Fumarate, ((R*,R*)-(+-))-isomer',\n",
       "   'Formoterol, ((R*,R*)-(+-))-isomer',\n",
       "   'Fumarato de Formoterol',\n",
       "   'Oxis'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068760': {'ID': 'D000068760',\n",
       "  'name': 'Inibidores da Recaptação de Serotonina e Norepinefrina[Serotonin and Noradrenaline Reuptake Inhibitors]',\n",
       "  'scope': 'Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.',\n",
       "  'terms': ['Inibidor da Recaptação de Serotonina e Noradrenalina',\n",
       "   'Inibidor da Recaptação de Serotonina e Norepinefrina',\n",
       "   'Inibidores da Recaptação da Serotonina e da Noradrenalina',\n",
       "   'Inibidores da Recaptação da Serotonina e da Norepinefrina',\n",
       "   'Inibidores da Recaptação de Serotonina e Noradrenalina',\n",
       "   'Inibidores da Recaptação de Serotonina e Norepinefrina',\n",
       "   'NRIs and SSRIs',\n",
       "   'SNRIs',\n",
       "   'SSRIs and NRIs',\n",
       "   'Serotonin and Noradrenaline Reuptake Inhibitors',\n",
       "   'Serotonin and Noradrenaline Uptake Inhibitors',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitors',\n",
       "   'Serotonin and Norepinephrine Uptake Inhibitors'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068776': {'ID': 'D000068776',\n",
       "  'name': 'Medicamentos Indutores do Sono[Sleep Aids, Pharmaceutical]',\n",
       "  'scope': 'Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.',\n",
       "  'terms': ['Adjuvantes Farmacêuticos do Sono',\n",
       "   'Agents, Sleep Promoting',\n",
       "   'Auxiliares Farmacológicos do Sono',\n",
       "   'Auxiliares Medicamentosos do Sono',\n",
       "   'Fármacos Indutores de Sono',\n",
       "   'Fármacos Indutores do Sono',\n",
       "   'Fármacos para Dormir',\n",
       "   'Indutores Farmacológicos do Sono',\n",
       "   'Indutores Medicamentosos do Sono',\n",
       "   'Medicamentos Indutores do Sono',\n",
       "   'Medicamentos para Dormir',\n",
       "   'Pharmaceutical Sleep Aids',\n",
       "   'Pílulas do Sono',\n",
       "   'Remédios Indutores do Sono',\n",
       "   'Remédios para Dormir',\n",
       "   'Sleep Aids, Pharmaceutical',\n",
       "   'Sleep Inducers',\n",
       "   'Sleep Promoting Agents',\n",
       "   'Sonífero',\n",
       "   'Soníferos'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068796': {'ID': 'D000068796',\n",
       "  'name': 'Antagonistas dos Receptores de Orexina[Orexin Receptor Antagonists]',\n",
       "  'scope': 'Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS.',\n",
       "  'terms': ['Antagonista Dual de Receptores de Orexina',\n",
       "   'Antagonistas Duais de Receptores de Orexina',\n",
       "   'Antagonistas de Receptores de Orexina',\n",
       "   'Antagonistas dos Receptores de Orexina',\n",
       "   'Antagonists, Orexin Receptor',\n",
       "   'Blockers, Orexin Receptor',\n",
       "   'Dual Orexin Receptor Antagonists',\n",
       "   'Orexin Receptor Antagonists',\n",
       "   'Orexin Receptor Blockers',\n",
       "   'Receptor Antagonists, Orexin',\n",
       "   'Receptor Blockers, Orexin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068797': {'ID': 'D000068797',\n",
       "  'name': 'Orexinas[Orexins]',\n",
       "  'scope': 'Neuropeptide hormones that play a role in regulating a variety of behavioral and physiological processes in response to motivational stimuli.',\n",
       "  'terms': ['Hypocretin 1',\n",
       "   'Hypocretin 2',\n",
       "   'Hypocretin-1',\n",
       "   'Hypocretin-2',\n",
       "   'Hypocretins',\n",
       "   'Orexin A',\n",
       "   'Orexin B',\n",
       "   'Orexin-A',\n",
       "   'Orexin-B',\n",
       "   'Orexinas',\n",
       "   'Orexins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068798': {'ID': 'D000068798',\n",
       "  'name': 'Hoodia[Hoodia]',\n",
       "  'scope': 'A genus in the dogbane family (Apocynaceae) used in TRADITIONAL MEDICINE for appetite-suppressant properties.',\n",
       "  'terms': ['Hoodia', 'Hoodia', 'Hoodia gordonii'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068799': {'ID': 'D000068799',\n",
       "  'name': 'Cloridrato de Prasugrel[Prasugrel Hydrochloride]',\n",
       "  'scope': 'A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.',\n",
       "  'terms': ['640315, LY',\n",
       "   '747, CS',\n",
       "   'CS 747',\n",
       "   'CS-747',\n",
       "   'CS747',\n",
       "   'Cloridrato de Prasugrel',\n",
       "   'Effient',\n",
       "   'Effient',\n",
       "   'Efient',\n",
       "   'Efient',\n",
       "   'HCl, Prasugrel',\n",
       "   'Hidrocloreto de Prasugrel',\n",
       "   'Hydrochloride, Prasugrel',\n",
       "   'LY 640315',\n",
       "   'LY-640315',\n",
       "   'LY640315',\n",
       "   'Prasugrel',\n",
       "   'Prasugrel HCl',\n",
       "   'Prasugrel Hydrochloride'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068800': {'ID': 'D000068800',\n",
       "  'name': 'Etanercepte[Etanercept]',\n",
       "  'scope': 'A recombinant version of soluble human TNF receptor that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.',\n",
       "  'terms': ['001, TNR',\n",
       "   'Enbrel',\n",
       "   'Enbrel',\n",
       "   'Etanercept',\n",
       "   'Etanercept',\n",
       "   'Etanercepte',\n",
       "   'Fusion Protein, TNFR-Fc',\n",
       "   'Protein, TNFR-Fc Fusion',\n",
       "   'Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein',\n",
       "   'Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein',\n",
       "   'TNF Receptor Type II IgG Fusion Protein',\n",
       "   'TNF Receptor Type II-IgG Fusion Protein',\n",
       "   'TNFR Fc Fusion Protein',\n",
       "   'TNFR-Fc Fusion Protein',\n",
       "   'TNR 001',\n",
       "   'TNR-001',\n",
       "   'TNR001',\n",
       "   'TNT Receptor Fusion Protein',\n",
       "   'TNTR-Fc'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068801': {'ID': 'D000068801',\n",
       "  'name': 'Combinação Adapaleno e Peróxido de Benzoil[Adapalene, Benzoyl Peroxide Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of adapalene and benzoyl peroxide that is used as a DERMATOLOGIC AGENT for the topical treatment of ACNE.',\n",
       "  'terms': ['Adapalene - Benzoyl Peroxide Drug Combination',\n",
       "   'Adapalene Benzoyl Peroxide Drug Combination',\n",
       "   'Adapalene, Benzoyl Peroxide Drug Combination',\n",
       "   'Adapalene-Benzoyl Peroxide Drug Combination',\n",
       "   'Adapaleno e Peróxido de Benzoil',\n",
       "   'Adapaleno e Peróxido de Benzoil, Combinação de Medicamentos',\n",
       "   'Combinação Adapaleno e Peróxido de Benzoil',\n",
       "   'Combinação de Medicamentos Adapaleno e Peróxido de Benzoil',\n",
       "   'Epiduo'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068816': {'ID': 'D000068816',\n",
       "  'name': 'Adapaleno[Adapalene]',\n",
       "  'scope': 'A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.',\n",
       "  'terms': ['271, CD',\n",
       "   '6-(3-(1-adamantyl)-4-methoxyphenyl)-2-naphthoic acid',\n",
       "   'Adaferin',\n",
       "   'Adapalene',\n",
       "   'Adapaleno',\n",
       "   'CD 271',\n",
       "   'CD-271',\n",
       "   'CD271',\n",
       "   'Differin',\n",
       "   'Differin',\n",
       "   'Differine'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068817': {'ID': 'D000068817',\n",
       "  'name': 'Epoetina alfa[Epoetin Alfa]',\n",
       "  'scope': 'A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.',\n",
       "  'terms': ['Alfa Hexal, Epoetin',\n",
       "   'Alfa, Epoetin',\n",
       "   'Binocrit',\n",
       "   'Compound, HX575',\n",
       "   'Epoetin Alfa',\n",
       "   'Epoetin Alfa Hexal',\n",
       "   'Epoetina alfa',\n",
       "   'Epogen',\n",
       "   'Eprex',\n",
       "   'Eprex',\n",
       "   'HX575',\n",
       "   'HX575 Compound',\n",
       "   'Heberitro',\n",
       "   'Hexal, Epoetin Alfa',\n",
       "   'Procrit',\n",
       "   'Recombinant 1 165 Erythropoietin, Glycoform Alpha',\n",
       "   'Recombinant 1-165 Erythropoietin, Glycoform Alpha'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068818': {'ID': 'D000068818',\n",
       "  'name': 'Cetuximab[Cetuximab]',\n",
       "  'scope': 'A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.',\n",
       "  'terms': ['<i>cetuximab</i>',\n",
       "   '<i>cetuximabe</i>',\n",
       "   '<i>cetuximabe</i>',\n",
       "   'C225',\n",
       "   'Cetuximab',\n",
       "   'Cetuximab',\n",
       "   'Cetuximabe',\n",
       "   'Erbitux',\n",
       "   'Erbitux',\n",
       "   'IMC C225',\n",
       "   'IMC-C225',\n",
       "   'MAb C225'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068819': {'ID': 'D000068819',\n",
       "  'name': 'Hyssopus[Hyssopus Plant]',\n",
       "  'scope': 'A genus in the mint family (Lamiaceae). Members contain thujone and PHENOL. Distinguished from AGASTACHE (giant hyssop) and BACOPA (water hyssop).  Also distinguished from the genus of WASPS with the same genus name Hyssopus.',\n",
       "  'terms': ['Hyssop',\n",
       "   'Hyssops',\n",
       "   'Hyssopus',\n",
       "   'Hyssopus Plant',\n",
       "   'Hyssopus Plants',\n",
       "   'Hyssopus officinalis',\n",
       "   'Hyssopus officinalis',\n",
       "   'Plant, Hyssopus',\n",
       "   'Plants, Hyssopus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068836': {'ID': 'D000068836',\n",
       "  'name': 'Rivastigmina[Rivastigmine]',\n",
       "  'scope': 'A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.',\n",
       "  'terms': ['(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate',\n",
       "   '713, ENA',\n",
       "   '713, SDZ ENA',\n",
       "   'ENA 713',\n",
       "   'ENA 713, SDZ',\n",
       "   'ENA-713',\n",
       "   'ENA713',\n",
       "   'Exelon',\n",
       "   'Exelon',\n",
       "   'Hemitartarato de Rivastigmina',\n",
       "   'Hydrogen Tartrate, Rivastigmine',\n",
       "   'Rivastigmina',\n",
       "   'Rivastigmine',\n",
       "   'Rivastigmine Hydrogen Tartrate',\n",
       "   'RivastigmineTartrate',\n",
       "   'SDZ ENA 713',\n",
       "   'Tartrate, Rivastigmine Hydrogen'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068837': {'ID': 'D000068837',\n",
       "  'name': 'Parmeliaceae[Parmeliaceae]',\n",
       "  'scope': 'The largest family of lichen-forming fungi.',\n",
       "  'terms': ['Cetraria',\n",
       "   'Cetraria',\n",
       "   'Cetraria islandica',\n",
       "   'Iceland Moss',\n",
       "   'Iceland Mosses',\n",
       "   'Lichen islandicus',\n",
       "   'Líquen da Islândia',\n",
       "   'Líquen-Islândico',\n",
       "   'Líquen-da-Islândia',\n",
       "   'Moss, Iceland',\n",
       "   'Mosses, Iceland',\n",
       "   'Parmeliaceae',\n",
       "   'Parmeliaceae'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068838': {'ID': 'D000068838',\n",
       "  'name': 'Combinação Anlodipino e Valsartana[Amlodipine, Valsartan Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of amlodipine and valsartan that is used for the treatment of HYPERTENSION.',\n",
       "  'terms': ['- Valsartan, Amlodipine',\n",
       "   'Amlodipine - Valsartan',\n",
       "   'Amlodipine Valsartan',\n",
       "   'Amlodipine Valsartan Drug Combination',\n",
       "   'Amlodipine, Valsartan Drug Combination',\n",
       "   'Amlodipine-Valsartan',\n",
       "   'Amlodipine-Valsartan Drug Combination',\n",
       "   'Anlodipino e Valsartana',\n",
       "   'Anlodipino e Valsartana, Combinação de Medicamentos',\n",
       "   'Combination, Amlodipine-Valsartan Drug',\n",
       "   'Combinação Anlodipino e Valsartana',\n",
       "   'Combinação das Drogas Anlodipino e Valsartana',\n",
       "   'Combinação de Medicamentos Anlodipino e Valsartana',\n",
       "   'Combinação dos Medicamentos Anlodipino e Valsartana',\n",
       "   'Drug Combination, Amlodipine-Valsartan',\n",
       "   'Exforge',\n",
       "   'Valsartan, Amlodipine -'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068856': {'ID': 'D000068856',\n",
       "  'name': 'Eugenia[Eugenia]',\n",
       "  'scope': 'A genus in the family Myrtaceae sometimes known as \"stoppers\" in FOLK MEDICINE. Many species of the genus SYZYGIUM have synonymous names that begin with the Eugenia genus name.',\n",
       "  'terms': ['<i>alzira</i>',\n",
       "   '<i>alzira</i>',\n",
       "   '<i>beloni</i>',\n",
       "   '<i>beloni</i>',\n",
       "   '<i>edi</i>',\n",
       "   '<i>edi</i>',\n",
       "   '<i>ereni</i>',\n",
       "   '<i>ereni</i>',\n",
       "   '<i>georgina</i>',\n",
       "   '<i>georgina</i>',\n",
       "   '<i>ione</i>',\n",
       "   '<i>ione</i>',\n",
       "   '<i>ivanir</i>',\n",
       "   '<i>ivanir</i>',\n",
       "   '<i>jandira</i>',\n",
       "   '<i>jandira</i>',\n",
       "   '<i>nair</i>',\n",
       "   '<i>nair</i>',\n",
       "   '<i>rosalina</i>',\n",
       "   '<i>rosalina</i>',\n",
       "   'Brazilian Cherry Tree',\n",
       "   'Brazilian Cherry Trees',\n",
       "   'Cherry Tree, Brazilian',\n",
       "   'Cherry Tree, Surinam',\n",
       "   'Cherry Trees, Brazilian',\n",
       "   'Cherry Trees, Surinam',\n",
       "   'Eugenia',\n",
       "   'Eugenia',\n",
       "   'Eugenia uniflora',\n",
       "   'Eugenias',\n",
       "   'Euginia uniflora',\n",
       "   'Pitanga',\n",
       "   'Pitangas',\n",
       "   'Surinam Cherry Tree',\n",
       "   'Surinam Cherry Trees',\n",
       "   'Tree, Brazilian Cherry',\n",
       "   'Tree, Surinam Cherry',\n",
       "   'Trees, Brazilian Cherry',\n",
       "   'Trees, Surinam Cherry'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000068857': {'ID': 'D000068857',\n",
       "  'name': 'Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18[Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18]',\n",
       "  'scope': 'A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES of these subtypes.',\n",
       "  'terms': ['Gardasil',\n",
       "   'HPV L1 Vaccine, Quadrivalent 6,11,16,18',\n",
       "   'Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18',\n",
       "   'Human Papillomavirus Vaccine L1, Type 6,11,16,18',\n",
       "   'Vacina Quadrivalente Recombinante Anti-HPV tipos 6, 11, 16, 18',\n",
       "   'Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18',\n",
       "   'Vacina Quadrivalente Recombinante contra Papilomavirus Humano tipos 6, 11, 16, 18',\n",
       "   'Vacina Quadrivalente Recombinante para HPV 6, 11, 16, 18',\n",
       "   'Vacina Tetravalente Recombinante contra HPV tipos 6, 11, 16, 18'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068858': {'ID': 'D000068858',\n",
       "  'name': 'Chá de Kombucha[Kombucha Tea]',\n",
       "  'scope': 'A beverage made by FERMENTATION of black tea and/or green tea.',\n",
       "  'terms': ['Chá de Kombucha',\n",
       "   'Kombucha',\n",
       "   'Kombucha Tea',\n",
       "   'Kombucha Teas',\n",
       "   'Tea, Kombucha',\n",
       "   'Teas, Kombucha'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068876': {'ID': 'D000068876',\n",
       "  'name': 'Cloridrato de Fingolimode[Fingolimod Hydrochloride]',\n",
       "  'scope': 'A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.',\n",
       "  'terms': ['2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride',\n",
       "   'Cloridrato de Fingolimode',\n",
       "   'FTY 720',\n",
       "   'FTY-720',\n",
       "   'FTY720',\n",
       "   'Fingolimod',\n",
       "   'Fingolimod Hydrochloride',\n",
       "   'Fingolimode',\n",
       "   'Gilenia',\n",
       "   'Gilenya',\n",
       "   'Gilenya',\n",
       "   'Hidrocloreto de Fingolimode',\n",
       "   'Hydrochloride, Fingolimod'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068877': {'ID': 'D000068877',\n",
       "  'name': 'Mesilato de Imatinib[Imatinib Mesylate]',\n",
       "  'scope': 'A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.',\n",
       "  'terms': [\"Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide\",\n",
       "   'CGP 57148',\n",
       "   'CGP-57148',\n",
       "   'CGP57148',\n",
       "   'CGP57148B',\n",
       "   'Gleevec',\n",
       "   'Glivec',\n",
       "   'Glivec',\n",
       "   'Imatinib',\n",
       "   'Imatinib Mesylate',\n",
       "   'Imatinib Methanesulfonate',\n",
       "   'Imatinibe',\n",
       "   'Mesilato de Imatinib',\n",
       "   'Mesilato de Imatinibe',\n",
       "   'Mesylate, Imatinib',\n",
       "   'Methanesulfonate, Imatinib',\n",
       "   'ST 1571',\n",
       "   'ST1571',\n",
       "   'STI 571',\n",
       "   'STI-571',\n",
       "   'STI571'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068878': {'ID': 'D000068878',\n",
       "  'name': 'Trastuzumab[Trastuzumab]',\n",
       "  'scope': 'A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.',\n",
       "  'terms': ['<i>herceptin</i>',\n",
       "   '<i>herceptin</i>',\n",
       "   '<i>herceptin</i>',\n",
       "   '<i>trastuzumab</i>',\n",
       "   '<i>trastuzumab</i>',\n",
       "   '<i>trastuzumabe</i>',\n",
       "   '<i>trastuzumabe</i>',\n",
       "   '<i>trastuzumabe</i>',\n",
       "   'Herceptin',\n",
       "   'Trastuzumab',\n",
       "   'Trastuzumab',\n",
       "   'Trastuzumabe'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068879': {'ID': 'D000068879',\n",
       "  'name': 'Adalimumab[Adalimumab]',\n",
       "  'scope': \"A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.\",\n",
       "  'terms': ['Adalimumab',\n",
       "   'Adalimumab',\n",
       "   'Adalimumabe',\n",
       "   'Antibody, D2E7',\n",
       "   'D2E7 Antibody',\n",
       "   'Humira',\n",
       "   'Humira'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068880': {'ID': 'D000068880',\n",
       "  'name': 'Insulina Isófana Humana[Isophane Insulin, Human]',\n",
       "  'scope': 'Human isophane insulin that is used to manage BLOOD GLUCOSE levels in patients with DIABETES.',\n",
       "  'terms': ['Human Isophane Insulin',\n",
       "   'Human NPH Insulin',\n",
       "   'Humulin N',\n",
       "   'Insulatard',\n",
       "   'Insulin, Human Isophane',\n",
       "   'Insulin, Human NPH',\n",
       "   'Insulin, NPH, Human',\n",
       "   'Insulina Isófana Humana',\n",
       "   'Isophane Insulin, Human',\n",
       "   'N, Humulin',\n",
       "   'N, Novolin',\n",
       "   'NPH Insulin, Human',\n",
       "   'Novolin N',\n",
       "   'Protophan',\n",
       "   'Protophane'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068881': {'ID': 'D000068881',\n",
       "  'name': 'Animais Exóticos[Animals, Exotic]',\n",
       "  'scope': 'Animals native to a foreign country or of foreign origin or character, that are not native to the United States.',\n",
       "  'terms': ['Animais Exóticos',\n",
       "   'Animal, Exotic',\n",
       "   'Animals, Exotic',\n",
       "   'Exotic Animal',\n",
       "   'Exotic Animals',\n",
       "   'Exotic Pet',\n",
       "   'Exotic Pets',\n",
       "   'Pet, Exotic',\n",
       "   'Pets, Exotic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068882': {'ID': 'D000068882',\n",
       "  'name': 'Palmitato de Paliperidona[Paliperidone Palmitate]',\n",
       "  'scope': 'A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.',\n",
       "  'terms': ['3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one',\n",
       "   '9 Hydroxy risperidone',\n",
       "   '9 Hydroxyrisperidone',\n",
       "   '9 OH risperidone',\n",
       "   '9-Hydroxy-risperidone',\n",
       "   '9-Hydroxyrisperidone',\n",
       "   '9-OH-risperidone',\n",
       "   'Invega',\n",
       "   'Invega Sustenna',\n",
       "   'Invega Sustenna',\n",
       "   'Paliperidone',\n",
       "   'Paliperidone Palmitate',\n",
       "   'Palmitate, Paliperidone',\n",
       "   'Palmitato de Paliperidona',\n",
       "   'R 76477',\n",
       "   'R-76477',\n",
       "   'R76477',\n",
       "   'Sustenna, Invega'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068884': {'ID': 'D000068884',\n",
       "  'name': 'Imunossenescência[Immunosenescence]',\n",
       "  'scope': 'The decline in the function of the IMMUNE SYSTEM during aging.',\n",
       "  'terms': ['Immunosenescence',\n",
       "   'Imunossenescência',\n",
       "   'Senescência Imunológica'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068896': {'ID': 'D000068896',\n",
       "  'name': 'Canagliflozina[Canagliflozin]',\n",
       "  'scope': 'A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.',\n",
       "  'terms': ['1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973',\n",
       "   'Anhydrous Canagliflozin',\n",
       "   'Canagliflozin',\n",
       "   'Canagliflozin Hemihydrate',\n",
       "   'Canagliflozin, Anhydrous',\n",
       "   'Canagliflozina',\n",
       "   'Canagliflozina Anidra',\n",
       "   'Hemihydrate, Canagliflozin',\n",
       "   'Invokana',\n",
       "   'Invokana'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068897': {'ID': 'D000068897',\n",
       "  'name': 'Iridescência[Iridescence]',\n",
       "  'scope': 'The changing of the color of an object due to variations in the angle of illumination or observation.',\n",
       "  'terms': ['Coloring, Iridescent',\n",
       "   'Colorings, Iridescent',\n",
       "   'Goniochromism',\n",
       "   'Iridescence',\n",
       "   'Iridescent Coloring',\n",
       "   'Iridescent Colorings',\n",
       "   'Iridescência',\n",
       "   'Opalescence',\n",
       "   'Pearlescence'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068898': {'ID': 'D000068898',\n",
       "  'name': 'Raltegravir Potássico[Raltegravir Potassium]',\n",
       "  'scope': 'A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.',\n",
       "  'terms': ['0518, MK',\n",
       "   'Isentress',\n",
       "   'Isentress',\n",
       "   'MK 0518',\n",
       "   'MK-0518',\n",
       "   'MK0518',\n",
       "   'Potassium, Raltegravir',\n",
       "   'Raltegravir',\n",
       "   'Raltegravir',\n",
       "   'Raltegravir Potassium',\n",
       "   'Raltegravir Potássico'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068899': {'ID': 'D000068899',\n",
       "  'name': 'Combinação Fosfato de Sitagliptina e Cloridrato de Metformina[Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.',\n",
       "  'terms': ['Combinação Fosfato de Sitagliptina e Cloridrato de Metformina',\n",
       "   'Combinação das Drogas Fosfato de Sitagliptina e Cloridrato de Metformina',\n",
       "   'Combinação das Drogas Fosfato de Sitagliptina e Hidrocloreto de Metformina',\n",
       "   'Combinação de Medicamentos Fosfato de Sitagliptina e Cloridrato de Metformina',\n",
       "   'Fosfato de Sitagliptina e Cloridrato de Metformina',\n",
       "   'Fosfato de Sitagliptina e Cloridrato de Metformina, Combinação de Medicamentos',\n",
       "   'Janumet',\n",
       "   'Janumet',\n",
       "   'Sitagliptin Phosphate Metformin Hydrochloride Drug Combination',\n",
       "   'Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination',\n",
       "   'Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068900': {'ID': 'D000068900',\n",
       "  'name': 'Fosfato de Sitagliptina[Sitagliptin Phosphate]',\n",
       "  'scope': 'A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.',\n",
       "  'terms': ['0431, MK',\n",
       "   '4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine',\n",
       "   'Anhydrous, Sitagliptin Phosphate',\n",
       "   'Fosfato de Sitagliptina',\n",
       "   'Januvia',\n",
       "   'Januvia',\n",
       "   'MK 0431',\n",
       "   'MK-0431',\n",
       "   'MK0431',\n",
       "   'Monohydrate, Sitagliptin Monophosphate',\n",
       "   'Monohydrate, Sitagliptin Phosphate',\n",
       "   'Monophosphate Monohydrate, Sitagliptin',\n",
       "   'Phosphate Anhydrous, Sitagliptin',\n",
       "   'Phosphate Monohydrate, Sitagliptin',\n",
       "   'Phosphate, Sitagliptin',\n",
       "   'Sitagliptin',\n",
       "   'Sitagliptin Monophosphate Monohydrate',\n",
       "   'Sitagliptin Phosphate',\n",
       "   'Sitagliptin Phosphate Anhydrous',\n",
       "   'Sitagliptin Phosphate Monohydrate',\n",
       "   'Sitagliptina'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068916': {'ID': 'D000068916',\n",
       "  'name': 'Regressão Espacial[Spatial Regression]',\n",
       "  'scope': 'Methods used to take into account and incorporate spatial autocorrelation and regional variation into regression analysis models of data that has spatial dependency, and also to provide information on the spatial relationships among the variables.',\n",
       "  'terms': ['Geographically Weighted Regression',\n",
       "   'Geographically Weighted Regressions',\n",
       "   'Regression, Geographically Weighted',\n",
       "   'Regression, Spatial',\n",
       "   'Regressions, Geographically Weighted',\n",
       "   'Regressions, Spatial',\n",
       "   'Regressão Espacial',\n",
       "   'Spatial Regression',\n",
       "   'Spatial Regressions',\n",
       "   'Weighted Regression, Geographically',\n",
       "   'Weighted Regressions, Geographically'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068936': {'ID': 'D000068936',\n",
       "  'name': 'Nanomedicina Teranóstica[Theranostic Nanomedicine]',\n",
       "  'scope': 'An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.',\n",
       "  'terms': ['Nanomedicina Personalizada',\n",
       "   'Nanomedicina Teranóstica',\n",
       "   'Nanomedicina Tratanóstica',\n",
       "   'Nanomedicine, Theranostic',\n",
       "   'Nanomedicines, Theranostic',\n",
       "   'Nanoteranóstica',\n",
       "   'Nanotratanóstica',\n",
       "   'Teranóstica',\n",
       "   'Theranostic',\n",
       "   'Theranostic Nanomedicine',\n",
       "   'Theranostic Nanomedicines',\n",
       "   'Theranostics',\n",
       "   'Tratanóstica'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000068937': {'ID': 'D000068937',\n",
       "  'name': 'Cosmecêuticos[Cosmeceuticals]',\n",
       "  'scope': 'COSMETICS that are associated with therapeutic effects.',\n",
       "  'terms': ['Cosmeceuticals', 'Cosmecêuticos'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000068956': {'ID': 'D000068956',\n",
       "  'name': 'Dilema do Prisioneiro[Prisoner Dilemma]',\n",
       "  'scope': 'A scenario in decision analysis in which two individuals motivated entirely by self-preservation at the expense of the other, end up in a worse state than if they had cooperated with each other in the decision-making process.',\n",
       "  'terms': ['Dilema do Prisioneiro',\n",
       "   'Dilemma, Prisoner',\n",
       "   \"Dilemma, Prisoner's\",\n",
       "   'Dilemma, Prisoners',\n",
       "   'Prisoner Dilemma',\n",
       "   \"Prisoner's Dilemma\",\n",
       "   'Prisoners Dilemma'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068957': {'ID': 'D000068957',\n",
       "  'name': 'Jogos Recreativos[Games, Recreational]',\n",
       "  'scope': 'Activity typically involving several individuals for the purpose of leisure, amusement, entertainment or pleasure.',\n",
       "  'terms': ['Game, Recreational',\n",
       "   'Games, Recreational',\n",
       "   'Jogos Recreacionais',\n",
       "   'Jogos Recreativos',\n",
       "   'Recreational Game',\n",
       "   'Recreational Games'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068958': {'ID': 'D000068958',\n",
       "  'name': 'Volta ao Esporte[Return to Sport]',\n",
       "  'scope': 'Resumption of sporting activity following a hiatus or period of absence due to injury or other reasons.',\n",
       "  'terms': ['Activities Resumption, Recreational',\n",
       "   'Activities Resumptions, Recreational',\n",
       "   'Activity Resumption, Sporting',\n",
       "   'Activity Resumptions, Sporting',\n",
       "   'Play, Return to',\n",
       "   'Recreational Activities Resumption',\n",
       "   'Recreational Activities Resumptions',\n",
       "   'Resumption of Recreational Activities',\n",
       "   'Resumption of Sporting Activity',\n",
       "   'Retorno ao Esporte',\n",
       "   'Retorno da Prática Esportiva',\n",
       "   'Retorno à Atividade Esportiva',\n",
       "   'Retorno à Atividade Física',\n",
       "   'Retorno à Prática Esportiva',\n",
       "   'Return to Play',\n",
       "   'Return to Recreational Activities',\n",
       "   'Return to Sport',\n",
       "   'Return to Sporting Activities',\n",
       "   'Return to Sports',\n",
       "   'Sport, Return to',\n",
       "   'Sporting Activity Resumption',\n",
       "   'Sporting Activity Resumptions',\n",
       "   'Sports, Return to',\n",
       "   'Volta ao Esporte',\n",
       "   'Volta à Prática do Esporte',\n",
       "   'to Play, Return',\n",
       "   'to Sport, Return',\n",
       "   'to Sports, Return'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068959': {'ID': 'D000068959',\n",
       "  'name': 'Manutenção do Peso Corporal[Body Weight Maintenance]',\n",
       "  'scope': 'Sustaining BODY WEIGHT after BODY WEIGHT CHANGES have been achieved.',\n",
       "  'terms': ['Body Weight Maintenance',\n",
       "   'Body Weight Maintenances',\n",
       "   'Maintenance, Body Weight',\n",
       "   'Maintenances, Body Weight',\n",
       "   'Manutenção do Peso Corporal',\n",
       "   'Manutenção do Peso Corpóreo',\n",
       "   'Weight Maintenance, Body',\n",
       "   'Weight Maintenances, Body'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068977': {'ID': 'D000068977',\n",
       "  'name': 'Medicina Concierge[Concierge Medicine]',\n",
       "  'scope': 'An arrangement in which a patient pays an annual fee to a physician in exchange for services over and beyond normal insurance-reimbursed services.',\n",
       "  'terms': ['Assistência Médica Preferencial',\n",
       "   'Boutique Medicine',\n",
       "   'Concierge Medicine',\n",
       "   'Medicina Concierge',\n",
       "   'Medicina Exclusiva',\n",
       "   'Medicina Personalizada',\n",
       "   'Medicina de Adesão',\n",
       "   'Medicina de Filiação',\n",
       "   'Medicine, Boutique',\n",
       "   'Medicine, Concierge',\n",
       "   'Medicine, Retainer',\n",
       "   'Prática de Médicos Exclusivos',\n",
       "   'Retainer Medicine',\n",
       "   'Serviço Médico Pessoal Exclusivo'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068997': {'ID': 'D000068997',\n",
       "  'name': 'Smartphone[Smartphone]',\n",
       "  'scope': 'A cellular phone with advanced computing and connectivity capability built on an operating system.',\n",
       "  'terms': ['Phone, Smart',\n",
       "   'Phones, Smart',\n",
       "   'Smart Phone',\n",
       "   'Smart Phones',\n",
       "   'Smartfone',\n",
       "   'Smartfones',\n",
       "   'Smartphone',\n",
       "   'Smartphone',\n",
       "   'Smartphones',\n",
       "   'Telefone Inteligente'],\n",
       "  'qualifier': '#'},\n",
       " 'D000068998': {'ID': 'D000068998',\n",
       "  'name': 'Umidificadores[Humidifiers]',\n",
       "  'scope': 'Machines that add moisture to the air.',\n",
       "  'terms': ['Humidifier', 'Humidifiers', 'Umidificadores'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069': {'ID': 'D000069',\n",
       "  'name': 'Aculturação[Acculturation]',\n",
       "  'scope': 'Process of cultural change in which one group or members of a group assimilate various cultural patterns from another.',\n",
       "  'terms': ['Acculturation',\n",
       "   'Aculturação',\n",
       "   'Assimilation, Cultural',\n",
       "   'Assimilação Cultural',\n",
       "   'Assimilação Social',\n",
       "   'Cultural Assimilation'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069036': {'ID': 'D000069036',\n",
       "  'name': 'Insulina Glargina[Insulin Glargine]',\n",
       "  'scope': 'A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.',\n",
       "  'terms': ['901, HOE',\n",
       "   '<i>glargina</i>',\n",
       "   '<i>glargina</i>',\n",
       "   '<i>lanthus</i>',\n",
       "   '<i>lanthus</i>',\n",
       "   'A21 Gly B31 Arg B32 Arg insulin',\n",
       "   'A21-Gly-B31-Arg-B32-Arg-insulin',\n",
       "   'Basaglar',\n",
       "   'Basaglar',\n",
       "   'Glargine',\n",
       "   'Glargine, Insulin',\n",
       "   'HOE 901',\n",
       "   'HOE-901',\n",
       "   'HOE901',\n",
       "   'Insulin Glargine',\n",
       "   'Insulin, Gly(A21)-Arg(B31,B32)',\n",
       "   'Insulin, Glycyl(A21)-Arginyl(B31,B32)',\n",
       "   'Insulina Glargina',\n",
       "   'Lantus',\n",
       "   'Lantus',\n",
       "   'Lantus Solostar',\n",
       "   'Lantus Solostar',\n",
       "   'Solostar, Lantus'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069056': {'ID': 'D000069056',\n",
       "  'name': 'Cloridrato de Lurasidona[Lurasidone Hydrochloride]',\n",
       "  'scope': 'A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.',\n",
       "  'terms': ['13496, SM',\n",
       "   'Cloridrato de Lurasidona',\n",
       "   'HCl, Lurasidone',\n",
       "   'Hidrocloreto de Lurasidona',\n",
       "   'Hydrochloride, Lurasidone',\n",
       "   'Latuda',\n",
       "   'Lurasidona',\n",
       "   'Lurasidone',\n",
       "   'Lurasidone HCl',\n",
       "   'Lurasidone Hydrochloride',\n",
       "   'N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide',\n",
       "   'SM 13,496',\n",
       "   'SM 13496',\n",
       "   'SM-13,496',\n",
       "   'SM-13496',\n",
       "   'SM13,496',\n",
       "   'SM13496'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069057': {'ID': 'D000069057',\n",
       "  'name': 'Insulina Detemir[Insulin Detemir]',\n",
       "  'scope': 'A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.',\n",
       "  'terms': ['12C-Lys(B29)-DB30I',\n",
       "   'B29 tetradecanoyl Lys B30 des Ala insulin',\n",
       "   'B29-tetradecanoyl-Lys-B30-des-Ala-insulin',\n",
       "   'Basal Insulin Detemir',\n",
       "   'Des-(B30)-insulin, Lys(B29)-tetradecanoyl',\n",
       "   'Detemir, Basal Insulin',\n",
       "   'Detemir, Insulin',\n",
       "   'Insulin Detemir',\n",
       "   'Insulin Detemir, Basal',\n",
       "   'Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)',\n",
       "   'Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)',\n",
       "   'Insulina Detemir',\n",
       "   'Levemir',\n",
       "   'Levemir',\n",
       "   'NN 304',\n",
       "   'NN-304',\n",
       "   'NN304'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069058': {'ID': 'D000069058',\n",
       "  'name': 'Dicloridrato de Vardenafila[Vardenafil Dihydrochloride]',\n",
       "  'scope': 'A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the treatment of ERECTILE DYSFUNCTION.',\n",
       "  'terms': ['1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine',\n",
       "   'Anhydrous, Vardenafil Hydrochloride',\n",
       "   'Di-Hidrocloreto de Vardenafila',\n",
       "   'Dicloridrato de Vardenafila',\n",
       "   'Dihydrochloride, Vardenafil',\n",
       "   'Hydrochloride Anhydrous, Vardenafil',\n",
       "   'Hydrochloride Trihydrate, Vardenafil',\n",
       "   'Hydrochloride, Vardenafil',\n",
       "   'Levitra',\n",
       "   'Levitra',\n",
       "   'Trihydrate, Vardenafil Hydrochloride',\n",
       "   'Vardenafil',\n",
       "   'Vardenafil Dihydrochloride',\n",
       "   'Vardenafil Hydrochloride',\n",
       "   'Vardenafil Hydrochloride Anhydrous',\n",
       "   'Vardenafil Hydrochloride Trihydrate'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069059': {'ID': 'D000069059',\n",
       "  'name': 'Atorvastatina Cálcica[Atorvastatin Calcium]',\n",
       "  'scope': 'A pyrrole and heptanoic acid derivative,HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; AND TRIGLYCERIDES and to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS and prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.',\n",
       "  'terms': ['Anhydrous, Atorvastatin Calcium',\n",
       "   'Atorvastatin',\n",
       "   'Atorvastatin Calcium',\n",
       "   'Atorvastatin Calcium Anhydrous',\n",
       "   'Atorvastatin Calcium Hydrate',\n",
       "   'Atorvastatin Calcium Trihydrate',\n",
       "   'Atorvastatin, Calcium Salt',\n",
       "   'Atorvastatina Cálcica',\n",
       "   'CI 981',\n",
       "   'CI-981',\n",
       "   'CI981',\n",
       "   'Calcium Anhydrous, Atorvastatin',\n",
       "   'Calcium Hydrate, Atorvastatin',\n",
       "   'Calcium Salt Atorvastatin',\n",
       "   'Calcium Trihydrate, Atorvastatin',\n",
       "   'Calcium, Atorvastatin',\n",
       "   'Hydrate, Atorvastatin Calcium',\n",
       "   'Lipitor',\n",
       "   'Lipitor',\n",
       "   'Liptonorm',\n",
       "   'Trihydrate, Atorvastatin Calcium'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069076': {'ID': 'D000069076',\n",
       "  'name': 'Fraturas Múltiplas[Fractures, Multiple]',\n",
       "  'scope': 'Injuries involving the breaking of either several bones or one bone in two or more places.',\n",
       "  'terms': ['Fracture, Multiple',\n",
       "   'Fractures, Multiple',\n",
       "   'Fraturas Múltiplas',\n",
       "   'Multiple Fracture',\n",
       "   'Multiple Fractures',\n",
       "   'Múltiplas Fraturas'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069077': {'ID': 'D000069077',\n",
       "  'name': 'Consolidação da Memória[Memory Consolidation]',\n",
       "  'scope': 'Neurological process involving the conversion of learned information into long-term memory.',\n",
       "  'terms': ['Consolidation, Memory',\n",
       "   'Consolidations, Memory',\n",
       "   'Consolidação da Memória',\n",
       "   'Memory Consolidation',\n",
       "   'Memory Consolidations'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069078': {'ID': 'D000069078',\n",
       "  'name': 'Soroconversão[Seroconversion]',\n",
       "  'scope': 'The appearance of antibodies against causative agents in the blood of individuals during the course of an infection or following immunization.',\n",
       "  'terms': ['Seroconversion', 'Seroconversions', 'Soroconversão'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069079': {'ID': 'D000069079',\n",
       "  'name': 'Exposição à Radiação[Radiation Exposure]',\n",
       "  'scope': 'Phenomenon in which organisms are subjected to radiation.',\n",
       "  'terms': ['Exposição a Radiação',\n",
       "   'Exposição à Radiação',\n",
       "   'Exposure, Radiation',\n",
       "   'Radiation Exposure'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069098': {'ID': 'D000069098',\n",
       "  'name': 'Cartões Inteligentes de Saúde[Health Smart Cards]',\n",
       "  'scope': \"Hand-sized cards with built-in computer chips used for accessing, storing, and protecting patients' medical information.\",\n",
       "  'terms': ['Card, Patient Identification',\n",
       "   'Card, Smart',\n",
       "   'Cards, Patient Identification',\n",
       "   'Cards, Smart',\n",
       "   'Cartões Eletrônicos de Saúde do Paciente',\n",
       "   'Cartões Inteligentes de Saúde',\n",
       "   'Cartões de Saúde Inteligentes',\n",
       "   'Health Smart Card',\n",
       "   'Health Smart Cards',\n",
       "   'Identification Card, Patient',\n",
       "   'Identification Cards, Patient',\n",
       "   'Patient Identification Card',\n",
       "   'Patient Identification Cards',\n",
       "   'Smart Card',\n",
       "   'Smart Card, Health',\n",
       "   'Smart Cards',\n",
       "   'Smart Cards, Health'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069177': {'ID': 'D000069177',\n",
       "  'name': 'Sistemas de Secreção Tipo I[Type I Secretion Systems]',\n",
       "  'scope': 'Gram-negative bacterial secretion systems which translocate effectors in a single step across the inner and outer membranes. The one-step secretion is carried out by a channel that passes from the CYTOPLASM, through the inner membrane, PERIPLASMIC SPACE, and outer membrane, to the EXTRACELLULAR SPACE. The specificity of type I secretions systems are determined by the specificity of the three subcomponents forming the channel - an ATP transporter (ATP-BINDING CASSETTE TRANSPORTERS); a membrane fusion protein (MEMBRANE FUSION PROTEINS); and an outer membrane protein (BACTERIAL OUTER MEMBRANE PROTEINS.)',\n",
       "  'terms': ['Bacterial Secretion Systems, Type I',\n",
       "   'Secretion System, T1SS',\n",
       "   'Sistemas de Secreção Tipo I',\n",
       "   'System, T1SS Secretion',\n",
       "   'T1SS Secretion System',\n",
       "   'Type 1 Secretion System',\n",
       "   'Type 1 Secretion Systems',\n",
       "   'Type I Secretion System',\n",
       "   'Type I Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069178': {'ID': 'D000069178',\n",
       "  'name': 'Sistemas de Secreção Tipo II[Type II Secretion Systems]',\n",
       "  'scope': 'Gram-negative bacterial secretion systems which carry out the secretion of folded proteins.T2SSs secrete folded proteins from the PERIPLASMIC SPACE that have been exported there by SEC TRANSLOCASE or TAT SECRETION SYSTEMS, or they secrete folded proteins directly from the CYTOPLASM. The T2SSs have four substructures, an ATPase, an inner membrane platform, a pseudopilin, and secretin, an outer membrane complex which is a channel for secretion. (This bacterial secretin is not the same as the mammalian hormone also named SECRETIN.)',\n",
       "  'terms': ['Bacterial Secretion System, Type II',\n",
       "   'Secretion System, T2SS',\n",
       "   'Sistemas de Secreção Tipo II',\n",
       "   'System, T2SS Secretion',\n",
       "   'T2SS Secretion System',\n",
       "   'Type 2 Secretion System',\n",
       "   'Type 2 Secretion Systems',\n",
       "   'Type II Secretion System',\n",
       "   'Type II Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069196': {'ID': 'D000069196',\n",
       "  'name': 'Microbioma Gastrointestinal[Gastrointestinal Microbiome]',\n",
       "  'scope': 'All of the microbial organisms that naturally exist within the GASTROINTESTINAL TRACT.',\n",
       "  'terms': ['Bacteria, Enteric',\n",
       "   'Bactérias Entéricas',\n",
       "   'Enteric Bacteria',\n",
       "   'Flora Gastrointestinal',\n",
       "   'Flora Intestinal',\n",
       "   'Flora, Gastrointestinal',\n",
       "   'Flora, Gut',\n",
       "   'Flora, Intestinal',\n",
       "   'Gastrointestinal Flora',\n",
       "   'Gastrointestinal Microbiome',\n",
       "   'Gastrointestinal Microbiomes',\n",
       "   'Gastrointestinal Microbiota',\n",
       "   'Gastrointestinal Microbiotas',\n",
       "   'Gastrointestinal Microflora',\n",
       "   'Gut Flora',\n",
       "   'Gut Microbiome',\n",
       "   'Gut Microbiomes',\n",
       "   'Gut Microbiota',\n",
       "   'Gut Microbiotas',\n",
       "   'Gut Microflora',\n",
       "   'Intestinal Flora',\n",
       "   'Intestinal Microbiome',\n",
       "   'Intestinal Microbiomes',\n",
       "   'Intestinal Microbiota',\n",
       "   'Intestinal Microbiotas',\n",
       "   'Intestinal Microflora',\n",
       "   'Microbioma Gastrointestinal',\n",
       "   'Microbioma Gástrico',\n",
       "   'Microbioma Intestinal',\n",
       "   'Microbioma do Estômago',\n",
       "   'Microbioma dos Intestinos',\n",
       "   'Microbiome, Gastrointestinal',\n",
       "   'Microbiome, Gut',\n",
       "   'Microbiome, Intestinal',\n",
       "   'Microbiomes, Gastrointestinal',\n",
       "   'Microbiomes, Gut',\n",
       "   'Microbiomes, Intestinal',\n",
       "   'Microbiota Gastrointestinal',\n",
       "   'Microbiota Gástrica',\n",
       "   'Microbiota Intestinal',\n",
       "   'Microbiota do Estômago',\n",
       "   'Microbiota dos Intestinos',\n",
       "   'Microbiota, Gastrointestinal',\n",
       "   'Microbiota, Gut',\n",
       "   'Microbiota, Intestinal',\n",
       "   'Microbiotas, Gastrointestinal',\n",
       "   'Microbiotas, Gut',\n",
       "   'Microbiotas, Intestinal',\n",
       "   'Microflora Gastrointestinal',\n",
       "   'Microflora Intestinal',\n",
       "   'Microflora, Gastrointestinal',\n",
       "   'Microflora, Gut',\n",
       "   'Microflora, Intestinal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069216': {'ID': 'D000069216',\n",
       "  'name': 'Inquéritos sobre o Uso de Métodos Contraceptivos[Contraceptive Prevalence Surveys]',\n",
       "  'scope': 'Collections of data, obtained from voluntary subjects, that measure the usage rate of methods of CONTRACEPTION; CONTRACEPTIVE DEVICES; or CONTRACEPTIVE AGENTS.',\n",
       "  'terms': ['Contraceptive Prevalence Survey',\n",
       "   'Contraceptive Prevalence Surveys',\n",
       "   'Inquéritos de Prevalência Contraceptiva',\n",
       "   'Inquéritos sobre Prevalência Contraceptiva',\n",
       "   'Inquéritos sobre a Prevalência de Uso de Anticoncepcionais',\n",
       "   'Inquéritos sobre o Uso de Métodos Contraceptivos',\n",
       "   'Levantamentos sobre o Uso de Métodos Contraceptivos',\n",
       "   'Pesquisas de Prevalência Contraceptiva',\n",
       "   'Pesquisas de Prevalência da Prática Contraceptiva',\n",
       "   'Pesquisas sobre o Uso de Métodos Contraceptivos',\n",
       "   'Questionários Sobre Métodos Anticoncepcionais',\n",
       "   'Survey, Contraceptive Prevalence',\n",
       "   'Surveys, Contraceptive Prevalence'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069236': {'ID': 'D000069236',\n",
       "  'name': 'Líquido Pericárdico[Pericardial Fluid]',\n",
       "  'scope': 'Watery fluid produced in the serous and visceral pericardium surrounding the surface of the HEART.',\n",
       "  'terms': ['Fluid, Pericardial',\n",
       "   'Fluid, Pericardium',\n",
       "   'Fluids, Pericardial',\n",
       "   'Fluids, Pericardium',\n",
       "   'Líquido Pericárdico',\n",
       "   'Pericardial Fluid',\n",
       "   'Pericardial Fluids',\n",
       "   'Pericardium Fluid',\n",
       "   'Pericardium Fluids'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069237': {'ID': 'D000069237',\n",
       "  'name': 'Artrocentese[Arthrocentesis]',\n",
       "  'scope': 'Aspiration of SYNOVIAL FLUID from the TEMPOROMANDIBULAR JOINT cavity.',\n",
       "  'terms': ['Arthrocenteses',\n",
       "   'Arthrocenteses, TMJ',\n",
       "   'Arthrocenteses, Temporomandibular Joint',\n",
       "   'Arthrocentesis',\n",
       "   'Arthrocentesis, TMJ',\n",
       "   'Arthrocentesis, Temporomandibular Joint',\n",
       "   'Arthrocentesis,Temporomandibular Joint',\n",
       "   'Arthrocentesis,Temporomandibular Joints',\n",
       "   'Artrocentese',\n",
       "   'Artrocentese da Articulação Temporomandibular',\n",
       "   'Aspiration, Temporomandibular Joint',\n",
       "   'Aspiration,Temporomandibular Joint',\n",
       "   'Aspiration,Temporomandibular Joints',\n",
       "   'Aspirations, Temporomandibular Joint',\n",
       "   'Joint Arthrocenteses, Temporomandibular',\n",
       "   'Joint Arthrocentesis, Temporomandibular',\n",
       "   'Joint Aspiration, Temporomandibular',\n",
       "   'Joint Aspirations, Temporomandibular',\n",
       "   'Joint, Arthrocentesis,Temporomandibular',\n",
       "   'Joint, Aspiration,Temporomandibular',\n",
       "   'Joints, Arthrocentesis,Temporomandibular',\n",
       "   'Joints, Aspiration,Temporomandibular',\n",
       "   'TMJ Arthrocenteses',\n",
       "   'TMJ Arthrocentesis',\n",
       "   'Temporomandibular Joint Arthrocenteses',\n",
       "   'Temporomandibular Joint Arthrocentesis',\n",
       "   'Temporomandibular Joint Aspiration',\n",
       "   'Temporomandibular Joint Aspirations'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069258': {'ID': 'D000069258',\n",
       "  'name': 'Toracentese[Thoracentesis]',\n",
       "  'scope': 'Aspiration of fluid or air from the THORACIC CAVITY. It is coupled sometimes  with the administration of drugs into the PLEURAL CAVITY.',\n",
       "  'terms': ['Aspiration, Chest',\n",
       "   'Aspiration, Pleural',\n",
       "   'Aspirations, Chest',\n",
       "   'Aspirations, Pleural',\n",
       "   'Chest Aspiration',\n",
       "   'Chest Aspirations',\n",
       "   'Pleural Aspiration',\n",
       "   'Pleural Aspirations',\n",
       "   'Pleurocenteses',\n",
       "   'Pleurocentesis',\n",
       "   'Thoracenteses',\n",
       "   'Thoracentesis',\n",
       "   'Thoracocenteses',\n",
       "   'Thoracocentesis',\n",
       "   'Toracentese'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069259': {'ID': 'D000069259',\n",
       "  'name': 'Sistema Musculoaponeurótico Superficial[Superficial Musculoaponeurotic System]',\n",
       "  'scope': 'Layer between the superficial fat compartment and superficial facial muscles in the head and the neck.',\n",
       "  'terms': ['Muscle, Platysma',\n",
       "   'Muscles, Platysma',\n",
       "   'Musculo-Aponeurotic System, Superficial',\n",
       "   'Musculo-Aponeurotic Systems, Superficial',\n",
       "   'Musculoaponeurotic System, Superficial',\n",
       "   'Musculoaponeurotic Systems, Superficial',\n",
       "   'Platysma Muscle',\n",
       "   'Platysma Muscles',\n",
       "   'Sistema Musculoaponeurótico Superficial',\n",
       "   'Sistema Musculoaponevrótico Superficial',\n",
       "   'Superficial Musculo Aponeurotic System',\n",
       "   'Superficial Musculo aponeurotic System (SMAS)',\n",
       "   'Superficial Musculo-Aponeurotic System',\n",
       "   'Superficial Musculo-Aponeurotic Systems',\n",
       "   'Superficial Musculo-aponeurotic System (SMAS)',\n",
       "   'Superficial Musculo-aponeurotic Systems (SMAS)',\n",
       "   'Superficial Musculoaponeurotic System',\n",
       "   'Superficial Musculoaponeurotic Systems',\n",
       "   'System, Superficial Musculo-Aponeurotic',\n",
       "   'System, Superficial Musculo-aponeurotic (SMAS)',\n",
       "   'System, Superficial Musculoaponeurotic',\n",
       "   'Systems, Superficial Musculo-Aponeurotic',\n",
       "   'Systems, Superficial Musculoaponeurotic'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069261': {'ID': 'D000069261',\n",
       "  'name': 'Podossomos[Podosomes]',\n",
       "  'scope': 'Actin-rich adhesive structures found at the ventral surface of metazoan ENDOTHELIAL CELLS. When found  in cultured cancer cells they are referred to as invadopodia. These are matrix-degrading structures composed of an ACTIN CYTOSKELETON core and an INTEGRINS-containing ring complex.',\n",
       "  'terms': ['Invadopodia',\n",
       "   'Invadopodium',\n",
       "   'Invadopodiums',\n",
       "   'Invadosome',\n",
       "   'Invadosomes',\n",
       "   'Podosome',\n",
       "   'Podosomes',\n",
       "   'Podossomos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069262': {'ID': 'D000069262',\n",
       "  'name': 'Placa Plantar[Plantar Plate]',\n",
       "  'scope': 'Fibrocartilaginous ligament at the metatarsophalangeal and the interphalangeal joint of the toe.',\n",
       "  'terms': ['Ligament, Plantar',\n",
       "   'Ligament, Toe Volar',\n",
       "   'Ligamenta Plantaria',\n",
       "   'Ligamenta Plantarias',\n",
       "   'Ligamenta Tarsometatarsea Plantaria',\n",
       "   'Ligamenta Tarsometatarsea Plantarias',\n",
       "   'Ligaments, Plantar',\n",
       "   'Ligaments, Toe Volar',\n",
       "   'Placa Plantar',\n",
       "   'Plantar Ligament',\n",
       "   'Plantar Ligaments',\n",
       "   'Plantar Plate',\n",
       "   'Plantar Plates',\n",
       "   'Plantaria, Ligamenta',\n",
       "   'Plantarias, Ligamenta',\n",
       "   'Plate, Plantar',\n",
       "   'Plate, Toe Volar',\n",
       "   'Plates, Plantar',\n",
       "   'Plates, Toe Volar',\n",
       "   'Tarsometatarsea Plantaria, Ligamenta',\n",
       "   'Toe Volar Ligament',\n",
       "   'Toe Volar Ligaments',\n",
       "   'Toe Volar Plate',\n",
       "   'Toe Volar Plates',\n",
       "   'Volar Ligament, Toe',\n",
       "   'Volar Ligaments, Toe',\n",
       "   'Volar Plate, Toe',\n",
       "   'Volar Plates, Toe'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069263': {'ID': 'D000069263',\n",
       "  'name': 'Fallopia[Fallopia]',\n",
       "  'scope': 'Genus of flowering herbaceous perennial plants and vines in the family Polygonaceae.',\n",
       "  'terms': ['Fallopia', 'Fallopia'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069278': {'ID': 'D000069278',\n",
       "  'name': 'Transposição das Grandes Artérias[Arterial Switch Operation]',\n",
       "  'scope': 'Surgical procedure for anatomical correction of transposed great arteries (e.g., DOUBLE OUTLET RIGHT VENTRICLE).',\n",
       "  'terms': ['Arterial Switch Operation',\n",
       "   'Arterial Switch Operations',\n",
       "   'Arterial Switch Procedure',\n",
       "   'Arterial Switch Procedures',\n",
       "   'Arterial Switch Technique',\n",
       "   'Arterial Switch Techniques',\n",
       "   'Atrial Switch Operation',\n",
       "   'Atrial Switch Operations',\n",
       "   'Atrial Switch Procedure',\n",
       "   'Atrial Switch Procedures',\n",
       "   'Atrial Switch Repair',\n",
       "   'Atrial Switch Repairs',\n",
       "   'Atrial Switch Technique',\n",
       "   'Atrial Switch Techniques',\n",
       "   'Cirurgia de Jatene',\n",
       "   'Cirurgia para a Correção da Transposição das Grandes Artérias',\n",
       "   'Correção Cirúrgica da Transposição das Grandes Artérias',\n",
       "   'Correção de Transposição dos Grandes Vasos',\n",
       "   'Double Switch Operation',\n",
       "   'Double Switch Procedure',\n",
       "   'Double Switch Technique',\n",
       "   'Double-Switch Operation',\n",
       "   'Double-Switch Operations',\n",
       "   'Double-Switch Procedure',\n",
       "   'Double-Switch Procedures',\n",
       "   'Double-Switch Technique',\n",
       "   'Double-Switch Techniques',\n",
       "   'Jatene Operation',\n",
       "   'Jatene Procedure',\n",
       "   'Jatene Technique',\n",
       "   'Mustard Operation',\n",
       "   'Mustard Procedure',\n",
       "   'Mustard Repair',\n",
       "   'Operation, Arterial Switch',\n",
       "   'Operation, Atrial Switch',\n",
       "   'Operation, Double-Switch',\n",
       "   'Operation, Jatene',\n",
       "   'Operation, Mustard',\n",
       "   'Operation, Rastelli',\n",
       "   'Operation, Senning',\n",
       "   'Operations, Arterial Switch',\n",
       "   'Operations, Atrial Switch',\n",
       "   'Operations, Double-Switch',\n",
       "   'Operação de Jatene',\n",
       "   'Operação de Transposição Arterial',\n",
       "   'Procedimento Cirúrgico de Jatene',\n",
       "   'Procedimento de Jatene',\n",
       "   'Procedure, Arterial Switch',\n",
       "   'Procedure, Atrial Switch',\n",
       "   'Procedure, Double-Switch',\n",
       "   'Procedure, Jatene',\n",
       "   'Procedure, Mustard',\n",
       "   'Procedure, Rastelli',\n",
       "   'Procedure, Senning',\n",
       "   'Procedures, Arterial Switch',\n",
       "   'Procedures, Atrial Switch',\n",
       "   'Procedures, Double-Switch',\n",
       "   'Rastelli Operation',\n",
       "   'Rastelli Procedure',\n",
       "   'Rastelli Repair',\n",
       "   'Rastelli Technique',\n",
       "   'Repair, Atrial Switch',\n",
       "   'Repair, Mustard',\n",
       "   'Repair, Rastelli',\n",
       "   'Repairs, Atrial Switch',\n",
       "   'Senning Operation',\n",
       "   'Senning Procedure',\n",
       "   'Technique, Arterial Switch',\n",
       "   'Technique, Atrial Switch',\n",
       "   'Technique, Double-Switch',\n",
       "   'Technique, Jatene',\n",
       "   'Technique, Rastelli',\n",
       "   'Techniques, Arterial Switch',\n",
       "   'Techniques, Atrial Switch',\n",
       "   'Techniques, Double-Switch',\n",
       "   'Transposição das Grandes Artérias'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069279': {'ID': 'D000069279',\n",
       "  'name': 'Epilepsia Resistente a Medicamentos[Drug Resistant Epilepsy]',\n",
       "  'scope': 'Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed.',\n",
       "  'terms': ['Drug Refractory Epilepsies',\n",
       "   'Drug Refractory Epilepsy',\n",
       "   'Drug Resistant Epilepsies',\n",
       "   'Drug Resistant Epilepsy',\n",
       "   'Epilepsia Fármaco-Resistente',\n",
       "   'Epilepsia Resistente a Drogas',\n",
       "   'Epilepsia Resistente a Fármacos',\n",
       "   'Epilepsia Resistente a Medicamentos',\n",
       "   'Epilepsies, Drug Refractory',\n",
       "   'Epilepsies, Drug Resistant',\n",
       "   'Epilepsies, Intractable',\n",
       "   'Epilepsies, Medication Resistant',\n",
       "   'Epilepsies, Refractory',\n",
       "   'Epilepsy, Drug Refractory',\n",
       "   'Epilepsy, Drug Resistant',\n",
       "   'Epilepsy, Intractable',\n",
       "   'Epilepsy, Medication Resistant',\n",
       "   'Epilepsy, Refractory',\n",
       "   'Intractable Epilepsies',\n",
       "   'Intractable Epilepsy',\n",
       "   'Medication Resistant Epilepsies',\n",
       "   'Medication Resistant Epilepsy',\n",
       "   'Refractory Epilepsies',\n",
       "   'Refractory Epilepsies, Drug',\n",
       "   'Refractory Epilepsy',\n",
       "   'Refractory Epilepsy, Drug',\n",
       "   'Resistant Epilepsies, Drug',\n",
       "   'Resistant Epilepsies, Medication',\n",
       "   'Resistant Epilepsy, Drug',\n",
       "   'Resistant Epilepsy, Medication'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069280': {'ID': 'D000069280',\n",
       "  'name': 'Eletrocorticografia[Electrocorticography]',\n",
       "  'scope': 'Recording of brain electrical activities in which the electrodes are placed directly on the CEREBRAL CORTEX.',\n",
       "  'terms': ['ECoG, Extraoperative',\n",
       "   'ECoG, Intraoperative',\n",
       "   'ECoGs, Extraoperative',\n",
       "   'ECoGs, Intraoperative',\n",
       "   'EEG, Intracranial',\n",
       "   'EEGs, Intracranial',\n",
       "   'Electrocorticographies',\n",
       "   'Electrocorticographies (EcoG)',\n",
       "   'Electrocorticographies, Extraoperative',\n",
       "   'Electrocorticographies, Intraoperative',\n",
       "   'Electrocorticography',\n",
       "   'Electrocorticography (EcoG)',\n",
       "   'Electrocorticography, Extraoperative',\n",
       "   'Electrocorticography, Intraoperative',\n",
       "   'Electroencephalographies, Intracranial',\n",
       "   'Electroencephalography, Intracranial',\n",
       "   'Eletrocorticografia',\n",
       "   'Extraoperative ECoG',\n",
       "   'Extraoperative ECoGs',\n",
       "   'Extraoperative Electrocorticographies',\n",
       "   'Extraoperative Electrocorticography',\n",
       "   'Intracranial EEG',\n",
       "   'Intracranial EEGs',\n",
       "   'Intracranial Electroencephalographies',\n",
       "   'Intracranial Electroencephalography',\n",
       "   'Intraoperative ECoG',\n",
       "   'Intraoperative ECoGs',\n",
       "   'Intraoperative Electrocorticographies',\n",
       "   'Intraoperative Electrocorticography'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069281': {'ID': 'D000069281',\n",
       "  'name': 'Hipofisite Autoimune[Autoimmune Hypophysitis]',\n",
       "  'scope': 'Immune-mediated inflammation of the PITUITARY GLAND often associated with other autoimmune diseases (e.g., HASHIMOTO DISEASE; GRAVES DISEASE; and ADDISON DISEASE).',\n",
       "  'terms': ['Adenohypophysitides, Lymphocytic',\n",
       "   'Adenohypophysitis, Lymphocytic',\n",
       "   'Anti PIT 1 Antibody Syndrome',\n",
       "   'Anti-PIT-1 Antibody Syndrome',\n",
       "   'Anti-PIT-1 Antibody Syndromes',\n",
       "   'Antibody Syndrome, Anti-PIT-1',\n",
       "   'Antibody Syndromes, Anti-PIT-1',\n",
       "   'Autoimmune Hypophysitides',\n",
       "   'Autoimmune Hypophysitis',\n",
       "   'Granulomatous Hypophysitides, Idiopathic',\n",
       "   'Granulomatous Hypophysitis, Idiopathic',\n",
       "   'Hipofisite Autoimune',\n",
       "   'Hypophysitides, Autoimmune',\n",
       "   'Hypophysitides, Idiopathic Granulomatous',\n",
       "   'Hypophysitides, IgG4-Related',\n",
       "   'Hypophysitides, Lymphocytic',\n",
       "   'Hypophysitides, Lymphoid',\n",
       "   'Hypophysitis, Autoimmune',\n",
       "   'Hypophysitis, Idiopathic Granulomatous',\n",
       "   'Hypophysitis, IgG4-Related',\n",
       "   'Hypophysitis, Lymphocytic',\n",
       "   'Hypophysitis, Lymphoid',\n",
       "   'Idiopathic Granulomatous Hypophysitides',\n",
       "   'Idiopathic Granulomatous Hypophysitis',\n",
       "   'IgG4 Related Hypophysitis',\n",
       "   'IgG4-Related Hypophysitides',\n",
       "   'IgG4-Related Hypophysitis',\n",
       "   'Infundibuloneurohypophysitides, Lymphocytic',\n",
       "   'Infundibuloneurohypophysitis, Lymphocytic',\n",
       "   'Lymphocytic Adenohypophysitides',\n",
       "   'Lymphocytic Adenohypophysitis',\n",
       "   'Lymphocytic Hypophysitides',\n",
       "   'Lymphocytic Hypophysitis',\n",
       "   'Lymphocytic Infundibuloneurohypophysitides',\n",
       "   'Lymphocytic Infundibuloneurohypophysitis',\n",
       "   'Lymphocytic Panhypophysitides',\n",
       "   'Lymphocytic Panhypophysitis',\n",
       "   'Lymphoid Hypophysitides',\n",
       "   'Lymphoid Hypophysitis',\n",
       "   'Panhypophysitides, Lymphocytic',\n",
       "   'Panhypophysitis, Lymphocytic',\n",
       "   'Syndrome, Anti-PIT-1 Antibody',\n",
       "   'Syndromes, Anti-PIT-1 Antibody'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069282': {'ID': 'D000069282',\n",
       "  'name': 'Canaliculite[Canaliculitis]',\n",
       "  'scope': 'Inflammation and infection of the lacrimal canaliculus area in the LACRIMAL APPARATUS.',\n",
       "  'terms': ['Canaliculite',\n",
       "   'Canaliculite Lacrimal',\n",
       "   'Canaliculitides',\n",
       "   'Canaliculitides, Lacrimal',\n",
       "   'Canaliculitis',\n",
       "   'Canaliculitis, Lacrimal',\n",
       "   'Lacrimal Canaliculitides',\n",
       "   'Lacrimal Canaliculitis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069283': {'ID': 'D000069283',\n",
       "  'name': 'Rituximab[Rituximab]',\n",
       "  'scope': 'A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.',\n",
       "  'terms': ['<i>lotes</i>',\n",
       "   '<i>lotes</i>',\n",
       "   'CD20 Antibody, Rituximab',\n",
       "   'GP2013',\n",
       "   'IDEC C2B8',\n",
       "   'IDEC C2B8 Antibody',\n",
       "   'IDEC-C2B8',\n",
       "   'IDEC-C2B8 Antibody',\n",
       "   'Mabthera',\n",
       "   'Mabthera',\n",
       "   'Rituxan',\n",
       "   'Rituximab',\n",
       "   'Rituximab',\n",
       "   'Rituximab CD20 Antibody',\n",
       "   'Rituximabe'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069284': {'ID': 'D000069284',\n",
       "  'name': 'Sistemas de Translocação de Proteínas[Protein Translocation Systems]',\n",
       "  'scope': 'Multiprotein complexes that carry out protein SECRETION PROCESSES.',\n",
       "  'terms': ['Protein Secretion Systems',\n",
       "   'Protein Translocation Systems',\n",
       "   'Secretion Systems, Protein',\n",
       "   'Sistemas de Translocação Proteica',\n",
       "   'Sistemas de Translocação de Proteínas',\n",
       "   'Systems, Protein Translocation',\n",
       "   'Translocation Systems, Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069285': {'ID': 'D000069285',\n",
       "  'name': 'Infliximab[Infliximab]',\n",
       "  'scope': \"A chimeric monoclonal antibody to TNF ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.\",\n",
       "  'terms': ['<i>infliximab</i>',\n",
       "   '<i>infliximabe</i>',\n",
       "   '<i>infliximabe</i>',\n",
       "   'Infliximab',\n",
       "   'Infliximab',\n",
       "   'Infliximabe',\n",
       "   'MAb cA2',\n",
       "   'Monoclonal Antibody cA2',\n",
       "   'Remicade',\n",
       "   'Remicade',\n",
       "   'cA2, Monoclonal Antibody'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069286': {'ID': 'D000069286',\n",
       "  'name': 'Bortezomib[Bortezomib]',\n",
       "  'scope': 'A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.',\n",
       "  'terms': ['341, PS',\n",
       "   'Bortezomib',\n",
       "   'Bortezomib',\n",
       "   'Bortezomibe',\n",
       "   'LDP 341',\n",
       "   'LDP-341',\n",
       "   'LDP341',\n",
       "   'PS 341',\n",
       "   'PS-341',\n",
       "   'PS341',\n",
       "   'Velcade',\n",
       "   'Velcade'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069287': {'ID': 'D000069287',\n",
       "  'name': 'Capecitabina[Capecitabine]',\n",
       "  'scope': 'A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.',\n",
       "  'terms': ['<i>capecitabina</i>',\n",
       "   '<i>capecitabina</i>',\n",
       "   '<i>xeloda</i>',\n",
       "   'Capecitabina',\n",
       "   'Capecitabine',\n",
       "   \"N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine\",\n",
       "   'Xeloda',\n",
       "   'Xeloda'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069289': {'ID': 'D000069289',\n",
       "  'name': 'Encistamento de Parasitas[Parasite Encystment]',\n",
       "  'scope': 'Process by which certain parasites such as GIARDIA and ENTAMOEBA convert from the TROPHOZOITE to SCHIZONT when exposed to stress.',\n",
       "  'terms': ['Encistamento Parasitário',\n",
       "   'Encistamento de Parasitas',\n",
       "   'Encistamento de Parasitos',\n",
       "   'Encistamento do Parasita',\n",
       "   'Encistamento do Parasito',\n",
       "   'Encysment, Protozoan Parasite',\n",
       "   'Encysments, Protozoan Parasite',\n",
       "   'Encystation, Parasite',\n",
       "   'Encystation, Protozoan',\n",
       "   'Encystation, Protozoan Parasite',\n",
       "   'Encystations, Parasite',\n",
       "   'Encystations, Protozoan',\n",
       "   'Encystations, Protozoan Parasite',\n",
       "   'Encystment, Parasite',\n",
       "   'Encystment, Protozoan',\n",
       "   'Encystments, Parasite',\n",
       "   'Encystments, Protozoan',\n",
       "   'Parasite Encysment, Protozoan',\n",
       "   'Parasite Encysments, Protozoan',\n",
       "   'Parasite Encystation',\n",
       "   'Parasite Encystation, Protozoan',\n",
       "   'Parasite Encystations',\n",
       "   'Parasite Encystations, Protozoan',\n",
       "   'Parasite Encystment',\n",
       "   'Parasite Encystments',\n",
       "   'Protozoan Encystation',\n",
       "   'Protozoan Encystations',\n",
       "   'Protozoan Encystment',\n",
       "   'Protozoan Encystments',\n",
       "   'Protozoan Parasite Encysment',\n",
       "   'Protozoan Parasite Encysments',\n",
       "   'Protozoan Parasite Encystation',\n",
       "   'Protozoan Parasite Encystations'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069290': {'ID': 'D000069290',\n",
       "  'name': 'Hérnia Incisional[Incisional Hernia]',\n",
       "  'scope': 'Protrusion of tissue at or near the site of an incision from a previous surgery.',\n",
       "  'terms': ['Hernia, Incisional',\n",
       "   'Hernia, Postoperative',\n",
       "   'Hernias, Incisional',\n",
       "   'Hernias, Postoperative',\n",
       "   'Hérnia Incisional',\n",
       "   'Incisional Hernia',\n",
       "   'Incisional Hernias',\n",
       "   'Postoperative Hernia',\n",
       "   'Postoperative Hernias'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069292': {'ID': 'D000069292',\n",
       "  'name': 'Piroptose[Pyroptosis]',\n",
       "  'scope': 'Type of programmed cell death associated with infection by intracellular pathogens. It is characterized by INFLAMMASOME formation; activation of CASPASE 1; and CYTOKINES mediated inflammation.',\n",
       "  'terms': ['Apoptoses, Inflammatory',\n",
       "   'Apoptosis, Inflammatory',\n",
       "   'Caspase 1 Dependent Cell Death',\n",
       "   'Caspase-1 Dependent Cell Death',\n",
       "   'Cell Death, Pyroptotic',\n",
       "   'Cell Deaths, Pyroptotic',\n",
       "   'Death, Pyroptotic Cell',\n",
       "   'Deaths, Pyroptotic Cell',\n",
       "   'Inflammatory Apoptoses',\n",
       "   'Inflammatory Apoptosis',\n",
       "   'Piroptose',\n",
       "   'Pyroptoses',\n",
       "   'Pyroptosis',\n",
       "   'Pyroptotic Cell Death',\n",
       "   'Pyroptotic Cell Deaths'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069293': {'ID': 'D000069293',\n",
       "  'name': 'Linfoma Plasmablástico[Plasmablastic Lymphoma]',\n",
       "  'scope': 'Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.',\n",
       "  'terms': ['Linfoma Plasmablástico',\n",
       "   'Lymphoma, Plasmablastic',\n",
       "   'Lymphomas, Plasmablastic',\n",
       "   'Plasmablastic Diffuse Large B cell Lymphoma',\n",
       "   'Plasmablastic Diffuse Large B-cell Lymphoma',\n",
       "   'Plasmablastic Lymphoma',\n",
       "   'Plasmablastic Lymphomas',\n",
       "   'Plasmablasts Diffuse Large B cell Lymphoma',\n",
       "   'Plasmablasts Diffuse Large B-cell Lymphoma'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069294': {'ID': 'D000069294',\n",
       "  'name': 'Sistema de Translocação de Argininas Geminadas[Twin-Arginine-Translocation System]',\n",
       "  'scope': 'Protein translocase in BACTERIA or CHLOROPLASTS that exports or secretes folded proteins. In GRAM-NEGATIVE BACTERIA, twin-arginine translocase (TAT) is involved in the export of folded proteins to the PERIPLASM. In chloroplasts, TAT is involved in transporting folded proteins across the membranes of THYLAKOIDS.',\n",
       "  'terms': ['Secretion Systems, TAT',\n",
       "   'Sistema Dependente de TAT',\n",
       "   'Sistema de Translocação Dependente de Argininas Gêmeas',\n",
       "   'Sistema de Translocação Dependente de Dupla Arginina',\n",
       "   'Sistema de Translocação Dependente de duas Argininas Geminadas',\n",
       "   'Sistema de Translocação Dependente de uma Dupla Arginina',\n",
       "   'Sistema de Translocação de Argininas Consecutivas',\n",
       "   'Sistema de Translocação de Argininas Geminadas',\n",
       "   'System, Twin-Arginine-Transport',\n",
       "   'Systems, TAT Secretion',\n",
       "   'Systems, Twin-Arginine-Translocation',\n",
       "   'TAT Secretion Systems',\n",
       "   'Twin Arginine Translocation System',\n",
       "   'Twin Arginine Translocation Systems',\n",
       "   'Twin Arginine Transport System',\n",
       "   'Twin-Arginine-Translocation System',\n",
       "   'Twin-Arginine-Translocation Systems',\n",
       "   'Twin-Arginine-Transport System'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069295': {'ID': 'D000069295',\n",
       "  'name': 'Carcinoma Secretor Análogo ao Mamário[Mammary Analogue Secretory Carcinoma]',\n",
       "  'scope': 'A malignant neoplasm of epithelial cells of the SALIVARY GLANDS, with microcystic architecture, low-grade nuclei, and granular vacuolated cytoplasm.',\n",
       "  'terms': ['Carcinoma Secretor Análogo ao Mamário',\n",
       "   'Mammary Analogue Secretory Carcinoma'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069296': {'ID': 'D000069296',\n",
       "  'name': 'Sistemas de Secreção Tipo III[Type III Secretion Systems]',\n",
       "  'scope': 'Multiprotein transmembrane complexes in GRAM-NEGATIVE BACTERIA involved in either the secretion of effector proteins from the bacterial cytoplasm into host cells, or the secretion and assembly of flagellar components. The major component of the T3SSs is called the injectosome or needle complex.',\n",
       "  'terms': ['Bacterial Secretion System, Type III',\n",
       "   'Secretion System, T3SS',\n",
       "   'Sistemas de Secreção Tipo III',\n",
       "   'System, T3SS Secretion',\n",
       "   'T3SS Secretion System',\n",
       "   'Type 3 Secretion System',\n",
       "   'Type 3 Secretion Systems',\n",
       "   'Type III Secretion System',\n",
       "   'Type III Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069316': {'ID': 'D000069316',\n",
       "  'name': 'Acne Conglobata[Acne Conglobata]',\n",
       "  'scope': 'Severe and chronic form of acne characterized by large, burrowing abscesses associated with disfigurement.',\n",
       "  'terms': ['Acne Conglobata',\n",
       "   'Acne Conglobata',\n",
       "   'Acne Conglobatas',\n",
       "   'Conglobata, Acne',\n",
       "   'Conglobatas, Acne'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069319': {'ID': 'D000069319',\n",
       "  'name': 'Sistemas de Secreção Tipo IV[Type IV Secretion Systems]',\n",
       "  'scope': 'Multiprotein complexes that transport single proteins, multiprotein complexes, and nucleoprotein complexes from the CYTOPLASM into the EXTRACELLULAR SPACE or into recipient cells. T4SSs are found in GRAM-NEGATIVE BACTERIA, while homologous components to T4SSs are found in GRAM-POSTIVE BACTERIA.',\n",
       "  'terms': ['Bacterial Secretion System, Type IV',\n",
       "   'Bacterial Secretion Systems, Type IV',\n",
       "   'Secretion System, T4SS',\n",
       "   'Sistemas de Secreção Tipo IV',\n",
       "   'System, T4SS Secretion',\n",
       "   'T4SS Secretion System',\n",
       "   'Type 4 Secretion System',\n",
       "   'Type 4 Secretion Systems',\n",
       "   'Type IV Secretion System',\n",
       "   'Type IV Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069320': {'ID': 'D000069320',\n",
       "  'name': 'Sistemas de Secreção Tipo V[Type V Secretion Systems]',\n",
       "  'scope': 'Subtypes of type V secretion systems that contain both a translocator domain and a passenger domain in a single polypeptide. After the passenger domain is transported to the extracellular millieu it is cleaved off as the mature secreted protein.',\n",
       "  'terms': ['Autotransporters',\n",
       "   'Bacterial Secretion System, Type V',\n",
       "   'Secretion Systems, Two-Partner',\n",
       "   'Sistemas de Secreção Tipo V',\n",
       "   'Systems, Two-Partner Secretion',\n",
       "   'Two Partner Secretion Systems',\n",
       "   'Two-Partner Secretion Systems',\n",
       "   'Type 5 Secretion System',\n",
       "   'Type 5 Secretion Systems',\n",
       "   'Type V Secretion System',\n",
       "   'Type V Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069321': {'ID': 'D000069321',\n",
       "  'name': 'Terapia de Substituição Mitocondrial[Mitochondrial Replacement Therapy]',\n",
       "  'scope': 'In vitro fertilization technique that uses mitochondrial DNA from a healthy donor in order to prevent the transmission of MITOCHONDRIAL DISEASE.',\n",
       "  'terms': ['Mitochondrial Replacement Therapies',\n",
       "   'Mitochondrial Replacement Therapy',\n",
       "   'Pronuclear Transfer Technique',\n",
       "   'Pronuclear Transfer Techniques',\n",
       "   'Replacement Therapies, Mitochondrial',\n",
       "   'Replacement Therapy, Mitochondrial',\n",
       "   'Spindle Transfer Technique',\n",
       "   'Spindle Transfer Techniques',\n",
       "   'Technique, Pronuclear Transfer',\n",
       "   'Technique, Spindle Transfer',\n",
       "   'Techniques, Pronuclear Transfer',\n",
       "   'Techniques, Spindle Transfer',\n",
       "   'Terapia de Reposição Mitocondrial',\n",
       "   'Terapia de Substituição Mitocondrial',\n",
       "   'Terapia de Substituição de Mitocôndrias',\n",
       "   'Therapies, Mitochondrial Replacement',\n",
       "   'Therapy, Mitochondrial Replacement',\n",
       "   'Transfer Technique, Pronuclear',\n",
       "   'Transfer Technique, Spindle',\n",
       "   'Transfer Techniques, Pronuclear',\n",
       "   'Transfer Techniques, Spindle'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069322': {'ID': 'D000069322',\n",
       "  'name': 'Stents Metálicos Autoexpansíveis[Self Expandable Metallic Stents]',\n",
       "  'scope': 'Cylindrical metallic tubes that are inserted to hold open a structure in order to treat vascular, bile duct, esophageal and other tubular organ constrictions.',\n",
       "  'terms': ['Self Expandable Metal Stent',\n",
       "   'Self Expandable Metal Stents',\n",
       "   'Self Expandable Metallic Stent',\n",
       "   'Self Expandable Metallic Stents',\n",
       "   'Stents Metálicos Autoexpansíveis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069336': {'ID': 'D000069336',\n",
       "  'name': 'Acoplamento Neurovascular[Neurovascular Coupling]',\n",
       "  'scope': 'Mechanism by which changes in neural activity are tightly associated with regional cortical HEMODYNAMICS and metabolism changes. The association is often inferred from NEUROIMAGING signals (e.g., fMRI; or NIR SPECTROSCOPY).',\n",
       "  'terms': ['Acoplamento Neurovascular',\n",
       "   'Brain Response, Hemodynamic',\n",
       "   'Brain Responses, Hemodynamic',\n",
       "   'Cortical Hemodynamic Response',\n",
       "   'Cortical Hemodynamic Responses',\n",
       "   'Coupling, Neurovascular',\n",
       "   'Couplings, Neurovascular',\n",
       "   'Hemodynamic Brain Response',\n",
       "   'Hemodynamic Brain Responses',\n",
       "   'Hemodynamic Response, Cortical',\n",
       "   'Hemodynamic Responses, Cortical',\n",
       "   'Neurovascular Coupling',\n",
       "   'Neurovascular Couplings',\n",
       "   'Response, Cortical Hemodynamic',\n",
       "   'Response, Hemodynamic Brain',\n",
       "   'Responses, Cortical Hemodynamic',\n",
       "   'Responses, Hemodynamic Brain',\n",
       "   'Resposta Hemodinâmica Cortical'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069337': {'ID': 'D000069337',\n",
       "  'name': 'Rim Fundido[Fused Kidney]',\n",
       "  'scope': 'Congenital fusion of two kidneys in the lower midline.',\n",
       "  'terms': ['Cake Kidney',\n",
       "   'Cake Kidneys',\n",
       "   'Congenital Fusion of Kidneys',\n",
       "   'Congenital Lobulation of Kidneys',\n",
       "   'Crossed Fused Ectopia',\n",
       "   'Crossed Fused Ectopia of Kidneys',\n",
       "   'Crossed Fused Ectopias',\n",
       "   'Fused Kidney',\n",
       "   'Fused Kidneys',\n",
       "   'Fusion of Kidney',\n",
       "   'Fusion, Renal',\n",
       "   'Fusions, Renal',\n",
       "   'Fusão Renal',\n",
       "   'Horseshoe Kidney',\n",
       "   'Horseshoe Kidneys',\n",
       "   'Kidney Fusion',\n",
       "   'Kidney Fusions',\n",
       "   'Kidney Lobulation',\n",
       "   'Kidney Lobulations',\n",
       "   'Kidney, Cake',\n",
       "   'Kidney, Fused',\n",
       "   'Kidney, Horseshoe',\n",
       "   'Kidney, Lobulated',\n",
       "   'Kidneys, Cake',\n",
       "   'Kidneys, Fused',\n",
       "   'Kidneys, Horseshoe',\n",
       "   'Kidneys, Lobulated',\n",
       "   'Lobulated Kidney',\n",
       "   'Lobulated Kidneys',\n",
       "   'Lobulation of Kidney',\n",
       "   'Pelvic Cake Kidney',\n",
       "   'Pelvic Cake Kidneys',\n",
       "   'Renal Fusion',\n",
       "   'Renal Fusions',\n",
       "   'Rim Fundido',\n",
       "   'Rim Fusionado',\n",
       "   'Rins Fundidos',\n",
       "   'Rins Fusionados'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069338': {'ID': 'D000069338',\n",
       "  'name': 'Neuropatologia[Neuropathology]',\n",
       "  'scope': 'The branch of medicine and biomedical science concerned with diseases of the nervous system.',\n",
       "  'terms': ['Neuropathologies',\n",
       "   'Neuropathologist',\n",
       "   'Neuropathologists',\n",
       "   'Neuropathology',\n",
       "   'Neuropatologia'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069339': {'ID': 'D000069339',\n",
       "  'name': 'Traquelectomia[Trachelectomy]',\n",
       "  'scope': 'Surgical removal or resection of the CERVIX UTERI.',\n",
       "  'terms': ['<i>leep</i>',\n",
       "   '<i>nicii</i>',\n",
       "   'Cervicectomies',\n",
       "   'Cervicectomies, Vaginal',\n",
       "   'Cervicectomy',\n",
       "   'Cervicectomy, Vaginal',\n",
       "   'Trachelectomies',\n",
       "   'Trachelectomies, Vaginal',\n",
       "   'Trachelectomy',\n",
       "   'Trachelectomy, Vaginal',\n",
       "   'Traquelectomia',\n",
       "   'Vaginal Cervicectomies',\n",
       "   'Vaginal Cervicectomy',\n",
       "   'Vaginal Trachelectomies',\n",
       "   'Vaginal Trachelectomy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069340': {'ID': 'D000069340',\n",
       "  'name': 'Desprescrições[Deprescriptions]',\n",
       "  'scope': 'Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.',\n",
       "  'terms': ['Deprescribing',\n",
       "   'Deprescription',\n",
       "   'Deprescriptions',\n",
       "   'Deprescrição',\n",
       "   'Deprescrições',\n",
       "   'Desprescrição',\n",
       "   'Desprescrições'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069341': {'ID': 'D000069341',\n",
       "  'name': 'Cuidado Transicional[Transitional Care]',\n",
       "  'scope': 'Health care provided during a transition to a different mode of care (e.g., TRANSITION TO ADULT CARE).',\n",
       "  'terms': ['Care, Transitional',\n",
       "   'Cares, Transitional',\n",
       "   'Cuidado Transicional',\n",
       "   'Cuidado de Transição',\n",
       "   'Cuidados de Transição',\n",
       "   'Transition Care',\n",
       "   'Transition Cares',\n",
       "   'Transitional Care',\n",
       "   'Transitional Cares',\n",
       "   'Tratamento Transicional',\n",
       "   'Tratamento de Transição'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069342': {'ID': 'D000069342',\n",
       "  'name': 'Sobremedicalização[Medical Overuse]',\n",
       "  'scope': 'Excessive or unnecessary utilization of health services by patients or physicians.',\n",
       "  'terms': ['Atendimento Médico não Desejado',\n",
       "   'Atendimentos Médicos não Desejados',\n",
       "   'Atenção Médica não Desejada',\n",
       "   'Cuidados Médicos não Desejados',\n",
       "   'Diagnósticos Errados do Médico',\n",
       "   'Diagnósticos Médicos Errados',\n",
       "   'Erro de Diagnóstico Escolhido pelo Médico',\n",
       "   'Erro de Diagnóstico Médico',\n",
       "   'Erro de Diagnóstico Médico Apresentado',\n",
       "   'Erro de Diagnóstico Médico Escolhido',\n",
       "   'Erro de Opção Diagnóstica Médica',\n",
       "   'Erro do Diagnóstico Médico',\n",
       "   'Erro no Diagnóstico',\n",
       "   'Erro no Diagnóstico Apresentado',\n",
       "   'Erro no Diagnóstico Escolhido',\n",
       "   'Erro no Diagnóstico Médico Apresentado',\n",
       "   'Erros nos Diagnósticos',\n",
       "   'Erros nos Diagnósticos Apresentados',\n",
       "   'Erros nos Diagnósticos Escolhidos',\n",
       "   'Health Services Overuse',\n",
       "   'Health Services Overuses',\n",
       "   'Health Services Overutilization',\n",
       "   'Medical Care, Unwanted',\n",
       "   'Medical Cares, Unwanted',\n",
       "   'Medical Overuse',\n",
       "   'Medical Overuses',\n",
       "   'Medical Preference Misdiagnoses',\n",
       "   'Medical Preference Misdiagnosis',\n",
       "   'Misdiagnoses, Medical Preference',\n",
       "   'Misdiagnoses, Preference',\n",
       "   'Misdiagnosis, Medical Preference',\n",
       "   'Misdiagnosis, Preference',\n",
       "   'Overdiagnoses',\n",
       "   'Overdiagnosis',\n",
       "   'Overmedication',\n",
       "   'Overmedications',\n",
       "   'Overtreatment',\n",
       "   'Overtreatments',\n",
       "   'Overuse, Health Services',\n",
       "   'Overuse, Medical',\n",
       "   'Overuses, Health Services',\n",
       "   'Overuses, Medical',\n",
       "   'Overutilization of Health Services',\n",
       "   'Overutilization, Health Services',\n",
       "   'Preference Misdiagnoses',\n",
       "   'Preference Misdiagnoses, Medical',\n",
       "   'Preference Misdiagnosis',\n",
       "   'Preference Misdiagnosis, Medical',\n",
       "   'Sobrediagnóstico',\n",
       "   'Sobrediagnósticos',\n",
       "   'Sobremedicalização',\n",
       "   'Sobretratamento',\n",
       "   'Sobretratamentos',\n",
       "   'Sobreuso da Medicina',\n",
       "   'Sobreuso de Serviço de Saúde',\n",
       "   'Sobreuso de Serviços Médicos',\n",
       "   'Sobreuso de Serviços de Saúde',\n",
       "   'Sobreuso do Serviço de Saúde',\n",
       "   'Sobreuso dos Serviços de Saúde',\n",
       "   'Sobreusos da Medicina',\n",
       "   'Sobreutilização da Medicina',\n",
       "   'Sobreutilização de Serviços de Saúde',\n",
       "   'Sobreutilizações da Medicina',\n",
       "   'Unwanted Medical Care',\n",
       "   'Unwanted Medical Cares',\n",
       "   'Uso Desnecessário de Produtos de Saúde',\n",
       "   'Uso Desnecessário de Produtos e Serviços de Saúde',\n",
       "   'Uso Desnecessário de Serviços de Saúde',\n",
       "   'Uso Exagerado de Serviço de Saúde',\n",
       "   'Uso Exagerado do Serviço de Saúde',\n",
       "   'Uso Excessivo da Medicina',\n",
       "   'Uso Excessivo de Produtos de Saúde',\n",
       "   'Uso Excessivo de Produtos e Serviços Médicos',\n",
       "   'Uso Excessivo de Produtos e Serviços da Medicina',\n",
       "   'Uso Excessivo de Produtos e Serviços de Saúde',\n",
       "   'Uso Excessivo de Serviço de Saúde',\n",
       "   'Uso Excessivo de Serviços Médicos',\n",
       "   'Uso Excessivo de Serviços de Saúde',\n",
       "   'Uso Excessivo do Serviço de Saúde',\n",
       "   'Uso Excessivo dos Serviços de Saúde',\n",
       "   'Usos Exagerados da Medicina',\n",
       "   'Usos Excessivos da Medicina',\n",
       "   'Utilização Excessiva dos Serviços de Saúde'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069343': {'ID': 'D000069343',\n",
       "  'name': 'Interface Osso-Implante[Bone-Implant Interface]',\n",
       "  'scope': 'Region of interaction between the bone and PROSTHESES AND IMPLANTS which becomes bonded through cellular and extracellular interactions similar to OSSEOINTEGRATION.',\n",
       "  'terms': ['Bone Implant Interface',\n",
       "   'Bone Prosthesis Interface',\n",
       "   'Bone-Implant Interface',\n",
       "   'Bone-Implant Interfaces',\n",
       "   'Bone-Prosthesis Interface',\n",
       "   'Bone-Prosthesis Interfaces',\n",
       "   'Interface Osso-Implante',\n",
       "   'Interface, Bone-Implant',\n",
       "   'Interface, Bone-Prosthesis',\n",
       "   'Interfaces, Bone-Implant',\n",
       "   'Interfaces, Bone-Prosthesis'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069347': {'ID': 'D000069347',\n",
       "  'name': 'Cloridrato de Erlotinib[Erlotinib Hydrochloride]',\n",
       "  'scope': 'A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.',\n",
       "  'terms': ['11C erlotinib',\n",
       "   '11C-erlotinib',\n",
       "   '358,774, CP',\n",
       "   '358774, CP',\n",
       "   'CP 358,774',\n",
       "   'CP 358774',\n",
       "   'CP-358,774',\n",
       "   'CP-358774',\n",
       "   'CP358,774',\n",
       "   'CP358774',\n",
       "   'Cloridrato de Erlotinib',\n",
       "   'Cloridrato de Erlotinibe',\n",
       "   'Erlotinib',\n",
       "   'Erlotinib HCl',\n",
       "   'Erlotinib Hydrochloride',\n",
       "   'HCl, Erlotinib',\n",
       "   'Hidrocloreto de Erlotinib',\n",
       "   'Hidrocloreto de Erlotinibe',\n",
       "   'Hydrochloride, Erlotinib',\n",
       "   'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine',\n",
       "   'OSI 774',\n",
       "   'OSI-774',\n",
       "   'OSI774',\n",
       "   'Tarceva',\n",
       "   'Tarceva'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069348': {'ID': 'D000069348',\n",
       "  'name': 'Fumarato de Quetiapina[Quetiapine Fumarate]',\n",
       "  'scope': 'A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.',\n",
       "  'terms': ['2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol',\n",
       "   '204,636, ICI',\n",
       "   '204636, ICI',\n",
       "   'Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)',\n",
       "   'Fumarate, Quetiapine',\n",
       "   'Fumarato de Quetiapina',\n",
       "   'ICI 204,636',\n",
       "   'ICI 204636',\n",
       "   'ICI-204636',\n",
       "   'ICI204636',\n",
       "   'Quetiapine',\n",
       "   'Quetiapine Fumarate',\n",
       "   'Seroquel',\n",
       "   'Seroquel'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069349': {'ID': 'D000069349',\n",
       "  'name': 'Linezolida[Linezolid]',\n",
       "  'scope': 'An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract.',\n",
       "  'terms': ['100766, U',\n",
       "   '<i>amicacina</i>',\n",
       "   '<i>ceftazidima</i>',\n",
       "   '<i>meropenem</i>',\n",
       "   '<i>meropenen</i>',\n",
       "   '<i>micafungina</i>',\n",
       "   '<i>tigeciclina</i>',\n",
       "   '<i>vancomicina</i>',\n",
       "   'Linezolid',\n",
       "   'Linezolida',\n",
       "   'Linezolide',\n",
       "   'N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide',\n",
       "   'PNU 100766',\n",
       "   'PNU-100766',\n",
       "   'PNU100766',\n",
       "   'U 100766',\n",
       "   'U-100766',\n",
       "   'U100766',\n",
       "   'Zyvox',\n",
       "   'Zyvox'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069350': {'ID': 'D000069350',\n",
       "  'name': 'Telerreabilitação[Telerehabilitation]',\n",
       "  'scope': 'Delivery of therapeutic rehabilitation at a distance or offsite using telecommunication technologies.',\n",
       "  'terms': ['Reabilitação à Distância',\n",
       "   'Rehabilitation, Remote',\n",
       "   'Rehabilitation, Virtual',\n",
       "   'Rehabilitations, Remote',\n",
       "   'Rehabilitations, Virtual',\n",
       "   'Remote Rehabilitation',\n",
       "   'Remote Rehabilitations',\n",
       "   'Tele rehabilitation',\n",
       "   'Tele-rehabilitation',\n",
       "   'Tele-rehabilitations',\n",
       "   'Telerehabilitation',\n",
       "   'Telerehabilitations',\n",
       "   'Telerreabilitação',\n",
       "   'Virtual Rehabilitation',\n",
       "   'Virtual Rehabilitations'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069356': {'ID': 'D000069356',\n",
       "  'name': 'Timpanocentese[Tympanocentesis]',\n",
       "  'scope': 'Needle aspiration of fluid from the MIDDLE EAR through a puncture in the TYMPANIC MEMBRANE.',\n",
       "  'terms': ['Timpanocentese', 'Tympanocenteses', 'Tympanocentesis'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069376': {'ID': 'D000069376',\n",
       "  'name': 'Sistemas de Secreção Tipo VI[Type VI Secretion Systems]',\n",
       "  'scope': 'Multiprotein complexes in GRAM NEGATIVE BACTERIA that deliver effector proteins into eukaryotic or prokaryotic cells by a mechanism similar to the contractile tail of bacteriophages. They are composed of a cell envelope-spanning tube which is surrounded by a contractile sheath and tipped by a cell puncturing complex; a base plate structure that anchors the assembly to the cell envelope; and an ATPase involved in the sheath contraction and disassembly of the complex.',\n",
       "  'terms': ['Bacterial Secretion System, Type VI',\n",
       "   'Secretion Systems, T6SS',\n",
       "   'Sistemas de Secreção Tipo VI',\n",
       "   'Systems, T6SS Secretion',\n",
       "   'T6SS Secretion Systems',\n",
       "   'Type 6 Secretion System',\n",
       "   'Type 6 Secretion Systems',\n",
       "   'Type VI Secretion System',\n",
       "   'Type VI Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069377': {'ID': 'D000069377',\n",
       "  'name': 'Sistemas de Secreção Tipo VII[Type VII Secretion Systems]',\n",
       "  'scope': 'Bacterial secretion systems found in bacteria that have a MYCOLIC ACID-containing outer membrane such as MYCOBACTERIACEAE; Corynebacteriaceae; and NOCARDIACEAE. These are also known as ESX secretion systems because the first to be discovered is involved in secreting major virulence factors EsxA and EsxB. There are several subtypes of T7SSs including ESX-1, ESX-2, ESX-3, ESX-4, and ESX-5 secretion systems. The subtypes share some core components including an inner membrane channel-forming ATPase complex, a membrane-anchored mycosin, and a second channel that spans the outer mycolic acid-containing membrane.',\n",
       "  'terms': ['ESX Secretion Systems',\n",
       "   'Secretion System, T7SS',\n",
       "   'Secretion Systems, ESX',\n",
       "   'Secretion Systems, Type 7',\n",
       "   'Secretion Systems, Type VII',\n",
       "   'Sistemas de Secreção Tipo VII',\n",
       "   'System, T7SS Secretion',\n",
       "   'Systems, ESX Secretion',\n",
       "   'T7SS Secretion System',\n",
       "   'Type 7 Secretion Systems',\n",
       "   'Type VII Secretion Systems'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069396': {'ID': 'D000069396',\n",
       "  'name': 'Ribossomos Mitocondriais[Mitochondrial Ribosomes]',\n",
       "  'scope': 'Multicomponent ribonucleoprotein structures contained in MITOCHONDRIA that specialize in the PROTEIN BIOSYNTHESIS of a small number of proteins involved in energy production for the cell.',\n",
       "  'terms': ['Mitochondrial Ribosome',\n",
       "   'Mitochondrial Ribosomes',\n",
       "   'Mitoribosome',\n",
       "   'Mitoribosomes',\n",
       "   'Ribosome, Mitochondrial',\n",
       "   'Ribosomes, Mitochondrial',\n",
       "   'Ribossomos Mitocondriais'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069416': {'ID': 'D000069416',\n",
       "  'name': 'Microscopia Intravital[Intravital Microscopy]',\n",
       "  'scope': 'Type of microscopy used to study biological systems at high resolution.',\n",
       "  'terms': ['Imagem Intravital',\n",
       "   'Imaging, Intravital',\n",
       "   'In Vivo Microscopy',\n",
       "   'Intravital Imaging',\n",
       "   'Intravital Microscopy',\n",
       "   'Microscopia Intravital',\n",
       "   'Microscopy, In Vivo',\n",
       "   'Microscopy, Intravital'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069436': {'ID': 'D000069436',\n",
       "  'name': 'Fenômenos Toxicológicos[Toxicological Phenomena]',\n",
       "  'scope': 'The nature and effects of chemical, physical or biological poisons on living organisms.',\n",
       "  'terms': ['Concept, Toxicological',\n",
       "   'Concepts, Toxicological',\n",
       "   'Fenômeno Toxicológico',\n",
       "   'Fenômenos Toxicológicos',\n",
       "   'Phenomena, Toxicologic',\n",
       "   'Phenomena, Toxicological',\n",
       "   'Phenomenon, Toxicologic',\n",
       "   'Phenomenon, Toxicological',\n",
       "   'Toxicologic Phenomena',\n",
       "   'Toxicologic Phenomenon',\n",
       "   'Toxicological Concept',\n",
       "   'Toxicological Concepts',\n",
       "   'Toxicological Phenomena',\n",
       "   'Toxicological Phenomenon'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069437': {'ID': 'D000069437',\n",
       "  'name': 'Fenômenos Farmacológicos[Pharmacological Phenomena]',\n",
       "  'scope': 'The metabolism of drugs and their mechanisms of action.',\n",
       "  'terms': ['Conceito Farmacológico',\n",
       "   'Conceitos Farmacológicos',\n",
       "   'Concept, Pharmacological',\n",
       "   'Concepts, Pharmacological',\n",
       "   'Fenômeno Farmacológico',\n",
       "   'Fenômenos Farmacológicos',\n",
       "   'Pharmacologic Phenomena',\n",
       "   'Pharmacologic Phenomenon',\n",
       "   'Pharmacologic Process',\n",
       "   'Pharmacologic Processes',\n",
       "   'Pharmacological Concept',\n",
       "   'Pharmacological Concepts',\n",
       "   'Pharmacological Phenomena',\n",
       "   'Pharmacological Phenomenon',\n",
       "   'Pharmacological Processes',\n",
       "   'Phenomena, Pharmacologic',\n",
       "   'Phenomena, Pharmacological',\n",
       "   'Phenomenon, Pharmacologic',\n",
       "   'Phenomenon, Pharmacological',\n",
       "   'Process, Pharmacologic',\n",
       "   'Processes, Pharmacologic',\n",
       "   'Processes, Pharmacological',\n",
       "   'Processo Farmacológico',\n",
       "   'Processos Farmacológicos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069438': {'ID': 'D000069438',\n",
       "  'name': 'Ezetimiba[Ezetimibe]',\n",
       "  'scope': 'An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.',\n",
       "  'terms': ['(1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)',\n",
       "   '58235, SCH',\n",
       "   'Ezetimib',\n",
       "   'Ezetimiba',\n",
       "   'Ezetimibe',\n",
       "   'Ezetrol',\n",
       "   'SCH 58235',\n",
       "   'SCH-58235',\n",
       "   'SCH58235',\n",
       "   'Zetia',\n",
       "   'Zetia'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069439': {'ID': 'D000069439',\n",
       "  'name': 'Dasatinibe[Dasatinib]',\n",
       "  'scope': 'A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.',\n",
       "  'terms': ['(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide',\n",
       "   '354825, BMS',\n",
       "   'BMS 354825',\n",
       "   'BMS-354825',\n",
       "   'BMS354825',\n",
       "   'Dasatinib',\n",
       "   'Dasatinibe',\n",
       "   'N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide',\n",
       "   'Sprycel',\n",
       "   'Sprycel'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069442': {'ID': 'D000069442',\n",
       "  'name': 'Natalizumab[Natalizumab]',\n",
       "  'scope': \"A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE.\",\n",
       "  'terms': ['Antegren',\n",
       "   'Natalizumab',\n",
       "   'Natalizumab',\n",
       "   'Natalizumabe',\n",
       "   'Tysabri',\n",
       "   'Tysabri'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069443': {'ID': 'D000069443',\n",
       "  'name': 'Vacina Pneumocócica Conjugada Heptavalente[Heptavalent Pneumococcal Conjugate Vaccine]',\n",
       "  'scope': 'A pneumococcal vaccine which contains 7 pneumococcal serotypes (6B, 14, 19F, 23F, 18C, 4, 9V), each conjugated individually to the outer membrane protein complex of NEISSERIA MENINGITIDIS.',\n",
       "  'terms': ['7 valent PncOMPC vaccine',\n",
       "   '7-valent PncOMPC vaccine',\n",
       "   'Heptavalent Pneumococcal Conjugate Vaccine',\n",
       "   'PCV7 vaccine',\n",
       "   'PNCRM7',\n",
       "   'PncOMPC vaccine, 7-valent',\n",
       "   'Prevenar',\n",
       "   'Prevnar',\n",
       "   'Seven Valent Pneumococcal PS Meningococcal OMPC Conjugate Vaccine',\n",
       "   'Seven-Valent Pneumococcal PS-Meningococcal OMPC Conjugate Vaccine',\n",
       "   'Vacina Pneumocócica Conjugada Heptavalente',\n",
       "   'Vacina Pneumocócica Heptavalente Conjugada'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069444': {'ID': 'D000069444',\n",
       "  'name': 'Omalizumab[Omalizumab]',\n",
       "  'scope': 'An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.',\n",
       "  'terms': ['Omalizumab', 'Omalizumab', 'Omalizumabe', 'Xolair', 'Xolair'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069445': {'ID': 'D000069445',\n",
       "  'name': 'Cloridrato de Atomoxetina[Atomoxetine Hydrochloride]',\n",
       "  'scope': 'A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.',\n",
       "  'terms': ['139603, LY',\n",
       "   'Atomoxetine',\n",
       "   'Atomoxetine HCl',\n",
       "   'Atomoxetine Hydrochloride',\n",
       "   'Cloridrato de Atomoxetina',\n",
       "   'HCl, Atomoxetine',\n",
       "   'Hidrocloreto de Atomexetina',\n",
       "   'Hydrochloride, Atomoxetine',\n",
       "   'LY 139603',\n",
       "   'N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride',\n",
       "   'Strattera',\n",
       "   'Strattera',\n",
       "   'Tomoxetine',\n",
       "   'Tomoxetine Hydrochloride, (+)-isomer - T351671',\n",
       "   'Tomoxetine Hydrochloride, (+-)-isomer',\n",
       "   'Tomoxetine Hydrochloride, (-)-isomer'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069446': {'ID': 'D000069446',\n",
       "  'name': 'Sulfato de Atazanavir[Atazanavir Sulfate]',\n",
       "  'scope': 'An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.',\n",
       "  'terms': ['232632, BMS',\n",
       "   '3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester',\n",
       "   '<i>abacavir</i>',\n",
       "   '<i>efavirenz</i>',\n",
       "   '<i>lamivudina</i>',\n",
       "   '<i>ritonavir</i>',\n",
       "   '<i>tenofovir</i>',\n",
       "   'Atazanavir',\n",
       "   'Atazanavir Sulfate',\n",
       "   'BMS 232632',\n",
       "   'BMS 232632 05',\n",
       "   'BMS-232632',\n",
       "   'BMS-232632-05',\n",
       "   'BMS232632',\n",
       "   'BMS23263205',\n",
       "   'CGP 73547',\n",
       "   'CGP 75136',\n",
       "   'CGP 75176',\n",
       "   'CGP 75355',\n",
       "   'CGP-73547',\n",
       "   'CGP-75136',\n",
       "   'CGP-75176',\n",
       "   'CGP-75355',\n",
       "   'CGP73547',\n",
       "   'CGP75136',\n",
       "   'CGP75176',\n",
       "   'CGP75355',\n",
       "   'Reyataz',\n",
       "   'Reyataz',\n",
       "   'Sulfato de Atazanavir'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069447': {'ID': 'D000069447',\n",
       "  'name': 'Brometo de Tiotrópio[Tiotropium Bromide]',\n",
       "  'scope': 'A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.',\n",
       "  'terms': ['679 BR, BA',\n",
       "   '7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide',\n",
       "   '<i>alenia</i>',\n",
       "   '<i>alenia</i>',\n",
       "   'BA 679 BR',\n",
       "   'BA-679 BR',\n",
       "   'BA679 BR',\n",
       "   'BR, BA 679',\n",
       "   'Brometo de Tiotrópio',\n",
       "   'Bromide, Tiotropium',\n",
       "   'Spiriva',\n",
       "   'Spiriva',\n",
       "   'Tiotropium',\n",
       "   'Tiotropium Bromide'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069448': {'ID': 'D000069448',\n",
       "  'name': 'Denosumab[Denosumab]',\n",
       "  'scope': 'A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.',\n",
       "  'terms': ['AMG 162',\n",
       "   'Denosumab',\n",
       "   'Denosumab',\n",
       "   'Denosumabe',\n",
       "   'Prolia',\n",
       "   'Prolia',\n",
       "   'Xgeva'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069449': {'ID': 'D000069449',\n",
       "  'name': 'Cloridrato de Cinacalcete[Cinacalcet Hydrochloride]',\n",
       "  'scope': 'A naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.',\n",
       "  'terms': ['073, AMG',\n",
       "   '1493, KRN',\n",
       "   'AMG 073',\n",
       "   'AMG073',\n",
       "   'Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride',\n",
       "   'Cinacalcet',\n",
       "   'Cinacalcet Hydrochloride',\n",
       "   'Cloridrato de Cinacalcete',\n",
       "   'Hidrocloreto de Cinacalcete',\n",
       "   'Hydrochloride, Cinacalcet',\n",
       "   'KRN 1493',\n",
       "   'Mimpara',\n",
       "   'Sensipar'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069450': {'ID': 'D000069450',\n",
       "  'name': 'Liraglutida[Liraglutide]',\n",
       "  'scope': 'An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.',\n",
       "  'terms': ['2211, NN',\n",
       "   'Liraglutida',\n",
       "   'Liraglutide',\n",
       "   'NN 2211',\n",
       "   'NN-2211',\n",
       "   'NN2211',\n",
       "   'Saxenda',\n",
       "   'Victoza',\n",
       "   'Victoza'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069451': {'ID': 'D000069451',\n",
       "  'name': 'Efeitos Adversos de Longa Duração[Long Term Adverse Effects]',\n",
       "  'scope': 'Persistent detrimental effects from treatment for a condition. Included are effects from surgery such as POSTOPERATIVE COMPLICATIONS, and from DRUG THERAPY, such as CHEMICALLY INDUCED DISORDERS, or other THERAPEUTICS. Failure to attain a desired outcome from treatment for the condition is not considered an adverse effect.',\n",
       "  'terms': ['Adverse Effects, Long Term',\n",
       "   'Efeitos Adversos a Longo Prazo',\n",
       "   'Efeitos Adversos de Longa Duração',\n",
       "   'Long Term Adverse Effects'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069452': {'ID': 'D000069452',\n",
       "  'name': 'Padrões Moleculares Associados a Patógenos[Pathogen-Associated Molecular Pattern Molecules]',\n",
       "  'scope': 'Sequences in molecules of pathogens that are recognized by PATTERN RECOGNITION RECEPTORS.',\n",
       "  'terms': ['Molecular Patterns, Pathogen-Associated',\n",
       "   'Molecules, Pathogen Associated Molecular Pattern',\n",
       "   'Molecules, Pathogen-Associated Molecular Pattern',\n",
       "   'Moléculas de Patógenos Associadas a Padrões Moleculares',\n",
       "   'PAMPs',\n",
       "   'Padrões Moleculares Associados a Patógenos',\n",
       "   'Pathogen Associated Molecular Pattern Molecules',\n",
       "   'Pathogen Associated Molecular Patterns',\n",
       "   'Pathogen-Associated Molecular Pattern Molecules',\n",
       "   'Pathogen-Associated Molecular Patterns',\n",
       "   'Patterns, Pathogen-Associated Molecular'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069453': {'ID': 'D000069453',\n",
       "  'name': 'Ondas Ultrassônicas[Ultrasonic Waves]',\n",
       "  'scope': 'Oscillating sound wave with a frequency higher than the upper limit of the human hearing range.',\n",
       "  'terms': ['LIPUS',\n",
       "   'Low Intensity Pulsed Ultrasound',\n",
       "   'Low Intensity Pulsed Ultrasound (LIPUS)',\n",
       "   'Low Intensity Pulsed Ultrasound Radiation',\n",
       "   'Low-Intensity Pulsed Ultrasound (LIPUS)',\n",
       "   'Low-Intensity Pulsed Ultrasounds (LIPUS)',\n",
       "   'Ondas Ultrassônicas',\n",
       "   'Pulsed Ultrasound',\n",
       "   'Pulsed Ultrasound, Low-Intensity (LIPUS)',\n",
       "   'Pulsed Ultrasounds',\n",
       "   'Pulsed Ultrasounds, Low-Intensity (LIPUS)',\n",
       "   'Radiation, Ultrasound',\n",
       "   'Ultrasonic Vibration',\n",
       "   'Ultrasonic Vibrations',\n",
       "   'Ultrasonic Wave',\n",
       "   'Ultrasonic Waves',\n",
       "   'Ultrasound Radiation',\n",
       "   'Ultrasound Wave',\n",
       "   'Ultrasound Waves',\n",
       "   'Ultrasound, Low-Intensity Pulsed (LIPUS)',\n",
       "   'Ultrasound, Pulsed',\n",
       "   'Ultrasounds, Low-Intensity Pulsed (LIPUS)',\n",
       "   'Ultrasounds, Pulsed',\n",
       "   'Vibration, Ultrasonic',\n",
       "   'Vibrations, Ultrasonic',\n",
       "   'Wave, Ultrasonic',\n",
       "   'Wave, Ultrasound',\n",
       "   'Waves, Ultrasonic',\n",
       "   'Waves, Ultrasound'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069454': {'ID': 'D000069454',\n",
       "  'name': 'Darunavir[Darunavir]',\n",
       "  'scope': 'An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.',\n",
       "  'terms': ['114, TMC',\n",
       "   '<i>etravirina</i>',\n",
       "   '<i>etravirina</i>',\n",
       "   'Darunavir',\n",
       "   'Darunavir',\n",
       "   'Darunavir Ethanolate',\n",
       "   'Etanolato de Darunavir',\n",
       "   'Ethanolate, Darunavir',\n",
       "   'Prezista',\n",
       "   'Prezista',\n",
       "   'TMC 114',\n",
       "   'TMC-114',\n",
       "   'TMC114',\n",
       "   'UIC 94017',\n",
       "   'UIC-94017',\n",
       "   'UIC94017'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069455': {'ID': 'D000069455',\n",
       "  'name': 'Palivizumab[Palivizumab]',\n",
       "  'scope': 'A humanized monoclonal antibody and ANTIVIRAL AGENT  that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.',\n",
       "  'terms': ['MEDI 493',\n",
       "   'MEDI-493',\n",
       "   'MEDI493',\n",
       "   'Monoclonal Antibody MEDI 493',\n",
       "   'Monoclonal Antibody MEDI-493',\n",
       "   'Monoclonal Antibody MEDI493',\n",
       "   'Palivizumab',\n",
       "   'Palivizumab',\n",
       "   'Palivizumabe',\n",
       "   'Synagis',\n",
       "   'Synagis'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069456': {'ID': 'D000069456',\n",
       "  'name': 'Mutação Silenciosa[Silent Mutation]',\n",
       "  'scope': \"A change to a DNA SEQUENCE that doesn't change the AMINO ACID SEQUENCE of the protein made.\",\n",
       "  'terms': ['Codon Substitution, Synonymous',\n",
       "   'Codon Substitutions, Synonymous',\n",
       "   'Mutation, Silent',\n",
       "   'Mutation, Synonymous',\n",
       "   'Mutations, Silent',\n",
       "   'Mutations, Synonymous',\n",
       "   'Mutação Silenciosa',\n",
       "   'Silent Mutation',\n",
       "   'Silent Mutations',\n",
       "   'Substitution, Synonymous Codon',\n",
       "   'Substitutions, Synonymous Codon',\n",
       "   'Synonymous Codon Substitution',\n",
       "   'Synonymous Codon Substitutions',\n",
       "   'Synonymous Mutation',\n",
       "   'Synonymous Mutations'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069457': {'ID': 'D000069457',\n",
       "  'name': 'Previsões Demográficas[Population Forecast]',\n",
       "  'scope': 'Estimates of projected population.',\n",
       "  'terms': ['Estimation, Population Growth',\n",
       "   'Estimations, Population Growth',\n",
       "   'Forecasts, Population',\n",
       "   'Growth Estimation, Population',\n",
       "   'Growth Estimations, Population',\n",
       "   'Métodos de Análise e Projeção da População',\n",
       "   'Population Forecast',\n",
       "   'Population Forecasts',\n",
       "   'Population Growth Estimation',\n",
       "   'Population Growth Estimations',\n",
       "   'Population Projection',\n",
       "   'Population Projections',\n",
       "   'Previsão Demográfica',\n",
       "   'Previsão de População',\n",
       "   'Previsões Demográficas',\n",
       "   'Previsões Populacionais',\n",
       "   'Projection, Population',\n",
       "   'Projeção de Taxas',\n",
       "   'Projeções de População'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069458': {'ID': 'D000069458',\n",
       "  'name': 'Ranolazina[Ranolazine]',\n",
       "  'scope': 'An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.',\n",
       "  'terms': ['43285, RS',\n",
       "   'Dihydrochloride, Ranolazine',\n",
       "   'HCl, Ranolazine',\n",
       "   'Hydrochloride, Ranolazine',\n",
       "   'N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide',\n",
       "   'RS 43285',\n",
       "   'RS 43285 193',\n",
       "   'RS 43285-193',\n",
       "   'RS 43285193',\n",
       "   'RS-43285',\n",
       "   'RS43285',\n",
       "   'Ranexa',\n",
       "   'Ranexa',\n",
       "   'Ranolazina',\n",
       "   'Ranolazine',\n",
       "   'Ranolazine Dihydrochloride',\n",
       "   'Ranolazine HCl',\n",
       "   'Ranolazine Hydrochloride',\n",
       "   'Renolazine'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069459': {'ID': 'D000069459',\n",
       "  'name': 'Chás de Ervas[Teas, Herbal]',\n",
       "  'scope': 'Beverages prepared from an infusion of plant tissues.',\n",
       "  'terms': ['Chá Herbal',\n",
       "   'Chá de Ervas',\n",
       "   'Chás Herbais',\n",
       "   'Chás de Ervas',\n",
       "   'Herbal Tea',\n",
       "   'Herbal Teas',\n",
       "   'Tea, Herbal',\n",
       "   'Teas, Herbal',\n",
       "   'Tisane',\n",
       "   'Tisanes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069460': {'ID': 'D000069460',\n",
       "  'name': 'Chás Medicinais[Teas, Medicinal]',\n",
       "  'scope': 'Beverages used in TRADITIONAL MEDICINE that are prepared from the infusion of plant tissue (HERBAL TEA), and/or animal tissue or other organisms such as FUNGI.',\n",
       "  'terms': ['Chá Medicinal',\n",
       "   'Chás Medicinais',\n",
       "   'Medicinal Tea',\n",
       "   'Medicinal Teas',\n",
       "   'Tea, Medicinal',\n",
       "   'Teas, Medicinal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069461': {'ID': 'D000069461',\n",
       "  'name': 'Cloridrato de Bendamustina[Bendamustine Hydrochloride]',\n",
       "  'scope': \"A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA.\",\n",
       "  'terms': ['Bendamustin',\n",
       "   'Bendamustina',\n",
       "   'Bendamustine',\n",
       "   'Bendamustine Hydrochloride',\n",
       "   'Cloridrato de Bendamustina',\n",
       "   'Cytostasan',\n",
       "   'Hidrocloreto de Bendamustina',\n",
       "   'Hydrochloride, Bendamustine',\n",
       "   'IMET 3393',\n",
       "   'Ribomustin',\n",
       "   'Treanda',\n",
       "   'Treanda',\n",
       "   'Zimet 3393'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069462': {'ID': 'D000069462',\n",
       "  'name': 'Fumarato de Dimetilo[Dimethyl Fumarate]',\n",
       "  'scope': 'A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.',\n",
       "  'terms': ['00012, BG',\n",
       "   '12 compound, BG',\n",
       "   '2-butenedioic acid, (2E)-, dimethyl ester',\n",
       "   '201, FAG',\n",
       "   'BG 00012',\n",
       "   'BG 12 compound',\n",
       "   'BG-00012',\n",
       "   'BG-12 compound',\n",
       "   'BG00012',\n",
       "   'BG12 compound',\n",
       "   'Dimethyl Fumarate',\n",
       "   'Dimethylfumarate',\n",
       "   'Dimetil Fumarato',\n",
       "   'Dimetilfumarato',\n",
       "   'FAG 201',\n",
       "   'FAG-201',\n",
       "   'FAG201',\n",
       "   'Fumaderm',\n",
       "   'Fumarate, Dimethyl',\n",
       "   'Fumarato de Dimetil',\n",
       "   'Fumarato de Dimetilo',\n",
       "   'Tecfidera',\n",
       "   'Tecfidera',\n",
       "   'compound, BG 12',\n",
       "   'compound, BG12'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069463': {'ID': 'D000069463',\n",
       "  'name': 'Azeite de Oliva[Olive Oil]',\n",
       "  'scope': 'Oil extracted from fruit of the OLIVE TREE (genus Olea).',\n",
       "  'terms': ['Azeite de Oliva',\n",
       "   'Azeites de Oliva',\n",
       "   'Oil, Olive',\n",
       "   'Oils, Olive',\n",
       "   'Olive Oil',\n",
       "   'Olive Oils'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069464': {'ID': 'D000069464',\n",
       "  'name': 'Succinato de Solifenacina[Solifenacin Succinate]',\n",
       "  'scope': 'A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.',\n",
       "  'terms': ['2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-',\n",
       "   '905, YM',\n",
       "   '<i>retemic</i>',\n",
       "   '<i>retemic</i>',\n",
       "   \"Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate\",\n",
       "   'Solifenacin',\n",
       "   'Solifenacin Succinate',\n",
       "   'Solifenacina',\n",
       "   'Succinate, Solifenacin',\n",
       "   'Succinato de Solifenacina',\n",
       "   'Vesicare',\n",
       "   'Vesicare',\n",
       "   'YM 905',\n",
       "   'YM905'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069465': {'ID': 'D000069465',\n",
       "  'name': 'Febuxostat[Febuxostat]',\n",
       "  'scope': 'A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.',\n",
       "  'terms': ['2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid',\n",
       "   '6720, TEI',\n",
       "   'Febuxostat',\n",
       "   'Febuxostat',\n",
       "   'TEI 6720',\n",
       "   'TEI-6720',\n",
       "   'TEI6720',\n",
       "   'Uloric'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069466': {'ID': 'D000069466',\n",
       "  'name': 'Carne Vermelha[Red Meat]',\n",
       "  'scope': 'Meat such as beef, pork, or lamb which contains more MYOGLOBIN than POULTRY or SEAFOOD.',\n",
       "  'terms': ['<i>alface</i>',\n",
       "   '<i>batata</i>',\n",
       "   '<i>carne</i>',\n",
       "   '<i>cenoura</i>',\n",
       "   '<i>feijao</i>',\n",
       "   '<i>frango</i>',\n",
       "   '<i>guisado</i>',\n",
       "   '<i>iogurte</i>',\n",
       "   '<i>mortadela</i>',\n",
       "   '<i>queijo</i>',\n",
       "   'Beef',\n",
       "   'Bife',\n",
       "   'Carne Vermelha',\n",
       "   'Meat, Red',\n",
       "   'Meats, Red',\n",
       "   'Pork',\n",
       "   'Red Meat',\n",
       "   'Red Meats'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069467': {'ID': 'D000069467',\n",
       "  'name': 'Transplante de Microbiota Fecal[Fecal Microbiota Transplantation]',\n",
       "  'scope': 'Transfer of GASTROINTESTINAL MICROBIOTA from one individual to another by infusion of donor FECES to the upper or lower GASTROINTESTINAL TRACT of the recipient.',\n",
       "  'terms': ['Donor Feces Infusion',\n",
       "   'Donor Feces Infusions',\n",
       "   'Fecal Microbiota Transplantation',\n",
       "   'Fecal Microbiota Transplantations',\n",
       "   'Fecal Transplant',\n",
       "   'Fecal Transplantation',\n",
       "   'Fecal Transplantations',\n",
       "   'Fecal Transplants',\n",
       "   'Feces Infusion, Donor',\n",
       "   'Feces Infusions, Donor',\n",
       "   'Infusion, Donor Feces',\n",
       "   'Infusions, Donor Feces',\n",
       "   'Intestinal Microbiota Transfer',\n",
       "   'Intestinal Microbiota Transfers',\n",
       "   'Microbiota Transfer, Intestinal',\n",
       "   'Microbiota Transfers, Intestinal',\n",
       "   'Microbiota Transplantation, Fecal',\n",
       "   'Microbiota Transplantations, Fecal',\n",
       "   'Transfer, Intestinal Microbiota',\n",
       "   'Transfers, Intestinal Microbiota',\n",
       "   'Transplant, Fecal',\n",
       "   'Transplantation, Fecal',\n",
       "   'Transplantation, Fecal Microbiota',\n",
       "   'Transplantations, Fecal',\n",
       "   'Transplantations, Fecal Microbiota',\n",
       "   'Transplante Fecal',\n",
       "   'Transplante de Microbiota Fecal',\n",
       "   'Transplants, Fecal'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069468': {'ID': 'D000069468',\n",
       "  'name': 'Succinato de Desvenlafaxina[Desvenlafaxine Succinate]',\n",
       "  'scope': 'A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.',\n",
       "  'terms': ['2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate',\n",
       "   '4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol',\n",
       "   '45,233, WY',\n",
       "   '45233, WY',\n",
       "   '<i>donarem</i>',\n",
       "   '<i>donarem</i>',\n",
       "   '<i>nortriptilina</i>',\n",
       "   '<i>nortriptilina</i>',\n",
       "   '<i>setralina</i>',\n",
       "   '<i>setralina</i>',\n",
       "   'Desvenlafaxina',\n",
       "   'Desvenlafaxine',\n",
       "   'Desvenlafaxine Succinate',\n",
       "   'Monohydrate, O-desmethylvenlafaxine Succinate',\n",
       "   'O desmethylvenlafaxine',\n",
       "   'O desmethylvenlafaxine Succinate',\n",
       "   'O desmethylvenlafaxine Succinate Monohydrate',\n",
       "   'O-desmethylvenlafaxine',\n",
       "   'O-desmethylvenlafaxine Succinate',\n",
       "   'O-desmethylvenlafaxine Succinate Monohydrate',\n",
       "   'Pristiq',\n",
       "   'Pristiq',\n",
       "   'Succinate Monohydrate, O-desmethylvenlafaxine',\n",
       "   'Succinate, Desvenlafaxine',\n",
       "   'Succinate, O-desmethylvenlafaxine',\n",
       "   'Succinato de Desvenlafaxina',\n",
       "   'WY 45,233',\n",
       "   'WY 45233',\n",
       "   'WY-45,233',\n",
       "   'WY-45233',\n",
       "   'WY45,233',\n",
       "   'WY45233'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069469': {'ID': 'D000069469',\n",
       "  'name': 'Enfermagem Médico-Cirúrgica[Medical-Surgical Nursing]',\n",
       "  'scope': 'The area of nursing concerned with the needs and care of adult medical and surgical patients.',\n",
       "  'terms': ['Enfermagem Médico-Cirúrgica',\n",
       "   'Medical Surgical Nursing',\n",
       "   'Medical-Surgical Nursing',\n",
       "   'Nursing, Medical Surgical',\n",
       "   'Nursing, Medical-Surgical'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069470': {'ID': 'D000069470',\n",
       "  'name': 'Cloridrato de Venlafaxina[Venlafaxine Hydrochloride]',\n",
       "  'scope': 'A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.',\n",
       "  'terms': ['1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl',\n",
       "   'Cloridrato de Venlafaxina',\n",
       "   'Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride',\n",
       "   'Dobupal',\n",
       "   'Efexor',\n",
       "   'Effexor',\n",
       "   'Hidrocloreto de Venlafaxina',\n",
       "   'Hydrochloride, Venlafaxine',\n",
       "   'Sila Venlafaxine',\n",
       "   'Sila-Venlafaxine',\n",
       "   'Trevilor',\n",
       "   'Vandral',\n",
       "   'Venlafaxina',\n",
       "   'Venlafaxine',\n",
       "   'Venlafaxine Hydrochloride',\n",
       "   'Wy 45,030',\n",
       "   'Wy 45030',\n",
       "   'Wy-45,030',\n",
       "   'Wy-45030',\n",
       "   'Wy45,030',\n",
       "   'Wy45030'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069471': {'ID': 'D000069471',\n",
       "  'name': 'Neurocirurgiões[Neurosurgeons]',\n",
       "  'scope': 'Qualified medical professionals who specialize in surgical treatment of diseases of the BRAIN and other parts of the NERVOUS SYSTEM.',\n",
       "  'terms': ['Neurocirurgiões',\n",
       "   'Neurological Surgeon',\n",
       "   'Neurological Surgeons',\n",
       "   'Neurosurgeon',\n",
       "   'Neurosurgeons',\n",
       "   'Surgeon, Neurological',\n",
       "   'Surgeons, Neurological'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069472': {'ID': 'D000069472',\n",
       "  'name': 'Cloridrato de Colesevelam[Colesevelam Hydrochloride]',\n",
       "  'scope': 'An allylamine derivative that binds BILE ACIDS in the intestine and is used as an ANTICHOLESTEREMIC AGENT in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.',\n",
       "  'terms': ['31104, GT',\n",
       "   'CholestaGel',\n",
       "   'Cholestagel',\n",
       "   'Cloridrato de Colesevelam',\n",
       "   'Colesevelam',\n",
       "   'Colesevelam HCl',\n",
       "   'Colesevelam Hydrochloride',\n",
       "   'GT 31104',\n",
       "   'GT-31104',\n",
       "   'GT31 104',\n",
       "   'GT31-104',\n",
       "   'GT31104',\n",
       "   'HCl, Colesevelam',\n",
       "   'Hidrocloreto de Colesevelam',\n",
       "   'Hydrochloride, Colesevelam',\n",
       "   'Welchol'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069473': {'ID': 'D000069473',\n",
       "  'name': 'Radioterapia Hipofracionada[Dose Hypofractionation]',\n",
       "  'scope': 'A treatment schedule in which the total dose of radiation is divided into large doses.',\n",
       "  'terms': ['Dose Hypofractionation',\n",
       "   'Dose, Hypofractionated',\n",
       "   'Doses, Hypofractionated',\n",
       "   'Hipofracionamento de Dose de Radiação',\n",
       "   'Hipofracionamento de Doses',\n",
       "   'Hypofractionated Dose',\n",
       "   'Hypofractionated Doses',\n",
       "   'Hypofractionation, Dose',\n",
       "   'Minibeam, Radiotherapy',\n",
       "   'Minibeams, Radiotherapy',\n",
       "   'Radioterapia Hipofracionada',\n",
       "   'Radiotherapy Minibeam',\n",
       "   'Radiotherapy Minibeams',\n",
       "   'Tratamento Hipofracionado de Radioterapia'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069474': {'ID': 'D000069474',\n",
       "  'name': 'Sofosbuvir[Sofosbuvir]',\n",
       "  'scope': 'A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.',\n",
       "  'terms': ['2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester',\n",
       "   '7977, PSI',\n",
       "   '<i>daclatasvir</i>',\n",
       "   '<i>daclatasvir</i>',\n",
       "   'GS 7977',\n",
       "   'GS-7977',\n",
       "   'GS7977',\n",
       "   'PSI 7977',\n",
       "   'PSI-7977',\n",
       "   'PSI7977',\n",
       "   'Sofosbuvir',\n",
       "   'Sofosbuvir',\n",
       "   'Sovaldi',\n",
       "   'Sovaldi'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069475': {'ID': 'D000069475',\n",
       "  'name': 'Reirradiação[Re-Irradiation]',\n",
       "  'scope': 'Treatment in which a repeat course of RADIOTHERAPY is administered.',\n",
       "  'terms': ['Re Irradiation',\n",
       "   'Re-Irradiation',\n",
       "   'Reirradiation',\n",
       "   'Reirradiação'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069476': {'ID': 'D000069476',\n",
       "  'name': 'Linagliptina[Linagliptin]',\n",
       "  'scope': 'A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.',\n",
       "  'terms': ['(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione',\n",
       "   '1356, BI',\n",
       "   '1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-',\n",
       "   'BI 1356',\n",
       "   'BI-1356',\n",
       "   'BI1356',\n",
       "   'Linagliptin',\n",
       "   'Linagliptina',\n",
       "   'Tradjenta',\n",
       "   'Trajenta',\n",
       "   'Trayenta'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069478': {'ID': 'D000069478',\n",
       "  'name': 'Dimesilato de Lisdexanfetamina[Lisdexamfetamine Dimesylate]',\n",
       "  'scope': 'A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.',\n",
       "  'terms': ['Dimesilato de Lisdexanfetamina',\n",
       "   'Dimesylate, Lis-dexamfetamine',\n",
       "   'Dimesylate, Lisdexamfetamine',\n",
       "   'Elvanse',\n",
       "   'Lis dexamfetamine Dimesylate',\n",
       "   'Lis-dexamfetamine Dimesylate',\n",
       "   'Lisdexamfetamine',\n",
       "   'Lisdexamfetamine Dimesylate',\n",
       "   'NRP 104',\n",
       "   'NRP-104',\n",
       "   'NRP104',\n",
       "   'Venvanse',\n",
       "   'Vyvanse'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069479': {'ID': 'D000069479',\n",
       "  'name': 'Combinação Buprenorfina e Naloxona[Buprenorphine, Naloxone Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.',\n",
       "  'terms': ['Associação Medicamentosa Buprenorfina e Naloxona',\n",
       "   'Associação de Medicamentos Buprenorfina e Naloxona',\n",
       "   'Associação dos Medicamentos Buprenorfina e Naloxona',\n",
       "   'Buprenorfina e Naloxona',\n",
       "   'Buprenorfina e Naloxona, Associação Medicamentosa',\n",
       "   'Buprenorfina e Naloxona, Combinação de Medicamentos',\n",
       "   'Buprenorphine Naloxone',\n",
       "   'Buprenorphine Naloxone Combination',\n",
       "   'Buprenorphine Naloxone Drug Combination',\n",
       "   'Buprenorphine, Naloxone Drug Combination',\n",
       "   'Buprenorphine-Naloxone',\n",
       "   'Buprenorphine-Naloxone Combination',\n",
       "   'Buprenorphine-Naloxone Drug Combination',\n",
       "   'Combination, Buprenorphine-Naloxone',\n",
       "   'Combination, Buprenorphine-Naloxone Drug',\n",
       "   'Combinação Buprenorfina e Naloxona',\n",
       "   'Combinação das Drogas Buprenorfina e Naloxona',\n",
       "   'Combinação de Medicamentos Buprenorfina e Naloxona',\n",
       "   'Drug Combination, Buprenorphine-Naloxone',\n",
       "   'Naloxone, Buprenorphine',\n",
       "   'Suboxone'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069480': {'ID': 'D000069480',\n",
       "  'name': 'Combinação Emtricitabina e Fumarato de Tenofovir Desoproxila[Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.',\n",
       "  'terms': ['Combinação Emtricitabina e Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação Emtricitabina e Fumarato de Tenofovir Disoproxil',\n",
       "   'Combinação de Drogas Emtricitabina e Disoproxil Fumarato de Tenofovir',\n",
       "   'Combinação de Drogas Emtricitabina e Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação de Drogas Emtricitabina e Fumarato de Tenofovir Disoproxil',\n",
       "   'Combinação de Medicamentos Emtricitabina e Disoproxil Fumarato de Tenofovir',\n",
       "   'Combinação de Medicamentos Emtricitabina e Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação de Medicamentos Emtricitabina e Fumarato de Tenofovir Disoproxil',\n",
       "   'Emtricitabina e Disoproxil Fumarato de Tenofovir, Combinação de Medicamentos',\n",
       "   'Emtricitabina e Fumarato de Tenofovir Desoproxil',\n",
       "   'Emtricitabina e Fumarato de Tenofovir Desoproxila',\n",
       "   'Emtricitabina e Fumarato de Tenofovir Desoproxila, Combinação de Medicamentos',\n",
       "   'Emtricitabina e Fumarato de Tenofovir Disoproxil, Combinação de Medicamentos',\n",
       "   'Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Truvada',\n",
       "   'Truvada'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069497': {'ID': 'D000069497',\n",
       "  'name': 'Origem da Vida[Origin of Life]',\n",
       "  'scope': 'The process by which life began.',\n",
       "  'terms': ['Biogênese',\n",
       "   'Genesis of Life',\n",
       "   'Life Geneses',\n",
       "   'Life Genesis',\n",
       "   'Life Origin',\n",
       "   'Life Origins',\n",
       "   'Origem da Vida',\n",
       "   'Origin of Life'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069499': {'ID': 'D000069499',\n",
       "  'name': 'Combinação Ezetimiba e Simvastatina[Ezetimibe, Simvastatin Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.',\n",
       "  'terms': ['Combination, Ezetimibe-Simvastatin',\n",
       "   'Combination, Ezetimibe-Simvastatin Drug',\n",
       "   'Combinação Ezetimiba e Simvastatina',\n",
       "   'Combinação das Drogas Ezetimiba e Simvastatina',\n",
       "   'Combinação de Medicamentos Ezetimiba e Simvastatina',\n",
       "   'Drug Combination, Ezetimibe-Simvastatin',\n",
       "   'Ezetimiba e Simvastatina',\n",
       "   'Ezetimiba e Simvastatina, Combinação de Medicamentos',\n",
       "   'Ezetimibe Simvastatin Combination',\n",
       "   'Ezetimibe Simvastatin Drug Combination',\n",
       "   'Ezetimibe, Simvastatin Drug Combination',\n",
       "   'Ezetimibe-Simvastatin Combination',\n",
       "   'Ezetimibe-Simvastatin Drug Combination',\n",
       "   'Inegy',\n",
       "   'Vytorin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069501': {'ID': 'D000069501',\n",
       "  'name': 'Acetato de Abiraterona[Abiraterone Acetate]',\n",
       "  'scope': 'An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.',\n",
       "  'terms': ['17-(3-pyridyl)-5,16-androstadien-3beta-acetate',\n",
       "   'Abiraterone Acetate',\n",
       "   'Acetato de Abiraterona',\n",
       "   'CB 7630',\n",
       "   'CB-7630',\n",
       "   'CB7630',\n",
       "   'Zytiga',\n",
       "   'Zytiga'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069502': {'ID': 'D000069502',\n",
       "  'name': 'Combinação Budesonida e Fumarato de Formoterol[Budesonide, Formoterol Fumarate Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.',\n",
       "  'terms': ['Associação de Budesonida e Fumarato de Formoterol',\n",
       "   'Budesonida e Fumarato de Formoterol',\n",
       "   'Budesonida e Fumarato de Formoterol, Combinação de Medicamentos',\n",
       "   'Budesonide Formoterol Drug Combination',\n",
       "   'Budesonide Formoterol Fumarate Drug Combination',\n",
       "   'Budesonide, Formoterol Fumarate Drug Combination',\n",
       "   'Budesonide-Formoterol Drug Combination',\n",
       "   'Budesonide-Formoterol Fumarate Drug Combination',\n",
       "   'Combination, Budesonide-Formoterol Drug',\n",
       "   'Combinação Budesonida e Fumarato de Formoterol',\n",
       "   'Combinação das Drogas Budesonida e Fumarato de Formoterol',\n",
       "   'Combinação de Medicamentos Budesonida e Fumarato de Formoterol',\n",
       "   'Drug Combination, Budesonide-Formoterol',\n",
       "   'Symbicort'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069503': {'ID': 'D000069503',\n",
       "  'name': 'Cloridrato de Vilazodona[Vilazodone Hydrochloride]',\n",
       "  'scope': 'A benzofuran, indole, and piperazine derivative that functions as a SEROTONIN UPTAKE INHIBITOR and partial SEROTONIN 5-HT1 RECEPTOR AGONIST. It is used as an ANTIDEPRESSIVE AGENT.',\n",
       "  'terms': ['2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)',\n",
       "   '5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide',\n",
       "   '68843, EMD',\n",
       "   'Cloridrato de Vilazodona',\n",
       "   'EMB 68843',\n",
       "   'EMB-68843',\n",
       "   'EMB68843',\n",
       "   'EMD 68843',\n",
       "   'HCl, Vilazodone',\n",
       "   'Hidrocloreto de Vilazodona',\n",
       "   'Hydrochloride, Vilazodone',\n",
       "   'Viibryd',\n",
       "   'Vilazodona',\n",
       "   'Vilazodone',\n",
       "   'Vilazodone HCl',\n",
       "   'Vilazodone Hydrochloride'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069516': {'ID': 'D000069516',\n",
       "  'name': 'Direito Internacional[International Law]',\n",
       "  'scope': 'The body of law that governs the legal relations between or among sovereign states or nations.',\n",
       "  'terms': ['Direito Internacional',\n",
       "   'International Law',\n",
       "   'International Law, Public',\n",
       "   'International Laws',\n",
       "   'Law of Nations',\n",
       "   'Law, International',\n",
       "   'Laws, International',\n",
       "   'Public International Law'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069520': {'ID': 'D000069520',\n",
       "  'name': 'Blogs[Blogs]',\n",
       "  'scope': 'A website that contains conversational personal reflections, comments and sometimes links to other sites; typically run by an individual or small group.',\n",
       "  'terms': ['Blogs', 'Blogs', 'Web Blogs', 'Weblogs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069537': {'ID': 'D000069537',\n",
       "  'name': 'Centros-Dia de Assistência à Saúde para Adultos[Adult Day Care Centers]',\n",
       "  'scope': 'Non-residential facilities that are designed to provide care and companionship for seniors who need assistance or supervision during the day.',\n",
       "  'terms': ['Adult Day Care Center',\n",
       "   'Adult Day Care Centers',\n",
       "   'Centros de Assistência Diurna de Adultos',\n",
       "   'Centros-Dia de Assistência à Saúde para Adultos',\n",
       "   'Day Care Center, Adult',\n",
       "   'Day Care Centers, Adult'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069544': {'ID': 'D000069544',\n",
       "  'name': 'Encefalite Infecciosa[Infectious Encephalitis]',\n",
       "  'scope': 'Brain inflammation caused by an infectious agent..',\n",
       "  'terms': ['Encefalite Infecciosa',\n",
       "   'Encephalitis Infection',\n",
       "   'Encephalitis Infections',\n",
       "   'Encephalitis, Infectious',\n",
       "   'Infection, Encephalitis',\n",
       "   'Infections, Encephalitis',\n",
       "   'Infectious Encephalitis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069545': {'ID': 'D000069545',\n",
       "  'name': 'Combinação Elvitegravir, Cobicistat, Emtricitabina e Fumarato de Tenofovir Desoproxila[Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination]',\n",
       "  'scope': 'A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.',\n",
       "  'terms': ['Combinação Elvitegravir, Cobicistat, Emtricitabina e Fumarato de Tenofovir Desoproxila',\n",
       "   'Combinação de Medicamentos Elvitegravir, Cobicistat, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Elvitegravir, Cobicistat, Emtricitabina, Fumarato de Tenofovir Desoproxila',\n",
       "   'Elvitegravir, Cobicistat, Emtricitabina, Fumarato de Tenofovir Desoproxila, Combinação de Medicamentos',\n",
       "   'Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate',\n",
       "   'Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination',\n",
       "   'Pill, Quad',\n",
       "   'Quad',\n",
       "   'Quad Pill',\n",
       "   'Stribild'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069547': {'ID': 'D000069547',\n",
       "  'name': 'Cobicistat[Cobicistat]',\n",
       "  'scope': 'A carbamate and thiazole derivative that functions as a CYTOCHROME P450 CYP3A INHIBITOR to enhance the concentration of ANTI-HIV AGENTS, with which it is used in combination, for the treatment of HIV INFECTIONS.',\n",
       "  'terms': ['9350, GS',\n",
       "   'Cobicistat',\n",
       "   'Cobicistat',\n",
       "   'GS 9350',\n",
       "   'GS-9350',\n",
       "   'GS9350',\n",
       "   'Tybost'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069549': {'ID': 'D000069549',\n",
       "  'name': 'Ustekinumab[Ustekinumab]',\n",
       "  'scope': 'A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.',\n",
       "  'terms': ['CNTO 1275',\n",
       "   'CNTO-1275',\n",
       "   'Stelara',\n",
       "   'Ustekinumab',\n",
       "   'Ustekinumab',\n",
       "   'Ustekinumabe'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069550': {'ID': 'D000069550',\n",
       "  'name': 'Aprendizado de Máquina[Machine Learning]',\n",
       "  'scope': 'A type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data.',\n",
       "  'terms': ['Aprendizado Automático',\n",
       "   'Aprendizado de Máquina',\n",
       "   'Aprendizagem Automática',\n",
       "   'Aprendizagem de Máquina',\n",
       "   'Learning, Machine',\n",
       "   'Machine Learning'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069551': {'ID': 'D000069551',\n",
       "  'name': 'Psicologia Ambiental[Environmental Psychology]',\n",
       "  'scope': 'The field that studies interactions between individuals and the built and natural environment. It includes investigating behaviors that inhibit or foster sustainable, climate-healthy, and nature-enhancing choices.',\n",
       "  'terms': ['Environmental Psychology',\n",
       "   'Psicologia Ambiental',\n",
       "   'Psychology, Environmental'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069552': {'ID': 'D000069552',\n",
       "  'name': 'Rivaroxabana[Rivaroxaban]',\n",
       "  'scope': 'A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM.  It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.',\n",
       "  'terms': ['5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide',\n",
       "   '<i>rivaroxabana</i>',\n",
       "   '<i>rivaroxabana</i>',\n",
       "   '<i>xarelto</i>',\n",
       "   'BAY 59 7939',\n",
       "   'BAY 59-7939',\n",
       "   'BAY 597939',\n",
       "   'Rivaroxaban',\n",
       "   'Rivaroxabana',\n",
       "   'Xarelto',\n",
       "   'Xarelto'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069553': {'ID': 'D000069553',\n",
       "  'name': 'Aprendizado de Máquina Supervisionado[Supervised Machine Learning]',\n",
       "  'scope': 'A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of labeled paired input-output training (sample) data.',\n",
       "  'terms': ['Active Machine Learning',\n",
       "   'Aprendizado Supervisionado de Máquina',\n",
       "   'Aprendizado de Máquina Supervisionado',\n",
       "   'Aprendizagem Supervisionada de Máquina',\n",
       "   'Aprendizagem de Máquina Supervisionada',\n",
       "   'Inductive Machine Learning',\n",
       "   'Learning from Labeled Data',\n",
       "   'Learning, Active Machine',\n",
       "   'Learning, Inductive Machine',\n",
       "   'Learning, Semi-supervised',\n",
       "   'Learning, Supervised Machine',\n",
       "   'Machine Learning with a Teacher',\n",
       "   'Machine Learning, Active',\n",
       "   'Machine Learning, Inductive',\n",
       "   'Machine Learning, Supervised',\n",
       "   'Semi supervised Learning',\n",
       "   'Semi-supervised Learning',\n",
       "   'Supervised Machine Learning'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069555': {'ID': 'D000069555',\n",
       "  'name': 'Injeção Intratimpânica[Injection, Intratympanic]',\n",
       "  'scope': 'The administration of  liquid substances into the TYMPANIC CAVITY with a hypodermic syringe.',\n",
       "  'terms': ['Administration, Transtympanic',\n",
       "   'Administrations, Transtympanic',\n",
       "   'Injection, Intratympanic',\n",
       "   'Injections, Intratympanic',\n",
       "   'Injeção Intratimpânica',\n",
       "   'Intratympanic Injection',\n",
       "   'Intratympanic Injections',\n",
       "   'Transtympanic Administration',\n",
       "   'Transtympanic Administrations'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069557': {'ID': 'D000069557',\n",
       "  'name': 'Travoprost[Travoprost]',\n",
       "  'scope': 'A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.',\n",
       "  'terms': ['(((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester',\n",
       "   '<i>azorga</i>',\n",
       "   '<i>bimatoprosta</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>combigan</i>',\n",
       "   '<i>combigan</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>dorzolamida</i>',\n",
       "   '<i>dorzolamida</i>',\n",
       "   '<i>drusolol</i>',\n",
       "   '<i>duotravatan</i>',\n",
       "   '<i>duotravatan</i>',\n",
       "   '<i>glaub</i>',\n",
       "   '<i>latanoprosta</i>',\n",
       "   '<i>latanoprosta</i>',\n",
       "   '<i>lumigan</i>',\n",
       "   '<i>timolol</i>',\n",
       "   '<i>timolol</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   'AL 6221',\n",
       "   'AL-6221',\n",
       "   'AL6221',\n",
       "   'Travatan',\n",
       "   'Travatan Z',\n",
       "   'Travoprost',\n",
       "   'Travoprost',\n",
       "   'Travoprosta',\n",
       "   'Z, Travatan'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069558': {'ID': 'D000069558',\n",
       "  'name': 'Aprendizado de Máquina não Supervisionado[Unsupervised Machine Learning]',\n",
       "  'scope': 'A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of unlabeled paired input-output training (sample) data.',\n",
       "  'terms': ['Aprendizado de Máquina não Supervisionado',\n",
       "   'Aprendizado não Supervisionada de Máquina',\n",
       "   'Aprendizagem de Máquina não Supervisionada',\n",
       "   'Aprendizagem não Supervisionada de Máquina',\n",
       "   'Learning, Unsupervised Machine',\n",
       "   'Machine Learning, Unsupervised',\n",
       "   'Unsupervised Machine Learning'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069559': {'ID': 'D000069559',\n",
       "  'name': 'Etabonato de Loteprednol[Loteprednol Etabonate]',\n",
       "  'scope': 'An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.',\n",
       "  'terms': ['17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl',\n",
       "   'Alrex',\n",
       "   'CEHOAC',\n",
       "   'Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate',\n",
       "   'Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate',\n",
       "   'Etabonate, Loteprednol',\n",
       "   'Etabonato de Loteprednol',\n",
       "   'Lotemax',\n",
       "   'Loteprednol',\n",
       "   'Loteprednol',\n",
       "   'Loteprednol Etabonate',\n",
       "   'Loteprol'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069576': {'ID': 'D000069576',\n",
       "  'name': 'Equidade em Saúde[Health Equity]',\n",
       "  'scope': 'Opportunity to attain full health potential and no one is disadvantaged from achieving this potential because of their social position or other socially determined circumstance.',\n",
       "  'terms': ['Equidade Social e em Saúde',\n",
       "   'Equidade de Gênero na Saúde',\n",
       "   'Equidade em Saúde',\n",
       "   'Equidade na Assistência à Saúde',\n",
       "   'Equidade na Saúde',\n",
       "   'Equity, Health',\n",
       "   'Health Equity'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069577': {'ID': 'D000069577',\n",
       "  'name': 'Morcelação[Morcellation]',\n",
       "  'scope': 'Use of a non-cautery–dependent mechanical device that simultaneously cuts and aspirates polyp and/or myoma tissue.',\n",
       "  'terms': ['Morcelação', 'Morcellation'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069578': {'ID': 'D000069578',\n",
       "  'name': 'Doenças Transmitidas pela Água[Waterborne Diseases]',\n",
       "  'scope': 'Illnesses due to micro-organisms and chemicals in drinking water, those caused by organisms having part of their lifecycle in water or those with water-related vectors, and others spread by aerosols containing pathogens.',\n",
       "  'terms': ['Disease, Water-related',\n",
       "   'Disease, Waterborne',\n",
       "   'Diseases, Water-related',\n",
       "   'Diseases, Waterborne',\n",
       "   'Doenças Relacionadas com a Água',\n",
       "   'Doenças Transmitidas pela Água',\n",
       "   'Doenças Veiculadas pela Água',\n",
       "   'Doenças de Origem Hídrica',\n",
       "   'Doenças de Transmissão Hídrica',\n",
       "   'Doenças de Veiculação Hídrica',\n",
       "   'Enfermidades de Origem Hídrica',\n",
       "   'Enfermidades de Transmissão Hídrica',\n",
       "   'Water related Diseases',\n",
       "   'Water-related Disease',\n",
       "   'Water-related Diseases',\n",
       "   'Waterborne Disease',\n",
       "   'Waterborne Diseases'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069579': {'ID': 'D000069579',\n",
       "  'name': 'Ranibizumab[Ranibizumab]',\n",
       "  'scope': 'A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.',\n",
       "  'terms': ['Lucentis',\n",
       "   'Lucentis',\n",
       "   'Ranibizumab',\n",
       "   'Ranibizumab',\n",
       "   'Ranibizumabe',\n",
       "   'RhuFab V2',\n",
       "   'V2, RhuFab'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069580': {'ID': 'D000069580',\n",
       "  'name': 'Bimatoprost[Bimatoprost]',\n",
       "  'scope': 'A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.',\n",
       "  'terms': ['192024, AGN',\n",
       "   '<i>azorga</i>',\n",
       "   '<i>azorga</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brimonidina</i>',\n",
       "   '<i>brinzolamida</i>',\n",
       "   '<i>combigan</i>',\n",
       "   '<i>combigan</i>',\n",
       "   '<i>combigan</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>cosopt</i>',\n",
       "   '<i>dorzolamida</i>',\n",
       "   '<i>drusolol</i>',\n",
       "   '<i>drusolol</i>',\n",
       "   '<i>duotravatan</i>',\n",
       "   '<i>duotravatan</i>',\n",
       "   '<i>duotravatan</i>',\n",
       "   '<i>glaub</i>',\n",
       "   '<i>glaub</i>',\n",
       "   '<i>latanoprosta</i>',\n",
       "   '<i>latanoprosta</i>',\n",
       "   '<i>latanoprosta</i>',\n",
       "   '<i>timolol</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travatan</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   '<i>travoprosta</i>',\n",
       "   'AGN 192024',\n",
       "   'Bimatoprost',\n",
       "   'Bimatoprost',\n",
       "   'Bimatoprosta',\n",
       "   'Latisse',\n",
       "   'Latisse',\n",
       "   'Lumigan',\n",
       "   'Lumigan'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069581': {'ID': 'D000069581',\n",
       "  'name': 'Exposição à Violência[Exposure to Violence]',\n",
       "  'scope': 'Experience of and exposure to VIOLENCE.',\n",
       "  'terms': ['Exposição à Violência',\n",
       "   'Exposure to Violence',\n",
       "   'Violence Exposure',\n",
       "   'Violence, Exposure to'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069582': {'ID': 'D000069582',\n",
       "  'name': 'Zopiclona[Eszopiclone]',\n",
       "  'scope': 'A pyridine, pyrazine, and piperazine derivative that is used as a HYPNOTIC AND SEDATIVE in the treatment of INSOMNIA.',\n",
       "  'terms': ['Estorra',\n",
       "   'Eszopiclona',\n",
       "   'Eszopiclone',\n",
       "   'Lunesta',\n",
       "   'Zopiclona',\n",
       "   'Zopiclone'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069583': {'ID': 'D000069583',\n",
       "  'name': 'Pregabalina[Pregabalin]',\n",
       "  'scope': 'A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.',\n",
       "  'terms': ['(R-)-3-isobutyl GABA',\n",
       "   '(S)-3-(aminomethyl)-5-methylhexanoic acid',\n",
       "   '(S+)-3-isobutyl GABA',\n",
       "   '1008, CI',\n",
       "   '3 isobutyl GABA',\n",
       "   '3-(aminomethyl)-5-methylhexanoic acid',\n",
       "   '3-isobutyl GABA',\n",
       "   '<i>amt</i>',\n",
       "   '<i>lyrica</i>',\n",
       "   '<i>pregabalina</i>',\n",
       "   '<i>pregabalina</i>',\n",
       "   'CI 1008',\n",
       "   'CI-1008',\n",
       "   'CI1008',\n",
       "   'Dorene',\n",
       "   'GABA, 3-isobutyl',\n",
       "   'Lyrica',\n",
       "   'Lyrica',\n",
       "   'Pregabalin',\n",
       "   'Pregabalina'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069584': {'ID': 'D000069584',\n",
       "  'name': 'Neoplasias Unilaterais da Mama[Unilateral Breast Neoplasms]',\n",
       "  'scope': 'Tumors or cancer found specifically in the human left BREAST.',\n",
       "  'terms': ['Breast Cancer, Left-Sided',\n",
       "   'Breast Cancer, Right-Sided',\n",
       "   'Breast Cancer, Unilateral',\n",
       "   'Breast Cancers, Left-Sided',\n",
       "   'Breast Cancers, Right-Sided',\n",
       "   'Breast Cancers, Unilateral',\n",
       "   'Breast Neoplasm, Left-Sided',\n",
       "   'Breast Neoplasm, Right-Sided',\n",
       "   'Breast Neoplasm, Unilateral',\n",
       "   'Breast Neoplasms, Left-Sided',\n",
       "   'Breast Neoplasms, Right-Sided',\n",
       "   'Breast Neoplasms, Unilateral',\n",
       "   'Câncer Mamário Unilateral',\n",
       "   'Câncer de Mama Unilateral',\n",
       "   'Left Sided Breast Cancer',\n",
       "   'Left Sided Breast Neoplasm',\n",
       "   'Left Sided Breast Neoplasms',\n",
       "   'Left-Sided Breast Cancer',\n",
       "   'Left-Sided Breast Cancers',\n",
       "   'Left-Sided Breast Neoplasm',\n",
       "   'Left-Sided Breast Neoplasms',\n",
       "   'Neoplasia da Mama Direita',\n",
       "   'Neoplasia da Mama Esquerda',\n",
       "   'Neoplasias Unilaterais da Mama',\n",
       "   'Neoplasias Unilaterais de Mama',\n",
       "   'Neoplasias da Mama Direita',\n",
       "   'Neoplasias da Mama Esquerda',\n",
       "   'Neoplasias da Mama Unilaterais',\n",
       "   'Neoplasias de Mama Direita',\n",
       "   'Neoplasias de Mama Esquerda',\n",
       "   'Neoplasias de Mama Unilaterais',\n",
       "   'Right Sided Breast Cancer',\n",
       "   'Right Sided Breast Neoplasm',\n",
       "   'Right Sided Breast Neoplasms',\n",
       "   'Right-Sided Breast Cancer',\n",
       "   'Right-Sided Breast Cancers',\n",
       "   'Right-Sided Breast Neoplasm',\n",
       "   'Right-Sided Breast Neoplasms',\n",
       "   'Unilateral Breast Cancer',\n",
       "   'Unilateral Breast Cancers',\n",
       "   'Unilateral Breast Neoplasms'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069585': {'ID': 'D000069585',\n",
       "  'name': 'Filgrastim[Filgrastim]',\n",
       "  'scope': 'A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.',\n",
       "  'terms': ['Filgrastim',\n",
       "   'Filgrastim',\n",
       "   'Filgrastim Sandoz',\n",
       "   'Filgrastim Sndz',\n",
       "   'Filgrastim-Sandoz',\n",
       "   'Filgrastim-Sndz',\n",
       "   'FilgrastimSandoz',\n",
       "   'G CSF Recombinant, Human Methionyl',\n",
       "   'G-CSF Recombinant, Human Methionyl',\n",
       "   'Granulokine',\n",
       "   'Neupogen',\n",
       "   'R metHuG CSF',\n",
       "   'R-metHuG-CSF',\n",
       "   'Recombinant Methionyl Human Granulocyte Colony Stimulating Factor',\n",
       "   'Recombinant-Methionyl Human Granulocyte Colony-Stimulating Factor',\n",
       "   'Topneuter',\n",
       "   'Zarxio'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069586': {'ID': 'D000069586',\n",
       "  'name': 'Adultos Sobreviventes de Eventos Adversos na Infância[Adult Survivors of Child Adverse Events]',\n",
       "  'scope': 'Persons who experienced traumatic events during childhood.',\n",
       "  'terms': ['Adult Survivors of Child Adverse Events',\n",
       "   'Adult Survivors of Childhood Trauma',\n",
       "   'Adultos Sobreviventes a Eventos Adversos na Infância',\n",
       "   'Adultos Sobreviventes a Eventos Traumáticos na Infância',\n",
       "   'Adultos Sobreviventes de Eventos Adversos na Infância',\n",
       "   'Sobreviventes Adultos de Eventos Adversos na Infância',\n",
       "   'Sobreviventes Adultos de Eventos Traumáticos na Infância'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069590': {'ID': 'D000069590',\n",
       "  'name': 'Ligamentos Redondos[Round Ligaments]',\n",
       "  'scope': 'Cord shaped ligament found spanning between the ULNAR and RADIUS bones near the ELBOW JOINT.',\n",
       "  'terms': ['Chorda Obliqua',\n",
       "   'Chorda Obliquas',\n",
       "   'Elbow Round Ligament',\n",
       "   'Elbow Round Ligaments',\n",
       "   'Ligament, Round',\n",
       "   'Ligamento Redondo',\n",
       "   'Ligamentos Redondos',\n",
       "   'Ligaments, Round',\n",
       "   'Ligamentum Tere',\n",
       "   'Ligamentum Teres',\n",
       "   'Oblique Cord',\n",
       "   'Oblique Cords',\n",
       "   'Round Ligament',\n",
       "   'Round Ligament of Elbow',\n",
       "   'Round Ligaments'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069592': {'ID': 'D000069592',\n",
       "  'name': 'Ligamento Redondo do Fígado[Round Ligament of Liver]',\n",
       "  'scope': 'A cord-like remnant structure formed from the closed left fetal UMBILICAL VEIN. It is located along the lower edge of the falciform ligament.',\n",
       "  'terms': ['Hepatic Round Ligament',\n",
       "   'Hepatic Round Ligaments',\n",
       "   'Ligament, Hepatic Round',\n",
       "   'Ligamento Redondo do Fígado',\n",
       "   'Ligaments, Hepatic Round',\n",
       "   'Ligamentum Teres Hepati',\n",
       "   'Ligamentum Teres Hepatis',\n",
       "   'Liver Round Ligament',\n",
       "   'Liver Round Ligaments',\n",
       "   'Round Ligament of Liver',\n",
       "   'Round Ligament, Hepatic',\n",
       "   'Round Ligaments, Hepatic'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069593': {'ID': 'D000069593',\n",
       "  'name': 'Ligamento da Cabeça do Fêmur[Round Ligament of Femur]',\n",
       "  'scope': 'Ligament that connects the fovea of the FEMUR HEAD and the ACETABULUM notch in the HIP JOINT.',\n",
       "  'terms': ['Femur Round Ligament',\n",
       "   'Femur Round Ligaments',\n",
       "   'Ligamento Redondo da Cabeça do Fêmur',\n",
       "   'Ligamento Redondo do Fêmur',\n",
       "   'Ligamento da Cabeça do Fêmur',\n",
       "   'Ligamentum Capitis Femori',\n",
       "   'Ligamentum Capitis Femori',\n",
       "   'Ligamentum Capitis Femoris',\n",
       "   'Ligamentum Capitis Femoris',\n",
       "   'Ligamentum Teres Femori',\n",
       "   'Ligamentum Teres Femoris',\n",
       "   'Round Ligament of Femur'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069594': {'ID': 'D000069594',\n",
       "  'name': 'Abatacepte[Abatacept]',\n",
       "  'scope': 'A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.',\n",
       "  'terms': ['Abatacept',\n",
       "   'Abatacept',\n",
       "   'Abatacepte',\n",
       "   'BMS 188667',\n",
       "   'BMS 224818',\n",
       "   'BMS-188667',\n",
       "   'BMS-224818',\n",
       "   'BMS188667',\n",
       "   'BMS224818',\n",
       "   'Belatacept',\n",
       "   'CTLA-4-Ig',\n",
       "   'CTLA4 Ig Immunoconjugate',\n",
       "   'CTLA4-Fc',\n",
       "   'CTLA4-Ig',\n",
       "   'CTLA4-Ig Immunoconjugate',\n",
       "   'Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin',\n",
       "   'Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin',\n",
       "   'Immunoconjugate, CTLA4-Ig',\n",
       "   'LEA29Y',\n",
       "   'Nulojix',\n",
       "   'Orencia'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069597': {'ID': 'D000069597',\n",
       "  'name': 'Presenteísmo[Presenteeism]',\n",
       "  'scope': 'Reporting for work despite feeling ill.',\n",
       "  'terms': ['Presence, Sickness',\n",
       "   'Presenteeism',\n",
       "   'Presenteísmo',\n",
       "   'Sickness Presence'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069599': {'ID': 'D000069599',\n",
       "  'name': 'Produção Agrícola[Crop Production]',\n",
       "  'scope': 'The science and practice of cultivating PLANTS that have economic value to man. It includes plant breeding, seed production, weeding, use of fertilizers, harvesting, storage, transportation, and marketing.',\n",
       "  'terms': ['Crop Production', 'Production, Crop', 'Produção Agrícola'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069600': {'ID': 'D000069600',\n",
       "  'name': 'Melhoramento Vegetal[Plant Breeding]',\n",
       "  'scope': 'The purposeful manipulation of plant species with the goal of creating desired genotypes and phenotypes, using techniques such as controlled pollination and or genetic engineering, followed by artificial selection of progeny.',\n",
       "  'terms': ['Breeding, Plant',\n",
       "   'Cruzamento de Plantas',\n",
       "   'Fitomelhoramento',\n",
       "   'Melhoramento Genético de Plantas',\n",
       "   'Melhoramento Vegetal',\n",
       "   'Melhoramento de Plantas',\n",
       "   'Plant Breeding'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069601': {'ID': 'D000069601',\n",
       "  'name': 'Proteção de Cultivos[Crop Protection]',\n",
       "  'scope': 'The science and practice of preventing, minimizing, or eliminating damage to AGRICULTURAL CROPS by pest organisms, weeds, and disease-causing agents.',\n",
       "  'terms': ['Crop Protection',\n",
       "   'Protection, Crop',\n",
       "   'Proteção Agrícola',\n",
       "   'Proteção de Cultivos'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069602': {'ID': 'D000069602',\n",
       "  'name': 'Trabalhadores Pobres[Working Poor]',\n",
       "  'scope': 'People who are in the labor force either working or looking for work for 27 weeks or more in a year, but whose income fall below a given poverty line.',\n",
       "  'terms': ['Poor, Working',\n",
       "   'Trabalhador Pobre',\n",
       "   'Trabalhadores Abaixo da Linha de Pobreza',\n",
       "   'Trabalhadores Pobres',\n",
       "   'Working Poor'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069603': {'ID': 'D000069603',\n",
       "  'name': 'Sevelamer[Sevelamer]',\n",
       "  'scope': 'A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.',\n",
       "  'terms': ['Carbonate, Sevelamer',\n",
       "   'Carbonato de Sevelamer',\n",
       "   'Cloridrato de Sevelamer',\n",
       "   'GT335 012',\n",
       "   'GT335-012',\n",
       "   'GT335-012',\n",
       "   'GT335012',\n",
       "   'Hydrochloride, Sevelamer',\n",
       "   'RenaGel',\n",
       "   'Renagel',\n",
       "   'Sevelamer',\n",
       "   'Sevelamer',\n",
       "   'Sevelamer Carbonate',\n",
       "   'Sevelamer Hydrochloride'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069604': {'ID': 'D000069604',\n",
       "  'name': 'Dabigatrana[Dabigatran]',\n",
       "  'scope': 'A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of  thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.',\n",
       "  'terms': ['BIBR 1048',\n",
       "   'Dabigatran',\n",
       "   'Dabigatran Etexilate',\n",
       "   'Dabigatran Etexilate Mesylate',\n",
       "   'Dabigatrana',\n",
       "   'Etexilate Mesylate, Dabigatran',\n",
       "   'Etexilate, Dabigatran',\n",
       "   'Etexilato de Dabigatrana',\n",
       "   'Mesylate, Dabigatran Etexilate',\n",
       "   'N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine',\n",
       "   'Pradaxa',\n",
       "   'Pradaxa'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069605': {'ID': 'D000069605',\n",
       "  'name': 'Cloridrato de Olopatadina[Olopatadine Hydrochloride]',\n",
       "  'scope': 'An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.',\n",
       "  'terms': ['11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid',\n",
       "   '4679, KW',\n",
       "   'Cloridrato de Olopatadina',\n",
       "   'Hidrocloreto de Olopatadina',\n",
       "   'Hydrochloride, Olopatadine',\n",
       "   'KW 4679',\n",
       "   'KW 4943A',\n",
       "   'KW-4679',\n",
       "   'KW-4943A',\n",
       "   'KW4943A',\n",
       "   'Olopatadina',\n",
       "   'Olopatadine',\n",
       "   'Olopatadine Hydrochloride',\n",
       "   'Patanol'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069616': {'ID': 'D000069616',\n",
       "  'name': 'Simeprevir[Simeprevir]',\n",
       "  'scope': 'Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS.',\n",
       "  'terms': ['435, TMC',\n",
       "   '435350, TMC',\n",
       "   'N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide',\n",
       "   'Olysio',\n",
       "   'Olysio',\n",
       "   'Simeprevir',\n",
       "   'Simeprevir',\n",
       "   'TMC 435',\n",
       "   'TMC 435350',\n",
       "   'TMC-435',\n",
       "   'TMC-435350',\n",
       "   'TMC435',\n",
       "   'TMC435350'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069636': {'ID': 'D000069636',\n",
       "  'name': 'Pedestres[Pedestrians]',\n",
       "  'scope': 'Persons traveling on foot.',\n",
       "  'terms': ['Pedestre', 'Pedestres', 'Pedestrians'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069756': {'ID': 'D000069756',\n",
       "  'name': 'Imigrantes Indocumentados[Undocumented Immigrants]',\n",
       "  'scope': 'Foreign nationals residing in a country without legal immigration status, or in violation of the immigration laws of that country.',\n",
       "  'terms': ['Alien, Illegal',\n",
       "   'Alien, Undocumented',\n",
       "   'Aliens, Illegal',\n",
       "   'Aliens, Undocumented',\n",
       "   'Illegal Alien',\n",
       "   'Illegal Aliens',\n",
       "   'Illegal Immigrant',\n",
       "   'Illegal Immigrants',\n",
       "   'Imigrantes Indocumentados',\n",
       "   'Imigrantes sem Documentação',\n",
       "   'Imigrantes sem Documentos',\n",
       "   'Immigrant, Illegal',\n",
       "   'Immigrant, Unauthorized',\n",
       "   'Immigrant, Undocumented',\n",
       "   'Immigrants, Illegal',\n",
       "   'Immigrants, Unauthorized',\n",
       "   'Immigrants, Undocumented',\n",
       "   'Unauthorized Immigrant',\n",
       "   'Unauthorized Immigrants',\n",
       "   'Undocumented Alien',\n",
       "   'Undocumented Aliens',\n",
       "   'Undocumented Immigrant',\n",
       "   'Undocumented Immigrants',\n",
       "   'Undocumented Worker',\n",
       "   'Undocumented Workers',\n",
       "   'Worker, Undocumented',\n",
       "   'Workers, Undocumented'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069796': {'ID': 'D000069796',\n",
       "  'name': 'Tecido Adiposo Bege[Adipose Tissue, Beige]',\n",
       "  'scope': 'Brown fat-like adipose tissue that develops in WHITE ADIPOSE TISSUE from non-MYOGENIC REGULATORY FACTOR 5 expressing cell lineage.',\n",
       "  'terms': ['Adipose Tissue, Beige',\n",
       "   'Adipose Tissue, Brite',\n",
       "   'Adipose Tissues, Beige',\n",
       "   'Adipose Tissues, Brite',\n",
       "   'Beige Adipose Tissue',\n",
       "   'Beige Adipose Tissues',\n",
       "   'Beige Brite Adipose Tissue',\n",
       "   'Beige Brite Fat',\n",
       "   'Beige Brite Fats',\n",
       "   'Beige Fat',\n",
       "   'Brite Adipose Tissue',\n",
       "   'Brite Adipose Tissues',\n",
       "   'Brite Fat',\n",
       "   'Brite Fat, Beige',\n",
       "   'Brite Fats, Beige',\n",
       "   'Fat, Beige',\n",
       "   'Fat, Beige Brite',\n",
       "   'Fat, Brite',\n",
       "   'Fats, Beige Brite',\n",
       "   'Gordura Bege',\n",
       "   'Gordura Bege Brite',\n",
       "   'Gordura Brite',\n",
       "   'Tecido Adiposo Bege',\n",
       "   'Tecido Adiposo Bege Brite',\n",
       "   'Tecido Adiposo Brite',\n",
       "   'Tissue, Beige Adipose',\n",
       "   'Tissue, Brite Adipose',\n",
       "   'Tissues, Beige Adipose',\n",
       "   'Tissues, Brite Adipose'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000069797': {'ID': 'D000069797',\n",
       "  'name': 'Adipócitos Bege[Adipocytes, Beige]',\n",
       "  'scope': 'Brown fat-like cells that develop in the WHITE FAT from non-MYOGENIC REGULATORY FACTOR 5 expressing CELL LINEAGE.',\n",
       "  'terms': ['Adipocyte, Beige',\n",
       "   'Adipocyte, Beige Brite',\n",
       "   'Adipocyte, Brite',\n",
       "   'Adipocytes, Beige',\n",
       "   'Adipocytes, Beige Brite',\n",
       "   'Adipocytes, Brite',\n",
       "   'Adipócitos Bege',\n",
       "   'Adipócitos Bege Brite',\n",
       "   'Adipócitos Brite',\n",
       "   'Adipócitos Marrons-Brancos',\n",
       "   'Beige Adipocyte',\n",
       "   'Beige Adipocytes',\n",
       "   'Beige Brite Adipocyte',\n",
       "   'Beige Brite Adipocytes',\n",
       "   'Beige Brite Cell',\n",
       "   'Beige Brite Cells',\n",
       "   'Beige Fat Cell',\n",
       "   'Beige Fat Cells',\n",
       "   'Brite Adipocyte',\n",
       "   'Brite Adipocyte, Beige',\n",
       "   'Brite Adipocytes',\n",
       "   'Brite Adipocytes, Beige',\n",
       "   'Brite Cell, Beige',\n",
       "   'Brite Cells, Beige',\n",
       "   'Brite Fat Cell',\n",
       "   'Brite Fat Cells',\n",
       "   'Cell, Beige Brite',\n",
       "   'Cell, Beige Fat',\n",
       "   'Cell, Brite Fat',\n",
       "   'Cells, Beige Brite',\n",
       "   'Cells, Beige Fat',\n",
       "   'Cells, Brite Fat',\n",
       "   'Células Adiposas Bege',\n",
       "   'Células Adiposas Brite',\n",
       "   'Células Adiposas Marrons-Brancas',\n",
       "   'Células Bege',\n",
       "   'Células Bege Brite',\n",
       "   'Células Brite',\n",
       "   'Células Gordurosas Bege',\n",
       "   'Células Gordurosas Brite',\n",
       "   'Células Gordurosas Marrons-Brancas',\n",
       "   'Células Marrons-Brancas',\n",
       "   'Células de Gordura Bege',\n",
       "   'Células de Gordura Brite',\n",
       "   'Fat Cell, Beige',\n",
       "   'Fat Cell, Brite',\n",
       "   'Fat Cells, Beige',\n",
       "   'Fat Cells, Brite'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069816': {'ID': 'D000069816',\n",
       "  'name': 'Canais de Translocação SEC[SEC Translocation Channels]',\n",
       "  'scope': 'The SEC translocase of ENDOPLASMIC RETICULUM membranes. The three subunits are SEC61alpha, SEC61beta, and SEC61gamma. Homologs of these subunits are also found in ARCHAEA,',\n",
       "  'terms': ['Canais SEC de Translocação',\n",
       "   'Canais de Translocação SEC',\n",
       "   'Channels, SEC Translocation',\n",
       "   'Channels, SEC61 Translocation',\n",
       "   'Channels, SecYEG Translocation',\n",
       "   'Complex, Sec61',\n",
       "   'Complex, SecYEG',\n",
       "   'Complexes, SEC',\n",
       "   'Complexes, SecYEG',\n",
       "   'Complexos SEC',\n",
       "   'Protein, SEC61',\n",
       "   'Proteins, SEC61',\n",
       "   'Proteins, SecYEG',\n",
       "   'SEC Complexes',\n",
       "   'SEC Translocase',\n",
       "   'SEC Translocation Channels',\n",
       "   'SEC Translocons',\n",
       "   'SEC61 Protein',\n",
       "   'SEC61 Proteins',\n",
       "   'SEC61 Translocase',\n",
       "   'SEC61 Translocation Channels',\n",
       "   'SEC61 Translocon',\n",
       "   'Sec Protein Translocation Systems',\n",
       "   'Sec61 Complex',\n",
       "   'Sec61 Protein Translocation System',\n",
       "   'SecY Translocase',\n",
       "   'SecYEG Complex',\n",
       "   'SecYEG Complexes',\n",
       "   'SecYEG Protein Translocation System',\n",
       "   'SecYEG Proteins',\n",
       "   'SecYEG Translocation Channels',\n",
       "   'SecYEG Translocon',\n",
       "   'Sistemas SEC de Translocação Proteica',\n",
       "   'Sistemas SEC de Translocação de Proteínas',\n",
       "   'Sistemas de Translocação Proteica SEC',\n",
       "   'Sistemas de Translocação de Proteínas SEC',\n",
       "   'Translocase SEC',\n",
       "   'Translocase, SEC',\n",
       "   'Translocase, SEC61',\n",
       "   'Translocase, SecY',\n",
       "   'Translocation Channels, SEC',\n",
       "   'Translocation Channels, SEC61',\n",
       "   'Translocation Channels, SecYEG',\n",
       "   'Translocon, SEC61',\n",
       "   'Translocon, SecYEG',\n",
       "   'Translocons SEC',\n",
       "   'Translocons, SEC'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069836': {'ID': 'D000069836',\n",
       "  'name': 'Desenluvamentos Cutâneos[Degloving Injuries]',\n",
       "  'scope': 'Avulsions of the superficial tissues of SKIN and SUBCUTANEOUS TISSUE from the underlying FASCIA.',\n",
       "  'terms': ['Avulsion Injuries, Skin',\n",
       "   'Avulsion Injury, Skin',\n",
       "   'Avulsion, Skin',\n",
       "   'Avulsions, Skin',\n",
       "   'Avulsão da Pele',\n",
       "   'Degloving Injuries',\n",
       "   'Degloving Injury',\n",
       "   'Degloving Wound',\n",
       "   'Degloving Wounds',\n",
       "   'Desenluvamentos Cutâneos',\n",
       "   'Ferimentos Descolantes',\n",
       "   'Ferimentos Desenluvados',\n",
       "   'Injuries, Degloving',\n",
       "   'Injuries, Skin Avulsion',\n",
       "   'Injury, Degloving',\n",
       "   'Injury, Skin Avulsion',\n",
       "   'Lesões de Avulsão da Pele',\n",
       "   'Lesões por Avulsão da Pele',\n",
       "   'Lesões por Desenluvamento Cutâneo',\n",
       "   'Skin Avulsion',\n",
       "   'Skin Avulsion Injuries',\n",
       "   'Skin Avulsion Injury',\n",
       "   'Skin Avulsions',\n",
       "   'Wound, Degloving',\n",
       "   'Wounds, Degloving'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069856': {'ID': 'D000069856',\n",
       "  'name': 'Cálculos Coraliformes[Staghorn Calculi]',\n",
       "  'scope': 'Renal calculi with a characteristic shape like antlers of a deer, formed as it extends into multiple calices of the RENAL PELVIS. A large number of staghorn calculi as well as other URINARY CALCULI are composed of STRUVITE.',\n",
       "  'terms': ['Calculi, Staghorn',\n",
       "   'Calculus, Staghorn',\n",
       "   'Cálculos Coraliformes',\n",
       "   'Staghorn Calculi',\n",
       "   'Staghorn Calculus'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000069877': {'ID': 'D000069877',\n",
       "  'name': 'Estruvita[Struvite]',\n",
       "  'scope': 'The mineral magnesium ammonium phosphate with the formula NH4MgPO4. It is associated with urea-splitting organisms in a high magnesium, high phosphate, alkaline environment. Accumulation of crystallized struvite is found in the urinary tract as struvite CALCULI and as scale on sewage system equipment and wastewater pipes.',\n",
       "  'terms': ['Ammonium Phosphate, Magnesium',\n",
       "   'Cristais de Estruvita',\n",
       "   'Crystals, Struvite',\n",
       "   'Dittmarita',\n",
       "   'Dittmarite',\n",
       "   'Estruvita',\n",
       "   'Estruvita (H3PO4-NH4-Mg (1:1:1))',\n",
       "   'Fosfato Monoidratado de Amônio e Magnésio',\n",
       "   'Fosfato de Amônio e Magnésio',\n",
       "   'Fosfato de Amônio e Magnésio Hexaidratado',\n",
       "   'Fosfato de Amônio e Magnésio Hexaidrato',\n",
       "   'Fosfato de Amônio e Magnésio Monoidratado',\n",
       "   'Fosfato de Amônio e Magnésio Monoidrato',\n",
       "   'Magnesium Ammonium Phosphate',\n",
       "   'Magnesium Ammonium Phosphate Hexahydrate',\n",
       "   'Magnesium Ammonium Phosphate Monohydrate',\n",
       "   'Phosphate, Magnesium Ammonium',\n",
       "   'Struvite',\n",
       "   'Struvite (H3PO4-NH4-Mg (1:1:1))',\n",
       "   'Struvite Crystals'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069896': {'ID': 'D000069896',\n",
       "  'name': 'Nucleases dos Efetores Semelhantes a Ativadores de Transcrição[Transcription Activator-Like Effector Nucleases]',\n",
       "  'scope': 'Artificial nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS. They are composed of an endodeoxyribonuclease fused to DNA-binding domains of the transcription activator-like effectors.',\n",
       "  'terms': ['Nucleases Efetoras Semelhantes a Ativadores de Transcrição',\n",
       "   'Nucleases dos Efetores Semelhantes a Ativadores de Transcrição',\n",
       "   'Nucleases, Transcription Activator Like Effector',\n",
       "   'Nucleases, Transcription Activator-Like Effector',\n",
       "   'TALENs',\n",
       "   'TALENs',\n",
       "   'Transcription Activator Like Effector Nucleases',\n",
       "   'Transcription Activator-Like Effector Nucleases'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069916': {'ID': 'D000069916',\n",
       "  'name': 'Ressecção Endoscópica de Mucosa[Endoscopic Mucosal Resection]',\n",
       "  'scope': 'A method for removing lesions from gastrointestinal MUCOUS MEMBRANES. The mucosal  tissue with the lesion is elevated by injecting a solution into the submucosal layer underneath it. Then a top layer of submucosal tissue below the fluid is dissected with an endoscopic scapel to remove the tissue with the lesion.',\n",
       "  'terms': ['Biopsies, Strip',\n",
       "   'Biopsy, Strip',\n",
       "   'Biópsia em Losango',\n",
       "   'Biópsia pelo Método de Canal Duplo',\n",
       "   'Biópsia por Laçamento',\n",
       "   'Dissection, Endoscopic Submucosal',\n",
       "   'Dissections, Endoscopic Submucosal',\n",
       "   'Endoscopic Mucosal Resection',\n",
       "   'Endoscopic Mucosal Resections',\n",
       "   'Endoscopic Mucous Membrane Resection',\n",
       "   'Endoscopic Submucosal Dissection',\n",
       "   'Endoscopic Submucosal Dissections',\n",
       "   'Mucosal Resection, Endoscopic',\n",
       "   'Mucosal Resections, Endoscopic',\n",
       "   'Mucosectomia Endoscópica',\n",
       "   'Resection, Endoscopic Mucosal',\n",
       "   'Resections, Endoscopic Mucosal',\n",
       "   'Ressecção Endoscópica da Submucosa',\n",
       "   'Ressecção Endoscópica de Membrana Mucosa',\n",
       "   'Ressecção Endoscópica de Mucosa',\n",
       "   'Strip Biopsies',\n",
       "   'Strip Biopsy',\n",
       "   'Strip Biopsy',\n",
       "   'Submucosal Dissection, Endoscopic',\n",
       "   'Submucosal Dissections, Endoscopic'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000069956': {'ID': 'D000069956',\n",
       "  'name': 'Chocolate[Chocolate]',\n",
       "  'scope': 'Food product prepared from fermenting, roasting, and grinding the seeds of the COCOA plant.',\n",
       "  'terms': ['<i>balas</i>',\n",
       "   '<i>balas</i>',\n",
       "   '<i>balas</i>',\n",
       "   '<i>biscoitos</i>',\n",
       "   '<i>biscoitos</i>',\n",
       "   '<i>biscoitos</i>',\n",
       "   '<i>bolachas</i>',\n",
       "   '<i>chocolate</i>',\n",
       "   '<i>chocolates</i>',\n",
       "   '<i>chocolates</i>',\n",
       "   '<i>doces</i>',\n",
       "   '<i>doces</i>',\n",
       "   '<i>frito</i>',\n",
       "   '<i>frito</i>',\n",
       "   '<i>iogurte</i>',\n",
       "   '<i>iogurte</i>',\n",
       "   '<i>linguica</i>',\n",
       "   '<i>maionese</i>',\n",
       "   '<i>maionese</i>',\n",
       "   '<i>pizza</i>',\n",
       "   '<i>pizza</i>',\n",
       "   '<i>pizza</i>',\n",
       "   '<i>refri</i>',\n",
       "   '<i>refri</i>',\n",
       "   '<i>refrigerantes</i>',\n",
       "   '<i>refrigerantes</i>',\n",
       "   '<i>refrigerantes</i>',\n",
       "   '<i>salgadinhos</i>',\n",
       "   '<i>salgados</i>',\n",
       "   '<i>sorvete</i>',\n",
       "   'Chocolate',\n",
       "   'Chocolate',\n",
       "   'Chocolates',\n",
       "   'Cocoa Powder',\n",
       "   'Cocoa Powders',\n",
       "   'Powder, Cocoa',\n",
       "   'Powders, Cocoa',\n",
       "   'Pó de Cacau'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069976': {'ID': 'D000069976',\n",
       "  'name': 'Bacillus licheniformis[Bacillus licheniformis]',\n",
       "  'scope': 'A species of  Bacillus that occurs in soil and is frequently found on bird feathers. Some strains cause FOODBORNE DISEASE, whereas other strains produce ANTIFUNGAL AGENTS and ANTIBACTERIAL AGENTS and function as PROBIOTICS. This species can also produce enzymes for industrial applications.',\n",
       "  'terms': ['Bacillus licheniformis', 'Bacillus licheniformis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069977': {'ID': 'D000069977',\n",
       "  'name': 'Bacillus amyloliquefaciens[Bacillus amyloliquefaciens]',\n",
       "  'scope': 'A non-pathogenic species of Bacillus that occurs in soil as well as some fermented vegetables and FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and ANTIFUNGAL AGENTS and is used in FOOD PRESERVATION as well as a PROBIOTIC.',\n",
       "  'terms': ['Bacillus amyloliquefaciens', 'Bacillus amyloliquefaciens'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069978': {'ID': 'D000069978',\n",
       "  'name': 'Bifidobacterium longum[Bifidobacterium longum]',\n",
       "  'scope': 'A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It inhibits the growth of pathogenic bacteria, may modulate the immune response, and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium longum', 'Bifidobacterium longum'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069979': {'ID': 'D000069979',\n",
       "  'name': 'Bacillus pumilus[Bacillus pumilus]',\n",
       "  'scope': 'A species of Bacillus that occurs in soil, especially around the roots of some plants where it has anti-fungal and anti-nematode activities. It can also produce enzymes for industrial applications.',\n",
       "  'terms': ['Bacillus pumilus', 'Bacillus pumilus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069980': {'ID': 'D000069980',\n",
       "  'name': 'Lactobacillus paracasei[Lactobacillus paracasei]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in the GUT MICROBIOTA of healthy humans as well as FERMENTED DAIRY PRODUCTS and fermented vegetables. It is used as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus paracasei', 'Lactobacillus paracasei'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069981': {'ID': 'D000069981',\n",
       "  'name': 'Escherichia coli O104[Escherichia coli O104]',\n",
       "  'scope': 'An enterohemorrhagic Escherichia coli of the O subfamily that can cause severe FOODBORNE DISEASE. The H4 serotype strain produces SHIGA TOXINS and has been linked to human disease outbreaks, including some cases of HEMOLYTIC-UREMIC SYNDROME, resulting from contamination of foods by feces containing E. coli O104.',\n",
       "  'terms': ['E coli O104',\n",
       "   'E coli O104',\n",
       "   'E coli O104-H4',\n",
       "   'E coli O104-H4',\n",
       "   'Escherichia coli O104',\n",
       "   'Escherichia coli O104',\n",
       "   'Escherichia coli O104-H4',\n",
       "   'Escherichia coli O104-H4'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069982': {'ID': 'D000069982',\n",
       "  'name': 'Bifidobacterium animalis[Bifidobacterium animalis]',\n",
       "  'scope': 'A species of Bifidobacterium that occurs in the LARGE INTESTINE of humans and other mammals and in FERMENTED DAIRY PRODUCTS. It is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium BB-12',\n",
       "   'Bifidobacterium BB-12',\n",
       "   'Bifidobacterium animalis',\n",
       "   'Bifidobacterium animalis',\n",
       "   'Bifidobacterium animalis animalis',\n",
       "   'Bifidobacterium animalis lactis',\n",
       "   'Bifidobacterium animalis subsp animalis',\n",
       "   'Bifidobacterium animalis subsp lactis',\n",
       "   'Bifidobacterium lactis',\n",
       "   'Bifidobacterium lactis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069983': {'ID': 'D000069983',\n",
       "  'name': 'Saccharomyces boulardii[Saccharomyces boulardii]',\n",
       "  'scope': 'A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.',\n",
       "  'terms': ['Saccharomyces boulardii',\n",
       "   'Saccharomyces boulardii',\n",
       "   'Saccharomyces boulardius',\n",
       "   'boulardii, Saccharomyces',\n",
       "   'boulardius, Saccharomyces'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069984': {'ID': 'D000069984',\n",
       "  'name': 'Bifidobacterium breve[Bifidobacterium breve]',\n",
       "  'scope': 'A species of Bifidobacterium present in the human GUT MICROBIOTA. It is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium breve', 'Bifidobacterium breve'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069985': {'ID': 'D000069985',\n",
       "  'name': 'Bifidobacterium bifidum[Bifidobacterium bifidum]',\n",
       "  'scope': 'A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT, especially in infants, and in FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium bifidum', 'Bifidobacterium bifidum'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069996': {'ID': 'D000069996',\n",
       "  'name': 'Lactobacillus salivarius[Lactobacillus salivarius]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and ORAL MUCOSA. It produces BACTERIOCINS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus salivarius', 'Lactobacillus salivarius'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069997': {'ID': 'D000069997',\n",
       "  'name': 'Resina Mástique[Mastic Resin]',\n",
       "  'scope': 'Dried tree sap from the MASTIC TREE that is used in TRADITIONAL MEDICINE and chewed as gum.',\n",
       "  'terms': ['Breu',\n",
       "   'Goma Mástique',\n",
       "   'Gum Mastic',\n",
       "   'Gum, Mastic',\n",
       "   'Mastic Gum',\n",
       "   'Mastic Resin',\n",
       "   'Mastic, Gum',\n",
       "   'Mastisol',\n",
       "   'Mastisol',\n",
       "   'Mástique',\n",
       "   'Resin, Mastic',\n",
       "   'Resina Mástique'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000069998': {'ID': 'D000069998',\n",
       "  'name': 'Lactobacillus gasseri[Lactobacillus gasseri]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in the human ORAL MUCOSA; GASTROINTESTINAL TRACT; and VAGINA. It produces BACTERIOCINS, can modulate the immune response, and is used as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus gasseri', 'Lactobacillus gasseri'],\n",
       "  'qualifier': '#'},\n",
       " 'D000069999': {'ID': 'D000069999',\n",
       "  'name': 'Lactobacillus johnsonii[Lactobacillus johnsonii]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It produces BACTERIOCINS and HYDROGEN PEROXIDE and is used as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus johnsonii', 'Lactobacillus johnsonii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070': {'ID': 'D000070',\n",
       "  'name': 'Acebutolol[Acebutolol]',\n",
       "  'scope': 'A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.',\n",
       "  'terms': ['Acebutolol',\n",
       "   'Acebutolol',\n",
       "   'Acebutolol Hydrochloride',\n",
       "   'Acetobutolol',\n",
       "   'Apo Acebutolol',\n",
       "   'Apo-Acebutolol',\n",
       "   'ApoAcebutolol',\n",
       "   'M & B 17803A',\n",
       "   'M&B 17803 A',\n",
       "   'M&B-17803 A',\n",
       "   'M&B17803 A',\n",
       "   'Monitan',\n",
       "   'Neptal',\n",
       "   'Novo Acebutolol',\n",
       "   'Novo-Acebutolol',\n",
       "   'NovoAcebutolol',\n",
       "   'Prent',\n",
       "   'Rhotral',\n",
       "   'Sectral'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070000': {'ID': 'D000070000',\n",
       "  'name': 'Bacillus coagulans[Bacillus coagulans]',\n",
       "  'scope': 'A microaerophilic, LACTIC ACID producing species of Bacillus that occurs in fermented foods. It also produces ANTI-INFECTIVE AGENTS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bacillus coagulans',\n",
       "   'Bacillus coagulans',\n",
       "   'Lactobacillus sporogenes',\n",
       "   'Lactobacillus sporogenes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070001': {'ID': 'D000070001',\n",
       "  'name': 'Streptococcus salivarius[Streptococcus salivarius]',\n",
       "  'scope': 'A species of Streptococcus that occurs in the human oral cavity and upper respiratory tract. It is a constituent of DENTAL PLAQUE and some strains may be pathogenic if they enter the bloodstream. However, other strains such as Streptococcus salivarius K12 produce BACTERIOCINS and are used as PROBIOTICS.',\n",
       "  'terms': ['Streptococcus salivarius', 'Streptococcus salivarius'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070002': {'ID': 'D000070002',\n",
       "  'name': 'Propionibacterium freudenreichii[Propionibacterium freudenreichii]',\n",
       "  'scope': 'A species of Propionibacterium that occurs in raw milk and cheese. It produces ANTI-INFECTIVE AGENTS and ANTI-INFLAMMATORY AGENTS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Propionibacterium freudenreichii',\n",
       "   'Propionibacterium freudenreichii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070003': {'ID': 'D000070003',\n",
       "  'name': 'Lactobacillus crispatus[Lactobacillus crispatus]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and the VAGINA of healthy women. It produces LACTIC ACID and HYDROGEN PEROXIDE, and is used as a PROBIOTIC. It is also used for the treatment and prevention of BACTERIAL VAGINOSIS.',\n",
       "  'terms': ['Lactobacillus crispatus', 'Lactobacillus crispatus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070004': {'ID': 'D000070004',\n",
       "  'name': 'Ocimum sanctum[Ocimum sanctum]',\n",
       "  'scope': 'A plant species of the genus OCIMUM, family LAMIACEAE that has been used in TRADITIONAL MEDICINE.',\n",
       "  'terms': ['Basil, Holy',\n",
       "   'Basils, Holy',\n",
       "   'Holy Basil',\n",
       "   'Holy Basils',\n",
       "   'Manjericão Sagrado',\n",
       "   'Manjericão-Santo',\n",
       "   'Ocimum sanctum',\n",
       "   'Ocimum sanctum',\n",
       "   'Ocimum tenuiflorum',\n",
       "   'Ocimum tenuiflorum',\n",
       "   'Tulasi',\n",
       "   'Tulsi'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070005': {'ID': 'D000070005',\n",
       "  'name': 'Bifidobacterium adolescentis[Bifidobacterium adolescentis]',\n",
       "  'scope': 'A species of Bifidobacterium that occurs in the GASTROINTESTINAL TRACT of mammals and healthy humans from birth until late adulthood. It produces ANTI-VIRAL AGENTS and ANTI-INFLAMMATORY AGENTS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium adolescentis', 'Bifidobacterium adolescentis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070006': {'ID': 'D000070006',\n",
       "  'name': 'Pediococcus pentosaceus[Pediococcus pentosaceus]',\n",
       "  'scope': 'A species of Pediococcus that occurs in fermented foods where its ability to produce LACTIC ACID and PEDIOCINS make it useful as a FOOD PRESERVATION agent. It is also used as a PROBIOTIC.',\n",
       "  'terms': ['Pediococcus pentosaceus', 'Pediococcus pentosaceus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070007': {'ID': 'D000070007',\n",
       "  'name': 'Leuconostoc mesenteroides[Leuconostoc mesenteroides]',\n",
       "  'scope': 'A species of Leuconostoc that occurs on fruits and vegetables and in their fermented products, as well as FERMENTED DAIRY PRODUCTS. It produces LACTIC ACID and BACTERIOCINS and is used as a PROBIOTIC; however, it has also caused infections in immunocompromised patients.',\n",
       "  'terms': ['Leuconostoc mesenteroides', 'Leuconostoc mesenteroides'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070016': {'ID': 'D000070016',\n",
       "  'name': 'Pediococcus acidilactici[Pediococcus acidilactici]',\n",
       "  'scope': 'A species of Pediococcus that occurs in fermented foods where its ability to produce LACTIC ACID and PEDIOCINS makes it useful in FOOD PRESERVATION. It is also used as a PROBIOTIC.',\n",
       "  'terms': ['Pediococcus acidilactici', 'Pediococcus acidilactici'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070017': {'ID': 'D000070017',\n",
       "  'name': 'Pediocinas[Pediocins]',\n",
       "  'scope': 'Bacteriocins produced by species of PEDIOCOCCUS. They range from 3.5-4.6 kDa in mass, contain a conserved YGNGVXCXK motif and beta sheet at their N-terminals, and a more diverse hydrophobic or amphiphilic C-terminal alpha helical domain. They function as antimicrobial peptides against several pathogenic species of GRAM POSITIVE BACTERIA, including LISTERIA MONOCYTOGENES and are useful as FOOD PRESERVATIVES.',\n",
       "  'terms': ['Pediocinas', 'Pediocins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070018': {'ID': 'D000070018',\n",
       "  'name': 'Lactobacillus pentosus[Lactobacillus pentosus]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in fermented foods where its ability to produce LACTIC ACID; ANTI-INFECTIVE AGENTS; and BACTERIOCINS make it useful as a FOOD PRESERVATION agent. It is also used as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus pentosus', 'Lactobacillus pentosus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070019': {'ID': 'D000070019',\n",
       "  'name': 'Bacillus clausii[Bacillus clausii]',\n",
       "  'scope': 'An alkalophilic species of Bacillus that occurs in soil. It produces ANTI-BACTERIAL AGENTS and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bacillus clausii', 'Bacillus clausii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070036': {'ID': 'D000070036',\n",
       "  'name': 'Faecalibacterium[Faecalibacterium]',\n",
       "  'scope': 'A genus of Gram-negative, non-spore forming, anaerobic, rod shaped bacteria in the Ruminococcaceae family, order Clostridiales that occur in the human gut.',\n",
       "  'terms': ['Faecalibacterium', 'Faecalibacterium'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070037': {'ID': 'D000070037',\n",
       "  'name': 'Faecalibacterium prausnitzii[Faecalibacterium prausnitzii]',\n",
       "  'scope': 'A species of FAECALIBACTERIUM, previously classified in the FUSOBACTERIUM genus, that is a major constituent of the GUT MICROBIOTA in healthy humans. It has anti-inflammatory activity and reduced numbers of this species occur in patients with INFLAMMATORY BOWEL DISEASES such as CROHN DISEASE.',\n",
       "  'terms': ['Faecalibacterium prausnitzii',\n",
       "   'Faecalibacterium prausnitzii',\n",
       "   'Fusobacterium prausnitzii',\n",
       "   'Fusobacterium prausnitzii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070057': {'ID': 'D000070057',\n",
       "  'name': 'Paenibacillus polymyxa[Paenibacillus polymyxa]',\n",
       "  'scope': 'A species of Paenibacillus formerly classified as Bacillus polymyxa that occurs in marine sediments and soil, especially around plant roots and RHIZOMES where it performs NITROGEN FIXATION. It has activity against several species of pathogenic bacteria and produces POLYMYXINS.',\n",
       "  'terms': ['Bacillus polymyxa',\n",
       "   'Bacillus polymyxa',\n",
       "   'Paenibacillus polymyxa',\n",
       "   'Paenibacillus polymyxa'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070058': {'ID': 'D000070058',\n",
       "  'name': 'Streptococcus iniae[Streptococcus iniae]',\n",
       "  'scope': 'A species of Streptococcus that is pathogenic in fish and may also cause disease in humans who routinely handle infected fish. Those who are of Asian descent, elderly, or have chronic diseases such as DIABETES MELLITUS; RHEUMATIC HEART DISEASE; or LIVER CIRRHOSIS are more susceptible to Streptococcus iniae infections.',\n",
       "  'terms': ['Streptococcus iniae', 'Streptococcus iniae'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070059': {'ID': 'D000070059',\n",
       "  'name': 'Paenibacillus larvae[Paenibacillus larvae]',\n",
       "  'scope': 'A species of Paenibacillus that causes American Foulbrood, a fatal disease of honeybees (APIS) and honeybee colonies.',\n",
       "  'terms': ['Paenibacillus larvae', 'Paenibacillus larvae'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070060': {'ID': 'D000070060',\n",
       "  'name': 'Bdellovibrio bacteriovorus[Bdellovibrio bacteriovorus]',\n",
       "  'scope': 'A non-pathogenic, obligate aerobic, Gram-negative species of Bdellovibrio that occurs in water and soil, as well as the intestines of birds and mammals. It can infect and lyse pathogenic GRAM-NEGATIVE BACTERIA and can function as a PROBIOTIC and ANTI-BACTERIAL AGENT.',\n",
       "  'terms': ['Bdellovibrio bacteriovorus', 'Bdellovibrio bacteriovorus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070076': {'ID': 'D000070076',\n",
       "  'name': 'Streptococcus faecium ATCC 9790[Enterococcus hirae]',\n",
       "  'scope': 'A species of Enterococcus that occurs in the GASTROINTESTINAL TRACT of birds and mammals, and to a lesser extent humans. Some strains cause diseases including DIARRHEA; BACTEREMIA; and ENDOCARDITIS  in humans and animals.',\n",
       "  'terms': ['Enterococcus hirae',\n",
       "   'Streptococcus faecalis ATCC 9790',\n",
       "   'Streptococcus faecalis ATCC 9790',\n",
       "   'Streptococcus faecium ATCC 9790',\n",
       "   'Streptococcus faecium ATCC 9790'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070077': {'ID': 'D000070077',\n",
       "  'name': 'Bacteroides thetaiotaomicron[Bacteroides thetaiotaomicron]',\n",
       "  'scope': 'A species of Bacteroides that is a major constituent of the human GUT MICROBIOTA. It normally produces enzymes important for the digestion of vegetable matter. However, it can also cause OPPORTUNISTIC INFECTIONS that result in intra-abdominal SEPSIS; BACTEREMIA; and PERITONITIS.',\n",
       "  'terms': ['Bacteroides thetaiotaomicron', 'Bacteroides thetaiotaomicron'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070079': {'ID': 'D000070079',\n",
       "  'name': 'Aeromonas veronii[Aeromonas veronii]',\n",
       "  'scope': 'A species of Aeromonas that occurs mostly as single cells in soil and freshwater environments. It also inhabits the digestive tract of the leech HIRUDO MEDICINALIS, where it aids in the digestion of blood and prevents colonization by other bacteria. It is pathogenic in fish and potentially in humans who consume infected fish or immunocompromised patients receiving LEECH THERAPY.',\n",
       "  'terms': ['Aeromonas veronii', 'Aeromonas veronii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070096': {'ID': 'D000070096',\n",
       "  'name': 'Pseudomonas chlororaphis[Pseudomonas chlororaphis]',\n",
       "  'scope': 'A non-pathogenic species of Pseudomonas that occurs in soil, especially in the RHIZOSPHERE surrounding plant roots, as well as on the leaves of plants. It has anti-fungal and anti-nematode activities and is used in agriculture as a biocontrol agent.',\n",
       "  'terms': ['Pseudomonas chlororaphis', 'Pseudomonas chlororaphis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070097': {'ID': 'D000070097',\n",
       "  'name': 'Butyrivibrio fibrisolvens[Butyrivibrio fibrisolvens]',\n",
       "  'scope': 'A species of Butyrivibrio that occurs primarily in the RUMEN where it has important activities in LIPID METABOLISM and the production of BUTYRATES.',\n",
       "  'terms': ['Butyrivibrio fibrisolvens', 'Butyrivibrio fibrisolvens'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070098': {'ID': 'D000070098',\n",
       "  'name': 'Bacillus firmus[Bacillus firmus]',\n",
       "  'scope': 'A species of Bacillus that occurs in soil and marine sediments. Many strains are alkalophilic and able to metabolize HEAVY METALS; it may therefore be a useful species for ENVIRONMENTAL BIODEGRADATION.',\n",
       "  'terms': ['Bacillus firmus', 'Bacillus firmus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070099': {'ID': 'D000070099',\n",
       "  'name': 'Streptococcus gallolyticus[Streptococcus gallolyticus]',\n",
       "  'scope': 'A species of Streptococcus that occurs in the GASTROINTESTINAL TRACT of birds, mammals and healthy humans.',\n",
       "  'terms': ['Streptococcus gallolyticus', 'Streptococcus gallolyticus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070100': {'ID': 'D000070100',\n",
       "  'name': 'Setor Informal[Informal Sector]',\n",
       "  'scope': 'A component of the private sector characterized by ease of entry; reliance on indigenous resources; family ownership; small scale operations;  skills acquired outside of the formal sector; and unregulated markets.',\n",
       "  'terms': ['Informal Sector', 'Sector, Informal', 'Setor Informal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070101': {'ID': 'D000070101',\n",
       "  'name': 'Megasphaera elsdenii[Megasphaera elsdenii]',\n",
       "  'scope': 'A species of Megasphaera that occurs primarily in the RUMEN and is able to metabolize LACTIC ACID.',\n",
       "  'terms': ['Megasphaera elsdenii', 'Megasphaera elsdenii'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070116': {'ID': 'D000070116',\n",
       "  'name': 'Loteae[Loteae]',\n",
       "  'scope': 'A tribe of the PEA FAMILY. The genus Lotus, a member of this tribe and formerly known as Tetragonolobus, is unrelated to other plants with the common name of lotus (NELUMBO and NYMPHAEA).',\n",
       "  'terms': ['Loteae',\n",
       "   'Loteae',\n",
       "   'Lotus arabicus',\n",
       "   'Lotus corniculatus',\n",
       "   'Lotus corniculatus',\n",
       "   'Lotus japonicus',\n",
       "   'Lotus japonicus',\n",
       "   'Trefoil',\n",
       "   'Trefoils',\n",
       "   'Trifólio',\n",
       "   'arabicus, Lotus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070136': {'ID': 'D000070136',\n",
       "  'name': 'Proteínas Associadas a Gotículas Lipídicas[Lipid Droplet Associated Proteins]',\n",
       "  'scope': 'Proteins, such as PERILIPINS, that localize to LIPID DROPLETS either transiently or constitutively.',\n",
       "  'terms': ['Lipid Droplet Associated Proteins',\n",
       "   'Lipid Droplet Coat Proteins',\n",
       "   'Lipid Droplet Proteins',\n",
       "   'Proteins, Lipid Droplet',\n",
       "   'Proteínas Associadas a Gotículas Lipídicas',\n",
       "   'Proteínas de Gotículas Lipídicas',\n",
       "   'Proteínas de Gotículas de Lipídeos',\n",
       "   'Proteínas de Revestimento de Gotículas Lipídicas'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070137': {'ID': 'D000070137',\n",
       "  'name': 'Perilipinas[Perilipins]',\n",
       "  'scope': 'A family of vertebrate and insect lipid droplet associated proteins. They consist of a conserved N-terminal PAT domain (an alpha-helical region of about 110 amino acids), an 11-mer repeat region, and lipid-binding hydrophobic regions or 4-helix bundles near their C-termini. Perilipins transiently or constitutively localize to LIPID DROPLETS in ADIPOCYTES and FOAM CELLS, especially in regions adjacent to the PLASMA MEMBRANE and ENDOPLASMIC RECTICULUM. They are critical for lipid droplet synthesis and homeostasis as well as the regulation of lipid metabolism. Genetic variations in perilipins are associated with ATHEROSCLEROSIS; OBESITY; and DIABETES MELLITUS.',\n",
       "  'terms': ['PAT Proteins',\n",
       "   'PLIN Proteins',\n",
       "   'Perilipin Adipophilin TIP47 Proteins',\n",
       "   'Perilipin Proteins',\n",
       "   'Perilipin-Adipophilin-TIP47 Proteins',\n",
       "   'Perilipinas',\n",
       "   'Perilipins',\n",
       "   'Proteins, PAT',\n",
       "   'Proteins, PLIN',\n",
       "   'Proteins, Perilipin',\n",
       "   'Proteins, Perilipin-Adipophilin-TIP47',\n",
       "   'Proteínas PAT',\n",
       "   'Proteínas PLIN',\n",
       "   'Proteínas Perilipina-Adipofilina-TIP47',\n",
       "   'Proteínas Perilipinas'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070156': {'ID': 'D000070156',\n",
       "  'name': 'Receptores Nogo[Nogo Receptors]',\n",
       "  'scope': 'GPI-linked proteins consisting of eight elongated leucine-rich repeats at their N-temini that are connected to the GPI  by a \"stalk\" region rich in prolines, serines and threonines. They bind to NOGO PROTEIN; however, some Nogo receptors also bind MYELIN ASSOCIATED GLYCOPROTEIN and other cell surface glycoproteins. Interactions between nogo receptors and their ligands modulate nerve growth and NEURONAL PLASTICITY.',\n",
       "  'terms': ['Nogo Receptors', 'Receptores Nogo', 'Receptors, Nogo'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070177': {'ID': 'D000070177',\n",
       "  'name': 'Pogostemon[Pogostemon]',\n",
       "  'scope': 'Genus in the Lamiaceae family. VOLATILE OILS from several species of Pogostemon are used in PERFUME; INSECT REPELLENTS; and ALTERNATIVE THERAPIES.',\n",
       "  'terms': ['Falso-Pachuli',\n",
       "   'Patchouli',\n",
       "   'Patchuli',\n",
       "   'Pogostemon',\n",
       "   'Pogostemon',\n",
       "   'Pogostemon cablin',\n",
       "   'Pogostemon cablin',\n",
       "   'Pogostemon heyneanus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070197': {'ID': 'D000070197',\n",
       "  'name': 'Streptococcus gallolyticus subspecies gallolyticus[Streptococcus gallolyticus subspecies gallolyticus]',\n",
       "  'scope': 'A subspecies of Streptococcus gallolyticus. It and other subspecies have been reported to cause infections resulting in BACTEREMIA; ENDOCARDITIS; and neonatal MENINGITIS.',\n",
       "  'terms': ['Streptococcus bovis biotipo I',\n",
       "   'Streptococcus bovis biotype I',\n",
       "   'Streptococcus gallolyticus gallolyticus',\n",
       "   'Streptococcus gallolyticus ssp. gallolyticus',\n",
       "   'Streptococcus gallolyticus subespécie gallolyticus',\n",
       "   'Streptococcus gallolyticus subsp. gallolyticus',\n",
       "   'Streptococcus gallolyticus subsp. gallolyticus',\n",
       "   'Streptococcus gallolyticus subspecies gallolyticus',\n",
       "   'Streptococcus gallolyticus subspecies gallolyticus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070216': {'ID': 'D000070216',\n",
       "  'name': 'Psacalium[Psacalium]',\n",
       "  'scope': 'A genus of the Asteraceae family. Several of its species are used in TRADITIONAL MEDICINE.',\n",
       "  'terms': ['Arbusto Indiano',\n",
       "   'Arbusto Indiano do Deserto',\n",
       "   'Cacalia decomposita',\n",
       "   'Cacalia decomposita',\n",
       "   'Desert Indianbush',\n",
       "   'Indianbush',\n",
       "   'Indianbush, Desert',\n",
       "   'Matarique',\n",
       "   'Matarique',\n",
       "   'Matariques',\n",
       "   'Odontotrichum decompositum',\n",
       "   'Odontotrichum decompositum',\n",
       "   'Psacalium',\n",
       "   'Psacalium',\n",
       "   'Psacalium decompositum',\n",
       "   'Psacalium decompositum',\n",
       "   'Psacalium peltatum',\n",
       "   'Psacalium peltatum',\n",
       "   'Psacalium peltatums',\n",
       "   'peltatum, Psacalium',\n",
       "   'peltatums, Psacalium'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070236': {'ID': 'D000070236',\n",
       "  'name': 'Bifidobacterium longum subspecies infantis[Bifidobacterium longum subspecies infantis]',\n",
       "  'scope': 'A subspecies of Bifidobacterium longum that occurs in the GASTROINTESTINAL TRACT of human infants and is used as a PROBIOTIC. It may also be used in the treatment of IRRITABLE BOWEL SYNDROME.',\n",
       "  'terms': ['Bifidobacterium infantis',\n",
       "   'Bifidobacterium infantis',\n",
       "   'Bifidobacterium longum infantis',\n",
       "   'Bifidobacterium longum ssp. infantis',\n",
       "   'Bifidobacterium longum ssp. infantis',\n",
       "   'Bifidobacterium longum subespécie infantis',\n",
       "   'Bifidobacterium longum subsp. infantis',\n",
       "   'Bifidobacterium longum subspecies infantis',\n",
       "   'Bifidobacterium longum subspecies infantis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070256': {'ID': 'D000070256',\n",
       "  'name': 'Lactobacillus sakei[Lactobacillus sakei]',\n",
       "  'scope': 'A species of Lactobacillus that occurs in fermented meat and fish. It produces the BACTERIOCIN Sakacin P and is used for FOOD PRESERVATION and as a PROBIOTIC.',\n",
       "  'terms': ['Lactobacillus sakei', 'Lactobacillus sakei'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070257': {'ID': 'D000070257',\n",
       "  'name': 'Bifidobacterium pseudocatenulatum[Bifidobacterium pseudocatenulatum]',\n",
       "  'scope': 'A species of Bifidobacterium that occurs in the GASTROINTESTINAL TRACT of mammals and healthy humans. It has anti-inflammatory activity and is used as a PROBIOTIC.',\n",
       "  'terms': ['Bifidobacterium pseudocatenulatum',\n",
       "   'Bifidobacterium pseudocatenulatum'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070260': {'ID': 'D000070260',\n",
       "  'name': 'Capacitação de Professores[Teacher Training]',\n",
       "  'scope': 'A curriculum-centered process of equipping individuals with professional knowledge and skills required to become effective teachers.',\n",
       "  'terms': ['Capacitação de Capacitadores',\n",
       "   'Capacitação de Professores',\n",
       "   'Capacitação de Treinadores',\n",
       "   'Education, Teacher',\n",
       "   'Educação de Professores',\n",
       "   'Teacher Education',\n",
       "   'Teacher Training',\n",
       "   'Trainers Training',\n",
       "   'Training of Trainers',\n",
       "   'Training, Teacher'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070263': {'ID': 'D000070263',\n",
       "  'name': 'Higiene do Sono[Sleep Hygiene]',\n",
       "  'scope': \"Habits and practices conducive to getting the right amount and quality of sleep, and include  responding to environmental factors that may influence one's sleep.\",\n",
       "  'terms': ['Bons Hábitos de Sono',\n",
       "   'Bons Hábitos do Sono',\n",
       "   'Good Sleep Habit',\n",
       "   'Good Sleep Habits',\n",
       "   'Habit, Good Sleep',\n",
       "   'Habits, Good Sleep',\n",
       "   'Higiene do Sono',\n",
       "   'Hygiene, Sleep',\n",
       "   'Sleep Habit, Good',\n",
       "   'Sleep Habits, Good',\n",
       "   'Sleep Hygiene'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070276': {'ID': 'D000070276',\n",
       "  'name': 'Determinação da Frequência Cardíaca[Heart Rate Determination]',\n",
       "  'scope': 'Methods, techniques, and processes by which HEART RATE is measured.',\n",
       "  'terms': ['Determination, Heart Rate',\n",
       "   'Determination, Pulse Rate',\n",
       "   'Determinação da Frequência Cardíaca',\n",
       "   'Determinação do Pulso',\n",
       "   'Determinação do Pulso Cardíaco',\n",
       "   'Heart Rate Determination',\n",
       "   'Pulse Rate Determination',\n",
       "   'Pulse Rate Determinations',\n",
       "   'Rate Determination, Heart',\n",
       "   'Rate Determination, Pulse',\n",
       "   'Rate Determinations, Pulse'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070297': {'ID': 'D000070297',\n",
       "  'name': 'Fricção em Ortodontia[Orthodontic Friction]',\n",
       "  'scope': 'Physical resistance to motion between dental surfaces.',\n",
       "  'terms': ['Friction, Orthodontic',\n",
       "   'Fricção Ortodôntica',\n",
       "   'Fricção em Ortodontia',\n",
       "   'Orthodontic Friction'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070316': {'ID': 'D000070316',\n",
       "  'name': 'Medicina de Emergência Pediátrica[Pediatric Emergency Medicine]',\n",
       "  'scope': 'Branch of EMERGENCY MEDICINE dealing with the emergency care of children.',\n",
       "  'terms': ['Emergency Medicine, Pediatric',\n",
       "   'Medicina de Emergência Pediátrica',\n",
       "   'Medicine, Pediatric Emergency',\n",
       "   'Pediatric Emergency Medicine'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070318': {'ID': 'D000070318',\n",
       "  'name': 'Planejamento Estratégico[Strategic Planning]',\n",
       "  'scope': 'A rigorous and systematic process which entails defining plans, decisions, and sequence of steps to be taken in the future.',\n",
       "  'terms': ['Planejamento Estratégico',\n",
       "   'Planning, Strategic',\n",
       "   'Strategic Planning'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070319': {'ID': 'D000070319',\n",
       "  'name': 'Clínica Dirigida por Estudantes[Student Run Clinic]',\n",
       "  'scope': 'A healthcare setting serviced predominantly by medical personnel in training, at no cost to the patients.',\n",
       "  'terms': ['Clinic, Resident Run',\n",
       "   'Clinic, Student Run',\n",
       "   'Clinic, Student-Run Free',\n",
       "   'Clinics, Resident Run',\n",
       "   'Clinics, Student Run',\n",
       "   'Clinics, Student-Run Free',\n",
       "   'Clínica Administrada por Estudantes',\n",
       "   'Clínica Dirigida por Estudantes',\n",
       "   'Clínica Gerida por Estudantes',\n",
       "   'Clínica Gratuita Dirigida por Estudantes',\n",
       "   'Free Clinic, Student-Run',\n",
       "   'Free Clinics, Student-Run',\n",
       "   'Resident Run Clinic',\n",
       "   'Resident Run Clinics',\n",
       "   'Student Run Clinic',\n",
       "   'Student Run Clinics',\n",
       "   'Student Run Free Clinic',\n",
       "   'Student-Run Free Clinic',\n",
       "   'Student-Run Free Clinics'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070337': {'ID': 'D000070337',\n",
       "  'name': 'Expropriação[Expropriation]',\n",
       "  'scope': 'Taking of goods, property, or right of use by GOVERNMENT or others.',\n",
       "  'terms': ['Expropriation', 'Expropriations', 'Expropriação'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070356': {'ID': 'D000070356',\n",
       "  'name': 'Pilotos[Pilots]',\n",
       "  'scope': 'Persons skilled and/or qualified to operate an aircraft or ship.',\n",
       "  'terms': ['Aviadores',\n",
       "   'Aviator',\n",
       "   'Aviators',\n",
       "   'Co Pilot',\n",
       "   'Co-Pilot',\n",
       "   'Co-Pilots',\n",
       "   'Copiloto',\n",
       "   'Pilot',\n",
       "   'Piloto',\n",
       "   'Pilotos',\n",
       "   'Pilots'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070357': {'ID': 'D000070357',\n",
       "  'name': 'Asparagaceae[Asparagaceae]',\n",
       "  'scope': 'A plant genus of the family Agavaceae (Aspargaceae) with fragrant, night-blooming flowers.',\n",
       "  'terms': ['Agavaceae',\n",
       "   'Agavaceae',\n",
       "   'Anemarrhenaceae',\n",
       "   'Anemarrhenaceae',\n",
       "   'Asparagaceae',\n",
       "   'Asparagaceae',\n",
       "   'Convallariaceae',\n",
       "   'Convallariaceae',\n",
       "   'Hesperaloe',\n",
       "   'Hesperaloe',\n",
       "   'Hyacinthaceae',\n",
       "   'Hyacinthaceae',\n",
       "   'Muscari',\n",
       "   'Muscari',\n",
       "   'Nolinoideae',\n",
       "   'Nolinoideae',\n",
       "   'Polianthes',\n",
       "   'Polianthes'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070376': {'ID': 'D000070376',\n",
       "  'name': 'Seguro Baseado em Valor[Value-Based Insurance]',\n",
       "  'scope': \"Approach to improve the quality of care by selectively encouraging or discouraging the use of specific health care services, based on their potential benefit to patients' health, relative to their cost. One element is lowering beneficiary cost sharing or out-of-pocket spending to increase medication adherence.\",\n",
       "  'terms': ['Insurance Designs, Value-Based',\n",
       "   'Insurance, Value-Based',\n",
       "   'Plano de Seguro Baseado em Valor',\n",
       "   'Seguro Baseado em Valor',\n",
       "   'Value Based Insurance',\n",
       "   'Value Based Insurance Design',\n",
       "   'Value-Based Insurance',\n",
       "   'Value-Based Insurance Design',\n",
       "   'Value-Based Insurance Designs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070377': {'ID': 'D000070377',\n",
       "  'name': 'Movimento contra Vacinação[Anti-Vaccination Movement]',\n",
       "  'scope': 'Group activities directed against VACCINATION.',\n",
       "  'terms': ['Anti Vaccination Groups',\n",
       "   'Anti Vaccination Movement',\n",
       "   'Anti Vaccine Groups',\n",
       "   'Anti Vaccine Movement',\n",
       "   'Anti-Vaccination Group',\n",
       "   'Anti-Vaccination Groups',\n",
       "   'Anti-Vaccination Movement',\n",
       "   'Anti-Vaccination Movements',\n",
       "   'Anti-Vaccine Group',\n",
       "   'Anti-Vaccine Groups',\n",
       "   'Anti-Vaccine Movement',\n",
       "   'Anti-Vaccine Movements',\n",
       "   'Antivaccination Movement',\n",
       "   'Antivaccination Movements',\n",
       "   'Group, Anti-Vaccination',\n",
       "   'Group, Anti-Vaccine',\n",
       "   'Groups, Anti-Vaccination',\n",
       "   'Groups, Anti-Vaccine',\n",
       "   'Grupos Antivacina',\n",
       "   'Grupos Antivacinação',\n",
       "   'Grupos contra Vacina',\n",
       "   'Grupos contra Vacinação',\n",
       "   'Movement, Anti-Vaccination',\n",
       "   'Movement, Anti-Vaccine',\n",
       "   'Movement, Antivaccination',\n",
       "   'Movements, Anti-Vaccination',\n",
       "   'Movements, Anti-Vaccine',\n",
       "   'Movements, Antivaccination',\n",
       "   'Movimento Antivacina',\n",
       "   'Movimento Antivacinação',\n",
       "   'Movimento contra Vacina',\n",
       "   'Movimento contra Vacinação'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070378': {'ID': 'D000070378',\n",
       "  'name': 'Amaryllidaceae[Amaryllidaceae]',\n",
       "  'scope': 'A plant genus of Amaryllidaceae.',\n",
       "  'terms': ['Amaryllidaceae',\n",
       "   'Amaryllidaceae',\n",
       "   'Clivia',\n",
       "   'Clivia',\n",
       "   'Cyrtanthus',\n",
       "   'Cyrtanthus',\n",
       "   'Hippeastrum',\n",
       "   'Hippeastrum',\n",
       "   'Zephyranthes',\n",
       "   'Zephyranthes',\n",
       "   'Zephyrlilies',\n",
       "   'Zephyrlily'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070379': {'ID': 'D000070379',\n",
       "  'name': 'Viés de Atenção[Attentional Bias]',\n",
       "  'scope': 'An increased focus or awareness of certain stimuli over others, which influence behavior.',\n",
       "  'terms': ['Atenção Enviesada',\n",
       "   'Attention, Biased',\n",
       "   'Attentional Bias',\n",
       "   'Attentional Biases',\n",
       "   'Bias, Attentional',\n",
       "   'Biased Attention',\n",
       "   'Biases, Attentional',\n",
       "   'Vieses de Atenção',\n",
       "   'Viés de Atenção'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070380': {'ID': 'D000070380',\n",
       "  'name': 'Xanthorrhoeaceae[Xanthorrhoeaceae]',\n",
       "  'scope': 'A plant genus of Xanthorrhoeaceae.',\n",
       "  'terms': ['Asphodelaceae',\n",
       "   'Asphodelaceae',\n",
       "   'Bulbine',\n",
       "   'Bulbine',\n",
       "   'Flax, New Zealand',\n",
       "   'Linho da Nova Zelândia',\n",
       "   'New Zealand Flax',\n",
       "   'Phormium',\n",
       "   'Phormium',\n",
       "   'Xanthorrhoeaceae',\n",
       "   'Xanthorrhoeaceae',\n",
       "   'Zealand Flax, New'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070381': {'ID': 'D000070381',\n",
       "  'name': 'Asparagales[Asparagales]',\n",
       "  'scope': 'A subgenera of Ornithogalum.',\n",
       "  'terms': ['Asparagales', 'Asparagales', 'Galtonia', 'Galtonia'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070396': {'ID': 'D000070396',\n",
       "  'name': 'Liliales[Liliales]',\n",
       "  'scope': 'A family of the order Liliales.',\n",
       "  'terms': ['Alstroemeriaceae', 'Alstroemeriaceae', 'Liliales', 'Liliales'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070416': {'ID': 'D000070416',\n",
       "  'name': 'Antagomirs[Antagomirs]',\n",
       "  'scope': 'Chemically-engineered oligonucleotides used to selectively inhibit expression of target genes through sequence-specific binding of corresponding microRNA (miRNA) sites.',\n",
       "  'terms': ['Antagomirs',\n",
       "   'Antagomirs',\n",
       "   'Anti miRs',\n",
       "   'Anti-miRs',\n",
       "   'Anti-miRs',\n",
       "   'Blockmirs',\n",
       "   'Blockmirs',\n",
       "   'Mirs Bloqueadores',\n",
       "   'Mirs Bloqueantes'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070436': {'ID': 'D000070436',\n",
       "  'name': 'Tannerella forsythia[Tannerella forsythia]',\n",
       "  'scope': 'A periodontal pathogen which is a gram-negative member of BACTEROIDETES. It is implicated in PERIODONTITIS.',\n",
       "  'terms': ['Bacteroides forsythus',\n",
       "   'Bacteroides forsythus',\n",
       "   'Bacteroides forsythus ATCC 43037',\n",
       "   'Bacteroides forsythus ATCC 43037',\n",
       "   'Tannerella forsythia',\n",
       "   'Tannerella forsythia',\n",
       "   'Tannerella forsythia ATCC 43037',\n",
       "   'Tannerella forsythia ATCC 43037'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070437': {'ID': 'D000070437',\n",
       "  'name': 'Colchicaceae[Colchicaceae]',\n",
       "  'scope': 'A family in the order Liliales.',\n",
       "  'terms': ['Colchicaceae', 'Colchicaceae'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070456': {'ID': 'D000070456',\n",
       "  'name': 'Call Centers[Call Centers]',\n",
       "  'scope': 'A facility set up for the purpose of handling large volumes of telephone calls. Call Centers typically utilize some form of computer automation for receiving, dispatching, screening, logging and forwarding telephone calls.',\n",
       "  'terms': ['Call Center',\n",
       "   'Call Center',\n",
       "   'Call Centers',\n",
       "   'Call Centers',\n",
       "   'Centers, Call'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070476': {'ID': 'D000070476',\n",
       "  'name': 'Hypoxidaceae[Hypoxidaceae]',\n",
       "  'scope': 'A family of perennial herbaceous plants, in the order Asparagales, with the underground storage organs, rhizomes or corms.',\n",
       "  'terms': ['Hypoxidaceae', 'Hypoxidaceae'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070496': {'ID': 'D000070496',\n",
       "  'name': 'Cineantropometria[Kinanthropometry]',\n",
       "  'scope': 'A measure of human size, shape, proportion, composition, maturation, and gross function; in relation to body movement, physical exercise, fitness, and performance.',\n",
       "  'terms': ['Cineantropometria', 'Kinanthropometries', 'Kinanthropometry'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070497': {'ID': 'D000070497',\n",
       "  'name': 'Estilo de Vida Saudável[Healthy Lifestyle]',\n",
       "  'scope': 'A pattern of behavior involving LIFE STYLE choices which ensure optimum health. Examples are eating right; maintaining physical, emotional, and spiritual wellness, and taking preemptive steps against communicable diseases.',\n",
       "  'terms': ['Estilo de Vida Saudável',\n",
       "   'Estilos de Vida Saudáveis',\n",
       "   'Estilos de Vida Saudável',\n",
       "   'Healthy Life Style',\n",
       "   'Healthy Life Styles',\n",
       "   'Healthy Lifestyle',\n",
       "   'Healthy Lifestyles',\n",
       "   'Hábitos Saudáveis',\n",
       "   'Life Style, Healthy',\n",
       "   'Life Styles, Healthy',\n",
       "   'Lifestyle, Healthy',\n",
       "   'Lifestyles, Healthy',\n",
       "   'Vida Sadia'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070516': {'ID': 'D000070516',\n",
       "  'name': 'Colaboração Intersetorial[Intersectoral Collaboration]',\n",
       "  'scope': 'Cooperative actions and ventures among health and health-related groups and organizations intended to improve health outcomes.',\n",
       "  'terms': ['Colaboração Intersetorial',\n",
       "   'Collaboration, Intersectoral',\n",
       "   'Collaborations, Intersectoral',\n",
       "   'Cooperation, Intersectoral',\n",
       "   'Cooperação Intersetorial',\n",
       "   'Intersectoral Collaboration',\n",
       "   'Intersectoral Collaborations',\n",
       "   'Intersectoral Cooperation'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070536': {'ID': 'D000070536',\n",
       "  'name': 'Avaliação Médica Independente[Independent Medical Evaluation]',\n",
       "  'scope': 'An assessment of HEALTH STATUS requested by third parties (e.g. insurers, adjudicating bodies, law enforcement, attorneys, etc) on a subject’s functional ability. Such information may be used in optimizing treatment or making informed decisions on compensation.',\n",
       "  'terms': ['Assessment, Independent Medical',\n",
       "   'Assessments, Independent Medical',\n",
       "   'Avaliação Médica Independente',\n",
       "   'Evaluation, Independent Medical',\n",
       "   'Evaluations, Independent Medical',\n",
       "   'Exame Médico Independente',\n",
       "   'Exames Médicos Independentes',\n",
       "   'Examination, Independent Medical',\n",
       "   'Examinations, Independent Medical',\n",
       "   'Independent Medical Assessment',\n",
       "   'Independent Medical Assessments',\n",
       "   'Independent Medical Evaluation',\n",
       "   'Independent Medical Evaluations',\n",
       "   'Independent Medical Examination',\n",
       "   'Independent Medical Examinations',\n",
       "   'Medical Assessment, Independent',\n",
       "   'Medical Assessments, Independent',\n",
       "   'Medical Evaluation, Independent',\n",
       "   'Medical Evaluations, Independent',\n",
       "   'Medical Examination, Independent',\n",
       "   'Medical Examinations, Independent'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070538': {'ID': 'D000070538',\n",
       "  'name': 'Domínios C2[C2 Domains]',\n",
       "  'scope': 'Protein modules that function in the targeting of proteins to CELL MEMBRANES. They consist of an eight-stranded anti-parallel beta-sandwich composed of a pair of four-stranded beta-sheets. This structural unit forms a pocket on the membrane-interacting face of the protein and co-ordinates the binding of 2 to 3 calcium ions; however, not all C2 domains bind calcium. Examples of C2 domain-containing proteins include PROTEIN KINASE C and PTEN PHOSPHOHYDROLASE.',\n",
       "  'terms': ['C2 Domain',\n",
       "   'C2 Domains',\n",
       "   'C2 Tensin type Domain',\n",
       "   'C2 Tensin-type Domain',\n",
       "   'C2 Tensin-type Domains',\n",
       "   'Domain, C2',\n",
       "   'Domain, C2 Tensin-type',\n",
       "   'Domains, C2',\n",
       "   'Domains, C2 Tensin-type',\n",
       "   'Domínio C2',\n",
       "   'Domínio do Tipo Tensina C2',\n",
       "   'Domínios C2',\n",
       "   'Tensin-type Domain, C2',\n",
       "   'Tensin-type Domains, C2'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070539': {'ID': 'D000070539',\n",
       "  'name': 'Domínios de Homologia à Plecstrina[Pleckstrin Homology Domains]',\n",
       "  'scope': 'Protein domains of approximately 120 amino acids that form two perpendicular anti-parallel beta sheets connected by a loop of variable length and a C-terminal amphipathic helix. PH domains occur in many INTRACELLULAR SIGNALING PROTEINS and CYTOSKELETAL PROTEINS where they bind PHOSPHATIDYLINOSITOLS within the CELL MEMBRANE and INTRACELLULAR MEMBRANES, as well as proteins that include the Betagamma-subunits of  HETEROTRIMERIC GTP-BINDING PROTEINS, and PROTEIN KINASE C. These interactions allow the targeting of proteins to different cellular compartments and SIGNAL TRANSDUCTION PATHWAYS.',\n",
       "  'terms': ['Domain, PH',\n",
       "   'Domain, Pleckstrin Homology',\n",
       "   'Domains, PH',\n",
       "   'Domains, Pleckstrin Homology',\n",
       "   'Domínio PH',\n",
       "   'Domínio de Homologia à Plecstrina',\n",
       "   'Domínios PH',\n",
       "   'Domínios de Homologia com Plecstrina',\n",
       "   'Domínios de Homologia à Plecstrina',\n",
       "   'Homology Domain, Pleckstrin',\n",
       "   'Homology Domains, Pleckstrin',\n",
       "   'PH Domain',\n",
       "   'PH Domains',\n",
       "   'Pleckstrin Homology Domain',\n",
       "   'Pleckstrin Homology Domains'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070556': {'ID': 'D000070556',\n",
       "  'name': 'Melanthiaceae[Melanthiaceae]',\n",
       "  'scope': 'A family in the order Liliales, of bulbous or rhizomatous woodland and alpine perennial herbs.',\n",
       "  'terms': ['Melanthiaceae', 'Melanthiaceae'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070557': {'ID': 'D000070557',\n",
       "  'name': 'Domínios de Imunoglobulina[Immunoglobulin Domains]',\n",
       "  'scope': 'Immunoglobulin-like domains similar to those of the immunoglobulin variable region. They occur in diverse protein families, including IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; T-CELL RECEPTORS;JUNCTIONAL ADHESION MOLECULES; and RECEPTOR PROTEIN-TYROSINE KINASES.',\n",
       "  'terms': ['C1-set Domain, Immunoglobulin',\n",
       "   'C1-set Domains, Immunoglobulin',\n",
       "   'C2-set Domain, Ig',\n",
       "   'C2-set Domain, Immunoglobulin',\n",
       "   'C2-set Domains, Ig',\n",
       "   'C2-set Domains, Immunoglobulin',\n",
       "   'Dobra de Imunoglobulina',\n",
       "   'Domain, Ig',\n",
       "   'Domain, Ig C2-set',\n",
       "   'Domain, Ig V-set',\n",
       "   'Domain, Ig-like',\n",
       "   'Domain, Immunoglobulin',\n",
       "   'Domain, Immunoglobulin C1-set',\n",
       "   'Domain, Immunoglobulin C2-set',\n",
       "   'Domain, Immunoglobulin I-set',\n",
       "   'Domain, Immunoglobulin V-set',\n",
       "   'Domain, Immunoglobulin-like',\n",
       "   'Domains, Ig',\n",
       "   'Domains, Ig C2-set',\n",
       "   'Domains, Ig V-set',\n",
       "   'Domains, Ig-like',\n",
       "   'Domains, Immunoglobulin',\n",
       "   'Domains, Immunoglobulin C1-set',\n",
       "   'Domains, Immunoglobulin C2-set',\n",
       "   'Domains, Immunoglobulin I-set',\n",
       "   'Domains, Immunoglobulin V-set',\n",
       "   'Domains, Immunoglobulin-like',\n",
       "   'Domínio C1 de Ig',\n",
       "   'Domínio C1 de Imunoglobulina',\n",
       "   'Domínio C2 de Ig',\n",
       "   'Domínio C2 de Imunoglobulina',\n",
       "   'Domínio I de Imunoglobulina',\n",
       "   'Domínio Ig',\n",
       "   'Domínio Semelhante a Ig',\n",
       "   'Domínio Semelhante a Imunoglobulina',\n",
       "   'Domínio V de Ig',\n",
       "   'Domínio V de Imunoglobulina',\n",
       "   'Domínio de Configuração C1 de Imunoglobulina',\n",
       "   'Domínio de Configuração C2 de Ig',\n",
       "   'Domínio de Configuração C2 de Imunoglobulina',\n",
       "   'Domínio de Configuração I de Imunoglobulina',\n",
       "   'Domínio de Configuração V de Imunoglobulina',\n",
       "   'Domínio de Imunoglobulina',\n",
       "   'Domínios Ig',\n",
       "   'Domínios de Imunoglobulina',\n",
       "   'Fold, Ig',\n",
       "   'Folds, Ig',\n",
       "   'I-set Domain, Immunoglobulin',\n",
       "   'I-set Domains, Immunoglobulin',\n",
       "   'Ig C2 set Domain',\n",
       "   'Ig C2-set Domain',\n",
       "   'Ig C2-set Domains',\n",
       "   'Ig Domain',\n",
       "   'Ig Domains',\n",
       "   'Ig Fold',\n",
       "   'Ig Folds',\n",
       "   'Ig V set Domain',\n",
       "   'Ig V-set Domain',\n",
       "   'Ig V-set Domains',\n",
       "   'Ig like Domain',\n",
       "   'Ig-like Domain',\n",
       "   'Ig-like Domains',\n",
       "   'Immunoglobulin C1 set Domain',\n",
       "   'Immunoglobulin C1-set Domain',\n",
       "   'Immunoglobulin C1-set Domains',\n",
       "   'Immunoglobulin C2 set Domain',\n",
       "   'Immunoglobulin C2-set Domain',\n",
       "   'Immunoglobulin C2-set Domains',\n",
       "   'Immunoglobulin Domain',\n",
       "   'Immunoglobulin Domains',\n",
       "   'Immunoglobulin I set Domain',\n",
       "   'Immunoglobulin I-set Domain',\n",
       "   'Immunoglobulin I-set Domains',\n",
       "   'Immunoglobulin V set Domain',\n",
       "   'Immunoglobulin V-set Domain',\n",
       "   'Immunoglobulin V-set Domains',\n",
       "   'Immunoglobulin like Domain',\n",
       "   'Immunoglobulin-like Domain',\n",
       "   'Immunoglobulin-like Domains',\n",
       "   'V-set Domain, Ig',\n",
       "   'V-set Domain, Immunoglobulin',\n",
       "   'V-set Domains, Ig',\n",
       "   'V-set Domains, Immunoglobulin'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070558': {'ID': 'D000070558',\n",
       "  'name': 'Pé Torto[Talipes]',\n",
       "  'scope': 'Deformity in which the foot is misaligned with respect to the TALUS in the ANKLE JOINT. While mostly congenital, as in CLUBFOOT, acquired deformities are included. Acquired talipedes are often associated with other foot deformities such as SYNDACTYLY and POLYDACTYLY.',\n",
       "  'terms': ['Calcaneovarus, Talipes',\n",
       "   'Calcaneus, Talipes',\n",
       "   'Pé Calcaneovaro',\n",
       "   'Pé Calcâneo',\n",
       "   'Pé Torto',\n",
       "   'Pé Torto Calcaneovaro',\n",
       "   'Pé Torto Calcâneo',\n",
       "   'Pé Torto Varo',\n",
       "   'Pé Varo',\n",
       "   'Pés Tortos',\n",
       "   'Talipe',\n",
       "   'Talipedes',\n",
       "   'Talipes',\n",
       "   'Talipes',\n",
       "   'Talipes Calcaneovarus',\n",
       "   'Talipes Calcaneus',\n",
       "   'Talipes Varus',\n",
       "   'Talípedes',\n",
       "   'Tálipe',\n",
       "   'Tálipe Calcaneovaro',\n",
       "   'Tálipe Varo',\n",
       "   'Tálipes',\n",
       "   'Tálipes Calcaneovaro',\n",
       "   'Tálipes Calcâneo',\n",
       "   'Tálipes Varo',\n",
       "   'Varus, Talipes'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070559': {'ID': 'D000070559',\n",
       "  'name': 'Moela não Aviária[Gizzard, Non-avian]',\n",
       "  'scope': 'A gizzard-like structure of the crustacean digestive system.',\n",
       "  'terms': ['Gastric Mill',\n",
       "   'Gastric Mills',\n",
       "   'Gizzard, Non avian',\n",
       "   'Gizzard, Non-avian',\n",
       "   'Gizzards, Non-avian',\n",
       "   'Mill, Gastric',\n",
       "   'Mills, Gastric',\n",
       "   'Moela não Aviária',\n",
       "   'Moinho Gástrico',\n",
       "   'Non-avian Gizzard',\n",
       "   'Non-avian Gizzards'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070576': {'ID': 'D000070576',\n",
       "  'name': 'Proteínas NLR[NLR Proteins]',\n",
       "  'scope': 'Intracellular signaling proteins that are defined by the presence of a NUCLEOTIDE-binding region and LEUCINE-rich repeats. Their general structure consists of any of a variety of effector domains at their N-termini such as a caspase recruitment domain (CARD), a central nucleotide-binding domain, and a variable number of C-terminal leucine-rich repeats. They are important for pathogen recognition in the INNATE IMMUNE RESPONSE of animals and plants. Members of the NLR protein family include the NOD SIGNALING ADAPTOR PROTEINS.',\n",
       "  'terms': ['NLR Protein',\n",
       "   'NLR Proteins',\n",
       "   'NOD like Receptors',\n",
       "   'NOD-like Receptors',\n",
       "   'Nucleotide binding Domain Leucine rich Repeat Proteins',\n",
       "   'Nucleotide-binding Domain Leucine-rich Repeat Proteins',\n",
       "   'Protein, NLR',\n",
       "   'Proteins, NLR',\n",
       "   'Proteína NLR',\n",
       "   'Proteínas NLR',\n",
       "   'Proteínas com Domínio de Ligação a Nucleotídeos e Repetições Ricas em Leucina',\n",
       "   'Receptores Semelhantes a NOD',\n",
       "   'Receptors, NOD-like'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070579': {'ID': 'D000070579',\n",
       "  'name': 'Proteínas Associadas à Doença de Parkinson[Parkinson Disease Associated Proteins]',\n",
       "  'scope': 'Proteins associated with sporadic or familial cases of PARKINSON DISEASE.',\n",
       "  'terms': ['Associated Proteins, Parkinson',\n",
       "   'PARK Proteins',\n",
       "   'Parkinson Associated Proteins',\n",
       "   'Parkinson Disease Associated Proteins',\n",
       "   'Proteins, PARK',\n",
       "   'Proteins, Parkinson Associated',\n",
       "   'Proteínas Associadas ao Parkinson',\n",
       "   'Proteínas Associadas à Doença de Parkinson',\n",
       "   'Proteínas PARK'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070580': {'ID': 'D000070580',\n",
       "  'name': 'Dedos de Zinco CYS2-HIS2[CYS2-HIS2 Zinc Fingers]',\n",
       "  'scope': 'A zinc finger motif of approximately 30 amino acids with the general sequence X2-Cys-X2,4-Cys-X12-His-X3,4,5-His that forms a simple beta sheet-beta sheet-alpha helix fold stabilized by zinc ions. It recognizes and binds to a variety of eukaryotic DNA sequences and is very common among sequence-specific DNA BINDING PROTEINS and TRANSCRIPTION FACTORS.',\n",
       "  'terms': ['C2H2 Zinc Finger',\n",
       "   'C2H2 Zinc Fingers',\n",
       "   'CYS2 HIS2 Zinc Finger Motifs',\n",
       "   'CYS2 HIS2 Zinc Fingers',\n",
       "   'CYS2-HIS2 Zinc Finger',\n",
       "   'CYS2-HIS2 Zinc Finger Motifs',\n",
       "   'CYS2-HIS2 Zinc Fingers',\n",
       "   'CYS2HIS2 Zinc Finger',\n",
       "   'CYS2HIS2 Zinc Fingers',\n",
       "   'Dedos de Zinco C2H2',\n",
       "   'Dedos de Zinco CYS2-HIS2',\n",
       "   'Dedos de Zinco CYS2HIS2',\n",
       "   'Finger, C2H2 Zinc',\n",
       "   'Finger, CYS2-HIS2 Zinc',\n",
       "   'Finger, CYS2HIS2 Zinc',\n",
       "   'Fingers, C2H2 Zinc',\n",
       "   'Fingers, CYS2-HIS2 Zinc',\n",
       "   'Fingers, CYS2HIS2 Zinc',\n",
       "   'Motivos de Dedos de Zinco CYS2-HIS2',\n",
       "   'Zinc Finger, C2H2',\n",
       "   'Zinc Finger, CYS2-HIS2',\n",
       "   'Zinc Finger, CYS2HIS2',\n",
       "   'Zinc Fingers, C2H2',\n",
       "   'Zinc Fingers, CYS2-HIS2',\n",
       "   'Zinc Fingers, CYS2HIS2'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070584': {'ID': 'D000070584',\n",
       "  'name': 'Proteínas com Motivo Tripartido[Tripartite Motif Proteins]',\n",
       "  'scope': 'A protein family defined by the presence of three ZINC FINGER domains, one of which is a RING FINGER DOMAIN, a coiled-coil region, and a highly variable C-terminal region. They function in many cellular processes including APOPTOSIS and CELL CYCLE regulation.',\n",
       "  'terms': ['Family, RBCC Protein',\n",
       "   'Family, TRIM Protein',\n",
       "   'Família de Proteínas RBCC',\n",
       "   'Família de Proteínas TRIM',\n",
       "   'Motif Proteins, Tripartite',\n",
       "   'Protein Family, RBCC',\n",
       "   'Protein Family, TRIM',\n",
       "   'Proteins, RBCC',\n",
       "   'Proteins, TRIM',\n",
       "   'Proteins, Tripartite Motif',\n",
       "   'Proteína com Motivo Tripartido',\n",
       "   'Proteínas RBCC',\n",
       "   'Proteínas TRIM',\n",
       "   'Proteínas com Motivo Tripartido',\n",
       "   'RBCC Protein Family',\n",
       "   'RBCC Proteins',\n",
       "   'TRIM Protein Family',\n",
       "   'TRIM Proteins',\n",
       "   'Tripartite Motif Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070585': {'ID': 'D000070585',\n",
       "  'name': 'Proteínas Relacionadas a Caderinas[Cadherin Related Proteins]',\n",
       "  'scope': 'Membrane proteins that contain at least two typical consecutive CADHERIN motifs but typically more than cadherin or protocadherin proteins. Their overall domain organization also differs from those of cadherins and protocadherins, and contains different and unique cytoplasmic domains.',\n",
       "  'terms': ['CDHR Proteins',\n",
       "   'Cadherin Related Proteins',\n",
       "   'Cadherin-Related Proteins',\n",
       "   'Proteins, CDHR',\n",
       "   'Proteins, Cadherin Related',\n",
       "   'Proteins, Cadherin-Related',\n",
       "   'Proteínas CDHR',\n",
       "   'Proteínas Relacionadas a Caderinas',\n",
       "   'Proteínas Relacionadas com Caderinas',\n",
       "   'Proteínas Relacionadas à Caderina',\n",
       "   'Related Proteins, Cadherin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070586': {'ID': 'D000070586',\n",
       "  'name': 'Política Fiscal[Fiscal Policy]',\n",
       "  'scope': 'Use of government spending and taxation to influence the economy.',\n",
       "  'terms': ['Fiscal Policies',\n",
       "   'Fiscal Policy',\n",
       "   'Policies, Fiscal',\n",
       "   'Policy, Fiscal',\n",
       "   'Política Fiscal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070587': {'ID': 'D000070587',\n",
       "  'name': 'Testes de Navegação Mental[Mental Navigation Tests]',\n",
       "  'scope': 'Measures of spatial cognition and memory.',\n",
       "  'terms': ['Mental Navigation Test',\n",
       "   'Mental Navigation Tests',\n",
       "   'Navigation Test, Mental',\n",
       "   'Navigation Tests, Mental',\n",
       "   'Test, Mental Navigation',\n",
       "   'Testes de Navegação Mental',\n",
       "   'Tests, Mental Navigation'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070589': {'ID': 'D000070589',\n",
       "  'name': 'Pé Cavo[Talipes Cavus]',\n",
       "  'scope': 'A foot deformity in which the arch of the foot is high and often the heel adducted.',\n",
       "  'terms': ['Cavovarus Foot Deformities',\n",
       "   'Cavovarus Foot Deformity',\n",
       "   'Cavus Deformities',\n",
       "   'Cavus Deformity',\n",
       "   'Cavus Foot',\n",
       "   'Deformação do Pé Cavovaro',\n",
       "   'Deformidade Cava',\n",
       "   'Deformidade do Pé Cavo',\n",
       "   'Foot Deformities, Cavovarus',\n",
       "   'Foot Deformity, Cavovarus',\n",
       "   'High Arched Foot',\n",
       "   'High-Arched Foot',\n",
       "   'Pes Cavus',\n",
       "   'Pes Cavus',\n",
       "   'Pé Cavo',\n",
       "   'Pé Supinado',\n",
       "   'Pé com Arco Alto',\n",
       "   'Pés Cavos',\n",
       "   'Talipes Cavo',\n",
       "   'Talipes Cavos',\n",
       "   'Talipes Cavus',\n",
       "   'Talipes Cavus',\n",
       "   'Tálipe Cavo',\n",
       "   'Tálipes Cavo',\n",
       "   'Tálipes Cavos'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070590': {'ID': 'D000070590',\n",
       "  'name': 'Proteínas Carreadoras de Solutos[Solute Carrier Proteins]',\n",
       "  'scope': 'A large diverse group of membrane transport proteins whose families are generally classified according to function. Most SLCs localize to the CELL MEMBRANE; however, some families such as SLC25, localize to MITOCHONDRIAL MEMBRANES or other ORGANELLES.',\n",
       "  'terms': ['Carrier Proteins, Solute',\n",
       "   'Proteins, SLC',\n",
       "   'Proteins, Solute Carrier',\n",
       "   'Proteínas Carreadoras de Solutos',\n",
       "   'Proteínas Carregadoras de Solutos',\n",
       "   'Proteínas SLC',\n",
       "   'SLC Proteins',\n",
       "   'Solute Carrier Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070591': {'ID': 'D000070591',\n",
       "  'name': 'Metatarso Valgo[Metatarsal Valgus]',\n",
       "  'scope': 'A foot anomaly in which the forefoot is angled outward relative to the hindfoot.',\n",
       "  'terms': ['Marcha com Pés para Fora',\n",
       "   'Metatarsal Valgus',\n",
       "   'Metatarso Valgo',\n",
       "   'Metatarsus Valgus',\n",
       "   'Out Toeing',\n",
       "   'Out-Toeing',\n",
       "   'Out-Toeings',\n",
       "   'Pés para Fora',\n",
       "   'Toeing Out',\n",
       "   'Toeing Outs'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070592': {'ID': 'D000070592',\n",
       "  'name': 'Metatarso Varo[Metatarsus Varus]',\n",
       "  'scope': 'A foot anomaly in which the forefoot (METATARSUS) is angled inward relative to the heel.',\n",
       "  'terms': ['Adductovarus, Metatarsus',\n",
       "   'Adductus, Metatarsus',\n",
       "   'In Toeing',\n",
       "   'In-Toeing',\n",
       "   'Marcha com Pés para Dentro',\n",
       "   'Metatarsal Varus',\n",
       "   'Metatarso Adutor',\n",
       "   'Metatarso Varo',\n",
       "   'Metatarsus Adductovarus',\n",
       "   'Metatarsus Adductus',\n",
       "   'Metatarsus Varus',\n",
       "   'Pigeon Toed',\n",
       "   'Pigeon-Toed',\n",
       "   'Pés para Dentro',\n",
       "   'Toed, Pigeon',\n",
       "   'Toeing In',\n",
       "   'Varus, Metatarsal',\n",
       "   'Varus, Metatarsus'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070593': {'ID': 'D000070593',\n",
       "  'name': 'Domínio de Ligação a CpG Metilada[Methyl CpG Binding Domain]',\n",
       "  'scope': 'A protein domain of about 70 amino acids in length that folds into a sandwich structure consisting of a beta sheet, alpha helix, and C-terminal hairpin loop which forms a hydrophobic methylated-DNA binding patch. It binds to methylated CPG ISLANDS in eukaryotes and occurs with other DNA and CHROMATIN binding domains such as AT-HOOK MOTIFS in eukaryotic DNA BINDING PROTEINS.',\n",
       "  'terms': ['Domínio de Ligação a CpG Metilada',\n",
       "   'Domínio de Ligação a CpG-Metil',\n",
       "   'Domínio de Ligação ao DNA com CpG Metilada',\n",
       "   'Methyl CpG Binding Domain',\n",
       "   'Methyl CpG DNA Binding Domain'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070597': {'ID': 'D000070597',\n",
       "  'name': 'Processo Coracoide[Coracoid Process]',\n",
       "  'scope': 'A beak-like bone projection located at the lateral end of the superior anterior border of the SCAPULA.',\n",
       "  'terms': ['Apófise Coracoide',\n",
       "   'Coracoid Process',\n",
       "   'Coracoid Processes',\n",
       "   'Processo Coracoide',\n",
       "   'Processus Coracoideus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070598': {'ID': 'D000070598',\n",
       "  'name': 'Lesões do Ligamento Cruzado Anterior[Anterior Cruciate Ligament Injuries]',\n",
       "  'scope': 'Sprain or tear injuries to the ANTERIOR CRUCIATE LIGAMENT of the knee.',\n",
       "  'terms': ['ACL Injuries',\n",
       "   'ACL Injury',\n",
       "   'ACL Tear',\n",
       "   'ACL Tears',\n",
       "   'Anterior Cruciate Ligament Injuries',\n",
       "   'Anterior Cruciate Ligament Injury',\n",
       "   'Anterior Cruciate Ligament Tear',\n",
       "   'Anterior Cruciate Ligament Tears',\n",
       "   'Injuries, ACL',\n",
       "   'Injury, ACL',\n",
       "   'Laceração do LCA',\n",
       "   'Laceração do Ligamento Cruzado Anterior',\n",
       "   'Lacerações do LCA',\n",
       "   'Lacerações do Ligamento Cruzado Anterior',\n",
       "   'Lesão do LCA',\n",
       "   'Lesão do Ligamento Cruzado Anterior',\n",
       "   'Lesões do LCA',\n",
       "   'Lesões do Ligamento Cruzado Anterior',\n",
       "   'Ruptura do LCA',\n",
       "   'Ruptura do Ligamento Cruzado Anterior',\n",
       "   'Rupturas do LCA',\n",
       "   'Rupturas do Ligamento Cruzado Anterior',\n",
       "   'Tear, ACL',\n",
       "   'Tears, ACL'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070599': {'ID': 'D000070599',\n",
       "  'name': 'Lesões do Ombro[Shoulder Injuries]',\n",
       "  'scope': 'Injuries involving the SHOULDERS.',\n",
       "  'terms': ['Injuries, Shoulder',\n",
       "   'Injury, Shoulder',\n",
       "   'Lesões SLAP',\n",
       "   'Lesões do Lábio Glenoidal Superior',\n",
       "   'Lesões do Lábio Glenoidal Superior com Extensão para o Anterior',\n",
       "   'Lesões do Ombro',\n",
       "   'SLAP Tear',\n",
       "   'SLAP Tears',\n",
       "   'Shoulder Injuries',\n",
       "   'Shoulder Injury',\n",
       "   'Superior Labrum from Anterior to Posterior Injuries',\n",
       "   'Tear, SLAP',\n",
       "   'Tears, SLAP'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070600': {'ID': 'D000070600',\n",
       "  'name': 'Lesões do Menisco Tibial[Tibial Meniscus Injuries]',\n",
       "  'scope': 'Injuries to the TIBIAL MENISCUS of the leg.',\n",
       "  'terms': ['Bucket Handle Tear',\n",
       "   'Bucket Handle Tears',\n",
       "   'Flap Tear',\n",
       "   'Flap Tears',\n",
       "   'Injuries, Tibial Meniscus',\n",
       "   'Injury, Tibial Meniscus',\n",
       "   'Lesões do Menisco Tibial',\n",
       "   'Lesões em Alça de Balde',\n",
       "   'Lesões em Retalho',\n",
       "   'Meniscus Injuries, Tibial',\n",
       "   'Meniscus Injury, Tibial',\n",
       "   'Meniscus Tear, Tibial',\n",
       "   'Meniscus Tears, Tibial',\n",
       "   'Meniscus, Torn Tibial',\n",
       "   'Rompimento do Menisco Tibial',\n",
       "   'Roturas do Menisco Tibial',\n",
       "   'Roturas em Alça de Balde',\n",
       "   'Rupturas do Menisco Tibial',\n",
       "   'Rupturas em Alça de Balde',\n",
       "   'Tear, Tibial Meniscus',\n",
       "   'Tears, Flap',\n",
       "   'Tears, Tibial Meniscus',\n",
       "   'Tibial Meniscus Injuries',\n",
       "   'Tibial Meniscus Injury',\n",
       "   'Tibial Meniscus Tear',\n",
       "   'Tibial Meniscus Tears',\n",
       "   'Tibial Meniscus, Torn',\n",
       "   'Torn Tibial Meniscus'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070601': {'ID': 'D000070601',\n",
       "  'name': 'Dieta da Carga de Carboidratos[Diet, Carbohydrate Loading]',\n",
       "  'scope': 'A diet rich in DIETARY CARBOHYDRATES.',\n",
       "  'terms': ['Carbohydrate Loading',\n",
       "   'Carbohydrate Loading Diet',\n",
       "   'Carbohydrate Loading Diets',\n",
       "   'Carga de Carboidrato',\n",
       "   'Diet, Carbohydrate Loading',\n",
       "   'Dieta da Carga de Carboidratos'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070602': {'ID': 'D000070602',\n",
       "  'name': 'Caixa Torácica[Rib Cage]',\n",
       "  'scope': 'The bony thoracic enclosure consisting of the vertebral column; the RIBS; the STERNUM; and the COSTAL CARTILAGE.',\n",
       "  'terms': ['Arco Costal',\n",
       "   'Caixa Torácica',\n",
       "   'Caixa Toráxica',\n",
       "   'Costal Arch',\n",
       "   'Costal Margin',\n",
       "   'Costal Margins',\n",
       "   'Margem Costal',\n",
       "   'Margin, Costal',\n",
       "   'Margin, Rib',\n",
       "   'Margins, Costal',\n",
       "   'Margins, Rib',\n",
       "   'Rib Cage',\n",
       "   'Rib Cages',\n",
       "   'Rib Margin',\n",
       "   'Rib Margins',\n",
       "   'Ribcage',\n",
       "   'Ribcages',\n",
       "   'Thoracic Cage',\n",
       "   'Thoracic Cages'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070603': {'ID': 'D000070603',\n",
       "  'name': 'Coxa Magna[Coxa Magna]',\n",
       "  'scope': 'Deformity of the hip characterized by enlargement and deformation of the FEMUR HEAD and FEMUR NECK, often with associated changes in the ACETABULUM. These changes may be secondary to other diseases (e.g.  LEGG-PERTHES DISEASE; ARTHRITIS; HIP DISLOCATION, CONGENITAL) or TRAUMA.',\n",
       "  'terms': ['Coxa Magna',\n",
       "   'Coxa Magna',\n",
       "   'Coxa Magnas',\n",
       "   'Deformidade da Cabeça Femoral',\n",
       "   'Deformidade da Cabeça do Fêmur',\n",
       "   'Deformities, Femoral Head',\n",
       "   'Deformity, Femoral Head',\n",
       "   'Femoral Head Deformities',\n",
       "   'Femoral Head Deformity'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070604': {'ID': 'D000070604',\n",
       "  'name': 'Coalizão Tarsal[Tarsal Coalition]',\n",
       "  'scope': 'Congenital, complete or partial fusion of the TARSAL BONES of the foot. PES PLANUS is usually a feature.',\n",
       "  'terms': ['Coalizão Tarsal',\n",
       "   'Sinostose Tarsal',\n",
       "   'Synostoses, Tarsal',\n",
       "   'Synostosis, Tarsal',\n",
       "   'Tarsal Coalition',\n",
       "   'Tarsal Coalitions',\n",
       "   'Tarsal Synostoses',\n",
       "   'Tarsal Synostosis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070606': {'ID': 'D000070606',\n",
       "  'name': 'Aponeurose[Aponeurosis]',\n",
       "  'scope': 'The flattened and/or expanded “tendon-like” dense fibrous connective tissue that connects skeletal muscles to each other or to bone.',\n",
       "  'terms': ['<i>sutura</i>',\n",
       "   'Aponeurose',\n",
       "   'Aponeuroses',\n",
       "   'Aponeuroses',\n",
       "   'Aponeurosis'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070607': {'ID': 'D000070607',\n",
       "  'name': 'Neuroma Intermetatársico[Morton Neuroma]',\n",
       "  'scope': 'A nerve inflammation in the foot caused by chronic compression of the plantar nerve between the METATARSAL BONES.',\n",
       "  'terms': [\"Disease, Morton's\",\n",
       "   'Doença de Morton',\n",
       "   'Intermetatarsal Neuroma',\n",
       "   'Intermetatarsal Neuromas',\n",
       "   'Metatarsalgia de Morton',\n",
       "   \"Metatarsalgia, Morton's\",\n",
       "   'Morton Disease',\n",
       "   'Morton Metatarsalgia',\n",
       "   'Morton Neuralgia',\n",
       "   'Morton Neuroma',\n",
       "   \"Morton's Disease\",\n",
       "   \"Morton's Metatarsalgia\",\n",
       "   \"Morton's Neuralgia\",\n",
       "   \"Morton's Neuroma\",\n",
       "   'Mortons Disease',\n",
       "   'Mortons Metatarsalgia',\n",
       "   'Mortons Neuralgia',\n",
       "   'Mortons Neuroma',\n",
       "   'Neuralgia de Morton',\n",
       "   \"Neuralgia, Morton's\",\n",
       "   'Neuroma Intermetatársico',\n",
       "   'Neuroma, Intermetatarsal',\n",
       "   'Neuroma, Morton',\n",
       "   \"Neuroma, Morton's\",\n",
       "   'Neuromas, Intermetatarsal'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070614': {'ID': 'D000070614',\n",
       "  'name': 'Núcleo Pulposo[Nucleus Pulposus]',\n",
       "  'scope': 'Fibrocartilage inner core of the intervertebral disc. Prolapsed or bulged nucleus pulposus leads to INTERVERTEBRAL DISC DISPLACEMENT while proliferation of cells in the nucleus pulposus is associated with INTERVERTEBRAL DISC DEGENERATION.',\n",
       "  'terms': ['Nucleus Pulposus', 'Núcleo Pulposo'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070616': {'ID': 'D000070616',\n",
       "  'name': 'Anel Fibroso[Annulus Fibrosus]',\n",
       "  'scope': 'Outer portion of the intervertebral disc that surrounds the NUCLEUS PULPOSUS.',\n",
       "  'terms': ['Anel Fibroso', 'Annulus Fibrosus', 'Anulus Fibrosus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070617': {'ID': 'D000070617',\n",
       "  'name': 'Microtraumatismos Físicos[Microtrauma, Physical]',\n",
       "  'scope': 'Small injuries caused by external force applied to the body including bones, muscles, nerves and tendons.',\n",
       "  'terms': ['Micro Trauma, Physical',\n",
       "   'Micro Traumas, Physical',\n",
       "   'Microtrauma Físico',\n",
       "   'Microtrauma, Physical',\n",
       "   'Microtraumas Físicos',\n",
       "   'Microtraumas, Physical',\n",
       "   'Microtraumatismo Físico',\n",
       "   'Microtraumatismos Físicos',\n",
       "   'Physical Micro Trauma',\n",
       "   'Physical Micro Traumas',\n",
       "   'Physical Microtrauma',\n",
       "   'Physical Microtraumas',\n",
       "   'Trauma, Physical Micro',\n",
       "   'Traumas, Physical Micro'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070621': {'ID': 'D000070621',\n",
       "  'name': 'Cistografia[Cystography]',\n",
       "  'scope': 'Radiography of the URINARY BLADDER.',\n",
       "  'terms': ['<i>cistocopia</i>',\n",
       "   '<i>uretrocistoscopia</i>',\n",
       "   'Cistografia',\n",
       "   'Cistograma',\n",
       "   'Cystogram',\n",
       "   'Cystograms',\n",
       "   'Cystographies',\n",
       "   'Cystography'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070624': {'ID': 'D000070624',\n",
       "  'name': 'Contusão Encefálica[Brain Contusion]',\n",
       "  'scope': 'A bruise of the brain from an impact of the skull.',\n",
       "  'terms': ['Brain Contusion',\n",
       "   'Brain Contusions',\n",
       "   'Cerebellar Contusion',\n",
       "   'Cerebellar Contusions',\n",
       "   'Cerebral Contusion',\n",
       "   'Cerebral Contusions',\n",
       "   'Contusio Cerebri',\n",
       "   'Contusio Cerebri',\n",
       "   'Contusion, Brain',\n",
       "   'Contusion, Cerebellar',\n",
       "   'Contusion, Cerebral',\n",
       "   'Contusion, Cortical',\n",
       "   'Contusions, Brain',\n",
       "   'Contusions, Cerebellar',\n",
       "   'Contusions, Cerebral',\n",
       "   'Contusions, Cortical',\n",
       "   'Contusão Cerebelar',\n",
       "   'Contusão Cerebral',\n",
       "   'Contusão Cortical',\n",
       "   'Contusão Encefálica',\n",
       "   'Cortical Contusion',\n",
       "   'Cortical Contusions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070625': {'ID': 'D000070625',\n",
       "  'name': 'Lesões Encefálicas Difusas[Brain Injuries, Diffuse]',\n",
       "  'scope': 'Brain injuries occurring over a wide area instead of specific focal area.',\n",
       "  'terms': ['Brain Injuries, Diffuse',\n",
       "   'Brain Injury, Diffuse',\n",
       "   'Cerebral Injuries, Diffuse',\n",
       "   'Cerebral Injury, Diffuse',\n",
       "   'Diffuse Axonal Brain Injury',\n",
       "   'Diffuse Brain Injuries',\n",
       "   'Diffuse Brain Injury',\n",
       "   'Diffuse Cerebral Injuries',\n",
       "   'Diffuse Cerebral Injury',\n",
       "   'Lesão Encefálica Axonal Difusa',\n",
       "   'Lesão Encefálica Difusa',\n",
       "   'Lesões Cerebrais Difusas',\n",
       "   'Lesões Encefálicas Difusas'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070627': {'ID': 'D000070627',\n",
       "  'name': 'Encefalopatia Traumática Crônica[Chronic Traumatic Encephalopathy]',\n",
       "  'scope': 'Degenerative brain disease linked to repetitive brain trauma. Progressive symptoms may include MEMORY LOSS; AGGRESSION; or DEPRESSION.',\n",
       "  'terms': ['Chronic Encephalopathies, Post-Concussive',\n",
       "   'Chronic Encephalopathy, Post Concussive',\n",
       "   'Chronic Encephalopathy, Post-Concussive',\n",
       "   'Chronic Post Concussive Encephalopathy',\n",
       "   'Chronic Post Traumatic Encephalopathy',\n",
       "   'Chronic Post-Concussive Encephalopathies',\n",
       "   'Chronic Post-Concussive Encephalopathy',\n",
       "   'Chronic Post-Traumatic Encephalopathies',\n",
       "   'Chronic Post-Traumatic Encephalopathy',\n",
       "   'Chronic Traumatic Encephalopathy',\n",
       "   'Encefalopatia Crônica Pós-Comocional',\n",
       "   'Encefalopatia Crônica Pós-Concussional',\n",
       "   'Encefalopatia Crônica Pós-Concussiva',\n",
       "   'Encefalopatia Crônica Pós-Traumática',\n",
       "   'Encefalopatia Crônica Traumática',\n",
       "   'Encefalopatia Pós-Concussiva',\n",
       "   'Encefalopatia Pós-Traumática',\n",
       "   'Encefalopatia Traumática Crônica',\n",
       "   'Encephalopathies, Post-Concussive',\n",
       "   'Encephalopathies, Post-Traumatic',\n",
       "   'Encephalopathy, Post Concussive',\n",
       "   'Encephalopathy, Post Traumatic',\n",
       "   'Encephalopathy, Post-Concussive',\n",
       "   'Encephalopathy, Post-Traumatic',\n",
       "   'Encephalopathy, Post-Traumatic, Chronic',\n",
       "   'Post Concussive Encephalopathy',\n",
       "   'Post Traumatic Encephalopathy',\n",
       "   'Post-Concussive Chronic Encephalopathies',\n",
       "   'Post-Concussive Chronic Encephalopathy',\n",
       "   'Post-Concussive Encephalopathies',\n",
       "   'Post-Concussive Encephalopathy',\n",
       "   'Post-Traumatic Encephalopathies',\n",
       "   'Post-Traumatic Encephalopathy',\n",
       "   'Traumatic Encephalopathy, Chronic'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070628': {'ID': 'D000070628',\n",
       "  'name': 'Redução Fechada[Closed Fracture Reduction]',\n",
       "  'scope': 'A procedure in which normal alignment of a fractured bone is restored by ORTHOPEDIC MANIPULATION without incision.',\n",
       "  'terms': ['Closed Fracture Reduction',\n",
       "   'Closed Fracture Reductions',\n",
       "   'Closed Reduction, Fracture',\n",
       "   'Fracture Closed Reduction',\n",
       "   'Fracture Closed Reductions',\n",
       "   'Fracture Reduction, Closed',\n",
       "   'Fracture Reductions, Closed',\n",
       "   'Reduction, Fracture Closed',\n",
       "   'Reductions, Fracture Closed',\n",
       "   'Redução Fechada',\n",
       "   'Redução Fechada de Fratura'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070630': {'ID': 'D000070630',\n",
       "  'name': 'Diástase Muscular[Diastasis, Muscle]',\n",
       "  'scope': 'Abnormal separation of muscles.',\n",
       "  'terms': ['Diastases, Muscle',\n",
       "   'Diastasis, Muscle',\n",
       "   'Diástase Muscular',\n",
       "   'Miodiástase',\n",
       "   'Muscle Diastases',\n",
       "   'Muscle Diastasis',\n",
       "   'Myodiastases',\n",
       "   'Myodiastasis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070631': {'ID': 'D000070631',\n",
       "  'name': 'Diástase Óssea[Diastasis, Bone]',\n",
       "  'scope': 'Abnormal separation of bones, often from a LIGAMENT.',\n",
       "  'terms': ['Bone Diastases',\n",
       "   'Bone Diastasis',\n",
       "   'Diastases, Bone',\n",
       "   'Diastasis, Bone',\n",
       "   'Diástase Óssea'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070632': {'ID': 'D000070632',\n",
       "  'name': 'Tendões dos Músculos Isquiotibiais[Hamstring Tendons]',\n",
       "  'scope': 'A group of tendons that attach the HAMSTRING MUSCLES proximally to the PELVIS and to the TIBIA and FIBULA at the KNEE JOINT.',\n",
       "  'terms': ['Biceps Femoris Tendon',\n",
       "   'Biceps Femoris Tendons',\n",
       "   'Hamstring Tendon',\n",
       "   'Hamstring Tendons',\n",
       "   'Semimembranosus Tendon',\n",
       "   'Semimembranosus Tendons',\n",
       "   'Semitendinosus Tendon',\n",
       "   'Semitendinosus Tendons',\n",
       "   'Tendon, Biceps Femoris',\n",
       "   'Tendon, Hamstring',\n",
       "   'Tendon, Semimembranosus',\n",
       "   'Tendon, Semitendinosus',\n",
       "   'Tendons, Biceps Femoris',\n",
       "   'Tendons, Hamstring',\n",
       "   'Tendons, Semimembranosus',\n",
       "   'Tendons, Semitendinosus',\n",
       "   'Tendão do Biceps Femoris',\n",
       "   'Tendão do Semimembranosus',\n",
       "   'Tendão do Semitendinosus',\n",
       "   'Tendões dos Isquiotibiais',\n",
       "   'Tendões dos Músculos Isquiotibiais'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070633': {'ID': 'D000070633',\n",
       "  'name': 'Músculos Isquiotibiais[Hamstring Muscles]',\n",
       "  'scope': 'A group of muscles in the posterior THIGH area that are involved in connecting the KNEE JOINT and the PELVIS.',\n",
       "  'terms': ['Biceps Femoris',\n",
       "   'Hamstring Muscle',\n",
       "   'Hamstring Muscles',\n",
       "   'Isquiossurais',\n",
       "   'Isquitibiais',\n",
       "   'Muscle, Hamstring',\n",
       "   'Muscles, Hamstring',\n",
       "   'Músculo Biceps Femoris',\n",
       "   'Músculo Bíceps Femoral',\n",
       "   'Músculo Posterior da Coxa',\n",
       "   'Músculo Semimembranoso',\n",
       "   'Músculo Semimembranosus',\n",
       "   'Músculo Semimembranáceo',\n",
       "   'Músculo Semitendinoso',\n",
       "   'Músculo Semitendinosus',\n",
       "   'Músculo Semitendíneo',\n",
       "   'Músculos Isquiossurais',\n",
       "   'Músculos Isquiotibiais',\n",
       "   'Músculos Posteriores da Coxa',\n",
       "   'Músculos do Jarrete',\n",
       "   'Semimembranosus',\n",
       "   'Semitendinosus'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070634': {'ID': 'D000070634',\n",
       "  'name': 'Sistema Colinérgico não Neuronal[Non-Neuronal Cholinergic System]',\n",
       "  'scope': 'The system of ACETYLCHOLINE-synthesizing enzymes, transporters, receptors and degrading enzymes that characterize non-neuronal cholinergic cells such as airway and skin EPITHELIAL CELLS.',\n",
       "  'terms': ['Cholinergic System, Non-Neuronal',\n",
       "   'Cholinergic System, Nonneuronal',\n",
       "   'Cholinergic Systems, Non-Neuronal',\n",
       "   'Cholinergic Systems, Nonneuronal',\n",
       "   'Non Neuronal Cholinergic System',\n",
       "   'Non-Neuronal Cholinergic System',\n",
       "   'Non-Neuronal Cholinergic Systems',\n",
       "   'Nonneuronal Cholinergic System',\n",
       "   'Nonneuronal Cholinergic Systems',\n",
       "   'Sistema Colinérgico não Neuronal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070635': {'ID': 'D000070635',\n",
       "  'name': 'Plug Lacrimal[Punctal Plugs]',\n",
       "  'scope': 'Small devices that are inserted into the tear ducts (NASOLACRIMAL DUCTS). They are used to block the drainage of TEARS for the treatment of DRY EYE SYNDROMES.',\n",
       "  'terms': ['Collagen Punctal Plug',\n",
       "   'Collagen Punctal Plugs',\n",
       "   'Plug Lacrimal',\n",
       "   'Plug Lacrimal de Colágeno',\n",
       "   'Plug Lacrimal de Silicone',\n",
       "   'Plug, Collagen Punctal',\n",
       "   'Plug, Punctal',\n",
       "   'Plug, Silicone Punctal',\n",
       "   'Plugs, Collagen Punctal',\n",
       "   'Plugs, Punctal',\n",
       "   'Plugs, Silicone Punctal',\n",
       "   'Punctal Plug',\n",
       "   'Punctal Plug, Collagen',\n",
       "   'Punctal Plug, Silicone',\n",
       "   'Punctal Plugs',\n",
       "   'Punctal Plugs, Collagen',\n",
       "   'Punctal Plugs, Silicone',\n",
       "   'Silicone Punctal Plug',\n",
       "   'Silicone Punctal Plugs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070636': {'ID': 'D000070636',\n",
       "  'name': 'Lesões do Manguito Rotador[Rotator Cuff Injuries]',\n",
       "  'scope': 'Rupture of the tendons in the ROTATOR CUFF of the shoulder joint due to injury.',\n",
       "  'terms': ['Cuff Injury, Rotator',\n",
       "   'Glenoid Labral Tear',\n",
       "   'Glenoid Labral Tears',\n",
       "   'Injuries, Rotator Cuff',\n",
       "   'Injury, Rotator Cuff',\n",
       "   'Labral Tear, Glenoid',\n",
       "   'Labral Tears, Glenoid',\n",
       "   'Lesões do Ligamento Glenoidal',\n",
       "   'Lesões do Ligamento Glenoídeo',\n",
       "   'Lesões do Ligamento Glenóideo',\n",
       "   'Lesões do Manguito Rotador',\n",
       "   'Rotator Cuff Injuries',\n",
       "   'Rotator Cuff Injury',\n",
       "   'Rotator Cuff Tear',\n",
       "   'Rotator Cuff Tears',\n",
       "   'Rotator Cuff Tendinitides',\n",
       "   'Rotator Cuff Tendinitis',\n",
       "   'Rotator Cuff Tendinoses',\n",
       "   'Rotator Cuff Tendinosis',\n",
       "   'Roturas da Coifa dos Rotadores',\n",
       "   'Roturas do Ligamento Glenoidal',\n",
       "   'Roturas do Ligamento Glenoídeo',\n",
       "   'Roturas do Ligamento Glenóideo',\n",
       "   'Roturas do Manguito Rotador',\n",
       "   'Ruptura do Manguito Rotador',\n",
       "   'Rupturas da Coifa dos Rotadores',\n",
       "   'Rupturas do Ligamento Glenoidal',\n",
       "   'Rupturas do Ligamento Glenoídeo',\n",
       "   'Rupturas do Ligamento Glenóideo',\n",
       "   'Rupturas do Manguito Rotador',\n",
       "   'Tear, Glenoid Labral',\n",
       "   'Tear, Rotator Cuff',\n",
       "   'Tears, Glenoid Labral',\n",
       "   'Tears, Rotator Cuff',\n",
       "   'Tendinite da Coifa dos Rotadores',\n",
       "   'Tendinite do Manguito Rotador',\n",
       "   'Tendinitis, Rotator Cuff',\n",
       "   'Tendinose da Coifa dos Rotadores',\n",
       "   'Tendinose do Manguito Rotador',\n",
       "   'Tendinoses, Rotator Cuff',\n",
       "   'Tendinosis, Rotator Cuff'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070637': {'ID': 'D000070637',\n",
       "  'name': 'Ligamento Colateral Ulnar[Collateral Ligament, Ulnar]',\n",
       "  'scope': 'The internal lateral ligament that travels from the medial aspect of the ELBOW uniting the distal aspect of the HUMERUS to the proximal aspect of the ULNA.',\n",
       "  'terms': ['Collateral Ligament, Ulnar',\n",
       "   'Collateral Ligaments, Ulnar',\n",
       "   'Ligament, Ulnar Collateral',\n",
       "   'Ligamento Colateral Ulnar',\n",
       "   'Ligaments, Ulnar Collateral',\n",
       "   'Ulnar Collateral Ligament'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070638': {'ID': 'D000070638',\n",
       "  'name': 'Reconstrução do Ligamento Colateral Ulnar[Ulnar Collateral Ligament Reconstruction]',\n",
       "  'scope': 'Surgical reconstruction of injured or insufficient ULNAR COLLATERAL LIGAMENT in the ELBOW JOINT.',\n",
       "  'terms': ['Cirurgia de Tommy John',\n",
       "   'Cirurgia do Ligamento Colateral Ulnar',\n",
       "   \"John's Surgery, Tommy\",\n",
       "   'Medial Ulnar Collateral Ligament Reconstruction',\n",
       "   'Reconstrução do Ligamento Colateral Ulnar',\n",
       "   'Reconstrução do Ligamento Colateral Ulnar Medial',\n",
       "   'Surgery, Tommy John',\n",
       "   \"Surgery, Tommy John's\",\n",
       "   'Tommy John Surgery',\n",
       "   \"Tommy John's Surgery\",\n",
       "   'Tommy Johns Surgery',\n",
       "   'Ulnar Collateral Ligament Reconstruction',\n",
       "   'Ulnar Collateral Ligament Surgery'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070639': {'ID': 'D000070639',\n",
       "  'name': 'Tendinopatia do Cotovelo[Elbow Tendinopathy]',\n",
       "  'scope': 'Inflammation (tendinitis) or degeneration (tendinosis) of the tendons of the elbow.',\n",
       "  'terms': ['Cotovelo de Golfista',\n",
       "   'Elbow Tendinopathies',\n",
       "   'Elbow Tendinopathy',\n",
       "   'Epicondilite Medial',\n",
       "   'Epicondylitides, Medial',\n",
       "   'Epicondylitis, Medial',\n",
       "   \"Golfer's Elbow\",\n",
       "   'Golfers Elbow',\n",
       "   'Medial Epicondylitides',\n",
       "   'Medial Epicondylitis',\n",
       "   'Tendinopathies, Elbow',\n",
       "   'Tendinopathy, Elbow',\n",
       "   'Tendinopatia do Cotovelo'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070642': {'ID': 'D000070642',\n",
       "  'name': 'Lesões Encefálicas Traumáticas[Brain Injuries, Traumatic]',\n",
       "  'scope': 'A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.',\n",
       "  'terms': ['Brain Injuries, Traumatic',\n",
       "   'Brain Injury, Traumatic',\n",
       "   'Brain Trauma',\n",
       "   'Brain Traumas',\n",
       "   'Encefalopatia Traumática',\n",
       "   'Encephalopathies, Traumatic',\n",
       "   'Encephalopathy, Traumatic',\n",
       "   'Injury, Brain, Traumatic',\n",
       "   'LCT (Lesão Cerebral Traumática)',\n",
       "   'LCTs (Lesões Cerebrais Traumáticas)',\n",
       "   'Lesão Encefálica Traumática',\n",
       "   'Lesão Traumática do Encéfalo',\n",
       "   'Lesões Encefálicas Traumáticas',\n",
       "   'Lesões Traumáticas Encefálicas',\n",
       "   'TBI (Traumatic Brain Injuries)',\n",
       "   'TBI (Traumatic Brain Injury)',\n",
       "   'TBIs (Traumatic Brain Injuries)',\n",
       "   'Trauma de Encéfalo',\n",
       "   'Trauma, Brain',\n",
       "   'Traumas, Brain',\n",
       "   'Traumatic Brain Injuries',\n",
       "   'Traumatic Brain Injury',\n",
       "   'Traumatic Encephalopathies',\n",
       "   'Traumatic Encephalopathy',\n",
       "   'Traumatismo Cerebral',\n",
       "   'Traumatismo do Encéfalo',\n",
       "   'Traumatismos Cerebrais',\n",
       "   'Traumatismos Encefálicos'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070656': {'ID': 'D000070656',\n",
       "  'name': 'Artropatia de Ruptura do Manguito Rotador[Rotator Cuff Tear Arthropathy]',\n",
       "  'scope': 'Rapidly destructive shoulder joint and bone disease found mainly in elderly, and predominantly in women. It is characterized by SHOULDER PAIN; JOINT INSTABILITY; and the presence of crystalline CALCIUM PHOSPHATES in the SYNOVIAL FLUID. It is associated with ROTATOR CUFF INJURIES.',\n",
       "  'terms': ['Arthropathy, Cuff Tear',\n",
       "   'Artropatia Degenerativa do Manguito Rotador',\n",
       "   'Artropatia de Ruptura do Manguito Rotador',\n",
       "   'Cuff Tear Arthropathy',\n",
       "   'Milwaukee Shoulder',\n",
       "   'Milwaukee Shoulder Syndrome',\n",
       "   'Ombro de Milwaukee',\n",
       "   'Rotator Cuff Tear Arthropathy',\n",
       "   'Shoulder, Milwaukee',\n",
       "   'Síndrome do Ombro de Milwaukee'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070657': {'ID': 'D000070657',\n",
       "  'name': 'Artropatias por Cristais[Crystal Arthropathies]',\n",
       "  'scope': 'Joint disorders that are characterized by accumulation of microcrystals in and around the joint including in the SYNOVIAL FLUID. They are classified according to the chemical nature of the crystals such as CALCIUM PYROPHOSPHATE; basic CALCIUM PHOSPHATES; and monosodium urate (see URIC ACID).',\n",
       "  'terms': ['Arthritides, Crystal',\n",
       "   'Arthritides, Crystalline',\n",
       "   'Arthritis, Crystal',\n",
       "   'Arthritis, Crystalline',\n",
       "   'Arthropathies, Crystal',\n",
       "   'Arthropathies, Crystalline',\n",
       "   'Arthropathy, Crystal',\n",
       "   'Arthropathy, Crystalline',\n",
       "   'Artrite Cristalina',\n",
       "   'Artrite por Cristais',\n",
       "   'Artropatias Cristalinas',\n",
       "   'Artropatias por Cristais',\n",
       "   'Artropatias por Deposição de Cristais',\n",
       "   'Crystal Arthritides',\n",
       "   'Crystal Arthritis',\n",
       "   'Crystal Arthropathies',\n",
       "   'Crystal Arthropathy',\n",
       "   'Crystalline Arthritides',\n",
       "   'Crystalline Arthritis',\n",
       "   'Crystalline Arthropathies',\n",
       "   'Crystalline Arthropathy'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070658': {'ID': 'D000070658',\n",
       "  'name': 'Vigna[Vigna]',\n",
       "  'scope': 'Plant genus in the pea family (Fabaceae).',\n",
       "  'terms': ['Adzuki Bean',\n",
       "   'Adzuki Beans',\n",
       "   'Bean, Adzuki',\n",
       "   'Bean, Moth',\n",
       "   'Bean, Mung',\n",
       "   'Bean, Rice',\n",
       "   'Beans, Adzuki',\n",
       "   'Beans, Moth',\n",
       "   'Beans, Mung',\n",
       "   'Beans, Rice',\n",
       "   'Black Gram',\n",
       "   'Blackeyed Pea',\n",
       "   'Blackeyed Peas',\n",
       "   'Cowpea',\n",
       "   'Cowpeas',\n",
       "   'Feijão-Arroz',\n",
       "   'Feijão-Azuqui',\n",
       "   'Feijão-Fradinho',\n",
       "   'Feijão-Mungo',\n",
       "   'Feijão-Preto',\n",
       "   'Feijão-Selim',\n",
       "   'Feijão-da-China',\n",
       "   'Feijão-da-Índia',\n",
       "   'Feijão-de-Corda',\n",
       "   'Gram, Black',\n",
       "   'Moth Bean',\n",
       "   'Moth Beans',\n",
       "   'Mung Bean',\n",
       "   'Mung Beans',\n",
       "   'Pea, Blackeyed',\n",
       "   'Peas, Blackeyed',\n",
       "   'Phaseolus mungo',\n",
       "   'Phaseolus mungo',\n",
       "   'Rice Bean',\n",
       "   'Rice Beans',\n",
       "   'Vigna',\n",
       "   'Vigna',\n",
       "   'Vigna aconitifolia',\n",
       "   'Vigna aconitifolia',\n",
       "   'Vigna angularis',\n",
       "   'Vigna angularis',\n",
       "   'Vigna mungo',\n",
       "   'Vigna mungo',\n",
       "   'Vigna radiata',\n",
       "   'Vigna radiata',\n",
       "   'Vigna umbellata',\n",
       "   'Vigna umbellata',\n",
       "   'Vigna unguiculata',\n",
       "   'Vigna unguiculata'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070659': {'ID': 'D000070659',\n",
       "  'name': 'Conforto do Paciente[Patient Comfort]',\n",
       "  'scope': 'Patient care intended to prevent or relieve suffering in conditions that ensure optimal quality living.',\n",
       "  'terms': ['Assistência em Conforto',\n",
       "   'Care, Comfort',\n",
       "   'Comfort Care',\n",
       "   'Comfort, Patient',\n",
       "   'Conforto do Paciente',\n",
       "   'Patient Comfort'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070660': {'ID': 'D000070660',\n",
       "  'name': 'Wolfiporia[Wolfiporia]',\n",
       "  'scope': 'The type species of Wolfiporia, formerly known as Poria cocos. It grows as a coconut-shaped sclerotium on the roots of pine trees and conifers.',\n",
       "  'terms': ['Fu Ling',\n",
       "   'Fu Ling',\n",
       "   'Fu-Ling',\n",
       "   'Fu-Ling',\n",
       "   'Fuling',\n",
       "   'Fungo Tuckahoe',\n",
       "   'Fungus, Tuckahoe',\n",
       "   'Poria cocos',\n",
       "   'Poria cocos',\n",
       "   'Tuckahoe Fungus',\n",
       "   'Wolfiporia',\n",
       "   'Wolfiporia',\n",
       "   'Wolfiporia cocos',\n",
       "   'Wolfiporia cocos',\n",
       "   'Wolfiporia extensa',\n",
       "   'Wolfiporia extensa'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070676': {'ID': 'D000070676',\n",
       "  'name': 'Entesopatia[Enthesopathy]',\n",
       "  'scope': 'A disorder occurring at the site of insertion of TENDONS or LIGAMENTS into bones or JOINT CAPSULES.',\n",
       "  'terms': ['Entesopatia', 'Enthesopathies', 'Enthesopathy'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070677': {'ID': 'D000070677',\n",
       "  'name': 'Gentianales[Gentianales]',\n",
       "  'scope': 'An angiosperm plant order that includes the APOCYNACEAE; ASCLEPIADACEAE; GENTIANACEAE; LOGANIACEAE; and RUBIACEAE  families.',\n",
       "  'terms': ['Gentianales', 'Gentianales'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000070696': {'ID': 'D000070696',\n",
       "  'name': 'Leitelho[Buttermilk]',\n",
       "  'scope': \"A beverage made from cow's milk fermented by LACTIC ACID-producing bacteria, especially LACTOCOCCUS LACTIS and LACTOBACILLUS BULGARICUS.\",\n",
       "  'terms': ['Butter Milk', 'Buttermilk', 'Leitelho', 'Milk, Butter'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070716': {'ID': 'D000070716',\n",
       "  'name': 'Kefir[Kefir]',\n",
       "  'scope': 'Symbiotic associations of different, predominantly LACTIC ACID-producing bacteria and yeast that exist in a polysaccharide and protein matrix, forming small grain-like aggregates in KEFIR.',\n",
       "  'terms': ['Grain, Kefir',\n",
       "   'Grains, Kefir',\n",
       "   'Grãos Kefir',\n",
       "   'Grãos Quefir',\n",
       "   'Grãos de Kefir',\n",
       "   'Grãos de Quefir',\n",
       "   'Kefir',\n",
       "   'Kefir',\n",
       "   'Kefir Grain',\n",
       "   'Kefir Grains',\n",
       "   'Quefir'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070736': {'ID': 'D000070736',\n",
       "  'name': 'Kumis[Koumiss]',\n",
       "  'scope': \"A beverage made from horse's milk that is fermented by endogenous LACTIC ACID-producing bacteria and ETHANOL-producing yeast.\",\n",
       "  'terms': ['Cúmis', 'Koumiss', 'Kumis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070777': {'ID': 'D000070777',\n",
       "  'name': 'Professores Escolares[School Teachers]',\n",
       "  'scope': 'Members of staff responsible for TEACHING students in a school from pre-kindergarten through twelfth grade.',\n",
       "  'terms': ['Elementary School Teacher',\n",
       "   'Elementary School Teachers',\n",
       "   'High School Teacher',\n",
       "   'High School Teachers',\n",
       "   'Middle School Teacher',\n",
       "   'Middle School Teachers',\n",
       "   'Pre School Teachers',\n",
       "   'Pre-School Teacher',\n",
       "   'Pre-School Teachers',\n",
       "   'Professores Escolares',\n",
       "   'Professores de Ensino Fundamental',\n",
       "   'Professores de Ensino Fundamental e Médio',\n",
       "   'Professores de Ensino Infantil',\n",
       "   'Professores de Ensino Médio',\n",
       "   'Professores de Ensino Pré-Escolar',\n",
       "   'Professores de Ensino Superior',\n",
       "   'Professores do Ensino Fundamental',\n",
       "   'Professores do Ensino Fundamental e Médio',\n",
       "   'Professores do Ensino Infantil',\n",
       "   'Professores do Ensino Médio',\n",
       "   'Professores do Ensino Pré-Escolar',\n",
       "   'Professores do Ensino Superior',\n",
       "   'School Teacher',\n",
       "   'School Teacher, Elementary',\n",
       "   'School Teacher, High',\n",
       "   'School Teacher, Middle',\n",
       "   'School Teachers',\n",
       "   'School Teachers, Elementary',\n",
       "   'School Teachers, High',\n",
       "   'School Teachers, Middle',\n",
       "   'Teacher, Elementary School',\n",
       "   'Teacher, High School',\n",
       "   'Teacher, Middle School',\n",
       "   'Teacher, Pre-School',\n",
       "   'Teacher, School',\n",
       "   'Teachers, Elementary School',\n",
       "   'Teachers, High School',\n",
       "   'Teachers, Middle School',\n",
       "   'Teachers, Pre-School',\n",
       "   'Teachers, School'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070778': {'ID': 'D000070778',\n",
       "  'name': 'Perilipina-1[Perilipin-1]',\n",
       "  'scope': 'A lipid droplet protein that is expressed primarily by ADIPOCYTES of WHITE ADIPOSE TISSUE and BROWN ADIPOSE TISSUE. It co-localizes with MACROPHAGES and FOAM CELLS of artherosclerotic lesions and stabilizes LIPID DROPLETS by inhibiting HORMONE SENSITIVE LIPASE. It may also protect TRIGLYCERIDES against hydrolysis within the PLASMA MEMBRANE and modulate CHOLESTEROL ESTER HYDROLASE activity.',\n",
       "  'terms': ['PERI Protein',\n",
       "   'Perilipin',\n",
       "   'Perilipin 1',\n",
       "   'Perilipin A Protein',\n",
       "   'Perilipin B Protein',\n",
       "   'Perilipin Protein',\n",
       "   'Perilipin-1',\n",
       "   'Perilipina',\n",
       "   'Perilipina-1',\n",
       "   'Plin Protein',\n",
       "   'Protein, PERI',\n",
       "   'Protein, Perilipin',\n",
       "   'Protein, Perilipin A',\n",
       "   'Protein, Perilipin B',\n",
       "   'Protein, Plin',\n",
       "   'Proteína PERI',\n",
       "   'Proteína Perilipina',\n",
       "   'Proteína Perilipina A',\n",
       "   'Proteína Perilipina B',\n",
       "   'Proteína Plin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070779': {'ID': 'D000070779',\n",
       "  'name': 'Tumor de Células Gigantes de Bainha Tendinosa[Giant Cell Tumor of Tendon Sheath]',\n",
       "  'scope': 'A tumor arising in the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath. It is characterized by OSTEOCLAST-like GIANT CELLS; FOAM CELLS; pigmented HEMOSIDERIN-laden MACROPHAGES and inflammatory infiltrate. It is classified either as diffuse or localized tenosynovitis.',\n",
       "  'terms': ['Fibrous Histiocytoma of Tendon Sheath',\n",
       "   'Giant Cell Tumor of Tendon Sheath',\n",
       "   'Histiocitoma Fibroso da Bainha Tendínea',\n",
       "   'Histiocitoma Fibroso da Bainha do Tendão',\n",
       "   'Histiocitoma Fibroso das Bainhas Tendinosas',\n",
       "   'Histiocitoma Fibroso das Bainhas Tendíneas',\n",
       "   'Histiocitoma Fibroso de Bainha Tendinosa',\n",
       "   'Histiocitoma Fibroso de Bainha Tendínea',\n",
       "   'Localized Giant Cell Tumor of the Tendon Sheath',\n",
       "   'Localized Nodular Tenosynovitides',\n",
       "   'Localized Nodular Tenosynovitis',\n",
       "   'Localized Pigmented Villonodular Synovitis',\n",
       "   'Nodular Tenosynovitides',\n",
       "   'Nodular Tenosynovitides, Localized',\n",
       "   'Nodular Tenosynovitis',\n",
       "   'Nodular Tenosynovitis, Localized',\n",
       "   'Sinovite Vilonodular Pigmentada Localizada',\n",
       "   'Tenossinovite Nodular',\n",
       "   'Tenossinovite Nodular Localizada',\n",
       "   'Tenosynovial Giant Cell Tumor',\n",
       "   'Tenosynovitides, Localized Nodular',\n",
       "   'Tenosynovitides, Nodular',\n",
       "   'Tenosynovitis, Localized Nodular',\n",
       "   'Tenosynovitis, Nodular',\n",
       "   'Tumor Localizado de Células Gigantes da Bainha do Tendão',\n",
       "   'Tumor Tenossinovial de Células Gigantes',\n",
       "   'Tumor de Células Gigantes Tenossinovial',\n",
       "   'Tumor de Células Gigantes da Bainha Tendínea',\n",
       "   'Tumor de Células Gigantes da Bainha do Tendão',\n",
       "   'Tumor de Células Gigantes de Bainha Tendinosa',\n",
       "   'Tumor de Células Gigantes de Bainha Tendínea',\n",
       "   'Tumor de Células Gigantes de Bainha de Tendão',\n",
       "   'Tumor de Células Gigantes, Tenossinovial'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070780': {'ID': 'D000070780',\n",
       "  'name': 'Perilipina-2[Perilipin-2]',\n",
       "  'scope': 'A perilipin that is expressed by many different cell types. It binds FATTY ACIDS and CHOLESTEROL,  stabilizes TRIGLYCERIDES, and localizes to both the surface and hydrophobic core of LIPID DROPLETS, as well as the ENDOPLASMIC RECTICULUM and PLASMA MEMBRANE in MACROPHAGES. It also plays a central role in the biogenesis of lipid droplets and FOAM CELLS and is highly expressed by macrophages at atherosclerotic lesions in human arteries along with the INFLAMMATION markers TNF-ALPHA; MCP-1 RECEPTOR; and IL-6.',\n",
       "  'terms': ['ADRP Protein',\n",
       "   'Adipofilina',\n",
       "   'Adipophilin',\n",
       "   'Adipose Differentiation Related Protein',\n",
       "   'Adipose Differentiation-Related Protein',\n",
       "   'PLIN2 Protein',\n",
       "   'Perilipin 2',\n",
       "   'Perilipin 2 Protein',\n",
       "   'Perilipin-2',\n",
       "   'Perilipina-2',\n",
       "   'Protein, Adipose Differentiation-Related',\n",
       "   'Protein, PLIN2',\n",
       "   'Protein, Perilipin 2',\n",
       "   'Proteína ADRP',\n",
       "   'Proteína PLIN2',\n",
       "   'Proteína Perilipina 2',\n",
       "   'Proteína Relacionada à Diferenciação Adiposa'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070796': {'ID': 'D000070796',\n",
       "  'name': 'Perilipina-3[Perilipin-3]',\n",
       "  'scope': 'A perilipin that localizes to LIPID DROPLETS; CYTOPLASM; ENDOSOMES; and PLASMA MEMBRANE, especially in MACROPHAGES. It functions as a transporter of free fatty acids to lipid droplets to promote their biogenesis and growth. It is also required for the transport of the MANNOSE-6-PHOSPHATE RECEPTOR from endosomes to the TRANS-GOLGI NETWORK. Its structure consists of four helix bundles that interact with the hydrophobic lipid droplet surface.',\n",
       "  'terms': ['47 kDa MPR binding Protein',\n",
       "   '47 kDa MPR-binding Protein',\n",
       "   '47 kDa Mannose 6 Phosphate Receptor Binding Protein',\n",
       "   '47 kDa Mannose 6-Phosphate Receptor-Binding Protein',\n",
       "   'Cargo Selection Protein TIP47',\n",
       "   'Mannose 6 Phosphate Receptor Binding Protein 1',\n",
       "   'Mannose-6-Phosphate Receptor-Binding Protein 1',\n",
       "   'PLIN3 Protein',\n",
       "   'Perilipin 3',\n",
       "   'Perilipin 3 Protein',\n",
       "   'Perilipin-3',\n",
       "   'Perilipina-3',\n",
       "   'Placental Protein 17',\n",
       "   'Protein, PLIN3',\n",
       "   'Protein, Perilipin 3',\n",
       "   'Protein, TIP47',\n",
       "   'Proteína 1 de Ligação ao Receptor de Manose 6-Fosfato',\n",
       "   'Proteína PLIN3',\n",
       "   'Proteína Perilipina 3',\n",
       "   'Proteína Placentária 17',\n",
       "   'Proteína TIP de 47 kDa',\n",
       "   'Proteína TIP47',\n",
       "   'Proteína TIP47 de Seleção de Carga',\n",
       "   'Proteína de Ligação ao MPR de 47 kDa',\n",
       "   'Proteína de Ligação ao Receptor de Manose 6-Fosfato de 47kDa',\n",
       "   'TIP47 Protein',\n",
       "   'Tail Interacting Protein of 47 kDa'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070797': {'ID': 'D000070797',\n",
       "  'name': 'Perilipina-5[Perilipin-5]',\n",
       "  'scope': 'A perilipin that functions in LIPOGENESIS; LIPOLYSIS; and fatty acid oxidation in BROWN ADIPOSE TISSUE; heart, liver, and skeletal muscle. It recruits MITOCHONDRIA to the surface of LIPID DROPLETS where it functions in both the storage of fatty acids as TRIGLYCERIDES, and their release for mitochondrial fatty acid oxidation in response to metabolic needs.',\n",
       "  'terms': ['LSDP5 Protein',\n",
       "   'Lipid Storage Droplet Protein 5',\n",
       "   'OXPAT Protein',\n",
       "   'PLIN5 Protein',\n",
       "   'Perilipin 5',\n",
       "   'Perilipin 5 Protein',\n",
       "   'Perilipin-5',\n",
       "   'Perilipina-5',\n",
       "   'Protein, LSDP5',\n",
       "   'Protein, OXPAT',\n",
       "   'Protein, PLIN5',\n",
       "   'Protein, Perilipin 5',\n",
       "   'Proteína 5 de Armazenamento de Gotícula Lipídica',\n",
       "   'Proteína LSDP5',\n",
       "   'Proteína OXPAT',\n",
       "   'Proteína PLIN5',\n",
       "   'Proteína Perilipina 5'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070798': {'ID': 'D000070798',\n",
       "  'name': 'Proteínas Nogo[Nogo Proteins]',\n",
       "  'scope': 'Myelin proteins that are expressed as three isoforms: Nogo-A, Nogo-B, and Nogo-C. These share a C-terminal reticulon homology domain (RHD), consisting of two hydrophobic membrane domains flanking a 66 amino acid (Nogo-66) hydrophilic region. A long transmembrane region allows conformations that either span the entire membrane or fold into a hairpin conformation. Nogo inhibits NEURITE outgrowth and modulates wiring and the restriction of SYNAPTIC PLASTICITY in the adult central nervous system. It also regulates neurite fasciculation, branching, and extension in the developing nervous system.',\n",
       "  'terms': ['Inibidor do Crescimento de Neuritos 35-350',\n",
       "   'NI 220 Protein',\n",
       "   'NI 250 Protein',\n",
       "   'NI 35 250',\n",
       "   'NI 35 Protein',\n",
       "   'NI-220 Protein',\n",
       "   'NI-250 Protein',\n",
       "   'NI-35 Protein',\n",
       "   'NI-35-250',\n",
       "   'NI-35-250',\n",
       "   'Neurite Growth Inhibitor 35 350',\n",
       "   'Neurite Growth Inhibitor 35-350',\n",
       "   'Nogo 66 Protein',\n",
       "   'Nogo A Protein',\n",
       "   'Nogo B Protein',\n",
       "   'Nogo C Protein',\n",
       "   'Nogo Protein',\n",
       "   'Nogo Proteins',\n",
       "   'Nogo-66 Protein',\n",
       "   'Nogo-A Protein',\n",
       "   'Nogo-B Protein',\n",
       "   'Nogo-C Protein',\n",
       "   'Proteína NI-220',\n",
       "   'Proteína NI-250',\n",
       "   'Proteína NI-35',\n",
       "   'Proteína Nogo',\n",
       "   'Proteína Nogo-66',\n",
       "   'Proteína Nogo-A',\n",
       "   'Proteína Nogo-B',\n",
       "   'Proteína Nogo-C',\n",
       "   'Proteína Reticulon 4-B',\n",
       "   'Proteína Reticulon-4',\n",
       "   'Proteínas Nogo',\n",
       "   'Reticulon 4 B Protein',\n",
       "   'Reticulon 4 Protein',\n",
       "   'Reticulon 4-B Protein',\n",
       "   'Reticulon-4 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070799': {'ID': 'D000070799',\n",
       "  'name': 'Redução Aberta[Open Fracture Reduction]',\n",
       "  'scope': 'Restoration of normal alignment of a fractured bone via an OPERATIVE SURGICAL PROCEDURE.',\n",
       "  'terms': ['Fracture Open Reduction',\n",
       "   'Fracture Open Reductions',\n",
       "   'Fracture Reduction, Open',\n",
       "   'Open Fracture Reduction',\n",
       "   'Open Fracture Reductions',\n",
       "   'Open Reduction, Fracture',\n",
       "   'Open Reductions, Fracture',\n",
       "   'Reduction, Fracture Open',\n",
       "   'Reductions, Fracture Open',\n",
       "   'Redução Aberta',\n",
       "   'Redução Aberta de Fratura'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070816': {'ID': 'D000070816',\n",
       "  'name': 'Receptor Nogo 1[Nogo Receptor 1]',\n",
       "  'scope': 'A high affinity receptor for myelin-associated inhibitors (MAIs) that include NOGO-A PROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN. It is expressed primarily by neurons in the brain and OLFACTORY BULBS. During embryonic development, it is expressed in the PERIPHERAL NERVOUS SYSTEM.  It localizes to GROWTH CONES and may inhibit neurite outgrowth following SPINAL INJURY.',\n",
       "  'terms': ['NgR1 Protein',\n",
       "   'Nogo 66 Receptor',\n",
       "   'Nogo Receptor 1',\n",
       "   'Nogo-66 Receptor',\n",
       "   'Protein, NgR1',\n",
       "   'Protein, RTN4R',\n",
       "   'Proteína NgR1',\n",
       "   'Proteína RTN4R',\n",
       "   'RTN4R Protein',\n",
       "   'Receptor Nogo 1',\n",
       "   'Receptor Nogo-66',\n",
       "   'Receptor de Reticulon-4',\n",
       "   'Receptor, Nogo-66',\n",
       "   'Receptor, Reticulon-4',\n",
       "   'Reticulon 4 Receptor',\n",
       "   'Reticulon-4 Receptor'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070817': {'ID': 'D000070817',\n",
       "  'name': 'Receptor Nogo 2[Nogo Receptor 2]',\n",
       "  'scope': 'A Nogo receptor that binds to MYELIN-ASSOCIATED GLYCOPROTEIN. It localizes to the GROWTH CONES of neurons in the THALAMUS; CORTEX: AMYGDALA; OLFACTORY BULBS; and HYPOTHALAMUS.',\n",
       "  'terms': ['Homólogo 1 ao Receptor Nogo-66',\n",
       "   'NgR2 Protein',\n",
       "   'Nogo 66 Receptor Homolog 1',\n",
       "   'Nogo 66 Receptor related Protein 2',\n",
       "   'Nogo Receptor 2',\n",
       "   'Nogo Receptor like 3 Protein',\n",
       "   'Nogo Receptor-like 3 Protein',\n",
       "   'Nogo-66 Receptor Homolog 1',\n",
       "   'Nogo-66 Receptor-related Protein 2',\n",
       "   'Protein, NgR2',\n",
       "   'Protein, RTN4RL2',\n",
       "   'Proteína 2 Relacionada ao Receptor Nogo-66',\n",
       "   'Proteína 2 Semelhante a Receptor de Reticulon 4',\n",
       "   'Proteína 3 Semelhante a Receptor Nogo',\n",
       "   'Proteína NgR2',\n",
       "   'Proteína RTN4RL2',\n",
       "   'RTN4RL2 Protein',\n",
       "   'Receptor Nogo 2',\n",
       "   'Reticulon 4 Receptor like 2 Protein',\n",
       "   'Reticulon 4 Receptor-like 2 Protein'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070818': {'ID': 'D000070818',\n",
       "  'name': 'Receptores com Domínio Discoidina[Discoidin Domain Receptors]',\n",
       "  'scope': 'Receptor tyrosine kinases that bind COLLAGENS. They are characterized by the presence of extracellular DISCOIDIN DOMAINS that activate SIGNAL TRANSDUCTION PATHWAYS in response to collagen binding. They may also be cleaved by MATRIX METALLOPROTEINASES to mediate cell interactions with the EXTRACELLULAR MATRIX.',\n",
       "  'terms': ['DDR Proteins',\n",
       "   'Discoidin Domain Receptor',\n",
       "   'Discoidin Domain Receptors',\n",
       "   'Proteins, DDR',\n",
       "   'Proteínas DDR',\n",
       "   'Receptor, Discoidin Domain',\n",
       "   'Receptores com Domínio Discoidina',\n",
       "   'Receptores com Domínios Discoidina',\n",
       "   'Receptores de Domínio de Discoidina',\n",
       "   'Receptores de Domínios Discoidina',\n",
       "   'Receptores de Domínios de Discoidina',\n",
       "   'Receptores do Domínio Discoidina',\n",
       "   'Receptores do Domínio de Discoidina',\n",
       "   'Receptors, Discoidin Domain'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070819': {'ID': 'D000070819',\n",
       "  'name': 'Receptor com Domínio Discoidina 1[Discoidin Domain Receptor 1]',\n",
       "  'scope': 'A discoidin domain receptor for FIBRILLAR COLLAGEN that functions in a variety of cellular processes. For example, it regulates cell attachment to the EXTRACELLULAR MATRIX, remodeling of the extracellular matrix, CELL MIGRATION; CELL DIFFERENTIATION; CELL PROLIFERATION; and CELL SURVIVAL.',\n",
       "  'terms': ['Antigen, CD167',\n",
       "   'Antígeno CD167',\n",
       "   'CD167 Antigen',\n",
       "   'DDR1 Protein',\n",
       "   'Discoidin Domain Receptor 1',\n",
       "   'Discoidin Domain Receptor Family, Member 1 Protein',\n",
       "   'Discoidin Domain Receptor Tyrosine Kinase 1',\n",
       "   'Protein, DDR1',\n",
       "   'Proteína DDR1',\n",
       "   'Proteína Membro 1 da Família de Receptores com Domínio Discoidina',\n",
       "   'Receptor com Domínio Discoidina 1',\n",
       "   'Receptor com Domínio de Discoidina 1',\n",
       "   'Receptor de Domínio Discoidina 1',\n",
       "   'Receptor de Domínio de Discoidina 1',\n",
       "   'Receptor do Domínio Discoidina 1',\n",
       "   'Receptor do Domínio de Discoidina 1',\n",
       "   'Tirosina Quinase 1 do Receptor com Domínio Discoidina'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070820': {'ID': 'D000070820',\n",
       "  'name': 'Receptor com Domínio Discoidina 2[Discoidin Domain Receptor 2]',\n",
       "  'scope': 'A discoidin domain receptor for FIBRILLAR COLLAGEN and non-fibrillar COLLAGEN TYPE X. It functions in many cellular and developmental processes that include remodeling of the EXTRACELLULAR MATRIX; CELL MIGRATION; CELL DIFFERENTIATION; and CELL PROLIFERATION; as well as OSTEOGENESIS and the maturation of CHONDROCYTES.',\n",
       "  'terms': ['Antigen, CD167b',\n",
       "   'Antígeno CD167b',\n",
       "   'CD167b Antigen',\n",
       "   'DDR2 Kinase',\n",
       "   'DDR2 Protein',\n",
       "   'Discoidin Domain Receptor 2',\n",
       "   'Discoidin Domain Receptor Family, Member 2 Protein',\n",
       "   'Discoidin Domain Receptor Tyrosine Kinase 2',\n",
       "   'Kinase, DDR2',\n",
       "   'Neurotrophic Tyrosine Kinase, Receptor Related 3 Protein',\n",
       "   'Neurotrophic Tyrosine Kinase, Receptor-Related 3 Protein',\n",
       "   'Protein, DDR2',\n",
       "   'Proteína 3 Relacionada a Receptor Tirosina Quinase Neurotrópico',\n",
       "   'Proteína DDR2',\n",
       "   'Proteína Membro 2 da Família de Receptores com Domínio Discoidina',\n",
       "   'Quinase DDR2',\n",
       "   'Receptor Tirosina Quinase Tipo 10',\n",
       "   'Receptor com Domínio Discoidina 2',\n",
       "   'Receptor de Domínio de Discoidina 2',\n",
       "   'Receptor do Domínio de Discoidina 2',\n",
       "   'Tirosina Quinase 2 do Receptor com Domínio Discoidina',\n",
       "   'Tyrosine Kinase Receptor Type 10'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070821': {'ID': 'D000070821',\n",
       "  'name': 'Discoidinas[Discoidins]',\n",
       "  'scope': 'Lectins that were identified in DICTYOSTELIUM DISCOIDEUM. They bind to GALACTOSE and are involved in cell-substratum adhesion, maintenance of morphology during aggregation, and spore formation.',\n",
       "  'terms': ['Discoidin I',\n",
       "   'Discoidin II',\n",
       "   'Discoidin-I',\n",
       "   'Discoidin-II',\n",
       "   'Discoidina-I',\n",
       "   'Discoidina-II',\n",
       "   'Discoidinas',\n",
       "   'Discoidins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070822': {'ID': 'D000070822',\n",
       "  'name': 'Domínio Discoidina[Discoidin Domain]',\n",
       "  'scope': 'A protein domain originally identified in DISCOIDINS. It occurs in a variety of unrelated proteins in multicellular organisms, where it recognizes different ligands with distinct biological functions. Structurally, it consists of two antiparallel beta sheets that form a \"jellyroll\" configuration stabilized by two intramolecular disulfide bonds. Sequence differences within this module determine ligand specificity; in DISCOIDIN DOMAIN RECEPTORS, it binds to FIBRILLAR COLLAGENS and NON-FIBRILLAR COLLAGENS.',\n",
       "  'terms': ['Discoidin Domain',\n",
       "   'Discoidin Domains',\n",
       "   'Domain, Discoidin',\n",
       "   'Domains, Discoidin',\n",
       "   'Domínio Discoidina',\n",
       "   'Domínios Discoidina'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070837': {'ID': 'D000070837',\n",
       "  'name': 'Lisina Acetiltransferases[Lysine Acetyltransferases]',\n",
       "  'scope': 'Acetyltransferases that can transfer an acyl group  to specific LYSINE residues within HISTONES (HISTONE ACETYLTRANSFERASES) and/or non-histone proteins.',\n",
       "  'terms': ['Acetyltransferases, K-Lysine',\n",
       "   'Acetyltransferases, Lysine',\n",
       "   'K Lysine Acetyltransferases',\n",
       "   'K-Lisina Acetiltransferases',\n",
       "   'K-Lysine Acetyltransferases',\n",
       "   'Lisina Acetiltransferases',\n",
       "   'Lysine Acetyltransferases'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070838': {'ID': 'D000070838',\n",
       "  'name': 'Pesquisa em Farmácia[Pharmacy Research]',\n",
       "  'scope': 'RESEARCH activity focused on PHARMACY.',\n",
       "  'terms': ['Pesquisa em Farmácia', 'Pharmacy Research', 'Research, Pharmacy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070840': {'ID': 'D000070840',\n",
       "  'name': 'Farmácia Nuclear[Nuclear Pharmacy]',\n",
       "  'scope': 'An application of PHARMACY involving the preparation and dispensing of radioactive materials for use in medications.',\n",
       "  'terms': ['Farmácia Nuclear', 'Nuclear Pharmacy', 'Pharmacy, Nuclear'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070856': {'ID': 'D000070856',\n",
       "  'name': 'Treinamento com Simulação de Alta Fidelidade[High Fidelity Simulation Training]',\n",
       "  'scope': 'A controlled learning environment that closely represents reality.',\n",
       "  'terms': ['High Fidelity Simulation Training',\n",
       "   'Treinamento com Simulador de Alta Fidelidade',\n",
       "   'Treinamento com Simulação de Alta Fidelidade'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070857': {'ID': 'D000070857',\n",
       "  'name': 'Teste de Caminhada[Walk Test]',\n",
       "  'scope': 'A measure of endurance tests that show how far and fast an individual can walk without stopping within a certain period of time.',\n",
       "  'terms': ['6 Minute Walk Test',\n",
       "   '6-Minute Walk Test',\n",
       "   '6-Minute Walk Tests',\n",
       "   'ESWT',\n",
       "   'Endurance Shuttle Walk Test',\n",
       "   'ISWT',\n",
       "   'Incremental Shuttle Walk Test',\n",
       "   'Test, 6-Minute Walk',\n",
       "   'Test, Walk',\n",
       "   'Teste de Caminhada',\n",
       "   'Teste de Caminhada com Carga Progressiva',\n",
       "   'Teste de Caminhada de 6 Minutos',\n",
       "   'Teste de Caminhada de Resistência',\n",
       "   'Teste de Caminhada de Seis Minutos',\n",
       "   'Tests, 6-Minute Walk',\n",
       "   'Tests, Walk',\n",
       "   'Walk Test',\n",
       "   'Walk Test, 6-Minute',\n",
       "   'Walk Tests',\n",
       "   'Walk Tests, 6-Minute'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000070876': {'ID': 'D000070876',\n",
       "  'name': 'Tensinas[Tensins]',\n",
       "  'scope': 'A family of multidomain microfilament proteins that bind ACTIN FILAMENTS and INTEGRINS at FOCAL ADHESIONS. They generally consist of an N-terminal domain with homology to PHOSPHOTYROSINE PHOSPHATASE, a C2 DOMAIN; unique central regions rich in PROLINE; ALANINE; GLYCINE; and SERINE; an SH2 DOMAIN; and a C-terminal phosphotyrosine-binding region. They are involved in CELL MIGRATION; CELL ADHESION; SIGNAL TRANSDUCTION; and reorganization of the CYTOSKELETON.',\n",
       "  'terms': ['Tensin', 'Tensina', 'Tensinas', 'Tensins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070896': {'ID': 'D000070896',\n",
       "  'name': 'Lesões de Bankart[Bankart Lesions]',\n",
       "  'scope': 'HUMERAL HEAD defect created by the sharp edge of the anterior GLENOID LABRUM as the humeral head dislocates over it.',\n",
       "  'terms': ['Bankart Fractures',\n",
       "   'Bankart Lesion',\n",
       "   'Bankart Lesion, Bony',\n",
       "   'Bankart Lesion, Osseous',\n",
       "   'Bankart Lesions',\n",
       "   'Bankart Lesions, Bony',\n",
       "   'Bankart Lesions, Osseous',\n",
       "   'Bankart Tears',\n",
       "   'Bony Bankart Lesion',\n",
       "   'Bony Bankart Lesions',\n",
       "   'Fractures, Bankart',\n",
       "   'Fraturas Bankart',\n",
       "   'Fraturas de Bankart',\n",
       "   'Hill Sachs Lesion',\n",
       "   'Hill Sachs Lesions',\n",
       "   'Hill-Sachs Lesion',\n",
       "   'Hill-Sachs Lesions',\n",
       "   'Lacerações Bankart',\n",
       "   'Lacerações de Bankart',\n",
       "   'Lesion, Bankart',\n",
       "   'Lesion, Bony Bankart',\n",
       "   'Lesion, Hill-Sachs',\n",
       "   'Lesion, Osseous Bankart',\n",
       "   'Lesions, Bankart',\n",
       "   'Lesions, Bony Bankart',\n",
       "   'Lesions, Hill-Sachs',\n",
       "   'Lesions, Osseous Bankart',\n",
       "   'Lesão Bankart',\n",
       "   'Lesão de Bankart',\n",
       "   'Lesão de Hill-Sachs',\n",
       "   'Lesão Óssea de Bankart',\n",
       "   'Lesões de Bankart',\n",
       "   'Lesões de Will-Sachs',\n",
       "   'Lesões Ósseas de Bankart',\n",
       "   'Osseous Bankart Lesion',\n",
       "   'Osseous Bankart Lesions',\n",
       "   'Rupturas Bankart',\n",
       "   'Rupturas de Bankart',\n",
       "   'Tears, Bankart'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000070916': {'ID': 'D000070916',\n",
       "  'name': 'Tenócitos[Tenocytes]',\n",
       "  'scope': 'Elongated FIBROBLASTS and fibrocytes that lie between the collagen fibers and form the TENDON proper.',\n",
       "  'terms': ['Tenocyte', 'Tenocytes', 'Tenócitos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070918': {'ID': 'D000070918',\n",
       "  'name': 'Sinoviócitos[Synoviocytes]',\n",
       "  'scope': 'Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN).',\n",
       "  'terms': ['Célula Sinovial',\n",
       "   'Células Sinoviais',\n",
       "   'Sinoviócitos',\n",
       "   'Synoviocyte',\n",
       "   'Synoviocytes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000070956': {'ID': 'D000070956',\n",
       "  'name': 'Proteínas MutL[MutL Proteins]',\n",
       "  'scope': 'DNA repair proteins that include the bacterial MutL protein and its eukaryotic homologs. They consist of a conserved N-terminal region with weak ATPase activity, an endonuclease motif, and a C-terminal domain that forms MutL homodimers or heterodimers between MLH1 and the PMS1, MISMATCH REPAIR ENDONUCLEASE PMS2; or MLH3 proteins. These complexes function in DNA repair pathways, primarily DNA MISMATCH REPAIR, where MutL/MLH1 and the MUTS DNA MISMATCH-BINDING PROTEIN are targeted to damaged DNA.',\n",
       "  'terms': ['Homólogos MutL',\n",
       "   'MutL Homologs',\n",
       "   'MutL Proteins',\n",
       "   'Proteínas MutL'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070957': {'ID': 'D000070957',\n",
       "  'name': 'Proteína 1 Homóloga a MutL[MutL Protein Homolog 1]',\n",
       "  'scope': 'Eukaryotic homolog of the bacterial MutL DNA MISMATCH REPAIR protein. It heterodimerizes with MISMATCH REPAIR ENDONUCLEASE PMS2 to form MutL alpha, which is recruited to DNA mismatch sites by the MUTS DNA MISMATCH-BINDING PROTEIN. Mutations in the human MLH1 gene are associated with COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS.',\n",
       "  'terms': ['COCA2 Protein',\n",
       "   'Colon Cancer, Nonpolyposis Type 2 Protein',\n",
       "   'Homólogo 1 de MutL',\n",
       "   'MLH1 Protein',\n",
       "   'MutL Homolog 1',\n",
       "   'MutL Protein Homolog 1',\n",
       "   'Proteína 1 Homóloga a MutL',\n",
       "   'Proteína COCA2',\n",
       "   'Proteína MLH1',\n",
       "   'Proteína do Tipo 2 do Câncer do Colo não Polipoide'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070976': {'ID': 'D000070976',\n",
       "  'name': 'Endonuclease PMS2 de Reparo de Erro de Pareamento[Mismatch Repair Endonuclease PMS2]',\n",
       "  'scope': 'A MutL protein and component of the DNA MISMATCH REPAIR system. Its ENDONUCLEASE activity introduces SINGLE-STRAND DNA BREAKS which create entry points for EXO1 exonuclease to remove the strand containing the mismatch. It may also function in DNA DAMAGE signaling.',\n",
       "  'terms': ['Endonuclease PMS2 de Reparo de Erro de Pareamento',\n",
       "   'Mismatch Repair Endonuclease PMS2',\n",
       "   'PMS 2 Protein',\n",
       "   'PMS-2 Protein',\n",
       "   'PMS1 Homolog 2, Mismatch Repair Protein',\n",
       "   'PMS2 Protein',\n",
       "   'Postmeiotic Segregation Increased S. cerevisiae 2',\n",
       "   'Postmeiotic Segregation Increased-S. cerevisiae-2',\n",
       "   'Proteína PMS-2',\n",
       "   'Proteína PMS2',\n",
       "   'Proteína de Reparo de Erro de Pareamento 2 Homóloga a PMS-1',\n",
       "   'Segregação Pós-Meiótica Aumentada em S. cerevisiae-2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070996': {'ID': 'D000070996',\n",
       "  'name': 'Subfamília G de Transportadores de Cassetes de Ligação de ATP[ATP Binding Cassette Transporter, Sub-Family G]',\n",
       "  'scope': 'A subfamily of ATP binding cassette transporters that function primarily in the transport of lipids and STEROLS across the CELL MEMBRANE. They also export UREA and various drugs resulting in MULTIDRUG RESISTANCE. They are smaller than most other ATP binding cassette proteins, consisting of six transmembrane alpha helices and a distinct N-terminal cytoplasmic ATP-binding domain, and function as homo- or heterodimers with other ABCG transporters.',\n",
       "  'terms': ['ABCG Proteins',\n",
       "   'ABCG Transporters',\n",
       "   'ATP Binding Cassette Transporter, Sub Family G',\n",
       "   'ATP Binding Cassette Transporter, Sub-Family G',\n",
       "   'Proteínas ABCG',\n",
       "   'Subfamília G de Transportadores de Cassetes de Ligação de ATP',\n",
       "   'Transportadores ABCG',\n",
       "   'Transportadores de Cassetes de Ligação de ATP Subfamília G'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070997': {'ID': 'D000070997',\n",
       "  'name': 'Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP[ATP Binding Cassette Transporter, Sub-Family G, Member 2]',\n",
       "  'scope': 'An ATP binding cassette transporter, sub-family G protein that functions as a high capacity UREA exporter, transporter of STEROLS, and in the absorption and efflux of many drugs. Its efflux activity for ANTINEOPLASTIC AGENTS contributes to DRUG RESISTANCE. It functions as a homodimer and is expressed by cells in a variety of organs, as well as by NEOPLASTIC STEM CELLS.',\n",
       "  'terms': ['ABCG2 Protein',\n",
       "   'ABCG2 Transporter',\n",
       "   'ATP Binding Cassette Transporter, Sub-Family G, Member 2',\n",
       "   'Antigen, CD338',\n",
       "   'Antígeno CD338',\n",
       "   'CD338 Antigen',\n",
       "   'Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP',\n",
       "   'Proteína ABCG2',\n",
       "   'Transportador ABCG2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000070998': {'ID': 'D000070998',\n",
       "  'name': 'Membro 1 da Subfamília G de Transportadores de Cassetes de Ligação de ATP[ATP Binding Cassette Transporter, Sub-Family G, Member 1]',\n",
       "  'scope': 'An ATP binding cassette transporter that functions primarily as a lipid and CHOLESTEROL exporter in MACROPHAGES.  It may also function in intracellular lipid transport and homoeostasis.',\n",
       "  'terms': ['ABCG1 Protein',\n",
       "   'ABCG1 Transporter',\n",
       "   'ATP Binding Cassette Transporter 8',\n",
       "   'ATP Binding Cassette Transporter, Sub-Family G, Member 1',\n",
       "   'ATP-Binding Cassette Transporter 8',\n",
       "   'Homólogo à Proteína White',\n",
       "   'Membro 1 da Subfamília G de Transportadores de Cassetes de Ligação de ATP',\n",
       "   'Proteína ABCG1',\n",
       "   'Transportador 8 de Cassetes de Ligação de ATP',\n",
       "   'Transportador ABCG1',\n",
       "   'White Protein Homolog'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071017': {'ID': 'D000071017',\n",
       "  'name': 'Hiperecplexia[Hyperekplexia]',\n",
       "  'scope': 'A neurological disorder characterized by an excessive startle reaction with ABNORMAL REFLEX;  MYOCLONIC JERKS; and MUSCLE HYPERTONIA.',\n",
       "  'terms': ['Hiperecplexia', 'Hyperekplexia', 'Hyperekplexias'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071018': {'ID': 'D000071018',\n",
       "  'name': 'Membro 5 da Subfamília G de Transportadores de Cassetes de Ligação de ATP[ATP Binding Cassette Transporter, Sub-Family G, Member 5]',\n",
       "  'scope': 'An ATP binding cassette transporter, sub-family G protein that functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 8 in the selective transport of DIETARY CHOLESTEROL and PHYTOSTEROLS into and export out of ENTEROCYTES. It also functions in selective sterol excretion by the liver into bile.',\n",
       "  'terms': ['ABCG5 Protein',\n",
       "   'ATP Binding Cassette Transporter, Sub-Family G, Member 5',\n",
       "   'Esterolina-1',\n",
       "   'Membro 5 da Subfamília G de Transportadores de Cassetes de Ligação de ATP',\n",
       "   'Proteína ABCG5',\n",
       "   'Proteína Esterolina-1',\n",
       "   'Sterolin 1 Protein',\n",
       "   'Sterolin-1 Protein',\n",
       "   'Transportador de Cassetes de Ligação de ATP Subfamília G, Membro 5',\n",
       "   'Transportadores de Cassetes de Ligação de ATP Subfamília G, Membro 5'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071019': {'ID': 'D000071019',\n",
       "  'name': 'Membro 8 da Subfamília G de Transportadores de Cassetes de Ligação de ATP[ATP Binding Cassette Transporter, Sub-Family G, Member 8]',\n",
       "  'scope': 'An ATP binding cassette transporter, sub-family G protein that functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 5 in the selective transport of DIETARY CHOLESTEROL and PHYTOSTEROLS into and export out of ENTEROCYTES. It also functions in selective sterol excretion by the liver into bile.',\n",
       "  'terms': ['ABCG8 Protein',\n",
       "   'ATP Binding Cassette Transporter, Sub-Family G, Member 8',\n",
       "   'Esterolina-2',\n",
       "   'Membro 8 da Subfamília G de Transportadores de Cassetes de Ligação de ATP',\n",
       "   'Proteína ABCG8',\n",
       "   'Proteína Esterolina-2',\n",
       "   'Sterolin 2 Protein',\n",
       "   'Sterolin-2 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071020': {'ID': 'D000071020',\n",
       "  'name': 'Proteína da Hemocromatose[Hemochromatosis Protein]',\n",
       "  'scope': 'A membrane protein and MHC class I antigen. It contains an IMMUNOGLOBULIN C1-SET DOMAIN and interacts with BETA 2-MICROGLOBULIN. It may also regulate the interaction of TRANSFERRIN with the TRANSFERRIN RECEPTOR. Mutations in the HFE gene are associated with cases of FAMILIAL HEMOCHROMATOSIS.',\n",
       "  'terms': ['Antigen, HLA-H',\n",
       "   'Antígeno HLA-H',\n",
       "   'HFE Protein',\n",
       "   'HLA H Antigen',\n",
       "   'HLA-H Antigen',\n",
       "   'Hemochromatosis Protein',\n",
       "   'Proteína HFE',\n",
       "   'Proteína da Hemocromatose'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071036': {'ID': 'D000071036',\n",
       "  'name': 'Linfonodo Sentinela[Sentinel Lymph Node]',\n",
       "  'scope': 'First lymph node to receive drainage from the primary tumor. SENTINEL LYMPH NODE BIOPSY is performed to determine early METASTASIS status because cancer cells may appear first in the sentinel node.',\n",
       "  'terms': ['Linfonodo Sentinela',\n",
       "   'Lymph Node, Sentinel',\n",
       "   'Lymph Nodes, Sentinel',\n",
       "   'Node, Sentinal',\n",
       "   'Nodes, Sentinal',\n",
       "   'Nodo Sentinela',\n",
       "   'Sentinal Node',\n",
       "   'Sentinal Nodes',\n",
       "   'Sentinel Lymph Node',\n",
       "   'Sentinel Lymph Nodes'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071037': {'ID': 'D000071037',\n",
       "  'name': 'Células de Lugar[Place Cells]',\n",
       "  'scope': 'Pyramidal neurons in the HIPPOCAMPUS that play a role in cognitive representation of a specific location within a space.',\n",
       "  'terms': ['Cell, Hippocampal Place',\n",
       "   'Cell, Place',\n",
       "   'Cells, Hippocampal Place',\n",
       "   'Cells, Place',\n",
       "   'Células Hipocampais de Lugar',\n",
       "   'Células de Lugar',\n",
       "   'Células de Lugar Hipocampais',\n",
       "   'Células de Lugar do Hipocampo',\n",
       "   'Hippocampal Place Cell',\n",
       "   'Hippocampal Place Cells',\n",
       "   'Place Cell',\n",
       "   'Place Cell, Hippocampal',\n",
       "   'Place Cells',\n",
       "   'Place Cells, Hippocampal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071038': {'ID': 'D000071038',\n",
       "  'name': 'Células de Grade[Grid Cells]',\n",
       "  'scope': 'Neurons in the ENTORHINAL CORTEX that project to the HIPPOCAMPUS. Grid cells and PLACE CELLS play a role in cognitive representation of spatial memory and navigation.',\n",
       "  'terms': ['Cell, Grid',\n",
       "   'Cells, Grid',\n",
       "   'Células de Grade',\n",
       "   'Grid Cell',\n",
       "   'Grid Cells'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071039': {'ID': 'D000071039',\n",
       "  'name': 'Córtex Perirrinal[Perirhinal Cortex]',\n",
       "  'scope': 'An area in the temporal lobe that is important for memory encoding and retrieval. It is bordered caudally by the parahippocampal cortex (see HIPPOCAMPUS) and ventrally and medially by the ENTORHINAL CORTEX.',\n",
       "  'terms': ['Cortex, Perirhinal',\n",
       "   'Cortices, Perirhinal',\n",
       "   'Córtex Perirrinal',\n",
       "   'Perirhinal Cortex',\n",
       "   'Perirhinal Cortices'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071040': {'ID': 'D000071040',\n",
       "  'name': 'Segmento Inicial do Axônio[Axon Initial Segment]',\n",
       "  'scope': 'First segment of axon that connects distal axon segments to the neuronal CELL BODY at the axon hillock region. The axon initial segment is not protected by the MYELIN SHEATH and has properties critical for axonal growth. The axon initial segment and the axon hillock form an axonal trigger zone.',\n",
       "  'terms': ['Axon Hillock',\n",
       "   'Axon Hillocks',\n",
       "   'Axon Initial Segment',\n",
       "   'Axon Initial Segments',\n",
       "   'Axonal Trigger Zone',\n",
       "   'Axonal Trigger Zones',\n",
       "   'Cone Axônico',\n",
       "   'Cone do Axônio',\n",
       "   'Segmento Inicial do Axônio',\n",
       "   'Trigger Zone, Axonal',\n",
       "   'Zona de Disparo Axonal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071041': {'ID': 'D000071041',\n",
       "  'name': 'Mucosa Esofágica[Esophageal Mucosa]',\n",
       "  'scope': 'Circular innermost layer of the ESOPHAGUS wall that mediates esophageal PERISTALSIS which pushes ingested food bolus toward the stomach.',\n",
       "  'terms': ['Esophageal Mucosa',\n",
       "   'Esophagus Mucosa',\n",
       "   'Mucosa Esofágica',\n",
       "   'Mucosa do Esôfago',\n",
       "   'Mucosa, Esophageal',\n",
       "   'Mucosa, Esophagus',\n",
       "   'Mucosa, Oesophageal',\n",
       "   'Oesophageal Mucosa'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071056': {'ID': 'D000071056',\n",
       "  'name': 'Malformações Anorretais[Anorectal Malformations]',\n",
       "  'scope': 'Congenital defects in the anus and the rectum often involving the urinary and genital tracts.',\n",
       "  'terms': ['Anomalias Anorretais',\n",
       "   'Anomalies, Anorectal',\n",
       "   'Anomaly, Anorectal',\n",
       "   'Anorectal Anomalies',\n",
       "   'Anorectal Anomaly',\n",
       "   'Anorectal Atresia',\n",
       "   'Anorectal Atresias',\n",
       "   'Anorectal Malformation',\n",
       "   'Anorectal Malformations',\n",
       "   'Anorectal Stenoses',\n",
       "   'Anorectal Stenosis',\n",
       "   'Atresia Anorretal',\n",
       "   'Atresia, Anorectal',\n",
       "   'Atresias, Anorectal',\n",
       "   'Estenose Anorretal',\n",
       "   'Malformation, Anorectal',\n",
       "   'Malformations, Anorectal',\n",
       "   'Malformação Anorretal',\n",
       "   'Malformações Anorretais',\n",
       "   'Stenoses, Anorectal',\n",
       "   'Stenosis, Anorectal'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071057': {'ID': 'D000071057',\n",
       "  'name': 'Discinesia Tardia[Tardive Dyskinesia]',\n",
       "  'scope': 'Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).',\n",
       "  'terms': ['Discinesia Tardia',\n",
       "   'Discinesias Tardias',\n",
       "   'Distonia Tardia',\n",
       "   'Distonias Tardias',\n",
       "   'Dyskinesia, Tardive',\n",
       "   'Dyskinesias, Tardive',\n",
       "   'Dystonia, Tardive',\n",
       "   'Dystonias, Tardive',\n",
       "   'Tardive Dyskinesia',\n",
       "   'Tardive Dyskinesias',\n",
       "   'Tardive Dystonia',\n",
       "   'Tardive Dystonias'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071058': {'ID': 'D000071058',\n",
       "  'name': 'Proteína Huntingtina[Huntingtin Protein]',\n",
       "  'scope': 'A protein that is highly expressed in the nervous system as well as other tissues; its size and structure vary due to polymorphisms. Expanded CAG TRINUCLEOTIDE REPEATS have been identified in the Huntingtin (HD) Gene of patients with HUNTINGTON DISEASE and are associated with abnormal PROTEIN AGGREGATES. Huntingtin interacts with proteins involved in a variety of gene expression and cellular processes; it is also essential for embryonic development.',\n",
       "  'terms': ['Huntingtin Protein',\n",
       "   'Huntingtina',\n",
       "   'Huntington Disease Protein',\n",
       "   'IT15 Protein',\n",
       "   'Proteína Huntingtina',\n",
       "   'Proteína IT15',\n",
       "   'Proteína da Doença de Huntington',\n",
       "   'Proteína de Huntington'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071059': {'ID': 'D000071059',\n",
       "  'name': 'Terapia por Fagos[Phage Therapy]',\n",
       "  'scope': 'Therapeutic use of BACTERIOPHAGES to treat diseases.',\n",
       "  'terms': ['Bacteriophage Therapies',\n",
       "   'Bacteriophage Therapy',\n",
       "   'Phage Therapies',\n",
       "   'Phage Therapy',\n",
       "   'Terapia por Bacteriófagos',\n",
       "   'Terapia por Fagos'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071060': {'ID': 'D000071060',\n",
       "  'name': 'Densidade da Mama[Breast Density]',\n",
       "  'scope': 'Measurement of relative composition of different BREAST tissue types often determined from MAMMOGRAPHY; ULTRASONOGRAPHY; or MRI.',\n",
       "  'terms': ['Breast Densities',\n",
       "   'Breast Densities, Mammographic',\n",
       "   'Breast Density',\n",
       "   'Breast Density, Mammographic',\n",
       "   'Densidade Mamográfica',\n",
       "   'Densidade Mamográfica da Mama',\n",
       "   'Densidade da Mama',\n",
       "   'Density, Mammographic',\n",
       "   'Mammographic Breast Densities',\n",
       "   'Mammographic Breast Density',\n",
       "   'Mammographic Densities',\n",
       "   'Mammographic Density'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071061': {'ID': 'D000071061',\n",
       "  'name': 'Diagnóstico Tradicional pelo Pulso[Traditional Pulse Diagnosis]',\n",
       "  'scope': 'Technique used in AYURVEDIC MEDICINE, and EAST ASIAN TRADITIONAL MEDICINE, in which reading PULSE is used in the diagnosis of diseases.',\n",
       "  'terms': ['Diagnóstico Tradicional do Pulso',\n",
       "   'Diagnóstico Tradicional pelo Pulso',\n",
       "   'Pulse Diagnoses, Traditional',\n",
       "   'Pulse Diagnosis, Traditional',\n",
       "   'Pulse Reading, Traditional',\n",
       "   'Pulse Readings, Traditional',\n",
       "   'Traditional Pulse Diagnoses',\n",
       "   'Traditional Pulse Diagnosis',\n",
       "   'Traditional Pulse Reading',\n",
       "   'Traditional Pulse Readings'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071062': {'ID': 'D000071062',\n",
       "  'name': 'Procedimentos Cirúrgicos sem Sutura[Sutureless Surgical Procedures]',\n",
       "  'scope': 'Surgical techniques in which SUTURES are not applied to surgical wounds.',\n",
       "  'terms': ['Cirurgia sem Sutura',\n",
       "   'Procedimentos Cirúrgicos sem Sutura',\n",
       "   'Repair Technique, Sutureless',\n",
       "   'Repair Techniques, Sutureless',\n",
       "   'Reparo sem Sutura',\n",
       "   'Surgeries, Sutureless',\n",
       "   'Surgery, Sutureless',\n",
       "   'Surgical Procedure, Sutureless',\n",
       "   'Surgical Procedures, Sutureless',\n",
       "   'Sutureless Repair',\n",
       "   'Sutureless Repair Technique',\n",
       "   'Sutureless Repair Techniques',\n",
       "   'Sutureless Repairs',\n",
       "   'Sutureless Surgeries',\n",
       "   'Sutureless Surgery',\n",
       "   'Sutureless Surgical Procedure',\n",
       "   'Sutureless Surgical Procedures',\n",
       "   'Técnica de Reparo sem Sutura'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071063': {'ID': 'D000071063',\n",
       "  'name': 'Endoglina[Endoglin]',\n",
       "  'scope': 'A membrane glycoprotein and ANGIOGENESIS FACTOR that is expressed by cells of the VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; and MONOCYTES. It functions as a co-receptor for TRANSFORMING GROWTH FACTOR BETA and modulates CELL ADHESION. Mutations in the endoglin gene are associated with cases of HEREDITARY HEMORRHAGIC TELANGIECTASIA.',\n",
       "  'terms': ['Antigen, CD105',\n",
       "   'Antígeno CD105',\n",
       "   'CD105 Antigen',\n",
       "   'Endoglin',\n",
       "   'Endoglin Protein',\n",
       "   'Endoglina',\n",
       "   'Proteína Endoglina'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071064': {'ID': 'D000071064',\n",
       "  'name': 'Fadiga de Alarmes do Pessoal de Saúde[Alert Fatigue, Health Personnel]',\n",
       "  'scope': 'Mental fatigue experienced by health care providers who encounter numerous alerts and reminders from the use of CLINICAL DECISION SUPPORT SYSTEMS. As the numbers of alerts and reminders designed to provide meaningful assistance to the patient care process increases, many health personnel may ignore them.',\n",
       "  'terms': ['Alert Fatigue Health Personnel',\n",
       "   'Alert Fatigue, Health Personnel',\n",
       "   'Fadiga de Alarmes do Pessoal de Saúde',\n",
       "   'Fadiga de Alerta do Pessoal de Saúde',\n",
       "   'Health Personnel Alert Fatigue'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071065': {'ID': 'D000071065',\n",
       "  'name': 'Prescrições Permanentes[Standing Orders]',\n",
       "  'scope': 'Medical procedures and prescriptions regarding treatment of a patient that can be exercised by other health care personnel when predetermined conditions have been met.',\n",
       "  'terms': ['Ordem Permanente',\n",
       "   'Ordens Permanentes',\n",
       "   'Prescrição Permanente',\n",
       "   'Prescrições Permanentes',\n",
       "   'Standing Order',\n",
       "   'Standing Order Prescription',\n",
       "   'Standing Order Prescriptions',\n",
       "   'Standing Orders'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071066': {'ID': 'D000071066',\n",
       "  'name': 'Medidas de Resultados Relatados pelo Paciente[Patient Reported Outcome Measures]',\n",
       "  'scope': 'Assessment of the quality and effectiveness of health care as measured and directly reported by the patient.',\n",
       "  'terms': ['Medidas de Resultados Relatadas por Pacientes',\n",
       "   'Medidas de Resultados Relatados pelo Paciente',\n",
       "   'Outcome, Patient Reported',\n",
       "   'Outcomes, Patient Reported',\n",
       "   'Patient Reported Outcome',\n",
       "   'Patient Reported Outcome Measures',\n",
       "   'Patient Reported Outcomes',\n",
       "   'Reported Outcome, Patient',\n",
       "   'Reported Outcomes, Patient',\n",
       "   'Resultado Relatado pelo Paciente',\n",
       "   'Resultado Relatado por Pacientes',\n",
       "   'Resultados Relatados pelo Paciente',\n",
       "   'Resultados Relatados por Pacientes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071067': {'ID': 'D000071067',\n",
       "  'name': 'Pneumonia Necrosante[Pneumonia, Necrotizing]',\n",
       "  'scope': 'Severe complication of pneumonia characterized by liquefaction of lung tissue.',\n",
       "  'terms': ['Necrotizing Pneumonia',\n",
       "   'Necrotizing Pneumonias',\n",
       "   'Pneumonia Necrosante',\n",
       "   'Pneumonia Necrotizante',\n",
       "   'Pneumonia Necrótica',\n",
       "   'Pneumonia, Necrotizing',\n",
       "   'Pneumonias, Necrotizing'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071068': {'ID': 'D000071068',\n",
       "  'name': 'Lipocalina-2[Lipocalin-2]',\n",
       "  'scope': 'A lipocalin of approximately 200 amino acids that functions as an iron transporter and is expressed by cells of BONE MARROW and many other cells with secretory functions. It is involved in APOPTOSIS and may function to limit pathogenic bacterial growth as part of the INNATE IMMUNE RESPONSE.',\n",
       "  'terms': ['Lipocalin 2',\n",
       "   'Lipocalin 2 Protein',\n",
       "   'Lipocalin-2',\n",
       "   'Lipocalin-2 Protein',\n",
       "   'Lipocalina Associada a Gelatinase de Neutrófilo',\n",
       "   'Lipocalina-2',\n",
       "   'NGAL Protein',\n",
       "   'Neutrophil Gelatinase Associated Lipocalin',\n",
       "   'Neutrophil Gelatinase-Associated Lipocalin',\n",
       "   'Oncogene 24p3 Protein',\n",
       "   'Proteína Lipocalina-2',\n",
       "   'Proteína NGAL',\n",
       "   'Proteína Oncogênica 24p3',\n",
       "   'Proteína Siderocalina',\n",
       "   'Siderocalin Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071069': {'ID': 'D000071069',\n",
       "  'name': 'Múltiplas Afecções Crônicas[Multiple Chronic Conditions]',\n",
       "  'scope': 'Two or more concurrent chronic physical, mental, or behavioral health problems in an individual.',\n",
       "  'terms': ['<i>aerogenes</i>',\n",
       "   '<i>aures</i>',\n",
       "   '<i>aureus</i>',\n",
       "   'Afecções Crônicas Múltiplas',\n",
       "   'Chronic Conditions, Multiple',\n",
       "   'Chronic Disease, Multiple',\n",
       "   'Chronic Diseases, Multiple',\n",
       "   'Chronic Illnesses, Multiple',\n",
       "   'Condições Médicas Crônicas Múltiplas',\n",
       "   'Condições de Saúde Crônicas Múltiplas',\n",
       "   'Doenças Crônicas Múltiplas',\n",
       "   'Doenças Múltiplas Crônicas',\n",
       "   'Enfermidades Crônicas Múltiplas',\n",
       "   'Morbidity, Multiple',\n",
       "   'Multi',\n",
       "   'Multiple Chronic Conditions',\n",
       "   'Multiple Chronic Disease',\n",
       "   'Multiple Chronic Diseases',\n",
       "   'Multiple Chronic Health Conditions',\n",
       "   'Multiple Chronic Illnesses',\n",
       "   'Multiple Chronic Medical Conditions',\n",
       "   'Multiple Morbidity',\n",
       "   'Multus',\n",
       "   'Múltiplas Afecções Crônicas',\n",
       "   'Múltiplas Doenças Crônicas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071070': {'ID': 'D000071070',\n",
       "  'name': 'Lipomatose Múltipla Familiar[Familial Multiple Lipomatosis]',\n",
       "  'scope': \"A rare autosomal disorder characterized by numerous encapsulated lipomas on the trunk and extremities. The lipomas are usually not painful but can cause pain when growing. In rare cases, one lipoma can become painful and progress to multiple painful lipomas; it is then referred to as Dercum's Disease Type III\",\n",
       "  'terms': ['Adipose Dolorosa Tipo III',\n",
       "   'Adiposis Dolorosa Type III',\n",
       "   \"Dercum's Disease Type III\",\n",
       "   'Doença de Dercum Tipo III',\n",
       "   'Familial Multiple Lipoma',\n",
       "   'Familial Multiple Lipomas',\n",
       "   'Familial Multiple Lipomatoses',\n",
       "   'Familial Multiple Lipomatosis',\n",
       "   'Lipoma Dolorosa',\n",
       "   'Lipoma Doloroso',\n",
       "   'Lipomas Múltiplos Familiares',\n",
       "   'Lipomatose Múltipla Familiar',\n",
       "   'Lipomatoses, Familial Multiple',\n",
       "   'Lipomatosis, Familial Multiple',\n",
       "   'Multiple Lipoma, Familial',\n",
       "   'Multiple Lipomas, Familial'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071071': {'ID': 'D000071071',\n",
       "  'name': 'Microaneurisma[Microaneurysm]',\n",
       "  'scope': 'Aneurysm of the MICROVASCULATURE. Charcot–Bouchard aneurysms are aneurysms of the brain vasculature which is a common cause of CEREBRAL HEMORRHAGE. Retinal microaneurysm is an early diagnostic sign of DIABETIC RETINOPATHY.',\n",
       "  'terms': ['Aneurisma Miliar',\n",
       "   'Aneurisma de Charcot-Bouchard',\n",
       "   'Aneurismas de Charcot-Bouchard',\n",
       "   'Aneurysm, Charcot-Bouchard',\n",
       "   'Aneurysm, Miliary',\n",
       "   'Aneurysms, Charcot-Bouchard',\n",
       "   'Aneurysms, Miliary',\n",
       "   'Charcot Bouchard Aneurysm',\n",
       "   'Charcot Bouchard Aneurysms',\n",
       "   'Charcot-Bouchard Aneurysm',\n",
       "   'Charcot-Bouchard Aneurysms',\n",
       "   'Microaneurisma',\n",
       "   'Microaneurisma da Retina',\n",
       "   'Microaneurysm',\n",
       "   'Microaneurysm, Retinal',\n",
       "   'Microaneurysms',\n",
       "   'Microaneurysms, Retinal',\n",
       "   'Miliary Aneurysm',\n",
       "   'Miliary Aneurysms',\n",
       "   'Retinal Microaneurysm',\n",
       "   'Retinal Microaneurysms'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071072': {'ID': 'D000071072',\n",
       "  'name': 'Encefalopatia Aguda Febril[Acute Febrile Encephalopathy]',\n",
       "  'scope': 'Acute onset of fever accompanied by seizures, cerebral inflammation and a change in mental status (e.g., confusion, disorientation, and coma).',\n",
       "  'terms': ['Acute Encephalitis Syndrome',\n",
       "   'Acute Encephalitis Syndromes',\n",
       "   'Acute Febrile Encephalopathies',\n",
       "   'Acute Febrile Encephalopathy',\n",
       "   'Encefalopatia Aguda Febril',\n",
       "   'Encefalopatia Febril',\n",
       "   'Encefalopatia Febril Aguda',\n",
       "   'Encefalopatias Febrís',\n",
       "   'Encephalopathies, Acute Febrile',\n",
       "   'Encephalopathies, Febrile',\n",
       "   'Encephalopathy, Acute Febrile',\n",
       "   'Encephalopathy, Febrile',\n",
       "   'Febrile Encephalopathies',\n",
       "   'Febrile Encephalopathies, Acute',\n",
       "   'Febrile Encephalopathy',\n",
       "   'Síndrome da Encefalite Aguda'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071074': {'ID': 'D000071074',\n",
       "  'name': 'Sepse Neonatal[Neonatal Sepsis]',\n",
       "  'scope': 'Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.',\n",
       "  'terms': ['Early-Onset Sepses, Neonatal',\n",
       "   'Early-Onset Sepsis, Neonatal',\n",
       "   'Late-Onset Sepses, Neonatal',\n",
       "   'Late-Onset Sepsis, Neonatal',\n",
       "   'Neonatal Early Onset Sepsis',\n",
       "   'Neonatal Early-Onset Sepses',\n",
       "   'Neonatal Early-Onset Sepsis',\n",
       "   'Neonatal Late Onset Sepsis',\n",
       "   'Neonatal Late-Onset Sepses',\n",
       "   'Neonatal Late-Onset Sepsis',\n",
       "   'Neonatal Sepses',\n",
       "   'Neonatal Sepsis',\n",
       "   'Sepse Neonatal',\n",
       "   'Sepse Neonatal de Início Precoce',\n",
       "   'Sepse Neonatal de Início Tardio',\n",
       "   'Sepses, Neonatal',\n",
       "   'Sepses, Neonatal Early-Onset',\n",
       "   'Sepses, Neonatal Late-Onset',\n",
       "   'Sepsis, Neonatal',\n",
       "   'Sepsis, Neonatal Early-Onset',\n",
       "   'Sepsis, Neonatal Late-Onset'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071075': {'ID': 'D000071075',\n",
       "  'name': 'Neuropatia de Pequenas Fibras[Small Fiber Neuropathy]',\n",
       "  'scope': 'Disorder of the peripheral nerves that primarily impair small nerve fibers. The affected small nerve fibers include myelinated A-delta fibers (see A FIBERS) and unmyelinated C FIBERS. Because these small fibers innervate skin and help control autonomic function, their neuropathy presents with neuropathic pain, reduced thermal and pain sensitivity, and autonomic dysfunction (e.g. abnormal sweating or facial flushing). Small fiber neuropathy can be idiopathic or associated with underlying diseases (e.g., AMYLOIDOSIS; DIABETES MELLITUS; SARCOIDOSIS; or VASCULITIS).',\n",
       "  'terms': ['Neuropathies, Small Fiber',\n",
       "   'Neuropathies, Small Fibre',\n",
       "   'Neuropathy, Small Fiber',\n",
       "   'Neuropathy, Small Fibre',\n",
       "   'Neuropatia de Fibras Finas',\n",
       "   'Neuropatia de Fibras Pequenas',\n",
       "   'Neuropatia de Pequenas Fibras',\n",
       "   'Neuropatia de Pequenas Fibras Nervosas',\n",
       "   'Small Fiber Neuropathies',\n",
       "   'Small Fiber Neuropathy',\n",
       "   'Small Fibre Neuropathies',\n",
       "   'Small Fibre Neuropathy',\n",
       "   'Small Nerve Fiber Neuropathy'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071076': {'ID': 'D000071076',\n",
       "  'name': 'Meta-Análise em Rede[Network Meta-Analysis]',\n",
       "  'scope': 'Meta-analysis of randomized trials in which estimates of comparative treatment effects are visualized and interpreted from a network of interventions that may or may not have been evaluated directly against each other. Common considerations in network meta-analysis include conceptual and statistical heterogeneity and incoherence.',\n",
       "  'terms': ['Meta-Analyses, Mixed Treatment',\n",
       "   'Meta-Analyses, Network',\n",
       "   'Meta-Analysis, Mixed Treatment',\n",
       "   'Meta-Analysis, Network',\n",
       "   'Meta-Análise de Comparação de Múltiplos Tratamentos',\n",
       "   'Meta-Análise de Comparação de Tratamento Múltiplo',\n",
       "   'Meta-Análise de Tratamento Misto',\n",
       "   'Meta-Análise em Rede',\n",
       "   'Mixed Treatment Meta Analysis',\n",
       "   'Mixed Treatment Meta-Analyses',\n",
       "   'Mixed Treatment Meta-Analysis',\n",
       "   'Multiple Treatment Comparison Meta Analysis',\n",
       "   'Multiple Treatment Comparison Meta-Analysis',\n",
       "   'Network Meta Analysis',\n",
       "   'Network Meta-Analyses',\n",
       "   'Network Meta-Analysis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071077': {'ID': 'D000071077',\n",
       "  'name': 'Oncologia Cirúrgica[Surgical Oncology]',\n",
       "  'scope': 'A surgical specialty concerned with management of cancer.',\n",
       "  'terms': ['Cirurgia Oncológica',\n",
       "   'Oncologia Cirúrgica',\n",
       "   'Oncology, Surgical',\n",
       "   'Surgical Oncology'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071078': {'ID': 'D000071078',\n",
       "  'name': 'Estenose de Veia Pulmonar[Stenosis, Pulmonary Vein]',\n",
       "  'scope': 'Narrowing of the PULMONARY VEIN.',\n",
       "  'terms': ['Estenose da Veia Pulmonar',\n",
       "   'Estenose das Veias Pulmonares',\n",
       "   'Estenose de Veia Pulmonar',\n",
       "   'Estenose de Veias Pulmonares',\n",
       "   'Pulmonary Vein Stenoses',\n",
       "   'Pulmonary Vein Stenosis',\n",
       "   'Stenoses, Pulmonary Vein',\n",
       "   'Stenosis, Pulmonary Vein',\n",
       "   'Vein Stenoses, Pulmonary',\n",
       "   'Vein Stenosis, Pulmonary'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071079': {'ID': 'D000071079',\n",
       "  'name': 'Estenose de Artéria Pulmonar[Stenosis, Pulmonary Artery]',\n",
       "  'scope': 'Narrowing of the PULMONARY ARTERIES.',\n",
       "  'terms': ['Artery Stenoses, Pulmonary',\n",
       "   'Artery Stenosis, Pulmonary',\n",
       "   'Estenose da Artéria Pulmonar',\n",
       "   'Estenose das Artérias Pulmonares',\n",
       "   'Estenose de Artéria Pulmonar',\n",
       "   'Estenose de Artérias Pulmonares',\n",
       "   'Pulmonary Artery Stenoses',\n",
       "   'Pulmonary Artery Stenosis',\n",
       "   'Stenoses, Pulmonary Artery',\n",
       "   'Stenosis, Pulmonary Artery'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071080': {'ID': 'D000071080',\n",
       "  'name': 'Excitabilidade Cortical[Cortical Excitability]',\n",
       "  'scope': 'Measurable changes in activities in the CEREBRAL CORTEX upon a stimulation. A change in cortical excitability as measured by various techniques (e.g., TRANSCRANIAL MAGNETIC STIMULATION) is associated with brain disorders.',\n",
       "  'terms': ['Cortical Excitabilities',\n",
       "   'Cortical Excitability',\n",
       "   'Excitabilidade Cortical',\n",
       "   'Excitabilities, Cortical',\n",
       "   'Excitability, Cortical'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071081': {'ID': 'D000071081',\n",
       "  'name': 'Diferença Mínima Clinicamente Importante[Minimal Clinically Important Difference]',\n",
       "  'scope': 'A statistically significant minimum set of clinical outcomes that demonstrates a clinical benefit of an intervention or treatment.',\n",
       "  'terms': ['Diferença Mínima Clinicamente Importante',\n",
       "   'Minimal Clinically Important Difference',\n",
       "   'Mínima Diferença Clinicamente Importante'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071085': {'ID': 'D000071085',\n",
       "  'name': 'Enteroscopia de Balão Único[Single-Balloon Enteroscopy]',\n",
       "  'scope': 'A balloon-assisted enteroscopy utilizing a flexible endoscope with one overtube balloon control unit.',\n",
       "  'terms': ['Endoscopia de Balão Simples',\n",
       "   'Endoscopia de Balão Único',\n",
       "   'Endoscopy, Single-Balloon',\n",
       "   'Enteroscopia de Balão Simples',\n",
       "   'Enteroscopia de Balão Único',\n",
       "   'Enteroscopy, Single-Balloon',\n",
       "   'Single Balloon Endoscopy',\n",
       "   'Single Balloon Enteroscopy',\n",
       "   'Single-Balloon Endoscopy',\n",
       "   'Single-Balloon Enteroscopy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071087': {'ID': 'D000071087',\n",
       "  'name': 'Enteroscopia de Balão[Balloon Enteroscopy]',\n",
       "  'scope': 'An endoscopy of the small intestines accomplished while advancing the endoscope, which is assisted by one or two balloons',\n",
       "  'terms': ['Balloon Enteroscopies',\n",
       "   'Balloon Enteroscopy',\n",
       "   'Enteroscopia com Balão',\n",
       "   'Enteroscopia de Balão',\n",
       "   'Enteroscopies, Balloon',\n",
       "   'Enteroscopy, Balloon'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071096': {'ID': 'D000071096',\n",
       "  'name': 'Proteínas ADAMTS[ADAMTS Proteins]',\n",
       "  'scope': 'A subfamily of ADAMTS proteins that lack a protease domain.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase With Thrombospondin Motifs Proteins',\n",
       "   'ADAMTS Like Proteins',\n",
       "   'ADAMTS Proteases',\n",
       "   'ADAMTS Proteins',\n",
       "   'ADAMTS-Like Proteins',\n",
       "   'ADAMTSL Proteins',\n",
       "   'Adam Metallopeptidases With Thrombospondin Type 1 Motif Proteins',\n",
       "   'Proteases ADAMTS',\n",
       "   'Proteínas ADAMTS',\n",
       "   'Proteínas ADAMTSL',\n",
       "   'Proteínas Desintegrina e Metaloproteinase com Motivos de Trombospondina',\n",
       "   'Proteínas Metalopeptidases ADAM com Motivo de Trombospondina Tipo 1',\n",
       "   'Proteínas Semelhantes a ADAMTS'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071097': {'ID': 'D000071097',\n",
       "  'name': 'Proteína ADAMTS1[ADAMTS1 Protein]',\n",
       "  'scope': 'An ADAMTS protease that contains two disintegrin loops and three C-terminal thrombospondin (TS) motifs. It functions as an ANGIOGENESIS INHIBITOR as well as in normal tissue growth and fertility.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 Protein',\n",
       "   'ADAMTS 1 Protein',\n",
       "   'ADAMTS-1 Protein',\n",
       "   'ADAMTS1 Protease',\n",
       "   'ADAMTS1 Protein',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 1',\n",
       "   'Proteases ADAMTS1',\n",
       "   'Proteína ADAMTS-1',\n",
       "   'Proteína ADAMTS1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071116': {'ID': 'D000071116',\n",
       "  'name': 'Proteína ADAMTS5[ADAMTS5 Protein]',\n",
       "  'scope': 'An ADAMTS protease that contains two C-terminal thrombospondin (TS) motifs. It functions primarily as an aggrecanase, cleaving AGGRECAN in CARTILAGE, and may be involved in the destruction of aggrecan in ARTHRITIS.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Protein',\n",
       "   'ADAMTS 5 Protein',\n",
       "   'ADAMTS-5 Protein',\n",
       "   'ADAMTS11 Protein',\n",
       "   'ADAMTS5 Protease',\n",
       "   'ADAMTS5 Protein',\n",
       "   'Aggrecanase 2',\n",
       "   'Aggrecanase-2',\n",
       "   'Agrecanase-2',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 5',\n",
       "   'Protease ADAMTS5',\n",
       "   'Proteína ADAMTS-5',\n",
       "   'Proteína ADAMTS11',\n",
       "   'Proteína ADAMTS5'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071117': {'ID': 'D000071117',\n",
       "  'name': 'Valores Críticos Laboratoriais[Laboratory Critical Values]',\n",
       "  'scope': 'Test results which deviate substantially from normal ranges of REFERENCE VALUES or other qualitative results. They trigger CLINICAL LABORATORY SERVICES to place a special alert to ensure PATIENT SAFETY.',\n",
       "  'terms': ['Alert Value, Laboratory',\n",
       "   'Alert Values, Laboratory',\n",
       "   'Critical Value, Laboratory',\n",
       "   'Critical Values, Laboratory',\n",
       "   'Laboratory Alert Value',\n",
       "   'Laboratory Alert Values',\n",
       "   'Laboratory Critical Value',\n",
       "   'Laboratory Critical Values',\n",
       "   'Valores Críticos Laboratoriais'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071118': {'ID': 'D000071118',\n",
       "  'name': 'Proteína ADAMTS7[ADAMTS7 Protein]',\n",
       "  'scope': 'An ADAMTS protease that contains four central and four C-terminal thrombospondin (TS) motifs. It binds to and degrades CARTILAGE OLIGOMERIC MATRIX PROTEIN.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase With Thrombospondin Motifs 7 Protein',\n",
       "   'ADAMTS 7 Protein',\n",
       "   'ADAMTS-7 Protein',\n",
       "   'ADAMTS7 Protein',\n",
       "   'COMPase',\n",
       "   'COMPase',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 7',\n",
       "   'Proteína ADAMTS-7',\n",
       "   'Proteína ADAMTS7'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071119': {'ID': 'D000071119',\n",
       "  'name': 'Proteína ADAMTS9[ADAMTS9 Protein]',\n",
       "  'scope': 'An ADAMTS protease that contains 15 THROMBOSPONDIN (TS) motifs. It cleaves the PROTEOGLYCANS AGGRECAN and VERSICAN and also functions in protein transport from the ENDOPLASMIC RETICULUM to the GOLGI APPARATUS.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase With Thrombospondin Motifs 9 Protein',\n",
       "   'ADAMTS 9 Protein',\n",
       "   'ADAMTS-9 Protein',\n",
       "   'ADAMTS9 Protein',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 9',\n",
       "   'Proteína ADAMTS-9',\n",
       "   'Proteína ADAMTS9'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071120': {'ID': 'D000071120',\n",
       "  'name': 'Proteína ADAMTS13[ADAMTS13 Protein]',\n",
       "  'scope': 'An ADAMTS protease that contains eight thrombospondin (TS) motifs. It cleaves VON WILLEBRAND FACTOR to control vWF-mediated THROMBOSIS. Mutations in the ADAMTS13 gene have been identified in familial cases of PURPURA, THROMBOTIC THROMBOCYTOPENIC and defects in ADAMTS13 activity are associated with MYOCARDIAL INFARCTION; BRAIN ISCHEMIA; PRE-ECLAMPSIA; and MALARIA.',\n",
       "  'terms': ['A Disintegrin and Metalloproteinase with Thrombospondin Motifs 13 Protein',\n",
       "   'ADAMTS 13 Protein',\n",
       "   'ADAMTS-13 Protein',\n",
       "   'ADAMTS13 Protease',\n",
       "   'ADAMTS13 Protein',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 13',\n",
       "   'Protease ADAMTS13',\n",
       "   'Protease Clivadora de Fator de von Willebrand',\n",
       "   'Protease Clivadora de vWF',\n",
       "   'Proteína ADAMTS-13',\n",
       "   'Proteína ADAMTS13',\n",
       "   'vWF Cleaving Protease',\n",
       "   'vWF-Cleaving Protease',\n",
       "   'von Willebrand Factor Cleaving Protease',\n",
       "   'von Willebrand Factor-Cleaving Protease'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071121': {'ID': 'D000071121',\n",
       "  'name': 'Proteína ADAMTS4[ADAMTS4 Protein]',\n",
       "  'scope': 'An ADAMTS protease similar to ADAMTS5 PROTEIN. It contains a single C-terminal thrombospondin (TS) motif and cleaves AGGRECAN in CARTILAGE. It may also be involved in the destruction of aggrecan in ARTHRITIS.',\n",
       "  'terms': ['A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4 Protein',\n",
       "   'ADAMTS 4 Protein',\n",
       "   'ADAMTS-4 Protein',\n",
       "   'ADAMTS4 Protein',\n",
       "   'Aggrecanase 1',\n",
       "   'Aggrecanase-1',\n",
       "   'Agrecanase-1',\n",
       "   'Desintegrina e Metaloproteinase com Proteínas com Motivos de Trombospondina 4',\n",
       "   'Proteína ADAMTS-4',\n",
       "   'Proteína ADAMTS4'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071137': {'ID': 'D000071137',\n",
       "  'name': 'Poli(ADP-Ribose) Polimerase-1[Poly (ADP-Ribose) Polymerase-1]',\n",
       "  'scope': 'A poly(ADP-ribose) polymerase that contains two ZINC FINGERS in its N-terminal DNA-binding region. It modifies NUCLEAR PROTEINS involved in chromatin architecture and BASE EXCISION REPAIR with POLY ADENOSINE DIPHOSPHATE RIBOSE.',\n",
       "  'terms': ['NAD+ ADP ribosyltransferase 1',\n",
       "   'NAD+ ADP-Ribosiltransferase-1',\n",
       "   'NAD+ ADP-ribosyltransferase-1',\n",
       "   'PARP 1 Protein',\n",
       "   'PARP-1 Protein',\n",
       "   'PARP1 Protein',\n",
       "   'Poli (ADP-Ribose) Polimerase-1',\n",
       "   'Poli (ADP-Ribose) Sintase-1',\n",
       "   'Poli ADP-Ribose Polimerase-1',\n",
       "   'Poli ADP-Ribose Sintase-1',\n",
       "   'Poli(ADP-Ribose) Polimerase-1',\n",
       "   'Poli(ADP-Ribose) Sintase-1',\n",
       "   'Poly (ADP-Ribose) Polymerase-1',\n",
       "   'Poly (ADP-Ribose) Synthase-1',\n",
       "   'Proteína PARP-1',\n",
       "   'Proteína PARP1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071156': {'ID': 'D000071156',\n",
       "  'name': 'Proteína da Leucemia Promielocítica[Promyelocytic Leukemia Protein]',\n",
       "  'scope': 'A tripartite motif protein that contains three ZINC FINGERS, including a RING FINGER DOMAIN, at its N-terminal. Several nuclear and one cytoplasmic isoforms result from alternative splicing of the PML gene; most nuclear isoforms localize to subnuclear structures (PML nuclear bodies) that are disrupted in ACUTE PROMYELOCYTIC LEUKEMIA cells.',\n",
       "  'terms': ['Promyelocytic Leukemia Protein',\n",
       "   'Proteína RNF71',\n",
       "   'Proteína TRIM19',\n",
       "   'Proteína da Leucemia Promielocítica',\n",
       "   'RNF71 Protein',\n",
       "   'TRIM19 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071158': {'ID': 'D000071158',\n",
       "  'name': 'Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina[Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]',\n",
       "  'scope': 'A serine/threonine protein kinase with GTPase activity that contains 12 LEUCINE-rich repeats in its central region and 7 WD repeats C-terminal to its kinase and GTPase domains. It localizes to TRANSPORT VESICLES; the OUTER MITOCHONDRIAL MEMBRANE; and the GOLGI APPARATUS. It functions in PROTEIN TRANSPORT; regulates neuron morphology in the central nervous system, and also functions in the trafficking of SYNAPTIC VESICLES. Mutations in the LRRK2 gene have been identified in autosomal dominant cases of PARKINSON DISEASE (PARK8).',\n",
       "  'terms': ['Dardarin Protein',\n",
       "   'LRRK2 Protein',\n",
       "   'Leucine Rich Repeat Serine Threonine Protein Kinase 2',\n",
       "   'Leucine-Rich Repeat Serine-Threonine Protein Kinase-2',\n",
       "   'PARK8 Protein',\n",
       "   'Proteína Dardarina',\n",
       "   'Proteína LRRK2',\n",
       "   'Proteína PARK8',\n",
       "   'Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071161': {'ID': 'D000071161',\n",
       "  'name': 'Proteína Forkhead Box O1[Forkhead Box Protein O1]',\n",
       "  'scope': 'A forkhead box transcription factor that is a major target of INSULIN signaling and regulator of metabolic homeostasis in response to OXIDATIVE STRESS. It binds to the insulin RESPONSE ELEMENT (IRE) and the related Daf-16 family binding element (DBE). Its activity is suppressed by insulin and it also regulates OSTEOBLAST proliferation, controls bone mass, and skeletal regulation of GLUCOSE metabolism. It promotes GLUCONEOGENESIS in HEPATOCYTES and regulates gene expression in ADIPOSE TISSUE. It is also an important CELL DEATH regulator. Chromosomal aberrations involving the FOXO1 gene occur in RHABDOMYOSARCOMA.',\n",
       "  'terms': ['FOXO1 Protein',\n",
       "   'Forkhead Box Protein O1',\n",
       "   'Forkhead in Rhabdomyosarcoma Protein',\n",
       "   'Proteína FOXO1',\n",
       "   'Proteína Forkhead Box O1',\n",
       "   'Proteína Forkhead em Rabdomiossarcoma'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071162': {'ID': 'D000071162',\n",
       "  'name': 'Fatores Trefoil[Trefoil Factors]',\n",
       "  'scope': 'A family of small peptides expressed primarily by MUCOUS MEMBRANE EPITHELIAL CELLS in vertebrates. Their structure is highly conserved and is defined by a three-leaved (trefoil) domain of 42 or 43 amino acids; it includes six cysteines that create the trefoil structure through disulfide bridges. Trefoil peptides may form dimers with each other, or associate with MUCINS and other factors. They are important for maintaining epithelial integrity and for protection from noxious agents.',\n",
       "  'terms': ['Fatores Trefoil',\n",
       "   'Fatores Trifólio',\n",
       "   'Peptídeos  da Família do Fator Trefoil',\n",
       "   'Peptídeos  da Família do Fator Trifólio',\n",
       "   'Peptídeos TFF',\n",
       "   'Peptídeos Trefoil',\n",
       "   'Peptídeos Trifólio',\n",
       "   'Proteínas  da Família do Fator Trefoil',\n",
       "   'Proteínas  da Família do Fator Trifólio',\n",
       "   'Proteínas Trefoil',\n",
       "   'Proteínas Trifólio',\n",
       "   'TFF Peptides',\n",
       "   'Trefoil Factor Family Peptides',\n",
       "   'Trefoil Factor Family Proteins',\n",
       "   'Trefoil Factors',\n",
       "   'Trefoil Peptides',\n",
       "   'Trefoil Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071163': {'ID': 'D000071163',\n",
       "  'name': 'Fator Trefoil-1[Trefoil Factor-1]',\n",
       "  'scope': 'A 60 amino acid (6.5 kDa) trefoil factor that contains a single trefoil domain. It is expressed primarily by surface EPITHELIAL CELLS of the GASTRIC MUCOSA, where it associates with MUCIN 5AC.',\n",
       "  'terms': ['Fator Trefoil-1',\n",
       "   'Fator Trifólio-1',\n",
       "   'Peptídeo TFF1',\n",
       "   'Peptídeo Trefoil 1',\n",
       "   'Peptídeo Trifólio 1',\n",
       "   'Protein pS2',\n",
       "   'Proteína TFF1',\n",
       "   'Proteína pS2',\n",
       "   'TFF1 Peptide',\n",
       "   'TFF1 Protein',\n",
       "   'Trefoil Factor 1',\n",
       "   'Trefoil Factor-1',\n",
       "   'Trefoil Peptide 1',\n",
       "   'pS2, Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071164': {'ID': 'D000071164',\n",
       "  'name': 'Fator Trefoil-2[Trefoil Factor-2]',\n",
       "  'scope': 'A 106 amino acid (12 kDa) trefoil factor that contains two trefoil domains and associates with MUCIN-6. It is expressed in the GASTROINTESTINAL TRACT by cells of BRUNNER GLANDS; PYLORIC GLANDS and mucous neck cells. It inhibits GASTROINTESTINAL MOTILITY and GASTRIC ACID secretion and may help maintain the structural integrity of gastric mucus.',\n",
       "  'terms': ['Fator Trefoil-2',\n",
       "   'Fator Trifólio-2',\n",
       "   'Peptídeo TFF2',\n",
       "   'Proteína TFF2',\n",
       "   'TFF2 Peptide',\n",
       "   'TFF2 Protein',\n",
       "   'Trefoil Factor 2',\n",
       "   'Trefoil Factor-2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071165': {'ID': 'D000071165',\n",
       "  'name': 'Fator Trefoil-3[Trefoil Factor-3]',\n",
       "  'scope': 'A 59 amino acid (6.6 kDa) trefoil factor that contains a single trefoil domain. It is expressed in all tissues with MUCOUS MEMBRANES, including GOBLET CELLS of the SMALL INTESTINE and LARGE INTESTINE. It associates with MUCIN-2 in the small intestine and may regulate epithelial CELL MIGRATION and WOUND HEALING.',\n",
       "  'terms': ['Fator Intestinal Trefoil',\n",
       "   'Fator Intestinal Trifólio',\n",
       "   'Fator Trefoil-3',\n",
       "   'Fator Trifólio-3',\n",
       "   'Intestinal Trefoil Factor',\n",
       "   'Peptídeo TFF3',\n",
       "   'Proteína TFF3',\n",
       "   'TFF3 Peptide',\n",
       "   'TFF3 Protein',\n",
       "   'Trefoil Factor 3',\n",
       "   'Trefoil Factor, Intestinal',\n",
       "   'Trefoil Factor-3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071176': {'ID': 'D000071176',\n",
       "  'name': 'Família de Moléculas de Sinalização da Ativação Linfocitária[Signaling Lymphocytic Activation Molecule Family]',\n",
       "  'scope': 'Type-I membrane glycoproteins that are expressed primarily on the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation.',\n",
       "  'terms': ['Família de Moléculas de Sinalização da Ativação Linfocitária',\n",
       "   'Família de Receptores SLAM',\n",
       "   'Moléculas de Sinalização da Ativação Linfocitária',\n",
       "   'Receptores SLAMF',\n",
       "   'Receptores da Família de Moléculas de Sinalização da Ativação Linfocitária',\n",
       "   'Receptores de Moléculas de Sinalização da Ativação Linfocitária',\n",
       "   'SLAM Family Receptors',\n",
       "   'SLAMF Receptors',\n",
       "   'Signaling Lymphocytic Activation Molecule Family',\n",
       "   'Signaling Lymphocytic Activation Molecule Family Receptors',\n",
       "   'Signaling Lymphocytic Activation Molecule Receptors',\n",
       "   'Signaling Lymphocytic Activation Molecules'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071177': {'ID': 'D000071177',\n",
       "  'name': 'Membro 1 da Família de Moléculas de Sinalização da Ativação Linfocitária[Signaling Lymphocytic Activation Molecule Family Member 1]',\n",
       "  'scope': 'A 70-kDa SLAM family receptor that consists of an extracellular IMMUNOGLOBULIN-LIKE DOMAIN and an IMMUNOGLOBULIN C2-SET DOMAIN. It is expressed primarily by THYMOCYTES and activated T-LYMPHOCYTES, as well as by MACROPHAGES and DENDRITIC CELLS. It binds SLAMF1 receptors on other cells to mediate T-cell maturation and proliferation. It is also a receptor for the MEASLES VIRUS.',\n",
       "  'terms': ['Antigen, CD150',\n",
       "   'Antígeno CD150',\n",
       "   'CD150 Antigen',\n",
       "   'CDw150 Protein',\n",
       "   'Membro 1 da Família de Moléculas de Sinalização da Ativação Linfocitária',\n",
       "   'Proteína CDw150',\n",
       "   'Proteína SLAM',\n",
       "   'Proteína SLAMF1',\n",
       "   'Receptor SLAM',\n",
       "   'Receptor SLAMF1',\n",
       "   'SLAM Protein',\n",
       "   'SLAM Receptor',\n",
       "   'SLAMF1 Protein',\n",
       "   'SLAMF1 Receptor',\n",
       "   'Signaling Lymphocytic Activation Molecule Family Member 1'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071178': {'ID': 'D000071178',\n",
       "  'name': 'Antígeno CD48[CD48 Antigen]',\n",
       "  'scope': 'A 40-45 KDa GPI-linked protein in the SLAM family that consists of two IMMUNOGLOBULIN C2-SET DOMAINS. It is expressed on the surface of a variety of cells with immune functions, including THYMOCYTES; mature B-LYMPHOCYTES and T-LYMPHOCYTES; NATURAL KILLER CELLS; DENDRITIC CELLS; MAST CELLS; and EOSINOPHILS. It  binds to CD2 and 2B4 (CD244) receptors to activate and modulate the immunologic response.',\n",
       "  'terms': ['Antigen, CD48',\n",
       "   'Antigen, MRC OX-45',\n",
       "   'Antigen, P41',\n",
       "   'Antígeno Blast1',\n",
       "   'Antígeno CD48',\n",
       "   'Antígeno MRC OX-45',\n",
       "   'Antígeno P41',\n",
       "   'Antígeno de Leucócitos MEM-102',\n",
       "   'Antígeno de Superfície BCM1',\n",
       "   'B Lymphocyte Activation Marker BLAST 1',\n",
       "   'B-Lymphocyte Activation Marker BLAST-1',\n",
       "   'BCM1 Surface Antigen',\n",
       "   'Blast1 Antigen',\n",
       "   'CD48 Antigen',\n",
       "   'Glicoproteína-60 de Transdução de Sinal',\n",
       "   'Glycoprotein-60, Signal-Transducing',\n",
       "   'Leukocyte Antigen MEM 102',\n",
       "   'Leukocyte Antigen MEM-102',\n",
       "   'MEM-102, Leukocyte Antigen',\n",
       "   'MRC OX 45 Antigen',\n",
       "   'MRC OX-45 Antigen',\n",
       "   'Marcador de Ativação de Linfócitos B BLAST-1',\n",
       "   'Membro 2 da Família SLAM',\n",
       "   'Membro 2 da Família de Moléculas de Sinalização da Ativação Linfocítica',\n",
       "   'Molécula 2 de Sinalização da Ativação Linfocítica',\n",
       "   'P41 Antigen',\n",
       "   'Proteína SLAMF2',\n",
       "   'SLAM Family Member 2',\n",
       "   'SLAMF2 Protein',\n",
       "   'Signal Transducing Glycoprotein 60',\n",
       "   'Signal-Transducing Glycoprotein-60',\n",
       "   'Signaling Lymphocytic Activation Molecule 2',\n",
       "   'Signaling Lymphocytic Activation Molecule Family Member 2',\n",
       "   'Surface Antigen, BCM1'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071179': {'ID': 'D000071179',\n",
       "  'name': 'Proteína Associada à Molécula de Sinalização da Ativação Linfocitária[Signaling Lymphocytic Activation Molecule Associated Protein]',\n",
       "  'scope': 'A signal transducing adaptor protein that contains a single SH2 DOMAIN and is essential for the regulation of SLAM FAMILY RECEPTORS in the immune response. Mutations in the SLAM-associated protein gene have been identified in cases of X-LINKED LYMPHOPROLIFERATIVE DISEASE.',\n",
       "  'terms': ['Proteína Associada a SLAM',\n",
       "   'Proteína Associada à Molécula de Sinalização da Ativação Linfocitária',\n",
       "   'Proteína SH2D1A',\n",
       "   'SH2D1A Protein',\n",
       "   'SLAM Associated Protein',\n",
       "   'SLAM-Associated Protein',\n",
       "   'Signaling Lymphocytic Activation Molecule Associated Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071181': {'ID': 'D000071181',\n",
       "  'name': 'Membro 2 da Subfamília B de Cassetes de Ligação de ATP[ATP-Binding Cassette Sub-Family B Member 2]',\n",
       "  'scope': 'An ATP-binding cassette, sub-family B protein (ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY B) that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It also acts as a molecular scaffold for the final stage of MHC class I PROTEIN FOLDING.',\n",
       "  'terms': ['ABCB2 Protein',\n",
       "   'ATP Binding Cassette Sub Family B Member 2',\n",
       "   'ATP-Binding Cassette Sub-Family B Member 2',\n",
       "   'Antigen Peptide Transporter 1',\n",
       "   'Antigen Peptide Transporter-1',\n",
       "   'Membro 2 da Subfamília B de Cassetes de Ligação de ATP',\n",
       "   'PSF1, Peptide Transporter',\n",
       "   'Peptide Transporter PSF1',\n",
       "   'Peptide Transporter TAP1',\n",
       "   'Proteína ABCB2',\n",
       "   'Proteína RING4',\n",
       "   'Proteína Realmente Interessante do Novo Gene 4',\n",
       "   'Proteína TAP-1',\n",
       "   'Proteína TAP1',\n",
       "   'RING4',\n",
       "   'RING4 Protein',\n",
       "   'Really Interesting New Gene 4 Protein',\n",
       "   'TAP 1 Protein',\n",
       "   'TAP-1 Protein',\n",
       "   'TAP1 Protein',\n",
       "   'TAP1, Peptide Transporter',\n",
       "   'Transportador 1 de Cassete de Ligação de ATP da Subfamília B',\n",
       "   'Transportador de Peptídeo PSF1',\n",
       "   'Transportador de Peptídeo TAP1',\n",
       "   'Transportador-1 de Antígeno Peptídico',\n",
       "   'Transportador-1 de Peptídeo Antigênico',\n",
       "   'Transportador-1 de Peptídeo de Antígeno',\n",
       "   'Transporter 1, ATP-Binding Cassette, Sub-Family B (MDR-TAP)'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071182': {'ID': 'D000071182',\n",
       "  'name': 'Autofagossomos[Autophagosomes]',\n",
       "  'scope': 'Large spherical double-layered structures which function in AUTOPHAGY to engulf intracellular components such as ORGANELLES or pathogens. Their outer membrane then fuses with the LYSOSOME and the inner membrane and contents are digested by lysosomal HYDROLASES.',\n",
       "  'terms': ['Autofagossomo',\n",
       "   'Autofagossomos',\n",
       "   'Autophagosome',\n",
       "   'Autophagosomes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071183': {'ID': 'D000071183',\n",
       "  'name': 'Proteínas Relacionadas à Autofagia[Autophagy-Related Proteins]',\n",
       "  'scope': 'Proteins and enzymes that function, often as components of MULTIPROTEIN COMPLEXES, to assemble AUTOPHAGOSOMES and carry out AUTOPHAGY.',\n",
       "  'terms': ['Autophagy Related Proteins',\n",
       "   'Autophagy-Related Proteins',\n",
       "   'Proteínas Relacionadas à Autofagia'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071184': {'ID': 'D000071184',\n",
       "  'name': 'Variantes Farmacogenômicos[Pharmacogenomic Variants]',\n",
       "  'scope': 'Naturally occurring genetic variations associated with drug response (e.g., dosage, extent and rate of metabolic processes). While these variants are not markers for GENETIC PREDISPOSITION TO DISEASE they influence PHARMACOKINETICS and pharmacodynamics and often occur on genes encoding drug metabolism enzymes and transporters (e.g., ANGIOTENSIN CONVERTING ENZYME; CYTOCHROME P-450 CYP2D6).',\n",
       "  'terms': ['Genetic Variant, Pharmacokinetic',\n",
       "   'Genetic Variants, Pharmacokinetic',\n",
       "   'Pharmacogenetic Variant',\n",
       "   'Pharmacogenetic Variants',\n",
       "   'Pharmacogenomic Variant',\n",
       "   'Pharmacogenomic Variants',\n",
       "   'Pharmacokinetic Genetic Variant',\n",
       "   'Pharmacokinetic Genetic Variants',\n",
       "   'Variant, Pharmacogenetic',\n",
       "   'Variant, Pharmacogenomic',\n",
       "   'Variantes Farmacogenéticos',\n",
       "   'Variantes Farmacogenômicos',\n",
       "   'Variantes Genéticos Farmacocinéticos',\n",
       "   'Variants, Pharmacogenetic',\n",
       "   'Variants, Pharmacogenomic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071185': {'ID': 'D000071185',\n",
       "  'name': 'Testes Farmacogenômicos[Pharmacogenomic Testing]',\n",
       "  'scope': 'The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.',\n",
       "  'terms': ['Análise Farmacogenética',\n",
       "   'Análise Farmacogenômica',\n",
       "   'Estudo Farmacogenético',\n",
       "   'Estudo Farmacogenômico',\n",
       "   'Pharmacogenetic Analyses',\n",
       "   'Pharmacogenetic Analysis',\n",
       "   'Pharmacogenetic Screening',\n",
       "   'Pharmacogenetic Screenings',\n",
       "   'Pharmacogenetic Studies',\n",
       "   'Pharmacogenetic Study',\n",
       "   'Pharmacogenetic Testing',\n",
       "   'Pharmacogenetic Testings',\n",
       "   'Pharmacogenomic Analyses',\n",
       "   'Pharmacogenomic Analysis',\n",
       "   'Pharmacogenomic Screening',\n",
       "   'Pharmacogenomic Screenings',\n",
       "   'Pharmacogenomic Studies',\n",
       "   'Pharmacogenomic Study',\n",
       "   'Pharmacogenomic Testing',\n",
       "   'Pharmacogenomic Testings',\n",
       "   'Studies, Pharmacogenetic',\n",
       "   'Testes Farmacogenéticos',\n",
       "   'Testes Farmacogenômicos',\n",
       "   'Triagem Farmacogenética',\n",
       "   'Triagem Farmacogenômica'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071186': {'ID': 'D000071186',\n",
       "  'name': 'Proteína Beclina-1[Beclin-1]',\n",
       "  'scope': 'An autophagy related protein which functions as a core subunit of PHOSPHATIDYLINOSITOL 3-KINASE MULTIPROTEIN COMPLEXES. It mediates the formation of  phosphatidylinositol 3-phosphate and functions in AUTOPHAGY, where it is required for maturation of the AUTOPHAGOSOME. It also functions in ENDOCYTOSIS and CYTOKINESIS as part of a separate complex. Beclin-1 associates with INTRACELLULAR MEMBRANES and interacts with the PROTO-ONCOGENE PROTEINS C-BCL-2 and BCL-X PROTEIN.',\n",
       "  'terms': ['ATG 6 Protein',\n",
       "   'ATG-6 Protein',\n",
       "   'ATG6 Protein',\n",
       "   'Beclin 1',\n",
       "   'Beclin 1 Protein',\n",
       "   'Beclin-1',\n",
       "   'Beclin-1 Protein',\n",
       "   'Beclin1',\n",
       "   'Beclina1',\n",
       "   'Coiled coil Myosin like Bcl2 interacting Protein',\n",
       "   'Coiled-coil Myosin-like Bcl2-interacting Protein',\n",
       "   'GT197 Protein',\n",
       "   'Proteína ATG-6',\n",
       "   'Proteína ATG6',\n",
       "   'Proteína Beclina-1',\n",
       "   'Proteína GT197',\n",
       "   'Proteína de Espiral Enrolada Semelhante à Miosina de Interação com Bcl2',\n",
       "   'Proteína de Espiral Enrolada Semelhante à Miosina que Interage com Bcl2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071187': {'ID': 'D000071187',\n",
       "  'name': 'Proteína 5 Relacionada à Autofagia[Autophagy-Related Protein 5]',\n",
       "  'scope': 'An autophagy-related protein that functions in AUTOPHAGOSOME biogenesis. It is conjugated to the ATG12 PROTEIN via a process that is similar to UBIQUITINATION and involves the ATG7 PROTEIN and ATG10 enzyme. The ATG12-ATG5 conjugate acts as an E3 UBIQUITIN LIGASE-like enzyme and is required for the localization of ATG8 PROTEINS to AUTOPHAGOSOME vesicle membranes and modification of membrane lipids.',\n",
       "  'terms': ['ATG 5 Protein',\n",
       "   'ATG-5 Protein',\n",
       "   'ATG5 Protein',\n",
       "   'Apoptosis Specific Protein',\n",
       "   'Apoptosis-Specific Protein',\n",
       "   'Autophagy Protein 5',\n",
       "   'Autophagy Protein-5',\n",
       "   'Autophagy Related 5 Protein',\n",
       "   'Autophagy Related Protein 5',\n",
       "   'Autophagy-Related 5 Protein',\n",
       "   'Autophagy-Related Protein 5',\n",
       "   'Proteína 5 Relacionada à Autofagia',\n",
       "   'Proteína ATG-5',\n",
       "   'Proteína ATG5',\n",
       "   'Proteína Específica de Apoptose',\n",
       "   'Proteína Relacionada à Autofagia 5',\n",
       "   'Proteína-5 de Autofagia'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071189': {'ID': 'D000071189',\n",
       "  'name': 'Proteína Homóloga à Proteína-1 Relacionada à Autofagia[Autophagy-Related Protein-1 Homolog]',\n",
       "  'scope': 'A serine/threonine-protein kinase that functions in AUTOPHAGY in response to starvation. It acts on the PHOSPHATIDYLINOSITOL 3-KINASE complex PIK3C3 to regulate AUTOPHAGOSOME formation. It also functions as both a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) and is activated by AMPK, which it also negatively regulates.',\n",
       "  'terms': ['Autophagy Related Protein 1 Homolog',\n",
       "   'Autophagy-Related Protein-1 Homolog',\n",
       "   'Proteína Homóloga à Proteína-1 Relacionada à Autofagia',\n",
       "   'Proteína ULK1',\n",
       "   'Quinase 1 Semelhante a Unc-51',\n",
       "   'Quinase 1 de Ativação de Autofagia Semelhante a Unc-51',\n",
       "   'Serina-Treonina Proteína Quinase ULK1',\n",
       "   'Serine Threonine Protein Kinase ULK1',\n",
       "   'Serine-Threonine Protein Kinase ULK1',\n",
       "   'ULK1 Protein',\n",
       "   'Unc 51 Like Autophagy Activating Kinase 1',\n",
       "   'Unc 51 Like Kinase 1',\n",
       "   'Unc-51 Like Autophagy Activating Kinase 1',\n",
       "   'Unc-51-Like Kinase 1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071190': {'ID': 'D000071190',\n",
       "  'name': 'Família da Proteína 8 Relacionada à Autofagia[Autophagy-Related Protein 8 Family]',\n",
       "  'scope': 'UBIQUITIN-like modifier proteins that function in CYTOPLASM to VACUOLE transport (Cvt), vesicle transport within the GOLGI APPARATUS, and AUTOPHAGOSOME biogenesis. They are also required for selective autophagic degradation of the nucleus (nucleophagy) and MITOPHAGY.',\n",
       "  'terms': ['ATG8 Family Proteins',\n",
       "   'ATG8 Proteins',\n",
       "   'Autophagy Related Protein 8 Family',\n",
       "   'Autophagy-Related Protein 8 Family',\n",
       "   'Família da Proteína 8 Relacionada à Autofagia',\n",
       "   'GABARAPL2 Protein',\n",
       "   'Gamma Aminobutyric Acid Receptor Associated Protein Like 2',\n",
       "   'Gamma-Aminobutyric Acid Receptor-Associated Protein-Like 2',\n",
       "   'Proteína 2 Semelhante à Associada ao Receptor de Ácido gama-Aminobutírico',\n",
       "   'Proteína ATG8',\n",
       "   'Proteína GABARAPL2',\n",
       "   'Proteínas da Família ATG8'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071192': {'ID': 'D000071192',\n",
       "  'name': 'Proteína 12 Relacionada à Autofagia[Autophagy-Related Protein 12]',\n",
       "  'scope': 'A UBIQUITIN-like modifier protein that functions in AUTOPHAGOSOME formation, CYTOPLASM to VACUOLE transport, MITOPHAGY, and nucleophagy. Conjugation with ATG5 PROTEIN or ATG10 is essential for its function. The ATG12-ATG5 conjugate acts as an E3 UBIQUITIN LIGASE-like enzyme for lipid modification of ATG8 FAMILY PROTEINS and their localization to vesicle membranes.',\n",
       "  'terms': ['ATG12 Protein',\n",
       "   'ATG12, Ubiquitin-Like Protein',\n",
       "   'Autophagy Related Protein 12',\n",
       "   'Autophagy-Related Protein 12',\n",
       "   'Proteína 12 Relacionada à Autofagia',\n",
       "   'Proteína ATG12',\n",
       "   'Proteína ATG12 Semelhante a Ubiquitina',\n",
       "   'Ubiquitin Like Protein ATG12',\n",
       "   'Ubiquitin-Like Protein ATG12'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071193': {'ID': 'D000071193',\n",
       "  'name': 'Proteína 7 Relacionada à Autofagia[Autophagy-Related Protein 7]',\n",
       "  'scope': 'An autophagy related protein  that is similar to UBIQUITIN-ACTIVATING ENZYME E1. It functions in CYTOPLASM to VACUOLE transport (Cvt) and AUTOPHAGY by activating ATG12 PROTEIN for its conjugation with ATG5 PROTEIN, as well as the conjugation of ATG8 FAMILY PROTEINS with phosphatidylethanolamine for ATG8 association to Cvt vesicles and AUTOPHAGOSOME membranes. It is also required for the nitrogen starvation response in yeast, MITOPHAGY; and autophagic cell death induced by CASPASE 8 inhibition.',\n",
       "  'terms': ['ATG12 Activating Enzyme E1 ATG7',\n",
       "   'ATG12-Activating Enzyme E1 ATG7',\n",
       "   'ATG7 Protein',\n",
       "   'Autophagy Related Protein 7',\n",
       "   'Autophagy-Related Protein 7',\n",
       "   'Enzima ATG7 Modificadora-Ativadora Semelhante a Ubiquitina',\n",
       "   'Enzima E1 ATG7 Ativadora de ATG12',\n",
       "   'Enzima Modificadora-Ativadora Semelhante a Ubiquitina ATG7',\n",
       "   'Proteína 7 Relacionada à Autofagia',\n",
       "   'Proteína ATG7',\n",
       "   'Proteína ATG7 Semelhante à Enzima Modificadora-Ativadora de Ubiquitina',\n",
       "   'Proteína Semelhante à Enzima E1 de Ativação de Ubiquitina',\n",
       "   'Proteína Semelhante à Enzima Modificadora-Ativadora de Ubiquitina ATG7',\n",
       "   'Ubiquitin Activating Enzyme E1 like Protein',\n",
       "   'Ubiquitin Like Modifier Activating Enzyme ATG7',\n",
       "   'Ubiquitin-Activating Enzyme E1-like Protein',\n",
       "   'Ubiquitin-Like Modifier-Activating Enzyme ATG7'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071194': {'ID': 'D000071194',\n",
       "  'name': 'Camelidae[Camelidae]',\n",
       "  'scope': 'The only extant family of the suborder Tylopoda (order Artiodactyla). Currently living members include domesticated species, DROMEDARIES (with one-hump); BACTRIAN CAMELS (with two humps); LLAMAS; ALPACAS, and wild feral camels; VICUNAS; and GUANACOS. Although they get nutrients from plants by rumination, they evolved separately from the RUMINANTS which have four-chambered stomachs. Camelidae have three-chambered stomachs.',\n",
       "  'terms': ['Camelidae', 'Camelidae', 'Camelídeos'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071195': {'ID': 'D000071195',\n",
       "  'name': 'Pessoal de Educação[Educational Personnel]',\n",
       "  'scope': 'Professionals responsible for teaching in an institution or place of learning such as a school, college, vocational institute, or university.',\n",
       "  'terms': ['Educational Personnel',\n",
       "   'Personnel, Educational',\n",
       "   'Pessoal de Educação'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071196': {'ID': 'D000071196',\n",
       "  'name': 'Domínio Pirina[Pyrin Domain]',\n",
       "  'scope': 'A protein interaction domain of the death domain superfamily. It is characterized by a 6-helix bundle similar to those that occur in DEATH DOMAIN RECEPTORS. Pyrin domains are present in a variety of proteins, especially those that function in INFLAMMASOMES; AUTOPHAGY; and APOPTOSIS. They form homodimers or heterodimers with death domain proteins to facilitate the assembly of signaling complexes.',\n",
       "  'terms': ['DAPIN Domain',\n",
       "   'DAPIN Domains',\n",
       "   'Domínio DAPIN',\n",
       "   'Domínio PAAD-DAPIN-PIRINA',\n",
       "   'Domínio PADD',\n",
       "   'Domínio PYD',\n",
       "   'Domínio Pirina',\n",
       "   'PAAD DAPIN PYRIN Domain',\n",
       "   'PAAD-DAPIN-PYRIN Domain',\n",
       "   'PAAD-DAPIN-PYRIN Domains',\n",
       "   'PADD Domain',\n",
       "   'PADD Domains',\n",
       "   'PYD Domain',\n",
       "   'PYD Domains',\n",
       "   'Pyrin Domain',\n",
       "   'Pyrin Domains'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071197': {'ID': 'D000071197',\n",
       "  'name': 'Domínio B30.2-SPRY[B30.2-SPRY Domain]',\n",
       "  'scope': 'A protein interaction domain that is characterized by a bent \"beta-sandwich\" consisting of two antiparallel beta-sheets. It occurs in eukaryotic proteins, including many TRIPARTITE MOTIF PROTEINS, which function in a variety of cellular processes.',\n",
       "  'terms': ['B30.2 Domain',\n",
       "   'B30.2 Domains',\n",
       "   'B30.2 SPRY Domain',\n",
       "   'B30.2-SPRY Domain',\n",
       "   'B30.2-SPRY Domains',\n",
       "   'Domínio B30.2',\n",
       "   'Domínio B30.2-SPRY',\n",
       "   'Domínio PRY',\n",
       "   'Domínio PRY-SPRY',\n",
       "   'Domínio PRYSPRY',\n",
       "   'Domínio SPRY',\n",
       "   'PRY Domain',\n",
       "   'PRY Domains',\n",
       "   'PRY SPRY Domain',\n",
       "   'PRY-SPRY Domain',\n",
       "   'PRY-SPRY Domains',\n",
       "   'PRYSPRY Domain',\n",
       "   'PRYSPRY Domains',\n",
       "   'SPRY Domain',\n",
       "   'SPRY Domains'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071198': {'ID': 'D000071198',\n",
       "  'name': 'Pirina[Pyrin]',\n",
       "  'scope': 'A tripartite motif protein that consists of an N-terminal pyrin domain, a central coiled-coil region and B-box type ZINC FINGER, and C-terminal regions that mediate homotrimerization and interactions with other proteins (the B30.2/SPRY DOMAIN). It is expressed primarily by mature GRANULOCYTES and associates with the cytoskeleton in the perinuclear area as well as AUTOPHAGOSOMES, where it co-ordinates the assembly of AUTOPHAGY-RELATED PROTEINS and degradation of INFLAMMASOME components. It functions in INNATE IMMUNITY and INFLAMMATION; mutations in the Pyrin protein (MEFV) gene are associated with FAMILIAL MEDITERRANEAN FEVER.',\n",
       "  'terms': ['MEFV Protein',\n",
       "   'Marenostrin',\n",
       "   'Marenostrina',\n",
       "   'Mediterranean Fever Protein',\n",
       "   'Pirina',\n",
       "   'Proteína MEFV',\n",
       "   'Proteína TRIM20',\n",
       "   'Proteína da Febre Familiar do Mediterrâneo',\n",
       "   'Proteína da Febre Mediterrânea',\n",
       "   'Proteína da Febre do Mediterrâneo',\n",
       "   'Proteína de Febre Familiar do Mediterrâneo',\n",
       "   'Proteína de Febre Mediterrânea',\n",
       "   'Proteína de Febre do Mediterrâneo',\n",
       "   'Pyrin',\n",
       "   'TRIM20 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071199': {'ID': 'D000071199',\n",
       "  'name': 'Proteína 3 que Contém Domínio de Pirina da Família NLR[NLR Family, Pyrin Domain-Containing 3 Protein]',\n",
       "  'scope': 'An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME.',\n",
       "  'terms': ['Cold Autoinflammatory Syndrome 1 Protein',\n",
       "   'NACHT, LRR and PYD Domains Containing Protein 3',\n",
       "   'NACHT, LRR and PYD Domains-Containing Protein 3',\n",
       "   'NLR Family, Pyrin Domain Containing 3 Protein',\n",
       "   'NLR Family, Pyrin Domain-Containing 3 Protein',\n",
       "   'NLRP3 Protein',\n",
       "   'Proteína 1 da Síndrome Autoinflamatória por Frio',\n",
       "   'Proteína 3 que Contém Domínio de Pirina da Família NLR',\n",
       "   'Proteína 4 que Contém os Domínios NACHT, LRR e PYD',\n",
       "   'Proteína NLRP3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071216': {'ID': 'D000071216',\n",
       "  'name': 'Docentes de Farmácia[Faculty, Pharmacy]',\n",
       "  'scope': 'Teaching and administrative staff having academic rank in a pharmacy school or department.',\n",
       "  'terms': ['Docente de Farmácia',\n",
       "   'Docentes de Farmácia',\n",
       "   'Faculty, Pharmacy',\n",
       "   'Pharmacy Faculty'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071217': {'ID': 'D000071217',\n",
       "  'name': 'Ritmo Infradiano[Infradian Rhythm]',\n",
       "  'scope': 'A biological rhythm with a period longer than 24 hours.',\n",
       "  'terms': ['Ciclo Infradiano',\n",
       "   'Ciclo Infradianos',\n",
       "   'Cycle, Infradian',\n",
       "   'Cycles, Infradian',\n",
       "   'Infradian Cycle',\n",
       "   'Infradian Cycles',\n",
       "   'Infradian Rhythm',\n",
       "   'Infradian Rhythms',\n",
       "   'Rhythm, Infradian',\n",
       "   'Rhythms, Infradian',\n",
       "   'Ritmo Infradiano'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071218': {'ID': 'D000071218',\n",
       "  'name': 'Ritmo Ultradiano[Ultradian Rhythm]',\n",
       "  'scope': 'A biological rhythm with a period shorter than 24 hours.',\n",
       "  'terms': ['Ciclo Ultradiano',\n",
       "   'Ciclos Ultradianos',\n",
       "   'Cycle, Ultradian',\n",
       "   'Cycles, Ultradian',\n",
       "   'Rhythm, Ultradian',\n",
       "   'Rhythms, Ultradian',\n",
       "   'Ritmo Ultradiano',\n",
       "   'Ultradian Cycle',\n",
       "   'Ultradian Cycles',\n",
       "   'Ultradian Rhythm',\n",
       "   'Ultradian Rhythms'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071219': {'ID': 'D000071219',\n",
       "  'name': 'Carga Global da Doença[Global Burden of Disease]',\n",
       "  'scope': 'Measure of the burden of disease using the disability-adjusted-life-year (DALY). This time-based measure combines years of life lost due to premature mortality and years of life lost due to time lived in states of less than full health. The metric was developed to assess the burden of disease consistently across diseases, risk factors and regions.',\n",
       "  'terms': ['Carga Global da Doença',\n",
       "   'Disease Global Burdens',\n",
       "   'Global Burden of Disease'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071220': {'ID': 'D000071220',\n",
       "  'name': 'Pesquisa Farmacêutica[Pharmaceutical Research]',\n",
       "  'scope': 'RESEARCH activity focused on pharmaceutical products and services.',\n",
       "  'terms': ['Pesquisa Farmacêutica',\n",
       "   'Pharmaceutical Research',\n",
       "   'Research, Pharmaceutical'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071221': {'ID': 'D000071221',\n",
       "  'name': 'Proteína Potenciadora do Homólogo 2 de Zeste[Enhancer of Zeste Homolog 2 Protein]',\n",
       "  'scope': 'A histone-lysine N-methyltransferase and catalytic subunit of Polycomb Repressive Complex 2.  It methylates LYSINE 9 (H3K9me) and LYSINE 27 (H3K27me) of HISTONE H3, leading to transcriptional repression of the affected target gene. EZH2 also methylates non-histone proteins such as GATA4 TRANSCRIPTION FACTOR and the nuclear receptor RORA. It regulates CIRCADIAN CLOCKS via histone methylation at the PROMOTER REGIONS of the circadian genes and its repressive activity is also important for the identity and differentiation of EMBRYONIC STEM CELLS.',\n",
       "  'terms': ['EZH2, Histone-Lysine N-Methyltransferase',\n",
       "   'Enhancer of Zeste Homolog 2',\n",
       "   'Enhancer of Zeste Homolog 2 Protein',\n",
       "   'Histona-Lisina N-Metiltransferase EZH2',\n",
       "   'Histone Lysine N Methyltransferase EZH2',\n",
       "   'Histone-Lysine N-Methyltransferase EZH2',\n",
       "   'Lisina N-Metiltransferase 6',\n",
       "   'Lysine N Methyltransferase 6',\n",
       "   'Lysine N-Methyltransferase-6',\n",
       "   'Proteína Potenciadora do Homólogo 2 de Zeste',\n",
       "   'Proteína Potenciadora do Homólogo de Zeste 2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071222': {'ID': 'D000071222',\n",
       "  'name': 'Proteína 1 Supressora da Sinalização de Citocina[Suppressor of Cytokine Signaling 1 Protein]',\n",
       "  'scope': 'A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS1 functions as a negative regulator of CYTOKINES that signal through the JANUS KINASES-STAT 3 TRANSCRIPTION FACTOR (JAK/STAT3) pathway by inhibiting the activity of JANUS KINASES.',\n",
       "  'terms': ['Protein, SOCS1',\n",
       "   'Proteína 1 Supressora da Sinalização de Citocina',\n",
       "   'Proteína SOCS1',\n",
       "   'Proteína Supressora da Sinalização de Citocinas 1',\n",
       "   'SOCS1 Protein',\n",
       "   'Suppressor of Cytokine Signaling 1 Protein',\n",
       "   'Suppressor of Cytokine Signaling Protein 1',\n",
       "   'Suppressor of Cytokine Signaling Protein 1 -'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071223': {'ID': 'D000071223',\n",
       "  'name': 'Proteína 3 Supressora da Sinalização de Citocinas[Suppressor of Cytokine Signaling 3 Protein]',\n",
       "  'scope': 'A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS3 inhibits cytokine signaling by binding to RECEPTOR PROTEIN-TYROSINE KINASES as well as CYTOKINE RECEPTOR GP130; ERYTHROPOIETIN RECEPTORS; INSULIN RECEPTOR; and the LEPTIN RECEPTOR. Its functions include suppression of ERYTHROPOIESIS in the fetal liver.',\n",
       "  'terms': ['Protein, SOCS3',\n",
       "   'Proteína 3 Supressora da Sinalização de Citocina',\n",
       "   'Proteína 3 Supressora da Sinalização de Citocinas',\n",
       "   'Proteína SOCS3',\n",
       "   'Proteína Supressora da Sinalização de Citocinas 3',\n",
       "   'SOCS3 Protein',\n",
       "   'Suppressor of Cytokine Signaling 3 Protein',\n",
       "   'Suppressor of Cytokine Signaling Protein 3',\n",
       "   'Supressor 3 da Sinalização de Citocinas',\n",
       "   'Supressor 3 da Sinalização de Citoquinas'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071225': {'ID': 'D000071225',\n",
       "  'name': 'Vírus da Influenza A Subtipo H5N8[Influenza A Virus, H5N8 Subtype]',\n",
       "  'scope': 'A subtype of INFLUENZA A VIRUS that is highly virulent in poultry and wild birds, but shows varying degrees of pathogenicity in mice. The H5N8 virus subtype has a polybasic amino acid motif at the HA cleavage site which explains its pathogenicity in birds, and expresses surface proteins HEMAGGLUTININ 5 and NEURAMINIDASE 8 which are typical of Highly Pathogenic Avian Influenza viruses.',\n",
       "  'terms': ['H5N8 Virus',\n",
       "   'H5N8 Viruses',\n",
       "   'Influenza A Virus, H5N8 Subtype',\n",
       "   'Virus, H5N8',\n",
       "   'Viruses, H5N8',\n",
       "   'Vírus H5N8',\n",
       "   'Vírus da Influenza A Subtipo H5N8'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071228': {'ID': 'D000071228',\n",
       "  'name': 'Polieletrólitos[Polyelectrolytes]',\n",
       "  'scope': 'A class of water-soluble polyelectrolytes with pi-delocalized structure and functional ionic properties used for fluorescent staining of cells and as semi-conducting materials in electronic devices.',\n",
       "  'terms': ['Conjugated Polyelectrolytes',\n",
       "   'Polieletrólitos',\n",
       "   'Polieletrólitos Conjugados',\n",
       "   'Polyelectrolytes',\n",
       "   'Polyelectrolytes, Conjugated'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071229': {'ID': 'D000071229',\n",
       "  'name': 'Perilipina-4[Perilipin-4]',\n",
       "  'scope': 'A perilipin protein characterized by an extensive 11-mer repeat region, which forms five adjacent alpha-helices. It is expressed primarily in WHITE ADIPOSE TISSUE and differentiating ADIPOCYTES, as well as skeletal muscle and heart.  It is soluble in the cytoplasm but re-localizes to the surface of LIPID DROPLETS under high lipid conditions.',\n",
       "  'terms': ['Perilipin 4',\n",
       "   'Perilipin 4 Protein',\n",
       "   'Perilipin-4',\n",
       "   'Perilipina-4',\n",
       "   'Plin4 Protein',\n",
       "   'Proteína Perilipina 4',\n",
       "   'Proteína Plin4',\n",
       "   'Proteína S3-12',\n",
       "   'S3-12 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071230': {'ID': 'D000071230',\n",
       "  'name': 'Regulador Transcricional ERG[Transcriptional Regulator ERG]',\n",
       "  'scope': \"A trans-activator and member of the erythroblast transformation-specific family of transcriptions factors that contain a characteristic ETS MOTIF. It is required for PLATELET CELL ADHESION to the subendothelium and associates with CHIMERIC ONCOGENE PROTEINS in PROSTATE CANCER; EWING'S SARCOMA; and ACUTE MYELOID LEUKEMIA.\",\n",
       "  'terms': ['Proteína ERG de Transformação',\n",
       "   'Proteína Homóloga ao Vírus Oncogênico E26 da Eritoblastose Aviária V-Ets',\n",
       "   'Proteína Relacionada ao Vírus Oncogênico E26 da Eritoblastose Aviária V-Ets',\n",
       "   'Regulador Transcricional ERG',\n",
       "   'Transcriptional Regulator ERG',\n",
       "   'Transforming Protein ERG',\n",
       "   'V Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein',\n",
       "   'V Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein',\n",
       "   'V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein',\n",
       "   'V-Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071231': {'ID': 'D000071231',\n",
       "  'name': 'Anidrase Carbônica IX[Carbonic Anhydrase IX]',\n",
       "  'scope': 'A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass transmembrane domain, and a short intracellular tail. It functions as a dimer and is expressed primarily by cells of the GASTROINTESTINAL TRACT; BILE DUCT EPITHELIUM; and GALL BLADDER. It is expressed at high levels in many solid tumors, especially CLEAR CELL RENAL CARCINOMA, in response to CELL HYPOXIA.',\n",
       "  'terms': ['Anidrase Carbônica 9',\n",
       "   'Anidrase Carbônica IX',\n",
       "   'CAIX Protein',\n",
       "   'Carbonic Anhydrase 9',\n",
       "   'Carbonic Anhydrase IX',\n",
       "   'Proteína CAIX'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071232': {'ID': 'D000071232',\n",
       "  'name': 'Proteoglicanos Pequenos Ricos em Leucina[Small Leucine-Rich Proteoglycans]',\n",
       "  'scope': 'A proteoglycan family (SLRPs) that is defined by a central domain which consists of a variable number of repeats of the motif LXXLxLXXNxL, where L may be LEUCINE; ISOLEUCINE; VALINE; or other hydrophobic amino acids. The N-terminal contains four conserved CYSTEINE residues and may be modified depending on function. SLRPs provide structural support to the EXTRACELLULAR MATRIX and are critical for regulating its assembly and dynamics at CELL-MATRIX JUNCTIONS.',\n",
       "  'terms': ['Pequeno Proteoglicano Rico em Repetições de Leucina',\n",
       "   'Pequenos Proteoglicanos Ricos em Leucina',\n",
       "   'Pequenos Proteoglicanos Ricos em Repetições de Leucina',\n",
       "   'Proteoglicano Pequeno Rico em Leucina',\n",
       "   'Proteoglicano Pequeno Rico em Repetições de Leucina',\n",
       "   'Proteoglicano SLRP',\n",
       "   'Proteoglicanos Pequenos Ricos em Leucina',\n",
       "   'Proteoglicanos Pequenos Ricos em Repetições de Leucina',\n",
       "   'Proteoglicanos SLRP',\n",
       "   'SLRP Proteoglycans',\n",
       "   'Small Leucine Rich Proteoglycans',\n",
       "   'Small Leucine Rich Repeat Proteoglycan',\n",
       "   'Small Leucine Rich Repeat Proteoglycans',\n",
       "   'Small Leucine-Rich Proteoglycans',\n",
       "   'Small Leucine-Rich Repeat Proteoglycan',\n",
       "   'Small Leucine-Rich Repeat Proteoglycans'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071234': {'ID': 'D000071234',\n",
       "  'name': 'Lumicana[Lumican]',\n",
       "  'scope': 'A small leucine-rich proteoglycan that contains 10 tandem leucine repeats and four N-linked sites within the leucine repeat region that may be substituted with KERATAN SULFATE. These properties and its horseshoe shape allow it to mediate interactions among COLLAGEN molecules within fibrils. It is expressed in most mesenchymal tissues as well as the CORNEA, where it functions to maintain transparency.',\n",
       "  'terms': ['Lumican',\n",
       "   'Lumican Proteoglycan',\n",
       "   'Lumicana',\n",
       "   'Proteoglicana Lumicana'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071235': {'ID': 'D000071235',\n",
       "  'name': 'Fibromodulina[Fibromodulin]',\n",
       "  'scope': 'A small leucine-rich proteoglycan that contains 4 KERATAN SULFATE chains within the leucine repeat region. It interacts with COLLAGEN TYPE I and COLLAGEN TYPE II fibrils and may function to control the rate of EXTRACELLULAR MATRIX assembly. It also sequesters TRANSFORMING GROWTH FACTOR BETA in the extracellular matrix.',\n",
       "  'terms': ['FMOD Protein', 'Fibromodulin', 'Fibromodulina', 'Proteína FMOD'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071238': {'ID': 'D000071238',\n",
       "  'name': 'Domínio de Fibronectina Tipo III[Fibronectin Type III Domain]',\n",
       "  'scope': 'A highly conserved immunoglobulin-like protein domain of about 100 amino acids that forms a beta sandwich structure.',\n",
       "  'terms': ['Domínio FN III',\n",
       "   'Domínio de Fibronectina Tipo III',\n",
       "   'Domínios de Fibronectina Tipo III',\n",
       "   'FN III Domain',\n",
       "   'FN III Domains',\n",
       "   'FN Type III Domain',\n",
       "   'Fibronectin Type III Domain',\n",
       "   'Fibronectin Type III Domains'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071241': {'ID': 'D000071241',\n",
       "  'name': 'Motivo de Ligação ao RNA de Cadeia Dupla[Double-Stranded RNA Binding Motif]',\n",
       "  'scope': 'An RNA-binding motif characterized by an alpha-beta-beta-beta-alpha fold that binds DOUBLE-STRANDED RNA. It occurs in many eukaryotic proteins as well as in bacterial and viral proteins.',\n",
       "  'terms': ['Domínio de Ligação ao RNA Dupla Hélice',\n",
       "   'Domínio de Ligação ao RNA de Cadeia Dupla',\n",
       "   'Double Stranded RNA Binding Domain',\n",
       "   'Double Stranded RNA Binding Motif',\n",
       "   'Double-Stranded RNA Binding Domain',\n",
       "   'Double-Stranded RNA Binding Motif',\n",
       "   'Motivo de Ligação ao RNA Dupla Hélice',\n",
       "   'Motivo de Ligação ao RNA de Cadeia Dupla',\n",
       "   'dsRBD',\n",
       "   'dsRBD',\n",
       "   'dsRBM',\n",
       "   'dsRBM'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071243': {'ID': 'D000071243',\n",
       "  'name': 'Infecção por Zika virus[Zika Virus Infection]',\n",
       "  'scope': 'A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is a cause of congenital brain abnormalities, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.',\n",
       "  'terms': ['Disease, Zika Virus',\n",
       "   'Doença pelo Vírus Zika',\n",
       "   'Doença pelo Zika virus',\n",
       "   'Doença pelo Zikavirus',\n",
       "   'Doença por Vírus Zika',\n",
       "   'Doença por Zika virus',\n",
       "   'Febre Zika',\n",
       "   'Febre pelo Vírus Zika',\n",
       "   'Febre por Vírus Zika',\n",
       "   'Febre por Zika',\n",
       "   'Febre por Zika virus',\n",
       "   'Fever, Zika',\n",
       "   'Infection, ZikV',\n",
       "   'Infection, Zika Virus',\n",
       "   'Infecção pelo Zika virus',\n",
       "   'Infecção pelo Zikavirus',\n",
       "   'Infecção por Vírus Zika',\n",
       "   'Infecção por Zika',\n",
       "   'Infecção por Zika virus',\n",
       "   'Infecção por Zikavirus',\n",
       "   'Virus Disease, Zika',\n",
       "   'Virus Infection, Zika',\n",
       "   'ZikV Infection',\n",
       "   'Zika Fever',\n",
       "   'Zika Virus Disease',\n",
       "   'Zika Virus Infection'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071244': {'ID': 'D000071244',\n",
       "  'name': 'Zika virus[Zika Virus]',\n",
       "  'scope': 'An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas.',\n",
       "  'terms': ['Virus, Zika',\n",
       "   'Vírus Zika',\n",
       "   'Vírus da Febre Zika',\n",
       "   'Vírus da Zika',\n",
       "   'Vírus de Zika',\n",
       "   'ZIKV',\n",
       "   'ZikV',\n",
       "   'ZikV',\n",
       "   'Zika Virus',\n",
       "   'Zika virus',\n",
       "   'Zikavirus'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071245': {'ID': 'D000071245',\n",
       "  'name': 'Proteínas de Desacoplamento Mitocondrial[Mitochondrial Uncoupling Proteins]',\n",
       "  'scope': 'Mitochondrial anion carrier proteins that function as dimers and form proton channels in the INNER MITOCHONDRIAL MEMBRANE which creates proton leaks and uncouples OXIDATIVE PHOSPHORYLATION from ATP synthesis, resulting in the generation of heat instead of ATP.',\n",
       "  'terms': ['Mitochondrial UCPs',\n",
       "   'Mitochondrial Uncoupling Proteins',\n",
       "   'Proteínas Desacopladoras',\n",
       "   'Proteínas de Desacoplamento Mitocondrial',\n",
       "   'UCPs Mitocondriais',\n",
       "   'UCPs, Mitochondrial',\n",
       "   'Uncoupling Proteins',\n",
       "   'Uncoupling Proteins, Mitochondrial'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071246': {'ID': 'D000071246',\n",
       "  'name': 'Proteína Desacopladora 2[Uncoupling Protein 2]',\n",
       "  'scope': 'A mitochondrial uncoupling protein that is expressed in many tissues and exhibits the greatest expression in SKELETAL MUSCLE. It regulates mitochondrial ATP production and the generation of REACTIVE OXYGEN SPECIES.',\n",
       "  'terms': ['Carreador de Soluto, Família 25, Membro 8',\n",
       "   'Carreador de Solutos, Família 25, Membro 8',\n",
       "   'Membro 8 da Família 25 de Carreadores de Soluto',\n",
       "   'Membro 8 da Família 25 de Carreadores de Solutos',\n",
       "   'Membro 8 da Família 25 de Transportadores de Soluto',\n",
       "   'Membro 8 da Família 25 de Transportadores de Solutos',\n",
       "   'Mitochondrial Uncoupling Protein 2',\n",
       "   'Proteína Desacopladora 2',\n",
       "   'Proteína Desacopladora Mitocondrial 2',\n",
       "   'Proteína Desacopladora-2',\n",
       "   'Proteína SLC25A8',\n",
       "   'Proteína UCP2',\n",
       "   'SLC25A8 Protein',\n",
       "   'Solute Carrier Family 25 Member 8',\n",
       "   'Transportador de Soluto, Família 25, Membro 8',\n",
       "   'Transportador de Solutos, Família 25, Membro 8',\n",
       "   'UCP2 Protein',\n",
       "   'Uncoupling Protein 2',\n",
       "   'Uncoupling Protein-2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071247': {'ID': 'D000071247',\n",
       "  'name': 'Proteína Desacopladora 3[Uncoupling Protein 3]',\n",
       "  'scope': 'A mitochondrial uncoupling protein that is expressed in heart and skeletal muscle tissues. It functions to regulate tissue respiration, energy balance, and THERMOGENESIS. Mutations in the UCP3 gene are associated with OBESITY.',\n",
       "  'terms': ['Carreador de Soluto Família 25 Membro 9',\n",
       "   'Carreador de Solutos Família 25 Membro 9',\n",
       "   'Membro 9 da Família 25 de Carreadores de Soluto',\n",
       "   'Membro 9 da Família 25 de Carreadores de Solutos',\n",
       "   'Membro 9 da Família 25 de Transportadores de Soluto',\n",
       "   'Membro 9 da Família 25 de Transportadores de Solutos',\n",
       "   'Mitochondrial Uncoupling Protein 3',\n",
       "   'Proteína Desacopladora 3',\n",
       "   'Proteína Desacopladora Mitocondrial 3',\n",
       "   'Proteína Desacopladora-3',\n",
       "   'Proteína Mitocondrial Desacopladora 3',\n",
       "   'Proteína SLC25A9',\n",
       "   'Proteína UCP3',\n",
       "   'SLC25A9 Protein',\n",
       "   'Solute Carrier Family 25 Member 9',\n",
       "   'Transportador de Soluto Família 25 Membro 9',\n",
       "   'Transportador de Solutos Família 25 Membro 9',\n",
       "   'UCP3 Protein',\n",
       "   'Uncoupling Protein 3',\n",
       "   'Uncoupling Protein-3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071248': {'ID': 'D000071248',\n",
       "  'name': 'Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo[Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha]',\n",
       "  'scope': 'A transcriptional co-activator for NUCLEAR RECEPTORS. It is characterized by an N-terminal LxxLL sequence, a region that interacts with PPAR GAMMA, and a C-terminal RNA RECOGNITION MOTIF. It increases expression of MITOCHONDRIAL UNCOUPLING PROTEIN to regulate genes involved in metabolic reprogramming in response to dietary restriction and the integration of CIRCADIAN RHYTHMS with ENERGY METABOLISM.',\n",
       "  'terms': ['Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo',\n",
       "   'Coativador l-alfa do Receptor gama Ativado por Proliferador de Peroxissoma',\n",
       "   'PGC 1 alpha Protein',\n",
       "   'PGC-1-alpha Protein',\n",
       "   'PPARGC 1 alpha Protein',\n",
       "   'PPARGC-1-alpha Protein',\n",
       "   'PPARGC1a Protein',\n",
       "   'Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 alpha',\n",
       "   'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha',\n",
       "   'Proteína PGC-1-alfa',\n",
       "   'Proteína PPARGC-1-alfa',\n",
       "   'Proteína PPARGC1a'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071250': {'ID': 'D000071250',\n",
       "  'name': 'Fatores de Transcrição da Família Snail[Snail Family Transcription Factors]',\n",
       "  'scope': 'A transcription factor family characterized by the presence of several  C-terminal CYS2-HIS2 ZINC FINGERS. They function in many developmental processes including the induction of the EPITHELIAL-MESENCHYMAL TRANSITION; maintenance of embryonic MESODERM; growth arrest, CELL SURVIVAL; and CELL MIGRATION.',\n",
       "  'terms': ['Fatores de Transcrição SNAI1',\n",
       "   'Fatores de Transcrição Slug',\n",
       "   'Fatores de Transcrição Snail',\n",
       "   'Fatores de Transcrição da Família SNAI1',\n",
       "   'Fatores de Transcrição da Família Snail',\n",
       "   'Slug Transcription Factors',\n",
       "   'Snail Family Transcription Factors',\n",
       "   'Snail Transcription Factors',\n",
       "   'Transcription Factors, Slug',\n",
       "   'Transcription Factors, Snail'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071251': {'ID': 'D000071251',\n",
       "  'name': 'Ambientes Extremos[Extreme Environments]',\n",
       "  'scope': 'An ENVIRONMENT which falls outside the range of tolerance for the survival of organisms that are not specifically adapted to survive or thrive in it. Examples of such environments are among the hottest and coldest places on earth.',\n",
       "  'terms': ['Ambientes Extremos',\n",
       "   'Environment, Extreme',\n",
       "   'Environments, Extreme',\n",
       "   'Extreme Environment',\n",
       "   'Extreme Environments'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071252': {'ID': 'D000071252',\n",
       "  'name': 'Tutoria[Mentoring]',\n",
       "  'scope': 'The art and practice of training, guiding, COUNSELING, and providing support to a less experienced, trained, or knowledgeable person.',\n",
       "  'terms': ['Coaching', 'Coaching', 'Instrução', 'Mentoring', 'Tutoria'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071253': {'ID': 'D000071253',\n",
       "  'name': 'Metadados[Metadata]',\n",
       "  'scope': 'Structured data elements used to describe other data.',\n",
       "  'terms': ['Meta Tags', 'Metadados', 'Metadata', 'Metatag', 'Metatags'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071256': {'ID': 'D000071256',\n",
       "  'name': 'Proteína Desacopladora 1[Uncoupling Protein 1]',\n",
       "  'scope': 'A mitochondrial uncoupling protein that is expressed in BROWN ADIPOSE TISSUE. It is critical for NONSHIVERING THERMOGENESIS to prevent heat loss in NEONATES.',\n",
       "  'terms': ['BAT Uncoupling Protein',\n",
       "   'Brown Adipose Tissue Uncoupling Protein',\n",
       "   'Carreador de Soluto Família 25 Membro 7',\n",
       "   'Carreador de Solutos Família 25 Membro 7',\n",
       "   'Membro 7 da Família 25 de Carreadores de Soluto',\n",
       "   'Membro 7 da Família 25 de Carreadores de Solutos',\n",
       "   'Mitochondrial Brown Fat Uncoupling Protein 1',\n",
       "   'Mitochondrial Uncoupling Protein',\n",
       "   'Proteína Desacopladora 1',\n",
       "   'Proteína Desacopladora 1a',\n",
       "   'Proteína Desacopladora BAT',\n",
       "   'Proteína Desacopladora Mitocondrial',\n",
       "   'Proteína Desacopladora da Membrana Mitocondrial',\n",
       "   'Proteína Desacopladora de Tecido Adiposo Marrom',\n",
       "   'Proteína Desacopladora do Tecido Adiposo Marrom',\n",
       "   'Proteína Mitocondrial 1 Desacopladora de Tecido Adiposo Marrom',\n",
       "   'Proteína Mitocondrial 1 Desacopladora do Tecido Adiposo Marrom',\n",
       "   'Proteína Mitocondrial Desacopladora',\n",
       "   'Proteína SLC25A7',\n",
       "   'Proteína UCP1',\n",
       "   'SLC25A7 Protein',\n",
       "   'Solute Carrier Family 25 Member 7',\n",
       "   'Termogenina',\n",
       "   'Thermogenin',\n",
       "   'Transportador de Soluto Família 25 Membro 7',\n",
       "   'Transportador de Solutos Família 25 Membro 7',\n",
       "   'UCP1 Protein',\n",
       "   'Uncoupling Protein 1',\n",
       "   'Uncoupling Protein 1a',\n",
       "   'Uncoupling Protein, BAT',\n",
       "   'Uncoupling Protein, Mitochondrial',\n",
       "   'Uncoupling Protein, Mitochondrial Membrane'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071257': {'ID': 'D000071257',\n",
       "  'name': 'Delírio do Despertar[Emergence Delirium]',\n",
       "  'scope': 'A form of DELIRIUM which occurs after GENERAL ANESTHESIA.',\n",
       "  'terms': ['Agitated Emergence',\n",
       "   'Agitation, Emergence',\n",
       "   'Agitations, Emergence',\n",
       "   'Agitação Pós-Anestesia',\n",
       "   'Agitação Pós-Operatória',\n",
       "   'Agitação no Despertar',\n",
       "   'Agitação no Despertar Pós-Operatório',\n",
       "   'Anesthesia Emergence Delirium',\n",
       "   'Delirium, Anesthesia Emergence',\n",
       "   'Delirium, Emergence',\n",
       "   'Delírio de Emergência',\n",
       "   'Delírio do Despertar',\n",
       "   'Emergence Agitation',\n",
       "   'Emergence Delirium',\n",
       "   'Emergence Delirium, Anesthesia',\n",
       "   'Emergence Excitement',\n",
       "   'Emergence, Agitated',\n",
       "   'Excitamento Pós-Anestésico',\n",
       "   'Excitamento do Despertar',\n",
       "   'Excitement, Emergence',\n",
       "   'Excitement, Postanesthetic',\n",
       "   'Postanesthetic Excitement'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071277': {'ID': 'D000071277',\n",
       "  'name': 'Assédio não Sexual[Harassment, Non-Sexual]',\n",
       "  'scope': 'The act of systematic and/or continuous unwanted and irritating actions of a non-sexual nature, by a party or group against another. This behavior may include threats, BULLYING, taunts, blackmail, and demands.',\n",
       "  'terms': ['Assédio não Sexual',\n",
       "   'Harassment, Non Sexual',\n",
       "   'Harassment, Non-Sexual',\n",
       "   'Harassment, Nonsexual',\n",
       "   'Non Sexual Harassment',\n",
       "   'Non-Sexual Harassment',\n",
       "   'Nonsexual Harassment'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071278': {'ID': 'D000071278',\n",
       "  'name': 'Domesticação[Domestication]',\n",
       "  'scope': 'A systematic process of adapting wild species of animals and plants into new environments often in close association or proximity to humans.',\n",
       "  'terms': ['Animal Taming',\n",
       "   'Domestication',\n",
       "   'Domesticação',\n",
       "   'Domesticação de Animais',\n",
       "   'Taming, Animal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071296': {'ID': 'D000071296',\n",
       "  'name': 'Empregados do Governo[Government Employees]',\n",
       "  'scope': 'Persons employed by the GOVERNMENT.',\n",
       "  'terms': ['Diplomat',\n",
       "   'Diplomata',\n",
       "   'Diplomats',\n",
       "   'Employee, Government',\n",
       "   'Employees, Government',\n",
       "   'Empregados Públicos',\n",
       "   'Empregados do Governo',\n",
       "   'Funcionários Públicos',\n",
       "   'Government Employee',\n",
       "   'Government Employees',\n",
       "   'Government Official',\n",
       "   'Government Officials',\n",
       "   'Official, Government',\n",
       "   'Officials, Government',\n",
       "   'Oficiais do Governo',\n",
       "   'Servidores Públicos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071297': {'ID': 'D000071297',\n",
       "  'name': 'Síndrome Retroviral Aguda[Acute Retroviral Syndrome]',\n",
       "  'scope': 'Early stage of HIV infection. Symptoms resemble INFLUENZA or INFECTIOUS MONONUCLEOSIS.',\n",
       "  'terms': ['Acute Retroviral Syndrome',\n",
       "   'Retroviral Syndrome, Acute',\n",
       "   'Síndrome Retroviral Aguda'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071298': {'ID': 'D000071298',\n",
       "  'name': 'Restos Mortais[Body Remains]',\n",
       "  'scope': 'The physical entity of a deceased human or animal.',\n",
       "  'terms': ['Animal Remains',\n",
       "   'Body Remains',\n",
       "   'Human Remains',\n",
       "   'Remains, Animal',\n",
       "   'Remains, Body',\n",
       "   'Remains, Human',\n",
       "   'Remains, Skeletal',\n",
       "   'Restos Animais',\n",
       "   'Restos Corpóreos',\n",
       "   'Restos Esqueléticos',\n",
       "   'Restos Humanos',\n",
       "   'Restos Mortais',\n",
       "   'Restos de Animais',\n",
       "   'Restos de Esqueletos',\n",
       "   'Restos do Corpo',\n",
       "   'Skeletal Remains'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071316': {'ID': 'D000071316',\n",
       "  'name': 'Proteína Forkhead Box O3[Forkhead Box Protein O3]',\n",
       "  'scope': \"A forkhead box transcription factor and transcriptional activator which triggers type 1 programmed cell death (APOPTOSIS) in the absence of APOPTOSIS INHIBITING PROTEINS, including neuronal cell death induced by OXIDATIVE STRESS. It recognizes and binds to the DNA sequence 5'-(AG)TAAA(TC)A-3' and also functions in post-transcriptional regulation of the c-MYC PROTO-ONCOGENE.\",\n",
       "  'terms': ['FOXO3 Protein',\n",
       "   'Forkhead Box Protein O3',\n",
       "   'Forkhead in Rhabdomyosarcoma Like 1 Protein',\n",
       "   'Forkhead in Rhabdomyosarcoma-Like 1 Protein',\n",
       "   'Protein, FOXO3',\n",
       "   'Proteína 1 Semelhante a Forkhead em Rabdomiossarcoma',\n",
       "   'Proteína 1 Semelhante a Forkhead no Rabdomiossarcoma',\n",
       "   'Proteína 1 Semelhante a Forquilha em Rabdomiossarcoma',\n",
       "   'Proteína FOXM3',\n",
       "   'Proteína Forkhead Box O3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071317': {'ID': 'D000071317',\n",
       "  'name': 'Proteína Homeobox Nanog[Nanog Homeobox Protein]',\n",
       "  'scope': 'A homeodomain protein and transcription regulator that functions in BLASTOCYST INNER CELL MASS and EMBRYONIC STEM CELL proliferation and CELL SELF RENEWAL. It confers pluripotency on embryonic stem cells and prevents their differentiation towards extraembryonic ENDODERM and trophectoderm (TROPHOBLAST) CELL LINEAGES.',\n",
       "  'terms': ['Fator de Transcrição com Homeobox Nanog',\n",
       "   'Homeobox Protein, Nanog',\n",
       "   'Nanog Homeobox Protein',\n",
       "   'Nanog Homeobox Transcription Factor',\n",
       "   'Nanog Protein',\n",
       "   'Proteína Homeobox Nanog',\n",
       "   'Proteína Nanog'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071336': {'ID': 'D000071336',\n",
       "  'name': 'Efetores Semelhantes a Ativadores de Transcrição[Transcription Activator-Like Effectors]',\n",
       "  'scope': 'Virulence factors of pathogenic plant bacteria, such as XANTHOMONAS species, that bind to specific sequences in the PROMOTER REGIONS of host DNA to induce transcription of specific host genes.  Variations in the DNA binding domain of TALE family members account for the variations in DNA specificity. The TALE DNA-binding domains are used in various GENETIC TECHNIQUES by fusing them with various DNA modifying enzymes to detect and manipulate sequence-specific targeted DNA sites.',\n",
       "  'terms': ['Efetores Semelhantes a Ativadores de Transcrição',\n",
       "   'Efetores TAL',\n",
       "   'Effectors, TAL',\n",
       "   'Effectors, Transcription Activator-Like',\n",
       "   'TAL Effectors',\n",
       "   'Transcription Activator Like Effectors',\n",
       "   'Transcription Activator-Like Effectors'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071376': {'ID': 'D000071376',\n",
       "  'name': 'Motivos de Ligação ao RNA[RNA-Binding Motifs]',\n",
       "  'scope': 'Amino acid motifs that bind RNA.',\n",
       "  'terms': ['Domínios de Ligação ao RNA',\n",
       "   'Motivos de Ligação ao RNA',\n",
       "   'RNA Binding Domains',\n",
       "   'RNA Binding Motifs',\n",
       "   'RNA-Binding Domain',\n",
       "   'RNA-Binding Domains',\n",
       "   'RNA-Binding Motif',\n",
       "   'RNA-Binding Motifs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071377': {'ID': 'D000071377',\n",
       "  'name': 'Motivo de Reconhecimento de RNA[RNA Recognition Motif]',\n",
       "  'scope': 'An approximately 80 amino acid RNA binding motif that consists of four anti-parallel surface beta sheets and two alpha helices arranged in a beta-alpha-beta-beta-alpha-beta configuration. One of the surface beta sheets interacts with two or three specific RNA bases. Interactions between additional sequences and the RNA, as well as within the RNA recognition motif increase the affinity and specificity of the protein-RNA interaction.',\n",
       "  'terms': ['Domínio de Ribonucleoproteína',\n",
       "   'Motivo RRM',\n",
       "   'Motivo de Reconhecimento de RNA',\n",
       "   'RNA Recognition Motif',\n",
       "   'RNA Recognition Motifs',\n",
       "   'RRM Motif',\n",
       "   'RRM Motifs',\n",
       "   'Ribonucleoprotein Domain',\n",
       "   'Ribonucleoprotein Domains'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071378': {'ID': 'D000071378',\n",
       "  'name': 'Joanete[Bunion]',\n",
       "  'scope': 'Abnormal swelling of the inner aspect of the first metatarsal head affecting the first METATARSOPHALANGEAL JOINT.',\n",
       "  'terms': ['Bunion', 'Bunions', 'Joanete'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071380': {'ID': 'D000071380',\n",
       "  'name': 'Fibromatose Plantar[Fibromatosis, Plantar]',\n",
       "  'scope': 'A fibromatosis of the plantar fascia characterized by thickening of the fibrous bands on the plantar aponeurosis in the sole of the foot and toes.',\n",
       "  'terms': ['Doença de Ledderhose',\n",
       "   'Fibromatose Plantar',\n",
       "   'Fibromatosis, Plantar',\n",
       "   'Ledderhose Disease',\n",
       "   \"Ledderhose's Disease\",\n",
       "   'Plantar Fibromatosis'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071396': {'ID': 'D000071396',\n",
       "  'name': 'Aldeído-Desidrogenase Mitocondrial[Aldehyde Dehydrogenase, Mitochondrial]',\n",
       "  'scope': 'An aldehyde dehydrogenase expressed in the mitochondrial matrix that is essential for the metabolism of ETHANOL.',\n",
       "  'terms': ['ALDH2 Protein',\n",
       "   'Aldehyde Dehydrogenase, Mitochondrial',\n",
       "   'Aldeído-Desidrogenase Mitocondrial',\n",
       "   'Dehydrogenase, Mitochondrial Aldehyde',\n",
       "   'Mitochondrial Aldehyde Dehydrogenase',\n",
       "   'Proteína ALDH2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071416': {'ID': 'D000071416',\n",
       "  'name': 'Fatores de Transcrição Twist[Twist Transcription Factors]',\n",
       "  'scope': 'A  highly-conserved family of basic helix-loop-helix (bHLH) transcription factors.  They function as dimers with other bHLH proteins and bind E-BOX ELEMENTS to control gene expression during EMBRYOGENESIS and the EPITHELIAL-MESENCHYMAL TRANSITION.',\n",
       "  'terms': ['Família Twist de Fatores de Transcrição',\n",
       "   'Família de Fatores de Transcrição Twist',\n",
       "   'Fatores de Transcrição Twist',\n",
       "   'Fatores de Transcrição da Família Twist',\n",
       "   'Transcription Factors, Twist',\n",
       "   'Twist Family Transcription Factors',\n",
       "   'Twist Transcription Factor Family',\n",
       "   'Twist Transcription Factors'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071417': {'ID': 'D000071417',\n",
       "  'name': 'Proteína 2 Relacionada a Twist[Twist-Related Protein 2]',\n",
       "  'scope': 'A twist family transcription factor that is expressed in MESODERM as well as the DERMIS during mammalian EMBRYOGENESIS. It is structurally and functionally similar to TWIST-RELATED PROTEIN 1; it also regulates OSTEOGENESIS and the expression of CYTOKINES in response to INFLAMMATION.',\n",
       "  'terms': ['Dermo 1 Protein',\n",
       "   'Dermo-1 Protein',\n",
       "   'Fator de Transcrição Bhlh 2 da Família Twist',\n",
       "   'Proteína 2 Relacionada a Twist',\n",
       "   'Proteína Dermo-1',\n",
       "   'Proteína TWIST2',\n",
       "   'TWIST2',\n",
       "   'TWIST2 Protein',\n",
       "   'Twist Family Bhlh Transcription Factor 2',\n",
       "   'Twist Related Protein 2',\n",
       "   'Twist-Related Protein 2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071419': {'ID': 'D000071419',\n",
       "  'name': 'Motivo ETS[ETS Motif]',\n",
       "  'scope': 'A helix-turn-helix motif characterized by three alpha-helices and four-stranded beta-sheets arranged in the order alpha1-beta1-beta2-alpha2-alpha3-beta3-beta4. The third alpha-helix contacts the major groove of DNA. The ETS motif and the flanking amino acid sequences of Ets proteins influence the binding affinity, and the alteration of a single amino acid in the Ets domain can change its DNA binding specificity.',\n",
       "  'terms': ['Domínio ETS',\n",
       "   'ETS Domain',\n",
       "   'ETS Domains',\n",
       "   'ETS Motif',\n",
       "   'ETS Motifs',\n",
       "   'Helix Turn Helix, ETS Type Domain Containing',\n",
       "   'Helix-Turn-Helix, ETS-Type Domain Containing',\n",
       "   'Hélice-Volta-Hélice que Contém Domínio Tipo ETS',\n",
       "   'Motivo ETS'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071421': {'ID': 'D000071421',\n",
       "  'name': 'Traços de História de Vida[Life History Traits]',\n",
       "  'scope': 'Morphological or behavioral traits influenced by various living conditions that a population encounters especially as it pertains to REPRODUCTION and survival of the population (see POPULATION DYNAMICS) such as age at first reproductive event, number and size of offspring, and lifespan.',\n",
       "  'terms': ['Características de História de Vida',\n",
       "   'Estratégia de História de Vida',\n",
       "   'Estratégias de História de Vida',\n",
       "   'Life History Characteristic',\n",
       "   'Life History Characteristics',\n",
       "   'Life History Strategies',\n",
       "   'Life History Strategy',\n",
       "   'Life History Theory',\n",
       "   'Life History Trait',\n",
       "   'Life History Traits',\n",
       "   'Life History Variation',\n",
       "   'Life History Variations',\n",
       "   'Strategies, Life History',\n",
       "   'Strategy, Life History',\n",
       "   'Teoria da História de Vida',\n",
       "   'Traços de História de Vida',\n",
       "   'Variação de História de Vida'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071422': {'ID': 'D000071422',\n",
       "  'name': 'Depressão por Endogamia[Inbreeding Depression]',\n",
       "  'scope': 'A reduced GENETIC VARIATION and GENETIC FITNESS due to INBREEDING.',\n",
       "  'terms': ['Depression, Inbreeding',\n",
       "   'Depressão por Consanguinidade',\n",
       "   'Depressão por Endogamia',\n",
       "   'Inbreeding Depression'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071425': {'ID': 'D000071425',\n",
       "  'name': 'Proteína 1 de Transformação que Contém Domínio 2 de Homologia de Src[Src Homology 2 Domain-Containing, Transforming Protein 1]',\n",
       "  'scope': 'An SHC-signaling adaptor protein that transduces PHOSPHOTYROSINE-dependent signals downstream of RECEPTOR PROTEIN-TYROSINE KINASES and non-receptor tyrosine kinases. It is required for TGF-BETA-induced CELL MIGRATION; NEOLPASM INVASION; and METASTASIS of BREAST NEOPLASMS; its SH2 DOMAIN is essential for tumor survival. It also functions in signaling downstream of  ANGIOPOIETIN RECEPTOR TIE-2, regulating the migration of ENDOTHELIAL CELLS; and PHYSIOLOGIC NEOVASCULARIZATION.',\n",
       "  'terms': ['Proteína 1 de Transformação SHC',\n",
       "   'Proteína 1 de Transformação SHC (Src Homology 2 Domain-Containing)',\n",
       "   'Proteína 1 de Transformação que Contém Domínio 2 de Homologia de Src',\n",
       "   'Proteína SHC1',\n",
       "   'Proteína SHC1 (que Contém Domínio 2 de Homologia à Src)',\n",
       "   'Proteína ShcA',\n",
       "   'Proteína de Transformação 1 que Contém Domínio 2 de Homologia à Src',\n",
       "   'Proteína de Transformação C1 que Contém o Domínio 2 de Homologia à Src',\n",
       "   'SHC (Src Homology 2 Domain-Containing) Transforming Protein 1',\n",
       "   'SHC Transforming Protein 1',\n",
       "   'SHC-Transforming Protein 1',\n",
       "   'SHC1 (Src Homology 2 Domain-Containing) Protein',\n",
       "   'SHC1 Protein',\n",
       "   'ShcA Protein',\n",
       "   'Src Homology 2 Domain Containing Transforming Protein C1',\n",
       "   'Src Homology 2 Domain Containing, Transforming Protein 1',\n",
       "   'Src Homology 2 Domain-Containing, Transforming Protein 1',\n",
       "   'Src Homology 2 Domain-Containing-Transforming Protein C1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071426': {'ID': 'D000071426',\n",
       "  'name': 'Proteína 2 de Transformação que Contém Domínio 2 de Homologia de Src[Src Homology 2 Domain-Containing, Transforming Protein 2]',\n",
       "  'scope': 'An SHC-signaling adaptor protein that links GROWTH FACTOR RECEPTORS to SIGNAL TRANSDUCTION PATHWAYS in neurons.',\n",
       "  'terms': ['Proteína 2 de Transformação que Contém Domínio 2 de Homologia de Src',\n",
       "   'Proteína 2 de Transformação que Contém Domínio 2 de Homologia à Src',\n",
       "   'Proteína SHC2',\n",
       "   'Proteína SHC2 (que Contém Domínio 2 de Homologia à Src)',\n",
       "   'Proteína ShcB',\n",
       "   'Proteína de Transformação 2 que Contém Domínio 2 de Homologia à Src',\n",
       "   'Proteína de Transformação C2 que Contém o Domínio 2 de Homologia à Src',\n",
       "   'SHC (Src Homology 2 Domain-Containing) Transforming Protein 2',\n",
       "   'SHC2 (Src Homology 2 Domain-Containing) Protein',\n",
       "   'SHC2 Protein',\n",
       "   'ShcB Protein',\n",
       "   'Src Homology 2 Domain Containing Transforming Protein C2',\n",
       "   'Src Homology 2 Domain Containing, Transforming Protein 2',\n",
       "   'Src Homology 2 Domain-Containing, Transforming Protein 2',\n",
       "   'Src Homology 2 Domain-Containing-Transforming Protein C2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071427': {'ID': 'D000071427',\n",
       "  'name': 'Proteína 3 de Transformação que Contém Domínio 2 de Homologia de Src[Src Homology 2 Domain-Containing, Transforming Protein 3]',\n",
       "  'scope': 'An SHC-signaling adaptor protein that links GROWTH FACTOR RECEPTORS to SIGNAL TRANSDUCTION PATHWAYS in neurons, including NEUROTROPHINS signaling in the CENTRAL NERVOUS SYSTEM.',\n",
       "  'terms': ['Proteína 3 de Transformação que Contém Domínio 2 de Homologia de Src',\n",
       "   'Proteína 3 de Transformação que Contém Domínio 2 de Homologia à Src',\n",
       "   'Proteína SHC3',\n",
       "   'Proteína SHC3 (que Contém Domínio 2 de Homologia à Src)',\n",
       "   'Proteína SHCC',\n",
       "   'Proteína de Transformação 3 que Contém Domínio 2 de Homologia à Src',\n",
       "   'SHC3 (Src Homology 2 Domain-Containing) Protein',\n",
       "   'SHC3 Protein',\n",
       "   'SHCC Protein',\n",
       "   'Src Homology 2 Domain Containing Transforming Protein C3',\n",
       "   'Src Homology 2 Domain Containing, Transforming Protein 3',\n",
       "   'Src Homology 2 Domain-Containing, Transforming Protein 3',\n",
       "   'Src Homology 2 Domain-Containing-Transforming Protein C3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071436': {'ID': 'D000071436',\n",
       "  'name': 'Termotolerância[Thermotolerance]',\n",
       "  'scope': 'The ability of an organism to reduce susceptibility to heat shock, and adapt to HOT TEMPERATURE.',\n",
       "  'terms': ['Adaptação ao Calor',\n",
       "   'Heat Adaptation',\n",
       "   'Heat Tolerance',\n",
       "   'Termotolerância',\n",
       "   'Thermotolerance',\n",
       "   'Tolerance, Heat',\n",
       "   'Tolerances, Heat',\n",
       "   'Tolerância ao Calor'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071437': {'ID': 'D000071437',\n",
       "  'name': 'Orientação de Axônios[Axon Guidance]',\n",
       "  'scope': 'The mechanism by which a neuronal process outgrows toward a target led by the GROWTH CONE. Local guidance cues are provided by cell surface proteins that act on the growing axon.',\n",
       "  'terms': ['Axon Guidance',\n",
       "   'Axon Pathfinding',\n",
       "   'Axonal Pathfinding',\n",
       "   'Neural Guidance',\n",
       "   'Neural Pathfinding',\n",
       "   'Neurite Guidance',\n",
       "   'Neuronal Guidance',\n",
       "   'Neuronal Pathfinding',\n",
       "   'Orientação Axonal',\n",
       "   'Orientação Neural',\n",
       "   'Orientação Neuronal',\n",
       "   'Orientação de Axônios',\n",
       "   'Orientação de Neuritos',\n",
       "   'Pathfinding, Axon'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071438': {'ID': 'D000071438',\n",
       "  'name': 'Proteína 7 de Ligação a Ácidos Graxos[Fatty Acid-Binding Protein 7]',\n",
       "  'scope': 'A fatty acid-binding protein expressed by ASTROCYTES during CENTRAL NERVOUS SYSTEM development, and by MALIGNANT GLIOMA cells. It is also expressed by ASTROCYTES in response to injury or ISCHEMIA, and may function in repair of the MYELIN SHEATH.',\n",
       "  'terms': ['Brain Lipid Binding Protein',\n",
       "   'Brain Lipid-Binding Protein',\n",
       "   'Fatty Acid Binding Protein 7',\n",
       "   'Fatty Acid Binding Protein, Brain',\n",
       "   'Fatty Acid-Binding Protein 7',\n",
       "   'Fatty Acid-Binding Protein, Brain',\n",
       "   'Lipid-Binding Protein, Brain',\n",
       "   'Mammary Derived Growth Inhibitor Related Protein',\n",
       "   'Mammary-Derived Growth Inhibitor Related Protein',\n",
       "   'Proteína 7 de Ligação a Ácidos Graxos',\n",
       "   'Proteína Encefálica de Ligação a Ácidos Graxos',\n",
       "   'Proteína Relacionada ao Inibidor de Crescimento Derivado Mamário',\n",
       "   'Proteína de Ligação a Lipídeos do Encéfalo'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071439': {'ID': 'D000071439',\n",
       "  'name': 'Regiões Pseudoautossômicas[Pseudoautosomal Regions]',\n",
       "  'scope': \"Homologous chromosomal regions at either end of the X CHROMOSOME or Y CHROMOSOME. These two regions pair regularly at male MEIOSIS and undergo RECOMBINATION. Pseudoautosomal region 1 (PAR1) is located  at the tip of the short 'p' arms (Xp22 and Yp11) and Pseudoautosomal region 2 (PAR2) is located at the tip of the long 'q' arms (Xq28 and Yq12).\",\n",
       "  'terms': ['Pseudoautosomal Region',\n",
       "   'Pseudoautosomal Regions',\n",
       "   'Região Pseudoautossômica',\n",
       "   'Regiões Pseudoautossômicas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071441': {'ID': 'D000071441',\n",
       "  'name': 'Terapia Focada em Emoções[Emotion-Focused Therapy]',\n",
       "  'scope': 'Intervention that relies on free expression of emotions with coaching to enhance awareness of emotional experiences.',\n",
       "  'terms': ['Emotion Focused Therapy',\n",
       "   'Emotion-Focused Therapies',\n",
       "   'Emotion-Focused Therapy',\n",
       "   'Terapia Focada em Emoções',\n",
       "   'Terapia Focada na Emoção',\n",
       "   'Terapia Focada nas Emoções',\n",
       "   'Therapies, Emotion-Focused',\n",
       "   'Therapy, Emotion-Focused'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071442': {'ID': 'D000071442',\n",
       "  'name': 'Resposta Táctica[Taxis Response]',\n",
       "  'scope': 'A behavior in free-moving organism that results in motion or orientation toward or away from an external stimulus.',\n",
       "  'terms': ['Avoidance, Heat',\n",
       "   'Avoidance, Thermal',\n",
       "   'Compass Orientation',\n",
       "   'Esquivamento Térmico',\n",
       "   'Esquivamento do Calor',\n",
       "   'Galvanotaxia',\n",
       "   'Galvanotaxis',\n",
       "   'Heat Avoidance',\n",
       "   'Orientation, Compass',\n",
       "   'Orientação Magnética',\n",
       "   'Orientação por Bússola',\n",
       "   'Response, Taxis',\n",
       "   'Responses, Taxis',\n",
       "   'Resposta Táctica',\n",
       "   'Taxis Response',\n",
       "   'Taxis Responses',\n",
       "   'Termotaxia',\n",
       "   'Thermal Avoidance',\n",
       "   'Thermotaxis',\n",
       "   'Tropotaxia',\n",
       "   'Tropotaxis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071443': {'ID': 'D000071443',\n",
       "  'name': 'Antígeno 12E7[12E7 Antigen]',\n",
       "  'scope': 'A cell adhesion molecule that, in humans, is encoded by a gene on the PSEUDOAUTOSOMAL REGION of SEX CHROMOSOMES. It functions in CELL ADHESION of T-LYMPHOCYTES and ROSETTE FORMATION by ERYTHROCYTES. It is also involved in the migration of LEUKOCYTES through the ENDOTHELIUM BASEMENT MEMBRANE. The 12E7 antigen co-localizes with, but functions independently of PECAM-1.',\n",
       "  'terms': ['12E7 Antigen',\n",
       "   '12E7 Protein',\n",
       "   'Antigen, 12E7',\n",
       "   'Antigen, CD99',\n",
       "   'Antigen, E2',\n",
       "   'Antigens, CD99',\n",
       "   'Antígeno 12E7',\n",
       "   'Antígeno CD99',\n",
       "   'Antígeno E2',\n",
       "   'Antígenos CD99',\n",
       "   'CD99 Antigen',\n",
       "   'CD99 Antigens',\n",
       "   'CD99 Molecule',\n",
       "   'E2 Antigen',\n",
       "   'Glicoproteína E2 de Superfície de Célula T',\n",
       "   'Glicoproteína de Superfície E2 de Célula T',\n",
       "   'MIC2 Protein',\n",
       "   'Molécula CD99',\n",
       "   'Proteína 12E7',\n",
       "   'Proteína MIC2',\n",
       "   'T Cell Surface Glycoprotein E2',\n",
       "   'T-Cell Surface Glycoprotein E2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071444': {'ID': 'D000071444',\n",
       "  'name': 'Fototaxia[Phototaxis]',\n",
       "  'scope': 'A behavioral change that results in an organism moving or orienting toward or away from the light source.',\n",
       "  'terms': ['Fotocinese',\n",
       "   'Fototaxia',\n",
       "   'Photokineses',\n",
       "   'Photokinesis',\n",
       "   'Phototaxis'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071446': {'ID': 'D000071446',\n",
       "  'name': 'Crescimento Neuronal[Neuronal Outgrowth]',\n",
       "  'scope': 'Formation of neuronal processes (AXONS; NEURITES) toward a target cell.',\n",
       "  'terms': ['Axon Outgrowth',\n",
       "   'Crescimento Neuronal',\n",
       "   'Crescimento de Axônios',\n",
       "   'Crescimento de Neuritos',\n",
       "   'Neurite Outgrowth',\n",
       "   'Neuronal Outgrowth'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071447': {'ID': 'D000071447',\n",
       "  'name': 'Proteína Proto-Oncogênica N-Myc[N-Myc Proto-Oncogene Protein]',\n",
       "  'scope': 'A basic helix-loop-helix leucine zipper (bHLHZ) transcription factor and proto-oncogene protein that functions in cell growth and proliferation. In mammals, it is highly expressed in the brain during embryogenesis and is essential for brain development; it is not expressed in adult tissues. Amplification or overexpression of N-Myc occurs in at least 20% of tumors and is associated with a poor prognosis in cases of NEUROBLASTOMA; ALVEOLAR RHABDOMYOSARCOMA; SMALL CELL LUNG CARCINOMA; and neuroendocrine prostate cancer.',\n",
       "  'terms': ['BHLHE37 Protein',\n",
       "   'Class E Basic Helix Loop Helix Protein 37',\n",
       "   'Class E Basic Helix-Loop-Helix Protein 37',\n",
       "   'MYCN Protein',\n",
       "   'N Myc Protein',\n",
       "   'N Myc Proto Oncogene Protein',\n",
       "   'N-Myc Protein',\n",
       "   'N-Myc Proto-Oncogene Protein',\n",
       "   'NMYC Protein',\n",
       "   'Proteína 37 Hélice-Alça-Hélice Básica da Classe E',\n",
       "   'Proteína BHLHE37',\n",
       "   'Proteína MYCN',\n",
       "   'Proteína N-Myc',\n",
       "   'Proteína NMYC',\n",
       "   'Proteína Proto-Oncogênica N-Myc',\n",
       "   'Proto-Oncogene Protein, N-Myc'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071448': {'ID': 'D000071448',\n",
       "  'name': 'Fasciculação Axônica[Axon Fasciculation]',\n",
       "  'scope': 'Process of organizing neighboring AXONS into a bundle or a fascicle during neurite outgrowth mediated by CELL ADHESION MOLECULES.',\n",
       "  'terms': ['Agrupamento Axônico',\n",
       "   'Axon Fasciculation',\n",
       "   'Axonal Bundling',\n",
       "   'Axonal Fasciculation',\n",
       "   'Bundling, Axonal',\n",
       "   'Fasciculation, Axon',\n",
       "   'Fasciculation, Axonal',\n",
       "   'Fasciculation, Neurite',\n",
       "   'Fasciculação Axônica',\n",
       "   'Fasciculação de Axônios',\n",
       "   'Fasciculação de Neuritos',\n",
       "   'Fasciculação dos Axônios',\n",
       "   'Neurite Fasciculation'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071449': {'ID': 'D000071449',\n",
       "  'name': 'Pró-Proteína Convertase 9[Proprotein Convertase 9]',\n",
       "  'scope': 'A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS.',\n",
       "  'terms': ['Convertase 1 Regulada por Apoptose Neural',\n",
       "   'Convertase 1 Regulada por Apoptose de Células Nervosas',\n",
       "   'Convertase 9, Proprotein',\n",
       "   'NARC 1 Protein',\n",
       "   'NARC-1 Protein',\n",
       "   'Neural Apoptosis Regulated Convertase 1',\n",
       "   'Neural Apoptosis-Regulated Convertase 1',\n",
       "   'PCSK9',\n",
       "   'Proprotein Convertase 9',\n",
       "   'Proprotein Convertase, Subtilisin Kexin Type 9',\n",
       "   'Proprotein Convertase, Subtilisin-Kexin Type 9',\n",
       "   'Proproteína Convertase 9',\n",
       "   'Proteína NARC-1',\n",
       "   'Pró-Proteína Convertase 9',\n",
       "   'Pró-Proteína Convertase Subtilisina-Kexina Tipo 9'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071450': {'ID': 'D000071450',\n",
       "  'name': 'Membro 3 da Subfamília B de Cassetes de Ligação de ATP[ATP-Binding Cassette, Sub-Family B, Member 3]',\n",
       "  'scope': 'An ATP-binding cassette, sub-family B protein (ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY B) that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It functions as a heterodimer with ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 2.',\n",
       "  'terms': ['ABCB3 Protein',\n",
       "   'ATP-Binding Cassette, Sub-Family B, Member 3',\n",
       "   'Antigen Peptide Transporter 2',\n",
       "   'Antigen Peptide Transporter-2',\n",
       "   'Fator 2 Fornecedor de Peptídeos',\n",
       "   'Fator 2 de Fornecimento de Peptídeos',\n",
       "   'Membro 3 da Subfamília B de Cassetes de Ligação de ATP',\n",
       "   'Peptide Supply Factor 2',\n",
       "   'Peptide Transporter Tap2',\n",
       "   'Proteína ABCB3',\n",
       "   'Tap2, Peptide Transporter',\n",
       "   'Transportador Tap2 de Peptídeos',\n",
       "   'Transportador de Peptídeos Tap2',\n",
       "   'Transportador-2 de Antígeno Peptídico'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071451': {'ID': 'D000071451',\n",
       "  'name': 'Proteína 1 Semelhante à Quitinase-3[Chitinase-3-Like Protein 1]',\n",
       "  'scope': 'A lectin that binds CHITIN, but lacks chitinase activity. It may be involved in tissue remodeling and cellular responses to the environment, including the response of type 2 HELPER T-CELLS to INFLAMMATION and sensitization to ALLERGENS. Mutations in the CHI3L1 gene are associated with ASTHMA.',\n",
       "  'terms': ['CGP 39 Protein',\n",
       "   'CGP-39 Protein',\n",
       "   'CHI3L1 Protein',\n",
       "   'Cartilage Glycoprotein 39',\n",
       "   'Chitinase 3 Like Protein 1',\n",
       "   'Chitinase-3-Like Protein 1',\n",
       "   'GP 39 Protein',\n",
       "   'GP-39 Protein',\n",
       "   'Glicoproteína 39 de Cartilagem',\n",
       "   'Glicoproteína de Cartilagem 39',\n",
       "   'Glycoprotein 39, Cartilage',\n",
       "   'Proteína 1 Semelhante à Quitinase-3',\n",
       "   'Proteína CGP-39',\n",
       "   'Proteína CHI3L1',\n",
       "   'Proteína GP-39',\n",
       "   'Proteína YLK-40',\n",
       "   'YLK 40 Protein',\n",
       "   'YLK-40 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071456': {'ID': 'D000071456',\n",
       "  'name': 'Proteína Sequestossoma-1[Sequestosome-1 Protein]',\n",
       "  'scope': 'A multidomain protein that is highly conserved among multicellular organisms. It contains a ZZ-type ZINC FINGER domain, C-terminal UBIQUITIN - associated (UBA) domain, and interacts with many other signaling proteins and enzymes including, atypical PROTEIN KINASE C; TNF RECEPTOR-ASSOCIATED FACTOR 6; subunits of the mTORC1 complex, and CASPASE-8. It functions in AUTOPHAGY as a receptor for the degradation of ubiquitinated substrates, and to co-ordinate signaling in response to OXIDATIVE STRESS.',\n",
       "  'terms': ['EBI3 Associated Protein of 60 KDa',\n",
       "   'EBI3-Associated Protein of 60 KDa',\n",
       "   'EBIAP Protein',\n",
       "   'Ligante para o Domínio Lck SH2 de 62 kDa Independente de Fosfotirosina',\n",
       "   'Phosphotyrosine Independent Ligand For The Lck SH2 Domain Of 62 Kda',\n",
       "   'Phosphotyrosine-Independent Ligand For The Lck SH2 Domain Of 62 Kda',\n",
       "   'Proteína Associada de EBI3 de 60 kDa',\n",
       "   'Proteína EBIAP',\n",
       "   'Proteína Sequestosoma 1',\n",
       "   'Proteína Sequestosoma-1',\n",
       "   'Proteína Sequestossoma 1',\n",
       "   'Proteína Sequestossoma-1',\n",
       "   'Proteína de Ligação à Ubiquitina p62',\n",
       "   'Proteína p62 de Ligação à Ubicuitina',\n",
       "   'Proteína p62 de Ligação à Ubiquitina',\n",
       "   'Sequestosome 1 Protein',\n",
       "   'Sequestosome-1 Protein',\n",
       "   'Ubiquitin Binding Protein p62',\n",
       "   'Ubiquitin-Binding Protein p62'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071457': {'ID': 'D000071457',\n",
       "  'name': 'Proteína DEAD-box 58[DEAD Box Protein 58]',\n",
       "  'scope': \"A DEAD-box RNA helicase that contains an N-terminal DEATH-LIKE DOMAIN, AAA+ ATPase domain, and C-terminal RNA HELICASE activity. It functions as an innate immune receptor through its recognition of viral nucleic acids. It also induces the expression of INTERFERON TYPE I and proinflammatory CYTOKINES. Its ligands include: 5'-triphosphorylated SINGLE-STRANDED RNA, DOUBLE-STRANDED RNA (dsRNA), and short dsRNA (less than 1 kb in length).\",\n",
       "  'terms': ['DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 58',\n",
       "   'DEAD Box Protein 58',\n",
       "   'Polipeptídeo DEAD (Asp-Glu-Ala-Asp) Box',\n",
       "   'Probable ATP Dependent RNA Helicase DDX58',\n",
       "   'Probable ATP-Dependent RNA Helicase DDX58',\n",
       "   'Proteína DEAD-box 58',\n",
       "   'RIG I like Receptor 1',\n",
       "   'RIG-I-like Receptor 1',\n",
       "   'RNA Helicase DDX58 Provável Dependente de ATP',\n",
       "   'Receptor 1 Semelhante a RIG-I'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071458': {'ID': 'D000071458',\n",
       "  'name': 'Superfamília de Domínios de Morte[Death Domain Superfamily]',\n",
       "  'scope': 'A family of structurally-related protein interaction domains characterized by 6-helical closed bundle fold, with Greek key topology and an internal pseudo two-fold symmetry. Death-like domains occur in many proteins that are essential for APOPTOSIS, including CASPASE RECRUITMENT DOMAIN CONTAINING PROTEINS and DEATH DOMAIN RECEPTORS.',\n",
       "  'terms': ['Death Domain Superfamilies',\n",
       "   'Death Domain Superfamily',\n",
       "   'Death Like Domain',\n",
       "   'Death Like Domains',\n",
       "   'Death-Like Domain',\n",
       "   'Death-Like Domains',\n",
       "   'Domain Superfamilies, Death',\n",
       "   'Domain Superfamily, Death',\n",
       "   'Domínio Semelhante ao de Morte',\n",
       "   'Domínios Semelhantes aos de Morte',\n",
       "   'Superfamilies, Death Domain',\n",
       "   'Superfamily, Death Domain',\n",
       "   'Superfamília de Domínios de Morte'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071459': {'ID': 'D000071459',\n",
       "  'name': 'Domínio de Morte[Death Domain]',\n",
       "  'scope': 'A conserved protein interaction domain of the death domain superfamily that is structurally similar to the DEATH EFFECTOR DOMAIN and CASPASE RECRUITMENT DOMAIN. Death domains bind each other to form oligomers and occur on DEATH DOMAIN RECEPTORS, where they are required for APOPTOSIS signaling and non-apoptotic functions.',\n",
       "  'terms': ['Death Domain',\n",
       "   'Death Domains',\n",
       "   'Domínio de Morte',\n",
       "   'Domínios de Morte'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071461': {'ID': 'D000071461',\n",
       "  'name': 'Domínio Efetor de Morte[Death Effector Domain]',\n",
       "  'scope': 'A homotypic protein interaction module of the death domain superfamily that is composed of a bundle of six alpha-helices. The death effector domain shares sequence and structural similarities with the DEATH DOMAIN and CASPASE RECRUITMENT DOMAIN. It occurs in many proteins with essential functions in APOPTOSIS.',\n",
       "  'terms': ['DED Domain',\n",
       "   'DED Domains',\n",
       "   'Death Effector Domain',\n",
       "   'Death Effector Domains',\n",
       "   'Domínio DED',\n",
       "   'Domínio Efetor de Morte'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071476': {'ID': 'D000071476',\n",
       "  'name': 'Domínio de Ativação e Recrutamento de Caspases[Caspase Activation and Recruitment Domain]',\n",
       "  'scope': 'A homotypic protein interaction module of the death domain superfamily. It is composed of a bundle of six alpha-helices that is related in sequence and structure to the DEATH DOMAIN and DEATH EFFECTOR DOMAIN. The Caspase Activation and Recruitment Domain (CARD domain) typically associates with other CARD-containing proteins, forming either dimers or trimers. CARD domains may occur in isolation, or in combination with other domains in CARD signaling adaptor proteins and initiator CASPASES that function in APOPTOSIS.',\n",
       "  'terms': ['CARD Domain',\n",
       "   'CARD Domains',\n",
       "   'Caspase Activation and Recruitment Domain',\n",
       "   'Caspase Activation and Recruitment Domains',\n",
       "   'Caspase Recruitment Domain',\n",
       "   'Caspase Recruitment Domains',\n",
       "   'Domínio CARD',\n",
       "   'Domínio de Ativação e Recrutamento de Caspases',\n",
       "   'Domínio de Recrutamento de Caspases',\n",
       "   'Domínio de Recrutamento e Ativação de Caspase',\n",
       "   'Domínios CARD',\n",
       "   'Domínios de Ativação e Recrutamento de Caspases',\n",
       "   'Domínios de Recrutamento de Caspases',\n",
       "   'Recruitment Domain, Caspase',\n",
       "   'Recruitment Domains, Caspase'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071477': {'ID': 'D000071477',\n",
       "  'name': 'Gubernáculo[Gubernaculum]',\n",
       "  'scope': 'An embryonic structure that helps guide proper descent of gonads into their final positions. It attaches the caudal end of the fetal GONADS to the developing SCROTUM in male and the labium majorum in female. It gives rise to the caudal ligaments of the gonad: the scrotal ligament in male and the uterine round and proper ovarian ligaments in female. It includes morphofunctional equivalent structures in non-mammals.',\n",
       "  'terms': ['Gubernacula', 'Gubernaculum', 'Gubernáculo', 'Gubernáculos'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071478': {'ID': 'D000071478',\n",
       "  'name': 'Desaminases APOBEC[APOBEC Deaminases]',\n",
       "  'scope': 'A family of conserved cytidine deaminases that catalyze the DEAMINATION of CYTIDINE to URIDINE. They are characterized by N and C-terminal zinc-dependent catalytic domains and have important functions in RNA EDITING; EPIGENTIC PROCESSES; and the INNATE IMMUNE RESPONSE against viruses.',\n",
       "  'terms': ['AID APOBEC Deaminases',\n",
       "   'AID-APOBEC Deaminases',\n",
       "   'APOBEC Deaminases',\n",
       "   'APOBEC Enzymes',\n",
       "   'APOBEC Family Proteins',\n",
       "   'Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptides',\n",
       "   'Deaminases, AID-APOBEC',\n",
       "   'Deaminases, APOBEC',\n",
       "   'Desaminases AID-APOBEC',\n",
       "   'Desaminases APOBEC',\n",
       "   'Enzimas APOBEC',\n",
       "   'Polipeptídeos Catalíticos da Enzima de Edição do RNAm da Apolipoproteína B',\n",
       "   'Polipeptídeos Catalíticos da Enzima de Edição do RNAm de Apolipoproteína B',\n",
       "   'Proteínas da Família APOBEC'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071479': {'ID': 'D000071479',\n",
       "  'name': 'Desaminase APOBEC-1[APOBEC-1 Deaminase]',\n",
       "  'scope': 'An APOBEC deaminase catalytic subunit of the apolipoprotein B (APOB) MESSENGER RNA (mRNA) editing enzyme complex that is involved in post-transcriptional editing of a CAA codon for GLYCINE to a UAA STOP CODON in the ApoB mRNA. It also functions in CGA (ARGININE) to UGA STOP CODON editing of NEUROFIBROMIN 1 mRNA and EPIGENETIC PROCESSES.',\n",
       "  'terms': ['APOBEC 1 Deaminase',\n",
       "   'APOBEC 1 Protein',\n",
       "   'APOBEC-1',\n",
       "   'APOBEC-1',\n",
       "   'APOBEC-1 Deaminase',\n",
       "   'APOBEC-1 Protein',\n",
       "   'APOBEC1 Deaminase',\n",
       "   'APOBEC1 Protein',\n",
       "   'Apo B mRNA Editing Protein',\n",
       "   'ApoB mRNA Editing Catalytic Subunit',\n",
       "   'Apolipoprotein B mRNA Editing Enzyme',\n",
       "   'Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide 1',\n",
       "   'Deaminase, APOBEC-1',\n",
       "   'Deaminase, APOBEC1',\n",
       "   'Desaminase APOBEC-1',\n",
       "   'Enzima de Edição do RNAm da Apolipoproteína B',\n",
       "   'HEPR Protein',\n",
       "   'Polipeptídeo 1 Catalítico da Enzima de Edição do RNAm da Apolipoproteína B',\n",
       "   'Proteína APOBEC-1',\n",
       "   'Proteína APOBEC1',\n",
       "   'Proteína HEPR',\n",
       "   'Proteína de Edição do RNAm da ApoB'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071480': {'ID': 'D000071480',\n",
       "  'name': 'Desaminase APOBEC-3G[APOBEC-3G Deaminase]',\n",
       "  'scope': 'An APOBEC deaminase that functions as an inhibitor of RETROVIRIDAE replication and inhibits the mobility of RETROTRANSPOSONS via deaminase-dependent and independent mechanisms. It is selective for SINGLE-STRANDED DNA and does not deaminate double-stranded DNA or single or DOUBLE-STRANDED RNA. It exhibits potent antiviral activity against VIF PROTEIN deficient HIV-1 through the creation of hypermutations in the VIRAL DNA. It also has anti-viral activity against SIMIAN IMMUNODEFICIENCY VIRUSES and HEPATITIS B VIRUS.',\n",
       "  'terms': ['APOBEC 3G Deaminase',\n",
       "   'APOBEC 3G Protein',\n",
       "   'APOBEC 3G dC dU Editing Enzyme',\n",
       "   'APOBEC Related Cytidine Deaminase',\n",
       "   'APOBEC Related Protein',\n",
       "   'APOBEC-3G Deaminase',\n",
       "   'APOBEC-3G Protein',\n",
       "   'APOBEC-3G dC-dU Editing Enzyme',\n",
       "   'APOBEC-Related Cytidine Deaminase',\n",
       "   'APOBEC-Related Protein',\n",
       "   'APOBEC3G Deaminase',\n",
       "   'APOBEC3G Protein',\n",
       "   'CEM15 Protein',\n",
       "   'Citidina Desaminase Relacionada à APOBEC',\n",
       "   'Cytidine Deaminase, APOBEC-Related',\n",
       "   'Deaminase, APOBEC-3G',\n",
       "   'Deaminase, APOBEC3G',\n",
       "   'Desaminase APOBEC-3G',\n",
       "   'Desaminase APOBEC3G',\n",
       "   'Enzima de Edição APOBEC-3G dC-dU',\n",
       "   'Proteína APOBEC-3G',\n",
       "   'Proteína APOBEC3G',\n",
       "   'Proteína CEM15',\n",
       "   'Proteína Relacionada à APOBEC'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071496': {'ID': 'D000071496',\n",
       "  'name': 'Enzimas AlkB[AlkB Enzymes]',\n",
       "  'scope': 'A family of alpha- KETOGLUTARIC ACID and Fe(II)-dependent dioxygenases that are homologous to AlkB, an enzyme that repairs alkylated nucleic acids in E. coli. The mammalian homologs have diverse substrate specificities and functions that include DNA REPAIR, generating unique wobble modifications in URIDINE tRNA, demethylation of nucleotides in DNA and RNA, and demethylation of LYSINE residues on certain proteins, including ACTIN and histones (HISTONE CODE).',\n",
       "  'terms': ['AlkB Enzymes',\n",
       "   'AlkB Homologs',\n",
       "   'Alkylated DNA Repair Protein AlkB Homologs',\n",
       "   'Alkylation Repair Homolog Proteins',\n",
       "   'Alkylation Repair Homologs',\n",
       "   'Enzimas AlkB',\n",
       "   'Enzymes, AlkB',\n",
       "   'Homólogos AlkB',\n",
       "   'Homólogos AlkB da Proteína de Reparo de DNA Alquilado',\n",
       "   'Homólogos de Reparo de Alquilação',\n",
       "   'Proteínas Homólogas às de Reparo de Alquilação'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071497': {'ID': 'D000071497',\n",
       "  'name': 'Imunogenicidade da Vacina[Immunogenicity, Vaccine]',\n",
       "  'scope': 'The capacity of VACCINES to stimulate the ADAPTIVE IMMUNE RESPONSE to produce antibodies and antigen-specific T-CELL responses.',\n",
       "  'terms': ['Antigenicidade Vacinal',\n",
       "   'Antigenicidade da Vacina',\n",
       "   'Antigenicity, Vaccine',\n",
       "   'Immunogenicity, Vaccine',\n",
       "   'Imunogenicidade Vacinal',\n",
       "   'Imunogenicidade da Vacina',\n",
       "   'Vaccine Antigenicity',\n",
       "   'Vaccine Immunogenicity'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071498': {'ID': 'D000071498',\n",
       "  'name': 'Homólogo AlkB 1 da Histona H2a Dioxigenase[AlkB Homolog 1, Histone H2a Dioxygenase]',\n",
       "  'scope': 'A dioxygenase and alkylation repair homolog that functions by oxidative demethylation in RNA and DNA REPAIR of substrates which contain 3-methylcytosine. It also functions as one of the HISTONE DEMETHYLASES involved in embryonic development and maintaining the pluripotency of EMBRYONIC STEM CELLS.',\n",
       "  'terms': ['ABH1, Alpha-Ketoglutarate-Dependent Dioxygenase',\n",
       "   'ABH1, DNA Lyase',\n",
       "   'ALKBH Protein',\n",
       "   'AlkB Homolog 1, Histone H2a Dioxygenase',\n",
       "   'Alkylated DNA Repair Protein AlkB Homolog 1',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase ABH1',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase ABH1',\n",
       "   'DNA Desmetilase Oxidativa ALKBH1',\n",
       "   'DNA Liase ABH1',\n",
       "   'DNA Lyase ABH1',\n",
       "   'DNA Oxidative Demethylase ALKBH1',\n",
       "   'Desmetilase Oxidativa de DNA ALKBH1',\n",
       "   'Dioxigenase ABH1 Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo 1 de AlkB da Dioxigenase da Histona H2a',\n",
       "   'Homólogo 1 de AlkB da Histona H2a Dioxigenase',\n",
       "   'Homólogo AlkB 1 da Histona H2a Dioxigenase',\n",
       "   'Homólogo AlkB 1 da Proteína de Reparo de DNA Alquilado',\n",
       "   'Proteína ALKBH'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071499': {'ID': 'D000071499',\n",
       "  'name': 'Homólogo AlkB 2 da Dioxigenase Dependente de alfa-Cetoglutarato[AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase]',\n",
       "  'scope': 'A dioxygenase and alkylation repair homolog that repairs alkylated DNA and RNA containing 1-methyladenine and 3-methylcytosine by oxidative demethylation. It can also repair alkylated DNA containing 1-ethenoadenine in vitro. It has highest affinity for double-stranded DNA.',\n",
       "  'terms': ['AlkB Homolog 2, Alpha Ketoglutarate Dependent Dioxygenase',\n",
       "   'AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase',\n",
       "   'Alkylated DNA Repair Protein AlkB Homolog 2',\n",
       "   'Alpha ketoglutarate Dependent Dioxygenase AlkB Homolog 2',\n",
       "   'Alpha-ketoglutarate-Dependent Dioxygenase AlkB Homolog 2',\n",
       "   'DNA Desmetilase Oxidativa ALKBH2',\n",
       "   'DNA Oxidative Demethylase ALKBH2',\n",
       "   'Desmetilase Oxidativa de DNA ALKBH2',\n",
       "   'Homólogo 2 de AlkB da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 2 da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 2 da Proteína de Reparo de DNA Alquilado',\n",
       "   'Oxy DC1 Protein',\n",
       "   'Proteína Oxy DC1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071500': {'ID': 'D000071500',\n",
       "  'name': 'Homólogo AlkB 3 da Dioxigenase Dependente de alfa-Cetoglutarato[AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase]',\n",
       "  'scope': 'A dioxygenase and alkylation repair homolog that repairs alkylated DNA containing 1-methyladenine (1meA) and 3-methylcytosine (3meC) by oxidative demethylation. It has a strong preference for SINGLE-STRANDED DNA and may also act on RNA.',\n",
       "  'terms': ['AlkB Homolog 3, Alpha Ketoglutarate Dependent Dioxygenase',\n",
       "   'AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase',\n",
       "   'Alkylated DNA Repair Protein AlkB Homolog 3',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase AlkB Homolog 3',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase AlkB Homolog 3',\n",
       "   'Antígeno do Câncer Prostático 1',\n",
       "   'Homólogo 3 AlkB da Proteína de Reparo de DNA Alquilado',\n",
       "   'Homólogo 3 de AlkB da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 3 da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 3 da Proteína de Reparo de DNA Alquilado',\n",
       "   'Prostate Cancer Antigen 1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071501': {'ID': 'D000071501',\n",
       "  'name': 'Homólogo AlkB 4 da Lisina Desmetilase[AlkB Homolog 4, Lysine Demethylase]',\n",
       "  'scope': \"A dioxygenase and alkylation repair homolog that mediates demethylation of ACTIN monomethylated at 'Lys-84' (K84me1).  Demethylation of actin LYSINE 84 (K84me1) is required for maintaining actin and MYOSIN dynamics to support normal cleavage furrow ingression during CYTOKINESIS and CELL MIGRATION. It may also be involved in transcription regulation.\",\n",
       "  'terms': ['AlkB Homolog 4, Lysine Demethylase',\n",
       "   'Alkylated DNA Repair Protein AlkB Homolog 4',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase Alkb Homolog 4',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase Alkb Homolog 4',\n",
       "   'Homólogo 4 de AlkB da Desmetilase de Lisina',\n",
       "   'Homólogo 4 de AlkB da Lisina Desmetilase',\n",
       "   'Homólogo AlkB 4 da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 4 da Lisina Desmetilase',\n",
       "   'Homólogo AlkB 4 da Proteína de Reparo de DNA Alquilado'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071502': {'ID': 'D000071502',\n",
       "  'name': 'Homólogo AlkB 5 da RNA Desmetilase[AlkB Homolog 5, RNA Demethylase]',\n",
       "  'scope': 'A dioxygenase and alkylation repair homolog  that demethylates RNA by oxidative demethylation. It specifically demethylates N(6)-methyladenosine (m6A) RNA, the most common internal modification of MESSENGER RNA in higher eukaryotes.  It can also demethylate N(6)-methyladenosine in SINGLE-STRANDED DNA.',\n",
       "  'terms': ['ALKBH5, RNA Demethylase',\n",
       "   'AlkB Homolog 5, RNA Demethylase',\n",
       "   'Alkylated DNA Repair Protein AlkB Homolog 5',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase AlkB Homolog 5',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase AlkB Homolog 5',\n",
       "   'Demethylase ALKBH5, RNA',\n",
       "   'Homólogo 5 de AlkB da Desmetilase de RNA',\n",
       "   'Homólogo 5 de AlkB da RNA Desmetilase',\n",
       "   'Homólogo AlkB 5 da Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Homólogo AlkB 5 da Proteína de Reparo de DNA Alquilado',\n",
       "   'Homólogo AlkB 5 da RNA Desmetilase',\n",
       "   'RNA Demethylase ALKBH5',\n",
       "   'RNA Desmetilase ALKBH5'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071503': {'ID': 'D000071503',\n",
       "  'name': 'Homólogo AlkB 8 da RNAt Metiltransferase[AlkB Homolog 8, tRNA Methyltransferase]',\n",
       "  'scope': 'A dioxygenase and alkylation repair homolog that catalyzes the methylation of 5-carboxymethyl URIDINE to 5-methylcarboxymethyl uridine at the wobble position of the ANTICODON loop in TRANSFER RNA (tRNA) via its methyltransferase domain. It has a preference for tRNA (ARGININE) and tRNA (GLUTAMATE), and does not bind tRNA (LYSINE).',\n",
       "  'terms': ['AlkB Homolog 8, tRNA Methyltransferase',\n",
       "   'Alkylated DNA Repair Protein Alkb Homolog 8',\n",
       "   'Homólogo 8 de AlkB da Metiltransferase de RNAt',\n",
       "   'Homólogo 8 de AlkB da RNAt Metiltransferase',\n",
       "   'Homólogo AlkB 8 da Proteína de Reparo de DNA Alquilado',\n",
       "   'Homólogo AlkB 8 da RNAt Metiltransferase',\n",
       "   'Probable Alpha Ketoglutarate Dependent Dioxygenase ABH8',\n",
       "   'Probable Alpha-Ketoglutarate-Dependent Dioxygenase ABH8',\n",
       "   'Provável ABH8 Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Provável Dioxigenase Dependente de alfa-Cetoglutarato ABH8',\n",
       "   'RNAt (Carboximetiluridina(34)-5-O)-Metiltransferase ABH8',\n",
       "   'RNAt Metiltransferase ABH8 Dependente de S-Adenosil-L-Metionina',\n",
       "   'RNAt Metiltransferase Dependente de S-Adenosil-L-Metionina ABH8',\n",
       "   'S Adenosyl L Methionine Dependent tRNA Methyltransferase ABH8',\n",
       "   'S-Adenosyl-L-Methionine-Dependent tRNA Methyltransferase ABH8',\n",
       "   'tRNA (Carboximetiluridina(34)-5-O)-Metiltransferase ABH8',\n",
       "   'tRNA (Carboxymethyluridine(34)-5-O)-Methyltransferase ABH8'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071516': {'ID': 'D000071516',\n",
       "  'name': 'Dioxigenase FTO Dependente de alfa-Cetoglutarato[Alpha-Ketoglutarate-Dependent Dioxygenase FTO]',\n",
       "  'scope': 'A dioxygenase that repairs alkylated DNA and RNA by oxidative demethylation. It has highest activity towards single-stranded RNA containing 3-methyluracil, followed by SINGLE-STRANDED DNA containing 3-methylthymine and specifically demethylates N(6)-methyladenosine (m6A) RNA, the most common internal modification of MESSENGER RNA (mRNA) in higher EUKARYOTES. It contributes to the regulation of the global metabolic rate, energy HOMEOSTASIS, as well as body fat accumulation by regulating the differentiation of ADIPOCYTES into BROWN FAT CELLS or WHITE FAT CELLS.',\n",
       "  'terms': ['AlkB Homolog 9 Protein',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase',\n",
       "   'Alpha Ketoglutarate Dependent Dioxygenase FTO',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase',\n",
       "   'Alpha-Ketoglutarate-Dependent Dioxygenase FTO',\n",
       "   'Dioxigenase Dependente de alfa-Cetoglutarato',\n",
       "   'Dioxigenase FTO Dependente de alfa-Cetoglutarato',\n",
       "   'Dioxygenase, Alpha-Ketoglutarate-Dependent',\n",
       "   'FTO, Alpha-Ketoglutarate-Dependent Dioxygenase',\n",
       "   'Fat Mass and Obesity Associated (FTO) Protein',\n",
       "   'Fat Mass and Obesity Associated Protein',\n",
       "   'Proteína 9 Homóloga de AlkB',\n",
       "   'Proteína Associada a Massa de Gordura e Obesidade',\n",
       "   'Proteína Associada a Massa de Gordura e Obesidade (FTO)'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071518': {'ID': 'D000071518',\n",
       "  'name': 'Receptores X do Fígado[Liver X Receptors]',\n",
       "  'scope': 'A liver X receptor that is ubiquitously expressed. Loss of LXR-beta function is associated with an increase in the expression of UNCOUPLING PROTEIN 1 as well as OBESITY.',\n",
       "  'terms': ['LXR Alpha Protein',\n",
       "   'LXR-Alpha Protein',\n",
       "   'LXR-Alpha, Oxysterols Receptor',\n",
       "   'LXR-Beta, Oxysterols Receptor',\n",
       "   'LXRalpha Protein',\n",
       "   'LXRbeta Protein',\n",
       "   'Liver X Receptor',\n",
       "   'Liver X Receptor Alpha',\n",
       "   'Liver X Receptor Beta',\n",
       "   'Liver X Receptor-Alpha',\n",
       "   'Liver X Receptor-Beta',\n",
       "   'Liver X Receptors',\n",
       "   'Membro 2 do Grupo H da Subfamília 1 de Receptores Nucleares',\n",
       "   'Membro 3 do Grupo H da Subfamília 1 de Receptores Nucleares',\n",
       "   'NR1H2 Protein',\n",
       "   'NR1H3 Protein',\n",
       "   'Nuclear Orphan Receptor LXR Alpha',\n",
       "   'Nuclear Orphan Receptor LXR-Alpha',\n",
       "   'Nuclear Oxysterol Receptors',\n",
       "   'Nuclear Receptor Subfamily 1, Group H, Member 2',\n",
       "   'Nuclear Receptor Subfamily 1, Group H, Member 3',\n",
       "   'Oxysterol Receptors, Nuclear',\n",
       "   'Oxysterols Receptor LXR Alpha',\n",
       "   'Oxysterols Receptor LXR Beta',\n",
       "   'Oxysterols Receptor LXR-Alpha',\n",
       "   'Oxysterols Receptor LXR-Beta',\n",
       "   'Proteína LXR alfa',\n",
       "   'Proteína LXR beta',\n",
       "   'Proteína LXR-alfa',\n",
       "   'Proteína LXRalfa',\n",
       "   'Proteína LXRbeta',\n",
       "   'Proteína NR1H2',\n",
       "   'Proteína NR1H3',\n",
       "   'Receptor Hepático X alfa',\n",
       "   'Receptor Hepático X beta',\n",
       "   'Receptor LXR-alfa de Oxisteróis',\n",
       "   'Receptor LXR-beta de Oxisteróis',\n",
       "   'Receptor Nuclear Órfão LXR-alfa',\n",
       "   'Receptor X Hepático',\n",
       "   'Receptor X Hepático alfa',\n",
       "   'Receptor X Hepático beta',\n",
       "   'Receptor X do Fígado',\n",
       "   'Receptor X do Fígado alfa',\n",
       "   'Receptor X do Fígado beta',\n",
       "   'Receptor X do Fígado-alfa',\n",
       "   'Receptor X do Fígado-beta',\n",
       "   'Receptores Nucleares de Oxisteróis',\n",
       "   'Receptores X do Fígado',\n",
       "   'Receptores de Oxisteróis LXR beta',\n",
       "   'Receptores de Oxisteróis LXR-beta',\n",
       "   'Receptores de Oxisteróis Nucleares'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071538': {'ID': 'D000071538',\n",
       "  'name': 'Osso Cortical[Cortical Bone]',\n",
       "  'scope': 'A type of osseous tissue which makes up the outer layer of bone. It is dense, rigid, strong, and forms concentric lamellar OSTEONS.',\n",
       "  'terms': ['Compact Bone',\n",
       "   'Compact Bone Tissue',\n",
       "   'Compact Bones',\n",
       "   'Cortical Bone',\n",
       "   'Osso Compacto',\n",
       "   'Osso Cortical',\n",
       "   'Ossos Compactos',\n",
       "   'Substantia Compacta',\n",
       "   'Substância Compacta',\n",
       "   'Tecido do Osso Compacto',\n",
       "   'Tecido Ósseo Cortical'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071556': {'ID': 'D000071556',\n",
       "  'name': 'Osso Esponjoso[Cancellous Bone]',\n",
       "  'scope': 'A type of osseous tissue which makes up the inner part of bone.  It has a spongy, honeycomb-like structure with struts or trabecula and contains the BONE MARROW. It has higher rate of BONE REMODELING turnover than CORTICAL BONE.',\n",
       "  'terms': ['Bone, Cancellous',\n",
       "   'Bone, Spongy',\n",
       "   'Bone, Trabecular',\n",
       "   'Bones, Cancellous',\n",
       "   'Bones, Spongy',\n",
       "   'Bones, Trabecular',\n",
       "   'Cancellous Bone',\n",
       "   'Cancellous Bones',\n",
       "   'Osso Esponjoso',\n",
       "   'Osso Trabecular',\n",
       "   'Spongy Bone',\n",
       "   'Spongy Bones',\n",
       "   'Trabecular Bone',\n",
       "   'Trabecular Bones'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071557': {'ID': 'D000071557',\n",
       "  'name': 'beta-Arrestinas[beta-Arrestins]',\n",
       "  'scope': 'Non-visual system arrestins that negatively regulate G-PROTEIN-COUPLED RECEPTORS (GPCRs) and may also function independently of GPCR signaling. They bind and recruit many different signaling factors, including MITOGEN-ACTIVATED PROTEIN KINASES; SRC-FAMILY-KINASES; and FILAMIN to GPCRs and may recognize different phosphorylation states of the receptors to determine the specificity of the cellular response to signaling.',\n",
       "  'terms': ['Arrestina beta',\n",
       "   'Arrestina-beta',\n",
       "   'Arrestinas beta',\n",
       "   'Arrestinas-beta',\n",
       "   'beta Arrestin',\n",
       "   'beta Arrestins',\n",
       "   'beta-Arrestin',\n",
       "   'beta-Arrestina',\n",
       "   'beta-Arrestinas',\n",
       "   'beta-Arrestins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071559': {'ID': 'D000071559',\n",
       "  'name': 'beta-Arrestina 1[beta-Arrestin 1]',\n",
       "  'scope': 'A beta-arrestin that functions in the down-regulation of signaling by G-PROTEIN-COUPLED RECEPTORS. It is also a major regulator of INSULIN signaling via the ERK 1-2 PATHWAY, and many other signaling processes, especially in NEURONS and LEUKOCYTES.',\n",
       "  'terms': ['ARRB1 Protein',\n",
       "   'Arrestin 2',\n",
       "   'Arrestin, beta 1',\n",
       "   'Arrestin-2',\n",
       "   'Arrestina beta 1',\n",
       "   'Arrestina-2',\n",
       "   'Arrestina-beta 1',\n",
       "   'Arrestina-beta 1A',\n",
       "   'Arrestina-beta 1B',\n",
       "   'Proteína ARRB1',\n",
       "   'beta 1 Arrestin',\n",
       "   'beta Arrestin 1',\n",
       "   'beta Arrestin 1A',\n",
       "   'beta Arrestin 1B',\n",
       "   'beta-Arrestin 1',\n",
       "   'beta-Arrestin 1A',\n",
       "   'beta-Arrestin 1B',\n",
       "   'beta-Arrestina 1',\n",
       "   'beta-Arrestina 1A',\n",
       "   'beta-Arrestina 1B'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071560': {'ID': 'D000071560',\n",
       "  'name': 'beta-Arrestina 2[beta-Arrestin 2]',\n",
       "  'scope': 'A beta-arrestin that functions similarly to BETA-ARRESTIN 1 in regulating signaling by G-PROTEIN-COUPLED RECEPTORS. It is expressed at high levels in the central nervous system where it may regulate signaling by SYNAPTIC RECEPTORS.',\n",
       "  'terms': ['ARRB2 Protein',\n",
       "   'Arrestin 3',\n",
       "   'Arrestin, beta 2',\n",
       "   'Arrestin-3',\n",
       "   'Arrestina beta 2',\n",
       "   'Arrestina-3',\n",
       "   'Proteína ARRB2',\n",
       "   'beta 2 Arrestin',\n",
       "   'beta Arrestin 2',\n",
       "   'beta-Arrestin 2',\n",
       "   'beta-Arrestina 2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071562': {'ID': 'D000071562',\n",
       "  'name': 'Fratura Avulsão[Fractures, Avulsion]',\n",
       "  'scope': 'Tearing away of the CORTICAL BONE fragment at the location of a strong ligament or tendon attachment. The bone fragment detachment site often occurs near a soft site (e.g., GROWTH PLATE) at the base where LIGAMENTS; TENDONS; or JOINT CAPSULES attach. In younger patients it is most often caused by a sudden forceful pull on a tendon in the opposite direction of the bone movement. In the elderly it is associated with osteoporotic INSUFFICIENCY FRACTURES.',\n",
       "  'terms': ['Avulsion Fracture',\n",
       "   'Avulsion Fractures',\n",
       "   'Fracture, Avulsion',\n",
       "   'Fracture, Sprain',\n",
       "   'Fractures, Avulsion',\n",
       "   'Fractures, Sprain',\n",
       "   'Fratura Avulsão',\n",
       "   'Fratura por Entorse',\n",
       "   'Fratura-Avulsão',\n",
       "   'Sprain Fracture',\n",
       "   'Sprain Fractures'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071576': {'ID': 'D000071576',\n",
       "  'name': 'Lesões por Esmagamento[Crush Injuries]',\n",
       "  'scope': 'Excessive compression of parts of the body that causes muscle swelling, fracture, and/or neurological disturbances in the affected areas. Crush injury with systemic manifestations is referred to as CRUSH SYNDROME.',\n",
       "  'terms': ['Crush Fracture',\n",
       "   'Crush Fractures',\n",
       "   'Crush Injuries',\n",
       "   'Crush Injury',\n",
       "   'Fracture, Crush',\n",
       "   'Fractures, Crush',\n",
       "   'Fratura por Esmagamento',\n",
       "   'Fraturas por Esmagamento',\n",
       "   'Injuries, Crush',\n",
       "   'Injury, Crush',\n",
       "   'Lesão por Esmagamento',\n",
       "   'Lesões por Esmagamento'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071596': {'ID': 'D000071596',\n",
       "  'name': 'Músculos Abdominais Oblíquos[Abdominal Oblique Muscles]',\n",
       "  'scope': 'Muscles of the anterolateral abdominal wall consisting of the external oblique and the internal oblique muscles. The external abdominal oblique muscle fibers extend from lower thoracic ribs to the linea alba and the iliac crest. The internal abdominal oblique extend superomedially beneath the external oblique muscles.',\n",
       "  'terms': ['Abdominal Oblique Muscle',\n",
       "   'Abdominal Oblique Muscles',\n",
       "   'External Abdominal Oblique Muscle',\n",
       "   'External Oblique Muscle',\n",
       "   'External Oblique Muscles',\n",
       "   'Internal Abdominal Oblique Muscle',\n",
       "   'Internal Oblique Muscle',\n",
       "   'Internal Oblique Muscles',\n",
       "   'Muscle, Abdominal Oblique',\n",
       "   'Muscle, External Oblique',\n",
       "   'Muscles, Abdominal Oblique',\n",
       "   'Muscles, External Oblique',\n",
       "   'Muscles, Internal Oblique',\n",
       "   'Músculo Abdominal Oblíquo Externo',\n",
       "   'Músculo Abdominal Oblíquo Interno',\n",
       "   'Músculo Oblíquo Externo',\n",
       "   'Músculo Oblíquo Interno',\n",
       "   'Músculos Abdominais Oblíquos',\n",
       "   'Oblique Muscle, External',\n",
       "   'Oblique Muscle, Internal',\n",
       "   'Oblique Muscles, Abdominal',\n",
       "   'Oblique Muscles, External',\n",
       "   'Oblique Muscles, Internal'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071616': {'ID': 'D000071616',\n",
       "  'name': 'Fator de Transcrição CDX2[CDX2 Transcription Factor]',\n",
       "  'scope': 'An antennapedia-like homeodomain transcription factor that regulates the expression of multiple genes in the INTESTINAL MUCOSA. It plays a critical role in many processes from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine.',\n",
       "  'terms': ['CDX-2, Homeobox Protein',\n",
       "   'CDX2 Protein',\n",
       "   'CDX2 Transcription Factor',\n",
       "   'CDX2, Homeobox Protein',\n",
       "   'CDX2, Transcription Factor',\n",
       "   'Caudal Type Homeo Box 2 Protein',\n",
       "   'Caudal Type Homeo Box Transcription Factor 2',\n",
       "   'Caudal Type Homeobox Transcription Factor 2',\n",
       "   'Cdx 2 3 Protein',\n",
       "   'Cdx 2 Protein',\n",
       "   'Cdx 3 Protein',\n",
       "   'Cdx-2 Protein',\n",
       "   'Cdx-2-3 Protein',\n",
       "   'Cdx-3 Protein',\n",
       "   'Fator de Transcrição CDX2',\n",
       "   'Fator de Transcrição Homeobox 2 Tipo Caudal',\n",
       "   'Fator de Transcrição Homeobox 2 do Tipo Caudal',\n",
       "   'Homeobox Protein CDX 2',\n",
       "   'Homeobox Protein CDX-2',\n",
       "   'Homeobox Protein CDX2',\n",
       "   'Proteína CDX2',\n",
       "   'Proteína Cdx-2',\n",
       "   'Proteína Cdx-2-3',\n",
       "   'Proteína Cdx-3',\n",
       "   'Proteína Homeobox 2 Tipo Caudal',\n",
       "   'Proteína Homeobox CDX-2',\n",
       "   'Proteína Homeobox CDX2',\n",
       "   'Transcription Factor CDX2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071617': {'ID': 'D000071617',\n",
       "  'name': 'Proteína Desglicase DJ-1[Protein Deglycase DJ-1]',\n",
       "  'scope': 'A protein deglycase that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins, releasing repaired proteins and lactate or glycolate. It deglycates CYSTEINE, ARGININE and LYSINE residues to reactivate proteins by reversing glycation and prevent the formation of ADVANCED GLYCATION END PRODUCTS. It protects cells against OXIDATIVE STRESS and CELL DEATH by functioning as an oxidative stress sensor and redox-sensitive MOLECULAR CHAPERONE and PROTEASE. Mutations in the PARK7 gene are associated with autosomal-recessive, early-onset PARKINSON DISEASE.',\n",
       "  'terms': ['DJ 1 PARK7 Protein',\n",
       "   'DJ 1 Protein',\n",
       "   'DJ-1 Protein',\n",
       "   'DJ-1, Protein Deglycase',\n",
       "   'DJ-1-PARK7 Protein',\n",
       "   'DJ1 Protein',\n",
       "   'Deglicase Associada ao Parkinsonismo',\n",
       "   'Deglycase, Parkinsonism Associated',\n",
       "   'Desglicase Associada ao Parkinsonismo',\n",
       "   'PARK7 Protein',\n",
       "   'Parkinson Protein 7',\n",
       "   'Parkinsonism Associated Deglycase',\n",
       "   'Protein Deglycase DJ-1',\n",
       "   'Proteína DJ-1',\n",
       "   'Proteína DJ-1-PARK7',\n",
       "   'Proteína DJ1',\n",
       "   'Proteína Deglicase DJ-1',\n",
       "   'Proteína Desglicase DJ-1',\n",
       "   'Proteína PARK7',\n",
       "   'Proteína Parkinson 7',\n",
       "   'Proteína do Parkinson 7'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071636': {'ID': 'D000071636',\n",
       "  'name': 'Proteína Fosfatase 2C[Protein Phosphatase 2C]',\n",
       "  'scope': 'One of four major classes of mammalian serine/threonine specific protein phosphatases. Protein phosphatase 2C is a monomeric enzyme about 42 kDa in size. It shows broad substrate specificity dependent on divalent cations (mainly manganese and magnesium). Three isozymes are known in mammals: PP2C -alpha, -beta and -gamma. In yeast, there are four PP2C homologues: phosphatase PTC1 that have weak tyrosine phosphatase activity, phosphatase PTC2, phosphatase PTC3, and PTC4. Isozymes of PP2C also occur in Arabidopsis thaliana where the kinase-associated protein phosphatase (KAPP) containing a C-terminal PP2C domain, dephosphorylates Ser/Thr receptor-like kinase RLK5.',\n",
       "  'terms': ['2C, Protein Phosphatase',\n",
       "   'Fosfatase PPM1D',\n",
       "   'Fosfatase PPM1E',\n",
       "   'Fosfatase PPM1G',\n",
       "   'Fosfatase Ppm1b',\n",
       "   'Fosfatase Ptc2',\n",
       "   'Isoforma delta da Proteína Fosfatase 1D Dependente de Magnésio',\n",
       "   'Magnesium Dependent Protein Phosphatase 2C beta',\n",
       "   'Magnesium-Dependent Protein Phosphatase 2C beta',\n",
       "   'PP2C beta',\n",
       "   'PP2C beta',\n",
       "   'PP2C gama',\n",
       "   'PP2C épsilon',\n",
       "   'PP2Cepsilon',\n",
       "   'PP2Cgamma',\n",
       "   'PP2Cépsilon',\n",
       "   'PPM1 Magnesium Dependent Protein Phosphatases',\n",
       "   'PPM1 Magnesium-Dependent Protein Phosphatases',\n",
       "   'PPM1 Protein Phosphatases',\n",
       "   'PPM1D Phosphatase',\n",
       "   'PPM1E Phosphatase',\n",
       "   'PPM1G Phosphatase',\n",
       "   'Phosphatase 2C, Protein',\n",
       "   'Phosphatase, PPM1D',\n",
       "   'Phosphatase, PPM1E',\n",
       "   'Phosphatase, PPM1G',\n",
       "   'Phosphatase, Ppm1b',\n",
       "   'Phosphatase, Ptc2',\n",
       "   'Phosphatases, PPM1 Protein',\n",
       "   'Ppm1b Phosphatase',\n",
       "   'Protein Phosphatase 1D Magnesium Dependent, delta isoform',\n",
       "   'Protein Phosphatase 1D Magnesium-Dependent, delta isoform',\n",
       "   'Protein Phosphatase 2C',\n",
       "   'Protein Phosphatase 2C beta',\n",
       "   'Protein Phosphatase 2C delta',\n",
       "   'Protein Phosphatase 2C epsilon',\n",
       "   'Protein Phosphatase 2C gamma',\n",
       "   'Protein Phosphatases, PPM1',\n",
       "   'Proteína Fosfatase 2C',\n",
       "   'Proteína Fosfatase 2C beta',\n",
       "   'Proteína Fosfatase 2C beta Dependente de Magnésio',\n",
       "   'Proteína Fosfatase 2C delta',\n",
       "   'Proteína Fosfatase 2C epsilon',\n",
       "   'Proteína Fosfatase 2C gama',\n",
       "   'Proteína Fosfatase Dependente de Magnésio 2C beta',\n",
       "   'Proteína Fosfatases PPM1',\n",
       "   'Proteína Fosfatases PPM1 Dependentes de Magnésio',\n",
       "   'Proteínas Fosfatases PPM1 Dependentes de Magnésio',\n",
       "   'Ptc2 Phosphatase',\n",
       "   'beta, PP2C'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071656': {'ID': 'D000071656',\n",
       "  'name': 'Receptor Notch3[Receptor, Notch3]',\n",
       "  'scope': 'A notch receptor characterized by a large extracellular domain containing 34 EPIDERMAL GROWTH FACTOR-like repeats. It functions to regulate CELL DIFFERENTIATION; APOPTOSIS; and CELL PROLIFERATION. Mutations in the EGF repeats of Notch-3 are associated with CADASIL.',\n",
       "  'terms': ['Neurogenic Locus Notch Homolog Protein 3',\n",
       "   'Notch 3 Protein',\n",
       "   'Notch 3 Receptor',\n",
       "   'Notch-3 Protein',\n",
       "   'Notch-3 Receptor',\n",
       "   'Notch3 Protein',\n",
       "   'Notch3 Receptor',\n",
       "   'Proteína 3 Homóloga ao Locus Neurogênico de Notch',\n",
       "   'Proteína Notch 3',\n",
       "   'Proteína Notch-3',\n",
       "   'Receptor Notch 3',\n",
       "   'Receptor Notch-3',\n",
       "   'Receptor Notch3',\n",
       "   'Receptor, Notch3'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071657': {'ID': 'D000071657',\n",
       "  'name': 'Helicase da Síndrome de Werner[Werner Syndrome Helicase]',\n",
       "  'scope': \"A DNA-dependent helicase and 3'-5' exonuclease. It has  3'->5' exonuclease activity towards double-stranded DNA with a 5'-overhang and binds preferentially to DNA substrates containing alternate secondary structures, such as replication forks and HOLLIDAY JUNCTIONS. Mutations in the WRN gene are associated with WERNER SYNDROME.\",\n",
       "  'terms': ['Helicase Dependente de ATP da Síndrome de Werner',\n",
       "   'Helicase Semelhante a RecQ da Síndrome de Werner',\n",
       "   'Helicase Tipo RecQ da Síndrome de Werner',\n",
       "   'Helicase da Síndrome de Werner',\n",
       "   'Helicase, Werner Syndrome',\n",
       "   'Proteína RECQ3',\n",
       "   'Proteína RECQL2',\n",
       "   'RECQ3 Protein',\n",
       "   'RECQL2 Protein',\n",
       "   'Werner Syndrome ATP Dependent Helicase',\n",
       "   'Werner Syndrome ATP-Dependent Helicase',\n",
       "   'Werner Syndrome Helicase',\n",
       "   'Werner Syndrome RecQ Like Helicase',\n",
       "   'Werner Syndrome RecQ-Like Helicase'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071676': {'ID': 'D000071676',\n",
       "  'name': 'Proteína GLI1 em Dedos de Zinco[Zinc Finger Protein GLI1]',\n",
       "  'scope': 'A transcriptional activator and oncogene protein that contains two CYS2-HIS2 ZINC FINGERS. Two isoforms are expressed; both regulate the expression of specific genes during development of craniofacial features, digits, the CENTRAL NERVOUS SYSTEM; and the GASTROINTESTINAL TRACT. They also regulate SONIC HEDGEHOG PROTEIN signaling and cell proliferation.',\n",
       "  'terms': ['GLI Protein, Oncogene',\n",
       "   'Gli Protein',\n",
       "   'Gli1 Protein',\n",
       "   'Glioma Associated Oncogene Protein',\n",
       "   'Glioma-Associated Oncogene Protein',\n",
       "   'Oncogene GLI Protein',\n",
       "   'Oncogene Protein, Glioma-Associated',\n",
       "   'Proteína GLI1 em Dedos de Zinco',\n",
       "   'Proteína Gli',\n",
       "   'Proteína Gli1',\n",
       "   'Proteína Oncogênica Associada a Glioma',\n",
       "   'Proteína Oncogênica GLI',\n",
       "   'Zinc Finger Protein GLI1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071677': {'ID': 'D000071677',\n",
       "  'name': 'Histidina Quinase[Histidine Kinase]',\n",
       "  'scope': 'A member of the transferase superfamily of proteins. In the activated state, protein-histidine kinase autophosphorylates at a histidine residue, subsequently transferring high-energy phosphoryl groups to an aspartate residue of the response-regulator domain, which results in a conformational shift in the effector domain. Histidine kinases mediate signal transduction in a wide range of processes involving cellular adaptation to environmental stress.',\n",
       "  'terms': ['Histidina Quinase',\n",
       "   'Histidina Quinase Sensória',\n",
       "   'Histidine Kinase',\n",
       "   'Histidine Kinase, Sensor',\n",
       "   'Histidine Pros-Kinase, Protein',\n",
       "   'Histidine Protein Kinase',\n",
       "   'Histona H4 Histidina Quinase',\n",
       "   'Histone H4 Histidine Kinase',\n",
       "   'Kinase, Histidine',\n",
       "   'Kinase, Histidine Protein',\n",
       "   'Kinase, Protein-Histidine',\n",
       "   'Kinase, Sensor Histidine',\n",
       "   'Pros-Kinase, Protein Histidine',\n",
       "   'Protein Histidine Kinase',\n",
       "   'Protein Histidine Pros Kinase',\n",
       "   'Protein Histidine Pros-Kinase',\n",
       "   'Protein Histidine Tele Kinase',\n",
       "   'Protein Kinase, Histidine',\n",
       "   'Protein-Histidine Kinase',\n",
       "   'Protein-Histidine Tele-Kinase',\n",
       "   'Proteína Histidina Pros-Quinase',\n",
       "   'Proteína Histidina Tele-Quinase',\n",
       "   'Sensor Histidine Kinase',\n",
       "   'Tele-Kinase, Protein-Histidine'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071678': {'ID': 'D000071678',\n",
       "  'name': 'Repetições WD40[WD40 Repeats]',\n",
       "  'scope': 'Protein interaction motifs of approximately 40 amino acids that usually terminate in TRYPTOPHAN and ASPARTIC ACID. They form characteristic beta-propeller structures and occur in many eukaryotic proteins that function in a variety of cellular processes. Proteins that contain WD40 repeats often function as assembly platforms for MULTIPROTEIN COMPLEXES.',\n",
       "  'terms': ['Motif, WD40',\n",
       "   'Motifs, WD40',\n",
       "   'Motivo WD40',\n",
       "   'Repeat, WD',\n",
       "   'Repeat, WD40',\n",
       "   'Repeat, beta-Transducin',\n",
       "   'Repeats, WD',\n",
       "   'Repeats, WD40',\n",
       "   'Repeats, beta-Transducin',\n",
       "   'Repetição WD40',\n",
       "   'Repetições WD',\n",
       "   'Repetições WD40',\n",
       "   'Repetições de beta-Transducina',\n",
       "   'WD Repeat',\n",
       "   'WD Repeats',\n",
       "   'WD40 Motif',\n",
       "   'WD40 Motifs',\n",
       "   'WD40 Repeat',\n",
       "   'WD40 Repeats',\n",
       "   'beta Transducin Repeats',\n",
       "   'beta-Transducin Repeat',\n",
       "   'beta-Transducin Repeats'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071679': {'ID': 'D000071679',\n",
       "  'name': 'Glicogênio Sintase Quinase 3 beta[Glycogen Synthase Kinase 3 beta]',\n",
       "  'scope': 'A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER.',\n",
       "  'terms': ['GSK 3beta',\n",
       "   'GSK-3beta',\n",
       "   'GSK-3beta',\n",
       "   'GSK3B Protein',\n",
       "   'GSK3beta',\n",
       "   'GSK3beta',\n",
       "   'Glicogênio Sintase Quinase 3 beta',\n",
       "   'Glycogen Synthase Kinase 3 beta',\n",
       "   'Proteína GSK3B',\n",
       "   'Quinase Glicogênio Sintase 3 beta'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071681': {'ID': 'D000071681',\n",
       "  'name': 'Fosfatase Ácida Resistente a Tartarato[Tartrate-Resistant Acid Phosphatase]',\n",
       "  'scope': 'One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS.',\n",
       "  'terms': ['AcPase TRAP do Tipo 5',\n",
       "   'AcPase V',\n",
       "   'AcPase V',\n",
       "   'Acid Phosphatase V',\n",
       "   'Acid Phosphatase, Tartrate-Resistant',\n",
       "   'Fosfatase Ácida Resistente a Tartarato',\n",
       "   'Fosfatase Ácida Tartaratorresistente',\n",
       "   'Fosfatase Ácida Tartaratorresistente Tipo 5',\n",
       "   'Fosfatase Ácida V',\n",
       "   'Fosfatase Ácida do Tipo 5',\n",
       "   'Fosfatase Ácida do Tipo 5 Resistente a Tartarato',\n",
       "   'Fosfatase Ácida do Tipo 5 Tartaratorresistente',\n",
       "   'Phosphatase V, Acid',\n",
       "   'Phosphatase, Tartrate-Resistant Acid',\n",
       "   'TRAP Type 5 AcPase',\n",
       "   'TRAcP',\n",
       "   'TRAcP',\n",
       "   'Tartrate Resistant Acid Phosphatase',\n",
       "   'Tartrate Resistant Acid Phosphatase Type 5',\n",
       "   'Tartrate-Resistant Acid Phosphatase',\n",
       "   'Tartrate-Resistant Acid Phosphatase Type 5',\n",
       "   'Type 5 Acid Phosphatase',\n",
       "   'Uteroferrin',\n",
       "   'Uteroferrina',\n",
       "   'V, AcPase',\n",
       "   'V, Acid Phosphatase'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071682': {'ID': 'D000071682',\n",
       "  'name': 'Motivo Estéril alfa[Sterile Alpha Motif]',\n",
       "  'scope': 'A putative protein interaction module, approximately 70 amino acids long, that forms a small five-helix bundle with two large interfaces which may homo- and hetero-oligomerize, or bind non-sterile-alpha motif targets. The sterile alpha motif is present in a wide variety of eukaryotic proteins that function in diverse biological processes.',\n",
       "  'terms': ['Domínio SAM',\n",
       "   'Domínio do Motivo Estéril alfa',\n",
       "   'Domínio do Motivo alfa Estéril',\n",
       "   'Motif, Sterile Alpha',\n",
       "   'Motifs, Sterile Alpha',\n",
       "   'Motivo Estéril alfa',\n",
       "   'Motivo alfa Estéril',\n",
       "   'SAM Domain',\n",
       "   'SAM Domains',\n",
       "   'Sterile Alpha Motif',\n",
       "   'Sterile Alpha Motif Domain',\n",
       "   'Sterile Alpha Motifs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071696': {'ID': 'D000071696',\n",
       "  'name': 'Proteogenômica[Proteogenomics]',\n",
       "  'scope': 'The systematic study of annotated genomic information to global protein expression in order to determine the relationship between genomic sequences and both expressed proteins and predicted protein sequences.',\n",
       "  'terms': ['Analysis, Proteogenomic',\n",
       "   'Análise Proteogenômica',\n",
       "   'Perfil Proteogenômico',\n",
       "   'Pesquisa Proteogenômica',\n",
       "   'Profiling, Proteogenomic',\n",
       "   'Proteogenomic',\n",
       "   'Proteogenomic Analysis',\n",
       "   'Proteogenomic Profiling',\n",
       "   'Proteogenomic Research',\n",
       "   'Proteogenomics',\n",
       "   'Proteogenômica',\n",
       "   'Research, Proteogenomic',\n",
       "   'Researchs, Proteogenomic'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071697': {'ID': 'D000071697',\n",
       "  'name': 'Celulite[Cellulite]',\n",
       "  'scope': 'Skin lumpiness or skin surface dimpling often seen on the thighs, buttocks and abdomen. It is due to protrusion of SUBCUTANEOUS FAT into the DERMIS layer of skin.',\n",
       "  'terms': ['<i>erisipela</i>',\n",
       "   '<i>erispela</i>',\n",
       "   'Adiposidade Edematosa',\n",
       "   'Cellulite',\n",
       "   'Cellulites',\n",
       "   'Celulite',\n",
       "   'Dermatopaniculose Deformante',\n",
       "   'Lipodistrofia Ginoide'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071698': {'ID': 'D000071698',\n",
       "  'name': 'Diabetes Autoimune Latente em Adultos[Latent Autoimmune Diabetes in Adults]',\n",
       "  'scope': 'Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC ISLETS cell antigens.',\n",
       "  'terms': ['Diabetes Autoimune Latente de Adultos',\n",
       "   'Diabetes Autoimune Latente em Adultos',\n",
       "   'Diabetes Autoimune Latente em Adultos (LADA)',\n",
       "   'Diabetes Mellitus Tipo 1.5',\n",
       "   'Diabetes Mellitus Type 1.5',\n",
       "   'Diabetes Mellitus do Tipo 1.5',\n",
       "   'Diabetes do Tipo 1.5',\n",
       "   'Diabetes, Type 1.5',\n",
       "   'LADA, Latent Autoimmune Diabetes in Adults',\n",
       "   'Latent Autoimmune Diabetes in Adults',\n",
       "   'Latent Autoimmune Diabetes of Adults',\n",
       "   'Type 1.5 Diabetes',\n",
       "   'Type 1.5 Diabetes Mellitus'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071699': {'ID': 'D000071699',\n",
       "  'name': 'Vestibulopatia Bilateral[Bilateral Vestibulopathy]',\n",
       "  'scope': 'Impairment of the vestibular function of both inner ears which can cause difficulties with balance, gait, VERTIGO, and visual blurring.',\n",
       "  'terms': ['Arreflexia Vestibular',\n",
       "   'Bilateral Vestibular Deficiency',\n",
       "   'Bilateral Vestibular Insufficiency',\n",
       "   'Bilateral Vestibular Loss',\n",
       "   'Bilateral Vestibulopathy',\n",
       "   'Deficiência Vestibular Bilateral',\n",
       "   'Insuficiência Vestibular Bilateral',\n",
       "   'Perda Vestibular Bilateral',\n",
       "   'Vestibular Areflexia',\n",
       "   'Vestibular Deficiency, Bilateral',\n",
       "   'Vestibular Insufficiency, Bilateral',\n",
       "   'Vestibular Loss, Bilateral',\n",
       "   'Vestibulopathy, Bilateral',\n",
       "   'Vestibulopatia Bilateral'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071700': {'ID': 'D000071700',\n",
       "  'name': 'Distrofias de Cones e Bastonetes[Cone-Rod Dystrophies]',\n",
       "  'scope': 'Genetically heterogeneous and sometimes syndromic (e.g., BARDET BIEDL SYNDROME; and SPINOCEREBELLAR ATAXIA TYPE 7) retinopathies with initial RETINAL CONE involvement. They are characterized by decreased VISUAL ACUITY; COLOR VISION DEFECTS; progressive loss of peripheral vision and night blindness.',\n",
       "  'terms': ['Cone Rod Degenerations',\n",
       "   'Cone Rod Dystrophies',\n",
       "   'Cone Rod Dystrophy',\n",
       "   'Cone Rod Dystrophy 2',\n",
       "   'Cone Rod Retinal Dystrophy',\n",
       "   'Cone-Rod Degeneration',\n",
       "   'Cone-Rod Degenerations',\n",
       "   'Cone-Rod Dystrophies',\n",
       "   'Cone-Rod Dystrophies, Retinal',\n",
       "   'Cone-Rod Dystrophy',\n",
       "   'Cone-Rod Dystrophy 2',\n",
       "   'Cone-Rod Dystrophy, Retinal',\n",
       "   'Cone-Rod Retinal Dystrophies',\n",
       "   'Cone-Rod Retinal Dystrophy',\n",
       "   'Degenerações de Cones e Bastonetes',\n",
       "   'Distrofia 2 de Cones e Bastonetes',\n",
       "   'Distrofia Retiniana de Cones e Bastonetes',\n",
       "   'Distrofia de Cones e Bastonetes',\n",
       "   'Distrofias Retinianas de Cones e Bastonetes',\n",
       "   'Distrofias de Cones e Bastonetes',\n",
       "   'Retinal Cone Rod Dystrophy',\n",
       "   'Retinal Cone-Rod Dystrophies',\n",
       "   'Retinal Cone-Rod Dystrophy',\n",
       "   'Retinal Dystrophies, Cone-Rod',\n",
       "   'Retinal Dystrophy, Cone-Rod'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071701': {'ID': 'D000071701',\n",
       "  'name': 'Fatores de Transcrição de Fator Regulador X[Regulatory Factor X Transcription Factors]',\n",
       "  'scope': 'A family of eukaryotic transcription factors that recognize and bind to a highly-conserved cis-regulatory sequence (X-box) within the promoter region of MHC CLASS II GENES. They contain a conserved winged-helix DNA binding domain and function as homo or heterodimers.',\n",
       "  'terms': ['Factors, RFX Transcription',\n",
       "   'Fatores de Transcrição RFX',\n",
       "   'Fatores de Transcrição de Fator Regulador X',\n",
       "   'RFX Transcription Factors',\n",
       "   'Regulatory Factor X Transcription Factors',\n",
       "   'Transcription Factors, RFX'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071716': {'ID': 'D000071716',\n",
       "  'name': 'Fator Regulador X1[Regulatory Factor X1]',\n",
       "  'scope': 'A regulatory factor X transcription factor that is required for the expression of MHC CLASS II GENES. It also binds to inverted repeats of HEPATITIS B VIRUS DNA and is required for viral gene expression. RFX1 functions as a monomer or heterodimer with other RFX transcription factors.',\n",
       "  'terms': ['Fator Regulador RFX',\n",
       "   'Fator Regulador RFX de MHC Classe II',\n",
       "   'Fator Regulador X',\n",
       "   'Fator Regulador X de MHC Classe II',\n",
       "   'Fator Regulador X1',\n",
       "   'Fator Regulador-X',\n",
       "   'Fator Regulatório X1',\n",
       "   'Fator de Transcrição RFX1',\n",
       "   'MHC Class II Regulatory Factor RFX',\n",
       "   'Proteína RFX1',\n",
       "   'Proteína de Ligação RF-X',\n",
       "   'Proteína de Ligação a Box X',\n",
       "   'Proteína de Ligação a RF-X',\n",
       "   'Proteína de Ligação a X-Box',\n",
       "   'Proteína de Ligação a X-Box (RF-X)',\n",
       "   'RF X Binding Protein',\n",
       "   'RF-X Binding Protein',\n",
       "   'RFX Regulatory Factor',\n",
       "   'RFX1 Protein',\n",
       "   'RFX1 Transcription Factor',\n",
       "   'Regulatory Factor X',\n",
       "   'Regulatory Factor X1',\n",
       "   'Regulatory Factor, RFX',\n",
       "   'Regulatory Factor-X',\n",
       "   'Transcription Factor, RFX1',\n",
       "   'X Box Binding Protein (RF-X)'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071717': {'ID': 'D000071717',\n",
       "  'name': 'Proteína 1 de Ligação a X-Box[X-Box Binding Protein 1]',\n",
       "  'scope': 'A basic leucine zipper transcription factor that regulates expression of MHC CLASS II GENES through its binding to a conserved X-box DNA sequence in the promoter region. It regulates the expression of genes involved in the UNFOLDED PROTEIN RESPONSE.',\n",
       "  'terms': ['Proteína 1 de Ligação a X-Box',\n",
       "   'Proteína 5 de Ligação ao Elemento Responsivo a Tax',\n",
       "   'Proteína TREB-5',\n",
       "   'Proteína TREB5',\n",
       "   'Proteína XBP-1',\n",
       "   'Proteína XBP2',\n",
       "   'TREB 5 Protein',\n",
       "   'TREB-5 Protein',\n",
       "   'TREB5 Protein',\n",
       "   'Tax Responsive Element Binding Protein 5',\n",
       "   'Tax-Responsive Element-Binding Protein 5',\n",
       "   'X Box Binding Protein 1',\n",
       "   'X-Box Binding Protein 1',\n",
       "   'XBP 1 Protein',\n",
       "   'XBP-1 Protein',\n",
       "   'XBP2 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071736': {'ID': 'D000071736',\n",
       "  'name': 'Moléculas de Interação Estromal[Stromal Interaction Molecules]',\n",
       "  'scope': 'Membrane-associated calcium-binding proteins that are characterized by N-terminal EF HAND MOTIFS and a STERILE ALPHA MOTIF. They function as sensors of ENDOPLASMIC RETICULUM calcium levels and translocate from the ER to the plasma membrane to activate CALCIUM CHANNELS in response to intracellular calcium depletion.',\n",
       "  'terms': ['Molécula de Interação Estromal',\n",
       "   'Moléculas de Interação Estromal',\n",
       "   'Moléculas de Interação do Estroma',\n",
       "   'Stromal Interaction Molecules'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071737': {'ID': 'D000071737',\n",
       "  'name': 'Molécula 1 de Interação Estromal[Stromal Interaction Molecule 1]',\n",
       "  'scope': 'A stromal interaction molecule that functions in the regulation of calcium influx following depletion of intracellular calcium in the ENDOPLASMIC RETICULUM. It translocates to the plasma membrane upon calcium depletion where it activates the CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL ORAI1.',\n",
       "  'terms': ['Molécula 1 de Interação Estromal',\n",
       "   'Molécula 1 de Interação com o Estroma',\n",
       "   'Molécula 1 de Interação do Estroma',\n",
       "   'Proteína STIM1',\n",
       "   'STIM1 Protein',\n",
       "   'Stromal Interaction Molecule 1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071738': {'ID': 'D000071738',\n",
       "  'name': 'Molécula 2 de Interação Estromal[Stromal Interaction Molecule 2]',\n",
       "  'scope': 'A stromal interaction molecule that functions as a highly sensitive calcium sensor in the ENDOPLAMSIC RETICULUM and CYTOSOL. It can regulate CALCIUM RELEASE ACTIVATED CALCIUM CHANNELS in response to minor variations in intracellular calcium.',\n",
       "  'terms': ['Molécula 2 de Interação Estromal',\n",
       "   'Molécula 2 de Interação com o Estroma',\n",
       "   'Molécula 2 de Interação do Estroma',\n",
       "   'Proteína STIM2',\n",
       "   'STIM2 Protein',\n",
       "   'Stromal Interaction Molecule 2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071739': {'ID': 'D000071739',\n",
       "  'name': 'Canais de Cálcio Ativados pela Liberação de Cálcio[Calcium Release Activated Calcium Channels]',\n",
       "  'scope': 'Specialized calcium channels that localize to the ENDOPLAMSIC RETICULUM and PLASMA MEMBRANE. They contain the pore subunit ORAI1 PROTEIN which is activated by STROMAL INTERACTION MOLECULES upon intracellular calcium depletion.',\n",
       "  'terms': ['CRAC Channels',\n",
       "   'Calcium Release Activated Calcium Channels',\n",
       "   'Calcium Release Activated Channels',\n",
       "   'Calcium Release-Activated Calcium Channels',\n",
       "   'Calcium Release-Activated Channels',\n",
       "   'Canais Ativados por Liberação de Cálcio',\n",
       "   'Canais CRAC',\n",
       "   'Canais de Cálcio Ativados pela Liberação de Cálcio',\n",
       "   'Canais de Cálcio Ativados por Liberação de Cálcio'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071740': {'ID': 'D000071740',\n",
       "  'name': 'Proteína ORAI1[ORAI1 Protein]',\n",
       "  'scope': 'The pore-forming subunit of calcium release activated calcium channels. It is activated by STROMAL INTERACTION MOLECULE 1 upon intracellular calcium depletion.',\n",
       "  'terms': ['Calcium Release Activated Calcium Channel Protein 1',\n",
       "   'Calcium Release-Activated Calcium Channel Protein 1',\n",
       "   'Modulador de Cálcio ORAI 1 Ativado pela Liberação de Cálcio',\n",
       "   'ORAI Calcium Release Activated Calcium Modulator 1',\n",
       "   'ORAI Calcium Release-Activated Calcium Modulator 1',\n",
       "   'ORAI1',\n",
       "   'ORAI1 Protein',\n",
       "   'Proteína 1 do Canal de Cálcio Ativado pela Liberação de Cálcio',\n",
       "   'Proteína ORAI1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071741': {'ID': 'D000071741',\n",
       "  'name': 'Proteína ORAI2[ORAI2 Protein]',\n",
       "  'scope': 'A calcium release-activated calcium-like (CRAC-like) channel subunit which functions with STROMAL INTERACTION MOLECULE 1 to regulate cell calcium influx and increase (Ca2+)-selective current.',\n",
       "  'terms': ['CAP Binding Protein Complex Interacting Protein 2',\n",
       "   'CAP-Binding Protein Complex-Interacting Protein 2',\n",
       "   'Modulador de Cálcio ORAI 2 Ativado pela Liberação de Cálcio',\n",
       "   'ORAI Calcium Release Activated Calcium Modulator 2',\n",
       "   'ORAI Calcium Release-Activated Calcium Modulator 2',\n",
       "   'ORAI2',\n",
       "   'ORAI2 Protein',\n",
       "   'Proteína 2 de Interação com o Complexo Proteico de Ligação a CAP',\n",
       "   'Proteína ORAI2',\n",
       "   'Proteína Transmembrana 142B',\n",
       "   'Proteína Transmembrânica 142B',\n",
       "   'Transmembrane Protein 142B'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071756': {'ID': 'D000071756',\n",
       "  'name': 'Guanilil Ciclase Solúvel[Soluble Guanylyl Cyclase]',\n",
       "  'scope': 'A mammalian enzyme composed of a heterodimer of alpha and beta subunits. Each subunit consists of four domains; N-terminal HNOX domain, PAS-like domain, a coiled-coil domain, and a C-terminal catalytic domain. All four domains are homologous proteins with a similar conformation of functional domains. Soluble guanylate cyclase catalyzes the formation of cyclic GMP from GTP, and is a key enzyme of the nitric oxide signaling pathway involved in the regulation of a variety of biological and physiological processes in mammals.',\n",
       "  'terms': ['Cyclase, Soluble Guanylate',\n",
       "   'Cyclase, Soluble Guanylyl',\n",
       "   'Guanilil Ciclase Sensível a Óxido Nítrico',\n",
       "   'Guanilil Ciclase Solúvel',\n",
       "   'Guanylate Cyclase, Soluble',\n",
       "   'Guanylyl Cyclase, Soluble',\n",
       "   'Nitric Oxide Receptor',\n",
       "   'Nitric Oxide Receptors',\n",
       "   'Nitric Oxide Sensitive Guanylyl Cyclase',\n",
       "   'Nitric Oxide-Sensitive Guanylyl Cyclase',\n",
       "   'Oxide Receptor, Nitric',\n",
       "   'Oxide Receptors, Nitric',\n",
       "   'Receptor de Óxido Nítrico',\n",
       "   'Receptor, Nitric Oxide',\n",
       "   'Receptores de Óxido Nítrico',\n",
       "   'Soluble Guanylate Cyclase',\n",
       "   'Soluble Guanylyl Cyclase',\n",
       "   'Soluble Guanylyl Cyclase, alpha Subunit',\n",
       "   'Soluble Guanylyl Cyclase, beta Subunit',\n",
       "   'Subunidade alfa da Guanilil Ciclase',\n",
       "   'Subunidade beta da Guanilil Ciclase'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071757': {'ID': 'D000071757',\n",
       "  'name': 'Domínio BTB-POZ[BTB-POZ Domain]',\n",
       "  'scope': 'A homodimerization protein interaction domain occurring at the N terminus of proteins that contain multiple copies of either CYS2-HIS2 ZINC FINGERS or KELCH REPEATS. It is characterized by a tightly intertwined dimer with an extensive hydrophobic interface. A surface-exposed groove lined with conserved amino acids is formed at the dimer interface, suggesting a peptide-binding site. Many BTB proteins are transcriptional regulators that are thought to regulate CHROMATIN structure.',\n",
       "  'terms': ['BTB (POZ) Domain',\n",
       "   'BTB Domain',\n",
       "   'BTB Domains',\n",
       "   'BTB POZ Domain',\n",
       "   'BTB-POZ Domain',\n",
       "   'BTB-POZ Domains',\n",
       "   'Broad Complex, Tramtrack and Bric a Brac Domain',\n",
       "   'Broad-Complex, Tramtrack and Bric a Brac Domain',\n",
       "   'Domínio BTB',\n",
       "   'Domínio BTB (POZ)',\n",
       "   'Domínio BTB-POZ',\n",
       "   'Domínio POZ',\n",
       "   'Domínio de Poxvírus e Dedos de Zinco',\n",
       "   'POZ Domain',\n",
       "   'POZ Domains',\n",
       "   'POxvirus and Zinc Finger Domain'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071776': {'ID': 'D000071776',\n",
       "  'name': 'Repetição Kelch[Kelch Repeat]',\n",
       "  'scope': 'An amino acid sequence of about 50 residues long that is composed of X n-long repeats which form a four-stranded anti-parallel BETA-SHEET as a structural component, or blade, of a beta-propeller.',\n",
       "  'terms': ['Domínio Kelch',\n",
       "   'Kelch Domain',\n",
       "   'Kelch Domains',\n",
       "   'Kelch Motif',\n",
       "   'Kelch Motifs',\n",
       "   'Kelch Repeat',\n",
       "   'Kelch Repeat Type 1',\n",
       "   'Kelch Repeat Type 2',\n",
       "   'Kelch Repeats',\n",
       "   'Motif, Kelch',\n",
       "   'Motifs, Kelch',\n",
       "   'Motivo Kelch',\n",
       "   'Repetição Kelch',\n",
       "   'Repetição Kelch do Tipo 1',\n",
       "   'Repetição Kelch do Tipo 2',\n",
       "   'Repetições Kelch'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071796': {'ID': 'D000071796',\n",
       "  'name': 'Proteína SMARCB1[SMARCB1 Protein]',\n",
       "  'scope': 'A component of the SWI-SNF CHROMATIN REMODELING complex that functions  as a PROTEIN PHOSPHATASE 1 regulator and to stabilize CHROMATIN at PROMOTER REGIONS. It is important for regulating CELL PROLIFERATION and CELL DIFFERENTIATION. Mutations in the SMARCB1 gene are associated with malignant RHABDOID TUMORS.',\n",
       "  'terms': ['BAF47 Protein',\n",
       "   'BRG1 Associated Factor 47 Protein',\n",
       "   'BRG1-Associated Factor 47 Protein',\n",
       "   'Integrase Interactor 1 Protein',\n",
       "   'Membro 1 da Subfamília B Regulador da Cromatina Dependente de Actina Associado a Swi-Snf e Relacionado à Matriz',\n",
       "   'Proteína 1 de Interação com Integrase',\n",
       "   'Proteína BAF47',\n",
       "   'Proteína Homóloga a SNF5',\n",
       "   'Proteína SMARCB1',\n",
       "   'Proteína do Fator 47 Associado a BRG1',\n",
       "   'Regulador da Cromatina Dependente de Actina Associado a Swi-Snf e Relacionado à Matriz, Subfamília B, Membro 1',\n",
       "   'SMARCB1 Protein',\n",
       "   'SNF5 Homolog Protein',\n",
       "   'Swi Snf Related Matrix Associated Actin Dependent Regulator Of Chromatin Subfamily B Member 1',\n",
       "   'Swi-Snf-Related Matrix-Associated Actin-Dependent Regulator Of Chromatin Subfamily B Member 1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071797': {'ID': 'D000071797',\n",
       "  'name': 'Butirofilinas[Butyrophilins]',\n",
       "  'scope': 'A family of mammalian membrane glycoproteins characterized by extracellular IMMUNOGLOBULIN DOMAINS. Some members also have an intracellular B30.2-SPRY DOMAIN or SPRY DOMAIN. The butyrophilin protein (BTN) is expressed by MAMMARY GLAND EPITHELIUM during LACTATION; whereas other members are widely expressed in other tissues, including skeletal muscle, intestine, ERYTHROID CELLS (ERMAP protein); and nerve tissue (MYELIN-OLIGODENDROCYTE GLYCOPROTEIN).',\n",
       "  'terms': ['Butirofilina', 'Butirofilinas', 'Butyrophilin', 'Butyrophilins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071799': {'ID': 'D000071799',\n",
       "  'name': 'Homeobox 1 de Ligação a E-box em Dedo de Zinco[Zinc Finger E-box-Binding Homeobox 1]',\n",
       "  'scope': 'A transcription factor characterized by N-terminal and C-terminal CYS2-HIS2 ZINC FINGERS separated by a homeobox. It represses the expression of E-CADHERIN to induce the EPITHELIAL-MESENCHYMAL TRANSITION. It also represses PROTO-ONCOGENE PROTEINS C-BCL-6; regulates the cell type-specific expression of SODIUM-POTASSIUM-EXCHANGING ATPASE; and promotes neuronal differentiation.',\n",
       "  'terms': ['Fator de Transcrição 8',\n",
       "   'Fator de Transcrição Zeb1',\n",
       "   'Homeobox 1 de Ligação a E-box em Dedo de Zinco',\n",
       "   'NIL 2 A Zinc Finger Protein',\n",
       "   'NIL-2-A Zinc Finger Protein',\n",
       "   'Proteína em Dedo de Zinco NIL-2-A',\n",
       "   'Proteínas TCF8',\n",
       "   'TCF8 Protein',\n",
       "   'Transcription Factor 8',\n",
       "   'Transcription Factor, Zeb1',\n",
       "   'Zeb1 Transcription Factor',\n",
       "   'Zinc Finger E box Binding Homeobox 1',\n",
       "   'Zinc Finger E-box-Binding Homeobox 1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071816': {'ID': 'D000071816',\n",
       "  'name': 'Glicodelina[Glycodelin]',\n",
       "  'scope': 'A lipocalin that is the most abundant protein synthesized and secreted by the ENDOMETRIUM from mid-LUTEAL PHASE of the MENSTRUAL CYCLE through early PREGNANCY.',\n",
       "  'terms': ['Endometrial Protein, Progestagen-Associated',\n",
       "   'Glicodelina',\n",
       "   'Globulina alfa-2 do Endométrio Associada à Gestação',\n",
       "   'Globulina alfa-2 do Endométrio Associada à Gravidez',\n",
       "   'Glycodelin',\n",
       "   'Pregnancy Associated Endometrial Alpha 2 Globulin',\n",
       "   'Pregnancy-Associated Endometrial Alpha-2 Globulin',\n",
       "   'Progestagen Associated Endometrial Protein',\n",
       "   'Progestagen-Associated Endometrial Protein',\n",
       "   'Proteína do Endométrio Associada a Progestágenos',\n",
       "   'Proteína do Endométrio Associada à Progestinas',\n",
       "   'alfa-2 Globulina do Endométrio Associada à Gestação',\n",
       "   'alfa-2 Globulina do Endométrio Associada à Gravidez',\n",
       "   'α2-Globulina do Endométrio Associada à Gestação',\n",
       "   'α2-Globulina do Endométrio Associada à Gravidez'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071818': {'ID': 'D000071818',\n",
       "  'name': 'Proteína Wnt-5a[Wnt-5a Protein]',\n",
       "  'scope': 'A Wnt protein and ligand for FRIZZLED RECEPTORS that may function as an inhibitor or activator of the WNT SIGNALING PATHWAY. For example, it activates signaling in the presence of Frizzled-4 but is inhibitory when coupled with ROR2 TYROSINE KINASE. It is required for axis formation during EMBRYOGENESIS and inhibits the proliferation, migration, and invasiveness of cancer cells.',\n",
       "  'terms': ['Membro 5A da Família do Sítio de Integração MMTV do Tipo Wingless',\n",
       "   'Membro 5A da Família do Sítio de Integração MMTV do Tipo sem Asa',\n",
       "   'Proteína Wnt-5a',\n",
       "   'Proteína Wnt5a',\n",
       "   'Wingless Type MMTV Integration Site Family, Member 5A',\n",
       "   'Wingless-Type MMTV Integration Site Family, Member 5A',\n",
       "   'Wnt 5a Protein',\n",
       "   'Wnt-5a Protein',\n",
       "   'Wnt5a Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071819': {'ID': 'D000071819',\n",
       "  'name': 'Virófagos[Virophages]',\n",
       "  'scope': 'Circular, double-stranded DNA viruses that invade giant DNA viruses (GIANT VIRUSES) which infect eukaryotes.',\n",
       "  'terms': ['Virophage', 'Virophages', 'Virófagos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071820': {'ID': 'D000071820',\n",
       "  'name': 'Despacho de Emergência Médica[Emergency Medical Dispatch]',\n",
       "  'scope': 'The mobilization of EMERGENCY CARE to the locations and people that need them.',\n",
       "  'terms': ['Despacho de Emergência Médica',\n",
       "   'Despacho de Emergência Policial',\n",
       "   'Despacho de Emergência de Incêndio',\n",
       "   'Dispatch, Emergency Fire',\n",
       "   'Dispatch, Emergency Medical',\n",
       "   'Dispatch, Emergency Police',\n",
       "   'Dispatchs, Emergency Police',\n",
       "   'Emergency Fire Dispatch',\n",
       "   'Emergency Medical Dispatch',\n",
       "   'Emergency Police Dispatch',\n",
       "   'Emergency Police Dispatchs',\n",
       "   'Fire Dispatch, Emergency',\n",
       "   'Medical Dispatch, Emergency',\n",
       "   'Police Dispatch, Emergency',\n",
       "   'Police Dispatchs, Emergency'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071821': {'ID': 'D000071821',\n",
       "  'name': 'Distonina[Dystonin]',\n",
       "  'scope': 'A plakin characterized by repeat sequences homologous to SPECTRIN and PLECTIN and C-terminal EF HAND MOTIFS. It functions as an integrator of INTERMEDIATE FILAMENTS, ACTIN and MICROTUBULES in cytoskeleton networks. It is required for anchoring intermediate filaments to the actin cytoskeleton in neural and muscle cells as well as anchoring KERATIN-containing intermediate filaments to HEMIDESMOSOMES in EPITHELIAL CELLS.',\n",
       "  'terms': ['230 240 kDa Bullous Pemphigoid Antigen',\n",
       "   '230 kDa Bullous Pemphigoid Antigen',\n",
       "   '230-240 kDa Bullous Pemphigoid Antigen',\n",
       "   'Antígeno 1 do Penfigoide Bolhoso',\n",
       "   'Antígeno de 230 kDa do Penfigoide Bolhoso',\n",
       "   'Antígeno de 230-240 kDa do Penfigoide Bolhoso',\n",
       "   'Antígeno do Penfigoide Bolhoso de 230-240 kDa',\n",
       "   'Antígeno do Penfigoide Bolhoso de 230kDa',\n",
       "   'Bullous Pemphigoid Antigen 1',\n",
       "   'Distonina',\n",
       "   'Dystonin',\n",
       "   'Hemidesmosomal Plaque Protein',\n",
       "   'Proteína da Placa Hemidesmossômica',\n",
       "   'Proteína da Placa do Hemidesmossomo'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071822': {'ID': 'D000071822',\n",
       "  'name': 'Operador de Emergência Médica[Emergency Medical Dispatcher]',\n",
       "  'scope': 'Professionals responsible for relaying calls for the deployment of EMERGENCY MEDICAL SERVICES.',\n",
       "  'terms': ['Despachante de Emergência Médica',\n",
       "   'Dispatcher, Emergency Medical',\n",
       "   'Dispatchers, Emergency Medical',\n",
       "   'Emergency Medical Dispatcher',\n",
       "   'Emergency Medical Dispatchers',\n",
       "   'Medical Dispatcher, Emergency',\n",
       "   'Medical Dispatchers, Emergency',\n",
       "   'Operador de Emergência Médica'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071823': {'ID': 'D000071823',\n",
       "  'name': 'Operador de Emergência Policial[Emergency Police Dispatcher]',\n",
       "  'scope': 'Services for reporting EMERGENCIES to the police department.',\n",
       "  'terms': ['Despachante de Emergência Policial',\n",
       "   'Dispatcher, Emergency Police',\n",
       "   'Dispatchers, Emergency Police',\n",
       "   'Emergency Police Dispatcher',\n",
       "   'Emergency Police Dispatchers',\n",
       "   'Operador de Emergência Policial',\n",
       "   'Police Dispatcher, Emergency',\n",
       "   'Police Dispatchers, Emergency'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071825': {'ID': 'D000071825',\n",
       "  'name': 'Extremófilos[Extremophiles]',\n",
       "  'scope': 'Organisms specifically adapted to live in EXTREME ENVIRONMENTS.',\n",
       "  'terms': ['Extremophiles', 'Extremófilos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071826': {'ID': 'D000071826',\n",
       "  'name': 'Direção Distraída[Distracted Driving]',\n",
       "  'scope': 'Behavior which detracts from the focus necessary to operate an automobile safely.',\n",
       "  'terms': ['Direção Desatenta',\n",
       "   'Direção Distraída',\n",
       "   'Direção com Distração',\n",
       "   'Direção sem Atenção',\n",
       "   'Distracted Driving',\n",
       "   'Distraction, Driver',\n",
       "   'Distractions, Driver',\n",
       "   'Driver Distraction',\n",
       "   'Driver Distractions',\n",
       "   'Driving While Distracted',\n",
       "   'Driving, Distracted',\n",
       "   'Driving, Inattentive',\n",
       "   'Inattentive Driving'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071836': {'ID': 'D000071836',\n",
       "  'name': 'Lacunas da Prática Profissional[Professional Practice Gaps]',\n",
       "  'scope': 'Difference between observed and ideal DELIVERY OF HEALTH CARE and healthcare outcomes that reflect the current state of knowledge.',\n",
       "  'terms': ['Gap, Practice',\n",
       "   'Gap, Professional Practice',\n",
       "   'Gaps, Practice',\n",
       "   'Gaps, Professional Practice',\n",
       "   'Lacunas da Prática',\n",
       "   'Lacunas da Prática Profissional',\n",
       "   'Practice Gap',\n",
       "   'Practice Gap, Professional',\n",
       "   'Practice Gaps',\n",
       "   'Practice Gaps, Professional',\n",
       "   'Professional Practice Gap',\n",
       "   'Professional Practice Gaps'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071837': {'ID': 'D000071837',\n",
       "  'name': 'Fibrilinas[Fibrillins]',\n",
       "  'scope': 'A family of extracellular matrix glycoproteins that is structurally similar to  LATENT TGF-BETA BINDING PROTEINS, but contain additional TGF-beta binding domains, in addition to unique domains at their N and C-terminals. Fibrillins assemble into 10-12 nm MICROFIBRILS that function in a variety of cell interactions with the EXTRACELLULAR MATRIX and developmental processes such as ELASTIC TISSUE maintenance and assembly, and the targeting of growth factors to the extracellular matrix.',\n",
       "  'terms': ['Fibrilina', 'Fibrilinas', 'Fibrillin', 'Fibrillins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071838': {'ID': 'D000071838',\n",
       "  'name': 'Fibrilina-1[Fibrillin-1]',\n",
       "  'scope': 'A fibrillin (FBN1) that functions as a structural support protein for MICROFIBRILS. It also regulates the maturation of OSTEOBLASTS by controlling the availability and concentration of TGF-BETA and BONE MORPHOGENETIC PROTEINS. Mutations in the FBN1 gene are associated with MARFAN SYNDROME.',\n",
       "  'terms': ['Fibrilina-1',\n",
       "   'Fibrillin 1',\n",
       "   'Fibrillin-1',\n",
       "   'Profibrilina 1',\n",
       "   'Profibrilina-1',\n",
       "   'Profibrillin 1',\n",
       "   'Profibrillin-1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071840': {'ID': 'D000071840',\n",
       "  'name': 'Fibrilina-2[Fibrillin-2]',\n",
       "  'scope': 'A fibrillin (FBN2) that functions to regulate the assembly of ELASTIC FIBERS. Mutations in the FBN2 gene are associated with congenital contractural ARACHNODACTYLY.',\n",
       "  'terms': ['Fibrilina-2', 'Fibrillin 2', 'Fibrillin-2'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071841': {'ID': 'D000071841',\n",
       "  'name': 'Fator de Transcrição PAX6[PAX6 Transcription Factor]',\n",
       "  'scope': 'A paired box transcription factor that has important functions in the development of the eye, nose, central nervous system and pancreas. Mutations in the PAX6 gene are associated with ocular disorders such as ANIRIDIA.',\n",
       "  'terms': ['Aniridia Type II Protein',\n",
       "   'Factor PAX6, Transcription',\n",
       "   'Factor, PAX6 Transcription',\n",
       "   'Fator PAX6 de Transcrição',\n",
       "   'Fator de Transcrição 6 Box Pareado',\n",
       "   'Fator de Transcrição Box Pareado 6',\n",
       "   'Fator de Transcrição PAX6',\n",
       "   'Oculorhombin',\n",
       "   'Oculorrombina',\n",
       "   'PAX6 Protein',\n",
       "   'PAX6 Transcription Factor',\n",
       "   'PAX6, Transcription Factor',\n",
       "   'Paired Box Gene 6 Protein',\n",
       "   'Paired Box Protein Pax 6',\n",
       "   'Paired Box Protein Pax-6',\n",
       "   'Paired Box Transcription Factor 6',\n",
       "   'Pax 6 Protein',\n",
       "   'Pax-6 Protein',\n",
       "   'Pax6.1 Protein',\n",
       "   'Pax6.2 Protein',\n",
       "   'Protein, PAX6',\n",
       "   'Protein, Pax-6',\n",
       "   'Protein, Pax6.1',\n",
       "   'Protein, Pax6.2',\n",
       "   'Proteína 6 do Gene Box Pareado',\n",
       "   'Proteína Box Pareado Pax-6',\n",
       "   'Proteína PAX6',\n",
       "   'Proteína Pax-6',\n",
       "   'Proteína Pax6.1',\n",
       "   'Proteína Pax6.2',\n",
       "   'Proteína da Aniridia Tipo II',\n",
       "   'Transcription Factor PAX6',\n",
       "   'Transcription Factor, PAX6'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071856': {'ID': 'D000071856',\n",
       "  'name': 'Domínio Tudor[Tudor Domain]',\n",
       "  'scope': 'A conserved, approximately 50 amino acid, protein sequence that adopts a characteristic strongly bent, five stranded anti-parallel beta-sheet barrel-like fold. The Tudor domain recognizes dimethylated ARGININE through its negatively-charged surface and occurs in many proteins that co-localize with RNA; RIBONUCLEOPROTEINS or SINGLE-STRANDED DNA complexes in the CELL NUCLEUS; MITOCHONDRIA; or KINETOCHORES.',\n",
       "  'terms': ['Domínio Tudor',\n",
       "   'Domínios Tudor',\n",
       "   'Motif, Tudor',\n",
       "   'Motifs, Tudor',\n",
       "   'Motivo Tudor',\n",
       "   'Tudor Domain',\n",
       "   'Tudor Domains',\n",
       "   'Tudor Motif',\n",
       "   'Tudor Motifs'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071857': {'ID': 'D000071857',\n",
       "  'name': 'Proteína 1 de Ligação à Proteína Supressora de Tumor p53[Tumor Suppressor p53-Binding Protein 1]',\n",
       "  'scope': 'A nuclear and cytoplasmic protein that associates with KINETOCHORES and contains a C-terminal TUDOR DOMAIN. It plays a critical role in the cellular response to DNA DAMAGE and localizes to DOUBLE-STRAND DNA BREAKS. It may also function in M PHASE CELL CYCLE CHECKPOINTS and as an enhancer of TUMOR SUPPRESSOR PROTEIN P53-mediated transcriptional activation.',\n",
       "  'terms': ['53BP1 Protein',\n",
       "   'Proteína 1 de Ligação a p53',\n",
       "   'Proteína 1 de Ligação à Proteína Supressora de Tumor p53',\n",
       "   'Proteína 1 de Ligação à Proteína Tumoral p53',\n",
       "   'Proteína 53BP1',\n",
       "   'Proteína TP53BP1',\n",
       "   'Proteína p202',\n",
       "   'TP53BP1 Protein',\n",
       "   'Tumor Protein p53 Binding Protein, 1',\n",
       "   'Tumor Protein p53-Binding Protein, 1',\n",
       "   'Tumor Suppressor p53 Binding Protein 1',\n",
       "   'Tumor Suppressor p53-Binding Protein 1',\n",
       "   'p202 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071858': {'ID': 'D000071858',\n",
       "  'name': 'Molécula de Adesão da Célula Epitelial[Epithelial Cell Adhesion Molecule]',\n",
       "  'scope': 'A cell adhesion molecule that is expressed on the membranes of nearly all EPITHELIAL CELLS, especially at the junctions between intestinal epithelial cells and intraepithelial LYMPHOCYTES. It also is expressed on the surface of ADENOCARCINOMA and epithelial tumor cells.  It may function in the MUCOSA through homophilic interactions to provide a barrier against infection. It also regulates the proliferation and differentiation of EMBRYONIC STEM CELLS.',\n",
       "  'terms': ['Antigen, CD326',\n",
       "   'Antigen, ESA',\n",
       "   'Antigen, Epithelial Specific',\n",
       "   'Antigen, GA733',\n",
       "   'Antígeno Associado a Tumor GA733',\n",
       "   'Antígeno CD326',\n",
       "   'Antígeno ESA',\n",
       "   'Antígeno Epitelial Específico',\n",
       "   'Antígeno GA 733 Associado a Tumor',\n",
       "   'Antígeno GA733',\n",
       "   'Antígeno GA733 Associado a Tumor',\n",
       "   'CD326 Antigen',\n",
       "   'CD326 Protein',\n",
       "   'ESA Antigen',\n",
       "   'Ep-CAM',\n",
       "   'Ep-CAM',\n",
       "   'EpCAM',\n",
       "   'EpCAM',\n",
       "   'Epithelial Cell Adhesion Molecule',\n",
       "   'Epithelial Specific Antigen',\n",
       "   'GA 733 Tumor Associated Antigen',\n",
       "   'GA 733 Tumor-Associated Antigen',\n",
       "   'GA733 Antigen',\n",
       "   'GA733 Tumor Associated Antigen',\n",
       "   'GA733 Tumor-Associated Antigen',\n",
       "   'GA733, Tumor-Associated Antigen',\n",
       "   'Molécula de Adesão da Célula Epitelial',\n",
       "   'Proteína CD326',\n",
       "   'Proteína Tacstd1',\n",
       "   'Tacstd1 Protein',\n",
       "   'Tumor Associated Antigen GA733',\n",
       "   'Tumor-Associated Antigen GA733',\n",
       "   'Tumor-Associated Antigen, GA733'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071876': {'ID': 'D000071876',\n",
       "  'name': 'Prostaglandina-E Sintases[Prostaglandin-E Synthases]',\n",
       "  'scope': 'A cytosolic prostaglandin E synthase that catalyzes the oxidoreduction of PROSTAGLANDIN H2 to PROSTAGLANDIN E2.',\n",
       "  'terms': ['Cytosolic Prostaglandin E2 Synthase',\n",
       "   'E Synthases, Prostaglandin',\n",
       "   'Endoperoxide Isomerase',\n",
       "   'Endoperóxido Isomerase',\n",
       "   'Isomerase, Endoperoxide',\n",
       "   'Isomerase, PGE2',\n",
       "   'Isomerase, Prostaglandin E',\n",
       "   'PGE2 Isomerase',\n",
       "   'PGE2 Isomerase',\n",
       "   'PGE2 Sintase',\n",
       "   'PGE2 Synthase',\n",
       "   'PGR2 E Isomerase',\n",
       "   'PGR2 E-Isomerase',\n",
       "   'PGR2 E-Isomerase',\n",
       "   'PTGES2 Protein',\n",
       "   'PTGES3 Protein',\n",
       "   'Prostaglandin E Isomerase',\n",
       "   'Prostaglandin E Synthase',\n",
       "   'Prostaglandin E Synthase 1',\n",
       "   'Prostaglandin E Synthase 2',\n",
       "   'Prostaglandin E Synthase 3',\n",
       "   'Prostaglandin E Synthase-1',\n",
       "   'Prostaglandin E Synthases',\n",
       "   'Prostaglandin E2 Synthase',\n",
       "   'Prostaglandin Endoperoxide E Isomerase',\n",
       "   'Prostaglandin H2 E Isomerase',\n",
       "   'Prostaglandin H2 E-Isomerase',\n",
       "   'Prostaglandin H2 Prostaglandin E2 Isomerase',\n",
       "   'Prostaglandin H2-Prostaglandin E2 Isomerase',\n",
       "   'Prostaglandin R2 E Isomerase',\n",
       "   'Prostaglandin R2 E-Isomerase',\n",
       "   'Prostaglandin-E Synthase',\n",
       "   'Prostaglandin-E Synthases',\n",
       "   'Prostaglandina E Isomerase',\n",
       "   'Prostaglandina E Sintase',\n",
       "   'Prostaglandina E Sintase 1',\n",
       "   'Prostaglandina E Sintase 2',\n",
       "   'Prostaglandina E Sintase 3',\n",
       "   'Prostaglandina E Sintase-1',\n",
       "   'Prostaglandina E Sintases',\n",
       "   'Prostaglandina E2 Sintase',\n",
       "   'Prostaglandina E2 Sintase Citosólica',\n",
       "   'Prostaglandina Endoperóxido E Isomerase',\n",
       "   'Prostaglandina H2 E Isomerase',\n",
       "   'Prostaglandina H2-Prostaglandina E2 Isomerase',\n",
       "   'Prostaglandina R2 E-Isomerase',\n",
       "   'Prostaglandina-E Sintase',\n",
       "   'Prostaglandina-E Sintases',\n",
       "   'Proteína PTGES2',\n",
       "   'Proteína PTGES3',\n",
       "   'Synthase, PGE2',\n",
       "   'Synthase, Prostaglandin E',\n",
       "   'Synthase, Prostaglandin E2',\n",
       "   'Synthase, Prostaglandin-E',\n",
       "   'Synthases, Prostaglandin E',\n",
       "   'Synthases, Prostaglandin-E'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071877': {'ID': 'D000071877',\n",
       "  'name': 'Quinase 1 do Ponto de Checagem[Checkpoint Kinase 1]',\n",
       "  'scope': 'A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle.',\n",
       "  'terms': ['Checkpoint Kinase 1',\n",
       "   'Checkpoint-1 Kinase',\n",
       "   'Chk1 Kinase',\n",
       "   'Chk1 Protein Kinase',\n",
       "   'Protein Kinase, Chk1',\n",
       "   'Proteína Quinase Chk1',\n",
       "   'Quinase 1 do Ponto de Checagem',\n",
       "   'Quinase Chk1',\n",
       "   'Quinase do Ponto de Checagem 1',\n",
       "   'Quinase do Ponto de Checagem-1',\n",
       "   'Quinase-1 do Ponto de Checagem'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071896': {'ID': 'D000071896',\n",
       "  'name': 'Sintomas Inexplicáveis[Medically Unexplained Symptoms]',\n",
       "  'scope': 'Persistent health symptoms which remain unexplained after a complete medical evaluation. A cluster of symptoms that consistently appear together but without a known cause are referred to as a MEDICALLY UNEXPLAINED SYNDROME (MUS).',\n",
       "  'terms': ['Medically Unexplained Symptom',\n",
       "   'Medically Unexplained Symptoms',\n",
       "   'Sintoma Somático',\n",
       "   'Sintomas Inexplicáveis',\n",
       "   'Sintomas Inexplicáveis por Médicos',\n",
       "   'Sintomas Medicamente Inexplicáveis',\n",
       "   'Sintomas Somáticos',\n",
       "   'Somatic Symptom',\n",
       "   'Somatic Symptoms',\n",
       "   'Symptom, Medically Unexplained',\n",
       "   'Symptom, Somatic',\n",
       "   'Symptoms, Medically Unexplained',\n",
       "   'Symptoms, Somatic',\n",
       "   'Unexplained Symptom, Medically',\n",
       "   'Unexplained Symptoms, Medically'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071916': {'ID': 'D000071916',\n",
       "  'name': 'Antígeno AC133[AC133 Antigen]',\n",
       "  'scope': 'A member of the prominin family, AC133 Antigen is a 5-transmembrane antigen occurring as several isoforms produced by alternative splicing which are processed into mature forms. In humans, it is expressed as a subset of CD34 (bright) human hematopoietic stem cells and CD34 positive leukemias. Functionally, it is associated with roles in cell differentiation, proliferation, and apoptosis. Specifically, it regulates the organization of apical plasma membrane in epithelial cells, disk morphogenesis during early retinal development, MAPK and Akt signaling pathways, and in cholesterol metabolism.',\n",
       "  'terms': ['AC133 1 Antigen',\n",
       "   'AC133 2 Antigen',\n",
       "   'AC133 Antigen',\n",
       "   'AC133-1 Antigen',\n",
       "   'AC133-2 Antigen',\n",
       "   'AC141 Antigen',\n",
       "   'Antigen, AC133',\n",
       "   'Antigen, AC133-1',\n",
       "   'Antigen, AC133-2',\n",
       "   'Antigen, AC141',\n",
       "   'Antigen, CD133',\n",
       "   'Antígeno AC133',\n",
       "   'Antígeno AC133-1',\n",
       "   'Antígeno AC133-2',\n",
       "   'Antígeno AC141',\n",
       "   'Antígeno CD133',\n",
       "   'CD133 Antigen',\n",
       "   'Fudenina',\n",
       "   'Fudenine',\n",
       "   'PROML1',\n",
       "   'PROML1',\n",
       "   'PROML1 Semelhante a Prominina',\n",
       "   'Prominin',\n",
       "   'Prominin 1',\n",
       "   'Prominin Like PROML1',\n",
       "   'Prominin-1',\n",
       "   'Prominin-Like PROML1',\n",
       "   'Prominina',\n",
       "   'Prominina-1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000071936': {'ID': 'D000071936',\n",
       "  'name': 'Derrame Papilar[Nipple Discharge]',\n",
       "  'scope': 'Fluid that seeps out of one or both nipples of the breast.',\n",
       "  'terms': ['Derrame Papilar',\n",
       "   'Descarga Papilar',\n",
       "   'Discharge, Nipple',\n",
       "   'Discharges, Nipple',\n",
       "   'Nipple Discharge',\n",
       "   'Nipple Discharges'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071937': {'ID': 'D000071937',\n",
       "  'name': 'Volume Sanguíneo Cerebral[Cerebral Blood Volume]',\n",
       "  'scope': 'Volume of circulating blood in a region of the brain. It is a functional measure of the brain perfusion status which relates changes in this to changes in CEREBROVASULAR CIRCULATION that are often seen in brain diseases.',\n",
       "  'terms': ['Blood Volume, Cerebral',\n",
       "   'Cerebral Blood Volume',\n",
       "   'Volume Sanguíneo Cerebral',\n",
       "   'Volume, Cerebral Blood'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071938': {'ID': 'D000071938',\n",
       "  'name': 'Fasciotomia[Fasciotomy]',\n",
       "  'scope': \"Surgical incision on the FASCIA. It is used to decompress compartment pressure (e.g. in COMPARTMENT SYNDROMES; circumferential burns and extremity injuries) or to release contractures (e.g. in DUPUYTREN'S CONTRACTURE).\",\n",
       "  'terms': ['<i>amputacao</i>',\n",
       "   '<i>desarticulacao</i>',\n",
       "   '<i>desbri</i>',\n",
       "   '<i>supracondiliana</i>',\n",
       "   'Fasciectomia',\n",
       "   'Fasciectomy',\n",
       "   'Fasciotomia',\n",
       "   'Fasciotomy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071939': {'ID': 'D000071939',\n",
       "  'name': 'Reabilitação do Acidente Vascular Cerebral[Stroke Rehabilitation]',\n",
       "  'scope': 'Restoration of functions to the maximum degree possible in a person or persons suffering from a stroke.',\n",
       "  'terms': ['Reabilitação do Acidente Vascular Cerebral',\n",
       "   'Rehabilitation, Stroke',\n",
       "   'Stroke Rehabilitation'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071940': {'ID': 'D000071940',\n",
       "  'name': 'Núcleons[Nucleons]',\n",
       "  'scope': 'Subatomic particles that are either protons or neutrons.',\n",
       "  'terms': ['Nucleon', 'Nucleons', 'Núcleon', 'Núcleons'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071941': {'ID': 'D000071941',\n",
       "  'name': 'Enema Opaco[Barium Enema]',\n",
       "  'scope': 'X-RAY examination of LOWER GASTROINTESTINAL TRACT. Imaging is done while a BARIUM COMPOUND (e.g., BARIUM SULFATE) fills the large intestine via the rectum as a CONTRAST MATERIAL.',\n",
       "  'terms': ['Barium Enema',\n",
       "   'Barium Enemas',\n",
       "   'Enema Opaco',\n",
       "   'Enema com Bário',\n",
       "   'Enema por Bário',\n",
       "   'Enema, Barium'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071956': {'ID': 'D000071956',\n",
       "  'name': 'Contusões Miocárdicas[Myocardial Contusions]',\n",
       "  'scope': 'Bruise to the heart muscle due to blunt thoracic trauma.',\n",
       "  'terms': ['Blunt Cardiac Injuries',\n",
       "   'Blunt Cardiac Injury',\n",
       "   'Cardiac Contusion',\n",
       "   'Cardiac Contusions',\n",
       "   'Cardiac Injuries, Blunt',\n",
       "   'Cardiac Injury, Blunt',\n",
       "   'Contusio Cordis',\n",
       "   'Contusio Cordis',\n",
       "   'Contusion, Cardiac',\n",
       "   'Contusion, Heart',\n",
       "   'Contusion, Myocardial',\n",
       "   'Contusions, Cardiac',\n",
       "   'Contusions, Heart',\n",
       "   'Contusions, Myocardial',\n",
       "   'Contusão Cardíaca',\n",
       "   'Contusão Miocárdica',\n",
       "   'Contusões Cardíacas',\n",
       "   'Contusões Miocárdicas',\n",
       "   'Contusões do Coração',\n",
       "   'Cordis, Contusio',\n",
       "   'Heart Contusion',\n",
       "   'Heart Contusions',\n",
       "   'Injuries, Blunt Cardiac',\n",
       "   'Injury, Blunt Cardiac',\n",
       "   'Lesão Cardíaca Contundente',\n",
       "   'Lesão Cardíaca Contusa',\n",
       "   'Lesão Cardíaca Fechada',\n",
       "   'Lesão Cardíaca no Trauma Torácico Fechado',\n",
       "   'Lesão Cardíaca por Trauma Contundente',\n",
       "   'Lesão Cardíaca por Trauma Fechado',\n",
       "   'Lesão Cardíaca por Trauma Torácico Fechado',\n",
       "   'Lesão Cardíaca por Traumatismo Contundente',\n",
       "   'Lesão Cardíaca por Traumatismo Contuso',\n",
       "   'Lesão Cardíaca por Traumatismo não Penetrante',\n",
       "   'Myocardial Contusion',\n",
       "   'Myocardial Contusions'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071959': {'ID': 'D000071959',\n",
       "  'name': 'Gerentes de Casos[Case Managers]',\n",
       "  'scope': 'Professionals who are in charge of assessment, planning, facilitation, care coordination, evaluation, and advocacy for options and services to meet a patient’s and family’s comprehensive health needs.',\n",
       "  'terms': ['Case Manager',\n",
       "   'Case Managers',\n",
       "   'Gerentes de Casos',\n",
       "   'Manager, Case',\n",
       "   'Managers, Case'],\n",
       "  'qualifier': '#'},\n",
       " 'D000071960': {'ID': 'D000071960',\n",
       "  'name': 'Carcinoma de Mama in situ[Breast Carcinoma In Situ]',\n",
       "  'scope': 'A condition in which abnormal cells have not spread outside the duct, lobule, or nipple to other tissues of the breast. There are 3 types of breast carcinoma in situ: DUCTAL CARCINOMA IN SITU; LOBULAR CARCINOMA IN SITU; and PAGET DISEASE OF THE NIPPLE',\n",
       "  'terms': ['Breast Carcinoma In Situ',\n",
       "   'Carcinoma Lobular in situ',\n",
       "   'Carcinoma Lobular in situ (LCIS)',\n",
       "   'Carcinoma Mamário in situ',\n",
       "   'Carcinoma da Mama in situ',\n",
       "   'Carcinoma de Mama in situ',\n",
       "   'LCIS, Lobular Carcinoma In Situ',\n",
       "   'Lobular Carcinoma In Situ'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000071976': {'ID': 'D000071976',\n",
       "  'name': 'Músculo Grácil[Gracilis Muscle]',\n",
       "  'scope': 'A slender and most superficial muscle in the inner THIGH which originates at the ramus of the PUBIC BONE near the PUBIC SYMPHYSIS and inserts at the proximal medial TIBIA. Its function is to abduct thigh, flex knee, and rotate leg medially. It is a common  source of a MYOCUTANEOUS FLAP.',\n",
       "  'terms': ['Gracilis Muscle',\n",
       "   'Gracilis Muscles',\n",
       "   'Muscle, Gracilis',\n",
       "   'Muscles, Gracilis',\n",
       "   'Músculo Grácil'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000071997': {'ID': 'D000071997',\n",
       "  'name': 'Hemocultura[Blood Culture]',\n",
       "  'scope': 'Test to determine the presence of blood infection (e.g. SEPSIS; BACTEREMIA).',\n",
       "  'terms': ['<i>bacterioscopia</i>',\n",
       "   '<i>hemoc</i>',\n",
       "   '<i>hemocult</i>',\n",
       "   '<i>hemoculturas</i>',\n",
       "   '<i>hmc</i>',\n",
       "   '<i>hmcp</i>',\n",
       "   '<i>hmcs</i>',\n",
       "   '<i>negativahmc</i>',\n",
       "   '<i>negativohmc</i>',\n",
       "   '<i>urc</i>',\n",
       "   'Blood Culture',\n",
       "   'Blood Culture Test',\n",
       "   'Blood Culture Tests',\n",
       "   'Blood Cultures',\n",
       "   'Cultura de Sangue',\n",
       "   'Culture Test, Blood',\n",
       "   'Culture Tests, Blood',\n",
       "   'Culture, Blood',\n",
       "   'Cultures, Blood',\n",
       "   'Hemocultura',\n",
       "   'Test, Blood Culture',\n",
       "   'Teste de Hemocultura',\n",
       "   'Tests, Blood Culture'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000071999': {'ID': 'D000071999',\n",
       "  'name': 'Proteína A4 de Ligação a Cálcio da Família S100[S100 Calcium-Binding Protein A4]',\n",
       "  'scope': 'An S100 protein characterized by four helix bundles that form N- and C-terminal EF HAND MOTIFS. It functions as a homodimer and interacts with both intracellular and extracellular signaling proteins. Aberrant S100A4 activity is associated with NEOPLASM METASTASIS; FIBROSIS; and RHEUMATOID ARTHRITIS.',\n",
       "  'terms': ['Calcium-Binding Protein, Placental',\n",
       "   'Calvasculin Protein',\n",
       "   'Fibroblast Specific Protein 1',\n",
       "   'Fibroblast-Specific Protein 1',\n",
       "   'Metastasin Protein',\n",
       "   'Placental Calcium Binding Protein',\n",
       "   'Placental Calcium-Binding Protein',\n",
       "   'Proteína 1 Específica de Fibroblastos',\n",
       "   'Proteína A4 da Família S100 de Ligação a Cálcio',\n",
       "   'Proteína A4 de Ligação a Cálcio da Família S100',\n",
       "   'Proteína Calvasculina',\n",
       "   'Proteína Metastasina',\n",
       "   'Proteína Placentária de Ligação a Cálcio',\n",
       "   'Proteína S100A4',\n",
       "   'S100 Calcium Binding Protein A4',\n",
       "   'S100 Calcium-Binding Protein A4',\n",
       "   'S100A4 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072': {'ID': 'D000072',\n",
       "  'name': 'Acedapsona[Acedapsone]',\n",
       "  'scope': 'Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of DAPSONE. It has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.',\n",
       "  'terms': [\"4',4'''-Sulfonylbis(acetanilide)\",\n",
       "   \"4,4' Diacetyldiaminodiphenylsulfone\",\n",
       "   \"4,4'-Diacetyldiaminodiphenylsulfone\",\n",
       "   'Acedapsona',\n",
       "   'Acedapsone',\n",
       "   'Acetildifenazônio',\n",
       "   'Acetyldiphenazonum',\n",
       "   'DADDS',\n",
       "   'DADDS',\n",
       "   'Diacetildapsona',\n",
       "   'Diacetyldapsone',\n",
       "   'Hansolar',\n",
       "   'Rodilone',\n",
       "   'Sulfadiamine'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072000': {'ID': 'D000072000',\n",
       "  'name': 'Inibidor de NF-kappaB alfa[NF-KappaB Inhibitor alpha]',\n",
       "  'scope': 'An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding.',\n",
       "  'terms': ['I Kappa B alpha Protein',\n",
       "   'I Kappa B-alpha Protein',\n",
       "   'IKappaB alfa',\n",
       "   'IKappaB alpha',\n",
       "   'IKappaB-alfa',\n",
       "   'IKappaB-alpha',\n",
       "   'IKappaBalpha',\n",
       "   'Inhibitor alpha, NF-KappaB',\n",
       "   'Inibidor de NF-kappaB alfa',\n",
       "   'Major Histocompatibility Complex Enhancer Binding Protein MAD3',\n",
       "   'Major Histocompatibility Complex Enhancer-Binding Protein MAD3',\n",
       "   'NF KappaB Inhibitor alpha',\n",
       "   'NF-KappaB Inhibitor alpha',\n",
       "   'Proteína I kappa B alfa',\n",
       "   'Proteína MAD3 de Ligação ao Facilitador do Complexo de Histocompatibilidade Principal',\n",
       "   'Proteína p40',\n",
       "   'alpha, NF-KappaB Inhibitor',\n",
       "   'kappaB alfa I',\n",
       "   'kappaB-alfa I',\n",
       "   'p40 Protein (IKappaB-alpha)'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072001': {'ID': 'D000072001',\n",
       "  'name': 'Dieta Saudável[Healthy Diet]',\n",
       "  'scope': 'Dietary patterns which have been found to be important in reducing disease risk.',\n",
       "  'terms': ['Alimentação Saudável',\n",
       "   'Diet, Healthy',\n",
       "   'Dieta Saudável',\n",
       "   'Diets, Healthy',\n",
       "   'Eating Index, Healthy',\n",
       "   'Eating Indices, Healthy',\n",
       "   'Eating, Healthy',\n",
       "   'Healthy Diet',\n",
       "   'Healthy Diets',\n",
       "   'Healthy Eating',\n",
       "   'Healthy Eating Index',\n",
       "   'Healthy Eating Indices',\n",
       "   'Index, Healthy Eating',\n",
       "   'Indices, Healthy Eating',\n",
       "   'Índice de Alimentação Saudável'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072002': {'ID': 'D000072002',\n",
       "  'name': 'Proteínas Priônicas[Prion Proteins]',\n",
       "  'scope': 'An overlapping open reading frame within the PRNP gene that encodes a protein which is smaller and structurally unrelated to major prion protein.',\n",
       "  'terms': ['AltPrP',\n",
       "   'AltPrP',\n",
       "   'Alternative Prion Protein',\n",
       "   'Antigen, CD230',\n",
       "   'Antígeno CD230',\n",
       "   'CD230 Antigen',\n",
       "   'Creutzfeldt Jakob Disease Protein',\n",
       "   'Creutzfeldt-Jakob Disease Protein',\n",
       "   'Fatal Familial Insomnia Protein',\n",
       "   'Major Prion Protein',\n",
       "   'PrP Proteins',\n",
       "   'Prion Protein',\n",
       "   'Prion Protein, Alternative',\n",
       "   'Prion Protein, Major',\n",
       "   'Prion Proteins',\n",
       "   'Proteína Principal de Príon',\n",
       "   'Proteína Priônica',\n",
       "   'Proteína Priônica Alternativa',\n",
       "   'Proteína Priônica Principal',\n",
       "   'Proteína da Doença de Creutzfeldt-Jakob',\n",
       "   'Proteína da Insônia Familiar Fatal',\n",
       "   'Proteína de Príon',\n",
       "   'Proteínas PrP',\n",
       "   'Proteínas Priônicas'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072017': {'ID': 'D000072017',\n",
       "  'name': 'Enzimas Desubiquitinantes[Deubiquitinating Enzymes]',\n",
       "  'scope': 'Enzymes that remove UBIQUITIN from a protein substrate, including POLYUBIQUITIN, or from other molecules.',\n",
       "  'terms': ['Desubiquitinases',\n",
       "   'Deubiquitinases',\n",
       "   'Deubiquitinating Enzymes',\n",
       "   'Enzimas Desubiquitinantes',\n",
       "   'Enzymes, Deubiquitinating'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072018': {'ID': 'D000072018',\n",
       "  'name': 'Audiologistas[Audiologists]',\n",
       "  'scope': 'Professionals skilled at diagnostic testing of hearing, HEARING IMPAIRMENT, and CORRECTION OF HEARING IMPAIRMENT by non-medical or non-surgical means.',\n",
       "  'terms': ['Audiologist', 'Audiologistas', 'Audiologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072019': {'ID': 'D000072019',\n",
       "  'name': 'Proteína 1 Associada a ECH Semelhante a Kelch[Kelch-Like ECH-Associated Protein 1]',\n",
       "  'scope': 'An adaptor protein characterized by an N-terminal BTB-POZ DOMAIN and six KELCH REPEATS that functions as a substrate for the E3 UBIQUITIN LIGASE complex. It negatively-regulates NF-E2-RELATED FACTOR 2 by targeting it for ubiquitination and degradation by the PROTEASOME. It also represses genes regulated by ANTIOXIDANT RESPONSE ELEMENTS.',\n",
       "  'terms': ['KEAP 1 Protein',\n",
       "   'KEAP-1 Protein',\n",
       "   'KEAP1 Protein',\n",
       "   'Kelch Like ECH Associated Protein 1',\n",
       "   'Kelch-Like ECH-Associated Protein 1',\n",
       "   'Proteína 1 Associada a ECH Semelhante a Kelch',\n",
       "   'Proteína KEAP-1',\n",
       "   'Proteína KEAP1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072020': {'ID': 'D000072020',\n",
       "  'name': 'Mutações Sintéticas Letais[Synthetic Lethal Mutations]',\n",
       "  'scope': 'Mutations in genes which lead to cell or organism death when occurring in combination with mutations in one or more other genes.',\n",
       "  'terms': ['Letalidade Sintética',\n",
       "   'Lethal Mutation, Synthetic',\n",
       "   'Lethal Mutations, Synthetic',\n",
       "   'Lethality, Synthetic',\n",
       "   'Mutation, Synthetic Lethal',\n",
       "   'Mutations, Synthetic Lethal',\n",
       "   'Mutação Sintética Letal',\n",
       "   'Mutações Letais Sintéticas',\n",
       "   'Mutações Sintéticas Letais',\n",
       "   'Synthetic Lethal Mutation',\n",
       "   'Synthetic Lethal Mutations',\n",
       "   'Synthetic Lethality'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072036': {'ID': 'D000072036',\n",
       "  'name': 'Mastectomia Profilática[Prophylactic Mastectomy]',\n",
       "  'scope': 'Surgical removal of one or both breasts to prevent or reduce the risk of developing breast cancer in persons who may be predisposed.',\n",
       "  'terms': ['Mastectomia Profilática',\n",
       "   'Mastectomies, Prophylactic',\n",
       "   'Mastectomy, Prophylactic',\n",
       "   'Prophylactic Mastectomies',\n",
       "   'Prophylactic Mastectomy'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072038': {'ID': 'D000072038',\n",
       "  'name': 'Reabilitação Cardíaca[Cardiac Rehabilitation]',\n",
       "  'scope': 'Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.',\n",
       "  'terms': ['Cardiac Rehabilitation',\n",
       "   'Cardiac Rehabilitations',\n",
       "   'Cardiovascular Rehabilitation',\n",
       "   'Cardiovascular Rehabilitations',\n",
       "   'Reabilitação Cardiovascular',\n",
       "   'Reabilitação Cardíaca',\n",
       "   'Rehabilitation, Cardiac',\n",
       "   'Rehabilitation, Cardiovascular',\n",
       "   'Rehabilitations, Cardiac',\n",
       "   'Rehabilitations, Cardiovascular'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072039': {'ID': 'D000072039',\n",
       "  'name': 'Fratura-Luxação[Fracture Dislocation]',\n",
       "  'scope': 'Fracture of a bone near an articulation with concomitant dislocation of that joint.',\n",
       "  'terms': ['Dislocation Fracture',\n",
       "   'Dislocation Fractures',\n",
       "   'Dislocation, Fracture',\n",
       "   'Dislocations, Fracture',\n",
       "   'Fracture Dislocation',\n",
       "   'Fracture Dislocations',\n",
       "   'Fracture, Dislocation',\n",
       "   'Fractures, Dislocation',\n",
       "   'Fratura-Luxação'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000072040': {'ID': 'D000072040',\n",
       "  'name': 'Apolipoproteína A-V[Apolipoprotein A-V]',\n",
       "  'scope': 'A minor apolipoprotein that associates with HIGH-DENSITY LIPOPROTEINS (HDL), VERY-LOW-DENSITY LIPOPROTEINS (VLDL), and CHYLOMICRONS. It regulates levels of plasma TRIGLYCERIDES by activating APOLIPOPROTEIN C-II LIPOPROTEIN LIPASE and inhibiting hepatic VLDL triglyceride hydrolysis.',\n",
       "  'terms': ['APOA5 Protein',\n",
       "   'Apo A V Protein',\n",
       "   'Apo A-V Protein',\n",
       "   'Apo A5 Protein',\n",
       "   'ApoA V Protein',\n",
       "   'ApoA-V Protein',\n",
       "   'Apolipoprotein A V',\n",
       "   'Apolipoprotein A-V',\n",
       "   'Apolipoprotein A5',\n",
       "   'Apolipoproteína A-V',\n",
       "   'Proteína APOA5',\n",
       "   'Proteína Apo A-V',\n",
       "   'Proteína Apo A5',\n",
       "   'Proteína ApoA-V'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072041': {'ID': 'D000072041',\n",
       "  'name': 'Fator de Transcrição PAX3[PAX3 Transcription Factor]',\n",
       "  'scope': 'A paired box transcription factor that functions in CELL PROLIFERATION; CELL MIGRATION; and APOPTOSIS. It also is involved in MYOGENESIS and neural development. Mutations in the PAX3 gene are associated with WAARDENBURG SYNDROME TYPE 1.',\n",
       "  'terms': ['Factor PAX3, Transcription',\n",
       "   'Fator de Transcrição 3 Box Pareado',\n",
       "   'Fator de Transcrição Box Pareado 3',\n",
       "   'Fator de Transcrição PAX3',\n",
       "   'PAX3 Transcription Factor',\n",
       "   'PAX3, Transcription Factor',\n",
       "   'Paired Box 3 Protein',\n",
       "   'Paired Box Transcription Factor 3',\n",
       "   'Proteína 3 Box Pareado',\n",
       "   'Proteína Box Pareado 3',\n",
       "   'Transcription Factor PAX3',\n",
       "   'Transcription Factor, PAX3'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072042': {'ID': 'D000072042',\n",
       "  'name': 'Fraturas Salter-Harris[Salter-Harris Fractures]',\n",
       "  'scope': 'Fractures involving a GROWTH PLATE.',\n",
       "  'terms': ['Fracture, Growth Plate',\n",
       "   'Fractures, Growth Plate',\n",
       "   'Fractures, Salter-Harris',\n",
       "   'Fraturas Salter Harris',\n",
       "   'Fraturas Salter-Harris',\n",
       "   'Fraturas da Placa de Crescimento',\n",
       "   'Growth Plate Fracture',\n",
       "   'Growth Plate Fractures',\n",
       "   'Growth Plate Injuries',\n",
       "   'Growth Plate Injury',\n",
       "   'Lesões da Placa de Crescimento',\n",
       "   'Salter Harris Fractures',\n",
       "   'Salter-Harris Fractures'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000072056': {'ID': 'D000072056',\n",
       "  'name': 'Fatores de Transcrição HES-1[Transcription Factor HES-1]',\n",
       "  'scope': 'A basic-helix-loop-helix transcription factor that functions as a transcriptional repressor for genes transcribed by bHLH proteins. For example, it may negatively regulate MYOGENESIS by inhibiting MyoD1 and ASH1 proteins. It is also required for the stability of FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS and their localization to the cell nucleus in response to DNA DAMAGE.',\n",
       "  'terms': ['Fator de Transcrição Semelhante a Hairy',\n",
       "   'Fatores de Transcrição HES-1',\n",
       "   'HES-1, Transcription Factor',\n",
       "   'Hairy Like Transcription Factor',\n",
       "   'Hairy and Enhancer of Split 1 Protein',\n",
       "   'Hairy-Like Transcription Factor',\n",
       "   'Proteína HES-1',\n",
       "   'Transcription Factor HES 1',\n",
       "   'Transcription Factor HES-1',\n",
       "   'Transcription Factor, Hairy-Like'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072077': {'ID': 'D000072077',\n",
       "  'name': 'Anestesistas[Anesthetists]',\n",
       "  'scope': 'Persons trained and certified to administer ANESTHETICS.',\n",
       "  'terms': ['Anestesistas',\n",
       "   'Anesthesia Assistant',\n",
       "   'Anesthesia Assistants',\n",
       "   'Anesthetist',\n",
       "   'Anesthetists',\n",
       "   'Assistant, Anesthesia',\n",
       "   'Assistants, Anesthesia',\n",
       "   'Assistentes Anestesistas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072078': {'ID': 'D000072078',\n",
       "  'name': 'Tomografia Computadorizada com Tomografia por Emissão de Pósitrons[Positron Emission Tomography Computed Tomography]',\n",
       "  'scope': 'An imaging technique\\xa0that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner.\\xa0This establishes a\\xa0precise anatomic localization in the same session.',\n",
       "  'terms': ['CT PET',\n",
       "   'CT PET Scan',\n",
       "   'CT PET Scans',\n",
       "   'CT PETs',\n",
       "   'CT Scan, PET',\n",
       "   'CT Scans, PET',\n",
       "   'CT-PET',\n",
       "   'CT-PET Scan',\n",
       "   'PET CT',\n",
       "   'PET CT Scan',\n",
       "   'PET CT Scan',\n",
       "   'PET CT Scans',\n",
       "   'PET Scan, CT',\n",
       "   'PET Scans, CT',\n",
       "   'PET, CT',\n",
       "   'PET-CT',\n",
       "   'PET-CT Scan',\n",
       "   'PET-CT Scans',\n",
       "   'PETs, CT',\n",
       "   'Positron Emission Tomography Computed Tomography',\n",
       "   'Positron Emission Tomography-Computed Tomography',\n",
       "   'Scan, CT PET',\n",
       "   'Scan, PET CT',\n",
       "   'Scan, PET-CT',\n",
       "   'Scans, CT PET',\n",
       "   'Scans, PET CT',\n",
       "   'Scans, PET-CT',\n",
       "   'Tomografia Computadorizada com Tomografia por Emissão de Pósitrons',\n",
       "   'Tomografia Computadorizada por Emissão de Pósitrons',\n",
       "   'Tomografia Computadorizada-Tomografia por Emissão de Pósitrons',\n",
       "   'Tomografia por Emissão de Pósitrons com Tomografia Computadorizada'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072079': {'ID': 'D000072079',\n",
       "  'name': 'Receptores Patched[Patched Receptors]',\n",
       "  'scope': 'A family of 12-pass transmembrane proteins originally identified in Drosophila that are receptors for HEDGEHOG PROTEINS. They have important roles in regulating CELL PROLIFERATION; CELL DIFFERENTIAION; and BODY PATTERNING and may also function as TUMOR SUPPRESSOR PROTEINS.',\n",
       "  'terms': ['Patched Protein',\n",
       "   'Patched Receptor',\n",
       "   'Patched Receptors',\n",
       "   'Patched Sonic Hedgehog Receptors',\n",
       "   'Proteína Patched',\n",
       "   'Receptor Patched',\n",
       "   'Receptor, Patched',\n",
       "   'Receptores Patched',\n",
       "   'Receptors, Patched'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072080': {'ID': 'D000072080',\n",
       "  'name': 'Anestesiologistas[Anesthesiologists]',\n",
       "  'scope': 'Physicians specializing in ANESTHESIOLOGY.',\n",
       "  'terms': ['Anestesiologistas',\n",
       "   'Anesthesiologist',\n",
       "   'Anesthesiologists',\n",
       "   'Anesthetist, Physician',\n",
       "   'Anesthetists, Physician',\n",
       "   'Médicos Anestesistas',\n",
       "   'Physician Anesthetist',\n",
       "   'Physician Anesthetists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072081': {'ID': 'D000072081',\n",
       "  'name': 'Receptor Patched-1[Patched-1 Receptor]',\n",
       "  'scope': 'A patched receptor for several HEDGEHOG PROTEINS that associates with the SMOOTHENED RECEPTOR to modulate hedgehog signaling. It is also a TUMOR SUPPRESSOR PROTEIN; mutations in the patched-1 gene are associated with BASAL CELL NEVUS SYNDROME; SQUAMOUS CELL CARCNIOMA of the ESOPHAGUS; trichoepitheliomas, and CARCINOMA, TRANSITIONAL CELL of the URINARY BLADDER.',\n",
       "  'terms': ['Homólogo Patched-1',\n",
       "   'PTCH1 Protein',\n",
       "   'Patched 1 Protein',\n",
       "   'Patched 1 Receptor',\n",
       "   'Patched Homolog 1',\n",
       "   'Patched Homolog-1',\n",
       "   'Patched Receptor 1',\n",
       "   'Patched Receptor-1',\n",
       "   'Patched-1 Protein',\n",
       "   'Patched-1 Receptor',\n",
       "   'Proteína PTCH1',\n",
       "   'Proteína Patched-1',\n",
       "   'Receptor 1 Patched',\n",
       "   'Receptor Patched-1',\n",
       "   'Receptor, Patched-1',\n",
       "   'Receptor-1, Patched'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072082': {'ID': 'D000072082',\n",
       "  'name': 'Receptor Patched-2[Patched-2 Receptor]',\n",
       "  'scope': 'A patched receptor that may function redundantly with the PATCHED-1 RECEPTOR to modulate hedgehog signaling. It may also play a role in epidermal development and as a TUMOR SUPPRESSOR PROTEIN. Mutations in the patched-2 gene are associated with BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; and MEDULLOBLASTOMA.',\n",
       "  'terms': ['Homólogo 2 de Patched',\n",
       "   'Homólogo Patched-2',\n",
       "   'PTCH2 Protein',\n",
       "   'Patched 2 Protein',\n",
       "   'Patched 2 Receptor',\n",
       "   'Patched Homolog 2',\n",
       "   'Patched Homolog-2',\n",
       "   'Patched Receptor 2',\n",
       "   'Patched Receptor-2',\n",
       "   'Patched-2 Protein',\n",
       "   'Patched-2 Receptor',\n",
       "   'Proteína PTCH2',\n",
       "   'Proteína Patched-2',\n",
       "   'Receptor 2 Patched',\n",
       "   'Receptor Patched-2',\n",
       "   'Receptor, Patched-2'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072085': {'ID': 'D000072085',\n",
       "  'name': 'Dermatologistas[Dermatologists]',\n",
       "  'scope': 'Physicians who specialize in treating disorders of the skin.',\n",
       "  'terms': ['Dermatologist', 'Dermatologistas', 'Dermatologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072086': {'ID': 'D000072086',\n",
       "  'name': 'Receptor Smoothened[Smoothened Receptor]',\n",
       "  'scope': 'A frizzled-like, G-protein-coupled receptor that associates with PATCHED RECEPTORS to transduce signals from HEDGEHOG PROTEINS and initiate hedgehog signaling to ZINC FINGER PROTEIN GLI1. It may normally inhibit signaling in the absence of SONIC HEDGEHOG PROTEIN binding to PATCHED RECEPTOR-1.',\n",
       "  'terms': ['Proteína Smoothened',\n",
       "   'Receptor Smoothened',\n",
       "   'Receptor, Smoothened',\n",
       "   'Receptores Smoothened',\n",
       "   'Receptors, Smoothened',\n",
       "   'Smoothened Protein',\n",
       "   'Smoothened Receptor',\n",
       "   'Smoothened Receptors'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072087': {'ID': 'D000072087',\n",
       "  'name': 'Terapeutas Ocupacionais[Occupational Therapists]',\n",
       "  'scope': 'Professionals trained to help individuals develop or regain skills needed to achieve independence in their lives.',\n",
       "  'terms': ['Occupational Therapist',\n",
       "   'Occupational Therapists',\n",
       "   'Terapeutas Ocupacionais',\n",
       "   'Therapist, Occupational',\n",
       "   'Therapists, Occupational'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072096': {'ID': 'D000072096',\n",
       "  'name': 'Cardiologistas[Cardiologists]',\n",
       "  'scope': 'Qualified medical professionals who specialize in preventing and treating disorders of the heart and CARDIOVASCULAR SYSTEM.',\n",
       "  'terms': ['Cardiologist', 'Cardiologistas', 'Cardiologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072097': {'ID': 'D000072097',\n",
       "  'name': 'Endocrinologistas[Endocrinologists]',\n",
       "  'scope': 'Physicians who specialize in treating ENDOCRINE SYSTEM DISEASES.',\n",
       "  'terms': ['Endocrinologist', 'Endocrinologistas', 'Endocrinologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072098': {'ID': 'D000072098',\n",
       "  'name': 'Tomografia Computadorizada com Tomografia Computadorizada de Emissão de Fóton Único[Single Photon Emission Computed Tomography Computed Tomography]',\n",
       "  'scope': 'An imaging technique using a device which combines TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON and TOMOGRAPHY, X-RAY COMPUTED in the same session.',\n",
       "  'terms': ['CT SPECT',\n",
       "   'CT SPECT',\n",
       "   'CT SPECT Scan',\n",
       "   'CT SPECT Scan',\n",
       "   'CT SPECT Scans',\n",
       "   'CT SPECTs',\n",
       "   'CT Scan, SPECT',\n",
       "   'CT Scans, SPECT',\n",
       "   'SPECT CT',\n",
       "   'SPECT CT',\n",
       "   'SPECT CT Scan',\n",
       "   'SPECT CT Scan',\n",
       "   'SPECT CT Scans',\n",
       "   'SPECT Scan, CT',\n",
       "   'SPECT Scans, CT',\n",
       "   'SPECT, CT',\n",
       "   'SPECTs, CT',\n",
       "   'Scan, CT SPECT',\n",
       "   'Scan, SPECT CT',\n",
       "   'Scans, CT SPECT',\n",
       "   'Scans, SPECT CT',\n",
       "   'Single Photon Emission Computed Tomography Computed Tomography',\n",
       "   'Tomografia Computadorizada com Tomografia Computadorizada de Emissão de Fóton Único'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072099': {'ID': 'D000072099',\n",
       "  'name': 'Proteínas Serrate-Jagged[Serrate-Jagged Proteins]',\n",
       "  'scope': 'Cell surface proteins that consist of multiple extracellular EPIDERMAL GROWTH FACTOR - like repeat sequences (EGF repeats), including calcium-binding EGF repeats. They function as transmembrane ligands for NOTCH RECEPTORS to control CELL DIFFERENTIATION during development.',\n",
       "  'terms': ['Jagged Proteins',\n",
       "   'Proteína Serrate',\n",
       "   'Proteínas Jagged',\n",
       "   'Proteínas Serrate',\n",
       "   'Proteínas Serrate-Jagged',\n",
       "   'Serrate Jagged Proteins',\n",
       "   'Serrate Protein',\n",
       "   'Serrate Proteins',\n",
       "   'Serrate-Jagged Proteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072100': {'ID': 'D000072100',\n",
       "  'name': 'Proteína Jagged-1[Jagged-1 Protein]',\n",
       "  'scope': 'A serrate-jagged protein that functions as a ligand for NOTCH RECEPTORS. It may regulate CELL DIFFERENTIATION in HEMATOPOIESIS and PHYSIOLOGIC ANGIOGENESIS. Mutations in the Jagged-1 gene are associated with ALAGILLE SYNDROME 1.',\n",
       "  'terms': ['Alagille Syndrome Protein',\n",
       "   'Antigen, CD339',\n",
       "   'Antígeno CD339',\n",
       "   'CD339 Antigen',\n",
       "   'Jagged 1',\n",
       "   'Jagged 1 Protein',\n",
       "   'Jagged-1',\n",
       "   'Jagged-1',\n",
       "   'Jagged-1 Protein',\n",
       "   'Jagged1 Protein',\n",
       "   'Proteína Jagged-1',\n",
       "   'Proteína Jagged1',\n",
       "   'Proteína Serrate-1',\n",
       "   'Proteína Serrate1',\n",
       "   'Proteína da Síndrome de Alagille',\n",
       "   'Serrate 1 Protein',\n",
       "   'Serrate-1 Protein',\n",
       "   'Serrate1 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072101': {'ID': 'D000072101',\n",
       "  'name': 'Proteína Jagged-2[Jagged-2 Protein]',\n",
       "  'scope': 'A serrate-jagged protein that functions to modulate signal transduction from NOTCH RECEPTORS in CELL DIFFERENTIATION. It may also regulate the expression of CYTOKINES.',\n",
       "  'terms': ['Jagged 2 Protein',\n",
       "   'Jagged-2 Protein',\n",
       "   'Jagged2 Protein',\n",
       "   'Proteína Jagged-2',\n",
       "   'Proteína Jagged2',\n",
       "   'Proteína Serrate-2',\n",
       "   'Proteína Serrate2',\n",
       "   'Serrate 2 Protein',\n",
       "   'Serrate-2 Protein',\n",
       "   'Serrate2 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072102': {'ID': 'D000072102',\n",
       "  'name': 'Gastroenterologistas[Gastroenterologists]',\n",
       "  'scope': 'Physicians who specialize in treating diseases of the DIGESTIVE SYSTEM.',\n",
       "  'terms': ['Gastroenterologist',\n",
       "   'Gastroenterologistas',\n",
       "   'Gastroenterologists',\n",
       "   'Hepatologist',\n",
       "   'Hepatologistas',\n",
       "   'Hepatologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072103': {'ID': 'D000072103',\n",
       "  'name': 'Oncologistas[Oncologists]',\n",
       "  'scope': 'Physicians specializing in MEDICAL ONCOLOGY or its sub-specialties of RADIATION ONCOLOGY or SURGICAL ONCOLOGY.',\n",
       "  'terms': ['Oncologist', 'Oncologistas', 'Oncologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072104': {'ID': 'D000072104',\n",
       "  'name': 'Nefrologistas[Nephrologists]',\n",
       "  'scope': 'Qualified medical professionals who specialize in treating KIDNEY DISEASES.',\n",
       "  'terms': ['Nefrologistas', 'Nephrologist', 'Nephrologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072105': {'ID': 'D000072105',\n",
       "  'name': 'Superóxido Dismutase-1[Superoxide Dismutase-1]',\n",
       "  'scope': 'A superoxide dismutase (SOD1) that requires copper and zinc ions for its activity to destroy SUPEROXIDE FREE RADICALS within the CYTOPLASM. Mutations in the SOD1 gene are associated with AMYOTROPHIC LATERAL SCLEROSIS-1.',\n",
       "  'terms': ['Cu Zn Superoxide Dismutase',\n",
       "   'Cu-Zn Superoxide Dismutase',\n",
       "   'Cu-Zn Superóxido Dismutase',\n",
       "   'Cuprozinc Superoxide Dismutase',\n",
       "   'Proteína SOD-1',\n",
       "   'Proteína SOD1',\n",
       "   'SOD 1 Protein',\n",
       "   'SOD-1 Protein',\n",
       "   'SOD1 Protein',\n",
       "   'Superoxide Dismutase 1',\n",
       "   'Superoxide Dismutase, Cu-Zn',\n",
       "   'Superoxide Dismutase, Cuprozinc',\n",
       "   'Superoxide Dismutase-1',\n",
       "   'Superóxido Dismutase 1',\n",
       "   'Superóxido Dismutase Cu-Zn',\n",
       "   'Superóxido Dismutase Cuprozinco',\n",
       "   'Superóxido Dismutase de Cobre-Zinco',\n",
       "   'Superóxido Dismutase-1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072106': {'ID': 'D000072106',\n",
       "  'name': 'Pneumologistas[Pulmonologists]',\n",
       "  'scope': 'Physicians who specialize in treating disorders of the RESPIRATORY SYSTEM, especially diagnosing and treating diseases and defects of the lungs and bronchial tree.',\n",
       "  'terms': ['Pneumologistas', 'Pulmonologist', 'Pulmonologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072117': {'ID': 'D000072117',\n",
       "  'name': 'Conselheiros[Counselors]',\n",
       "  'scope': 'Professionals trained in providing information, guidance, and recommendations to individual clients or families to support their decision making and development of coping skills.',\n",
       "  'terms': ['Conselheiros', 'Counselor', 'Counselors'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072137': {'ID': 'D000072137',\n",
       "  'name': 'Vaping[Vaping]',\n",
       "  'scope': 'SMOKING vapors produced from ELECTRONIC NICOTINE DELIVERY SYSTEMS.',\n",
       "  'terms': ['Cigarette Use, Electronic',\n",
       "   'Cigarette Uses, Electronic',\n",
       "   'Electronic Cigarette Use',\n",
       "   'Electronic Cigarette Uses',\n",
       "   'Use, Electronic Cigarette',\n",
       "   'Uses, Electronic Cigarette',\n",
       "   'Uso de Cigarro Eletrônico',\n",
       "   'Vape',\n",
       "   'Vape',\n",
       "   'Vapes',\n",
       "   'Vaping',\n",
       "   'Vaping'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072138': {'ID': 'D000072138',\n",
       "  'name': 'Mosquitos Vetores[Mosquito Vectors]',\n",
       "  'scope': 'Mosquitoes (members of the family CULICIDAE) that transmit pathogens or their intermediate forms from one host to another.',\n",
       "  'terms': ['Mosquito Vector',\n",
       "   'Mosquito Vectors',\n",
       "   'Mosquitos Vetores',\n",
       "   'Vector, Mosquito',\n",
       "   'Vectors, Mosquito'],\n",
       "  'qualifier': 'anatomy & histology'},\n",
       " 'D000072139': {'ID': 'D000072139',\n",
       "  'name': 'Vírus Gigantes[Giant Viruses]',\n",
       "  'scope': 'DNA viruses that have genomes up to several megabases in length and infect primarily single-celled EUKARYOTES.',\n",
       "  'terms': ['Giant Virus',\n",
       "   'Giant Viruses',\n",
       "   'Giruses',\n",
       "   'Gírus',\n",
       "   'Megavirales',\n",
       "   'Megavirales',\n",
       "   'Megaviridae',\n",
       "   'Megaviridae',\n",
       "   'Megavírus',\n",
       "   'Virus, Giant',\n",
       "   'Viruses, Giant',\n",
       "   'Vírus Gigantes'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072140': {'ID': 'D000072140',\n",
       "  'name': 'Reumatologistas[Rheumatologists]',\n",
       "  'scope': 'Physicians who specialize in treating RHEUMATIC DISEASES.',\n",
       "  'terms': ['Reumatologistas', 'Rheumatologist', 'Rheumatologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072141': {'ID': 'D000072141',\n",
       "  'name': 'Neurologistas[Neurologists]',\n",
       "  'scope': 'Qualified medical professionals who specialize in treating NERVOUS SYSTEM DISEASES.',\n",
       "  'terms': ['Neurologist', 'Neurologistas', 'Neurologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072142': {'ID': 'D000072142',\n",
       "  'name': 'Patologistas[Pathologists]',\n",
       "  'scope': 'Physicians who assess changes in cellular or tissue structure and function to diagnose disease processes.',\n",
       "  'terms': ['<i>reunidos</i>', 'Pathologist', 'Pathologists', 'Patologistas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072143': {'ID': 'D000072143',\n",
       "  'name': 'Pediatras[Pediatricians]',\n",
       "  'scope': 'Qualified medical professionals specializing in maintaining health and providing medical care to children from birth through adolescence.',\n",
       "  'terms': ['Pediatras', 'Pediatrician', 'Pediatricians'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072156': {'ID': 'D000072156',\n",
       "  'name': 'Neonatologistas[Neonatologists]',\n",
       "  'scope': 'Physicians who specialize in providing medical care to newborn infants.',\n",
       "  'terms': ['Neonatologist', 'Neonatologistas', 'Neonatologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072157': {'ID': 'D000072157',\n",
       "  'name': 'Fisiatras[Physiatrists]',\n",
       "  'scope': 'Physicians specializing in treating physical disorders and injuries affecting the brain, spinal cord, nerves, bones, joints, ligaments, muscles, and tendons.',\n",
       "  'terms': ['Fisiatras', 'Physiatrist', 'Physiatrists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072158': {'ID': 'D000072158',\n",
       "  'name': 'Epidemiologistas[Epidemiologists]',\n",
       "  'scope': 'Qualified medical professionals who study the causes, incidence, and characteristic behavior of disease outbreaks or other health-related conditions and determine the interrelationships of hosts, agents, and environment related to the distribution and control of diseases.',\n",
       "  'terms': ['Epidemiologist', 'Epidemiologistas', 'Epidemiologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072159': {'ID': 'D000072159',\n",
       "  'name': 'Complexo Dinactina[Dynactin Complex]',\n",
       "  'scope': 'A multi-subunit protein of EUKARYOTIC CELLS. It functions in bidirectional intracellular transport of ORGANELLES and CYTOPLASMIC VESICLES by linking them to DYNEIN and KINESIN.',\n",
       "  'terms': ['150 kDa Dynein Associated Protein',\n",
       "   '150 kDa Dynein-Associated Protein',\n",
       "   '150-kDa Dynein-Associated Protein',\n",
       "   'Cadeia Leve de Dinactina de 22 KDa',\n",
       "   'Cadeia Leve de Dinactina p22',\n",
       "   'Complexo Dinactina',\n",
       "   'Dinactina',\n",
       "   'Dinactina 1',\n",
       "   'Dinactina-1',\n",
       "   'Dinactina-2',\n",
       "   'Dinactina-3',\n",
       "   'Dinactina-4',\n",
       "   'Dinactinas',\n",
       "   'Dinamitina p50',\n",
       "   'Dynactin',\n",
       "   'Dynactin 1',\n",
       "   'Dynactin 2',\n",
       "   'Dynactin 3',\n",
       "   'Dynactin 4',\n",
       "   'Dynactin Complex',\n",
       "   'Dynactin Subunit 1',\n",
       "   'Dynactin Subunit 2',\n",
       "   'Dynactin Subunit 3',\n",
       "   'Dynactin Subunit 4',\n",
       "   'Dynactin-2',\n",
       "   'Dynactin-3',\n",
       "   'Dynactin-4',\n",
       "   'Dynactins',\n",
       "   'Dynamitin Protein',\n",
       "   'Dynamitin, p50',\n",
       "   'Dynein Activator Protein',\n",
       "   'Dynein Associated Protein, 150 kDa',\n",
       "   'Dynein-Associated Protein, 150-kDa',\n",
       "   'Proteína Associada à Dineína de 150 kDa',\n",
       "   'Proteína Ativadora de Dineína',\n",
       "   'Proteína Dinamitina',\n",
       "   'Proteína de 150 kDa Associada à Dineína',\n",
       "   'Subunidade 1 de Dinactina',\n",
       "   'Subunidade 2 de Dinactina',\n",
       "   'Subunidade 3 de Dinactina',\n",
       "   'Subunidade 4 de Dinactina',\n",
       "   'p150 (Glued)',\n",
       "   'p150(Glued)',\n",
       "   'p22 Dynactin Light Chain',\n",
       "   'p50 Dynamitin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072160': {'ID': 'D000072160',\n",
       "  'name': 'Proteína Tumoral p73[Tumor Protein p73]',\n",
       "  'scope': 'A homolog of p53 TUMOR SUPPRESSOR PROTEIN that encodes full-length trans-activating and N-terminally-truncated (DeltaN) isoforms. Detection of splice variants and isoforms in the nervous system (human TELENCEPHALON, CHOROID PLEXUS; CEREBROSPINAL FLUID), embryonic tissue, human BREAST CANCER; OVARIAN CANCER, suggest roles in cellular differentiation.',\n",
       "  'terms': ['Human Tap73 Protein',\n",
       "   'Protein p73',\n",
       "   'Protein p73, Tumor',\n",
       "   'Protein, Human Tap73',\n",
       "   'Protein, TP73',\n",
       "   'Protein, p73',\n",
       "   'Proteína Humana Tap73',\n",
       "   'Proteína Supressora de Tumor p73',\n",
       "   'Proteína TP73',\n",
       "   'Proteína Tap73 Humana',\n",
       "   'Proteína Tap73, Humana',\n",
       "   'Proteína Tumoral p73',\n",
       "   'Proteína p73',\n",
       "   'TP73 Protein',\n",
       "   'Tap73 Protein, Human',\n",
       "   'Tumor Protein p73',\n",
       "   'Tumor Suppressor Protein p73',\n",
       "   'p73 Protein',\n",
       "   'p73 alpha',\n",
       "   'p73 beta',\n",
       "   'p73, Protein',\n",
       "   'p73, Tumor Protein',\n",
       "   'p73-alfa',\n",
       "   'p73-alpha',\n",
       "   'p73-beta',\n",
       "   'p73-beta'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072161': {'ID': 'D000072161',\n",
       "  'name': 'Cirurgiões Ortopédicos[Orthopedic Surgeons]',\n",
       "  'scope': 'Physicians specializing in medical, surgical, and physical methods used to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.',\n",
       "  'terms': ['Cirurgiões Ortopédicos',\n",
       "   'Orthopedic Surgeon',\n",
       "   'Orthopedic Surgeons',\n",
       "   'Orthopedist',\n",
       "   'Orthopedists',\n",
       "   'Ortopedistas',\n",
       "   'Surgeon, Orthopedic',\n",
       "   'Surgeons, Orthopedic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072162': {'ID': 'D000072162',\n",
       "  'name': 'Optometristas[Optometrists]',\n",
       "  'scope': 'Qualified professionals trained in primary eye and vision care, including measurement of visual abilities, diagnosing disorders of the visual system and provision of treatment such as prescriptions for correction of visual defects with lenses or glasses and vision therapy.',\n",
       "  'terms': ['Optometrist', 'Optometristas', 'Optometrists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072163': {'ID': 'D000072163',\n",
       "  'name': 'Oftalmologistas[Ophthalmologists]',\n",
       "  'scope': 'Qualified medical professionals specializing in medical and surgical treatment of defects and diseases of the eye.',\n",
       "  'terms': ['Oftalmologistas', 'Ophthalmologist', 'Ophthalmologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072176': {'ID': 'D000072176',\n",
       "  'name': 'Supercondutividade[Superconductivity]',\n",
       "  'scope': 'Expulsion of a magnetic field',\n",
       "  'terms': ['Bobina Supercondutora',\n",
       "   'Coil, Superconducting',\n",
       "   'Coils, Superconducting',\n",
       "   'Efeito Meissner',\n",
       "   'Effect, Meissner',\n",
       "   'Imãs Supercondutores',\n",
       "   'Magnet, Superconducting',\n",
       "   'Magnets, Superconducting',\n",
       "   'Meissner Effect',\n",
       "   'Superconducting Coil',\n",
       "   'Superconducting Coils',\n",
       "   'Superconducting Magnet',\n",
       "   'Superconducting Magnets',\n",
       "   'Superconductivities',\n",
       "   'Superconductivity',\n",
       "   'Superconductor',\n",
       "   'Superconductors',\n",
       "   'Supercondutividade',\n",
       "   'Supercondutores'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072177': {'ID': 'D000072177',\n",
       "  'name': 'Radiologistas[Radiologists]',\n",
       "  'scope': 'Physicians specializing in the use of x-ray and other forms of radiant energy to diagnosis and treatment of disease.',\n",
       "  'terms': ['Radiologist', 'Radiologistas', 'Radiologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072178': {'ID': 'D000072178',\n",
       "  'name': 'Urologistas[Urologists]',\n",
       "  'scope': 'Physicians specializing in the diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male.',\n",
       "  'terms': ['Urologist', 'Urologistas', 'Urologists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072179': {'ID': 'D000072179',\n",
       "  'name': 'Proteína 1 Semelhante a Receptor de Interleucina-1[Interleukin-1 Receptor-Like 1 Protein]',\n",
       "  'scope': 'A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It  contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION.',\n",
       "  'terms': ['IL1RL1 Protein',\n",
       "   'Interleukin 1 Receptor Like 1 Protein',\n",
       "   'Interleukin 1 Receptor Related Protein',\n",
       "   'Interleukin 1 Receptor-Related Protein',\n",
       "   'Interleukin 33 Receptor',\n",
       "   'Interleukin-1 Receptor-Like 1 Protein',\n",
       "   'Interleukin-33 Receptor',\n",
       "   'Proteína 1 Semelhante a Receptor de Interleucina-1',\n",
       "   'Proteína IL1RL1',\n",
       "   'Proteína Relacionada ao Receptor de Interleucina 1',\n",
       "   'Receptor de Interleucina-33',\n",
       "   'Receptor, Interleukin-33'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072180': {'ID': 'D000072180',\n",
       "  'name': 'Fosfatases de Fosfoinositídeos[Phosphoinositide Phosphatases]',\n",
       "  'scope': 'Phosphatases that catalyze the hydrolysis of phosphate groups on PHOSPHATIDYLINOSITOLS.',\n",
       "  'terms': ['Fosfatases de Fosfoinositídeos',\n",
       "   'Inositol Fosfato Fosfatases',\n",
       "   'Phosphatase, Phosphoinositide',\n",
       "   'Phosphatases, Phosphoinositide',\n",
       "   'Phosphoinositide Phosphatase',\n",
       "   'Phosphoinositide Phosphatases'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072181': {'ID': 'D000072181',\n",
       "  'name': 'Inositol Polifosfato 5-Fosfatases[Inositol Polyphosphate 5-Phosphatases]',\n",
       "  'scope': \"Phosphoinositide phosphatases that catalyze the removal of the 5' phosphate from INOSITOL 1,4,5-TRISPHOSPHATE  or myo-inositol 1,3,4,5-tetrakisphosphate, resulting in inositol 1,4-bisphosphate and phosphate. They have important functions in the metabolism of INOSITOL PHOSPHATES and inositol 1,4,5-trisphosphate signaling pathways such as CALCIUM SIGNALING.\",\n",
       "  'terms': ['1,4,5-Trifosfato-1,2,4,5-Tetraquisfosfato 5-Fosfatase',\n",
       "   '1,4,5-Triphosphate-1,2,4,5-Tetrakisphosphate 5-Phosphatase',\n",
       "   'Inositol 5 Phosphatase',\n",
       "   'Inositol 5-Fosfatase',\n",
       "   'Inositol 5-Phosphatase',\n",
       "   'Inositol Polifosfato 5-Fosfatase',\n",
       "   'Inositol Polifosfato 5-Fosfatases',\n",
       "   'Inositol Polyphosphate 5 Phosphatase',\n",
       "   'Inositol Polyphosphate 5 Phosphatases',\n",
       "   'Inositol Polyphosphate 5-Phosphatase',\n",
       "   'Inositol Polyphosphate 5-Phosphatases',\n",
       "   'Inositol Trifosfato 5-Fosfatase',\n",
       "   'Inositol Triphosphate 5 Phosphatase',\n",
       "   'Inositol Triphosphate 5-Phosphatase',\n",
       "   \"Inositol-1,4,5-Trifosfato 5'-Fosfatase\",\n",
       "   'Inositol-1,4,5-Trifosfato 5-Fosfatase',\n",
       "   \"Inositol-1,4,5-Trisphosphate 5'-Phosphatase\",\n",
       "   'Inositol-1,4,5-Trisphosphate 5-Phosphatase',\n",
       "   'Inositol-Polyphosphate 5-Phosphatase',\n",
       "   \"Ins(1,4,5)P3 5'-Fosfatase\",\n",
       "   \"Ins(1,4,5)P3 5'-Phosphatase\"],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072182': {'ID': 'D000072182',\n",
       "  'name': 'Instalações não Médicas Públicas e Privadas[Non-Medical Public and Private Facilities]',\n",
       "  'scope': 'Spaces and needed equipment provided for a specific, non-medical  function or service used by the public or specific group of persons.',\n",
       "  'terms': ['Instalações não Médicas Públicas e Privadas',\n",
       "   'Non Medical Public and Private Facilities',\n",
       "   'Non-Medical Public and Private Facilities'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072183': {'ID': 'D000072183',\n",
       "  'name': 'Fosfatidilinositol-3,4,5-Trifosfato 5-Fosfatases[Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases]',\n",
       "  'scope': 'Phosphoinositide phosphatases that catalyze the dephosphorylation (hydrolysis) of  phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P(3)) to produce PtdIns(3,4)P(2), which negatively regulates the PI3K ( 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES) pathways. They contain an SH2 DOMAIN and STERILE ALPHA MOTIF and have important functions in regulating the immune response and other cellular processes in vertebrates.',\n",
       "  'terms': ['Fosfatases SHIP',\n",
       "   'Fosfatidilinositol-3,4,5-Trifosfato 5-Fosfatases',\n",
       "   'Fosfatidilinositol-3,4,5-Trisfosfato 5-Fosfatases',\n",
       "   'Inositol Fosfatases que Contêm Domínio 2 de Homologia com Src',\n",
       "   'Inositol Fosfatases que Contêm Domínio de Homologia 2 com Src',\n",
       "   'Phosphatases, SHIP',\n",
       "   'Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases',\n",
       "   'SHIP Phosphatases',\n",
       "   'Src Homology 2 Domain Containing Inositol Phosphatases',\n",
       "   'Src Homology 2 Domain-Containing Inositol Phosphatases'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072184': {'ID': 'D000072184',\n",
       "  'name': 'Enfermeiras Especialistas[Nurse Specialists]',\n",
       "  'scope': 'Nursing professionals whose practice is limited to A particular area or discipline of medicine.',\n",
       "  'terms': ['Enfermeiras Especialistas',\n",
       "   'Nurse Specialist',\n",
       "   'Nurse Specialists',\n",
       "   'Specialist, Nurse',\n",
       "   'Specialists, Nurse'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072196': {'ID': 'D000072196',\n",
       "  'name': 'Fertilinas[Fertilins]',\n",
       "  'scope': 'Sperm surface proteins involved in sperm-egg fusion. They consist of two subunits, fertilin alpha (ADAM1a) and beta (ADAM2), both of which belong to the metalloprotease-disintegrin protein family. The beta subunit does not have catalytic activity.',\n",
       "  'terms': ['ADAM 1a Protein',\n",
       "   'ADAM 2 Protein',\n",
       "   'ADAM1 Protein',\n",
       "   'ADAM1a Protein',\n",
       "   'ADAM2 Protein',\n",
       "   'Fertilin',\n",
       "   'Fertilin Protein',\n",
       "   'Fertilin alpha',\n",
       "   'Fertilin beta',\n",
       "   'Fertilina',\n",
       "   'Fertilina alfa',\n",
       "   'Fertilina beta',\n",
       "   'Fertilinas',\n",
       "   'Fertilins',\n",
       "   'PH 30 Fusion Protein',\n",
       "   'PH 30 Protein',\n",
       "   'PH 30 alpha',\n",
       "   'PH 30 beta',\n",
       "   'PH-30 Fusion Protein',\n",
       "   'PH-30 Protein',\n",
       "   'PH-30 alpha',\n",
       "   'PH-30 beta',\n",
       "   'PH-30 beta',\n",
       "   'Proteína ADAM 1a',\n",
       "   'Proteína ADAM 2',\n",
       "   'Proteína ADAM1',\n",
       "   'Proteína ADAM1a',\n",
       "   'Proteína ADAM2',\n",
       "   'Proteína Fertilina',\n",
       "   'Proteína PH-30',\n",
       "   'Proteína de Fusão PH 30',\n",
       "   'Proteína de Fusão PH-30',\n",
       "   'alpha, Fertilin',\n",
       "   'alpha, PH-30',\n",
       "   'beta, Fertilin',\n",
       "   'beta, PH-30'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072197': {'ID': 'D000072197',\n",
       "  'name': 'Proteína ADAM10[ADAM10 Protein]',\n",
       "  'scope': 'A disintegrin and metalloproteinase domain-containing protein. It cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA between ALANINE 76 and VALINE 77 to its functional form, as well as several other CELL SURFACE PROTEINS to their soluble forms, including AMYLOID BETA-PROTEIN PRECURSOR and PRION PROTEIN.',\n",
       "  'terms': ['ADAM 10 Protein',\n",
       "   'ADAM-10 Protein',\n",
       "   'ADAM10 Protein',\n",
       "   'Antigen, CD156c',\n",
       "   'Antigen, CD156w',\n",
       "   'Antígeno CD156c',\n",
       "   'Antígeno CD156w',\n",
       "   'CD156c Antigen',\n",
       "   'CD156w Antigen',\n",
       "   'Disintegrin and Metalloproteinase Domain Containing Protein 10',\n",
       "   'Disintegrin and Metalloproteinase Domain-Containing Protein 10',\n",
       "   'Proteína 10 com Domínios Desintegrina e Metaloproteinase',\n",
       "   'Proteína 10 que Contém o Domínio de Desintegrina e Metaloproteinase',\n",
       "   'Proteína 10 que Contém os Domínios Desintegrina e Metaloproteinase',\n",
       "   'Proteína ADAM-10',\n",
       "   'Proteína ADAM10',\n",
       "   'Proteína com Domínio Desintegrina e Metaloproteinase 10',\n",
       "   'Proteína com Domínios Desintegrina e Metaloproteinase 10',\n",
       "   'Proteína que Contém os Domínios de Desintegrina e Metaloproteinase 10'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072198': {'ID': 'D000072198',\n",
       "  'name': 'Proteína ADAM17[ADAM17 Protein]',\n",
       "  'scope': 'A disintegrin and metalloproteinase domain-containing protein that cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA to its mature form. It cleaves several other CELL SURFACE PROTEINS, including INTERLEUKIN-1 RECEPTOR TYPE II; TRANSFORMING GROWTH FACTOR ALPHA; L-SELECTIN; MUCIN-1; and AMYLOID BETA-PROTEIN PRECURSOR. It can also function as an activator of the Notch signaling pathway by mediating the cleavage of NOTCH RECEPTORS.',\n",
       "  'terms': ['ADAM 17 Protein',\n",
       "   'ADAM-17',\n",
       "   'ADAM-17',\n",
       "   'ADAM-17 Protein',\n",
       "   'ADAM17 Protein',\n",
       "   'Antigen, CD156b',\n",
       "   'Antígeno CD156b',\n",
       "   'CD156b Antigen',\n",
       "   'Convertase do Fator de Necrose Tumoral alfa',\n",
       "   'Convertase, TNF-alpha',\n",
       "   'Disintegrin and Metalloproteinase Domain Containing Protein 17',\n",
       "   'Disintegrin and Metalloproteinase Domain-Containing Protein 17',\n",
       "   'Enzima Conversora de Fator de Necrose Tumoral alfa',\n",
       "   'Enzima Conversora de TNF-alfa',\n",
       "   'Enzima Convertedora de Fator de Necrose Tumoral alfa',\n",
       "   'Enzima Convertedora de TNF-alfa',\n",
       "   'Enzima TACA',\n",
       "   'Enzima TACE',\n",
       "   'Proteína 17 que Contém o Domínio de Desintegrina e Metaloproteinase',\n",
       "   'Proteína ADAM-17',\n",
       "   'Proteína ADAM17',\n",
       "   'TACA (Enzyme)',\n",
       "   'TACE (Enzyme)',\n",
       "   'TNF alpha Convertase',\n",
       "   'TNF alpha Converting Enzyme',\n",
       "   'TNF-alfa Convertase',\n",
       "   'TNF-alpha Convertase',\n",
       "   'TNF-alpha Converting Enzyme',\n",
       "   'Tumor Necrosis Factor Alpha Convertase',\n",
       "   'Tumor Necrosis Factor alpha Converting Enzyme',\n",
       "   'Tumor Necrosis Factor-alpha Convertase',\n",
       "   'Tumor Necrosis Factor-alpha Converting Enzyme'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072199': {'ID': 'D000072199',\n",
       "  'name': 'Proteína ADAM12[ADAM12 Protein]',\n",
       "  'scope': 'A disintegrin and metalloproteinase domain-containing protein that is expressed as two alternatively-spliced forms: a long transmembrane form (ADAM12-L) and a short soluble form  (ADAM12-S). It modulates the cleavage of INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS and may also regulate CELL FUSION during MYOGENESIS.',\n",
       "  'terms': ['ADAM 12 Protein',\n",
       "   'ADAM-12 Protein',\n",
       "   'ADAM12 L Protein',\n",
       "   'ADAM12 Protein',\n",
       "   'ADAM12 S Protein',\n",
       "   'ADAM12-L Protein',\n",
       "   'ADAM12-S Protein',\n",
       "   'Disintegrin and Metalloproteinase Domain Containing Protein 12',\n",
       "   'Disintegrin and Metalloproteinase Domain-Containing Protein 12',\n",
       "   'Meltrin alpha Protein',\n",
       "   'Meltrin-alpha Protein',\n",
       "   'Proteína 12 com Domínios Desintegrina e Metaloproteinase',\n",
       "   'Proteína 12 que Contém os Domínios Desintegrina e Metaloproteinase',\n",
       "   'Proteína ADAM 12',\n",
       "   'Proteína ADAM-12',\n",
       "   'Proteína ADAM12',\n",
       "   'Proteína ADAM12-L',\n",
       "   'Proteína ADAM12-S',\n",
       "   'Proteína Meltrina-alfa'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072200': {'ID': 'D000072200',\n",
       "  'name': 'Autoantígeno Ku[Ku Autoantigen]',\n",
       "  'scope': 'An ATP-dependent DNA HELICASE that preferentially binds SINGLE-STRANDED DNA. It is a heterodimer consisting of an 80 kDa subunit (XRCC5) and 70 kDa subunit (XRCC6) that functions with DNA LIGASE IV in the repair of DOUBLE-STRANDED DNA BREAKS and V(D)J RECOMBINATION.',\n",
       "  'terms': ['Antigen, G22P1',\n",
       "   'Antigen, Ku',\n",
       "   'Antigen, Ku70',\n",
       "   'Antigen, Ku80',\n",
       "   'Antígeno G22P1',\n",
       "   'Antígeno Ku70',\n",
       "   'Antígeno Ku80',\n",
       "   'Autoantigen, Ku',\n",
       "   'Autoantígeno Ku',\n",
       "   'Autoantígeno Ku de 70 kDa',\n",
       "   'Autoantígeno Ku de 80 kDa',\n",
       "   'G22P1 Antigen',\n",
       "   'Heterodimer, Ku',\n",
       "   'Heterodímero Ku',\n",
       "   'Ku Antigen',\n",
       "   'Ku Autoantigen',\n",
       "   'Ku Autoantigen, 70 kDa',\n",
       "   'Ku Autoantigen, 80 kDa',\n",
       "   'Ku Heterodimer',\n",
       "   'Ku Protein',\n",
       "   'Ku70 Antigen',\n",
       "   'Ku80 Antigen',\n",
       "   'Proteína 5 Complementar de Reparo de Raio-X',\n",
       "   'Proteína 6 Complementar de Reparo de Raio-X',\n",
       "   'Proteína Ku',\n",
       "   'Proteína XRCC5',\n",
       "   'Proteína XRCC6',\n",
       "   'X ray Repair Cross Complementing Protein 5',\n",
       "   'X ray Repair Cross Complementing Protein 6',\n",
       "   'X-ray Repair Cross-Complementing Protein 5',\n",
       "   'X-ray Repair Cross-Complementing Protein 6',\n",
       "   'XRCC5 Protein',\n",
       "   'XRCC6 Protein'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072216': {'ID': 'D000072216',\n",
       "  'name': 'Glicoproteínas da Zona Pelúcida[Zona Pellucida Glycoproteins]',\n",
       "  'scope': 'A glycoprotein of the ZONA PELLUCIDA that is essential for sperm binding and formation of the zona matrix.',\n",
       "  'terms': ['Glicoproteína-1 da Zona Pelúcida',\n",
       "   'Glicoproteína-2 da Zona Pelúcida',\n",
       "   'Glicoproteína-3 da Zona Pelúcida',\n",
       "   'Glicoproteínas da Zona Pelúcida',\n",
       "   'Glycoprotein-1, Zona Pellucida',\n",
       "   'Glycoprotein-2, Zona Pellucida',\n",
       "   'Glycoprotein-3, Zona Pellucida',\n",
       "   'Glycoproteins, Zona Pellucida',\n",
       "   'Pellucida Glycoprotein-1, Zona',\n",
       "   'Pellucida Glycoprotein-2, Zona',\n",
       "   'Pellucida Glycoprotein-3, Zona',\n",
       "   'Pellucida Glycoproteins, Zona',\n",
       "   'Proteins, ZP',\n",
       "   'Proteínas ZP',\n",
       "   'Receptores de Espermatozóide',\n",
       "   'Receptores de Espermatozóides',\n",
       "   'Receptors, Sperm',\n",
       "   'Sperm Receptors',\n",
       "   'ZP Proteins',\n",
       "   'Zona Pellucida Glycoprotein 1',\n",
       "   'Zona Pellucida Glycoprotein 2',\n",
       "   'Zona Pellucida Glycoprotein 3',\n",
       "   'Zona Pellucida Glycoprotein-1',\n",
       "   'Zona Pellucida Glycoprotein-2',\n",
       "   'Zona Pellucida Glycoprotein-3',\n",
       "   'Zona Pellucida Glycoproteins'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072218': {'ID': 'D000072218',\n",
       "  'name': 'Endodontistas[Endodontists]',\n",
       "  'scope': 'Dentists specializing in the treatment of injuries and diseases of the DENTAL PULP.',\n",
       "  'terms': ['<i>eame</i>',\n",
       "   '<i>exaem</i>',\n",
       "   '<i>examesem</i>',\n",
       "   '<i>exmae</i>',\n",
       "   '<i>messensibilidade</i>',\n",
       "   'Endodontist',\n",
       "   'Endodontista',\n",
       "   'Endodontistas',\n",
       "   'Endodontists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072219': {'ID': 'D000072219',\n",
       "  'name': 'Geriatras[Geriatricians]',\n",
       "  'scope': 'Physicians specializing in physiological and pathological aspects of aging and the aged, including the clinical problems of senescence and senility.',\n",
       "  'terms': ['Geriatras',\n",
       "   'Geriatrician',\n",
       "   'Geriatricians',\n",
       "   'Gerontologist',\n",
       "   'Gerontologists',\n",
       "   'Gerontólogos'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072220': {'ID': 'D000072220',\n",
       "  'name': 'Otorrinolaringologistas[Otolaryngologists]',\n",
       "  'scope': 'Physicians specializing in the treatment of disorders of the ear, nose, and throat.',\n",
       "  'terms': ['Otolaringologistas',\n",
       "   'Otolaryngologist',\n",
       "   'Otolaryngologists',\n",
       "   'Otologist',\n",
       "   'Otologistas',\n",
       "   'Otologists',\n",
       "   'Otorrinolaringologistas'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072221': {'ID': 'D000072221',\n",
       "  'name': 'Enfermeiras Neonatologistas[Nurses, Neonatal]',\n",
       "  'scope': 'Qualified nursing professionals specializing in care of newborn infants.',\n",
       "  'terms': ['Enfermeiras Neonatologistas',\n",
       "   'Neonatal Nurse',\n",
       "   'Neonatal Nurses',\n",
       "   'Nurse, Neonatal',\n",
       "   'Nurses, Neonatal'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072222': {'ID': 'D000072222',\n",
       "  'name': 'Enfermeiras Pediátricas[Nurses, Pediatric]',\n",
       "  'scope': 'Qualified nursing professionals specializing in the care of children from birth to adolescence.',\n",
       "  'terms': ['Enfermeiras Pediátricas',\n",
       "   'Enfermeiras de Pediatria',\n",
       "   'Enfermeiros Pediátricos',\n",
       "   'Enfermeiros de Pediatria',\n",
       "   'Nurse, Pediatric',\n",
       "   'Nurses, Pediatric',\n",
       "   'Pediatric Nurse',\n",
       "   'Pediatric Nurses'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072223': {'ID': 'D000072223',\n",
       "  'name': 'Alergistas[Allergists]',\n",
       "  'scope': 'Physicians specializing in treating individuals with hypersensitivity to ALLERGENS.',\n",
       "  'terms': ['Alergistas', 'Allergist', 'Allergists'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072224': {'ID': 'D000072224',\n",
       "  'name': 'Proteína 11 Semelhante a Bcl-2[Bcl-2-Like Protein 11]',\n",
       "  'scope': 'A BCL-2-like protein that has a C-terminal BCL-2 homology (BH3) domain and forms heterodimers with other BCL-2 FAMILY PROTEINS. It is a strong inducer of APOPTOSIS and ANOIKIS; several isoforms are expressed (BimEL, Bim L, Bim-alpha, Bim-s; and Bim-gamma) that have different potencies for inducing apoptosis.',\n",
       "  'terms': ['11, Bcl-2-Like Protein',\n",
       "   'BCL2L11 Protein',\n",
       "   'BIM Bcl-2-Binding Protein',\n",
       "   'BIM Protein',\n",
       "   'Bcl 2 Binding Protein, BIM',\n",
       "   'Bcl 2 Interacting Mediator of Cell Death',\n",
       "   'Bcl 2 Like Protein 11',\n",
       "   'Bcl-2-Binding Protein, BIM',\n",
       "   'Bcl-2-Interacting Mediator of Cell Death',\n",
       "   'Bcl-2-Like Protein 11',\n",
       "   'Mediador de Morte Celular de Interação com Bcl-2',\n",
       "   'Mediador de Morte Celular que Interage com Bcl-2',\n",
       "   'Protein 11, Bcl-2-Like',\n",
       "   'Protein, BCL2L11',\n",
       "   'Protein, BIM',\n",
       "   'Protein, BIM Bcl-2-Binding',\n",
       "   'Proteína 11 Semelhante a Bcl-2',\n",
       "   'Proteína BCL2L11',\n",
       "   'Proteína BIM',\n",
       "   'Proteína de Ligação a Bcl-2 BIM'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072226': {'ID': 'D000072226',\n",
       "  'name': 'Angiografia por Tomografia Computadorizada[Computed Tomography Angiography]',\n",
       "  'scope': 'A non-invasive method that uses a CT scanner for capturing images of\\xa0blood vessels and tissues.\\xa0A CONTRAST MATERIAL is injected,\\xa0which helps produce detailed images that aid in diagnosing VASCULAR DISEASES.',\n",
       "  'terms': ['Angiografia por CT',\n",
       "   'Angiografia por Tomografia Computadorizada',\n",
       "   'Angiographies, CT',\n",
       "   'Angiographies, Computed Tomography',\n",
       "   'Angiography, CT',\n",
       "   'Angiography, Computed Tomography',\n",
       "   'CT Angiografia',\n",
       "   'CT Angiographies',\n",
       "   'CT Angiography',\n",
       "   'Computed Tomography Angiographies',\n",
       "   'Computed Tomography Angiography',\n",
       "   'Tomography Angiographies, Computed',\n",
       "   'Tomography Angiography, Computed'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072227': {'ID': 'D000072227',\n",
       "  'name': 'Prótese de Ombro[Shoulder Prosthesis]',\n",
       "  'scope': 'Replacement for a SHOULDER JOINT.',\n",
       "  'terms': ['Articulação Artificial do Ombro',\n",
       "   'Artificial Shoulder Joint',\n",
       "   'Artificial Shoulder Joints',\n",
       "   'Head Prostheses, Humeral',\n",
       "   'Head Prosthesis, Humeral',\n",
       "   'Humeral Head Prostheses',\n",
       "   'Humeral Head Prosthesis',\n",
       "   'Joint, Artificial Shoulder',\n",
       "   'Joints, Artificial Shoulder',\n",
       "   'Ombro Protético',\n",
       "   'Prostheses, Humeral Head',\n",
       "   'Prostheses, Shoulder',\n",
       "   'Prosthesis, Humeral Head',\n",
       "   'Prosthesis, Shoulder',\n",
       "   'Prosthetic Shoulder',\n",
       "   'Prosthetic Shoulders',\n",
       "   'Prótese de Cabeça do Úmero',\n",
       "   'Prótese de Ombro',\n",
       "   'Shoulder Joint, Artificial',\n",
       "   'Shoulder Joints, Artificial',\n",
       "   'Shoulder Prostheses',\n",
       "   'Shoulder Prosthesis',\n",
       "   'Shoulder, Prosthetic',\n",
       "   'Shoulders, Prosthetic'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072228': {'ID': 'D000072228',\n",
       "  'name': 'Artroplastia do Ombro[Arthroplasty, Replacement, Shoulder]',\n",
       "  'scope': 'Replacement of the SHOULDER JOINT.',\n",
       "  'terms': ['Arthroplasties, Shoulder Replacement',\n",
       "   'Arthroplasty, Replacement, Shoulder',\n",
       "   'Arthroplasty, Shoulder Replacement',\n",
       "   'Artroplastia do Ombro',\n",
       "   'Replacement Arthroplasties, Shoulder',\n",
       "   'Replacement Arthroplasty, Shoulder',\n",
       "   'Replacement, Total Shoulder',\n",
       "   'Replacements, Total Shoulder',\n",
       "   'Shoulder Replacement Arthroplasties',\n",
       "   'Shoulder Replacement Arthroplasty',\n",
       "   'Shoulder Replacement, Total',\n",
       "   'Shoulder Replacements, Total',\n",
       "   'Substituição Total do Ombro',\n",
       "   'Total Shoulder Replacement',\n",
       "   'Total Shoulder Replacements'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072229': {'ID': 'D000072229',\n",
       "  'name': 'Reconstrução do Ligamento Cruzado Posterior[Posterior Cruciate Ligament Reconstruction]',\n",
       "  'scope': 'Rebuilding of the POSTERIOR CRUCIATE LIGAMENT to restore functional stability of the knee.',\n",
       "  'terms': ['Posterior Cruciate Ligament Reconstruction',\n",
       "   'Reconstrução do Ligamento Cruzado Posterior'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072230': {'ID': 'D000072230',\n",
       "  'name': 'Resposta Viral Sustentada[Sustained Virologic Response]',\n",
       "  'scope': 'The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.',\n",
       "  'terms': ['Response, Sustained Virologic',\n",
       "   'Resposta Viral Sustentada',\n",
       "   'Suppression, Sustained Viral',\n",
       "   'Supressão Viral Sustentada',\n",
       "   'Sustained Viral Suppression',\n",
       "   'Sustained Viral Suppressions',\n",
       "   'Sustained Virologic Response',\n",
       "   'Sustained Virologic Responses',\n",
       "   'Virologic Response, Sustained'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072231': {'ID': 'D000072231',\n",
       "  'name': 'Dosimetria in Vivo[In Vivo Dosimetry]',\n",
       "  'scope': 'A procedure to measure the amount of radiation absorbed by the body during RADIOTHERAPY by DOSIMETERS in the patient’s skin or natural cavities.',\n",
       "  'terms': ['Dosimetria in Vivo',\n",
       "   'Dosimetries, In Vivo',\n",
       "   'Dosimetry, In Vivo',\n",
       "   'In Vivo Dosimetries',\n",
       "   'In Vivo Dosimetry'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072232': {'ID': 'D000072232',\n",
       "  'name': 'Dosímetros de Radiação[Radiation Dosimeters]',\n",
       "  'scope': 'Devices that measure exposure to IONIZING RADIATION.',\n",
       "  'terms': ['Dosimeter',\n",
       "   'Dosimeter, Radiation',\n",
       "   'Dosimeters',\n",
       "   'Dosimeters, Radiation',\n",
       "   'Dosímetro',\n",
       "   'Dosímetro de Radiação',\n",
       "   'Dosímetros',\n",
       "   'Dosímetros de Radiação',\n",
       "   'Radiation Dosimeter',\n",
       "   'Radiation Dosimeters'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072233': {'ID': 'D000072233',\n",
       "  'name': 'Proteínas de Arcabouço Homer[Homer Scaffolding Proteins]',\n",
       "  'scope': 'Homer proteins belong to a family of adaptor and scaffold proteins which include Homer1, Homer2 and Homer3. Homer1 and Homer2 play a role in the regulation of calcium homeostasis, whereas Homer3 functions in stimulating changes in actin dynamics in neurons and T-cells. Homer proteins are best known as scaffold proteins at the post-synaptic density where they facilitate synaptic signaling. They function as a molecular switch in metabotropic glutamate receptor (MGluR) signaling, and are associated with human Fragile X syndrome.',\n",
       "  'terms': ['Homer 1',\n",
       "   'Homer 1',\n",
       "   'Homer 1 Proteins',\n",
       "   'Homer 1C',\n",
       "   'Homer 1C',\n",
       "   'Homer 1C Proteins',\n",
       "   'Homer 1a',\n",
       "   'Homer 1a',\n",
       "   'Homer 2',\n",
       "   'Homer 2',\n",
       "   'Homer 2 Proteins',\n",
       "   'Homer 3',\n",
       "   'Homer 3',\n",
       "   'Homer 3 Proteins',\n",
       "   'Homer Proteins',\n",
       "   'Homer Scaffolding Proteins',\n",
       "   'Proteins, Homer',\n",
       "   'Proteins, Homer 1',\n",
       "   'Proteins, Homer 1C',\n",
       "   'Proteins, Homer 2',\n",
       "   'Proteins, Homer 3',\n",
       "   'Proteins, Homer Scaffolding',\n",
       "   'Proteínas Homer',\n",
       "   'Proteínas Homer 1C',\n",
       "   'Proteínas Homer 1a',\n",
       "   'Proteínas Homer 2',\n",
       "   'Proteínas Homer 3',\n",
       "   'Proteínas de Arcabouço Homer',\n",
       "   'Scaffolding Proteins, Homer'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072234': {'ID': 'D000072234',\n",
       "  'name': 'Concepção de Doadores[Donor Conception]',\n",
       "  'scope': 'Assisted reproductive techniques where eggs, sperm, both eggs and sperm (double donation), or embryos from donors are used.',\n",
       "  'terms': ['Conception, Donor',\n",
       "   'Conceptions, Donor',\n",
       "   'Concepção de Doadores',\n",
       "   'Concepção do Doador',\n",
       "   'Donor Conception',\n",
       "   'Donor Conceptions'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072235': {'ID': 'D000072235',\n",
       "  'name': 'Fator de Acasalamento[Mating Factor]',\n",
       "  'scope': 'A protein also known as pheromone mating factor that occurs on the surfaces of organisms such as yeast and fungi.',\n",
       "  'terms': ['Agglutination Factor, Sexual',\n",
       "   'Aglutinina-alfa (Fúngica)',\n",
       "   'Factor, Mating',\n",
       "   'Factor, Sexual Agglutination',\n",
       "   'Factor, alpha-Mating',\n",
       "   'Fator de Acasalamento',\n",
       "   'Fator de Acasalamento-alfa',\n",
       "   'Fator de Aglutinação Sexual',\n",
       "   'Fator-alfa (Fúngico)',\n",
       "   'Feromônio Fator-a',\n",
       "   'Feromônio Fator-alfa',\n",
       "   'Hormone, Mating',\n",
       "   'Hormônio de Acasalamento',\n",
       "   'Mating Factor',\n",
       "   'Mating Hormone',\n",
       "   'Pheromone a Factor',\n",
       "   'Pheromone a-Factor',\n",
       "   'Pheromone alpha Factor',\n",
       "   'Pheromone alpha-Factor',\n",
       "   'Sexual Agglutination Factor',\n",
       "   'a-Factor, Pheromone',\n",
       "   'alpha Mating Factor',\n",
       "   'alpha-Agglutinin (Fungal)',\n",
       "   'alpha-Factor (Fungal)',\n",
       "   'alpha-Factor, Pheromone',\n",
       "   'alpha-Mating Factor'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072236': {'ID': 'D000072236',\n",
       "  'name': 'Proteínas Quimiotáticas Aceptoras de Metil[Methyl-Accepting Chemotaxis Proteins]',\n",
       "  'scope': 'Transmembrane sensor receptor proteins that are central components of the chemotactic systems of a number of motile bacterial species which include ESCHERICHIA COLI and SALMONELLA TYPHIMURIUM. Methyl-accepting chemotaxis proteins derive their name from a sensory adaptation process which involves methylation at several glutamyl residues in their cytoplasmic domain. Methyl-accepting chemotaxis proteins trigger chemotactic responses across spatial chemical gradients, causing organisms to move either toward favorable stimuli or away from toxic ones.',\n",
       "  'terms': ['Chemotaxis Proteins, Methyl-Accepting',\n",
       "   'MACP-I',\n",
       "   'MACP-I',\n",
       "   'MACP-II',\n",
       "   'MACP-II',\n",
       "   'Methyl Accepting Chemotaxis Protein 1',\n",
       "   'Methyl Accepting Chemotaxis Protein 2',\n",
       "   'Methyl Accepting Chemotaxis Protein 3',\n",
       "   'Methyl Accepting Chemotaxis Protein I',\n",
       "   'Methyl Accepting Chemotaxis Protein II',\n",
       "   'Methyl Accepting Chemotaxis Protein III',\n",
       "   'Methyl Accepting Chemotaxis Proteins',\n",
       "   'Methyl-Accepting Chemotaxis Protein I',\n",
       "   'Methyl-Accepting Chemotaxis Protein II',\n",
       "   'Methyl-Accepting Chemotaxis Protein III',\n",
       "   'Methyl-Accepting Chemotaxis Proteins',\n",
       "   'Proteins, Methyl-Accepting Chemotaxis',\n",
       "   'Proteína Quimiotática 1 Aceitadora de Metil',\n",
       "   'Proteína Quimiotática 1 Aceptora de Metil',\n",
       "   'Proteína Quimiotática 2 Aceitadora de Metil',\n",
       "   'Proteína Quimiotática 2 Aceptora de Metil',\n",
       "   'Proteína Quimiotática 3 Aceitadora de Metil',\n",
       "   'Proteína Quimiotática 3 Aceptora de Metil',\n",
       "   'Proteína Quimiotática I Aceitadora de Metil',\n",
       "   'Proteína Quimiotática I Aceptora de Metil',\n",
       "   'Proteína Quimiotática II Aceitadora de Metil',\n",
       "   'Proteína Quimiotática II Aceptora de Metil',\n",
       "   'Proteína Quimiotática III Aceitadora de Metil',\n",
       "   'Proteína Quimiotática III Aceptora de Metil',\n",
       "   'Proteínas Quimiotáticas Aceitadoras de Metil',\n",
       "   'Proteínas Quimiotáticas Aceptoras de Metil'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072237': {'ID': 'D000072237',\n",
       "  'name': 'Canal de Potássio ERG1[ERG1 Potassium Channel]',\n",
       "  'scope': 'One of three members of the ether-a-go-go (EAG) POTASSIUM CHANNELS gene family comprising ether-a-go-go (eag), eag-like (elk) and eag-related (erg) subfamilies. Ether-a-go-go-related gene 1 (ERG1) also known as KCNH2, encodes the pore-forming subunit of a rapidly activating-delayed rectifier potassium channel that plays an essential role in the final repolarization of ventricular action potential. Loss-of-function mutations in human hERG1 is associated with life-threatening ARRHYTHMIA.',\n",
       "  'terms': ['Canal de Potássio ERG1',\n",
       "   'Canal de Potássio Relacionado a Éter-A-Go-Go',\n",
       "   'Canal de Proteína-Potássio Kv11.1',\n",
       "   'Channel, ERG1 Potassium',\n",
       "   'Channel, Kv11.1 Protein-Potassium',\n",
       "   'ERG1 Potassium Channel',\n",
       "   'Ether A Go Go Related Potassium Channel 1',\n",
       "   'Ether-A-Go-Go-Related Potassium Channel 1',\n",
       "   'Kv11.1 Protein Potassium Channel',\n",
       "   'Kv11.1 Protein-Potassium Channel',\n",
       "   'Membro 2 da Subfamília H de Canais de Potássio Disparados por Voltagem',\n",
       "   'Potassium Channel, ERG1',\n",
       "   'Potassium Voltage-Gated Channel, Subfamily H, Member 2',\n",
       "   'Protein-Potassium Channel, Kv11.1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072257': {'ID': 'D000072257',\n",
       "  'name': 'Capacidade de Absorbância de Radicais de Oxigênio[Oxygen Radical Absorbance Capacity]',\n",
       "  'scope': 'A measure of the ability of a substance, such as a food, to quench oxygen free radicals in vitro.',\n",
       "  'terms': ['Assay, ORAC',\n",
       "   'Assays, ORAC',\n",
       "   'Capacidade de Absorbância de Radicais de Oxigênio',\n",
       "   'Ensaio ORAC',\n",
       "   'Ensaio TEAC',\n",
       "   'Ensaio da Capacidade Antioxidante de Equivalência Trolox',\n",
       "   'Method, ORAC',\n",
       "   'Methods, ORAC',\n",
       "   'Método ORAC',\n",
       "   'ORAC Assay',\n",
       "   'ORAC Assays',\n",
       "   'ORAC Method',\n",
       "   'ORAC Methods',\n",
       "   'Oxygen Radical Absorbance Capacity',\n",
       "   'TEAC Assay',\n",
       "   'Trolox Equivalence Antioxidant Capacity Assay'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072258': {'ID': 'D000072258',\n",
       "  'name': 'Hipóxia Tumoral[Tumor Hypoxia]',\n",
       "  'scope': 'Hypoxic conditions in tumor cells due to the tumor outgrowing its blood supply. It is associated with increased METASTASIS and resistance to RADIOTHERAPY and DRUG THERAPY.',\n",
       "  'terms': ['Cell Hypoxia, Tumor',\n",
       "   'Cell Hypoxias, Tumor',\n",
       "   'Hipóxia Tumoral',\n",
       "   'Hipóxia da Célula Tumoral',\n",
       "   'Hipóxia do Tumor',\n",
       "   'Hypoxia, Tumor',\n",
       "   'Hypoxia, Tumor Cell',\n",
       "   'Hypoxias, Tumor',\n",
       "   'Hypoxias, Tumor Cell',\n",
       "   'Tumor Cell Hypoxia',\n",
       "   'Tumor Cell Hypoxias',\n",
       "   'Tumor Hypoxia',\n",
       "   'Tumor Hypoxias'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072259': {'ID': 'D000072259',\n",
       "  'name': 'Conexina 26[Connexin 26]',\n",
       "  'scope': 'A gap junction protein encoded by the Gap Junction Beta 2 or GJB2 gene. In the cochlea and epidermis, its hexamers form channels between cells that open to allow cell-to-cell diffusion of small molecules as well as recycling of potassium. Mutations in Connexin 26 are associated with congenital SENSORINEURAL HEARING LOSS.',\n",
       "  'terms': ['26, Connexin',\n",
       "   'Conexina 26',\n",
       "   'Conexina Cx26',\n",
       "   'Conexina beta 2',\n",
       "   'Conexina beta-2',\n",
       "   'Connexin 26',\n",
       "   'Connexin Cx26',\n",
       "   'Connexin beta 2',\n",
       "   'Connexin beta-2',\n",
       "   'Connexin, beta2',\n",
       "   'Cx26, Connexin',\n",
       "   'Gap Junction beta 2 protein',\n",
       "   'Gap Junction beta-2 protein',\n",
       "   'Proteína beta-2 das Junções Gap',\n",
       "   'beta-2, Connexin',\n",
       "   'beta2 Connexin'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072260': {'ID': 'D000072260',\n",
       "  'name': 'Fatores de Processamento de RNA[RNA Splicing Factors]',\n",
       "  'scope': 'RNA-binding proteins that facilitate or inhibit RNA SPLICING.',\n",
       "  'terms': ['Factors, RNA Splicing',\n",
       "   'Factors, Splicing',\n",
       "   'Fatores de Processamento',\n",
       "   'Fatores de Processamento de RNA',\n",
       "   'Fatores de Processamento do RNA',\n",
       "   'Fatores de Splicing',\n",
       "   'Fatores de Splicing de RNA',\n",
       "   'Fatores de Splicing do RNA',\n",
       "   'RNA Splicing Factors',\n",
       "   'Splicing Factors',\n",
       "   'Splicing Factors, RNA'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072261': {'ID': 'D000072261',\n",
       "  'name': 'Proteínas Desgrenhadas[Dishevelled Proteins]',\n",
       "  'scope': 'A family of proteins that are key components of the WNT SIGNALING PATHWAY, where they function downstream of FRIZZLED RECEPTORS. They contain an N-terminal dishevelled-AXIN PROTEIN (DIX) domain, which mediates oligomerization; a central PDZ DOMAIN which binds to the frizzled receptor; and a C-terminal DEP domain which facilitates binding to the CELL MEMBRANE. Dishevelled proteins have important functions in CELL DIFFERENTIATION and establishing CELL POLARITY.',\n",
       "  'terms': ['Dishevelled 1 Protein',\n",
       "   'Dishevelled 2 Protein',\n",
       "   'Dishevelled 3 Protein',\n",
       "   'Dishevelled Protein',\n",
       "   'Dishevelled Proteins',\n",
       "   'Dishevelled-1 Protein',\n",
       "   'Dishevelled-2 Protein',\n",
       "   'Dishevelled-3 Protein',\n",
       "   'Proteína Desgrenhada',\n",
       "   'Proteína Desgrenhada-1',\n",
       "   'Proteína Desgrenhada-2',\n",
       "   'Proteína Desgrenhada-3',\n",
       "   'Proteína Dishevelled-1',\n",
       "   'Proteína Dishevelled-2',\n",
       "   'Proteína Dishevelled-3',\n",
       "   'Proteínas Desgrenhadas',\n",
       "   'Proteínas Dishevelled'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072263': {'ID': 'D000072263',\n",
       "  'name': 'Instalações Privadas[Private Facilities]',\n",
       "  'scope': 'Places designed, built, or installed to provide for a specific, non-medical function or service used by a specific, restricted group of persons.',\n",
       "  'terms': ['Facilities, Private',\n",
       "   'Facility, Private',\n",
       "   'Instalações Privadas',\n",
       "   'Private Facilities',\n",
       "   'Private Facility'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072264': {'ID': 'D000072264',\n",
       "  'name': 'Instalações Esportivas e Recreacionais[Sports and Recreational Facilities]',\n",
       "  'scope': 'Places designed, built, or installed for LEISURE ACTIVITIES outside of the home.',\n",
       "  'terms': ['Instalações Esportivas e Recreacionais',\n",
       "   'Instalações Recreacionais e Esportivas',\n",
       "   'Instalações Recreativas e Esportivas',\n",
       "   'Instalações de Recreação e Esportes',\n",
       "   'Instalações para Esporte e Recreação',\n",
       "   'Sports and Recreational Facilities'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072277': {'ID': 'D000072277',\n",
       "  'name': 'Pressões Respiratórias Máximas[Maximal Respiratory Pressures]',\n",
       "  'scope': \"A respiratory function test that includes the maximal inspiratory pressure and maximal expiratory pressure. It is determined by SPIROMETRY that measures the patient's RESIDUAL VOLUME and TOTAL LUNG CAPACITY and assesses the strength of RESPIRATORY MUSCLES.\",\n",
       "  'terms': ['Expiratory Pressure, Maximal',\n",
       "   'Expiratory Pressure, Maximum',\n",
       "   'Expiratory Pressures, Maximal',\n",
       "   'Expiratory Pressures, Maximum',\n",
       "   'Inspiratory Pressure, Maximal',\n",
       "   'Inspiratory Pressure, Maximum',\n",
       "   'Inspiratory Pressures, Maximal',\n",
       "   'Inspiratory Pressures, Maximum',\n",
       "   'Maximal Expiratory Pressure',\n",
       "   'Maximal Expiratory Pressures',\n",
       "   'Maximal Inspiratory Pressure',\n",
       "   'Maximal Inspiratory Pressures',\n",
       "   'Maximal Respiratory Pressure',\n",
       "   'Maximal Respiratory Pressures',\n",
       "   'Maximum Expiratory Pressure',\n",
       "   'Maximum Expiratory Pressures',\n",
       "   'Maximum Inspiratory Pressure',\n",
       "   'Maximum Inspiratory Pressures',\n",
       "   'Maximum Respiratory Pressure',\n",
       "   'Maximum Respiratory Pressures',\n",
       "   'Pressure, Maximal Expiratory',\n",
       "   'Pressure, Maximal Inspiratory',\n",
       "   'Pressure, Maximal Respiratory',\n",
       "   'Pressure, Maximum Expiratory',\n",
       "   'Pressure, Maximum Inspiratory',\n",
       "   'Pressure, Maximum Respiratory',\n",
       "   'Pressures, Maximal Expiratory',\n",
       "   'Pressures, Maximal Inspiratory',\n",
       "   'Pressures, Maximal Respiratory',\n",
       "   'Pressures, Maximum Expiratory',\n",
       "   'Pressures, Maximum Inspiratory',\n",
       "   'Pressures, Maximum Respiratory',\n",
       "   'Pressão Expiratória Máxima',\n",
       "   'Pressão Inspiratória Máxima',\n",
       "   'Pressão Máxima Expiratória',\n",
       "   'Pressão Máxima Inspiratória',\n",
       "   'Pressão Máxima Respiratória',\n",
       "   'Pressão Respiratória Máxima',\n",
       "   'Pressões Máximas Respiratórias',\n",
       "   'Pressões Respiratórias Máximas',\n",
       "   'Respiratory Pressure, Maximal',\n",
       "   'Respiratory Pressure, Maximum',\n",
       "   'Respiratory Pressures, Maximal',\n",
       "   'Respiratory Pressures, Maximum'],\n",
       "  'qualifier': 'methods'},\n",
       " 'D000072278': {'ID': 'D000072278',\n",
       "  'name': 'Proteína Forkhead Box M1[Forkhead Box Protein M1]',\n",
       "  'scope': 'A forkhead box transcription factor that is expressed primarily in adult organs which contain proliferating cells such as the thymus, testis, ovary, and small intestine. It controls the expression of CELL CYCLE genes essential for DNA REPLICATION and MITOSIS, and also functions in DNA REPAIR.',\n",
       "  'terms': ['FOXM1 Protein',\n",
       "   'Forkhead Box Protein M1',\n",
       "   'Proteína FOXM1',\n",
       "   'Proteína Forkhead Box M1'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " 'D000072280': {'ID': 'D000072280',\n",
       "  'name': 'Bactérias Termodúricas[Bacteria, Thermoduric]',\n",
       "  'scope': 'Bacteria resistant to high temperatures, as in PASTEURIZATION.',\n",
       "  'terms': ['Bacteria, Thermoduric',\n",
       "   'Bactérias Termodúricas',\n",
       "   'Thermoduric Bacteria'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072281': {'ID': 'D000072281',\n",
       "  'name': 'Linfadenopatia[Lymphadenopathy]',\n",
       "  'scope': 'Disease of LYMPH NODES which are abnormal in size, number or consistency.',\n",
       "  'terms': ['<i>adenomegalia</i>',\n",
       "   '<i>adenopatia</i>',\n",
       "   '<i>linfadenomegalia</i>',\n",
       "   '<i>linfadenomegalia</i>',\n",
       "   '<i>linfadenopatia</i>',\n",
       "   '<i>linfoadenomegalia</i>',\n",
       "   '<i>linfoadenomegalia</i>',\n",
       "   '<i>nodulacao</i>',\n",
       "   'Adenopathies',\n",
       "   'Adenopathy',\n",
       "   'Adenopatia',\n",
       "   'Linfadenopatia',\n",
       "   'Lymphadenopathies',\n",
       "   'Lymphadenopathy'],\n",
       "  'qualifier': 'diagnosis'},\n",
       " 'D000072282': {'ID': 'D000072282',\n",
       "  'name': 'Escherichia coli Extraintestinal Patogênica[Extraintestinal Pathogenic Escherichia coli]',\n",
       "  'scope': 'Strains of Escherichia coli that possess virulence traits which allow them to invade, colonize, and induce disease in tissues outside of the GASTROINTESTINAL TRACT. They are a cause of URINARY TRACT INFECTIONS (UROPATHOGENIC ESCHERICHIA COLI); neonatal MENINGITIS; SEPSIS; PNEUMONIA; and SURGICAL WOUND INFECTION.',\n",
       "  'terms': ['<i>espectoracao</i>',\n",
       "   '<i>espectoracao</i>',\n",
       "   'E. coli Extraintestinal Patogênica',\n",
       "   'Escherichia coli Extraintestinal Patogênica',\n",
       "   'ExPEC',\n",
       "   'ExPEC',\n",
       "   'Extraintestinal Pathogenic E. coli',\n",
       "   'Extraintestinal Pathogenic Escherichia coli'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072283': {'ID': 'D000072283',\n",
       "  'name': 'Células A549[A549 Cells]',\n",
       "  'scope': 'An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION.',\n",
       "  'terms': ['A549 Cell',\n",
       "   'A549 Cell Line',\n",
       "   'A549 Cell Lines',\n",
       "   'A549 Cells',\n",
       "   'Cell Line, A549',\n",
       "   'Cell Lines, A549',\n",
       "   'Cell, A549',\n",
       "   'Cells, A549',\n",
       "   'Células A549',\n",
       "   'Linhagem Celular A549'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072296': {'ID': 'D000072296',\n",
       "  'name': 'Aparelho Sanitário[Bathroom Equipment]',\n",
       "  'scope': 'Receptacles used for collection of human excrement.',\n",
       "  'terms': ['<i>cumadre</i>',\n",
       "   'Aparelho Sanitário',\n",
       "   'Bacias Sanitárias',\n",
       "   'Banheiras',\n",
       "   'Bathroom Equipment',\n",
       "   'Bathroom Equipments',\n",
       "   'Bedpan',\n",
       "   'Bedpans',\n",
       "   'Bidê',\n",
       "   'Comadre',\n",
       "   'Comadres',\n",
       "   'Commode',\n",
       "   'Commodes',\n",
       "   'Duchas',\n",
       "   'Equipamento de Banheiro',\n",
       "   'Equipment, Bathroom',\n",
       "   'Equipments, Bathroom',\n",
       "   'Louça Sanitária',\n",
       "   'Mictórios',\n",
       "   'Pias',\n",
       "   'Privadas',\n",
       "   'Urinal',\n",
       "   'Urinals',\n",
       "   'Urinóis',\n",
       "   'Vasos Sanitários'],\n",
       "  'qualifier': '#'},\n",
       " 'D000072316': {'ID': 'D000072316',\n",
       "  'name': 'Dioxinas e Compostos Semelhantes a Dioxinas[Dioxins and Dioxin-like Compounds]',\n",
       "  'scope': 'A group of toxic chemical compounds that share chemical structures and biological characteristics that are related to the potent carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin.',\n",
       "  'terms': ['Dioxinas e Compostos Semelhantes a Dioxinas',\n",
       "   'Dioxins and Dioxin like Compounds',\n",
       "   'Dioxins and Dioxin-like Compounds'],\n",
       "  'qualifier': 'pharmacology'},\n",
       " ...}"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dictMesh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "strr = \"meu[nome]\"\n",
    "strr = strr.replace('[', ' [')\n",
    "print(strr)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[0, 1, 2, 3, 4]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "eu = list(range(5))\n",
    "eu"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
